"","query","baseMean","log2FoldChange","lfcSE","pvalue","padj","blast_hit","evalue","ProteinNames","BiologicalProcess","GeneOntologyIDs","CellularComponent","MolecularFunction"
"1","Pocillopora_acuta_HIv2___RNAseq.g6351.t1",1780.06230928926,6.56357753057818,0.681219343726763,2.94893425547218e-24,4.26533850711496e-20,"B3EWY8",8.79e-09,"Skeletal aspartic acid-rich protein 2","","GO:0016020","membrane [GO:0016020]",""
"2","Pocillopora_acuta_HIv2___RNAseq.g28575.t1a",2844.3905409903,-17.6339071318262,4.14952775413278,4.38092456532403e-20,3.16828464564234e-16,"G5EBQ8",7.13e-107,"Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)","cell wall chitin biosynthetic process [GO:0006038]; chitin biosynthetic process [GO:0006031]; positive regulation of nematode larval development [GO:0061063]","GO:0004100; GO:0005886; GO:0006031; GO:0006038; GO:0030428; GO:0061063; GO:0071944","cell periphery [GO:0071944]; cell septum [GO:0030428]; plasma membrane [GO:0005886]","chitin synthase activity [GO:0004100]"
"3","Pocillopora_acuta_HIv2___RNAseq.g27038.t1",1882.71411858623,-16.9202428308059,3.9804471967516,1.68085400573769e-19,8.10395744632998e-16,"P24383",4.23e-13,"Protein Wnt-7a","angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; asymmetric protein localization involved in cell fate determination [GO:0045167]; canonical Wnt signaling pathway [GO:0060070]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cell proliferation in forebrain [GO:0021846]; cell-cell signaling [GO:0007267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system vasculogenesis [GO:0022009]; cerebellar granule cell differentiation [GO:0021707]; chondrocyte differentiation [GO:0002062]; dendritic spine morphogenesis [GO:0060997]; dorsal/ventral pattern formation [GO:0009953]; embryonic axis specification [GO:0000578]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; establishment of blood-brain barrier [GO:0060856]; establishment of cell polarity [GO:0030010]; limb development [GO:0060173]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neurogenesis [GO:0050768]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; non-canonical Wnt signaling pathway [GO:0035567]; oviduct development [GO:0060066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of excitatory synapse assembly [GO:1904891]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of axon diameter [GO:0031133]; regulation of axonogenesis [GO:0050770]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; secondary palate development [GO:0062009]; signal transduction [GO:0007165]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; stem cell development [GO:0048864]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; uterus development [GO:0060065]; uterus morphogenesis [GO:0061038]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing, spreading of epidermal cells [GO:0035313]","GO:0000578; GO:0001502; GO:0001525; GO:0002062; GO:0005102; GO:0005109; GO:0005125; GO:0005615; GO:0005788; GO:0006915; GO:0007165; GO:0007267; GO:0007269; GO:0007416; GO:0008284; GO:0009887; GO:0009953; GO:0009986; GO:0010595; GO:0010628; GO:0014719; GO:0014834; GO:0016055; GO:0021707; GO:0021846; GO:0022009; GO:0030010; GO:0030182; GO:0030326; GO:0031012; GO:0031133; GO:0032355; GO:0035019; GO:0035115; GO:0035116; GO:0035313; GO:0035567; GO:0042127; GO:0042733; GO:0043066; GO:0043627; GO:0045165; GO:0045167; GO:0045893; GO:0045944; GO:0046330; GO:0048103; GO:0048864; GO:0050678; GO:0050768; GO:0050770; GO:0050808; GO:0051216; GO:0051247; GO:0051965; GO:0060054; GO:0060065; GO:0060066; GO:0060070; GO:0060071; GO:0060173; GO:0060856; GO:0060997; GO:0061038; GO:0062009; GO:0071560; GO:0098685; GO:0098793; GO:0098978; GO:0099175; GO:1904891; GO:1905606; GO:2000300; GO:2000463","cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]","cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; signaling receptor binding [GO:0005102]"
"4","Pocillopora_acuta_HIv2___RNAseq.g2165.t1",1608.73918294661,-16.6746947195441,3.94518940435688,3.93557491195378e-19,1.22992044988348e-15,"Q9CXI3",9.57e-14,"DBH-like monooxygenase protein 1 (EC 1.14.17.-) (DBH-related protein) (Monooxygenase X)","dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]","GO:0004500; GO:0005507; GO:0005615; GO:0005789; GO:0006589; GO:0030667; GO:0042420; GO:0042421","endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; secretory granule membrane [GO:0030667]","copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]"
"5","Pocillopora_acuta_HIv2___TS.g18104.t1",1967.6090074664,-16.9318271063564,4.00057993657467,4.25166084721889e-19,1.22992044988348e-15,"P51029",7.78e-22,"Protein Wnt-8b","canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]; Wnt signaling pathway [GO:0016055]","GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0016055; GO:0021854; GO:0021879; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679","extracellular space [GO:0005615]","cytokine activity [GO:0005125]; frizzled binding [GO:0005109]"
"6","Pocillopora_acuta_HIv2___RNAseq.g14330.t3",2168.32101516159,16.3859028551501,3.71164199181217,6.70801192648671e-19,1.6170780750784e-15,"B8V7S0",6.57e-97,"CUB and peptidase domain-containing protein 1","acrosome reaction [GO:0007340]; proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508; GO:0007340","extracellular region [GO:0005576]","serine-type endopeptidase activity [GO:0004252]"
"7","Pocillopora_acuta_HIv2___RNAseq.g14090.t1",2027.22358063107,16.3370954212537,3.73834279607386,1.10295460143436e-18,2.12639546111904e-15,"G8HTB6",3.49e-20,"ZP domain-containing protein","","GO:0016020","membrane [GO:0016020]",""
"8","Pocillopora_acuta_HIv2___RNAseq.g14025.t1",2533.20105807112,16.5084028067417,3.78273122811433,1.17610368424726e-18,2.12639546111904e-15,NA,NA,NA,NA,NA,NA,NA
"9","Pocillopora_acuta_HIv2___RNAseq.g3832.t1",4681.36281946371,-12.4785131185064,2.35137496049029,5.40689841764502e-18,8.33689389499862e-15,"Q566X8",1.47e-36,"Diencephalon/mesencephalon homeobox protein 1-B","midbrain development [GO:0030901]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007346; GO:0030901; GO:0050767; GO:0051726; GO:0060041; GO:0061074","nucleus [GO:0005634]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"
"10","Pocillopora_acuta_HIv2___RNAseq.g8006.t1",1858.29368115358,16.1020452357264,3.77433853368534,5.77908626071355e-18,8.33689389499862e-15,NA,NA,NA,NA,NA,NA,NA
"11","Pocillopora_acuta_HIv2___RNAseq.g10378.t1",1200.09323446445,-16.2905649470886,3.9472514948705,6.34028158496853e-18,8.33689389499862e-15,"P22897",1.35e-39,"Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)","cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898]","GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353","cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886]","cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]"
"12","Pocillopora_acuta_HIv2___RNAseq.g14253.t1",1084.62610850225,-16.0445141663487,3.90624809872933,1.44591542596939e-17,1.74281006010177e-14,"Q96RW7",2.16e-33,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711","adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927]","calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]"
"13","Pocillopora_acuta_HIv2___RNAseq.g25431.t1",3378.81007684284,11.7319188755944,1.97006026347116,1.71090818491944e-17,1.82222793824338e-14,NA,NA,NA,NA,NA,NA,NA
"14","Pocillopora_acuta_HIv2___RNAseq.11056_t",1574.73889068724,15.8057091878608,3.68465160304805,1.76377151102097e-17,1.82222793824338e-14,NA,NA,NA,NA,NA,NA,NA
"15","Pocillopora_acuta_HIv2___RNAseq.g9588.t1",10129.8808156182,-12.6358761317567,2.8793424977771,1.99827164291061e-17,1.92686673620393e-14,"Q9PT61",6.33e-42,"Homeobox protein otx5-B (Orthodenticle homolog 5-B) (XOtx5b)","anterior/posterior pattern specification [GO:0009952]; eye photoreceptor cell fate commitment [GO:0042706]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000981; GO:0003677; GO:0005634; GO:0009952; GO:0042706; GO:0045944","nucleus [GO:0005634]","DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"
"16","Pocillopora_acuta_HIv2___TS.g30765.t1",1392.70364464146,-16.4413507058493,3.9888596577921,2.48455417397371e-17,2.24603697327223e-14,NA,NA,NA,NA,NA,NA,NA
"17","Pocillopora_acuta_HIv2___RNAseq.g14021.t1",1390.28685695327,15.62032217994,3.65440546495719,3.16359309782072e-17,2.69165944511052e-14,"G8HTB6",2.38e-12,"ZP domain-containing protein","","GO:0016020","membrane [GO:0016020]",""
"18","Pocillopora_acuta_HIv2___RNAseq.g19082.t1",922.112612153853,-15.8532165339263,3.89716880614919,5.07623846516481e-17,4.07903962000799e-14,NA,NA,NA,NA,NA,NA,NA
"19","Pocillopora_acuta_HIv2___RNAseq.g16202.t1",815.958547797283,-11.1060230459068,1.74359130212172,8.67494435822886e-17,6.60391553670643e-14,"Q9GZX3",1.09e-27,"Carbohydrate sulfotransferase 6 (Corneal N-acetylglucosamine-6-O-sulfotransferase) (C-GlcNAc6ST) (hCGn6ST) (EC 2.8.2.21) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-beta) (GST4-beta) (N-acetylglucosamine 6-O-sulfotransferase 5) (GlcNAc6ST-5) (Gn6st-5)","carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]","GO:0000139; GO:0001517; GO:0005794; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0018146; GO:0045130","Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]","keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]"
"20","Pocillopora_acuta_HIv2___TS.g19991.t2",950.24838269187,-15.8491231512087,3.91178478944968,1.16788102292082e-16,8.44611555776339e-14,NA,NA,NA,NA,NA,NA,NA
"21","Pocillopora_acuta_HIv2___RNAseq.g20860.t1",1265.2742161805,15.4983338823397,3.71895345249693,1.36647273022806e-16,9.41174360477082e-14,"Q01528",3.72e-11,"Hemagglutinin/amebocyte aggregation factor (18K-LAF)","collagen fibril organization [GO:0030199]","GO:0005615; GO:0030199; GO:0031012","extracellular matrix [GO:0031012]; extracellular space [GO:0005615]",""
"22","Pocillopora_acuta_HIv2___RNAseq.g8588.t1",783.119333561871,-15.6153127172643,3.9051028378868,2.20218782440551e-16,1.44783839510006e-13,"B3EWZ3",3.14e-104,"Coadhesin","","GO:0016020","membrane [GO:0016020]",""
"23","Pocillopora_acuta_HIv2___RNAseq.g26604.t1",3789.9648726559,-12.2911287548329,2.53919350422493,2.56009090762896e-16,1.60996325599762e-13,"Q9GLK0",3.7e-171,"Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1)","keratinization [GO:0031424]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]","GO:0003810; GO:0010838; GO:0016020; GO:0031424; GO:0045787; GO:0046872","membrane [GO:0016020]","metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]"
"24","Pocillopora_acuta_HIv2___TS.g27642.t1b",1146.75164624353,15.3047542211401,3.68533039362666,2.75843775108153e-16,1.61929485543386e-13,"P15535",1.41e-89,"Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1]","acute inflammatory response [GO:0002526]; angiogenesis involved in wound healing [GO:0060055]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; development of secondary sexual characteristics [GO:0045136]; epithelial cell development [GO:0002064]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]; galactose metabolic process [GO:0006012]; glycoprotein biosynthetic process [GO:0009101]; lactose biosynthetic process [GO:0005989]; lipid metabolic process [GO:0006629]; macrophage migration [GO:1905517]; negative regulation of epithelial cell proliferation [GO:0050680]; oligosaccharide biosynthetic process [GO:0009312]; penetration of zona pellucida [GO:0007341]; positive regulation of apoptotic process [GO:0043065]; positive regulation of circulating fibrinogen levels [GO:0061755]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; regulation of acrosome reaction [GO:0060046]; wound healing [GO:0042060]","GO:0000138; GO:0002064; GO:0002526; GO:0003831; GO:0003945; GO:0004461; GO:0005576; GO:0005794; GO:0005886; GO:0005989; GO:0006012; GO:0006486; GO:0006487; GO:0006629; GO:0007155; GO:0007339; GO:0007341; GO:0008092; GO:0008283; GO:0008378; GO:0009101; GO:0009312; GO:0009897; GO:0009986; GO:0016323; GO:0030057; GO:0030145; GO:0030175; GO:0030198; GO:0031526; GO:0032580; GO:0032991; GO:0042060; GO:0043065; GO:0045136; GO:0050673; GO:0050680; GO:0060046; GO:0060054; GO:0060055; GO:0061755; GO:1905517","basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; desmosome [GO:0030057]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi trans cisterna [GO:0000138]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]","beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; cytoskeletal protein binding [GO:0008092]; galactosyltransferase activity [GO:0008378]; lactose synthase activity [GO:0004461]; manganese ion binding [GO:0030145]; N-acetyllactosamine synthase activity [GO:0003945]"
"25","Pocillopora_acuta_HIv2___TS.g18100.t1",8027.26641448667,-10.5325438014964,1.84962012085678,2.79883651727368e-16,1.61929485543386e-13,"P51029",2.52e-27,"Protein Wnt-8b","canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]; Wnt signaling pathway [GO:0016055]","GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0016055; GO:0021854; GO:0021879; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679","extracellular space [GO:0005615]","cytokine activity [GO:0005125]; frizzled binding [GO:0005109]"
"26","Pocillopora_acuta_HIv2___RNAseq.g11588.t1",1254.25173047322,15.4166828681569,3.76196879269536,3.03484072475244e-16,1.68830524010843e-13,"B3EWY9",3.43e-26,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020","extracellular space [GO:0005615]; membrane [GO:0016020]","calcium ion binding [GO:0005509]"
"27","Pocillopora_acuta_HIv2___RNAseq.g25327.t1",1008.53047685861,11.8473784633747,1.96479267941957,3.8823782162128e-16,2.07980438960378e-13,"Q13887",2.02e-24,"Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2)","angiogenesis [GO:0001525]; cell-cell signaling via exosome [GO:0099156]; cellular response to leukemia inhibitory factor [GO:1990830]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816]","GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005654; GO:0005667; GO:0005794; GO:0006357; GO:0014816; GO:0014901; GO:0014908; GO:0030033; GO:0032534; GO:0043231; GO:0043426; GO:0045600; GO:0045944; GO:0046872; GO:0060576; GO:0061586; GO:0099156; GO:1902895; GO:1990830; GO:1990837","chromatin [GO:0000785]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; MRF binding [GO:0043426]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"
"28","Pocillopora_acuta_HIv2___RNAseq.g12281.t1",740.060962879886,-15.5067090837299,3.90148721466202,4.05396384464339e-16,2.09416189460436e-13,"P10586",7.23e-48,"Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR)","cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; negative regulation of receptor binding [GO:1900121]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of axon regeneration [GO:0048679]; synaptic membrane adhesion [GO:0099560]","GO:0004721; GO:0004725; GO:0005001; GO:0005886; GO:0007155; GO:0007185; GO:0008201; GO:0016477; GO:0031102; GO:0035335; GO:0035373; GO:0043005; GO:0043025; GO:0044877; GO:0048679; GO:0050839; GO:0070062; GO:0099560; GO:1900121","extracellular exosome [GO:0070062]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]","cell adhesion molecule binding [GO:0050839]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparin binding [GO:0008201]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
"29","Pocillopora_acuta_HIv2___RNAseq.g19085.t1",6069.90203768671,-11.0481230041545,2.0886102257513,4.61308551202408e-16,2.22412229486388e-13,"Q18DN4",2.43e-08,"Halomucin","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0005509; GO:0005576; GO:0007156; GO:0016020; GO:0030246","extracellular region [GO:0005576]; membrane [GO:0016020]","calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]"
"30","Pocillopora_acuta_HIv2___TS.g11360.t1",727.48293499131,-11.289081247624,1.83373701733755,4.95034924323213e-16,2.30973714368095e-13,NA,NA,NA,NA,NA,NA,NA
"31","Pocillopora_acuta_HIv2___RNAseq.g7803.t1",953.479854409614,15.0579469889864,3.61974780421182,5.74994399605745e-16,2.59897468621797e-13,"Q21305",1.37e-40,"Transcription factor sox-2","neuron differentiation [GO:0030182]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000977; GO:0000978; GO:0001228; GO:0005634; GO:0030182; GO:0045944; GO:0048665","nucleus [GO:0005634]","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"
"32","Pocillopora_acuta_HIv2___TS.g16008.t2",945.362231842888,15.0343277199068,3.62487264713676,6.07564309150005e-16,2.66297277804414e-13,"Q40778",1.37e-29,"Allene oxide synthase (EC 4.2.1.92) (Cytochrome P450 74A2) (Rubber particle protein) (RPP)","fatty acid biosynthetic process [GO:0006633]; oxylipin biosynthetic process [GO:0031408]","GO:0004497; GO:0005506; GO:0006633; GO:0009978; GO:0016705; GO:0020037; GO:0031408","","allene oxide synthase activity [GO:0009978]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"
"33","Pocillopora_acuta_HIv2___RNAseq.g22978.t3b",946.258537376439,15.0577107662656,3.64561803202333,7.39273316433192e-16,3.14495566143814e-13,NA,NA,NA,NA,NA,NA,NA
"34","Pocillopora_acuta_HIv2___RNAseq.g2406.t1",916.583525243243,15.0064266145823,3.62371896783477,8.17944371593904e-16,3.38021354020978e-13,NA,NA,NA,NA,NA,NA,NA
"35","Pocillopora_acuta_HIv2___RNAseq.g8119.t1",933.904971969952,15.0416546061331,3.63087837891924,8.61938244023793e-16,3.4630763226556e-13,NA,NA,NA,NA,NA,NA,NA
"36","Pocillopora_acuta_HIv2___TS.g9414.t1",1170.47134434928,15.4251745387749,3.7869541579057,9.71413742665974e-16,3.79744010105963e-13,"Q8BFR2",2.36e-58,"Follistatin-related protein 5 (Follistatin-like protein 5) (m-D/Bsp120I 1-2)","cell differentiation [GO:0030154]; regulation of BMP signaling pathway [GO:0030510]","GO:0005509; GO:0005576; GO:0030154; GO:0030510","extracellular region [GO:0005576]","calcium ion binding [GO:0005509]"
"37","Pocillopora_acuta_HIv2___RNAseq.g21374.t1",755.981336839023,10.2527357794183,1.63480679667673,1.64263770821997e-15,6.25239784518253e-13,NA,NA,NA,NA,NA,NA,NA
"38","Pocillopora_acuta_HIv2___RNAseq.g21000.t1",1227.75708253182,15.3794967604334,3.69854626417931,1.74863778356005e-15,6.48520433369553e-13,"G8HTB6",7.06e-32,"ZP domain-containing protein","","GO:0016020","membrane [GO:0016020]",""
"39","Pocillopora_acuta_HIv2___RNAseq.g5252.t1",685.237729174062,11.5969262649098,1.94835156403564,1.8654799813674e-15,6.72210967089134e-13,"Q00168",4.64e-72,"Calcium/calmodulin-dependent protein kinase type II alpha chain (CaM-kinase II alpha chain) (EC 2.7.11.17)","cellular response to starvation [GO:0009267]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cytokine production [GO:0001818]; negative regulation of lipid storage [GO:0010888]; neuromuscular junction development [GO:0007528]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; regulation of filopodium assembly [GO:0051489]; regulation of ovulation [GO:0060278]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]","GO:0001818; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005737; GO:0007268; GO:0007528; GO:0007611; GO:0007616; GO:0007619; GO:0008049; GO:0008582; GO:0009267; GO:0010888; GO:0030424; GO:0030425; GO:0032226; GO:0043005; GO:0045211; GO:0048786; GO:0051489; GO:0060278; GO:0106310; GO:2001234","axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]","ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]"
"40","Pocillopora_acuta_HIv2___RNAseq.g22853.t1",8612.30390232864,11.1479439185155,2.14634834160287,1.90546526898883e-15,6.72210967089134e-13,NA,NA,NA,NA,NA,NA,NA
"41","Pocillopora_acuta_HIv2___RNAseq.g17117.t1",1037.72978148286,14.9703947128071,3.6198624001064,2.20161878626952e-15,7.58195574395293e-13,"O19132",0,"Nitric oxide synthase 1 (EC 1.14.13.39) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Nitric oxide synthase, brain) (bNOS) (Peptidyl-cysteine S-nitrosylase NOS1)","nitric oxide biosynthetic process [GO:0006809]","GO:0004517; GO:0005516; GO:0006809; GO:0010181; GO:0020037; GO:0042383; GO:0043197; GO:0046872; GO:0050660; GO:0050661","dendritic spine [GO:0043197]; sarcolemma [GO:0042383]","calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]"
"42","Pocillopora_acuta_HIv2___TS.g16802.t1",3444.71837581509,10.752975556763,2.00020202877161,2.39917921208103e-15,7.93495143278663e-13,NA,NA,NA,NA,NA,NA,NA
"43","Pocillopora_acuta_HIv2___RNAseq.g25759.t1",808.98861100082,14.7788506363656,3.61123805426592,2.41384031417735e-15,7.93495143278663e-13,"Q27128",0,"Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase (PAPS synthase) (PAPS synthetase) (PAPSS) (Sulfurylase kinase) (SK) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)]","3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; sulfate assimilation [GO:0000103]","GO:0000103; GO:0004020; GO:0004781; GO:0005524; GO:0016779; GO:0050428","","adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781]"
"44","Pocillopora_acuta_HIv2___RNAseq.30415_t",893.176357470135,15.0123292043432,3.67814436797802,3.11455554886486e-15,9.94555914776152e-13,"Q6XYQ8",9.54e-39,"Synaptotagmin-10 (Synaptotagmin X) (SytX)","calcium-ion regulated exocytosis [GO:0017156]; chemical synaptic transmission [GO:0007268]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; sensory perception of smell [GO:0007608]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0007608; GO:0017156; GO:0030276; GO:0030658; GO:0042803; GO:0045956; GO:0046982; GO:0070382; GO:0098793; GO:0098978","exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; transport vesicle membrane [GO:0030658]","calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]"
"45","Pocillopora_acuta_HIv2___RNAseq.g24120.t1",770.649944734318,14.7451852409899,3.60873514035789,3.16299585728035e-15,9.94555914776152e-13,"Q862Z3",4.51e-46,"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829]; neutrophil migration [GO:1990266]","GO:0000922; GO:0005509; GO:0005615; GO:0005929; GO:0009986; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367; GO:1990266","apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular space [GO:0005615]; membrane [GO:0016020]; side of membrane [GO:0098552]; spindle pole [GO:0000922]","calcium ion binding [GO:0005509]"
"46","Pocillopora_acuta_HIv2___RNAseq.g14336.t1",765.622505305614,14.7730606729719,3.63952115566365,3.99814142536626e-15,1.23040675694676e-12,"B8V7S0",9.84e-94,"CUB and peptidase domain-containing protein 1","acrosome reaction [GO:0007340]; proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508; GO:0007340","extracellular region [GO:0005576]","serine-type endopeptidase activity [GO:0004252]"
"47","Pocillopora_acuta_HIv2___RNAseq.g26594.t2",3371.39523172936,13.8886527413258,3.282610267476,4.793602042259e-15,1.44447208206738e-12,"Q90632",4.11e-37,"Monocarboxylate transporter 3 (MCT 3) (Retinal epithelial membrane protein) (Solute carrier family 16 member 8)","monocarboxylic acid transport [GO:0015718]","GO:0005886; GO:0008028; GO:0015293; GO:0015718; GO:0016323","basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]","monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]"
"48","Pocillopora_acuta_HIv2___TS.g4983.t1",908.847886315208,-15.7568391540039,4.03533426581233,6.23050883080124e-15,1.82805731047726e-12,"Q9CZV8",7e-18,"F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like)","behavioral fear response [GO:0001662]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]","GO:0001662; GO:0005737; GO:0019005; GO:0031146; GO:0045202; GO:0098685; GO:0098793; GO:0098978; GO:0099575; GO:2000300","cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; SCF ubiquitin ligase complex [GO:0019005]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]",""
"49","Pocillopora_acuta_HIv2___RNAseq.g19115.t1",990.626313025877,10.4580911096879,1.82175872539878,6.31933528234673e-15,1.82805731047726e-12,"Q8NB59",7.09e-20,"Synaptotagmin-14 (Synaptotagmin XIV) (SytXIV)","","GO:0005543; GO:0016020","membrane [GO:0016020]","phospholipid binding [GO:0005543]"
"50","Pocillopora_acuta_HIv2___RNAseq.g28635.t1",3721.66147975373,13.7961328750219,3.38617482019348,7.78929119445387e-15,2.2009656144803e-12,"Q6P832",0,"Glycine amidinotransferase, mitochondrial (EC 2.1.4.1) (L-arginine:glycine amidinotransferase) (Transamidinase)","creatine biosynthetic process [GO:0006601]","GO:0005743; GO:0006601; GO:0015068","mitochondrial inner membrane [GO:0005743]","glycine amidinotransferase activity [GO:0015068]"
"51","Pocillopora_acuta_HIv2___RNAseq.g25317.t1",2252.95465312817,10.9818472149339,2.31071367689826,7.99232095454377e-15,2.2009656144803e-12,"Q03146",4.64e-09,"Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (Protein-tyrosine kinase MPK-6) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a)","axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell population proliferation [GO:0008283]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; wound healing, spreading of cells [GO:0044319]","GO:0001558; GO:0001952; GO:0005518; GO:0005524; GO:0005886; GO:0005903; GO:0007566; GO:0007595; GO:0008283; GO:0008285; GO:0010715; GO:0010976; GO:0014909; GO:0016323; GO:0038062; GO:0038063; GO:0038083; GO:0043235; GO:0043583; GO:0044319; GO:0046872; GO:0051897; GO:0060444; GO:0060749; GO:0061302; GO:0061564; GO:1990138","basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]","ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein tyrosine kinase collagen receptor activity [GO:0038062]"
"52","Pocillopora_acuta_HIv2___RNAseq.g21373.t1",662.832864169878,14.5145337705983,3.58881515322364,8.064932077396e-15,2.2009656144803e-12,NA,NA,NA,NA,NA,NA,NA
"53","Pocillopora_acuta_HIv2___RNAseq.g7627.t1",764.189970591372,14.6690918274047,3.6519048347241,8.4843479967849e-15,2.27254832269438e-12,"Q6T752",6.86e-13,"Toll-like receptor 2 (CD antigen CD282)","cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; toll-like receptor signaling pathway [GO:0002224]","GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0038023; GO:0042497; GO:0045087; GO:0045121; GO:0061809; GO:0071726; GO:0071727","Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]","NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; triacyl lipopeptide binding [GO:0042497]"
"54","Pocillopora_acuta_HIv2___RNAseq.g9210.t1",701.432652665035,14.3934041041603,3.59094208651907,1.71502415102391e-14,4.51020169461996e-12,NA,NA,NA,NA,NA,NA,NA
"55","Pocillopora_acuta_HIv2___TS.g16384.t1",645.704218748475,14.5260899966506,3.66076460605565,1.94779256929428e-14,5.0308699504058e-12,NA,NA,NA,NA,NA,NA,NA
"56","Pocillopora_acuta_HIv2___RNAseq.g27377.t1",735.340145124758,10.2428920290681,1.7738140585706,2.15264954142657e-14,5.46244262582349e-12,NA,NA,NA,NA,NA,NA,NA
"57","Pocillopora_acuta_HIv2___RNAseq.g13561.t1",640.62448814426,14.4963545568362,3.64744087262271,2.27225436689752e-14,5.52516311826445e-12,NA,NA,NA,NA,NA,NA,NA
"58","Pocillopora_acuta_HIv2___RNAseq.g1102.t1",682.410091221503,14.6023373011392,3.67785720095634,2.28968153358538e-14,5.52516311826445e-12,"Q9EQD2",2.11e-45,"Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor)","cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of MAPK cascade [GO:0043408]","GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0042277; GO:0043408","actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]","neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628]; peptide binding [GO:0042277]"
"59","Pocillopora_acuta_HIv2___RNAseq.g9631.t1",5786.08667327334,14.768504526969,3.15120134018703,2.3174845301231e-14,5.52516311826445e-12,"Q40375",3.73e-56,"Repetitive proline-rich cell wall protein 2","","GO:0005199; GO:0005576","extracellular region [GO:0005576]","structural constituent of cell wall [GO:0005199]"
"60","Pocillopora_acuta_HIv2___RNAseq.g1234.t1",3320.09020492918,-9.86954614336388,2.06377890651705,2.33016420225478e-14,5.52516311826445e-12,NA,NA,NA,NA,NA,NA,NA
"61","Pocillopora_acuta_HIv2___RNAseq.g11659.t1",606.94528410354,14.319183570754,3.59533995509287,2.67332337641821e-14,6.23660472846983e-12,NA,NA,NA,NA,NA,NA,NA
"62","Pocillopora_acuta_HIv2___TS.g1968.t2",570.15481360313,14.2936676995269,3.61121815875118,3.20551903197181e-14,7.35946464737146e-12,NA,NA,NA,NA,NA,NA,NA
"63","Pocillopora_acuta_HIv2___RNAseq.g1126.t1",3758.53930256433,-14.622203591558,3.17967327851235,3.81357666606464e-14,8.61868326530609e-12,"B3EWZ3",7.33e-54,"Coadhesin","","GO:0016020","membrane [GO:0016020]",""
"64","Pocillopora_acuta_HIv2___TS.g21863.t2",714.499186910933,11.5879874040301,2.24883406271559,3.9590184537389e-14,8.80972967921223e-12,NA,NA,NA,NA,NA,NA,NA
"65","Pocillopora_acuta_HIv2___RNAseq.g14484.t1",670.562029806778,14.5542871530708,3.68907256946155,4.69068629530564e-14,1.02797100871668e-11,"Q9JKM7",4.74e-106,"Ras-related protein Rab-37","protein transport [GO:0015031]","GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0015031; GO:0030141","endosome [GO:0005768]; Golgi apparatus [GO:0005794]; secretory granule [GO:0030141]","GTP binding [GO:0005525]; GTPase activity [GO:0003924]"
"66","Pocillopora_acuta_HIv2___RNAseq.g18517.t1",291.865888857358,9.4371731859068,1.47123420837542,5.44682318028932e-14,1.17586343999559e-11,NA,NA,NA,NA,NA,NA,NA
"67","Pocillopora_acuta_HIv2___RNAseq.g27621.t1",1470.664505119,-12.6373338826558,2.74178438047599,6.34545891708438e-14,1.34971643789277e-11,NA,NA,NA,NA,NA,NA,NA
"68","Pocillopora_acuta_HIv2___RNAseq.22067_t",613.52482329882,14.1077314167004,3.58502659999675,6.56876187276997e-14,1.37696480764848e-11,"Q98SN7",6.5e-110,"Protein Wnt-2b","camera-type eye photoreceptor cell differentiation [GO:0060219]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell population proliferation [GO:0008283]; cornea development in camera-type eye [GO:0061303]; embryonic camera-type eye formation [GO:0060900]; embryonic forelimb morphogenesis [GO:0035115]; iris morphogenesis [GO:0061072]; lens development in camera-type eye [GO:0002088]; limb development [GO:0060173]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of glial cell differentiation [GO:0045686]; negative regulation of neuron differentiation [GO:0045665]; neural retina development [GO:0003407]; neuron differentiation [GO:0030182]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor production [GO:0090270]; retina layer formation [GO:0010842]; Wnt signaling pathway [GO:0016055]","GO:0002011; GO:0002088; GO:0003407; GO:0005109; GO:0005125; GO:0005615; GO:0008283; GO:0010842; GO:0016055; GO:0030182; GO:0035115; GO:0045165; GO:0045665; GO:0045686; GO:0045743; GO:0060070; GO:0060173; GO:0060219; GO:0060828; GO:0060900; GO:0061072; GO:0061303; GO:0090270; GO:0090271","extracellular space [GO:0005615]","cytokine activity [GO:0005125]; frizzled binding [GO:0005109]"
"69","Pocillopora_acuta_HIv2___RNAseq.g27681.t1b",674.169731150683,14.281141124069,3.6286300578462,7.04802504488834e-14,1.45632334641807e-11,NA,NA,NA,NA,NA,NA,NA
"70","Pocillopora_acuta_HIv2___RNAseq.g28202.t1",2285.1584368848,13.0184119399894,3.30890497273828,7.83832806779605e-14,1.59681094609299e-11,"P12391",1.25e-61,"Neuronal acetylcholine receptor subunit beta-3","acetylcholine receptor signaling pathway [GO:0095500]; membrane depolarization [GO:0051899]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; response to nicotine [GO:0035094]; synaptic transmission, cholinergic [GO:0007271]","GO:0004888; GO:0005886; GO:0005892; GO:0007271; GO:0022848; GO:0032991; GO:0035094; GO:0042166; GO:0043005; GO:0045202; GO:0045211; GO:0051899; GO:0095500; GO:0098691; GO:0098793; GO:0099171","acetylcholine-gated channel complex [GO:0005892]; dopaminergic synapse [GO:0098691]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202]","acetylcholine binding [GO:0042166]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]"
"71","Pocillopora_acuta_HIv2___RNAseq.g8732.t1",507.240463637248,14.0172499130733,3.55483084689316,8.67731051999346e-14,1.74317526890535e-11,"Q8BGN2",3.01e-48,"UPF0462 protein C4orf33 homolog","","","",""
"72","Pocillopora_acuta_HIv2___RNAseq.g11810.t1",633.244866387664,14.2478182697593,3.64793837070251,1.06906708118933e-13,2.11821729620855e-11,"P15508",2.41e-37,"Spectrin beta chain, erythrocytic (Beta-I spectrin)","actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; hemopoiesis [GO:0030097]; plasma membrane organization [GO:0007009]; porphyrin-containing compound biosynthetic process [GO:0006779]","GO:0003779; GO:0005200; GO:0005886; GO:0006779; GO:0007009; GO:0008091; GO:0014731; GO:0016020; GO:0030036; GO:0030054; GO:0030097; GO:0030863; GO:0030864; GO:0042995; GO:0051015; GO:0051693; GO:0098794; GO:0098978","cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]","actin binding [GO:0003779]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]"
"73","Pocillopora_acuta_HIv2___RNAseq.g13.t1",493.162696204997,14.075752926846,3.61693106880795,1.09148182426637e-13,2.1334044738093e-11,"Q3V1M1",5.17e-10,"Immunoglobulin superfamily member 10 (IgSF10)","ossification [GO:0001503]; regulation of neuron migration [GO:2001222]; tissue regeneration [GO:0042246]","GO:0001503; GO:0005576; GO:0042246; GO:2001222","extracellular region [GO:0005576]",""
"74","Pocillopora_acuta_HIv2___RNAseq.g5007.t1",484.02351264286,13.9934773228157,3.56270382298771,1.13636941886028e-13,2.19152630325267e-11,NA,NA,NA,NA,NA,NA,NA
"75","Pocillopora_acuta_HIv2___RNAseq.g8062.t1",492.934930950537,-14.8066163606782,3.90803475302019,1.16948853665558e-13,2.22548829428386e-11,"Q9PVY8",6.3e-66,"Forkhead box protein C2-B (FoxC2-B) (FoxC2b) (Fork head domain-related protein 4') (FD-4') (xFD-4') (xFD4 B)","mesoderm development [GO:0007498]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]","GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007498; GO:0043565; GO:0045893; GO:0045944; GO:1990841","nucleus [GO:0005634]","DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; promoter-specific chromatin binding [GO:1990841]; sequence-specific DNA binding [GO:0043565]"
"76","Pocillopora_acuta_HIv2___RNAseq.g13400.t1",533.223747836275,14.1070815971388,3.58418088928484,1.18475247967268e-13,2.22548829428386e-11,"P51400",0,"Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase)","adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]","GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0008251; GO:0008285; GO:0016553; GO:0016556; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0042802; GO:0044387; GO:0045070; GO:0045202; GO:0046872; GO:0050685; GO:0050884; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049","cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]","double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]"
"77","Pocillopora_acuta_HIv2___RNAseq.g7514.t1",496.362437442143,13.9666814464222,3.57363472000533,1.30686492711426e-13,2.42339670586932e-11,NA,NA,NA,NA,NA,NA,NA
"78","Pocillopora_acuta_HIv2___RNAseq.g9231.t1",1272.97552268526,-10.9910045176629,2.7970546661123,1.36163704891206e-13,2.45931548893763e-11,NA,NA,NA,NA,NA,NA,NA
"79","Pocillopora_acuta_HIv2___RNAseq.g23883.t2",638.102436356512,11.7236862535958,2.33832528814591,1.3676557359512e-13,2.45931548893763e-11,"Q5VU97",8.26e-146,"VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1)","","GO:0005245; GO:0005891","voltage-gated calcium channel complex [GO:0005891]","voltage-gated calcium channel activity [GO:0005245]"
"80","Pocillopora_acuta_HIv2___RNAseq.g3939.t1",610.379215541957,-11.7772342941119,2.44037706543513,1.37724387862243e-13,2.45931548893763e-11,"Q9W770",1.17e-71,"Spondin-1 (F-spondin)","cell adhesion [GO:0007155]","GO:0005576; GO:0007155; GO:0031012; GO:0046872","extracellular matrix [GO:0031012]; extracellular region [GO:0005576]","metal ion binding [GO:0046872]"
"81","Pocillopora_acuta_HIv2___RNAseq.g17085.t1",542.201890374515,14.1182410877002,3.65307076782553,1.42116116843656e-13,2.50678965125201e-11,"G5EG78",2.82e-87,"Peroxidasin homolog pxn-2 (EC 1.11.2.-)","axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; embryonic body morphogenesis [GO:0010172]; muscle attachment [GO:0016203]; negative regulation of axon regeneration [GO:0048681]; regulation of basement membrane organization [GO:0110011]; response to oxidative stress [GO:0006979]","GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0007411; GO:0010172; GO:0016203; GO:0020037; GO:0046872; GO:0048681; GO:0071711; GO:0110011; GO:0140825","basement membrane [GO:0005604]; extracellular space [GO:0005615]","heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
"82","Pocillopora_acuta_HIv2___RNAseq.g3222.t1",584.314671432432,14.1510798881328,3.68326976422063,1.65695164352775e-13,2.88748777975727e-11,"P49013",1.81e-28,"Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III)","","GO:0005509; GO:0005576; GO:0009374","extracellular region [GO:0005576]","biotin binding [GO:0009374]; calcium ion binding [GO:0005509]"
"83","Pocillopora_acuta_HIv2___RNAseq.g17946.t1",517.195459073916,13.9774663797569,3.58026995358415,1.67871402458959e-13,2.89058567281712e-11,NA,NA,NA,NA,NA,NA,NA
"84","Pocillopora_acuta_HIv2___RNAseq.g30104.t1",700.233000546774,9.7875282832222,1.78722292134614,1.8813047318411e-13,3.20131666368819e-11,"Q80VF6",3.22e-10,"Protein FAM181B","","","",""
"85","Pocillopora_acuta_HIv2___TS.g22105.t1",586.4538651294,14.2897581911609,3.69068512818037,2.00934784760494e-13,3.37944270555325e-11,"F1PZV2",2.55e-32,"Major facilitator superfamily domain-containing protein 12","carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021]","GO:0005764; GO:0005765; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:1903712","lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886]","cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293]"
"86","Pocillopora_acuta_HIv2___RNAseq.g21722.t1",389.219325198085,9.9255099228446,1.69630323719484,2.03333976322973e-13,3.38048578567297e-11,"Q8VCR7",7.68e-44,"Putative protein-lysine deacylase ABHD14B (EC 2.3.1.-) (Alpha/beta hydrolase domain-containing protein 14B) (Abhydrolase domain-containing protein 14B)","positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0005634; GO:0005737; GO:0016787; GO:0045944; GO:0061733","cytoplasm [GO:0005737]; nucleus [GO:0005634]","hydrolase activity [GO:0016787]; peptide-lysine-N-acetyltransferase activity [GO:0061733]"
"87","Pocillopora_acuta_HIv2___RNAseq.g14933.t1",451.503456323017,13.8613479976949,3.5646599996599,2.16511015224924e-13,3.55865377751511e-11,"Q3UZD5",2.42e-88,"Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle)","methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468]","GO:0000122; GO:0005634; GO:0010468; GO:0022008; GO:0032259; GO:0042802; GO:0045892; GO:0046872; GO:0051151; GO:0140944","nucleus [GO:0005634]","histone H4K20 monomethyltransferase activity [GO:0140944]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
"88","Pocillopora_acuta_HIv2___RNAseq.g16988.t1",376.1632002207,11.0423465692767,2.05737462978991,2.30439245266472e-13,3.74502611633063e-11,NA,NA,NA,NA,NA,NA,NA
"89","Pocillopora_acuta_HIv2___RNAseq.g13796.t1",522.094512369359,14.1515822462773,3.64842154982876,2.4482290916341e-13,3.93457617571063e-11,"Q9D1E6",3.96e-86,"Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B)","cell differentiation [GO:0030154]; cytoplasmic microtubule organization [GO:0031122]; nervous system development [GO:0007399]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]","GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0007021; GO:0007023; GO:0007399; GO:0030154; GO:0031122; GO:0035371; GO:0043014; GO:0051010","cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]","alpha-tubulin binding [GO:0043014]; microtubule plus-end binding [GO:0051010]"
"90","Pocillopora_acuta_HIv2___RNAseq.g10163.t1",764.295436626259,10.277558307176,2.05922924828378,2.66725832088268e-13,4.23947520365352e-11,NA,NA,NA,NA,NA,NA,NA
"91","Pocillopora_acuta_HIv2___RNAseq.g12.t1",573.90599235064,14.0019685159375,3.61813017852458,2.9287722856609e-13,4.60453938476079e-11,"Q9NR99",8.15e-10,"Matrix-remodeling-associated protein 5 (Adhesion protein with leucine-rich repeats and immunoglobulin domains related to perlecan) (Adlican)","response to transforming growth factor beta [GO:0071559]","GO:0005201; GO:0005576; GO:0062023; GO:0070062; GO:0071559","collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]","extracellular matrix structural constituent [GO:0005201]"
"92","Pocillopora_acuta_HIv2___RNAseq.g18187.t1",361.132994907348,7.57387886437581,1.18764630181971,2.97178257394445e-13,4.62192076876694e-11,"Q6DBY9",1.7e-30,"Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST)","carbohydrate metabolic process [GO:0005975]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]","GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0042339; GO:0045130","Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]","keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]"
"93","Pocillopora_acuta_HIv2___RNAseq.g11522.t1",426.990692656728,9.359000599896,1.62715801420095,3.01723333546186e-13,4.6426875493745e-11,NA,NA,NA,NA,NA,NA,NA
"94","Pocillopora_acuta_HIv2___RNAseq.g31136.t1",426.941973838769,13.7634869400666,3.54339486748866,3.16904471566915e-13,4.82495397551985e-11,"Q1L8G7",6.83e-50,"GATA zinc finger domain-containing protein 1","chromatin organization [GO:0006325]; regulation of DNA-templated transcription [GO:0006355]","GO:0005634; GO:0006325; GO:0006355; GO:0031674; GO:0043565; GO:0046872","I band [GO:0031674]; nucleus [GO:0005634]","metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"
"95","Pocillopora_acuta_HIv2___RNAseq.g7672.t1",429.596418846362,13.7182298417789,3.53098464167824,3.27914770869679e-13,4.94058254776984e-11,NA,NA,NA,NA,NA,NA,NA
"96","Pocillopora_acuta_HIv2___TS.g28528.t1b",5194.87777708238,-9.81811791171972,2.9186044934637,3.68306673114544e-13,5.49194610301935e-11,"P18460",4.35e-37,"Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Tyrosine kinase receptor CEK2)","apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; regulation of macromolecule metabolic process [GO:0060255]","GO:0005007; GO:0005524; GO:0005886; GO:0006915; GO:0008284; GO:0017134; GO:0030154; GO:0043235; GO:0043410; GO:0060255","plasma membrane [GO:0005886]; receptor complex [GO:0043235]","ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]"
"97","Pocillopora_acuta_HIv2___RNAseq.g2813.t4",1653.40829342614,12.5822780147409,3.29886506853068,3.81906183909052e-13,5.63662351434748e-11,"Q3UP38",3.52e-55,"EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated channel regulator 2A) (Ras-related protein Rab-46)","activation of store-operated calcium channel activity [GO:0032237]; adaptive immune response [GO:0002250]; endosomal transport [GO:0016197]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of JNK cascade [GO:0046330]; response to histamine [GO:0034776]; store-operated calcium entry [GO:0002115]; T-helper 1 cell differentiation [GO:0045063]","GO:0000139; GO:0001772; GO:0002115; GO:0002250; GO:0003924; GO:0005509; GO:0005525; GO:0005737; GO:0005815; GO:0005886; GO:0016197; GO:0031982; GO:0032237; GO:0032588; GO:0033093; GO:0034776; GO:0045063; GO:0046330; GO:0051928","cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; immunological synapse [GO:0001772]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093]","calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]"
"98","Pocillopora_acuta_HIv2___TS.g10041.t1",413.393721368022,13.7174948553682,3.56851816057327,4.17816542276746e-13,6.1043418863544e-11,"V6CLA2",4.93e-12,"E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26)","determination of adult lifespan [GO:0008340]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of cell fate specification [GO:0042659]; regulation of germ cell proliferation [GO:1905936]; regulation of response to oxidative stress [GO:1902882]; regulation of vulval development [GO:0040028]","GO:0008340; GO:0016607; GO:0032436; GO:0040028; GO:0042659; GO:0043161; GO:0045746; GO:0045747; GO:0046872; GO:0061630; GO:0070534; GO:1902882; GO:1905936","nuclear speck [GO:0016607]","metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
"99","Pocillopora_acuta_HIv2___RNAseq.g18278.t1",406.840971288858,13.6919715572672,3.54927530761187,4.41375985352282e-13,6.3840622521354e-11,NA,NA,NA,NA,NA,NA,NA
"100","Pocillopora_acuta_HIv2___RNAseq.g13582.t1",398.602250368532,13.6690448116185,3.53764500088444,4.70148181932755e-13,6.7328943598766e-11,NA,NA,NA,NA,NA,NA,NA
"101","Pocillopora_acuta_HIv2___RNAseq.g14640.t1",409.087856433782,13.7235899288323,3.58471157258347,5.1867812515529e-13,7.35505921788835e-11,"Q6V0K7",4.43e-23,"Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein)","renal system process [GO:0003014]","GO:0003014; GO:0005509; GO:0005635","nuclear envelope [GO:0005635]","calcium ion binding [GO:0005509]"
"102","Pocillopora_acuta_HIv2___TS.g20007.t1",530.728095558458,14.1847023603794,3.7113653081871,5.43070981977338e-13,7.62619289642739e-11,"P49746",0,"Thrombospondin-3","bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931]","GO:0003417; GO:0005509; GO:0005576; GO:0007160; GO:0008201; GO:0043931; GO:0048471; GO:0060346; GO:0062023","collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]","calcium ion binding [GO:0005509]; heparin binding [GO:0008201]"
"103","Pocillopora_acuta_HIv2___RNAseq.g30663.t1",487.435148214201,10.6684844387455,2.08929181558024,5.92465461797252e-13,8.21890656144751e-11,"P25035",1.3e-37,"Cellular tumor antigen p53 (Tumor suppressor p53)","apoptotic process [GO:0006915]; DNA damage response [GO:0006974]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein tetramerization [GO:0051262]","GO:0000976; GO:0003700; GO:0005634; GO:0005737; GO:0005739; GO:0006915; GO:0006974; GO:0043066; GO:0045944; GO:0046872; GO:0051262; GO:0140693; GO:1990841","cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]","DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; molecular condensate scaffold activity [GO:0140693]; promoter-specific chromatin binding [GO:1990841]; transcription cis-regulatory region binding [GO:0000976]"
"104","Pocillopora_acuta_HIv2___RNAseq.g28971.t1a",1603.2281279156,-12.4634660911307,2.92123706107234,5.9664352112278e-13,8.21890656144751e-11,"Q91X17",8.41e-23,"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; ERAD pathway [GO:0036503]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; intracellular calcium ion homeostasis [GO:0006874]; intracellular chloride ion homeostasis [GO:0030644]; intracellular phosphate ion homeostasis [GO:0030643]; intracellular sodium ion homeostasis [GO:0006883]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; monoatomic ion homeostasis [GO:0050801]; multicellular organismal response to stress [GO:0033555]; multicellular organismal-level homeostasis [GO:0048871]; multicellular organismal-level water homeostasis [GO:0050891]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]","GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005509; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0019864; GO:0030643; GO:0030644; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0036503; GO:0044861; GO:0045177; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0050891; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097709; GO:0097744; GO:0098552; GO:0140367; GO:1990266","apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; spindle pole [GO:0000922]","calcium ion binding [GO:0005509]; IgG binding [GO:0019864]"
"105","Pocillopora_acuta_HIv2___RNAseq.g829.t1",2530.87772725239,-14.321435453364,3.31372350914801,6.42931815707619e-13,8.7729865871651e-11,"P63253",6.37e-87,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1) (IRK-1) (Potassium channel, inwardly rectifying subfamily J member 2)","cardiac muscle cell action potential involved in contraction [GO:0086002]; magnesium ion transport [GO:0015693]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of skeletal muscle contraction via regulation of action potential [GO:0014861]; relaxation of cardiac muscle [GO:0055119]; relaxation of skeletal muscle [GO:0090076]","GO:0005242; GO:0005546; GO:0005886; GO:0006813; GO:0008076; GO:0014861; GO:0015693; GO:0016020; GO:0034765; GO:0042802; GO:0051289; GO:0055119; GO:0060306; GO:0086002; GO:0086008; GO:0086091; GO:0090076; GO:1990573","membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]","identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]"
"106","Pocillopora_acuta_HIv2___TS.g6907.t1",2839.24667072626,9.44782665336514,2.3797359583937,6.54999877696355e-13,8.85412918785054e-11,NA,NA,NA,NA,NA,NA,NA
"107","Pocillopora_acuta_HIv2___RNAseq.g2437.t1",2337.698638039,13.2372201133115,2.98233354394315,6.94007037676421e-13,9.29455351199236e-11,"A2R9H9",2.3e-06,"Chromatin-remodeling ATPase INO80 (EC 3.6.4.-)","CENP-A containing chromatin assembly [GO:0034080]; DNA repair [GO:0006281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of TOR signaling [GO:0032006]; subtelomeric heterochromatin formation [GO:0031509]; telomere maintenance via recombination [GO:0000722]; transcription by RNA polymerase II [GO:0006366]","GO:0000722; GO:0000781; GO:0003677; GO:0005524; GO:0006281; GO:0006366; GO:0016887; GO:0031011; GO:0031509; GO:0032006; GO:0034080; GO:0043138; GO:0045944; GO:0140658","chromosome, telomeric region [GO:0000781]; Ino80 complex [GO:0031011]","3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]"
"108","Pocillopora_acuta_HIv2___RNAseq.g19042.t1",916.621468361507,11.4720472407446,2.51533199766972,7.42580462420659e-13,9.82187044410855e-11,"Q6IWH7",0,"Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G)","calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220]","GO:0005229; GO:0005254; GO:0005783; GO:0005829; GO:0005886; GO:0034220; GO:0046983; GO:0061588; GO:0070161; GO:1902476","anchoring junction [GO:0070161]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]","chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]"
"109","Pocillopora_acuta_HIv2___RNAseq.g2959.t1",461.103525953368,11.2630928486836,2.26716717944321,7.46961939195202e-13,9.82187044410855e-11,NA,NA,NA,NA,NA,NA,NA
"110","Pocillopora_acuta_HIv2___RNAseq.g16527.t1",431.570197991471,13.7419859122101,3.60959090984806,9.19927842028919e-13,1.1987239916312e-10,NA,NA,NA,NA,NA,NA,NA
"111","Pocillopora_acuta_HIv2___RNAseq.g25686.t1",380.659258700191,10.8405879681523,2.1600522863093,9.80798905863767e-13,1.26663172985835e-10,"Q32PP9",2.3e-38,"Transcription factor Sox-14","brain development [GO:0007420]; hypothalamus development [GO:0021854]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000122; GO:0000978; GO:0001228; GO:0005634; GO:0007420; GO:0021854; GO:0030182; GO:0045944","nucleus [GO:0005634]","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"112","Pocillopora_acuta_HIv2___TS.g14372.t1b",364.331645999331,13.493932844173,3.524081644979,1.00423149482976e-12,1.28541631338209e-10,NA,NA,NA,NA,NA,NA,NA
"113","Pocillopora_acuta_HIv2___RNAseq.g26783.t1",361.906669694196,13.4842588234659,3.53209151596,1.19882159911039e-12,1.52103119381865e-10,"Q0KHY3",1.47e-58,"Protein mesh","cell-matrix adhesion [GO:0007160]; smooth septate junction assembly [GO:0090528]","GO:0005615; GO:0005920; GO:0007160; GO:0016327; GO:0090528","apicolateral plasma membrane [GO:0016327]; extracellular space [GO:0005615]; smooth septate junction [GO:0005920]",""
"114","Pocillopora_acuta_HIv2___RNAseq.g299.t1",382.035799448043,13.5303609203879,3.57563092287098,1.2612746714604e-12,1.58209074372195e-10,"Q9NZJ4",0,"Sacsin (DnaJ homolog subfamily C member 29)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084","axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]","Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; proteasome binding [GO:0070628]; protein-folding chaperone binding [GO:0051087]"
"115","Pocillopora_acuta_HIv2___RNAseq.g26596.t1",503.322440157317,13.83455275543,3.64254352279667,1.26882277566196e-12,1.58209074372195e-10,"Q8NDA2",5.33e-26,"Hemicentin-2","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808]","GO:0005509; GO:0005576; GO:0005886; GO:0007156; GO:0008046; GO:0030424; GO:0032154; GO:0043025; GO:0050808; GO:0062023","axon [GO:0030424]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]","axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509]"
"116","Pocillopora_acuta_HIv2___RNAseq.g8688.t1",10616.8423315086,8.8679081224267,2.12570183115964,1.37085177439056e-12,1.69470086023803e-10,NA,NA,NA,NA,NA,NA,NA
"117","Pocillopora_acuta_HIv2___RNAseq.g24649.t1",769.933878983184,14.2273839871453,3.6109234923021,1.50886513438708e-12,1.84951061896395e-10,"Q9NZJ4",0,"Sacsin (DnaJ homolog subfamily C member 29)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084","axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]","Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; proteasome binding [GO:0070628]; protein-folding chaperone binding [GO:0051087]"
"118","Pocillopora_acuta_HIv2___RNAseq.g18982.t1",470.704900766149,13.7869895840083,3.69025530764007,1.5276220070858e-12,1.85233769449622e-10,NA,NA,NA,NA,NA,NA,NA
"119","Pocillopora_acuta_HIv2___RNAseq.g2567.t1",363.961123913796,13.3854841161733,3.50774931607659,1.53678459167275e-12,1.85233769449622e-10,"P0C7M7",9.38e-55,"Acyl-coenzyme A synthetase ACSM4, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 4)","acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]","GO:0004321; GO:0005524; GO:0005759; GO:0006633; GO:0006637; GO:0015645; GO:0046872; GO:0102391","mitochondrial matrix [GO:0005759]","ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]"
"120","Pocillopora_acuta_HIv2___TS.g1253.t1",528.009635951326,13.6469177092299,3.59542549739183,1.65492821729332e-12,1.97825468883724e-10,"Q91175",1.6e-45,"Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (MAR1)","adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; cell-cell signaling [GO:0007267]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAPK cascade [GO:0043410]","GO:0004937; GO:0005886; GO:0007200; GO:0007204; GO:0007267; GO:0043410; GO:0071880","plasma membrane [GO:0005886]","alpha1-adrenergic receptor activity [GO:0004937]"
"121","Pocillopora_acuta_HIv2___RNAseq.5883_t",372.245882521794,13.4880049348358,3.59127304138101,1.77901539349097e-12,2.10915398782405e-10,"Q5RCC4",2.53e-65,"Calcium/calmodulin-dependent protein kinase type II subunit alpha (CaM kinase II subunit alpha) (CaMK-II subunit alpha) (EC 2.7.11.17)","cellular response to interferon-beta [GO:0035458]; dendritic spine development [GO:0060996]; negative regulation of hydrolase activity [GO:0051346]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of neuron migration [GO:2001222]","GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005954; GO:0014069; GO:0035458; GO:0043197; GO:0046427; GO:0046872; GO:0051346; GO:0060996; GO:0106310; GO:1990443; GO:2000124; GO:2001222","calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]","ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]"
"122","Pocillopora_acuta_HIv2___RNAseq.g3739.t1",353.363753142325,13.5393877295466,3.58495011659154,1.97626295558832e-12,2.3052151120669e-10,NA,NA,NA,NA,NA,NA,NA
"123","Pocillopora_acuta_HIv2___RNAseq.g15990.t1",372.608312007925,13.505517464989,3.57159084400581,1.99377657248514e-12,2.307038747554e-10,NA,NA,NA,NA,NA,NA,NA
"124","Pocillopora_acuta_HIv2___RNAseq.g26586.t1",381.247139568541,13.6679395526645,3.62648260430233,2.02500689956088e-12,2.32457934882925e-10,"Q7TM99",4.51e-38,"Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)","carnitine transmembrane transport [GO:1902603]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]; urate metabolic process [GO:0046415]","GO:0005308; GO:0005886; GO:0008028; GO:0015226; GO:0015718; GO:0015881; GO:0046415; GO:1902603","plasma membrane [GO:0005886]","carnitine transmembrane transporter activity [GO:0015226]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]"
"125","Pocillopora_acuta_HIv2___RNAseq.g13044.t1",735.671212256975,11.5847433144061,2.61501052578743,2.43342802444564e-12,2.77142542878596e-10,"Q9UGM3",2.37e-79,"Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)","defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031]","GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062","cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]","calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]"
"126","Pocillopora_acuta_HIv2___RNAseq.g10988.t1",1437.01770911377,12.3283557665491,2.87001531748904,2.81468233064482e-12,3.15971571769814e-10,NA,NA,NA,NA,NA,NA,NA
"127","Pocillopora_acuta_HIv2___RNAseq.g30675.t1",961.143021798293,-9.5613729495454,2.09010097833329,2.81805397941828e-12,3.15971571769814e-10,"P32029",5.44e-27,"Fork head domain-containing protein FD5","anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0030154","nucleus [GO:0005634]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"128","Pocillopora_acuta_HIv2___RNAseq.11917_t",416.64625142896,13.4737149907287,3.60440521052398,2.84598408984947e-12,3.16648568273713e-10,"Q805E5",1.13e-45,"Carbohydrate sulfotransferase 14 (EC 2.8.2.-) (Dermatan 4-sulfotransferase 1) (D4ST-1) (zD4ST-1)","carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate proteoglycan metabolic process [GO:0050655]","GO:0000139; GO:0001537; GO:0008146; GO:0016051; GO:0050655","Golgi membrane [GO:0000139]","N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]"
"129","Pocillopora_acuta_HIv2___RNAseq.g10339.t1",392.049430458694,13.5164630216057,3.61694180685112,2.98625578864363e-12,3.297191124194e-10,"Q32ZE2",1.08e-33,"Adenosine receptor A2b","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cGMP-mediated signaling [GO:0019934]; mast cell degranulation [GO:0043303]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to non-antigenic stimulus [GO:0002882]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vascular endothelial growth factor production [GO:0010575]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; relaxation of vascular associated smooth muscle [GO:0060087]","GO:0001609; GO:0002882; GO:0005886; GO:0007189; GO:0010575; GO:0010753; GO:0019934; GO:0032722; GO:0032755; GO:0043303; GO:0043306; GO:0060087; GO:0098685; GO:0098793; GO:0098978; GO:0099171","glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]","G protein-coupled adenosine receptor activity [GO:0001609]"
"130","Pocillopora_acuta_HIv2___RNAseq.g5003.t1",327.196984667357,13.3321313371362,3.55014493736782,3.01361806278715e-12,3.30219482273889e-10,NA,NA,NA,NA,NA,NA,NA
"131","Pocillopora_acuta_HIv2___RNAseq.g22261.t1",1251.45084902703,-15.9898703829579,4.32646956749874,3.15422735104766e-12,3.42898034571482e-10,"B3EWY8",1.14e-104,"Skeletal aspartic acid-rich protein 2","","GO:0016020","membrane [GO:0016020]",""
"132","Pocillopora_acuta_HIv2___TS.g5308.t2",759.035885685081,-12.4239262847658,3.02289186001807,3.1767378755931e-12,3.42898034571482e-10,"Q9VBW3",7.83e-67,"Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303","apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]","ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
"133","Pocillopora_acuta_HIv2___RNAseq.g26798.t1",364.94746280198,13.3374776309653,3.52406687716602,3.28761126834265e-12,3.52237106557838e-10,NA,NA,NA,NA,NA,NA,NA
"134","Pocillopora_acuta_HIv2___RNAseq.g29539.t1",4459.14029207164,10.2817345859149,4.34501422301966,3.34152962826263e-12,3.55381503994049e-10,NA,NA,NA,NA,NA,NA,NA
"135","Pocillopora_acuta_HIv2___RNAseq.g2220.t1",4540.85774542795,8.64270244957571,2.12491634682641,3.43578331595336e-12,3.62738466291601e-10,NA,NA,NA,NA,NA,NA,NA
"136","Pocillopora_acuta_HIv2___RNAseq.g4369.t1",689.301300641021,9.4678317158024,2.10409255992176,3.51914836050663e-12,3.68774643478076e-10,"O75096",0,"Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)","amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395","cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]","apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]"
"137","Pocillopora_acuta_HIv2___RNAseq.g14366.t1",250.602068410561,-13.4718937528091,3.71557875963125,3.54394880001746e-12,3.68774643478076e-10,"Q5RFW0",7.91e-07,"Scavenger receptor class A member 5","endocytosis [GO:0006897]; intracellular iron ion homeostasis [GO:0006879]; iron ion transmembrane transport [GO:0034755]; protein homotrimerization [GO:0070207]","GO:0005886; GO:0006879; GO:0006897; GO:0034755; GO:0070207; GO:0070287","plasma membrane [GO:0005886]","ferritin receptor activity [GO:0070287]"
"138","Pocillopora_acuta_HIv2___RNAseq.g14347.t1",3739.22928222091,-9.56130060539418,2.39924640453721,3.75668654580499e-12,3.8811938713231e-10,"A2AX52",3.5e-14,"Collagen alpha-4(VI) chain","cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]","GO:0005518; GO:0005576; GO:0005581; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023","collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]","collagen binding [GO:0005518]"
"139","Pocillopora_acuta_HIv2___RNAseq.g3838.t1",1113.34691064372,12.0556303207608,3.40439726357215,3.7948450722691e-12,3.89281128548229e-10,"Q9HD45",0,"Transmembrane 9 superfamily member 3 (EP70-P-iso) (SM-11044-binding protein)","protein localization to membrane [GO:0072657]","GO:0016020; GO:0072657","membrane [GO:0016020]",""
"140","Pocillopora_acuta_HIv2___RNAseq.g2995.t1",1190.36858098257,12.3903972587385,2.89324084343905,3.84844922778363e-12,3.91999786131425e-10,"Q90Z12",2.22e-42,"Transcription factor HES-4-A (Hairy and enhancer of split 4-A) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2a)","BMP signaling pathway [GO:0030509]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest formation [GO:0014029]; prechordal plate formation [GO:0021501]","GO:0000122; GO:0002088; GO:0005634; GO:0014029; GO:0021501; GO:0030509; GO:0033504; GO:0043066; GO:0043425; GO:0043565; GO:0045892; GO:0046983","nucleus [GO:0005634]","bHLH transcription factor binding [GO:0043425]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]"
"141","Pocillopora_acuta_HIv2___RNAseq.g16699.t1",328.73878308999,13.3866112054687,3.59112341161435,4.41123612608259e-12,4.46182652640969e-10,"P19440",5.01e-149,"Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]","amino acid metabolic process [GO:0006520]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638]","GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0019344; GO:0031179; GO:0031638; GO:0036374; GO:0050727; GO:0070062; GO:0103068; GO:1901750","extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]","glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048]"
"142","Pocillopora_acuta_HIv2___RNAseq.g26267.t1",338.990367495423,13.3435463346376,3.59106948727826,4.5817969308231e-12,4.60216047273786e-10,"Q3MHX6",1.06e-31,"Protein OS-9","endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; protein retention in ER lumen [GO:0006621]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005788; GO:0006511; GO:0006621; GO:0030246; GO:0030968; GO:0030970; GO:0034976; GO:0036503","endoplasmic reticulum lumen [GO:0005788]","carbohydrate binding [GO:0030246]"
"143","Pocillopora_acuta_HIv2___RNAseq.g16486.t1",2676.39145640268,13.4201417444351,3.21116491655136,4.87701037922594e-12,4.86490193966372e-10,"B3EWY9",3.19e-114,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020","extracellular space [GO:0005615]; membrane [GO:0016020]","calcium ion binding [GO:0005509]"
"144","Pocillopora_acuta_HIv2___RNAseq.g7678.t1",349.961710497645,13.4322746285127,3.61287554085996,5.10502459397101e-12,5.05747094021895e-10,"Q60631",4.98e-85,"Growth factor receptor-bound protein 2 (Adapter protein GRB2) (SH2/SH3 adapter GRB2)","actin cytoskeleton organization [GO:0030036]; anatomical structure formation involved in morphogenesis [GO:0048646]; B cell receptor signaling pathway [GO:0050853]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to ionizing radiation [GO:0071479]; endodermal cell differentiation [GO:0035987]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-ERBB3 signaling pathway [GO:0038133]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; myelination [GO:0042552]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]","GO:0001784; GO:0005068; GO:0005091; GO:0005154; GO:0005168; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005768; GO:0005794; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0007165; GO:0007173; GO:0007265; GO:0008180; GO:0008286; GO:0008543; GO:0012506; GO:0014044; GO:0016020; GO:0017124; GO:0019899; GO:0019903; GO:0019904; GO:0030036; GO:0030674; GO:0030838; GO:0031623; GO:0032991; GO:0035987; GO:0038133; GO:0042552; GO:0042770; GO:0042802; GO:0043408; GO:0043560; GO:0044877; GO:0046875; GO:0048009; GO:0048646; GO:0050853; GO:0051219; GO:0060090; GO:0060670; GO:0070436; GO:0071479; GO:2000379","cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]","enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor adaptor activity [GO:0005091]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; molecular adaptor activity [GO:0060090]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]"
"145","Pocillopora_acuta_HIv2___RNAseq.g13102.t1",1328.68064326278,-12.6214148095541,3.31614617440699,5.33664525101566e-12,5.25096849732588e-10,NA,NA,NA,NA,NA,NA,NA
"146","Pocillopora_acuta_HIv2___RNAseq.g21444.t1",338.570538120978,13.198298868146,3.53475539455494,5.42472294150772e-12,5.30156706932214e-10,NA,NA,NA,NA,NA,NA,NA
"147","Pocillopora_acuta_HIv2___RNAseq.g14763.t1",411.149002352806,13.3945042127328,3.59316194222111,6.58159849185793e-12,6.38900943531766e-10,"Q90YK3",8.96e-06,"L-gulonolactone oxidase (LGO) (EC 1.1.3.8) (L-gulono-gamma-lactone oxidase) (GLO)","L-ascorbic acid biosynthetic process [GO:0019853]","GO:0003885; GO:0005789; GO:0019853; GO:0050105; GO:0050660; GO:0071949","endoplasmic reticulum membrane [GO:0005789]","D-arabinono-1,4-lactone oxidase activity [GO:0003885]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; L-gulonolactone oxidase activity [GO:0050105]"
"148","Pocillopora_acuta_HIv2___RNAseq.g4770.t1",383.96335456763,13.4282437093551,3.70935092353953,7.46058162026711e-12,7.19399017036956e-10,"Q8TE73",0,"Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)","cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158]","GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097728; GO:0097729","9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]"
"149","Pocillopora_acuta_HIv2___RNAseq.g17965.t1",339.145514157385,13.0876136277063,3.54424298568301,7.55307559973701e-12,7.22418440667859e-10,"O02824",5.16e-62,"Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor)","adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adult heart development [GO:0007512]; cell growth involved in cardiac muscle cell development [GO:0061049]; MAPK cascade [GO:0000165]; negative regulation of autophagy [GO:0010507]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; regulation of cardiac muscle contraction [GO:0055117]","GO:0000165; GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0004937; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005901; GO:0007200; GO:0007204; GO:0007512; GO:0010507; GO:0010613; GO:0031965; GO:0043410; GO:0045907; GO:0045987; GO:0046982; GO:0055117; GO:0061049; GO:0071880; GO:0097195; GO:0150099","caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]","alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982]"
"150","Pocillopora_acuta_HIv2___RNAseq.g21169.t1",384.726198752394,13.3536829777398,3.57782251220557,7.59178671055825e-12,7.22418440667859e-10,"P79218",7.24e-24,"Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2)","positive regulation of flagellated sperm motility [GO:1902093]; regulation of uterine smooth muscle contraction [GO:0070472]","GO:0005886; GO:0016497; GO:0061827; GO:0070472; GO:0097225; GO:1902093","plasma membrane [GO:0005886]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]","substance K receptor activity [GO:0016497]"
"151","Pocillopora_acuta_HIv2___TS.g1310.t1",377.334204249079,13.2702291049394,3.54096900970921,7.73338866877254e-12,7.3108322683089e-10,NA,NA,NA,NA,NA,NA,NA
"152","Pocillopora_acuta_HIv2___RNAseq.g9466.t1",3868.10737894307,8.98565382534514,5.52236153974918,7.7963705709949e-12,7.32251324278378e-10,"Q6RI86",1.07e-142,"Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor)","calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832]","GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014070; GO:0014832; GO:0015267; GO:0015278; GO:0016324; GO:0019233; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0070588; GO:0071244; GO:0071313; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760","apical plasma membrane [GO:0016324]; axon [GO:0030424]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421]","calcium channel activity [GO:0005262]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; intracellularly gated calcium channel activity [GO:0015278]; metal ion binding [GO:0046872]; monoatomic ion channel activity [GO:0005216]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245]"
"153","Pocillopora_acuta_HIv2___RNAseq.g14817.t1",308.277930305083,13.1315097545823,3.54647374870439,8.25940758970479e-12,7.61583038318804e-10,"E7F6F9",7.72e-39,"Kelch-like protein 3","distal tubule morphogenesis [GO:0072156]; monoatomic ion homeostasis [GO:0050801]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; renal sodium ion absorption [GO:0070294]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0003779; GO:0005829; GO:0005856; GO:0006511; GO:0016567; GO:0031463; GO:0050801; GO:0070294; GO:0070936; GO:0072156; GO:1990756","Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]","actin binding [GO:0003779]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]"
"154","Pocillopora_acuta_HIv2___RNAseq.g29834.t1",364.43583865093,13.3239560336293,3.66201827444784,8.26663004812308e-12,7.61583038318804e-10,NA,NA,NA,NA,NA,NA,NA
"155","Pocillopora_acuta_HIv2___RNAseq.g17943.t1",393.527067993985,13.4931784457954,3.5960601481577,8.63534595888924e-12,7.90516733856797e-10,NA,NA,NA,NA,NA,NA,NA
"156","Pocillopora_acuta_HIv2___RNAseq.g14014.t1",1371.2473120555,10.2113376336481,2.59900967709516,9.42244653858748e-12,8.518674240608e-10,"G8HTB6",1.54e-16,"ZP domain-containing protein","","GO:0016020","membrane [GO:0016020]",""
"157","Pocillopora_acuta_HIv2___RNAseq.g15827.t1",2147.21458205249,12.9002693701496,3.1522864042277,9.42331221306194e-12,8.518674240608e-10,NA,NA,NA,NA,NA,NA,NA
"158","Pocillopora_acuta_HIv2___RNAseq.g28815.t1",448.847439035537,13.3650848961499,3.64078166826103,9.63620840343742e-12,8.65702598430552e-10,"Q5R4J5",7.65e-31,"Synaptotagmin-1 (Synaptotagmin I) (SytI)","calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903235]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]","GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0019905; GO:0030154; GO:0030276; GO:0030424; GO:0030672; GO:0031045; GO:0042584; GO:0048488; GO:0048791; GO:0071277; GO:1903235","axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; dense core granule [GO:0031045]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]","calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; syntaxin binding [GO:0019905]"
"159","Pocillopora_acuta_HIv2___RNAseq.g3653.t1",1313.49523169237,12.3032875792221,3.00250522100216,1.00250518252326e-11,8.95076232099782e-10,"P29145",1.58e-161,"PC3-like endoprotease variant B (EC 3.4.21.-) (SPC3)","proteolysis [GO:0006508]","GO:0004252; GO:0006508","","serine-type endopeptidase activity [GO:0004252]"
"160","Pocillopora_acuta_HIv2___RNAseq.g22605.t1",3203.60822977716,13.6548035897069,3.36449895817456,1.04500401356861e-11,9.27296813021861e-10,"G8HTB6",6.89e-38,"ZP domain-containing protein","","GO:0016020","membrane [GO:0016020]",""
"161","Pocillopora_acuta_HIv2___RNAseq.g30781.t1",4420.15094556839,5.26391189977055,0.917528333432514,1.05958623349844e-11,9.3450337081228e-10,NA,NA,NA,NA,NA,NA,NA
"162","Pocillopora_acuta_HIv2___RNAseq.g17429.t1",270.985949703192,12.9770391197184,3.50798938821295,1.12864114760263e-11,9.86535852540382e-10,NA,NA,NA,NA,NA,NA,NA
"163","Pocillopora_acuta_HIv2___RNAseq.g20365.t1",286.998914749484,13.0475284785312,3.54629964844603,1.13222449890558e-11,9.86535852540382e-10,NA,NA,NA,NA,NA,NA,NA
"164","Pocillopora_acuta_HIv2___RNAseq.5910_t",434.904133567734,10.9758104476827,2.45219660893814,1.15949544174403e-11,1.00424802810693e-09,"G8HTB6",3.21e-12,"ZP domain-containing protein","","GO:0016020","membrane [GO:0016020]",""
"165","Pocillopora_acuta_HIv2___RNAseq.g7692.t1",381.610015450429,13.2793226179355,3.66773685032553,1.18625115671054e-11,1.02130575777746e-09,"O09118",0,"Netrin-1","animal organ morphogenesis [GO:0009887]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; dendrite development [GO:0016358]; glial cell proliferation [GO:0014009]; inner ear morphogenesis [GO:0042472]; mammary gland development [GO:0030879]; mammary gland duct morphogenesis [GO:0060603]; motor neuron axon guidance [GO:0008045]; motor neuron migration [GO:0097475]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of glial cell proliferation [GO:0060252]; Ras protein signal transduction [GO:0007265]; regulation of cell migration [GO:0030334]; regulation of glial cell migration [GO:1903975]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]; tissue development [GO:0009888]","GO:0001764; GO:0005576; GO:0005604; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0006930; GO:0007097; GO:0007265; GO:0007409; GO:0007411; GO:0008045; GO:0008283; GO:0009887; GO:0009888; GO:0014009; GO:0015629; GO:0016358; GO:0030334; GO:0030517; GO:0030879; GO:0032488; GO:0033564; GO:0042472; GO:0045202; GO:0045773; GO:0051963; GO:0060252; GO:0060603; GO:0061643; GO:0062023; GO:0071944; GO:0097475; GO:0098609; GO:0098978; GO:1903975; GO:2000147","actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cell periphery [GO:0071944]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; synapse [GO:0045202]",""
"166","Pocillopora_acuta_HIv2___RNAseq.g18342.t1",1995.30398268793,12.5070813993026,3.0928312049471,1.27876760044146e-11,1.09444346584529e-09,NA,NA,NA,NA,NA,NA,NA
"167","Pocillopora_acuta_HIv2___RNAseq.g31286.t1c",336.709257994196,13.2234554503822,3.67702577700665,1.32425308955011e-11,1.12670568748546e-09,"B8VIU6",2.62e-24,"Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","","GO:0005576","extracellular region [GO:0005576]",""
"168","Pocillopora_acuta_HIv2___RNAseq.g30046.t1",2980.31198903644,-8.30401498487618,5.59834163898317,1.70002818702376e-11,1.42960509866928e-09,NA,NA,NA,NA,NA,NA,NA
"169","Pocillopora_acuta_HIv2___RNAseq.g13339.t1",286.202190123045,12.9575878901316,3.53675889247504,1.74012014335989e-11,1.45407460759362e-09,"P86854",1.96e-20,"Perlucin-like protein","","GO:0005576; GO:0030246; GO:0038023","extracellular region [GO:0005576]","carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]"
"170","Pocillopora_acuta_HIv2___TS.g26248.t1",501.539228602979,13.7264448480645,3.61996106874057,1.7492324510598e-11,1.45407460759362e-09,NA,NA,NA,NA,NA,NA,NA
"171","Pocillopora_acuta_HIv2___TS.g29848.t1",292.521544072173,12.9964191958921,3.5629164775951,1.7886026861119e-11,1.47830567153843e-09,"O77775",5.75e-29,"Neutrophil cytosol factor 2 (NCF-2) (67 kDa neutrophil oxidase factor) (Neutrophil NADPH oxidase factor 2) (p67-phox)","phagocytosis [GO:0006909]; respiratory burst [GO:0045730]; superoxide anion generation [GO:0042554]","GO:0005737; GO:0006909; GO:0016176; GO:0042554; GO:0043020; GO:0045730","cytoplasm [GO:0005737]; NADPH oxidase complex [GO:0043020]","superoxide-generating NADPH oxidase activator activity [GO:0016176]"
"172","Pocillopora_acuta_HIv2___TS.g28126.t1",1512.9378096092,-12.9269880069597,3.47660656185481,1.84437122513997e-11,1.51330793218801e-09,NA,NA,NA,NA,NA,NA,NA
"173","Pocillopora_acuta_HIv2___RNAseq.g11198.t1",3305.3903417023,8.81745804929396,2.91557887128667,1.85187710175109e-11,1.51330793218801e-09,NA,NA,NA,NA,NA,NA,NA
"174","Pocillopora_acuta_HIv2___TS.g16172.t3",491.815198073264,10.5328249260696,2.38048869378298,2.06566210773939e-11,1.67852453518779e-09,"Q05973",0,"Sodium channel protein 1 brain (Sodium channel protein I brain)","membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]","GO:0001518; GO:0005248; GO:0019228; GO:0086010","voltage-gated sodium channel complex [GO:0001518]","voltage-gated sodium channel activity [GO:0005248]"
"175","Pocillopora_acuta_HIv2___TS.7324_t",804.567793162316,-12.3213566922495,3.20578436091942,2.12691271540615e-11,1.7186405315997e-09,"Q9W7E8",1.48e-11,"Homeobox protein koza (Homeodomain transcription factor koza)","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]","GO:0000981; GO:0003677; GO:0005634; GO:0042127; GO:0045944","nucleus [GO:0005634]","DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"
"176","Pocillopora_acuta_HIv2___RNAseq.g25168.t1",347.73098464024,13.4436127415317,3.68327082078523,2.28084573142434e-11,1.8327862588512e-09,"Q9DAJ5",9.74e-37,"Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic)","microtubule-based movement [GO:0007018]","GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045505","centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]","dynein intermediate chain binding [GO:0045505]"
"177","Pocillopora_acuta_HIv2___RNAseq.g16.t1",248.537159781759,12.8815631529001,3.54218623869265,2.32321398243537e-11,1.85651751612956e-09,"Q61006",2.7e-08,"Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor)","cell differentiation [GO:0030154]; enzyme-linked receptor protein signaling pathway [GO:0007167]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; motor neuron apoptotic process [GO:0097049]; negative regulation of gene expression [GO:0010629]; neuromuscular junction development [GO:0007528]; positive regulation of gene expression [GO:0010628]; positive regulation of motor neuron apoptotic process [GO:2000673]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; receptor clustering [GO:0043113]; regulation of DNA-templated transcription [GO:0006355]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; response to electrical stimulus [GO:0051602]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]","GO:0001934; GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0006355; GO:0007167; GO:0007528; GO:0007613; GO:0008582; GO:0009897; GO:0010628; GO:0010629; GO:0010976; GO:0016020; GO:0017147; GO:0019901; GO:0030154; GO:0030165; GO:0031594; GO:0032224; GO:0035022; GO:0042995; GO:0043113; GO:0043235; GO:0045202; GO:0045211; GO:0045887; GO:0046872; GO:0050731; GO:0051602; GO:0051897; GO:0060291; GO:0071340; GO:0097049; GO:1904395; GO:2000541; GO:2000673","cell projection [GO:0042995]; external side of plasma membrane [GO:0009897]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; synapse [GO:0045202]","ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147]"
"178","Pocillopora_acuta_HIv2___RNAseq.g13056.t1",308.242236055202,13.0214366779562,3.58449579057028,2.3917524523333e-11,1.89039931533054e-09,"Q18775",7.71e-07,"Dopamine receptor 4","adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]","GO:0004952; GO:0004993; GO:0005886; GO:0007186; GO:0007187; GO:0007191; GO:0007268; GO:0030425; GO:0030594; GO:0045211","dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]","dopamine neurotransmitter receptor activity [GO:0004952]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]"
"179","Pocillopora_acuta_HIv2___RNAseq.g27458.t1",269.761135860062,13.0671035599872,3.58601225559233,2.46695128371353e-11,1.92875585770986e-09,NA,NA,NA,NA,NA,NA,NA
"180","Pocillopora_acuta_HIv2___RNAseq.g1516.t1",374.092272868744,10.8491680313311,2.47368865579588,2.66961606566981e-11,2.06882526073087e-09,NA,NA,NA,NA,NA,NA,NA
"181","Pocillopora_acuta_HIv2___RNAseq.g24787.t1",282.087472281966,13.0363632353421,3.57089792760669,2.67471186225575e-11,2.06882526073087e-09,"E7FAM5",1.26e-34,"E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177","P-body [GO:0000932]","miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
"182","Pocillopora_acuta_HIv2___TS.g12860.t1",867.113858485982,-12.4390075914916,3.31498685272648,2.69724078675891e-11,2.07515376274898e-09,"Q801S8",1.54e-10,"Collagen alpha-1(VI) chain","cell adhesion [GO:0007155]","GO:0005576; GO:0005581; GO:0007155; GO:0062023","collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]",""
"183","Pocillopora_acuta_HIv2___RNAseq.g10896.t1",275.587057410985,12.9481545888046,3.55342849363558,2.81229157231266e-11,2.15222144454658e-09,"Q6XD76",1.39e-17,"Achaete-scute homolog 4 (ASH-4) (hASH4) (Achaete-scute-like protein 4) (Class A basic helix-loop-helix protein 44) (bHLHa44)","regulation of transcription by RNA polymerase II [GO:0006357]; skin development [GO:0043588]","GO:0000785; GO:0000977; GO:0000981; GO:0006357; GO:0043588; GO:0046983; GO:0090575","chromatin [GO:0000785]; RNA polymerase II transcription regulator complex [GO:0090575]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"
"184","Pocillopora_acuta_HIv2___RNAseq.g9054.t1",818.346861337894,-11.9472620205231,3.20051994183044,3.15465430365543e-11,2.40152209726696e-09,"Q68CP4",2.88e-135,"Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76)","heparan sulfate proteoglycan catabolic process [GO:0030200]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259]","GO:0005765; GO:0005886; GO:0007041; GO:0015019; GO:0016746; GO:0030200; GO:0035579; GO:0043202; GO:0051259; GO:0070821","lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]","acyltransferase activity [GO:0016746]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]"
"185","Pocillopora_acuta_HIv2___TS.g9777.t1",344.16556752033,13.3943886323264,3.66953992653749,3.21750823442464e-11,2.42649185757467e-09,"Q29RU2",4.18e-35,"Oncoprotein-induced transcript 3 protein","","GO:0005509; GO:0005635","nuclear envelope [GO:0005635]","calcium ion binding [GO:0005509]"
"186","Pocillopora_acuta_HIv2___RNAseq.g30235.t1",499.633037389693,-11.7370455826118,2.87670405812866,3.23918703192578e-11,2.42649185757467e-09,"P55115",1.2e-54,"Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270","extracellular region [GO:0005576]","metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
"187","Pocillopora_acuta_HIv2___RNAseq.g10991.t1",264.602602943548,12.9731650274865,3.56549743836066,3.24613062824939e-11,2.42649185757467e-09,"Q9UGM3",6.87e-86,"Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)","defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031]","GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062","cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]","calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]"
"188","Pocillopora_acuta_HIv2___RNAseq.g14358.t1",241.294677966493,-13.4991567983639,3.81464982577938,3.25455904569612e-11,2.42649185757467e-09,NA,NA,NA,NA,NA,NA,NA
"189","Pocillopora_acuta_HIv2___RNAseq.g22572.t1",587.18442038473,-9.21185745105263,2.46863707804481,3.3334228303493e-11,2.47254501631652e-09,"P55115",9.29e-54,"Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270","extracellular region [GO:0005576]","metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
"190","Pocillopora_acuta_HIv2___RNAseq.g14871.t1",360.811884576937,7.61399494000854,1.46596816681784,3.35610096849973e-11,2.4766655310398e-09,"P48442",1.34e-110,"Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; regulation of presynaptic membrane potential [GO:0099505]; response to calcium ion [GO:0051592]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; vasodilation [GO:0042311]","GO:0001503; GO:0002931; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0008284; GO:0009986; GO:0010038; GO:0010628; GO:0014070; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0030424; GO:0032024; GO:0032782; GO:0035729; GO:0042311; GO:0042734; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051592; GO:0051924; GO:0060613; GO:0070374; GO:0070509; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:0098978; GO:0099505; GO:1901653; GO:1902476","apical plasma membrane [GO:0016324]; axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]","amino acid binding [GO:0016597]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; integrin binding [GO:0005178]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325]"
"191","Pocillopora_acuta_HIv2___TS.g902.t1",264.583491307625,12.8095900890293,3.52547697855901,3.67072271817726e-11,2.68629399432735e-09,NA,NA,NA,NA,NA,NA,NA
"192","Pocillopora_acuta_HIv2___RNAseq.g3322.t1",1641.02979850087,12.6456619681149,3.20327538359614,3.67731063935851e-11,2.68629399432735e-09,"Q98879",1.66e-38,"Homeobox protein Dlx4a (DLX-8) (Distal-less homeobox protein 4a)","cell differentiation [GO:0030154]; chordate embryonic development [GO:0043009]; embryonic morphogenesis [GO:0048598]; negative regulation of transcription by RNA polymerase II [GO:0000122]","GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0030154; GO:0043009; GO:0048598","nucleus [GO:0005634]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"193","Pocillopora_acuta_HIv2___TS.g12050.t1",195.857715805126,-13.1370416633375,3.73893266638543,3.83396470456469e-11,2.77272327434119e-09,NA,NA,NA,NA,NA,NA,NA
"194","Pocillopora_acuta_HIv2___RNAseq.g14348.t1",242.989419613007,12.8191483453053,3.53959303930154,4.04945356913493e-11,2.88608038072635e-09,"A2AX52",1.61e-13,"Collagen alpha-4(VI) chain","cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]","GO:0005518; GO:0005576; GO:0005581; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023","collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]","collagen binding [GO:0005518]"
"195","Pocillopora_acuta_HIv2___RNAseq.g1018.t1",314.664717169831,13.0048313038399,3.60029612652654,4.05056911841433e-11,2.88608038072635e-09,"Q0VA40",2.36e-89,"Transcription factor Sp9","","GO:0003677; GO:0005634; GO:0046872","nucleus [GO:0005634]","DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
"196","Pocillopora_acuta_HIv2___TS.g28528.t1a",661.572430165367,-11.1374325797375,2.91170693260292,4.1101080955984e-11,2.91414723013408e-09,"Q9UBG0",1.2e-39,"C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280)","collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649]","GO:0001649; GO:0005518; GO:0005925; GO:0006897; GO:0016020; GO:0030246; GO:0030574; GO:0038023","focal adhesion [GO:0005925]; membrane [GO:0016020]","carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; signaling receptor activity [GO:0038023]"
"197","Pocillopora_acuta_HIv2___RNAseq.g5325.t1",1851.39599504816,12.8479782071997,3.28997364292742,4.20546753067494e-11,2.96719334717286e-09,NA,NA,NA,NA,NA,NA,NA
"198","Pocillopora_acuta_HIv2___RNAseq.g6468.t1",936.242664635455,9.53480371432601,2.84852730669837,4.22595291425338e-11,2.96719334717286e-09,"P11617",5.42e-18,"Adenosine receptor A2a","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic signaling pathway [GO:0097190]; eating behavior [GO:0042755]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of inflammatory response [GO:0050728]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; response to amphetamine [GO:0001975]; response to purine-containing compound [GO:0014074]; synaptic transmission, dopaminergic [GO:0001963]","GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0005516; GO:0005886; GO:0007189; GO:0007626; GO:0008289; GO:0014074; GO:0019899; GO:0032230; GO:0042755; GO:0042802; GO:0046636; GO:0050728; GO:0060080; GO:0097190; GO:0098794; GO:2001235","plasma membrane [GO:0005886]; postsynapse [GO:0098794]","calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]"
"199","Pocillopora_acuta_HIv2___RNAseq.g14932.t2",321.144066743527,13.2347292390362,3.71882661683053,4.25242862525388e-11,2.96848537397007e-09,"P0C6Y7",5.95e-49,"Histone-lysine N-methyltransferase PRDM9 (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)","chromatin remodeling [GO:0006338]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiosis I [GO:0007127]; meiotic gene conversion [GO:0006311]; methylation [GO:0032259]; negative regulation of apoptotic process [GO:0043066]; positive regulation of fertilization [GO:1905516]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]","GO:0000785; GO:0000976; GO:0005634; GO:0006311; GO:0006338; GO:0007127; GO:0007129; GO:0007283; GO:0007292; GO:0008270; GO:0010468; GO:0010844; GO:0010845; GO:0032259; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0045944; GO:0046975; GO:0048232; GO:0060903; GO:0140941; GO:0140944; GO:0140949; GO:0140955; GO:0140999; GO:1905516; GO:1990918","chromatin [GO:0000785]; nucleus [GO:0005634]","histone H3K36 methyltransferase activity [GO:0046975]; histone H3K36 trimethyltransferase activity [GO:0140955]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 trimethyltransferase activity [GO:0140999]; histone H3K9 trimethyltransferase activity [GO:0140949]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone H4K20me methyltransferase activity [GO:0140941]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]"
"200","Pocillopora_acuta_HIv2___RNAseq.g3439.t1",237.035201069787,12.6682622839635,3.47907522963754,4.26883958646139e-11,2.96848537397007e-09,NA,NA,NA,NA,NA,NA,NA
"201","Pocillopora_acuta_HIv2___RNAseq.g23400.t1",225.381549575393,12.6807564784389,3.49424576988782,4.43159370866383e-11,3.06691729196716e-09,NA,NA,NA,NA,NA,NA,NA
"202","Pocillopora_acuta_HIv2___RNAseq.g15331.t1",302.46734295645,10.2909936068741,2.31856741054328,4.58960336896555e-11,3.15792114252289e-09,"Q03046",1.06e-18,"Isopenicillin N epimerase (EC 5.1.1.17)","antibiotic biosynthetic process [GO:0017000]","GO:0017000; GO:0045439","","isopenicillin-N epimerase activity [GO:0045439]"
"203","Pocillopora_acuta_HIv2___RNAseq.g7759.t1",254.520370342243,12.8038345830299,3.517874117804,4.82440142817453e-11,3.27776994513966e-09,"Q9WYX8",2e-50,"Uncharacterized protein TM_0508","DNA recombination [GO:0006310]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]","GO:0000731; GO:0003677; GO:0005524; GO:0006261; GO:0006310; GO:0008047; GO:0009378; GO:0016887; GO:0017116","","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; four-way junction helicase activity [GO:0009378]; single-stranded DNA helicase activity [GO:0017116]"
"204","Pocillopora_acuta_HIv2___TS.g13571.t1",264.733380063895,12.8902110040639,3.58855154399739,4.82990293741343e-11,3.27776994513966e-09,"Q7RTR2",5.88e-31,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223","centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]","ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]"
"205","Pocillopora_acuta_HIv2___RNAseq.g8685.t1",253.737824638808,12.6745243438479,3.50486568722752,4.84957666108882e-11,3.27776994513966e-09,NA,NA,NA,NA,NA,NA,NA
"206","Pocillopora_acuta_HIv2___RNAseq.g21265.t1",347.296729007003,12.9361589800712,3.63970528064661,4.93074469637653e-11,3.31712982736699e-09,"Q9N126",8.65e-67,"Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase)","estrogen biosynthetic process [GO:0006703]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]","GO:0004303; GO:0004745; GO:0005829; GO:0006703; GO:0007601; GO:0042572; GO:0042622; GO:0052650","cytosol [GO:0005829]; photoreceptor outer segment membrane [GO:0042622]","all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]"
"207","Pocillopora_acuta_HIv2___RNAseq.g28641.t1",1378.32284485933,12.260241011996,3.22044393163886,5.08341061480347e-11,3.40400236724617e-09,"P31851",1.07e-85,"Protein TabA","lysine biosynthetic process via diaminopimelate [GO:0009089]","GO:0008836; GO:0009089","","diaminopimelate decarboxylase activity [GO:0008836]"
"208","Pocillopora_acuta_HIv2___RNAseq.g26781.t1",215.555654916289,12.6153597666115,3.47856226013953,5.23392007446987e-11,3.48863686438397e-09,NA,NA,NA,NA,NA,NA,NA
"209","Pocillopora_acuta_HIv2___RNAseq.g18273.t1",936.232722120782,11.9178881743014,2.9634189931708,5.41860727562818e-11,3.57942550272028e-09,"Q8IS64",0,"Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)","proteolysis [GO:0006508]","GO:0004175; GO:0004222; GO:0005886; GO:0006508; GO:0008270","plasma membrane [GO:0005886]","endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
"210","Pocillopora_acuta_HIv2___TS.g25577.t1a",635.713658056637,14.3335122359614,3.87589000129544,5.41962240801813e-11,3.57942550272028e-09,NA,NA,NA,NA,NA,NA,NA
"211","Pocillopora_acuta_HIv2___RNAseq.g1841.t1",225.001535912449,12.7315981431678,3.51842606547456,5.50090688005095e-11,3.61272470277095e-09,"Q8N3E9",8.21e-102,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-3) (Phospholipase C-delta-3) (PLC-delta-3)","angiogenesis [GO:0001525]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipid catabolic process [GO:0016042]; regulation of cell population proliferation [GO:0042127]","GO:0001525; GO:0004435; GO:0005654; GO:0005737; GO:0005886; GO:0016042; GO:0032154; GO:0035556; GO:0042127; GO:0046872; GO:0060716","cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]","metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]"
"212","Pocillopora_acuta_HIv2___RNAseq.g25839.t1",417.103348683199,13.2133629013513,3.56758849466137,5.51999557046723e-11,3.61272470277095e-09,"Q9UDY8",8.87e-39,"Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase)","B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]","GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0036094; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0043280; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051092; GO:0051168; GO:0051603; GO:2000321","CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096]; protein-containing complex [GO:0032991]","cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; small molecule binding [GO:0036094]; ubiquitin-protein transferase activity [GO:0004842]"
"213","Pocillopora_acuta_HIv2___RNAseq.g19355.t1",356.045024497617,10.6396816319439,2.51217628570134,5.80975652574195e-11,3.78523956704196e-09,NA,NA,NA,NA,NA,NA,NA
"214","Pocillopora_acuta_HIv2___RNAseq.g7975.t1",465.593153266525,9.84391581065605,2.22791184811019,6.02137178246751e-11,3.87080539829378e-09,NA,NA,NA,NA,NA,NA,NA
"215","Pocillopora_acuta_HIv2___TS.g12304.t1",114980.255845133,-5.89084566490943,1.20561838355778,6.31984219863399e-11,4.04469900712575e-09,"P00918",2.04e-48,"Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69)","angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; one-carbon metabolic process [GO:0006730]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; secretion [GO:0046903]","GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0006730; GO:0008270; GO:0015670; GO:0018820; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0046903; GO:0051453; GO:0070050; GO:0070062; GO:2001150; GO:2001225","apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]","arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; zinc ion binding [GO:0008270]"
"216","Pocillopora_acuta_HIv2___RNAseq.g27022.t1",1176.16342223307,-10.1564313262024,3.30427803471523,6.6245006300302e-11,4.22100339703775e-09,NA,NA,NA,NA,NA,NA,NA
"217","Pocillopora_acuta_HIv2___TS.6598_t",238.194855496312,12.7909129518035,3.57570529446804,6.76661656816086e-11,4.28750391511763e-09,"Q6L8S8",2.41e-71,"Beta-1,4-N-acetylgalactosaminyltransferase 3 (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)","chondroitin sulfate biosynthetic process [GO:0030206]","GO:0008376; GO:0030206; GO:0032580; GO:0033842; GO:0047238","Golgi cisterna membrane [GO:0032580]","acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity [GO:0033842]"
"218","Pocillopora_acuta_HIv2___RNAseq.g9089.t1",319.56517136315,10.090589517521,2.11114704302213,6.78815263109746e-11,4.28750391511763e-09,"A0A2K5X3B6",1.25e-51,"Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1)","3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; flavonoid metabolic process [GO:0009812]","GO:0004062; GO:0005829; GO:0008146; GO:0009812; GO:0050427","cytosol [GO:0005829]","aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]"
"219","Pocillopora_acuta_HIv2___TS.g4109.t3",319.818971445215,9.82364242451379,2.17668995160413,6.82560930600239e-11,4.2924179566095e-09,"Q0ZLH3",8.77e-14,"Pejvakin (Autosomal recessive deafness type 59 protein)","detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; pexophagy [GO:0000425]; programmed cell death in response to reactive oxygen species [GO:0097468]; regulation of peroxisome organization [GO:1900063]; response to reactive oxygen species [GO:0000302]; sensory perception of sound [GO:0007605]; stereocilium maintenance [GO:0120045]","GO:0000302; GO:0000425; GO:0005737; GO:0005778; GO:0007605; GO:0030864; GO:0035253; GO:0043025; GO:0050910; GO:0097468; GO:0120044; GO:0120045; GO:1900063","ciliary rootlet [GO:0035253]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; stereocilium base [GO:0120044]",""
"220","Pocillopora_acuta_HIv2___RNAseq.g12018.t1",4250.42387939196,3.55963206661598,0.585682190132876,6.89269720124825e-11,4.31584295752617e-09,NA,NA,NA,NA,NA,NA,NA
"221","Pocillopora_acuta_HIv2___RNAseq.g26032.t1",1243.05244410442,12.4140201960031,3.20015687495984,6.95237294060863e-11,4.33444492297256e-09,"Q85WU2",2.86e-10,"Protein TIC 214 (Translocon at the inner envelope membrane of chloroplasts 214) (AtTIC214)","protein transport [GO:0015031]","GO:0009706; GO:0015031","chloroplast inner membrane [GO:0009706]",""
"222","Pocillopora_acuta_HIv2___TS.g6104.t1",847.604023362473,11.3751535395578,2.87349272700753,7.12106833842365e-11,4.42056362433303e-09,"Q5HY64",3.55e-18,"Putative protein FAM47C","","","",""
"223","Pocillopora_acuta_HIv2___RNAseq.g29835.t1",632.036613902695,10.8263177388995,2.71878167648346,7.30553497447992e-11,4.49932615929005e-09,NA,NA,NA,NA,NA,NA,NA
"224","Pocillopora_acuta_HIv2___RNAseq.g3837.t1a",978.541972025751,12.0380544924722,3.07467403199536,7.31016072616953e-11,4.49932615929005e-09,"Q90268",1.29e-63,"Paired box protein Pax-2a (No isthmus protein) (Pax[Zf-b])","anterior/posterior pattern specification [GO:0009952]; anterior/posterior pattern specification involved in pronephros development [GO:0034672]; cell fate specification [GO:0001708]; cerebellum development [GO:0021549]; cerebellum formation [GO:0021588]; cilium assembly [GO:0060271]; closure of optic fissure [GO:0061386]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic pattern specification [GO:0009880]; hindbrain development [GO:0030902]; inner ear receptor cell differentiation [GO:0060113]; kidney development [GO:0001822]; locus ceruleus development [GO:0021703]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; nervous system development [GO:0007399]; otic placode formation [GO:0043049]; peripheral nervous system development [GO:0007422]; pronephric glomerulus morphogenesis [GO:0035775]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; regulation of transcription by RNA polymerase II [GO:0006357]; thyroid gland development [GO:0030878]; vestibular receptor cell development [GO:0060118]","GO:0000978; GO:0000981; GO:0001708; GO:0001822; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007399; GO:0007422; GO:0009880; GO:0009952; GO:0021549; GO:0021588; GO:0021703; GO:0030878; GO:0030901; GO:0030902; GO:0030917; GO:0034672; GO:0035775; GO:0043049; GO:0043565; GO:0048596; GO:0048793; GO:0060113; GO:0060118; GO:0060271; GO:0061386; GO:0072114","nucleus [GO:0005634]","DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
"225","Pocillopora_acuta_HIv2___RNAseq.7335_t",1155.23121310386,-11.2506838602395,3.12069984030484,7.38543189462971e-11,4.5263935137256e-09,"Q91619",1.16e-10,"Nodal homolog (Nodal-related protein 1) (Xnr-1) (Xnr1) (nr-1)","axial mesoderm development [GO:0048318]; axial mesoderm formation [GO:0048320]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; nodal signaling pathway [GO:0038092]; paraxial mesoderm development [GO:0048339]","GO:0003140; GO:0005125; GO:0005576; GO:0005615; GO:0007368; GO:0007507; GO:0008083; GO:0016015; GO:0038092; GO:0048318; GO:0048320; GO:0048339","extracellular region [GO:0005576]; extracellular space [GO:0005615]","cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; morphogen activity [GO:0016015]"
"226","Pocillopora_acuta_HIv2___RNAseq.g14576.t1",352.944013763663,13.2842688546036,3.75413260957411,7.45624887374227e-11,4.53757525744039e-09,"P46023",9.55e-52,"G-protein coupled receptor GRL101","","GO:0004930; GO:0005886","plasma membrane [GO:0005886]","G protein-coupled receptor activity [GO:0004930]"
"227","Pocillopora_acuta_HIv2___RNAseq.g14712.t1",259.163273632328,7.37054089335787,1.40534561441269,7.46641946398515e-11,4.53757525744039e-09,NA,NA,NA,NA,NA,NA,NA
"228","Pocillopora_acuta_HIv2___RNAseq.g23688.t1",747.922168689888,11.0596883314445,2.87775393603953,7.573755842142e-11,4.58354830547037e-09,NA,NA,NA,NA,NA,NA,NA
"229","Pocillopora_acuta_HIv2___RNAseq.g8579.t1",237.302808985398,12.6555352755487,3.54126600693397,7.66511345166165e-11,4.61950837353475e-09,NA,NA,NA,NA,NA,NA,NA
"230","Pocillopora_acuta_HIv2___TS.g15672.t1",261.983130716057,10.2037019736978,2.32057168503931,7.97940984578439e-11,4.78897029084753e-09,"Q91VN0",1.9e-41,"Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7)","adipose tissue development [GO:0060612]; amino acid transport [GO:0006865]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; blood vessel morphogenesis [GO:0048514]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mesodermal cell migration [GO:0008078]; negative regulation of osteoblast differentiation [GO:0045668]; nervous system development [GO:0007399]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; osteoblast proliferation [GO:0033687]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature development in camera-type eye [GO:0061298]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055]","GO:0001702; GO:0001944; GO:0002053; GO:0002076; GO:0005739; GO:0005783; GO:0005886; GO:0006007; GO:0006865; GO:0006897; GO:0007399; GO:0008078; GO:0008203; GO:0008217; GO:0009952; GO:0010467; GO:0015026; GO:0016055; GO:0017147; GO:0033687; GO:0033690; GO:0035019; GO:0035108; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048514; GO:0048539; GO:0051091; GO:0060033; GO:0060042; GO:0060070; GO:0060348; GO:0060349; GO:0060444; GO:0060603; GO:0060612; GO:0060764; GO:0060856; GO:0061178; GO:0061298; GO:0061299; GO:0061304; GO:0098609; GO:0110135; GO:1902262; GO:1990963","endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]","coreceptor activity [GO:0015026]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
"231","Pocillopora_acuta_HIv2___RNAseq.g21915.t1",239.410855885202,12.5603247309787,3.50379575616474,8.02355507521283e-11,4.79556614082142e-09,"Q6IND7",3.85e-110,"LRP2-binding protein","","GO:0005737","cytoplasm [GO:0005737]",""
"232","Pocillopora_acuta_HIv2___RNAseq.g18413.t1",302.638732308369,-11.420697828959,2.83422641612043,8.63480769528677e-11,5.13966495903818e-09,"Q8AWC7",4.91e-29,"Alpha-(1,3)-fucosyltransferase 11 (EC 2.4.1.-) (Fucosyltransferase XI) (Fuc-TXI) (FucT-XI) (Galactoside 3-L-fucosyltransferase 11) (Fucosyltransferase 11)","fucosylation [GO:0036065]; protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0032580; GO:0036065; GO:0046920","Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]","alpha-(1->3)-fucosyltransferase activity [GO:0046920]"
"233","Pocillopora_acuta_HIv2___RNAseq.7853_t",1313.27373726846,12.5750059002173,3.26291066945328,9.03002947008574e-11,5.35288304325082e-09,NA,NA,NA,NA,NA,NA,NA
"234","Pocillopora_acuta_HIv2___TS.g23308.t1",433.336818344534,8.18340259034887,1.81697703928565,9.07033071181521e-11,5.35482707819164e-09,"B8EIZ7",1.29e-173,"Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148)","","GO:0004499; GO:0034899; GO:0047822; GO:0050660; GO:0050661","","flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; trimethylamine monooxygenase activity [GO:0034899]"
"235","Pocillopora_acuta_HIv2___RNAseq.g2416.t1",191.354281203994,8.49744692303689,1.67806657327769,9.17860522005316e-11,5.39672137816459e-09,NA,NA,NA,NA,NA,NA,NA
"236","Pocillopora_acuta_HIv2___RNAseq.g25532.t1",344.325732515914,10.5613161322442,2.5624930318913,9.38471500046333e-11,5.4955675209191e-09,"Q5REJ1",1.31e-61,"Small ribosomal subunit protein uS5m (28S ribosomal protein S5, mitochondrial) (MRP-S5) (S5mt)","translation [GO:0006412]","GO:0003723; GO:0003735; GO:0005763; GO:0006412","mitochondrial small ribosomal subunit [GO:0005763]","RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
"237","Pocillopora_acuta_HIv2___RNAseq.g26092.t1",435.119893250857,9.16981810299998,2.08510283899894,9.43699677462144e-11,5.50390005435986e-09,NA,NA,NA,NA,NA,NA,NA
"238","Pocillopora_acuta_HIv2___RNAseq.1261_t",305.429133816307,12.800248377379,3.55743498053644,9.51510024405285e-11,5.52716505742893e-09,"Q58116",2.27e-71,"3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34)","coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; sterol biosynthetic process [GO:0016126]","GO:0004420; GO:0008299; GO:0015936; GO:0016126","","hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]"
"239","Pocillopora_acuta_HIv2___RNAseq.g12660.t1",293.90661207509,12.8287466636404,3.58580369757244,1.02386196025164e-10,5.92365575723188e-09,NA,NA,NA,NA,NA,NA,NA
"240","Pocillopora_acuta_HIv2___RNAseq.g9609.t1",210.694268716008,12.5213711709701,3.50154496501506,1.05132141832626e-10,6.05829202974943e-09,"G8XYX6",3.32e-69,"Monocarboxylate transporter 8 (MCT 8) (Solute carrier family 16 member 2)","brain development [GO:0007420]; central nervous system development [GO:0007417]; chordate embryonic development [GO:0043009]; locomotion [GO:0040011]; neuron differentiation [GO:0030182]; oligodendrocyte differentiation [GO:0048709]; optomotor response [GO:0071632]; regulation of thyroid hormone generation [GO:2000609]; Schwann cell differentiation [GO:0014037]; spinal cord development [GO:0021510]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; thyroid gland development [GO:0030878]; transmission of nerve impulse [GO:0019226]","GO:0007417; GO:0007420; GO:0014037; GO:0015349; GO:0016324; GO:0019226; GO:0021510; GO:0021529; GO:0030182; GO:0030878; GO:0040011; GO:0043009; GO:0048709; GO:0070324; GO:0071632; GO:2000609","apical plasma membrane [GO:0016324]","thyroid hormone binding [GO:0070324]; thyroid hormone transmembrane transporter activity [GO:0015349]"
"241","Pocillopora_acuta_HIv2___TS.g4148.t1b",261.243744564734,12.8094895058825,3.61913046930757,1.05618951991263e-10,6.0621925460382e-09,NA,NA,NA,NA,NA,NA,NA
"242","Pocillopora_acuta_HIv2___RNAseq.6257_t",1225.63410570247,12.3486864644056,3.1920024374979,1.09079560301146e-10,6.23607415097143e-09,"A6H584",2.93e-15,"Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain)","cell adhesion [GO:0007155]","GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023","collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]",""
"243","Pocillopora_acuta_HIv2___RNAseq.g5054.t1",255.372150994561,12.5468194685137,3.54578844973163,1.11267842315077e-10,6.33613413876091e-09,NA,NA,NA,NA,NA,NA,NA
"244","Pocillopora_acuta_HIv2___TS.g4148.t1c",2544.66451385655,6.36117381651855,1.32354877836706,1.13412858080629e-10,6.43295521285575e-09,"P98088",4.18e-06,"Mucin-5AC (MUC-5AC) (Gastric mucin) (Major airway glycoprotein) (Mucin-5 subtype AC, tracheobronchial) (Tracheobronchial mucin) (TBM)","","GO:0005201; GO:0005615; GO:0005796; GO:0005886; GO:0031012; GO:0046872; GO:0070062; GO:0070701","extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; mucus layer [GO:0070701]; plasma membrane [GO:0005886]","extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]"
"245","Pocillopora_acuta_HIv2___TS.g8934.t1",1086.976965865,5.6337518292812,1.09466238070908,1.18740772202113e-10,6.70885362941936e-09,NA,NA,NA,NA,NA,NA,NA
"246","Pocillopora_acuta_HIv2___RNAseq.g13682.t1",211.268369190467,12.6088769516168,3.55804395209688,1.27699534010326e-10,7.186949649515e-09,"Q1G7G9",1.61e-47,"TALPID3 protein","centrosome localization [GO:0051642]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458]; smoothened signaling pathway [GO:0007224]","GO:0005737; GO:0005813; GO:0005814; GO:0007224; GO:0036064; GO:0044458; GO:0051642; GO:0060271","centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]",""
"247","Pocillopora_acuta_HIv2___TS.g6682.t1",2368.98413027754,9.99608553376362,3.3217461649711,1.36561876128296e-10,7.65593401674292e-09,"Q6GM82",2.43e-154,"Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2)","2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]","GO:0004021; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853","","L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]"
"248","Pocillopora_acuta_HIv2___TS.g5115.t2",13271.9800359766,-5.73428714126196,1.17720429762016,1.4127839495395e-10,7.88977106028544e-09,"P07898",1.61e-11,"Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)","cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; glial cell differentiation [GO:0010001]; positive regulation of neuroblast proliferation [GO:0002052]; skeletal system development [GO:0001501]","GO:0001501; GO:0002052; GO:0005509; GO:0005540; GO:0005615; GO:0007155; GO:0007417; GO:0010001; GO:0030246; GO:0045202; GO:0072534","extracellular space [GO:0005615]; perineuronal net [GO:0072534]; synapse [GO:0045202]","calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
"249","Pocillopora_acuta_HIv2___RNAseq.g19043.t1",733.86103339952,11.2206004383845,3.08419265723761,1.4245767322608e-10,7.92502994439238e-09,"Q14AT5",0,"Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G)","calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; establishment of localization in cell [GO:0051649]","GO:0005254; GO:0005783; GO:0005886; GO:0017128; GO:0046983; GO:0051649; GO:0061588; GO:0061589; GO:0061590; GO:0061591; GO:1902476","endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]","chloride channel activity [GO:0005254]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]"
"250","Pocillopora_acuta_HIv2___RNAseq.g22818.t1",223.144981708577,12.5079823636837,3.52451733604643,1.44618538950046e-10,8.0144158903198e-09,NA,NA,NA,NA,NA,NA,NA
"251","Pocillopora_acuta_HIv2___RNAseq.g17427.t1",303.365582089317,12.9130137413601,3.6189204844768,1.4580478848031e-10,8.04931473503512e-09,NA,NA,NA,NA,NA,NA,NA
"252","Pocillopora_acuta_HIv2___RNAseq.g19428.t1",952.546508063329,11.8759115487074,3.06069764534494,1.56008346183544e-10,8.54736636060146e-09,"Q8IS64",0,"Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)","proteolysis [GO:0006508]","GO:0004175; GO:0004222; GO:0005886; GO:0006508; GO:0008270","plasma membrane [GO:0005886]","endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
"253","Pocillopora_acuta_HIv2___RNAseq.g29795.t1",402.139504546331,-11.353602111339,3.01944816308056,1.58125523484212e-10,8.6306700817949e-09,"O88799",2.25e-08,"Zonadhesin","binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; regulation of binding of sperm to zona pellucida [GO:2000359]","GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840; GO:2000359","extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]","extracellular matrix binding [GO:0050840]"
"254","Pocillopora_acuta_HIv2___RNAseq.g8849.t1",636.275971677191,11.4629443420845,2.93991346651318,1.62471904630045e-10,8.8345625134172e-09,"Q59I44",6.43e-68,"2-haloacrylate reductase (EC 1.3.1.103)","halogenated hydrocarbon catabolic process [GO:0042206]","GO:0003960; GO:0005829; GO:0016628; GO:0042206; GO:0070402; GO:0102523","cytosol [GO:0005829]","2-chloroacrylate reductase activity [GO:0102523]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]"
"255","Pocillopora_acuta_HIv2___RNAseq.g7509.t2",1718.62032504362,-6.70608209808779,4.36130890263325,1.73023795474928e-10,9.35462204491619e-09,"Q9Y2G1",2e-151,"Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal]","central nervous system myelin maintenance [GO:0032286]; central nervous system myelination [GO:0022010]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein autoprocessing [GO:0016540]; response to cocaine [GO:0042220]; response to immobilization stress [GO:0035902]","GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005829; GO:0008233; GO:0014003; GO:0016540; GO:0022010; GO:0031643; GO:0032286; GO:0035902; GO:0042220; GO:0042802; GO:0043565; GO:0045893; GO:0048709; GO:0048714","cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; sequence-specific DNA binding [GO:0043565]"
"256","Pocillopora_acuta_HIv2___TS.g13882.t1c",196.682004132868,-12.7705776133203,3.78179766669794,1.73329556695073e-10,9.35462204491619e-09,"Q20191",5.77e-07,"Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270","extracellular region [GO:0005576]","metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
"257","Pocillopora_acuta_HIv2___RNAseq.g13583.t1",188.304964680578,12.3968768167343,3.48677081514363,1.78515598611516e-10,9.59869746586234e-09,NA,NA,NA,NA,NA,NA,NA
"258","Pocillopora_acuta_HIv2___RNAseq.g7241.t1",474.333676086549,10.238737356585,2.54450883216366,1.79715723129689e-10,9.62743784943638e-09,"Q8WU66",1.99e-36,"Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170","cell surface [GO:0009986]; ciliary membrane [GO:0060170]; extracellular region [GO:0005576]; stereocilium [GO:0032420]",""
"259","Pocillopora_acuta_HIv2___RNAseq.g26552.t1",8991.89050197275,9.39039821155638,2.71549653200867,1.86285370044447e-10,9.94255200119143e-09,"Q9U6Y6",3.32e-59,"GFP-like fluorescent chromoprotein amFP486","bioluminescence [GO:0008218]; generation of precursor metabolites and energy [GO:0006091]","GO:0006091; GO:0008218","",""
"260","Pocillopora_acuta_HIv2___TS.g20196.t1",743.769775938976,11.7969847368547,3.07860837201454,1.91268007615615e-10,1.01709575814421e-08,"Q3UZD5",8.48e-95,"Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle)","methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468]","GO:0000122; GO:0005634; GO:0010468; GO:0022008; GO:0032259; GO:0042802; GO:0045892; GO:0046872; GO:0051151; GO:0140944","nucleus [GO:0005634]","histone H4K20 monomethyltransferase activity [GO:0140944]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"
"261","Pocillopora_acuta_HIv2___RNAseq.g24078.t1",228.186832937449,12.7109134935764,3.61346450126086,1.93593190509825e-10,1.02343146362217e-08,"Q96DX5",2.61e-33,"Ankyrin repeat and SOCS box protein 9 (ASB-9)","intracellular signal transduction [GO:0035556]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]","GO:0005739; GO:0005829; GO:0016567; GO:0031466; GO:0035556; GO:0043161; GO:0045732; GO:1990756","Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; mitochondrion [GO:0005739]","ubiquitin-like ligase-substrate adaptor activity [GO:1990756]"
"262","Pocillopora_acuta_HIv2___RNAseq.g3224.t1",1245.07091600311,12.3537828110542,3.27182688148989,1.93874599718249e-10,1.02343146362217e-08,NA,NA,NA,NA,NA,NA,NA
"263","Pocillopora_acuta_HIv2___TS.g15797.t1",226.062481669673,12.3633771906792,3.48894744741664,1.94736931857707e-10,1.02424544814177e-08,NA,NA,NA,NA,NA,NA,NA
"264","Pocillopora_acuta_HIv2___RNAseq.g20063.t1",1022.35153509226,9.8912720720197,2.76186500502802,1.99874479838378e-10,1.04745814361677e-08,NA,NA,NA,NA,NA,NA,NA
"265","Pocillopora_acuta_HIv2___RNAseq.g25934.t1",281.793136760874,12.6336486530072,3.56626447490167,2.00687932877409e-10,1.04792428199958e-08,"Q9TV36",4.47e-17,"Fibrillin-1 [Cleaved into: Asprosin]","anatomical structure morphogenesis [GO:0009653]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0008201; GO:0009653; GO:0031012","extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]","calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]"
"266","Pocillopora_acuta_HIv2___RNAseq.g28408.t1",303.661864320727,7.21139173820937,1.54235581540727,2.04191984926881e-10,1.0623859244541e-08,"Q9DCR2",9.28e-107,"AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adaptor-related protein complex 3 subunit sigma-1) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a)","anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; synaptic vesicle coating [GO:0016183]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]","GO:0005769; GO:0005802; GO:0006886; GO:0006896; GO:0008089; GO:0016020; GO:0016183; GO:0016192; GO:0030123; GO:0030659; GO:0035654; GO:0036465; GO:0043231; GO:0046907; GO:0048490; GO:0060155; GO:0098793; GO:1903232; GO:1904115","AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; presynapse [GO:0098793]; trans-Golgi network [GO:0005802]",""
"267","Pocillopora_acuta_HIv2___RNAseq.g14013.t1a",937.515505918064,11.8857291648388,3.12984226054913,2.10676801799163e-10,1.09106723389191e-08,"O42574",1.37e-29,"Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor) (x-BETA1AR)","adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; positive regulation of heart contraction [GO:0045823]","GO:0004940; GO:0005769; GO:0005886; GO:0045823; GO:0071880","early endosome [GO:0005769]; plasma membrane [GO:0005886]","beta1-adrenergic receptor activity [GO:0004940]"
"268","Pocillopora_acuta_HIv2___RNAseq.g28741.t1",193.979634261383,12.3833036884065,3.484829707572,2.1121323664943e-10,1.09106723389191e-08,"P57695",2.29e-71,"Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit)","cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; monoatomic ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; neuropeptide signaling pathway [GO:0007218]; response to alcohol [GO:0097305]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]","GO:0001964; GO:0004888; GO:0005886; GO:0006811; GO:0006821; GO:0006936; GO:0007218; GO:0008270; GO:0016594; GO:0016934; GO:0022824; GO:0030425; GO:0030594; GO:0030977; GO:0034707; GO:0043005; GO:0043025; GO:0043204; GO:0043231; GO:0045202; GO:0045211; GO:0051970; GO:0060012; GO:0060080; GO:0071230; GO:0071294; GO:0071361; GO:0097305; GO:1902476; GO:1902495","chloride channel complex [GO:0034707]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495]","extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; neurotransmitter receptor activity [GO:0030594]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity [GO:0022824]; zinc ion binding [GO:0008270]"
"269","Pocillopora_acuta_HIv2___RNAseq.g23418.t1",1185.96706002756,-12.5594378544196,3.68970917083941,2.15210591564985e-10,1.10427802951151e-08,NA,NA,NA,NA,NA,NA,NA
"270","Pocillopora_acuta_HIv2___RNAseq.g8080.t1",735.017606754467,11.5254921395258,3.15070652767912,2.1529756935996e-10,1.10427802951151e-08,"Q9P2E3",0,"NFX1-type zinc finger-containing protein 1","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607","cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380]","helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
"271","Pocillopora_acuta_HIv2___RNAseq.g26057.t1",470.870608811962,-8.41613987683188,2.18527204822184,2.25181916006572e-10,1.14684198349262e-08,"Q96P65",6.23e-25,"Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155)","cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0016020; GO:0032870; GO:0042277","membrane [GO:0016020]; plasma membrane [GO:0005886]","G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; peptide binding [GO:0042277]"
"272","Pocillopora_acuta_HIv2___RNAseq.g6500.t1",142.045236368868,-12.5772179232644,3.6588406076683,2.44421161845104e-10,1.23924432008629e-08,NA,NA,NA,NA,NA,NA,NA
"273","Pocillopora_acuta_HIv2___RNAseq.g29823.t1",598.356142947403,9.13406540987842,2.47013947849927,2.45038630769274e-10,1.23924432008629e-08,NA,NA,NA,NA,NA,NA,NA
"274","Pocillopora_acuta_HIv2___TS.g18521.t1b",182.216525273293,12.2756002431643,3.46347190772941,2.47314253965449e-10,1.24639490221472e-08,NA,NA,NA,NA,NA,NA,NA
"275","Pocillopora_acuta_HIv2___TS.g23175.t1",218.460484313913,12.410050917337,3.52778562066305,2.53077723892608e-10,1.26926325747905e-08,"Q96RW7",3.37e-66,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711","adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927]","calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]"
"276","Pocillopora_acuta_HIv2___RNAseq.g6446.t1",7264.0806341713,-4.25723385913054,0.765020624777039,2.53606942347516e-10,1.26926325747905e-08,"B3EWZ3",0,"Coadhesin","","GO:0016020","membrane [GO:0016020]",""
"277","Pocillopora_acuta_HIv2___RNAseq.g5386.t1",2718.69975807601,7.78869266624633,5.53064520615663,2.68793429240129e-10,1.34063040018249e-08,NA,NA,NA,NA,NA,NA,NA
"278","Pocillopora_acuta_HIv2___RNAseq.g7573.t1",197.555023493453,12.3083137229159,3.50844590583556,2.7346884052824e-10,1.35775851353588e-08,"Q96M20",4.21e-28,"Cyclic nucleotide-binding domain-containing protein 2","spermatogenesis [GO:0007283]","GO:0005829; GO:0007283; GO:0030552","cytosol [GO:0005829]","cAMP binding [GO:0030552]"
"279","Pocillopora_acuta_HIv2___TS.g19887.t1",525.99718908866,-11.8384687498707,3.1705863399387,2.76471130939357e-10,1.36016273398193e-08,"Q92051",2.1e-38,"Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase)","carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]; one-carbon metabolic process [GO:0006730]; regulation of pH [GO:0006885]","GO:0004089; GO:0005737; GO:0006730; GO:0006885; GO:0008270; GO:0015670; GO:0042539","cytoplasm [GO:0005737]","carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
"280","Pocillopora_acuta_HIv2___TS.g25258.t1",2035.87614383464,9.03279707716644,3.52760310389,2.8330254332194e-10,1.38904677512154e-08,"B3EWY9",0,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020","extracellular space [GO:0005615]; membrane [GO:0016020]","calcium ion binding [GO:0005509]"
"281","Pocillopora_acuta_HIv2___RNAseq.1449_t",2692.51660313172,6.76964986427974,5.03493197359299,2.86319144250583e-10,1.39909462920285e-08,"Q58A42",2.65e-67,"Protein DD3-3","","GO:0016020","membrane [GO:0016020]",""
"282","Pocillopora_acuta_HIv2___RNAseq.g2734.t1",2074.16025618192,12.7717191592797,3.48146738984921,2.92769078221195e-10,1.42579526848194e-08,NA,NA,NA,NA,NA,NA,NA
"283","Pocillopora_acuta_HIv2___RNAseq.g39.t2",624.418501450814,-11.2276074380742,3.24224056184406,2.94276858722585e-10,1.42832902166559e-08,"Q9IBG7",5.87e-17,"Kielin/chordin-like protein (Cysteine-rich motor neuron 2 protein) (CRIM-2) (Kielin)","","GO:0005576","extracellular region [GO:0005576]",""
"284","Pocillopora_acuta_HIv2___RNAseq.g25891.t1",1602.0530952941,9.58954215179262,2.66203604567093,2.96457673590096e-10,1.43410160227664e-08,"P48630",1.35e-119,"Omega-6 fatty acid desaturase, endoplasmic reticulum isozyme 1 (EC 1.14.19.-)","unsaturated fatty acid biosynthetic process [GO:0006636]","GO:0005789; GO:0006636; GO:0016491","endoplasmic reticulum membrane [GO:0005789]","oxidoreductase activity [GO:0016491]"
"285","Pocillopora_acuta_HIv2___RNAseq.g15526.t1",934.860262231967,11.4342667492802,3.10692705829082,3.06579675871141e-10,1.47812281060006e-08,"O93384",2.14e-162,"S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 (SAND) (Radical S-adenosyl methionine domain-containing protein 2) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) (Viperin)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of immune response [GO:0050778]","GO:0003824; GO:0005739; GO:0005789; GO:0005811; GO:0045087; GO:0046872; GO:0050778; GO:0051539; GO:0051607","endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]","4 iron, 4 sulfur cluster binding [GO:0051539]; catalytic activity [GO:0003824]; metal ion binding [GO:0046872]"
"286","Pocillopora_acuta_HIv2___RNAseq.g15097.t1",414.097998300102,8.77613608148459,2.24846940570622,3.09606177485947e-10,1.48775539905539e-08,"Q16322",1.7e-08,"Potassium voltage-gated channel subfamily A member 10 (Voltage-gated potassium channel subunit Kv1.8)","action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]","GO:0001508; GO:0005221; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016020; GO:0051260; GO:0071805","membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]","delayed rectifier potassium channel activity [GO:0005251]; intracellularly cyclic nucleotide-activated monoatomic cation channel activity [GO:0005221]; voltage-gated potassium channel activity [GO:0005249]"
"287","Pocillopora_acuta_HIv2___RNAseq.g6506.t1",185.419361870884,12.2013803013032,3.47497632079879,3.22913522676391e-10,1.54370445330735e-08,NA,NA,NA,NA,NA,NA,NA
"288","Pocillopora_acuta_HIv2___RNAseq.g26602.t1",134.181647093054,-12.5408567991062,3.66388552488646,3.23383883678185e-10,1.54370445330735e-08,NA,NA,NA,NA,NA,NA,NA
"289","Pocillopora_acuta_HIv2___RNAseq.g30398.t1",1296.99952263402,12.1538633941157,3.39410012118886,3.30238407124562e-10,1.57123957916108e-08,"P83858",2.55e-24,"Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155)","cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0032870; GO:0042277; GO:0097730","non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]","G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; peptide binding [GO:0042277]"
"290","Pocillopora_acuta_HIv2___RNAseq.g20587.t2",299.561781586977,10.1328783028929,2.5300404111321,3.34731328116774e-10,1.58739473110853e-08,NA,NA,NA,NA,NA,NA,NA
"291","Pocillopora_acuta_HIv2___RNAseq.g710.t1",707.193089478224,11.5446152463379,3.13813882575476,3.43122606504182e-10,1.6218710393714e-08,"Q7TN88",1e-49,"Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982","membrane [GO:0016020]","calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965]"
"292","Pocillopora_acuta_HIv2___RNAseq.g14886.t1",967.371642145282,8.5023305331241,3.41977427838104,3.87910945213185e-10,1.82760387998811e-08,"Q9Y2U5",5.86e-73,"Mitogen-activated protein kinase kinase kinase 2 (EC 2.7.11.25) (MAPK/ERK kinase kinase 2) (MEK kinase 2) (MEKK 2)","cellular response to mechanical stimulus [GO:0071260]; intracellular signal transduction [GO:0035556]","GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0019901; GO:0035556; GO:0046872; GO:0071260; GO:0106310","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]","ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]"
"293","Pocillopora_acuta_HIv2___RNAseq.g18767.t1",1916.46248474384,12.2497597975473,3.55440058701461,4.3623651905696e-10,2.0419822044142e-08,"P50430",1.07e-114,"Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)","anterior head development [GO:0097065]; autophagy [GO:0006914]; colon epithelial cell migration [GO:0061580]; dermatan sulfate catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]","GO:0003943; GO:0004065; GO:0005764; GO:0006914; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065","cell surface [GO:0009986]; lysosome [GO:0005764]","arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484]"
"294","Pocillopora_acuta_HIv2___RNAseq.g16881.t1",324.156246578324,10.1830101393788,2.64144576630061,4.56782563910585e-10,2.12440611074042e-08,NA,NA,NA,NA,NA,NA,NA
"295","Pocillopora_acuta_HIv2___TS.g18814.t1",407.539228353006,10.3898659790364,2.77771395818547,4.82887242504551e-10,2.23861572935443e-08,NA,NA,NA,NA,NA,NA,NA
"296","Pocillopora_acuta_HIv2___RNAseq.g11521.t1",253.366267241985,10.2201816757809,2.54301703596861,4.92199433931531e-10,2.27449604229574e-08,NA,NA,NA,NA,NA,NA,NA
"297","Pocillopora_acuta_HIv2___TS.g25259.t2",1914.03784261248,12.3713255903926,4.00322886092118,4.9480130498734e-10,2.27923760361047e-08,"B3EWY9",0,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020","extracellular space [GO:0005615]; membrane [GO:0016020]","calcium ion binding [GO:0005509]"
"298","Pocillopora_acuta_HIv2___TS.g2952.t1",159.858019637123,12.1217347290821,3.46251401979024,5.06038288855069e-10,2.31624614240497e-08,"A6QLU6",7.47e-15,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189","plasma membrane [GO:0005886]","G protein-coupled receptor activity [GO:0004930]"
"299","Pocillopora_acuta_HIv2___RNAseq.21015_t",2419.08023419196,-3.44580878606733,0.59954562611834,5.08208882470276e-10,2.31884330474766e-08,"Q95ND7",2.89e-40,"Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain]","blood coagulation [GO:0007596]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]","GO:0004175; GO:0004252; GO:0005509; GO:0005615; GO:0005788; GO:0005796; GO:0006508; GO:0007596; GO:0031638","endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]","calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]"
"300","Pocillopora_acuta_HIv2___RNAseq.g21457.t1",161.154540073917,12.1092686339519,3.46031010251959,5.09885870091484e-10,2.31917900157334e-08,"Q8NFZ0",1.53e-155,"F-box DNA helicase 1 (hFBH1) (EC 5.6.2.4) (DNA 3'-5' helicase 1) (F-box only protein 18)","DNA catabolic process [GO:0006308]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; replication fork processing [GO:0031297]; response to intra-S DNA damage checkpoint signaling [GO:0072429]","GO:0000724; GO:0000785; GO:0001934; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006308; GO:0006974; GO:0015616; GO:0016567; GO:0016853; GO:0016887; GO:0019005; GO:0031297; GO:0043138; GO:0072429; GO:1902231; GO:2000042","chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]","3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; isomerase activity [GO:0016853]; single-stranded DNA binding [GO:0003697]"
"301","Pocillopora_acuta_HIv2___RNAseq.g14337.t1",183.555105935626,12.308352068634,3.55387054973608,5.14734814618714e-10,2.33258910573949e-08,"B8V7S0",2.54e-93,"CUB and peptidase domain-containing protein 1","acrosome reaction [GO:0007340]; proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508; GO:0007340","extracellular region [GO:0005576]","serine-type endopeptidase activity [GO:0004252]"
"302","Pocillopora_acuta_HIv2___RNAseq.g29115.t1",762.405021667792,8.45712804024382,2.73292428424662,5.16059536668028e-10,2.33258910573949e-08,"P15989",1.08e-10,"Collagen alpha-3(VI) chain","cell adhesion [GO:0007155]","GO:0004867; GO:0005581; GO:0005615; GO:0007155; GO:0062023","collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]","serine-type endopeptidase inhibitor activity [GO:0004867]"
"303","Pocillopora_acuta_HIv2___RNAseq.g19312.t1",4224.36052959852,6.34234459440149,5.21512444690254,5.36746978435337e-10,2.41102742114556e-08,"P33435",6.65e-31,"Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)","bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; collagen catabolic process [GO:0030574]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; heart development [GO:0007507]; positive regulation of pancreatic trypsinogen secretion [GO:1904244]; protein catabolic process [GO:0030163]; protein metabolic process [GO:0019538]; proteolysis [GO:0006508]; response to hormone [GO:0009725]","GO:0001958; GO:0001968; GO:0003417; GO:0004222; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0006508; GO:0007507; GO:0008233; GO:0008270; GO:0009725; GO:0019538; GO:0022617; GO:0030163; GO:0030198; GO:0030282; GO:0030574; GO:0031012; GO:0046581; GO:0048306; GO:0050750; GO:0060349; GO:1904244","extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intercellular canaliculus [GO:0046581]","calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; low-density lipoprotein particle receptor binding [GO:0050750]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]"
"304","Pocillopora_acuta_HIv2___TS.g6681.t1",1375.40247079999,11.9724956350402,3.39178394674883,5.64394710143947e-10,2.52736999613686e-08,"Q6NYL5",2.28e-110,"Alanine aminotransferase 2-like (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2)","2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]","GO:0004021; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853","","L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]"
"305","Pocillopora_acuta_HIv2___RNAseq.g4591.t1",324.238675625821,12.8850799670535,3.80101731020635,5.7122334246356e-10,2.55005383499782e-08,NA,NA,NA,NA,NA,NA,NA
"306","Pocillopora_acuta_HIv2___RNAseq.g13576.t1",169.548760352034,12.158039955086,3.52101501934006,5.84560791531662e-10,2.59833993286909e-08,"P13608",5.61e-25,"Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)","cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; glial cell differentiation [GO:0010001]; positive regulation of neuroblast proliferation [GO:0002052]; skeletal system development [GO:0001501]","GO:0001501; GO:0002052; GO:0005509; GO:0005540; GO:0005576; GO:0005615; GO:0007155; GO:0007417; GO:0010001; GO:0030246; GO:0045202; GO:0072534","extracellular region [GO:0005576]; extracellular space [GO:0005615]; perineuronal net [GO:0072534]; synapse [GO:0045202]","calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]"
"307","Pocillopora_acuta_HIv2___RNAseq.g24021.t1",787.072394614161,11.762514415517,3.20287782181524,5.86257002388724e-10,2.59833993286909e-08,"O88823",5.82e-13,"Protein JTB","apoptotic mitochondrial changes [GO:0008637]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; positive regulation of protein kinase activity [GO:0045860]; regulation of cell population proliferation [GO:0042127]","GO:0000278; GO:0000281; GO:0005737; GO:0005739; GO:0005813; GO:0005819; GO:0008637; GO:0016020; GO:0019901; GO:0030496; GO:0042127; GO:0045860","centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; spindle [GO:0005819]","protein kinase binding [GO:0019901]"
"308","Pocillopora_acuta_HIv2___TS.g19999.t1",1687.93854435584,9.05658595236829,3.36033976952079,5.8742889798686e-10,2.59833993286909e-08,"O42357",1.98e-31,"Retinal homeobox protein Rx2","camera-type eye photoreceptor cell differentiation [GO:0060219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0045944; GO:0060219","nucleus [GO:0005634]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"309","Pocillopora_acuta_HIv2___RNAseq.g9825.t1",4116.90824066339,6.81645934744893,2.77797703355413,5.91065828679025e-10,2.60645614207726e-08,"B8NHE3",6.07e-10,"Methyltransferase flvH (EC 2.1.1.-) (Flavunoidine biosynthesis cluster protein H)","methylation [GO:0032259]; terpenoid biosynthetic process [GO:0016114]","GO:0008168; GO:0016114; GO:0032259; GO:0046872","","metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
"310","Pocillopora_acuta_HIv2___RNAseq.g913.t2",828.324464640465,10.6831176125128,3.05924035809018,6.35487610587883e-10,2.79382759864533e-08,"Q0VE29",5.36e-06,"Sterile alpha motif domain-containing protein 12 (SAM domain-containing protein 12)","cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0007169; GO:0009898","cytoplasmic side of plasma membrane [GO:0009898]",""
"311","Pocillopora_acuta_HIv2___TS.g11181.t1",232.349094023981,12.4547415955908,3.5833909121758,6.69912594534187e-10,2.93624720222499e-08,NA,NA,NA,NA,NA,NA,NA
"312","Pocillopora_acuta_HIv2___RNAseq.g3070.t1",186.231711242964,12.3071319325598,3.57932953216855,7.06367544142166e-10,3.08667678503694e-08,NA,NA,NA,NA,NA,NA,NA
"313","Pocillopora_acuta_HIv2___TS.g16486.t1",427.524815118564,10.0879348914449,2.65671259917123,7.32644307727638e-10,3.1918576105339e-08,NA,NA,NA,NA,NA,NA,NA
"314","Pocillopora_acuta_HIv2___RNAseq.g25241.t1",922.273299092604,8.36141171319341,2.82618349960971,7.41687488440396e-10,3.22155190174231e-08,"Q5HZE0",5.8e-99,"Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29)","acyl carnitine transmembrane transport [GO:1902616]; acyl carnitine transport [GO:0006844]; L-arginine transmembrane transport [GO:1903826]; L-histidine transmembrane transport [GO:0089709]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; organic cation transport [GO:0015695]; ornithine transport [GO:0015822]","GO:0005289; GO:0005292; GO:0005739; GO:0005743; GO:0006844; GO:0015174; GO:0015227; GO:0015695; GO:0015822; GO:0089709; GO:1902616; GO:1903401; GO:1903826; GO:1990575","mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]","acyl carnitine transmembrane transporter activity [GO:0015227]; basic amino acid transmembrane transporter activity [GO:0015174]; high-affinity L-arginine transmembrane transporter activity [GO:0005289]; high-affinity lysine transmembrane transporter activity [GO:0005292]"
"315","Pocillopora_acuta_HIv2___RNAseq.g18859.t1",155.451692126755,12.1168579904125,3.51549277513143,7.5058924758978e-10,3.25045595123909e-08,NA,NA,NA,NA,NA,NA,NA
"316","Pocillopora_acuta_HIv2___RNAseq.g17495.t1",695.276104890953,11.6759995838465,3.22255242766587,7.6656364979822e-10,3.3097243673676e-08,"Q6AX80",2.12e-90,"Bis(5'-adenosyl)-triphosphatase enpp4 (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4) (E-NPP 4) (NPP-4)","blood coagulation [GO:0007596]","GO:0005886; GO:0007596; GO:0046872; GO:0047710","plasma membrane [GO:0005886]","bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; metal ion binding [GO:0046872]"
"317","Pocillopora_acuta_HIv2___RNAseq.g23744.t1",356.775799097496,12.6596334081104,3.79594157606486,7.7290982722679e-10,3.32719278006199e-08,NA,NA,NA,NA,NA,NA,NA
"318","Pocillopora_acuta_HIv2___TS.g29407.t1",343.808020083342,12.9218981303055,3.87328726519456,7.89290335740597e-10,3.38762475256736e-08,"O00339",1.29e-24,"Matrilin-2","axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; response to axon injury [GO:0048678]","GO:0001764; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0048678; GO:0062023; GO:0120216","basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; matrilin complex [GO:0120216]","calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]"
"319","Pocillopora_acuta_HIv2___RNAseq.g1847.t1",595.300902733174,11.0915264794859,3.06279591734974,8.0635639181803e-10,3.45063279622958e-08,NA,NA,NA,NA,NA,NA,NA
"320","Pocillopora_acuta_HIv2___TS.g17433.t1",262.801516314106,9.86834288182246,2.46434594524724,8.17562682594133e-10,3.48826744573497e-08,NA,NA,NA,NA,NA,NA,NA
"321","Pocillopora_acuta_HIv2___RNAseq.g21572.t1a",170.494827583462,12.130632629906,3.5747065298009,8.35852507759263e-10,3.55581490359705e-08,"P63079",2.23e-50,"Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3)","brain development [GO:0007420]; cellular response to histamine [GO:0071420]; cellular response to zinc ion [GO:0071294]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chemical synaptic transmission, postsynaptic [GO:0099565]; chloride transmembrane transport [GO:1902476]; circadian sleep/wake cycle, REM sleep [GO:0042747]; cochlea development [GO:0090102]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hard palate development [GO:0060022]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; learning [GO:0007612]; memory [GO:0007613]; monoatomic ion transmembrane transport [GO:0034220]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuron development [GO:0048666]; regulation of postsynaptic membrane potential [GO:0060078]; reproductive behavior [GO:0019098]; response to anesthetic [GO:0072347]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; social behavior [GO:0035176]; synaptic transmission, GABAergic [GO:0051932]","GO:0004890; GO:0005216; GO:0005254; GO:0005886; GO:0007214; GO:0007268; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0009410; GO:0009986; GO:0019098; GO:0021549; GO:0022851; GO:0030594; GO:0030659; GO:0034220; GO:0034707; GO:0035176; GO:0035612; GO:0035640; GO:0042747; GO:0042802; GO:0043005; GO:0043195; GO:0045202; GO:0045211; GO:0048666; GO:0051932; GO:0060021; GO:0060022; GO:0060077; GO:0060078; GO:0060080; GO:0060119; GO:0060384; GO:0061744; GO:0071294; GO:0071420; GO:0072347; GO:0090102; GO:0098982; GO:0099565; GO:0099634; GO:1902476; GO:1902495; GO:1902711; GO:1904315; GO:1904862","cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; synapse [GO:0045202]; terminal bouton [GO:0043195]; transmembrane transporter complex [GO:1902495]","AP-2 adaptor complex binding [GO:0035612]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; identical protein binding [GO:0042802]; monoatomic ion channel activity [GO:0005216]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
"322","Pocillopora_acuta_HIv2___RNAseq.g8217.t1",745.87324476123,8.57004626859218,2.44107529432648,8.54211395490242e-10,3.62325912738148e-08,"Q16992",7.91e-09,"LWamide neuropeptides [Cleaved into: LWamide I; Metamorphosin A (MMA) (LWamide II); LWamide III; LWamide IV; LWamide V; LWamide VI; LWamide VII; LWamide VIII; LWamide IX]","extracellular matrix organization [GO:0030198]; neuropeptide signaling pathway [GO:0007218]","GO:0005615; GO:0007218; GO:0030020; GO:0030198; GO:0062023","collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]","extracellular matrix structural constituent conferring tensile strength [GO:0030020]"
"323","Pocillopora_acuta_HIv2___RNAseq.g16129.t1",1785.1124394865,6.80105210250094,5.50209575558321,8.59064274816008e-10,3.63318879267215e-08,"A1RYE4",9.57e-58,"Glyoxylate reductase (EC 1.1.1.26)","","GO:0005829; GO:0016618; GO:0030267; GO:0047964; GO:0051287","cytosol [GO:0005829]","glyoxylate reductase (NADH) activity [GO:0047964]; glyoxylate reductase (NADPH) activity [GO:0030267]; hydroxypyruvate reductase [NAD(P)H] activity [GO:0016618]; NAD binding [GO:0051287]"
"324","Pocillopora_acuta_HIv2___RNAseq.g30624.t2b",1458.34037951228,8.33560587272699,4.189926853337,8.66130944944366e-10,3.65239591477414e-08,"Q99NH0",5.34e-66,"Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein)","blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]","GO:0000785; GO:0001673; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246","chromatin [GO:0000785]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","chromatin binding [GO:0003682]; RNA binding [GO:0003723]"
"325","Pocillopora_acuta_HIv2___RNAseq.g25446.t1",633.200937971067,11.0063205940449,3.00868478945168,9.28886521472834e-10,3.8893127675162e-08,NA,NA,NA,NA,NA,NA,NA
"326","Pocillopora_acuta_HIv2___RNAseq.g619.t1",2642.45071876053,-5.65643529652427,4.08842805282284,9.30380404840019e-10,3.8893127675162e-08,"Q6P1S6",3.47e-18,"Myotrophin","","GO:0005634; GO:0048471","nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]",""
"327","Pocillopora_acuta_HIv2___RNAseq.g15838.t1",947.248888807,12.0418314102867,3.35164477645876,9.55788880600668e-10,3.9788897821051e-08,"A0JP86",5.07e-08,"Laminin subunit gamma-1","cell adhesion [GO:0007155]","GO:0005576; GO:0005604; GO:0007155","basement membrane [GO:0005604]; extracellular region [GO:0005576]",""
"328","Pocillopora_acuta_HIv2___RNAseq.g21562.t1",1563.29410087698,-7.60661588323067,3.55998046178761,9.57310318150287e-10,3.9788897821051e-08,"Q923L3",5.79e-12,"CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)","conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964]","GO:0001964; GO:0007613; GO:0008584; GO:0008585; GO:0016020; GO:0035846; GO:0042593; GO:0060745; GO:1990708","membrane [GO:0016020]",""
"329","Pocillopora_acuta_HIv2___RNAseq.g21375.t1",152.185947809757,11.9505254461593,3.45574082503797,9.72700733908437e-10,4.03127318488586e-08,NA,NA,NA,NA,NA,NA,NA
"330","Pocillopora_acuta_HIv2___RNAseq.g7628.t1",523.535700384145,10.3550608635211,2.90382271737131,9.86749102525641e-10,4.07781114826596e-08,"Q704V6",2.62e-16,"Toll-like receptor 6 (CD antigen CD286)","cellular response to diacyl bacterial lipopeptide [GO:0071726]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; toll-like receptor signaling pathway [GO:0002224]","GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0032731; GO:0035355; GO:0035663; GO:0038023; GO:0042802; GO:0045087; GO:0045121; GO:0061809; GO:0071723; GO:0071726; GO:1900227","Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355]","identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]"
"331","Pocillopora_acuta_HIv2___RNAseq.g27023.t1",1089.26043734581,-7.81362410379465,4.92445833656727,1.08507650030512e-09,4.44809308207318e-08,NA,NA,NA,NA,NA,NA,NA
"332","Pocillopora_acuta_HIv2___RNAseq.g17781.t1",430.259679473374,10.3921527506184,2.91812520004004,1.08557581441637e-09,4.44809308207318e-08,NA,NA,NA,NA,NA,NA,NA
"333","Pocillopora_acuta_HIv2___RNAseq.g14642.t1",167.480075040321,12.0389988922128,3.48505730843623,1.13957221509417e-09,4.65615042913051e-08,NA,NA,NA,NA,NA,NA,NA
"334","Pocillopora_acuta_HIv2___RNAseq.g3854.t1",848.165995444607,11.7039624984157,3.34546661539006,1.14834125135501e-09,4.66562018528058e-08,"P30974",4.07e-26,"Tachykinin-like peptides receptor 86C (NKD)","G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]","GO:0002121; GO:0004995; GO:0005886; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016020","membrane [GO:0016020]; plasma membrane [GO:0005886]","neuropeptide receptor activity [GO:0008188]; tachykinin receptor activity [GO:0004995]"
"335","Pocillopora_acuta_HIv2___RNAseq.g6379.t1",156.421421073687,12.0817326013273,3.51790546789668,1.21054446845791e-09,4.90457008172975e-08,"A6QLU6",8.77e-21,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189","plasma membrane [GO:0005886]","G protein-coupled receptor activity [GO:0004930]"
"336","Pocillopora_acuta_HIv2___RNAseq.g6505.t1",1954.75622105436,-8.04716548114269,2.49224710007666,1.27309283165171e-09,5.12925201030929e-08,NA,NA,NA,NA,NA,NA,NA
"337","Pocillopora_acuta_HIv2___RNAseq.18284_t",232.506557854377,12.4732506137765,3.76612386101456,1.29114163961321e-09,5.18752018760153e-08,"Q21565",1.4e-128,"Putative ammonium transporter 3","ammonium homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488]","GO:0005886; GO:0008519; GO:0072488; GO:0097272","plasma membrane [GO:0005886]","ammonium channel activity [GO:0008519]"
"338","Pocillopora_acuta_HIv2___RNAseq.g25699.t1",362.71124765533,10.2291684521406,2.78579910212427,1.32111967176568e-09,5.29211897136353e-08,"Q90YK3",5.02e-162,"L-gulonolactone oxidase (LGO) (EC 1.1.3.8) (L-gulono-gamma-lactone oxidase) (GLO)","L-ascorbic acid biosynthetic process [GO:0019853]","GO:0003885; GO:0005789; GO:0019853; GO:0050105; GO:0050660; GO:0071949","endoplasmic reticulum membrane [GO:0005789]","D-arabinono-1,4-lactone oxidase activity [GO:0003885]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; L-gulonolactone oxidase activity [GO:0050105]"
"339","Pocillopora_acuta_HIv2___RNAseq.g19434.t1",1914.29683892957,8.34622788584644,4.03817512604869,1.32449327131748e-09,5.29211897136353e-08,NA,NA,NA,NA,NA,NA,NA
"340","Pocillopora_acuta_HIv2___RNAseq.g1877.t1",482.089962221999,10.885125148242,3.07401145284878,1.33947164404391e-09,5.337222550813e-08,NA,NA,NA,NA,NA,NA,NA
"341","Pocillopora_acuta_HIv2___RNAseq.7765_t",851.664689586922,11.6806333619885,3.28829515101784,1.34409446532397e-09,5.34053026430425e-08,NA,NA,NA,NA,NA,NA,NA
"342","Pocillopora_acuta_HIv2___RNAseq.g28943.t1",161.347683153997,11.8887243645866,3.48381547166674,1.34768635679691e-09,5.34053026430425e-08,NA,NA,NA,NA,NA,NA,NA
"343","Pocillopora_acuta_HIv2___TS.g27848.t1",185402.900849584,5.56034556448057,1.26887342526349,1.37299484687624e-09,5.42595559158959e-08,"Q86VQ3",2.61e-13,"Thioredoxin domain-containing protein 2 (Spermatid-specific thioredoxin-1) (Sptrx-1)","cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; spermatogenesis [GO:0007283]","GO:0004791; GO:0005737; GO:0007283; GO:0030154; GO:0045454","cytoplasm [GO:0005737]","thioredoxin-disulfide reductase (NADPH) activity [GO:0004791]"
"344","Pocillopora_acuta_HIv2___RNAseq.g7644.t1",573.932030486125,11.0440910286145,3.20941264056543,1.40274345382363e-09,5.52841452754904e-08,"Q9BYK8",0,"3'-5' exoribonuclease HELZ2 (EC 3.1.13.1) (ATP-dependent RNA helicase PRIC285) (EC 3.6.4.13) (Helicase with zinc finger 2, transcriptional coactivator) (Helicase with zinc finger domain 2) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein)","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]","GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0008859; GO:0016020; GO:0016887; GO:0030374; GO:0035194; GO:0043186; GO:0045944; GO:0046872","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; P granule [GO:0043186]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; exoribonuclease II activity [GO:0008859]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
"345","Pocillopora_acuta_HIv2___RNAseq.g23049.t1",892.322187563531,8.93022056238308,2.71640802081022,1.45156700806935e-09,5.66481839017338e-08,"B3RFR8",7.89e-11,"Hydramacin-1 (Hm-1)","defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]","GO:0005576; GO:0016020; GO:0042742; GO:0044218; GO:0045087","extracellular region [GO:0005576]; membrane [GO:0016020]; other organism cell membrane [GO:0044218]",""
"346","Pocillopora_acuta_HIv2___RNAseq.g29592.t1",139.236206376654,11.9009867439318,3.4691160396019,1.45171182145541e-09,5.66481839017338e-08,NA,NA,NA,NA,NA,NA,NA
"347","Pocillopora_acuta_HIv2___TS.g4312.t1",138.823575900051,11.8717563504733,3.45452119313893,1.45301965068745e-09,5.66481839017338e-08,"O70277",5.42e-20,"Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22)","negative regulation of translation [GO:0017148]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252]","GO:0000209; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0017148; GO:0030371; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061630; GO:0070534; GO:0098794; GO:0098978; GO:0140252","cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]","identical protein binding [GO:0042802]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
"348","Pocillopora_acuta_HIv2___TS.g9570.t1",7006.63804083127,-6.76461013581096,2.22481111451693,1.46799650764071e-09,5.70782298024602e-08,NA,NA,NA,NA,NA,NA,NA
"349","Pocillopora_acuta_HIv2___RNAseq.g3441.t1",148.744932859109,11.909981932167,3.48592385631272,1.49603930425754e-09,5.80126340396273e-08,NA,NA,NA,NA,NA,NA,NA
"350","Pocillopora_acuta_HIv2___RNAseq.g22644.t1",1223.76428572696,11.54268602248,3.35580525446914,1.51537756405847e-09,5.86054039747106e-08,"P31597",1.72e-126,"Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1)","chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]","GO:0005313; GO:0005314; GO:0005886; GO:0015108; GO:0015501; GO:0015813; GO:0016324; GO:0031901; GO:0031902; GO:0033229; GO:0042883; GO:0043005; GO:0045202; GO:0046872; GO:0055038; GO:0070779; GO:0098712; GO:0140009; GO:1902476","apical plasma membrane [GO:0016324]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]","chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity L-glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]"
"351","Pocillopora_acuta_HIv2___RNAseq.g5871.t1",975.156347879303,-7.91524631998289,3.3106374456473,1.56252852616772e-09,6.02677669399731e-08,"Q96JQ5",3.47e-06,"Membrane-spanning 4-domains subfamily A member 4A (CD20 antigen-like 1) (Four-span transmembrane protein 1)","","GO:0005783; GO:0005794; GO:0005886; GO:0044853","endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]",""
"352","Pocillopora_acuta_HIv2___RNAseq.10969_t",147.544540612849,11.9596227674866,3.52243436894796,1.58709721702333e-09,6.10525908165569e-08,"O43704",1.12e-55,"Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase)","3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; biogenic amine metabolic process [GO:0006576]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]","GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006576; GO:0006805; GO:0008146; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923","cytoplasm [GO:0005737]; cytosol [GO:0005829]","aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]"
"353","Pocillopora_acuta_HIv2___TS.g25792.t1c",157.403227972141,12.1008784899277,3.55105668237293,1.61135284274705e-09,6.18212400994519e-08,"Q8TD84",5.33e-23,"Cell adhesion molecule DSCAML1 (Down syndrome cell adhesion molecule 2) (Down syndrome cell adhesion molecule-like protein 1)","axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal system morphogenesis [GO:0048704]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0001709; GO:0005615; GO:0005886; GO:0007156; GO:0007409; GO:0007411; GO:0007417; GO:0007420; GO:0009953; GO:0009986; GO:0030424; GO:0042803; GO:0045202; GO:0048704; GO:0070593; GO:0098632","axon [GO:0030424]; cell surface [GO:0009986]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; synapse [GO:0045202]","cell-cell adhesion mediator activity [GO:0098632]; protein homodimerization activity [GO:0042803]"
"354","Pocillopora_acuta_HIv2___RNAseq.g385.t1",1369.13096260708,7.64544743406227,2.71054843385071,1.64412220110246e-09,6.29115966051482e-08,NA,NA,NA,NA,NA,NA,NA
"355","Pocillopora_acuta_HIv2___RNAseq.g17934.t1",667.74028875006,8.85930191495457,2.68012537430214,1.66127095296143e-09,6.34000608539159e-08,NA,NA,NA,NA,NA,NA,NA
"356","Pocillopora_acuta_HIv2___RNAseq.g23857.t1",185.042253771809,12.2347248418884,3.62249429099927,1.67890145067166e-09,6.39042910066181e-08,NA,NA,NA,NA,NA,NA,NA
"357","Pocillopora_acuta_HIv2___RNAseq.g28227.t1",162.777210999485,12.0631460339588,3.6012939967275,1.68843002826326e-09,6.40982990257214e-08,"P10079",4.85e-90,"Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","","GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579","apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]","biotin binding [GO:0009374]; calcium ion binding [GO:0005509]"
"358","Pocillopora_acuta_HIv2___RNAseq.g11840.t1",608.420427976475,11.0862876769593,3.20795454594271,1.74957626330539e-09,6.60727704241494e-08,"Q6PEI7",0,"CTP synthase 1 (EC 6.3.4.2) (CTP synthetase 1) (UTP--ammonia ligase 1)","'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; notochord development [GO:0030903]; pyrimidine nucleobase biosynthetic process [GO:0019856]","GO:0003883; GO:0005524; GO:0005737; GO:0006241; GO:0006541; GO:0019856; GO:0030903; GO:0042802; GO:0044210; GO:0097268","cytoophidium [GO:0097268]; cytoplasm [GO:0005737]","ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]"
"359","Pocillopora_acuta_HIv2___TS.g16956.t1a",186.395461631915,12.126073253048,3.5893361684908,1.77730624756491e-09,6.69452019916116e-08,"P51398",3.95e-28,"Small ribosomal subunit protein mS29 (28S ribosomal protein S29, mitochondrial) (MRP-S29) (S29mt) (Death-associated protein 3) (DAP-3) (Ionizing radiation resistance conferring protein)","apoptotic signaling pathway [GO:0097190]; mitochondrial translation [GO:0032543]","GO:0003723; GO:0003735; GO:0005525; GO:0005654; GO:0005739; GO:0005743; GO:0005763; GO:0032543; GO:0097190","mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]","GTP binding [GO:0005525]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
"360","Pocillopora_acuta_HIv2___RNAseq.g4628.t1",143.384199761355,11.9030488464821,3.50284597684432,1.79059620709706e-09,6.72706065959788e-08,"Q9TU23",8.35e-07,"Centrosomal protein of 290 kDa (Cep290) (Nephrocystin-6)","camera-type eye development [GO:0043010]; ciliary basal body-plasma membrane docking [GO:0097711]; ciliary transition zone assembly [GO:1905349]; kidney development [GO:0001822]; non-motile cilium assembly [GO:1905515]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intracellular protein transport [GO:0090316]; protein transport [GO:0015031]","GO:0001822; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0015031; GO:0031410; GO:0032391; GO:0034451; GO:0035869; GO:0036038; GO:0043010; GO:0045893; GO:0090316; GO:0097711; GO:1905349; GO:1905515","centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]",""
"361","Pocillopora_acuta_HIv2___RNAseq.g14914.t1",325.083977909077,12.4662176165808,3.74568080789576,1.81395783476134e-09,6.79717257046322e-08,"Q8N371",2.56e-19,"Bifunctional peptidase and arginyl-hydroxylase JMJD5 (EC 1.14.11.73) (EC 3.4.-.-) (JmjC domain-containing protein 5) (Jumonji C domain-containing protein 5) (L-arginine (3R)-hydroxylase KDM8)","circadian regulation of gene expression [GO:0032922]; fibroblast proliferation [GO:0048144]; G2/M transition of mitotic cell cycle [GO:0000086]; in utero embryonic development [GO:0001701]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; protein destabilization [GO:0031648]; proteolysis [GO:0006508]; regulation of signal transduction by p53 class mediator [GO:1901796]","GO:0000086; GO:0001701; GO:0002039; GO:0003682; GO:0004175; GO:0004177; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006508; GO:0031648; GO:0032922; GO:0035064; GO:0045892; GO:0045893; GO:0046872; GO:0048144; GO:0051864; GO:0106157; GO:1901796","chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","aminopeptidase activity [GO:0004177]; chromatin binding [GO:0003682]; endopeptidase activity [GO:0004175]; histone H3K36 demethylase activity [GO:0051864]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; peptidyl-arginine 3-dioxygenase activity [GO:0106157]"
"362","Pocillopora_acuta_HIv2___RNAseq.g31026.t1",710.677220915606,9.84926598996339,2.7844066571537,1.87863448741918e-09,7.02133571732066e-08,NA,NA,NA,NA,NA,NA,NA
"363","Pocillopora_acuta_HIv2___TS.g16229.t1",4088.82997827338,1.11942643480742,2.20830507252198,1.93583618181659e-09,7.2142929889304e-08,NA,NA,NA,NA,NA,NA,NA
"364","Pocillopora_acuta_HIv2___RNAseq.g1200.t1",410.456973492759,10.6571376809538,3.07431370472475,1.94023781297976e-09,7.2142929889304e-08,"P31649",0,"Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13)","amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; taurine transmembrane transport [GO:0015734]","GO:0005283; GO:0005308; GO:0005332; GO:0005368; GO:0005369; GO:0005886; GO:0006836; GO:0006865; GO:0015185; GO:0015734; GO:0015881; GO:0016323; GO:0016597; GO:0035725; GO:0042995; GO:0051939; GO:0089718","basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; plasma membrane [GO:0005886]","amino acid binding [GO:0016597]; amino acid:sodium symporter activity [GO:0005283]; creatine transmembrane transporter activity [GO:0005308]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; taurine transmembrane transporter activity [GO:0005368]; taurine:sodium symporter activity [GO:0005369]"
"365","Pocillopora_acuta_HIv2___RNAseq.g25589.t1",156.375849257961,11.7956898786521,3.48700198563547,1.96875297671243e-09,7.30154950132528e-08,NA,NA,NA,NA,NA,NA,NA
"366","Pocillopora_acuta_HIv2___RNAseq.g18390.t1",242.237010228234,9.43007637238972,2.45121332158848,1.99743829552364e-09,7.38898913208539e-08,NA,NA,NA,NA,NA,NA,NA
"367","Pocillopora_acuta_HIv2___RNAseq.g13977.t1",1008.24770555451,6.99804565055399,4.84849761305432,2.00978337660869e-09,7.41569049981328e-08,"B3EWY9",0,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020","extracellular space [GO:0005615]; membrane [GO:0016020]","calcium ion binding [GO:0005509]"
"368","Pocillopora_acuta_HIv2___RNAseq.g15652.t1",146.946015513097,11.8793696801844,3.50332419583057,2.05485196310452e-09,7.56269180517653e-08,"Q6P4F7",7e-37,"Rho GTPase-activating protein 11A (Rho-type GTPase-activating protein 11A)","positive regulation of GTPase activity [GO:0043547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]","GO:0005096; GO:0005634; GO:0005829; GO:0007165; GO:0043547; GO:0051056","cytosol [GO:0005829]; nucleus [GO:0005634]","GTPase activator activity [GO:0005096]"
"369","Pocillopora_acuta_HIv2___TS.g20127.t1b",1359.92324999169,7.77031584612814,4.79199290338213,2.06864246084396e-09,7.59412298315916e-08,"Q5PQM2",1.52e-10,"Kinesin light chain 4 (KLC 4) (Kinesin-like protein 8)","microtubule-based movement [GO:0007018]","GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0019894","cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]","kinesin binding [GO:0019894]"
"370","Pocillopora_acuta_HIv2___RNAseq.g344.t1",3346.9184450828,1.10128171331864,2.09613786780445,2.11547861914593e-09,7.74640069552574e-08,"Q9LQU4",5.6e-16,"Protein PLANT CADMIUM RESISTANCE 2 (AtPCR2)","response to oxidative stress [GO:0006979]","GO:0005886; GO:0006979","plasma membrane [GO:0005886]",""
"371","Pocillopora_acuta_HIv2___RNAseq.g10736.t1",176.859999675485,12.2922084671008,3.61334353805291,2.21073093604864e-09,8.07475057045646e-08,"A0A0C2SRU0",1.77e-79,"Decarboxylase iboD (EC 4.1.1.-) (Ibotenic acid biosynthesis cluster protein D)","phospholipid biosynthetic process [GO:0008654]","GO:0004609; GO:0008654","","phosphatidylserine decarboxylase activity [GO:0004609]"
"372","Pocillopora_acuta_HIv2___RNAseq.g23421.t1",760.151212985779,11.101345848678,3.22713756022227,2.21769230651791e-09,8.07977368299119e-08,NA,NA,NA,NA,NA,NA,NA
"373","Pocillopora_acuta_HIv2___RNAseq.g26118.t1",743.19810752368,11.4731727519225,3.31835393616192,2.2599570096996e-09,8.21306989655653e-08,"C9D7C2",0,"Voltage-dependent calcium channel type A subunit alpha-1 (Cacophony protein)","calcium ion import across plasma membrane [GO:0098703]; chemical synaptic transmission [GO:0007268]","GO:0005509; GO:0005891; GO:0007268; GO:0008331; GO:0045202; GO:0098703","synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]","calcium ion binding [GO:0005509]; high voltage-gated calcium channel activity [GO:0008331]"
"374","Pocillopora_acuta_HIv2___RNAseq.g175.t1",1221.92043470924,7.07330376365231,5.14562385352266,2.28208440390661e-09,8.27269895190607e-08,NA,NA,NA,NA,NA,NA,NA
"375","Pocillopora_acuta_HIv2___RNAseq.g1971.t1",260.726450049051,10.23377690097,2.85976120067102,2.35391783703039e-09,8.49054054733354e-08,"Q2QLF8",6.66e-13,"Cortactin-binding protein 2 (CortBP2)","","GO:0005938; GO:0043197; GO:0090443","cell cortex [GO:0005938]; dendritic spine [GO:0043197]; FAR/SIN/STRIPAK complex [GO:0090443]",""
"376","Pocillopora_acuta_HIv2___RNAseq.g25689.t1",180.095814313841,11.8234364217421,3.47545727910038,2.39031214254899e-09,8.6003668730917e-08,"Q61184",3e-24,"Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of insulin secretion [GO:0046676]","GO:0004930; GO:0005886; GO:0007186; GO:0007193; GO:0007623; GO:0008502; GO:0042562; GO:0043025; GO:0043235; GO:0046676; GO:0097159","neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]","G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melatonin receptor activity [GO:0008502]; organic cyclic compound binding [GO:0097159]"
"377","Pocillopora_acuta_HIv2___RNAseq.g10927.t1",5557.52588219212,4.24249355412175,0.8327400679292,2.4422384527006e-09,8.74543555939999e-08,"A0A0B5RUB0",9.02e-112,"Trimethylamine transporter (TMA transporter) (TMA-specific transporter)","","GO:0005886; GO:0022857","plasma membrane [GO:0005886]","transmembrane transporter activity [GO:0022857]"
"378","Pocillopora_acuta_HIv2___RNAseq.g5108.t1b",386.986622824301,10.5469000066093,3.01050565540894,2.44272398091648e-09,8.74543555939999e-08,NA,NA,NA,NA,NA,NA,NA
"379","Pocillopora_acuta_HIv2___RNAseq.g7049.t1",175.142733381291,12.1470026677299,3.66893453564081,2.49061906249071e-09,8.89489237527547e-08,"Q6JZS3",5e-83,"Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1)","","GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0043231; GO:0070330","endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]","aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]"
"380","Pocillopora_acuta_HIv2___RNAseq.g24764.t1",547.641892946914,10.6060830968261,3.15068442499477,2.56935830705691e-09,9.13100701554574e-08,"P60899",7.71e-71,"DNA-directed RNA polymerase II subunit RPB9 (RNA polymerase II subunit B9) (DNA-directed RNA polymerase II subunit I) (RNA polymerase II 14.5 kDa subunit) (RPB14.5)","maintenance of transcriptional fidelity during transcription elongation by RNA polymerase II [GO:0001193]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]","GO:0001193; GO:0003676; GO:0003899; GO:0005634; GO:0005665; GO:0005730; GO:0006283; GO:0006366; GO:0006367; GO:0008270","nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]","DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
"381","Pocillopora_acuta_HIv2___TS.g12848.t1",975.410062617966,-6.9431363443658,4.57632919759084,2.59813710654168e-09,9.21065076201442e-08,"Q5RFW0",1.02e-17,"Scavenger receptor class A member 5","endocytosis [GO:0006897]; intracellular iron ion homeostasis [GO:0006879]; iron ion transmembrane transport [GO:0034755]; protein homotrimerization [GO:0070207]","GO:0005886; GO:0006879; GO:0006897; GO:0034755; GO:0070207; GO:0070287","plasma membrane [GO:0005886]","ferritin receptor activity [GO:0070287]"
"382","Pocillopora_acuta_HIv2___RNAseq.g993.t1",2110.82545169326,4.51259816780856,5.25185264736274,2.62035344020977e-09,9.2666973494362e-08,"P09917",2.26e-47,"Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34)","arachidonic acid metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426]","GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005576; GO:0005615; GO:0005635; GO:0005641; GO:0005654; GO:0005829; GO:0006691; GO:0006959; GO:0016363; GO:0016525; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030501; GO:0031965; GO:0034440; GO:0034774; GO:0036336; GO:0036403; GO:0042593; GO:0042759; GO:0045598; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904813; GO:1904999; GO:2001301","cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; secretory granule lumen [GO:0034774]","arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; hydrolase activity [GO:0016787]; iron ion binding [GO:0005506]"
"383","Pocillopora_acuta_HIv2___TS.g17424.t1",236.411443527629,12.3251522934278,3.69384418699767,2.68719388011587e-09,9.47989567853561e-08,NA,NA,NA,NA,NA,NA,NA
"384","Pocillopora_acuta_HIv2___TS.g21128.t1",169.891696028128,12.0467670747672,3.58601708269135,2.77086930027406e-09,9.72763435902038e-08,"Q20JQ7",0,"Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b)","membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; sodium ion transmembrane transport [GO:0035725]","GO:0001518; GO:0005248; GO:0019228; GO:0030424; GO:0035725; GO:0086010","axon [GO:0030424]; voltage-gated sodium channel complex [GO:0001518]","voltage-gated sodium channel activity [GO:0005248]"
"385","Pocillopora_acuta_HIv2___RNAseq.g17089.t1",175.086743847561,11.8876456662609,3.48239369965924,2.95131616837103e-09,1.03360380288907e-07,"G5EG78",1.9e-101,"Peroxidasin homolog pxn-2 (EC 1.11.2.-)","axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; embryonic body morphogenesis [GO:0010172]; muscle attachment [GO:0016203]; negative regulation of axon regeneration [GO:0048681]; regulation of basement membrane organization [GO:0110011]; response to oxidative stress [GO:0006979]","GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0007411; GO:0010172; GO:0016203; GO:0020037; GO:0046872; GO:0048681; GO:0071711; GO:0110011; GO:0140825","basement membrane [GO:0005604]; extracellular space [GO:0005615]","heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
"386","Pocillopora_acuta_HIv2___RNAseq.g16758.t1",155.698026509265,12.0163260311831,3.56887934231308,3.0782741652712e-09,1.06971699654875e-07,NA,NA,NA,NA,NA,NA,NA
"387","Pocillopora_acuta_HIv2___RNAseq.g1127.t2",394.894998028904,-9.99320026869055,3.20907678957576,3.0827714087192e-09,1.06971699654875e-07,"Q6V0K7",1.63e-26,"Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein)","renal system process [GO:0003014]","GO:0003014; GO:0005509; GO:0005635","nuclear envelope [GO:0005635]","calcium ion binding [GO:0005509]"
"388","Pocillopora_acuta_HIv2___TS.g22704.t2",475.446607313009,10.3626657076082,3.10179698403868,3.10657013875139e-09,1.07496245183971e-07,"Q5U206",1.45e-52,"Calmodulin-like protein 3","","GO:0005509; GO:0005737","cytoplasm [GO:0005737]","calcium ion binding [GO:0005509]"
"389","Pocillopora_acuta_HIv2___RNAseq.g13690.t1",602.058500897069,-10.0618688013091,3.95852167592917,3.12491113084245e-09,1.07872827199296e-07,NA,NA,NA,NA,NA,NA,NA
"390","Pocillopora_acuta_HIv2___RNAseq.g15408.t1",273.674816434166,9.37873507557415,2.51839773862,3.18274311160822e-09,1.09607610395955e-07,NA,NA,NA,NA,NA,NA,NA
"391","Pocillopora_acuta_HIv2___RNAseq.g1818.t1",865.729646052584,11.5821698019399,3.43869331246955,3.22515974067977e-09,1.10804537979079e-07,"G3MWR8",1.29e-17,"[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3)","actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]","GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0042995; GO:0046872; GO:0071949; GO:0120501","cell cortex [GO:0005938]; cell projection [GO:0042995]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]","actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"
"392","Pocillopora_acuta_HIv2___RNAseq.g13403.t1",858.519794854355,11.4434778659155,3.34483119039545,3.28292395826295e-09,1.1252182969743e-07,"Q86SS6",1.79e-35,"Synaptotagmin-9 (Synaptotagmin IX) (SytIX)","calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; regulation of calcium ion-dependent exocytosis [GO:0017158]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0017156; GO:0017158; GO:0030276; GO:0030669; GO:0030672; GO:0031045; GO:0042802; GO:0070382; GO:0098686; GO:0099502","clathrin-coated endocytic vesicle membrane [GO:0030669]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]","calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]"
"393","Pocillopora_acuta_HIv2___RNAseq.g29275.t1",140.77521572938,11.757686024162,3.47350796017732,3.46209090563187e-09,1.18103025610989e-07,"Q09081",1.11e-116,"Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2)","neuronal action potential [GO:0019228]; optic nerve structural organization [GO:0021633]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of circadian sleep/wake cycle, non-REM sleep [GO:0045188]; regulation of dopamine secretion [GO:0014059]; sensory perception of pain [GO:0019233]","GO:0005249; GO:0005251; GO:0005789; GO:0005886; GO:0008076; GO:0014059; GO:0019228; GO:0019233; GO:0021633; GO:0030027; GO:0030424; GO:0030425; GO:0031258; GO:0032809; GO:0033010; GO:0042734; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0045188; GO:0051260; GO:0071805","axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; juxtaparanode region of axon [GO:0044224]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; neuronal cell body membrane [GO:0032809]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076]","delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]"
"394","Pocillopora_acuta_HIv2___RNAseq.g21481.t1",792.065456771186,-7.17648888388596,1.79704122492023,3.49436589286265e-09,1.1892354888086e-07,"P24821",5.67e-52,"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)","bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611]","GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0062023; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098966","basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; interstitial matrix [GO:0005614]; membrane [GO:0016020]; perisynaptic extracellular matrix [GO:0098966]; tenascin complex [GO:0090733]","extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; syndecan binding [GO:0045545]"
"395","Pocillopora_acuta_HIv2___RNAseq.g26050.t1",4356.96245780312,-7.6887690737224,2.34576841765226,3.5111621223664e-09,1.19214668868328e-07,"Q9IA95",9.55e-45,"Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1)","canonical Wnt signaling pathway [GO:0060070]; cochlea morphogenesis [GO:0090103]; convergent extension involved in organogenesis [GO:0060029]; epithelial cell development [GO:0002064]; hepatocyte differentiation [GO:0070365]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell development [GO:0010721]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hepatocyte differentiation [GO:0070367]; negative regulation of Wnt signaling pathway [GO:0030178]; neural crest cell differentiation [GO:0014033]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fat cell differentiation [GO:0045600]; somite development [GO:0061053]","GO:0002064; GO:0005615; GO:0005737; GO:0008285; GO:0010721; GO:0014033; GO:0017147; GO:0030178; GO:0030308; GO:0035567; GO:0043065; GO:0045600; GO:0060029; GO:0060070; GO:0061037; GO:0061053; GO:0070365; GO:0070367; GO:0090090; GO:0090103","cytoplasm [GO:0005737]; extracellular space [GO:0005615]","Wnt-protein binding [GO:0017147]"
"396","Pocillopora_acuta_HIv2___RNAseq.g10024.t1",124.956797326471,11.696607501682,3.47989023887954,3.52987330685627e-09,1.1956929159337e-07,NA,NA,NA,NA,NA,NA,NA
"397","Pocillopora_acuta_HIv2___RNAseq.g15159.t1",303.969221846213,9.72265100616555,2.73906600696668,3.55282304030707e-09,1.2006549639019e-07,"Q7TN88",1.45e-54,"Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982","membrane [GO:0016020]","calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965]"
"398","Pocillopora_acuta_HIv2___TS.g27807.t1",791.766086285611,1.09237280979754,2.06884238581735,3.56330807794925e-09,1.2013913295911e-07,"Q86UK0",0,"Glucosylceramide transporter ABCA12 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 12) (ATP-binding cassette transporter 12) (ATP-binding cassette 12)","cellular homeostasis [GO:0019725]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; cholesterol efflux [GO:0033344]; corneocyte desquamation [GO:0003336]; establishment of skin barrier [GO:0061436]; intracellular protein transport [GO:0006886]; keratinization [GO:0031424]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lung alveolus development [GO:0048286]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of intracellular lipid transport [GO:0032379]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to plasma membrane [GO:0072659]; regulated exocytosis [GO:0045055]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of keratinocyte differentiation [GO:0045616]; secretion by cell [GO:0032940]; surfactant homeostasis [GO:0043129]","GO:0000139; GO:0003336; GO:0005102; GO:0005319; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006672; GO:0006869; GO:0006886; GO:0010875; GO:0016020; GO:0016887; GO:0019725; GO:0030658; GO:0031424; GO:0032379; GO:0032940; GO:0033344; GO:0033700; GO:0034040; GO:0034191; GO:0035627; GO:0042626; GO:0043129; GO:0043231; GO:0045055; GO:0045616; GO:0048286; GO:0055088; GO:0061178; GO:0061436; GO:0072659; GO:0097209; GO:0097234; GO:0140326; GO:0140359; GO:2000010","cytoplasm [GO:0005737]; cytosol [GO:0005829]; epidermal lamellar body [GO:0097209]; epidermal lamellar body membrane [GO:0097234]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]","ABC-type transporter activity [GO:0140359]; apolipoprotein A-I receptor binding [GO:0034191]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; signaling receptor binding [GO:0005102]"
"399","Pocillopora_acuta_HIv2___RNAseq.g28715.t1",157.218490745542,11.7877148036159,3.51520762008952,3.64989393428886e-09,1.22772246198963e-07,NA,NA,NA,NA,NA,NA,NA
"400","Pocillopora_acuta_HIv2___RNAseq.g6366.t1",214.077295911434,12.1786799969797,3.63192155005705,3.67178013829639e-09,1.23221874525102e-07,"Q7SY09",4.76e-36,"Adhesion G protein-coupled receptor L4","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; animal organ development [GO:0048513]; cell surface receptor signaling pathway [GO:0007166]","GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0007189; GO:0048513","plasma membrane [GO:0005886]","calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]"
"401","Pocillopora_acuta_HIv2___TS.g9752.t3",593.7277310131,11.3220834883753,3.31653983708618,3.70330308028924e-09,1.23992073503017e-07,"Q14517",4.66e-21,"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]","actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cellular response to angiotensin [GO:1904385]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]","GO:0002088; GO:0003382; GO:0003412; GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016324; GO:0016477; GO:0030027; GO:0030175; GO:0048471; GO:0070062; GO:0098609; GO:1904385; GO:1904754","apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]","calcium ion binding [GO:0005509]"
"402","Pocillopora_acuta_HIv2___RNAseq.g2526.t1",131.777735837222,11.7216388987492,3.49426616319318,3.83681890763741e-09,1.27983537512534e-07,NA,NA,NA,NA,NA,NA,NA
"403","Pocillopora_acuta_HIv2___RNAseq.g14951.t1",847.297592672048,8.24598636150645,2.5579848353381,3.84021399892421e-09,1.27983537512534e-07,"B3EWZ3",1.5e-76,"Coadhesin","","GO:0016020","membrane [GO:0016020]",""
"404","Pocillopora_acuta_HIv2___RNAseq.g15257.t1",1581.91802845492,7.38491773682319,2.479764914778,3.8779717282126e-09,1.28944788682453e-07,NA,NA,NA,NA,NA,NA,NA
"405","Pocillopora_acuta_HIv2___TS.g5171.t1",295.198265472461,9.50160868217047,2.63395328055217,4.02751198475326e-09,1.33609938870347e-07,"P52569",2.27e-146,"Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)","amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-ornithine transmembrane transport [GO:1903352]; transport across blood-brain barrier [GO:0150104]","GO:0000064; GO:0005886; GO:0006865; GO:0015171; GO:0015174; GO:0015179; GO:0015189; GO:0015807; GO:0030054; GO:0061459; GO:0089718; GO:0097638; GO:0150104; GO:1902475; GO:1903352; GO:1903826","cell junction [GO:0030054]; plasma membrane [GO:0005886]","amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]"
"406","Pocillopora_acuta_HIv2___TS.g19097.t2",208.317013045612,12.3002516267982,3.7467033134532,4.29654014298411e-09,1.41883919242288e-07,"Q94887",1.07e-14,"Neurexin-4 (Neurexin IV)","axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; terminal button organization [GO:0072553]","GO:0003015; GO:0005886; GO:0005919; GO:0007391; GO:0008039; GO:0008104; GO:0008366; GO:0019991; GO:0021682; GO:0035151; GO:0045202; GO:0045216; GO:0048786; GO:0060857; GO:0061343; GO:0072553; GO:0097105","plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]",""
"407","Pocillopora_acuta_HIv2___RNAseq.g10294.t1",175.429385145671,12.0693942690402,3.61858065197314,4.37188580436956e-09,1.43715809714549e-07,"Q58A42",5.84e-70,"Protein DD3-3","","GO:0016020","membrane [GO:0016020]",""
"408","Pocillopora_acuta_HIv2___RNAseq.g12752.t1",1551.67452238722,6.97787877947129,5.09634657642847,4.41537930996045e-09,1.44816431608318e-07,"Q9UKP5",3.14e-146,"A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-)","aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508]","GO:0001822; GO:0003279; GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976","extracellular matrix [GO:0031012]; extracellular region [GO:0005576]","metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]"
"409","Pocillopora_acuta_HIv2___RNAseq.g7553.t1",178.606610751168,12.0518319046221,3.64363533236514,4.54055072968482e-09,1.48284785485233e-07,"Q14517",2.69e-09,"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]","actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cellular response to angiotensin [GO:1904385]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]","GO:0002088; GO:0003382; GO:0003412; GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016324; GO:0016477; GO:0030027; GO:0030175; GO:0048471; GO:0070062; GO:0098609; GO:1904385; GO:1904754","apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]","calcium ion binding [GO:0005509]"
"410","Pocillopora_acuta_HIv2___RNAseq.g15598.t1",2185.21135854465,5.15371813106107,5.01902915769547,4.54163163509115e-09,1.48284785485233e-07,NA,NA,NA,NA,NA,NA,NA
"411","Pocillopora_acuta_HIv2___RNAseq.g10096.t1",187.351047511824,12.065621175001,3.61449935128563,4.5899975147137e-09,1.48831360253238e-07,NA,NA,NA,NA,NA,NA,NA
"412","Pocillopora_acuta_HIv2___RNAseq.g11039.t1",612.291924077895,8.98227422766052,2.58873378458689,4.59159595335997e-09,1.48831360253238e-07,NA,NA,NA,NA,NA,NA,NA
"413","Pocillopora_acuta_HIv2___RNAseq.g15137.t1",188.012888832924,12.1939572259459,3.76838584578775,4.59953111402083e-09,1.48831360253238e-07,"Q9Z2E3",0,"Serine/threonine-protein kinase/endoribonuclease IRE2 (Endoplasmic reticulum-to-nucleus signaling 2) (Inositol-requiring protein 2) (Ire1-beta) (IRE1b) (mIre1) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]","apoptotic chromosome condensation [GO:0030263]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; response to endoplasmic reticulum stress [GO:0034976]; rRNA catabolic process [GO:0016075]","GO:0000287; GO:0004521; GO:0004674; GO:0005524; GO:0005829; GO:0006355; GO:0006397; GO:0006468; GO:0016075; GO:0030263; GO:0034976; GO:0036498; GO:0043507; GO:0044322; GO:0045892; GO:0051082; GO:0070059; GO:0106310; GO:1990604","cytosol [GO:0005829]; endoplasmic reticulum quality control compartment [GO:0044322]; IRE1-TRAF2-ASK1 complex [GO:1990604]","ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA endonuclease activity [GO:0004521]; unfolded protein binding [GO:0051082]"
"414","Pocillopora_acuta_HIv2___RNAseq.g18882.t1",213.343504217865,9.19554984074956,2.45563868131006,4.70309572005891e-09,1.51842804676188e-07,NA,NA,NA,NA,NA,NA,NA
"415","Pocillopora_acuta_HIv2___RNAseq.g14869.t1",277.224405250264,12.7484831681796,3.87597965134195,4.79434145492606e-09,1.54443997336416e-07,"Q9Y5X5",6.03e-26,"Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor)","cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0042277; GO:0043408","actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]","G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628]; peptide binding [GO:0042277]"
"416","Pocillopora_acuta_HIv2___RNAseq.g8276.t1",579.755694514519,10.7039881490871,3.23227924173698,4.88564334217679e-09,1.56687240135799e-07,"Q6VAB6",7.67e-45,"Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1)","calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265]","GO:0004672; GO:0004674; GO:0005078; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007265; GO:0019722; GO:0031434; GO:0043410; GO:0046872; GO:0106310; GO:0120162","cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]","ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]"
"417","Pocillopora_acuta_HIv2___RNAseq.g30992.t1",924.626802302463,11.2811431824601,3.66197966530291,5.10274278098788e-09,1.63287768991612e-07,"Q9Z2J0",0,"Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3)","brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]","GO:0005737; GO:0005886; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015143; GO:0015229; GO:0015882; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837","apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]","dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium ion transmembrane transporter activity [GO:0015081]; urate transmembrane transporter activity [GO:0015143]"
"418","Pocillopora_acuta_HIv2___RNAseq.g3492.t1",120.360259548669,11.5470574659084,3.43457649373502,5.12270362649917e-09,1.63564647359126e-07,NA,NA,NA,NA,NA,NA,NA
"419","Pocillopora_acuta_HIv2___RNAseq.g16525.t1",160.960115596749,9.44327833451652,2.47408844442266,5.13781685981339e-09,1.63685865771676e-07,"Q6VTH5",1.59e-89,"Radial spoke head 1 homolog (Meichroacidin homolog) (Meichroacidin-like sperm-specific axonemal protein) (Testis-specific gene A2-like protein)","cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; spermatogenesis [GO:0007283]","GO:0001535; GO:0007283; GO:0030154; GO:0036126; GO:0051321; GO:0097729","9+2 motile cilium [GO:0097729]; radial spoke head [GO:0001535]; sperm flagellum [GO:0036126]",""
"420","Pocillopora_acuta_HIv2___RNAseq.673_t",1356.35628188467,-7.99476356187196,3.48214811860989,5.23045502891535e-09,1.66270992391718e-07,"Q7TSY2",9.23e-33,"LHFPL tetraspan subfamily member 4 protein (Lipoma HMGIC fusion partner-like 4 protein)","gamma-aminobutyric acid receptor clustering [GO:0097112]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of inhibitory synapse assembly [GO:1905702]; sensory perception of sound [GO:0007605]","GO:0005886; GO:0007605; GO:0030425; GO:0045211; GO:0050811; GO:0060077; GO:0097112; GO:0098982; GO:0099572; GO:0099645; GO:1905702","dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]","GABA receptor binding [GO:0050811]"
"421","Pocillopora_acuta_HIv2___RNAseq.g16193.t1",298.365124692412,10.2421959744512,3.02928498285637,5.48409065077709e-09,1.73951506957982e-07,"Q496Y0",1.46e-90,"LON peptidase N-terminal domain and RING finger protein 3 (RING finger protein 127)","","GO:0005737; GO:0046872; GO:0061630","cytoplasm [GO:0005737]","metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
"422","Pocillopora_acuta_HIv2___RNAseq.g13533.t1",410.709756185949,10.4101288225619,3.19972313203827,5.51805341575353e-09,1.74645786882843e-07,"Q6V4S5",4.55e-54,"Protein sidekick-2","camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]","GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0045202; GO:0060219","plasma membrane [GO:0005886]; synapse [GO:0045202]",""
"423","Pocillopora_acuta_HIv2___RNAseq.g18966.t1",158.819416209824,11.903979094868,3.60449731401537,5.84517252092795e-09,1.8379255509283e-07,"P63142",1.56e-142,"Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2)","action potential [GO:0001508]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; neuronal action potential [GO:0019228]; optic nerve development [GO:0021554]; optic nerve structural organization [GO:0021633]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of circadian sleep/wake cycle, non-REM sleep [GO:0045188]; regulation of dopamine secretion [GO:0014059]; sensory perception of pain [GO:0019233]","GO:0001508; GO:0005249; GO:0005251; GO:0005768; GO:0005789; GO:0005886; GO:0008076; GO:0014059; GO:0015271; GO:0016020; GO:0019228; GO:0019233; GO:0019894; GO:0021554; GO:0021633; GO:0021987; GO:0022038; GO:0030027; GO:0030424; GO:0030425; GO:0031258; GO:0032809; GO:0033010; GO:0034705; GO:0042734; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0044305; GO:0045188; GO:0045211; GO:0051260; GO:0071805; GO:0097623; GO:0098978; GO:0099508; GO:1905030","axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; juxtaparanode region of axon [GO:0044224]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; potassium channel complex [GO:0034705]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076]","delayed rectifier potassium channel activity [GO:0005251]; kinesin binding [GO:0019894]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249]"
"424","Pocillopora_acuta_HIv2___RNAseq.g2199.t1",169.962640449185,11.7938883965972,3.57093021911008,5.93434619554998e-09,1.86109962809701e-07,NA,NA,NA,NA,NA,NA,NA
"425","Pocillopora_acuta_HIv2___RNAseq.g16715.t1",164499.295892458,-3.51677493485201,0.67520375869984,5.94460749571917e-09,1.86109962809701e-07,"Q9LF88",2.78e-07,"Late embryogenesis abundant protein At3g53040 (LEA domain-containing protein At3g53040)","floral organ abscission [GO:0010227]","GO:0005829; GO:0010227","cytosol [GO:0005829]",""
"426","Pocillopora_acuta_HIv2___RNAseq.g15988.t1",402.615652985082,10.0033248562199,3.03660664452885,6.08385669929639e-09,1.90058106476507e-07,NA,NA,NA,NA,NA,NA,NA
"427","Pocillopora_acuta_HIv2___RNAseq.g3500.t1",395.143572980361,9.81981552415582,2.9756858536418,6.11346101167791e-09,1.90193714787838e-07,NA,NA,NA,NA,NA,NA,NA
"428","Pocillopora_acuta_HIv2___RNAseq.g9811.t1",280.135989197837,9.94524424283772,2.90936695438978,6.19142705416905e-09,1.92173392513951e-07,"Q924H0",7.27e-29,"Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor)","cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of MAPK cascade [GO:0043408]","GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0042277; GO:0043408","actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]","neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628]; peptide binding [GO:0042277]"
"429","Pocillopora_acuta_HIv2___RNAseq.g8523.t1",133.456897571417,11.7992715715928,3.58303260481524,6.21835885174262e-09,1.92596022337485e-07,"B3EWZ3",2.54e-29,"Coadhesin","","GO:0016020","membrane [GO:0016020]",""
"430","Pocillopora_acuta_HIv2___RNAseq.g27399.t1",695.194086628675,10.4088508837032,3.34893162711642,6.52420444723569e-09,2.00864590402327e-07,"O57382",1.05e-16,"Tolloid-like protein 2 (EC 3.4.24.-) (Metalloprotease xolloid) (Xenopus tolloid)","cell differentiation [GO:0030154]; proteolysis [GO:0006508]","GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008270; GO:0030154","extracellular region [GO:0005576]","calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
"431","Pocillopora_acuta_HIv2___RNAseq.g19083.t1",2772.76454279608,-7.53033162206631,2.26835769838629,6.5927869797614e-09,2.02458749204393e-07,"P0C6X2",6.74e-08,"Replicase polyprotein 1ab (pp1ab) (ORF1ab polyprotein) [Cleaved into: Host translation inhibitor nsp1 (nsp1) (p28); Non-structural protein 2 (nsp2) (p65); Papain-like proteinase nsp3 (PL-PRO) (EC 3.4.19.12) (EC 3.4.22.-) (Non-structural protein 3) (nsp3) (p210); Non-structural protein 4 (nsp4) (Peptide HD2) (p44); 3C-like proteinase nsp5 (3CL-PRO) (3CLp) (EC 3.4.22.-) (M-PRO) (nsp5) (p27); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7) (p10); Non-structural protein 8 (nsp8) (p22); Viral protein genome-linked nsp9 (Non-structural protein 9) (nsp9) (RNA-capping enzyme subunit nsp9) (p12); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL) (p15); RNA-directed RNA polymerase nsp12 (Pol) (RdRp) (EC 2.7.7.48) (EC 2.7.7.50) (nsp12) (p100); Helicase nsp13 (Hel) (EC 3.6.4.12) (EC 3.6.4.13) (nsp13) (p67); Guanine-N7 methyltransferase nsp14 (ExoN) (EC 2.1.1.56) (EC 3.1.13.-) (nsp14); Uridylate-specific endoribonuclease nsp15 (EC 4.6.1.-) (NendoU) (nsp15) (p35); 2'-O-methyltransferase nsp16 (EC 2.1.1.57) (nsp16)]","DNA-templated transcription [GO:0006351]; induction by virus of host autophagy [GO:0039520]; proteolysis [GO:0006508]; symbiont-mediated degradation of host mRNA [GO:0039595]; symbiont-mediated perturbation of host ubiquitin-like protein modification [GO:0039648]; symbiont-mediated suppression of host ISG15-protein conjugation [GO:0039579]; symbiont-mediated suppression of host NF-kappaB cascade [GO:0085034]; symbiont-mediated suppression of host type I interferon-mediated signaling pathway [GO:0039502]; viral genome replication [GO:0019079]; viral protein processing [GO:0019082]; viral translational frameshifting [GO:0075523]; virus-mediated perturbation of host defense response [GO:0019049]","GO:0000175; GO:0003724; GO:0003727; GO:0003968; GO:0004197; GO:0004482; GO:0004483; GO:0004519; GO:0004843; GO:0005524; GO:0006351; GO:0006508; GO:0008242; GO:0008270; GO:0016020; GO:0016829; GO:0016887; GO:0019049; GO:0019079; GO:0019082; GO:0033644; GO:0039502; GO:0039520; GO:0039579; GO:0039595; GO:0039648; GO:0044172; GO:0044220; GO:0075523; GO:0085034","host cell endoplasmic reticulum-Golgi intermediate compartment [GO:0044172]; host cell membrane [GO:0033644]; host cell perinuclear region of cytoplasm [GO:0044220]; membrane [GO:0016020]","3'-5'-RNA exonuclease activity [GO:0000175]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; endonuclease activity [GO:0004519]; lyase activity [GO:0016829]; mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; mRNA 5'-cap (guanine-N7-)-methyltransferase activity [GO:0004482]; omega peptidase activity [GO:0008242]; RNA helicase activity [GO:0003724]; RNA-dependent RNA polymerase activity [GO:0003968]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]"
"432","Pocillopora_acuta_HIv2___RNAseq.g7626.t1",648.380386902381,7.43677800140771,3.47414464666673,6.6978517621737e-09,2.05249423491696e-07,"Q9V477",6.49e-15,"Toll-like receptor Tollo (Toll-like receptor 8)","axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response [GO:0045087]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165]","GO:0003401; GO:0005886; GO:0007165; GO:0016324; GO:0045087; GO:0048018; GO:0048935; GO:0060026; GO:0060049; GO:0061809","apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886]","NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; receptor ligand activity [GO:0048018]"
"433","Pocillopora_acuta_HIv2___RNAseq.g13270.t1",193.255076777531,8.78361251953714,2.21048387200277,7.04515825677372e-09,2.15435875319186e-07,NA,NA,NA,NA,NA,NA,NA
"434","Pocillopora_acuta_HIv2___RNAseq.g8086.t1",748.221244176246,10.2828134945078,3.37805260920869,7.1272682947707e-09,2.17486178457194e-07,"Q8R151",1.86e-146,"NFX1-type zinc finger-containing protein 1","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607","cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380]","helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
"435","Pocillopora_acuta_HIv2___TS.g19988.t1",141.406931162774,11.5040124844868,3.51596908731953,7.14227978202206e-09,2.17486178457194e-07,NA,NA,NA,NA,NA,NA,NA
"436","Pocillopora_acuta_HIv2___RNAseq.g26672.t1",145.888738484697,11.5912552658795,3.4793257860518,7.24035679025674e-09,2.2000949708881e-07,"P54131",1.59e-110,"Neuronal acetylcholine receptor subunit alpha-7","calcium ion transport [GO:0006816]; cognition [GO:0050890]; intracellular calcium ion homeostasis [GO:0006874]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]","GO:0001540; GO:0001666; GO:0005886; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0032720; GO:0035094; GO:0042166; GO:0042803; GO:0043005; GO:0043410; GO:0045202; GO:0045211; GO:0045766; GO:0050890","acetylcholine-gated channel complex [GO:0005892]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]","acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]"
"437","Pocillopora_acuta_HIv2___TS.g3229.t1",1043.02960614867,-7.78648793664759,2.69414933785955,7.26633732098582e-09,2.20336065012031e-07,NA,NA,NA,NA,NA,NA,NA
"438","Pocillopora_acuta_HIv2___TS.g1516.t1",150.250077371187,9.01127856230663,2.36695796161086,7.38560031110545e-09,2.23483939120982e-07,"A0AUR5",8.27e-124,"Ubiquitin carboxyl-terminal hydrolase MINDY-3 (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-3) (Protein CARP)","apoptotic process [GO:0006915]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]","GO:0004843; GO:0005634; GO:0006508; GO:0006915; GO:0071108; GO:1990380","nucleus [GO:0005634]","cysteine-type deubiquitinase activity [GO:0004843]; K48-linked deubiquitinase activity [GO:1990380]"
"439","Pocillopora_acuta_HIv2___RNAseq.g15141.t1",178.382300019555,12.0042174487723,3.7519328546521,7.60708950707844e-09,2.29705516973659e-07,"Q8L8B8",1.54e-56,"Cytokinin riboside 5'-monophosphate phosphoribohydrolase LOG3 (EC 3.2.2.n1) (Protein LONELY GUY 3)","cytokinin biosynthetic process [GO:0009691]","GO:0005634; GO:0005829; GO:0009691; GO:0016799; GO:0102682","cytosol [GO:0005829]; nucleus [GO:0005634]","cytokinin riboside 5'-monophosphate phosphoribohydrolase activity [GO:0102682]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]"
"440","Pocillopora_acuta_HIv2___RNAseq.g24018.t1",147.620403608054,-9.70153497844579,2.75152591705979,7.64370467748351e-09,2.3033030094817e-07,NA,NA,NA,NA,NA,NA,NA
"441","Pocillopora_acuta_HIv2___RNAseq.g27413.t1",680.37379867378,10.7835948228793,3.38537838516793,7.85272294937471e-09,2.36136766610719e-07,"P63079",4.11e-92,"Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3)","brain development [GO:0007420]; cellular response to histamine [GO:0071420]; cellular response to zinc ion [GO:0071294]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chemical synaptic transmission, postsynaptic [GO:0099565]; chloride transmembrane transport [GO:1902476]; circadian sleep/wake cycle, REM sleep [GO:0042747]; cochlea development [GO:0090102]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hard palate development [GO:0060022]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; learning [GO:0007612]; memory [GO:0007613]; monoatomic ion transmembrane transport [GO:0034220]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuron development [GO:0048666]; regulation of postsynaptic membrane potential [GO:0060078]; reproductive behavior [GO:0019098]; response to anesthetic [GO:0072347]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; social behavior [GO:0035176]; synaptic transmission, GABAergic [GO:0051932]","GO:0004890; GO:0005216; GO:0005254; GO:0005886; GO:0007214; GO:0007268; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0009410; GO:0009986; GO:0019098; GO:0021549; GO:0022851; GO:0030594; GO:0030659; GO:0034220; GO:0034707; GO:0035176; GO:0035612; GO:0035640; GO:0042747; GO:0042802; GO:0043005; GO:0043195; GO:0045202; GO:0045211; GO:0048666; GO:0051932; GO:0060021; GO:0060022; GO:0060077; GO:0060078; GO:0060080; GO:0060119; GO:0060384; GO:0061744; GO:0071294; GO:0071420; GO:0072347; GO:0090102; GO:0098982; GO:0099565; GO:0099634; GO:1902476; GO:1902495; GO:1902711; GO:1904315; GO:1904862","cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; synapse [GO:0045202]; terminal bouton [GO:0043195]; transmembrane transporter complex [GO:1902495]","AP-2 adaptor complex binding [GO:0035612]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; identical protein binding [GO:0042802]; monoatomic ion channel activity [GO:0005216]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]"
"442","Pocillopora_acuta_HIv2___RNAseq.g9381.t1",374.196229111387,-9.82914883379292,3.26762234190971,7.89830293314742e-09,2.37014634076855e-07,"Q60928",3.76e-122,"Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]","cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638]","GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006536; GO:0006749; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068","extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle [GO:0031982]","aminoacyltransferase activity [GO:0016755]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]"
"443","Pocillopora_acuta_HIv2___RNAseq.g21627.t1",740.285196352006,6.67639053389872,4.3937305053453,7.96008013076504e-09,2.38373910996657e-07,"Q96N23",0,"Cilia- and flagella-associated protein 54","cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283]","GO:0005576; GO:0005930; GO:0007283; GO:0051649; GO:0060271; GO:0060294; GO:0090660; GO:0120197; GO:0120316","axoneme [GO:0005930]; extracellular region [GO:0005576]",""
"444","Pocillopora_acuta_HIv2___RNAseq.g21884.t1",182.225498377468,11.8174603908241,3.62839151011413,8.0078418445597e-09,2.39308728181222e-07,"Q9Y227",2.93e-168,"Ectonucleoside triphosphate diphosphohydrolase 4 (NTPDase 4) (EC 3.6.1.15) (EC 3.6.1.6) (Golgi UDPase) (Lysosomal apyrase-like protein of 70 kDa) (Uridine-diphosphatase) (UDPase) (EC 3.6.1.42)","CTP metabolic process [GO:0046036]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule catabolic process [GO:0034656]; UDP catabolic process [GO:0006256]","GO:0000139; GO:0000421; GO:0003924; GO:0004382; GO:0005765; GO:0005794; GO:0006256; GO:0016020; GO:0017110; GO:0017111; GO:0031410; GO:0034656; GO:0036384; GO:0043273; GO:0045134; GO:0046036; GO:0046712","autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]","CDP phosphatase activity [GO:0036384]; CTPase activity [GO:0043273]; GDP phosphatase activity [GO:0004382]; GTPase activity [GO:0003924]; nucleoside diphosphate phosphatase activity [GO:0017110]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; UDP phosphatase activity [GO:0045134]"
"445","Pocillopora_acuta_HIv2___RNAseq.g22676.t1",476.674802435943,10.7057455856685,3.2546582670638,8.39515963996121e-09,2.48827026705736e-07,NA,NA,NA,NA,NA,NA,NA
"446","Pocillopora_acuta_HIv2___RNAseq.g7443.t1",443.172271713954,10.4186645634902,3.22294687693799,8.52432183057736e-09,2.52138631814869e-07,"Q32NG4",2.39e-94,"Glutamine amidotransferase-like class 1 domain-containing protein 1 (Ferry endosomal RAB5 effector complex subunit 5) (Fy-5) (Parkinson disease 7 domain-containing protein 1)","","GO:0005576; GO:0005769","early endosome [GO:0005769]; extracellular region [GO:0005576]",""
"447","Pocillopora_acuta_HIv2___RNAseq.g2173.t1",371.361882073016,10.3043787485905,3.22269542157418,8.6323264097914e-09,2.54812182022904e-07,"Q8N0W5",4.39e-49,"IQ domain-containing protein K","","","",""
"448","Pocillopora_acuta_HIv2___RNAseq.g994.t1",1097.04685468941,6.07105113835859,4.81572164462276,8.83236326330014e-09,2.60185951609721e-07,"P09917",1.46e-46,"Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34)","arachidonic acid metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426]","GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005576; GO:0005615; GO:0005635; GO:0005641; GO:0005654; GO:0005829; GO:0006691; GO:0006959; GO:0016363; GO:0016525; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030501; GO:0031965; GO:0034440; GO:0034774; GO:0036336; GO:0036403; GO:0042593; GO:0042759; GO:0045598; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904813; GO:1904999; GO:2001301","cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; secretory granule lumen [GO:0034774]","arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; hydrolase activity [GO:0016787]; iron ion binding [GO:0005506]"
"449","Pocillopora_acuta_HIv2___TS.g12453.t2",884.199820296655,-1.49900556260973,3.92325238130988,8.93397843215589e-09,2.62150705486234e-07,"O08746",2.22e-19,"Matrilin-2","axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; response to axon injury [GO:0048678]","GO:0001764; GO:0005509; GO:0005604; GO:0005615; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0031175; GO:0048678; GO:0062023; GO:0120216","basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; matrilin complex [GO:0120216]","calcium ion binding [GO:0005509]"
"450","Pocillopora_acuta_HIv2___TS.g1768.t1",504.477650228987,10.8075458896987,3.31510378446183,8.93530819999401e-09,2.62150705486234e-07,"P16621",2.14e-07,"Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124]","GO:0004725; GO:0005001; GO:0005158; GO:0005925; GO:0007155; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0009986; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0045467; GO:0046627; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0061484; GO:0120034; GO:1903386","axon [GO:0030424]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; focal adhesion [GO:0005925]","heparin binding [GO:0008201]; insulin receptor binding [GO:0005158]; protein tyrosine phosphatase activity [GO:0004725]; SAM domain binding [GO:0032093]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
"451","Pocillopora_acuta_HIv2___TS.g2144.t1",187.44216437744,12.0268982974054,3.7987505918117,9.0807173906294e-09,2.65877522951546e-07,NA,NA,NA,NA,NA,NA,NA
"452","Pocillopora_acuta_HIv2___RNAseq.g13716.t1",1305.77810102607,1.17674952037561,2.26848584378242,9.22959249925716e-09,2.69690557392436e-07,"D2IYS2",7.39e-70,"Tyrosine-protein kinase receptor torso (EC 2.7.10.1)","cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0043235; GO:0046872","plasma membrane [GO:0005886]; receptor complex [GO:0043235]","ATP binding [GO:0005524]; metal ion binding [GO:0046872]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
"453","Pocillopora_acuta_HIv2___RNAseq.g18617.t1",610.494460611408,11.1096862863115,3.52049747055427,9.94604916072801e-09,2.8945604639994e-07,"Q795M8",3.45e-08,"Putative potassium channel protein YugO","","GO:0005267; GO:0005886","plasma membrane [GO:0005886]","potassium channel activity [GO:0005267]"
"454","Pocillopora_acuta_HIv2___TS.g28037.t1",120.114117307913,11.4721103378421,3.51871321267501,1.00338734171246e-08,2.91425592580905e-07,NA,NA,NA,NA,NA,NA,NA
"455","Pocillopora_acuta_HIv2___TS.g16482.t1",595.102737753852,10.2035806135741,3.41266142039557,1.0264461722576e-08,2.97525399509697e-07,"P31649",0,"Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13)","amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; taurine transmembrane transport [GO:0015734]","GO:0005283; GO:0005308; GO:0005332; GO:0005368; GO:0005369; GO:0005886; GO:0006836; GO:0006865; GO:0015185; GO:0015734; GO:0015881; GO:0016323; GO:0016597; GO:0035725; GO:0042995; GO:0051939; GO:0089718","basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; plasma membrane [GO:0005886]","amino acid binding [GO:0016597]; amino acid:sodium symporter activity [GO:0005283]; creatine transmembrane transporter activity [GO:0005308]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; taurine transmembrane transporter activity [GO:0005368]; taurine:sodium symporter activity [GO:0005369]"
"456","Pocillopora_acuta_HIv2___TS.g12260.t1",509.973649229557,-6.91491653769028,1.93573774799341,1.0363909157579e-08,2.99759187690609e-07,"P55024",3.06e-70,"Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase)","melanin biosynthetic process [GO:0042438]; pigmentation [GO:0043473]; response to blue light [GO:0009637]","GO:0004503; GO:0009637; GO:0033162; GO:0042438; GO:0042470; GO:0043473; GO:0046872","melanosome [GO:0042470]; melanosome membrane [GO:0033162]","metal ion binding [GO:0046872]; tyrosinase activity [GO:0004503]"
"457","Pocillopora_acuta_HIv2___TS.g1731.t1",516.555249517255,10.4023616193407,3.23273332910321,1.04443592830243e-08,3.00721575576434e-07,"P10079",5.83e-76,"Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","","GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579","apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]","biotin binding [GO:0009374]; calcium ion binding [GO:0005509]"
"458","Pocillopora_acuta_HIv2___RNAseq.g1195.t1",121.864309158679,11.3571694226644,3.4368688910809,1.04578921816196e-08,3.00721575576434e-07,"P24668",2.85e-06,"Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) (46 kDa mannose 6-phosphate receptor) (MPR 46)","intracellular protein transport [GO:0006886]; lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299]","GO:0005765; GO:0005768; GO:0005770; GO:0005802; GO:0006622; GO:0006886; GO:0007041; GO:0019904; GO:0033299; GO:0048471; GO:1905394","endosome [GO:0005768]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]","protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394]"
"459","Pocillopora_acuta_HIv2___RNAseq.g1932.t1",163.973548814544,11.854347140163,3.69761800836141,1.06142843891693e-08,3.04613113898699e-07,"P23999",4.72e-09,"Protein S-Myc","apoptotic process [GO:0006915]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0006915; GO:0046983","nucleus [GO:0005634]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"460","Pocillopora_acuta_HIv2___RNAseq.19049_t",22594.1017712648,3.34150673652034,0.648294348715337,1.07020126616224e-08,3.0652259631229e-07,NA,NA,NA,NA,NA,NA,NA
"461","Pocillopora_acuta_HIv2___RNAseq.g14868.t1b",329.465398600593,9.90525563281419,2.99026045239694,1.11250509428009e-08,3.18009361337297e-07,"P46825",2.56e-08,"Kinesin light chain (KLC)","microtubule-based movement [GO:0007018]","GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0019894","cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]","kinesin binding [GO:0019894]"
"462","Pocillopora_acuta_HIv2___RNAseq.g29822.t1",2126.25199022812,-4.43523924718478,0.961869978907184,1.13435439911589e-08,3.23615424631405e-07,NA,NA,NA,NA,NA,NA,NA
"463","Pocillopora_acuta_HIv2___RNAseq.g14726.t1",143.755575253737,11.9228705115142,3.6251017294896,1.14071869711967e-08,3.24790457384625e-07,NA,NA,NA,NA,NA,NA,NA
"464","Pocillopora_acuta_HIv2___RNAseq.g24123.t1",284.034595306127,9.80692619593776,2.93839974179619,1.21599667871128e-08,3.45543732040863e-07,NA,NA,NA,NA,NA,NA,NA
"465","Pocillopora_acuta_HIv2___RNAseq.6942_t",1070.86015112357,11.0533442080858,3.40645420269311,1.2322089856734e-08,3.49464132721179e-07,"Q8CBH5",5.47e-52,"Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2)","adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]","GO:0002250; GO:0005886; GO:0032393; GO:0042288; GO:0042590","plasma membrane [GO:0005886]","MHC class I protein binding [GO:0042288]; MHC class I receptor activity [GO:0032393]"
"466","Pocillopora_acuta_HIv2___RNAseq.g4978.t1",626.035372161439,10.4372000046803,3.29570896259417,1.23897432768461e-08,3.50695199131707e-07,"Q6P1X6",1.81e-68,"UPF0598 protein C8orf82","","","",""
"467","Pocillopora_acuta_HIv2___RNAseq.g7550.t1",700.369251626463,7.202332783858,4.27706303175773,1.24474858026139e-08,3.51641473923843e-07,"Q8VI63",1.13e-69,"MOB kinase activator 2 (Mob2 homolog) (Mps one binder kinase activator-like 2) (Ovary-specific MOB-like protein)","actin cytoskeleton organization [GO:0030036]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165]","GO:0001934; GO:0005634; GO:0005737; GO:0007165; GO:0010976; GO:0030036; GO:0030295; GO:0044306; GO:0046872; GO:0048471","cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]","metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]"
"468","Pocillopora_acuta_HIv2___TS.g11075.t2",373.064562057703,9.94243309622813,3.11473206702746,1.27725413475834e-08,3.59420307493087e-07,"P30051",0,"Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13)","cellular response to retinoic acid [GO:0071300]; embryonic heart tube morphogenesis [GO:0003143]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; hippo signaling [GO:0035329]; lateral mesoderm development [GO:0048368]; notochord development [GO:0030903]; paraxial mesoderm development [GO:0048339]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; transition between fast and slow fiber [GO:0014883]","GO:0000978; GO:0000981; GO:0003143; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0006357; GO:0007507; GO:0010468; GO:0014883; GO:0030307; GO:0030903; GO:0035329; GO:0042127; GO:0045893; GO:0045944; GO:0048339; GO:0048368; GO:0048568; GO:0071300; GO:0140552; GO:1902459","nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667]","DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"469","Pocillopora_acuta_HIv2___TS.g5006.t1c",506.296844231968,10.712852613191,3.32884093512308,1.30125344205652e-08,3.65462714289427e-07,NA,NA,NA,NA,NA,NA,NA
"470","Pocillopora_acuta_HIv2___RNAseq.g672.t1",528.012808858935,10.3560543690957,3.23315376591107,1.33347806019572e-08,3.73353616118166e-07,"B3EWZ3",2.84e-96,"Coadhesin","","GO:0016020","membrane [GO:0016020]",""
"471","Pocillopora_acuta_HIv2___RNAseq.g10393.t1",270.13557583126,9.58225980847998,2.92555974524984,1.33451202663919e-08,3.73353616118166e-07,"A9UMP7",1.21e-72,"Enolase 4 (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase)","glycolytic process [GO:0006096]","GO:0000015; GO:0000287; GO:0004634; GO:0006096","phosphopyruvate hydratase complex [GO:0000015]","magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]"
"472","Pocillopora_acuta_HIv2___RNAseq.12690_t",645.084818474978,10.1568629795329,3.31030508230996,1.36784502686601e-08,3.81940356536485e-07,"Q9VQX4",0,"Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)","NAD salvage [GO:0034355]; response to oxidative stress [GO:0006979]","GO:0004516; GO:0005829; GO:0006979; GO:0016740; GO:0034355; GO:0046872","cytosol [GO:0005829]","metal ion binding [GO:0046872]; nicotinate phosphoribosyltransferase activity [GO:0004516]; transferase activity [GO:0016740]"
"473","Pocillopora_acuta_HIv2___RNAseq.g20653.t1",563.476190521502,-5.80036292922699,4.2780565170371,1.39052274019911e-08,3.86733053811053e-07,NA,NA,NA,NA,NA,NA,NA
"474","Pocillopora_acuta_HIv2___RNAseq.g29670.t2",209.219227652221,11.9829100257538,3.72869172451691,1.39303042751354e-08,3.86733053811053e-07,"Q16281",1.33e-122,"Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3)","inorganic cation import across plasma membrane [GO:0098659]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic cation transport [GO:0006812]; response to cAMP [GO:0051591]; response to magnesium ion [GO:0032026]; signal transduction [GO:0007165]; visual perception [GO:0007601]","GO:0005222; GO:0005223; GO:0005262; GO:0005272; GO:0005886; GO:0006812; GO:0007165; GO:0007601; GO:0015276; GO:0017022; GO:0017071; GO:0030425; GO:0030553; GO:0032026; GO:0043194; GO:0043204; GO:0044877; GO:0045296; GO:0051591; GO:0097386; GO:0098655; GO:0098659; GO:1902495","axon initial segment [GO:0043194]; dendrite [GO:0030425]; glial cell projection [GO:0097386]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495]","cadherin binding [GO:0045296]; calcium channel activity [GO:0005262]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223]; ligand-gated monoatomic ion channel activity [GO:0015276]; myosin binding [GO:0017022]; protein-containing complex binding [GO:0044877]; sodium channel activity [GO:0005272]"
"475","Pocillopora_acuta_HIv2___RNAseq.g7243.t1",147.910878249033,11.6712059557933,3.67165236126784,1.39730315743657e-08,3.87176108604646e-07,"Q8WU66",1.73e-32,"Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170","cell surface [GO:0009986]; ciliary membrane [GO:0060170]; extracellular region [GO:0005576]; stereocilium [GO:0032420]",""
"476","Pocillopora_acuta_HIv2___RNAseq.g14744.t1",298.315985477422,9.84881175563975,3.10652453114571,1.40042507792183e-08,3.8729920319429e-07,"Q7SC45",1.39e-33,"Protein btn-1","L-arginine transmembrane transport [GO:1903826]; lysine transport [GO:0015819]; regulation of intracellular pH [GO:0051453]","GO:0000324; GO:0005773; GO:0005774; GO:0015819; GO:0051453; GO:1903826","fungal-type vacuole [GO:0000324]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]",""
"477","Pocillopora_acuta_HIv2___RNAseq.g8965.t1",348.376074581586,10.035522153067,3.23742996187236,1.4955668864786e-08,4.12822126832566e-07,"Q640L5",8.02e-105,"Coiled-coil domain-containing protein 18","","GO:0005737; GO:0034451","centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]",""
"478","Pocillopora_acuta_HIv2___RNAseq.g673.t1",447.099874280538,-8.53773044996844,2.85328485257599,1.56545844808983e-08,4.31291257012787e-07,"O15460",4.76e-137,"Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2)","","GO:0004656; GO:0005506; GO:0005654; GO:0005783; GO:0005788; GO:0005829; GO:0009055; GO:0031418; GO:0043231","cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]","electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
"479","Pocillopora_acuta_HIv2___RNAseq.g7635.t1",6055.09317309642,-3.81508617303201,0.787347161133503,1.6139369944757e-08,4.42959861254204e-07,"C0H690",1.84e-11,"Small cysteine-rich protein 1 (Amil-SCRiP1) (SCRiP1)","","GO:0005576; GO:0042151; GO:0090729","extracellular region [GO:0005576]; nematocyst [GO:0042151]","toxin activity [GO:0090729]"
"480","Pocillopora_acuta_HIv2___RNAseq.g3580.t1",975.169963019767,6.8362126112229,5.39449148099654,1.63048144025588e-08,4.46653097573125e-07,"Q7ZSX3",2.09e-57,"Pancreas transcription factor 1 subunit alpha (Pancreas-specific transcription factor 1a) (bHLH transcription factor p48)","amacrine cell differentiation [GO:0035881]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; developmental process [GO:0032502]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; hindbrain development [GO:0030902]; neuron development [GO:0048666]; pancreas development [GO:0031016]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; tissue development [GO:0009888]","GO:0000977; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0009887; GO:0009888; GO:0030154; GO:0030902; GO:0031016; GO:0031017; GO:0032502; GO:0035881; GO:0043565; GO:0045893; GO:0046983; GO:0048384; GO:0048666; GO:0048699","cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]","DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"
"481","Pocillopora_acuta_HIv2___RNAseq.g21538.t1",130.209241528971,11.6944028022717,3.60865752034472,1.6343870640531e-08,4.46876644507826e-07,"O43704",2.35e-56,"Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase)","3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; biogenic amine metabolic process [GO:0006576]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]","GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006576; GO:0006805; GO:0008146; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923","cytoplasm [GO:0005737]; cytosol [GO:0005829]","aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]"
"482","Pocillopora_acuta_HIv2___RNAseq.g30417.t1",444.065290897144,7.30332989370723,3.2916222003146,1.64717719913366e-08,4.49523981288099e-07,NA,NA,NA,NA,NA,NA,NA
"483","Pocillopora_acuta_HIv2___RNAseq.g22977.t1",124.38488833886,11.6454873614423,3.57239084986899,1.67634639193661e-08,4.56622866534296e-07,NA,NA,NA,NA,NA,NA,NA
"484","Pocillopora_acuta_HIv2___RNAseq.g18756.t2",130.629689073319,11.5139781596643,3.61593899350778,1.68030901235382e-08,4.56841908922662e-07,"O75382",1.34e-10,"Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97)","negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]","GO:0000209; GO:0005737; GO:0005769; GO:0005794; GO:0007399; GO:0008270; GO:0015031; GO:0017148; GO:0030371; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061630; GO:0070534","cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]","identical protein binding [GO:0042802]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
"485","Pocillopora_acuta_HIv2___TS.g18947.t1",17030.606210404,3.3767720071822,0.66717727607668,1.70622074474507e-08,4.63016451256899e-07,"Q9QWN8",4.06e-57,"Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41)","actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; adult behavior [GO:0030534]; cellular response to ethanol [GO:0071361]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; multicellular organism growth [GO:0035264]; postsynapse organization [GO:0099173]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of postsynaptic specialization assembly [GO:0099150]; synapse assembly [GO:0007416]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005200; GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0007416; GO:0008021; GO:0008091; GO:0016079; GO:0016081; GO:0016192; GO:0016324; GO:0016363; GO:0017158; GO:0021692; GO:0030036; GO:0030054; GO:0030534; GO:0030864; GO:0033010; GO:0035264; GO:0042995; GO:0043025; GO:0048471; GO:0051015; GO:0051693; GO:0071361; GO:0098688; GO:0098793; GO:0098918; GO:0098978; GO:0099150; GO:0099173; GO:0099186; GO:0099189","apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; parallel fiber to Purkinje cell synapse [GO:0098688]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic spectrin-associated cytoskeleton [GO:0099189]; presynapse [GO:0098793]; spectrin [GO:0008091]; synaptic vesicle [GO:0008021]","actin filament binding [GO:0051015]; phospholipid binding [GO:0005543]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of postsynapse [GO:0099186]; structural constituent of synapse [GO:0098918]"
"486","Pocillopora_acuta_HIv2___RNAseq.g9165.t1",258.445565897004,9.99853115572532,3.0398179676824,1.73457389427781e-08,4.69829153686035e-07,NA,NA,NA,NA,NA,NA,NA
"487","Pocillopora_acuta_HIv2___RNAseq.g27209.t1",284.55292772011,9.63944391928495,2.95061941510127,1.77913909416426e-08,4.80999399214802e-07,NA,NA,NA,NA,NA,NA,NA
"488","Pocillopora_acuta_HIv2___RNAseq.g8521.t2",282.523299634093,8.46000137377623,2.5275444784944,1.78823012618799e-08,4.81682747828712e-07,"P55023",1.56e-19,"Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase)","melanin biosynthetic process [GO:0042438]","GO:0004503; GO:0042438; GO:0046872","","metal ion binding [GO:0046872]; tyrosinase activity [GO:0004503]"
"489","Pocillopora_acuta_HIv2___RNAseq.g18640.t1",150.631664968056,11.6956212364073,3.68744892211206,1.7883271265488e-08,4.81682747828712e-07,"D2GXS7",1.03e-40,"Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]","GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0030371; GO:0043161; GO:0043523; GO:0061630","cytoplasm [GO:0005737]","translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
"490","Pocillopora_acuta_HIv2___TS.g29621.t1",108.096164372217,11.4685193539207,3.55032426686363,1.79857378752229e-08,4.83542216779226e-07,"O75581",0,"Low-density lipoprotein receptor-related protein 6 (LRP-6)","canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]","GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0051091; GO:0060070; GO:0071397; GO:0071542; GO:0071901; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909","cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]","coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
"491","Pocillopora_acuta_HIv2___RNAseq.g17953.t1",487.413425434407,-9.16321645913447,3.59795196519048,1.80699991220422e-08,4.84906247312093e-07,NA,NA,NA,NA,NA,NA,NA
"492","Pocillopora_acuta_HIv2___RNAseq.g14952.t1",100.504765074165,11.2862835125813,3.46062845272308,1.84515029622909e-08,4.94226923789955e-07,"B3EWZ3",5.23e-51,"Coadhesin","","GO:0016020","membrane [GO:0016020]",""
"493","Pocillopora_acuta_HIv2___RNAseq.g3741.t1",229.974031769155,9.76574001707291,2.94690915421863,1.86932588329599e-08,4.99776886802092e-07,"Q8R323",0,"Replication factor C subunit 3 (Activator 1 38 kDa subunit) (A1 38 kDa subunit) (Activator 1 subunit 3) (Replication factor C 38 kDa subunit) (RF-C 38 kDa subunit) (RFC38)","DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683]","GO:0003677; GO:0003689; GO:0005634; GO:0005663; GO:0006261; GO:0006281; GO:0016887; GO:0017116; GO:0031390; GO:0046683; GO:1900264","Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]","ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; single-stranded DNA helicase activity [GO:0017116]"
"494","Pocillopora_acuta_HIv2___RNAseq.g21476.t1",97.5912124262545,8.8194446487158,2.24016371878266,1.90754910273284e-08,5.0811768364508e-07,"P24821",1.15e-46,"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)","bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611]","GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0062023; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098966","basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; interstitial matrix [GO:0005614]; membrane [GO:0016020]; perisynaptic extracellular matrix [GO:0098966]; tenascin complex [GO:0090733]","extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; syndecan binding [GO:0045545]"
"495","Pocillopora_acuta_HIv2___RNAseq.g720.t1",1195.83569752563,6.91347925200145,2.75170159708711,1.95352555235224e-08,5.19407970390125e-07,NA,NA,NA,NA,NA,NA,NA
"496","Pocillopora_acuta_HIv2___RNAseq.g16404.t1",128.520335179793,7.2577408121314,1.82440772757369,2.04354287370743e-08,5.42345029822096e-07,NA,NA,NA,NA,NA,NA,NA
"497","Pocillopora_acuta_HIv2___RNAseq.g28213.t1",2856.05827329361,7.51296404042818,4.31047083328445,2.04918246990428e-08,5.42845700452298e-07,"C3ZQF9",4.07e-23,"QRFP-like peptide receptor","cellular response to hormone stimulus [GO:0032870]; cellular response to peptide [GO:1901653]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0032870; GO:0042277; GO:1901653","plasma membrane [GO:0005886]","G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; peptide binding [GO:0042277]"
"498","Pocillopora_acuta_HIv2___RNAseq.g8582.t1",396.200784749825,10.3637654716983,3.28257183479135,2.07334141552453e-08,5.48241503366485e-07,NA,NA,NA,NA,NA,NA,NA
"499","Pocillopora_acuta_HIv2___RNAseq.g2780.t1",379.656734273056,10.485407232934,3.29837451598546,2.10287785215695e-08,5.55036957182448e-07,"Q7YS61",3.27e-112,"tRNA (cytosine(38)-C(5))-methyltransferase (EC 2.1.1.204) (DNA (cytosine-5)-methyltransferase-like protein 2) (Dnmt2)","tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416]","GO:0003723; GO:0005634; GO:0005737; GO:0016428; GO:0030488; GO:0036416","cytoplasm [GO:0005737]; nucleus [GO:0005634]","RNA binding [GO:0003723]; tRNA (cytidine-5-)-methyltransferase activity [GO:0016428]"
"500","Pocillopora_acuta_HIv2___RNAseq.g11785.t1",185.500463514639,11.8988493991729,3.63872886963992,2.12853109372151e-08,5.60784585420546e-07,"P79888",7.01e-51,"S-adenosylmethionine decarboxylase proenzyme (AdoMetDC) (SAMDC) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain]","spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]","GO:0004014; GO:0006597; GO:0008295","","adenosylmethionine decarboxylase activity [GO:0004014]"
"501","Pocillopora_acuta_HIv2___RNAseq.g16070.t1",127.99356372656,11.4248442848774,3.591477219295,2.15722590126872e-08,5.6731118974456e-07,NA,NA,NA,NA,NA,NA,NA
"502","Pocillopora_acuta_HIv2___TS.g18900.t1",320.154464622215,9.60506640958115,3.15223353524023,2.29014518620705e-08,5.9899927618985e-07,NA,NA,NA,NA,NA,NA,NA
"503","Pocillopora_acuta_HIv2___RNAseq.g12573.t1",9305.29095810737,5.56398419682422,1.50492032965863,2.34732739066265e-08,6.12847353403333e-07,NA,NA,NA,NA,NA,NA,NA
"504","Pocillopora_acuta_HIv2___RNAseq.g22296.t1",560.58780770675,5.51336466582666,5.88945233784106,2.42920852436603e-08,6.3308238011586e-07,"Q5DTY9",4.9e-43,"BTB/POZ domain-containing protein KCTD16","protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]","GO:0008277; GO:0042734; GO:0042995; GO:0043235; GO:0045211; GO:0051260","cell projection [GO:0042995]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]",""
"505","Pocillopora_acuta_HIv2___RNAseq.g12548.t1b",125.972937957615,11.4014489030035,3.62738239038723,2.4455510754845e-08,6.36195157478559e-07,"Q9DBQ9",9.59e-50,"Transcriptional protein SWT1","","GO:0005634","nucleus [GO:0005634]",""
"506","Pocillopora_acuta_HIv2___RNAseq.g22394.t1",622.246947671507,10.2033072359415,3.3800743516788,2.46852555865644e-08,6.41018917062959e-07,NA,NA,NA,NA,NA,NA,NA
"507","Pocillopora_acuta_HIv2___RNAseq.g15709.t1",395.864670932925,10.2963208621028,3.26174487315178,2.58103001188916e-08,6.69032582293276e-07,NA,NA,NA,NA,NA,NA,NA
"508","Pocillopora_acuta_HIv2___TS.g21030.t2",881.776434015257,6.50746153898342,5.57508062726284,2.65289808690528e-08,6.85205677303536e-07,"Q2I327",1.48e-41,"Doublesex- and mab-3-related transcription factor A2 (Doublesex- and mab-3-related transcription factor 5)","sex differentiation [GO:0007548]","GO:0000978; GO:0000981; GO:0005634; GO:0007548; GO:0046872","nucleus [GO:0005634]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"509","Pocillopora_acuta_HIv2___RNAseq.g1274.t1",255.64261169626,11.7198055717955,3.76472042141665,2.6723819101131e-08,6.89007699605631e-07,"Q6P8B3",1.15e-173,"Speckle-type POZ protein","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]","GO:0005634; GO:0016567; GO:0016607; GO:0031463; GO:0043161","Cul3-RING ubiquitin ligase complex [GO:0031463]; nuclear speck [GO:0016607]; nucleus [GO:0005634]",""
"510","Pocillopora_acuta_HIv2___RNAseq.25384_t",433.724339600263,10.3572338938109,3.40963029949457,2.73265166429996e-08,7.03293125844034e-07,"B3TP03",7.71e-126,"Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)","L-arginine import across plasma membrane [GO:0097638]; L-lysine import across plasma membrane [GO:0097639]; L-ornithine transmembrane transport [GO:1903352]","GO:0000064; GO:0005737; GO:0005794; GO:0005886; GO:0015189; GO:0031410; GO:0061459; GO:0097638; GO:0097639; GO:1903352","cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]","L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]"
"511","Pocillopora_acuta_HIv2___TS.g8089.t1",326.160840258056,9.25252337231639,2.84266665321492,2.78805275073894e-08,7.16276997987354e-07,"Q02290",8.03e-07,"Endo-1,4-beta-xylanase B (Xylanase B) (EC 3.2.1.8) (1,4-beta-D-xylan xylanohydrolase B)","xylan catabolic process [GO:0045493]","GO:0005576; GO:0030248; GO:0031176; GO:0045493","extracellular region [GO:0005576]","cellulose binding [GO:0030248]; endo-1,4-beta-xylanase activity [GO:0031176]"
"512","Pocillopora_acuta_HIv2___RNAseq.g25691.t1",566.031155267787,10.3857966296717,3.30064104433978,2.81311364629456e-08,7.20157093451408e-07,"Q5RC04",5.13e-159,"Ras-GEF domain-containing family member 1B","Ras protein signal transduction [GO:0007265]","GO:0005085; GO:0005769; GO:0005770; GO:0005886; GO:0007265; GO:0030496","early endosome [GO:0005769]; late endosome [GO:0005770]; midbody [GO:0030496]; plasma membrane [GO:0005886]","guanyl-nucleotide exchange factor activity [GO:0005085]"
"513","Pocillopora_acuta_HIv2___RNAseq.g8220.t1",328.178762902617,10.0729577441209,3.18950640721359,2.81894124766836e-08,7.20373961241612e-07,NA,NA,NA,NA,NA,NA,NA
"514","Pocillopora_acuta_HIv2___RNAseq.g17559.t1",552.611619037662,6.89724884588383,3.87349310928108,2.91730506906909e-08,7.44195776349477e-07,"P34410",2.48e-29,"TWiK family of potassium channels protein 7","potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]","GO:0005886; GO:0015271; GO:0022841; GO:0030322; GO:0071805","plasma membrane [GO:0005886]","outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]"
"515","Pocillopora_acuta_HIv2___RNAseq.g24455.t1",302.293861394897,9.57814191953588,3.2037631060374,3.04682149336961e-08,7.74503094553569e-07,NA,NA,NA,NA,NA,NA,NA
"516","Pocillopora_acuta_HIv2___RNAseq.g19116.t1",614.653193044081,7.54570784434155,3.29980148281726,3.13795672971073e-08,7.96270283132211e-07,"Q7TN84",2.18e-32,"Synaptotagmin-14 (Synaptotagmin XIV) (SytXIV)","","GO:0005543; GO:0016020; GO:0042802","membrane [GO:0016020]","identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]"
"517","Pocillopora_acuta_HIv2___RNAseq.g13312.t1",811.72965471155,5.37294043893162,4.68398482633283,3.14853512569562e-08,7.97555377549238e-07,NA,NA,NA,NA,NA,NA,NA
"518","Pocillopora_acuta_HIv2___RNAseq.g1812.t1",9662.94937539683,-3.7761055919089,0.799345949611728,3.41218895652369e-08,8.5982406040346e-07,"P12716",0,"Actin, cytoplasmic (EC 3.6.4.-) [Cleaved into: Actin, cytoplasmic, intermediate form]","","GO:0005524; GO:0005737; GO:0005856; GO:0016787","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]","ATP binding [GO:0005524]; hydrolase activity [GO:0016787]"
"519","Pocillopora_acuta_HIv2___RNAseq.6093_tb",123.150744365596,7.91830190673049,2.19249091983866,3.52229958278802e-08,8.8602680287732e-07,"Q8K5B3",2.12e-22,"Multiple coagulation factor deficiency protein 2 homolog (Neural stem cell-derived neuronal survival protein)","carboxylic acid metabolic process [GO:0019752]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","GO:0005509; GO:0005576; GO:0005783; GO:0005793; GO:0005794; GO:0015031; GO:0016192; GO:0019752","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]","calcium ion binding [GO:0005509]"
"520","Pocillopora_acuta_HIv2___RNAseq.g13552.t1",463.707549207443,10.0991395172925,3.3859111484343,3.56088142801018e-08,8.94176891922555e-07,"P48547",3.35e-106,"Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4)","action potential [GO:0001508]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; corpus callosum development [GO:0022038]; globus pallidus development [GO:0021759]; optic nerve development [GO:0021554]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein tetramerization [GO:0051262]; response to amine [GO:0014075]; response to auditory stimulus [GO:0010996]; response to fibroblast growth factor [GO:0071774]; response to light intensity [GO:0009642]; response to nerve growth factor [GO:1990089]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636]","GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0009636; GO:0009642; GO:0009986; GO:0010996; GO:0014075; GO:0019894; GO:0021549; GO:0021554; GO:0021759; GO:0022038; GO:0030673; GO:0032590; GO:0032809; GO:0035864; GO:0042734; GO:0043679; GO:0044305; GO:0044325; GO:0045211; GO:0051260; GO:0051262; GO:0071466; GO:0071774; GO:0071805; GO:0099508; GO:1901381; GO:1990089","axolemma [GO:0030673]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; dendrite membrane [GO:0032590]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076]","delayed rectifier potassium channel activity [GO:0005251]; kinesin binding [GO:0019894]; transmembrane transporter binding [GO:0044325]; voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249]"
"521","Pocillopora_acuta_HIv2___RNAseq.g25909.t1",129.504017661606,11.3729545803849,3.63513145490963,3.57502063985954e-08,8.96171551731861e-07,NA,NA,NA,NA,NA,NA,NA
"522","Pocillopora_acuta_HIv2___RNAseq.g33.t1",30447.9102108154,2.84515184427981,0.559598471687161,3.58337669737807e-08,8.96712120257378e-07,"G8HTB6",6.7e-42,"ZP domain-containing protein","","GO:0016020","membrane [GO:0016020]",""
"523","Pocillopora_acuta_HIv2___RNAseq.g15567.t1",456.827221571118,8.49576217792316,2.94587365708034,3.61235955975552e-08,9.02403604012157e-07,"P54357",2.51e-43,"Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain)","actin filament-based movement [GO:0030048]","GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036","cytosol [GO:0005829]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]","calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]"
"524","Pocillopora_acuta_HIv2___RNAseq.g4482.t1",698.606251710426,6.75881861745675,4.13859489419192,3.66403109272925e-08,9.13733546986824e-07,NA,NA,NA,NA,NA,NA,NA
"525","Pocillopora_acuta_HIv2___RNAseq.g4938.t1",145.737455678457,11.6224776873002,3.74265090268501,3.67705295653145e-08,9.1540264997024e-07,"E7FAM5",1.12e-121,"E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177","P-body [GO:0000932]","miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
"526","Pocillopora_acuta_HIv2___TS.g17158.t1",132.027835699952,5.70062853963509,1.38844869430379,3.81886951289511e-08,9.49074375163486e-07,NA,NA,NA,NA,NA,NA,NA
"527","Pocillopora_acuta_HIv2___RNAseq.g1119.t1",934.210540933629,-1.42967552418416,3.11701310121979,3.82883936722843e-08,9.49919941811183e-07,"Q8C6K9",5.82e-52,"Collagen alpha-6(VI) chain","cell adhesion [GO:0007155]","GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023","collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]",""
"528","Pocillopora_acuta_HIv2___RNAseq.g28097.t1b",100.538406776974,11.2580700685298,3.55759309629547,3.86845208196024e-08,9.5745890929783e-07,NA,NA,NA,NA,NA,NA,NA
"529","Pocillopora_acuta_HIv2___RNAseq.g19152.t1",364.257946022413,9.90659747874139,3.42491041946311,3.87246585964623e-08,9.5745890929783e-07,"P30825",7.14e-165,"High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter)","amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-histidine import across plasma membrane [GO:1903810]; L-ornithine transmembrane transport [GO:1903352]; lysine transport [GO:0015819]; ornithine transport [GO:0015822]; positive regulation of T cell proliferation [GO:0042102]; transport across blood-brain barrier [GO:0150104]","GO:0000064; GO:0001618; GO:0005290; GO:0005886; GO:0006865; GO:0009925; GO:0015171; GO:0015174; GO:0015189; GO:0015807; GO:0015819; GO:0015822; GO:0016020; GO:0016323; GO:0016324; GO:0032991; GO:0042102; GO:0061459; GO:0089718; GO:0097638; GO:0150104; GO:1903352; GO:1903810; GO:1903826","apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]","amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-arginine transmembrane transporter activity [GO:0061459]; L-histidine transmembrane transporter activity [GO:0005290]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; virus receptor activity [GO:0001618]"
"530","Pocillopora_acuta_HIv2___RNAseq.g8219.t1",577.021992761047,10.1225042424455,3.31335698714885,3.90688910326294e-08,9.64183398893119e-07,NA,NA,NA,NA,NA,NA,NA
"531","Pocillopora_acuta_HIv2___TS.g21290.t1",463.981529188155,-6.93938435502696,4.80687880762025,3.92617039408216e-08,9.65784499659937e-07,NA,NA,NA,NA,NA,NA,NA
"532","Pocillopora_acuta_HIv2___RNAseq.g30954.t1",542.335819053487,-6.44514066133048,2.45471114299052,3.99778491168896e-08,9.81731085953636e-07,"A1KZ92",2.07e-33,"Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2)","hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]","GO:0004519; GO:0004601; GO:0005615; GO:0005783; GO:0005886; GO:0006979; GO:0020037; GO:0042744; GO:0046872; GO:0140825","endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]","endonuclease activity [GO:0004519]; heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
"533","Pocillopora_acuta_HIv2___RNAseq.g12215.t1",490.349528173503,7.44126382592393,3.49930864909668,4.05841127041624e-08,9.92192761849474e-07,"P08629",3.14e-30,"Thioredoxin (Trx)","positive regulation of DNA binding [GO:0043388]; response to radiation [GO:0009314]","GO:0005576; GO:0005634; GO:0005737; GO:0009314; GO:0015035; GO:0043388","cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]","protein-disulfide reductase activity [GO:0015035]"
"534","Pocillopora_acuta_HIv2___RNAseq.g12796.t1",189.865687458002,12.1028165994149,3.88769856992619,4.09622677811019e-08,9.97438116474508e-07,"Q4HX89",1.23e-41,"Protein BTN1","amino acid transport [GO:0006865]","GO:0005774; GO:0006865","vacuolar membrane [GO:0005774]",""
"535","Pocillopora_acuta_HIv2___TS.g20646.t1",113.521512290606,11.3255110746797,3.63243609038829,4.19190846676249e-08,1.01902124476055e-06,NA,NA,NA,NA,NA,NA,NA
"536","Pocillopora_acuta_HIv2___TS.g16852.t1",9806.12586180218,6.10162562330186,1.47010136604982,4.2169880500873e-08,1.02339790530978e-06,NA,NA,NA,NA,NA,NA,NA
"537","Pocillopora_acuta_HIv2___TS.g2710.t1",25241.7068372189,2.76695972841773,0.546027608466104,4.3294317583642e-08,1.04892631412026e-06,"G8HTB6",2.94e-156,"ZP domain-containing protein","","GO:0016020","membrane [GO:0016020]",""
"538","Pocillopora_acuta_HIv2___RNAseq.g11333.t1",588.405309632289,1.01734318783,1.90211507342425,4.37673464240651e-08,1.05861354293926e-06,"Q5ZID0",2.54e-17,"NmrA-like family domain-containing protein 1","","GO:0005634; GO:0048471","nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]",""
"539","Pocillopora_acuta_HIv2___RNAseq.g10683.t1",709.010726469878,1.20759493246805,2.46858047689913,4.45082331126249e-08,1.07473636684642e-06,"Q9VCA2",5.37e-73,"Organic cation transporter protein","apoptotic process [GO:0006915]; monoatomic ion transport [GO:0006811]","GO:0006811; GO:0006915; GO:0016020; GO:0022857","membrane [GO:0016020]","transmembrane transporter activity [GO:0022857]"
"540","Pocillopora_acuta_HIv2___TS.g10567.t1",1767.88110476561,4.16367469047411,4.80070141524172,4.46584238437432e-08,1.07656573745984e-06,NA,NA,NA,NA,NA,NA,NA
"541","Pocillopora_acuta_HIv2___RNAseq.g367.t1",388.933550516527,9.9557000989127,3.36832010869964,4.57546880090132e-08,1.09974210185354e-06,"G8HTB6",6.37e-37,"ZP domain-containing protein","","GO:0016020","membrane [GO:0016020]",""
"542","Pocillopora_acuta_HIv2___RNAseq.g22675.t2",2729.83046484347,3.78314371994513,0.812070892750158,4.57718988741589e-08,1.09974210185354e-06,NA,NA,NA,NA,NA,NA,NA
"543","Pocillopora_acuta_HIv2___RNAseq.g18214.t1",325.638543771285,9.74695363837114,3.3109946996034,4.59540890997852e-08,1.10025776827209e-06,"A0A1D5NSM8",1.02e-53,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)","cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of complement activation, classical pathway [GO:0045959]","GO:0001945; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0045959; GO:0090136","cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]","calcium ion binding [GO:0005509]"
"544","Pocillopora_acuta_HIv2___RNAseq.g28451.t1",35500.3421110759,-3.7541963161325,0.819341538762142,4.60215673260935e-08,1.10025776827209e-06,NA,NA,NA,NA,NA,NA,NA
"545","Pocillopora_acuta_HIv2___RNAseq.g14020.t1",192.015211131491,11.9592923657233,3.87884371149518,4.74262148380008e-08,1.13196826966476e-06,"G8HTB6",3.1e-10,"ZP domain-containing protein","","GO:0016020","membrane [GO:0016020]",""
"546","Pocillopora_acuta_HIv2___RNAseq.g14732.t1",1589.69937243968,-5.47381234358639,1.49319000671694,4.77966019330476e-08,1.13892924276705e-06,NA,NA,NA,NA,NA,NA,NA
"547","Pocillopora_acuta_HIv2___TS.g8259.t1b",611.373388321682,-5.58514722323131,4.12805535305958,4.88440386460633e-08,1.16197397200109e-06,"P13590",6.63e-23,"Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1)","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synaptic membrane adhesion [GO:0099560]","GO:0005886; GO:0007156; GO:0099560","plasma membrane [GO:0005886]",""
"548","Pocillopora_acuta_HIv2___RNAseq.g14728.t1",490.644217686924,9.84671841591412,3.61607959520833,4.93034211745474e-08,1.17097649239516e-06,NA,NA,NA,NA,NA,NA,NA
"549","Pocillopora_acuta_HIv2___RNAseq.g19648.t1",108.374212776461,11.083227791175,3.49848729121557,5.03712709460584e-08,1.19047395909116e-06,"Q6GPB9",0,"Dynein axonemal intermediate chain 4 (WD repeat-containing protein 78)","","GO:0005856; GO:0031514; GO:0120293","cytoskeleton [GO:0005856]; dynein axonemal particle [GO:0120293]; motile cilium [GO:0031514]",""
"550","Pocillopora_acuta_HIv2___TS.g8093.t1",595.165127859721,6.21686123212469,4.87483741384981,5.05002865285178e-08,1.19157609192248e-06,NA,NA,NA,NA,NA,NA,NA
"551","Pocillopora_acuta_HIv2___RNAseq.g12618.t1",235.542586495445,9.26915407536581,3.06583493657489,5.19971840132786e-08,1.22142849760188e-06,NA,NA,NA,NA,NA,NA,NA
"552","Pocillopora_acuta_HIv2___RNAseq.g27370.t1",522.275412147148,7.0771657805337,2.97438924764283,5.30272431977361e-08,1.24107774370883e-06,NA,NA,NA,NA,NA,NA,NA
"553","Pocillopora_acuta_HIv2___RNAseq.g21261.t1",254.975517794546,9.30565588206061,3.09828821241854,5.34197042966984e-08,1.24824330039975e-06,"Q00808",4.43e-11,"Vegetative incompatibility protein HET-E-1","","GO:0005525","","GTP binding [GO:0005525]"
"554","Pocillopora_acuta_HIv2___TS.g3863.t1",332.130659162261,9.8708375680573,3.60553602737505,5.35314050855934e-08,1.24883587606133e-06,"O88813",0,"Long-chain-fatty-acid--CoA ligase 5 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 5) (LACS 5)","cellular response to insulin stimulus [GO:0032869]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to cholesterol [GO:0070723]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to sucrose [GO:0009744]","GO:0001676; GO:0004467; GO:0005524; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005886; GO:0006631; GO:0007584; GO:0009744; GO:0009749; GO:0010747; GO:0010867; GO:0016020; GO:0032869; GO:0035338; GO:0047676; GO:0070723; GO:0090434","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]","arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; oleoyl-CoA ligase activity [GO:0090434]"
"555","Pocillopora_acuta_HIv2___RNAseq.g1187.t1",403.69447428007,10.0741379397882,3.22289893661272,5.37409604549444e-08,1.25170571983948e-06,NA,NA,NA,NA,NA,NA,NA
"556","Pocillopora_acuta_HIv2___RNAseq.20930_t",12932.7641873083,-4.14881646014162,0.959490656905821,5.39841061926099e-08,1.25534744689696e-06,"B8EIZ7",3.42e-180,"Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148)","","GO:0004499; GO:0034899; GO:0047822; GO:0050660; GO:0050661","","flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; trimethylamine monooxygenase activity [GO:0034899]"
"557","Pocillopora_acuta_HIv2___RNAseq.g16285.t1",1143.46418208127,-6.2618191014246,2.07809506723877,5.42616309212852e-08,1.25977564951119e-06,"Q01484",3.37e-06,"Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)","atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]","GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259","A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]","ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325]"
"558","Pocillopora_acuta_HIv2___RNAseq.g3735.t1",483.811508840921,7.39321833070281,4.02463324300704,5.46091990866832e-08,1.26416087701393e-06,NA,NA,NA,NA,NA,NA,NA
"559","Pocillopora_acuta_HIv2___RNAseq.g22749.t1",578.594742820273,6.47595920125851,3.58882341611956,5.557069219744e-08,1.28193698874605e-06,"Q6EJB7",7.95e-60,"Transcription factor Sox-3","brain development [GO:0007420]; central nervous system development [GO:0007417]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; otic placode development [GO:1905040]; otic placode formation [GO:0043049]; ovarian follicle development [GO:0001541]; peripheral nervous system development [GO:0007422]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000978; GO:0001228; GO:0001541; GO:0005634; GO:0006357; GO:0007417; GO:0007420; GO:0007422; GO:0030182; GO:0043049; GO:0045944; GO:1905040","nucleus [GO:0005634]","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"560","Pocillopora_acuta_HIv2___TS.g13342.t1",123.653371550396,8.53087411178165,2.45096711145465,5.59718315598661e-08,1.28913466828329e-06,"Q7Z494",1.2e-38,"Nephrocystin-3","atrial septum development [GO:0003283]; cilium assembly [GO:0060271]; convergent extension [GO:0060026]; convergent extension involved in gastrulation [GO:0060027]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; determination of stomach left/right asymmetry [GO:0071909]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment or maintenance of cell polarity [GO:0007163]; extracellular matrix organization [GO:0030198]; heart looping [GO:0001947]; kidney development [GO:0001822]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; maintenance of animal organ identity [GO:0048496]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; ureter development [GO:0072189]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001947; GO:0003283; GO:0005576; GO:0005829; GO:0005929; GO:0006629; GO:0007163; GO:0007368; GO:0016055; GO:0030198; GO:0030324; GO:0035469; GO:0045494; GO:0048496; GO:0060026; GO:0060027; GO:0060271; GO:0060287; GO:0060993; GO:0071908; GO:0071909; GO:0071910; GO:0072189; GO:0090090; GO:0097543; GO:0097546; GO:1905515; GO:2000095","ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]",""
"561","Pocillopora_acuta_HIv2___RNAseq.g19392.t1",343.308985662354,10.1132592133494,3.34996999383092,6.09738474469118e-08,1.39766359662779e-06,"A2AP18",8.2e-180,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2)","lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; release of sequestered calcium ion into cytosol [GO:0051209]","GO:0004435; GO:0004629; GO:0005509; GO:0005737; GO:0005886; GO:0007200; GO:0016042; GO:0046488; GO:0048015; GO:0051209","cytoplasm [GO:0005737]; plasma membrane [GO:0005886]","calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]"
"562","Pocillopora_acuta_HIv2___RNAseq.g20232.t1",90.204866967561,11.1037094956987,3.52676042603195,6.37211285737481e-08,1.45832658811818e-06,"Q8TER0",6.47e-56,"Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1)","cell-matrix adhesion [GO:0007160]","GO:0005112; GO:0005509; GO:0005576; GO:0007160; GO:0031012","extracellular matrix [GO:0031012]; extracellular region [GO:0005576]","calcium ion binding [GO:0005509]; Notch binding [GO:0005112]"
"563","Pocillopora_acuta_HIv2___RNAseq.g18162.t1",227.651838111013,11.431592808643,3.8835311985499,6.40243338005072e-08,1.46295097012723e-06,"B3DFV0",2.99e-25,"LYR motif-containing protein 9","","","",""
"564","Pocillopora_acuta_HIv2___RNAseq.g3013.t1",198.097621881605,9.13351069953066,3.05879833089842,6.43553662897416e-08,1.46588349293673e-06,NA,NA,NA,NA,NA,NA,NA
"565","Pocillopora_acuta_HIv2___TS.g3401.t1",92.6948107633524,11.155814778876,3.5495535430961,6.48265436770369e-08,1.47429422601362e-06,"Q0V8E4",8.22e-94,"Asparagine synthetase domain-containing protein 1","asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541]","GO:0004066; GO:0006529; GO:0006541","","asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]"
"566","Pocillopora_acuta_HIv2___TS.g18522.t1a",495.555808296377,6.89487672561401,3.14956703264119,6.70210293218119e-08,1.52180874114708e-06,NA,NA,NA,NA,NA,NA,NA
"567","Pocillopora_acuta_HIv2___RNAseq.g9900.t1",294.089431598299,9.88384186953154,3.22380150859432,6.84167397231338e-08,1.55106539710879e-06,NA,NA,NA,NA,NA,NA,NA
"568","Pocillopora_acuta_HIv2___RNAseq.g25181.t1",191.698986966452,9.44074646435566,3.08601466283067,6.87576715316475e-08,1.55635518158646e-06,"Q9CQ40",1.74e-19,"Large ribosomal subunit protein mL49 (39S ribosomal protein L49, mitochondrial) (L49mt) (MRP-L49)","mitochondrial translation [GO:0032543]","GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0032543","mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]","structural constituent of ribosome [GO:0003735]"
"569","Pocillopora_acuta_HIv2___RNAseq.g11747.t1",567.232966867167,10.3471784689438,3.47906202008097,6.89981284830653e-08,1.55935770371728e-06,"Q3SYV5",5.43e-80,"Tetraspanin-33 (Tspan-33)","protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]","GO:0005737; GO:0005886; GO:0005912; GO:0051604; GO:0072659","adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]",""
"570","Pocillopora_acuta_HIv2___RNAseq.g15830.t1",578.69738830599,3.52630908382669,0.751052831875228,7.00020820106359e-08,1.57711855794679e-06,NA,NA,NA,NA,NA,NA,NA
"571","Pocillopora_acuta_HIv2___RNAseq.g11882.t1",417.31323745721,10.0593428950401,3.43288572760176,7.05576012195172e-08,1.58716196584619e-06,"O00628",7.6e-126,"Peroxisomal targeting signal 2 receptor (PTS2 receptor) (Peroxin-7)","endochondral ossification [GO:0001958]; ether lipid biosynthetic process [GO:0008611]; fatty acid beta-oxidation [GO:0006635]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]","GO:0001764; GO:0001958; GO:0005053; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0007031; GO:0008611; GO:0016558; GO:0019899; GO:0042803","cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]","enzyme binding [GO:0019899]; peroxisome matrix targeting signal-2 binding [GO:0005053]; protein homodimerization activity [GO:0042803]"
"572","Pocillopora_acuta_HIv2___RNAseq.g1504.t1",415.223847450787,6.33054445592358,3.92017325259901,7.2682419438778e-08,1.63242005397901e-06,"Q9WYJ1",2.66e-76,"L-threonine ammonia-lyase (EC 4.3.1.19) (L-serine ammonia-lyase) (EC 4.3.1.17) (Threonine dehydratase)","isoleucine biosynthetic process [GO:0009097]; L-serine catabolic process [GO:0006565]; threonine catabolic process [GO:0006567]","GO:0003941; GO:0004794; GO:0006565; GO:0006567; GO:0009097; GO:0030170","","L-serine ammonia-lyase activity [GO:0003941]; pyridoxal phosphate binding [GO:0030170]; threonine deaminase activity [GO:0004794]"
"573","Pocillopora_acuta_HIv2___RNAseq.g4757.t1",627.126961368613,1.14575196087778,2.25263457016033,7.28873445811205e-08,1.63448457677725e-06,"Q92556",0,"Engulfment and cell motility protein 1 (Protein ced-12 homolog)","actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell motility [GO:0048870]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]","GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0048870","cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]","SH3 domain binding [GO:0017124]"
"574","Pocillopora_acuta_HIv2___RNAseq.g10518.t1",136.689837543789,11.4892175189837,3.76185831689396,7.31426615182737e-08,1.6376709848302e-06,"A5D8N2",1.26e-75,"Protein DPCD","","","",""
"575","Pocillopora_acuta_HIv2___RNAseq.g30591.t1",105.230581610497,11.1834938733973,3.61304332128262,7.52260869110577e-08,1.6791205572246e-06,NA,NA,NA,NA,NA,NA,NA
"576","Pocillopora_acuta_HIv2___TS.g9749.t1",91.5713759454203,10.9879700427619,3.50648188465997,7.61987717356855e-08,1.6982111469722e-06,"P10079",2.84e-72,"Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","","GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579","apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]","biotin binding [GO:0009374]; calcium ion binding [GO:0005509]"
"577","Pocillopora_acuta_HIv2___RNAseq.g3974.t1",383.311981062322,1.06371496896941,2.02607181047404,8.45780034299734e-08,1.87916473365766e-06,"Q5XK92",0,"Protein CIP2A homolog L","chromosome organization [GO:0051276]; DNA damage response [GO:0006974]","GO:0004864; GO:0005694; GO:0005737; GO:0006974; GO:0051276","chromosome [GO:0005694]; cytoplasm [GO:0005737]","protein phosphatase inhibitor activity [GO:0004864]"
"578","Pocillopora_acuta_HIv2___RNAseq.g1103.t1",548.103799979681,9.74674098349918,3.66822495520976,8.49687965864063e-08,1.88206535042233e-06,"Q96EH3",2.75e-24,"Mitochondrial assembly of ribosomal large subunit protein 1","negative regulation of mitochondrial translation [GO:0070130]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of translation [GO:0017148]; ribosomal large subunit biogenesis [GO:0042273]","GO:0005739; GO:0005759; GO:0005829; GO:0017148; GO:0042273; GO:0043023; GO:0070130; GO:0090071; GO:0140978","cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]","mitochondrial large ribosomal subunit binding [GO:0140978]; ribosomal large subunit binding [GO:0043023]"
"579","Pocillopora_acuta_HIv2___RNAseq.g20584.t1",1077.43875565576,-5.46961826181474,1.49377402810655,8.63466385498187e-08,1.90674470226653e-06,NA,NA,NA,NA,NA,NA,NA
"580","Pocillopora_acuta_HIv2___RNAseq.g12560.t1",282.368854717941,9.44441250496295,3.29898003561814,8.6611263978526e-08,1.90967274723384e-06,NA,NA,NA,NA,NA,NA,NA
"581","Pocillopora_acuta_HIv2___RNAseq.g14724.t1",1653.60689603483,5.38750646155462,4.21088298273016,8.6933418976579e-08,1.91385840498819e-06,NA,NA,NA,NA,NA,NA,NA
"582","Pocillopora_acuta_HIv2___RNAseq.g10475.t1",124.644748807805,11.3049701221352,3.65255385328758,8.76130991569691e-08,1.92589037417386e-06,"Q9NZM1",0,"Myoferlin (Fer-1-like protein 3)","blood circulation [GO:0008015]; muscle contraction [GO:0006936]; plasma membrane repair [GO:0001778]; regulation of neurotransmitter secretion [GO:0046928]","GO:0001778; GO:0005509; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0006936; GO:0008015; GO:0030672; GO:0031410; GO:0031965; GO:0034451; GO:0043231; GO:0046928; GO:0070062","caveola [GO:0005901]; centriolar satellite [GO:0034451]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]","calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]"
"583","Pocillopora_acuta_HIv2___RNAseq.g16722.t1",461.129665980811,6.28443384586617,2.03109632026379,8.954318038221e-08,1.96533013816128e-06,"A6NFN9",3.59e-59,"Protein ANKUB1 (Ankyrin repeat and ubiquitin domain-containing 1)","","","",""
"584","Pocillopora_acuta_HIv2___RNAseq.g23757.t1",309.627096107252,1.00566827989955,1.87868268798493,9.07801957029726e-08,1.98645196769712e-06,"D4G3R4",1.84e-22,"tRNA(Glu)-specific nuclease WapA (EC 3.1.-.-) (Cell wall-associated protein) (RNase WapA) (Toxin WapA)","tRNA decay [GO:0016078]","GO:0004519; GO:0004549; GO:0005576; GO:0016078; GO:0016798; GO:0090729","extracellular region [GO:0005576]","endonuclease activity [GO:0004519]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; toxin activity [GO:0090729]; tRNA-specific ribonuclease activity [GO:0004549]"
"585","Pocillopora_acuta_HIv2___RNAseq.g26808.t1",339.308661844513,8.473510087692,2.75220441135504,9.19804352106792e-08,2.00664406468667e-06,NA,NA,NA,NA,NA,NA,NA
"586","Pocillopora_acuta_HIv2___RNAseq.g7107.t1",303.667043588515,9.70379180843505,3.27475299715108,9.24416128540465e-08,2.01063983206155e-06,"O02833",9.97e-24,"Insulin-like growth factor-binding protein complex acid labile subunit (ALS)","cell adhesion [GO:0007155]","GO:0005576; GO:0005886; GO:0007155","extracellular region [GO:0005576]; plasma membrane [GO:0005886]",""
"587","Pocillopora_acuta_HIv2___TS.g16770.t1",578.612156492158,6.06734841730591,4.22106322020802,9.30284152617907e-08,2.02036486238219e-06,NA,NA,NA,NA,NA,NA,NA
"588","Pocillopora_acuta_HIv2___RNAseq.g12258.t1",434.161742988113,-4.0545471698699,5.76382898892312,9.72011134100455e-08,2.10466602449536e-06,"F1NWE3",1.64e-24,"Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha)","negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; peptidyl-tyrosine dephosphorylation [GO:0035335]; synaptic membrane adhesion [GO:0099560]","GO:0004725; GO:0005886; GO:0008201; GO:0030424; GO:0030426; GO:0030517; GO:0030672; GO:0035335; GO:0042803; GO:0043204; GO:0043395; GO:0048671; GO:0048681; GO:0061000; GO:0098839; GO:0099560","axon [GO:0030424]; growth cone [GO:0030426]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; synaptic vesicle membrane [GO:0030672]","heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]"
"589","Pocillopora_acuta_HIv2___TS.g27307.t1",535.785514532457,5.07175677652715,5.07382886231731,1.00357596231179e-07,2.16668528799445e-06,"Q6B9X6",1.04e-16,"Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase)","contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]","GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006971; GO:0018209; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177; GO:0106310","contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]","ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]"
"590","Pocillopora_acuta_HIv2___RNAseq.10010_t",685.382212840851,4.84349570061812,5.90627999901685,1.00364984994212e-07,2.16668528799445e-06,"O75762",6.47e-137,"Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor)","calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to hydrogen peroxide [GO:0070301]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transport [GO:0006811]; protein homotetramerization [GO:0051289]; response to cold [GO:0009409]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]","GO:0005262; GO:0005886; GO:0006811; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014070; GO:0015267; GO:0015278; GO:0019233; GO:0032421; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0051289; GO:0070301; GO:0070588; GO:0097604","plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421]","calcium channel activity [GO:0005262]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; intracellularly gated calcium channel activity [GO:0015278]; temperature-gated cation channel activity [GO:0097604]"
"591","Pocillopora_acuta_HIv2___RNAseq.g18385.t1",410.637004646469,-8.0121375354464,2.69362200695947,1.01761898142146e-07,2.1935679504143e-06,"O95429",3.1e-07,"BAG family molecular chaperone regulator 4 (BAG-4) (Bcl-2-associated athanogene 4) (Silencer of death domains)","cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA modification [GO:0090367]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion [GO:0045785]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; ruffle assembly [GO:0097178]","GO:0000774; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0010763; GO:0016020; GO:0030838; GO:0031625; GO:0033138; GO:0043066; GO:0044877; GO:0045785; GO:0050821; GO:0051087; GO:0051496; GO:0051897; GO:0071356; GO:0071364; GO:0072659; GO:0090367; GO:0097178; GO:1903215","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]","adenyl-nucleotide exchange factor activity [GO:0000774]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]"
"592","Pocillopora_acuta_HIv2___RNAseq.g5826.t1",542.666453766602,7.22432461721695,3.18005634932106,1.11225759874323e-07,2.38336206047735e-06,"Q9BVS4",5.13e-150,"Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2)","maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274]","GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0030071; GO:0030490; GO:0030688; GO:0042274; GO:0046777; GO:0046872; GO:0106310; GO:2000208; GO:2000234","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]","ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]"
"593","Pocillopora_acuta_HIv2___RNAseq.g5752.t1",90.4847002374835,10.9614864980207,3.59283508823806,1.13848978505073e-07,2.43236576823837e-06,"Q9NX04",5.38e-18,"AFG2-interacting ribosome maturation factor (Ribosome biogenesis protein C1orf109)","ribosomal large subunit biogenesis [GO:0042273]","GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0042273","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",""
"594","Pocillopora_acuta_HIv2___RNAseq.g28466.t1",431.131496060928,1.15136934778043,2.09030089782191,1.14595879352728e-07,2.44471209285821e-06,"O73874",8.06e-14,"Ephrin-B2a","angioblast cell migration involved in selective angioblast sprouting [GO:0035475]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; optic vesicle morphogenesis [GO:0003404]; regulation of chemotaxis [GO:0050920]; rhombomere boundary formation [GO:0021654]; somitogenesis [GO:0001756]; synaptic target recognition [GO:0008039]","GO:0001568; GO:0001756; GO:0002042; GO:0003404; GO:0005886; GO:0007155; GO:0007411; GO:0007412; GO:0008039; GO:0009952; GO:0021654; GO:0035475; GO:0042734; GO:0046875; GO:0048013; GO:0048514; GO:0050920; GO:0098978","glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]","ephrin receptor binding [GO:0046875]"
"595","Pocillopora_acuta_HIv2___RNAseq.g24860.t1",907.634386168352,7.19846365159009,3.5697008975038,1.17637494228124e-07,2.49488081600525e-06,"P55862",0,"DNA replication licensing factor mcm5-A (xMCM5-A) (EC 3.6.4.12) (CDC46 homolog A) (xCDC46-A) (CDC46p) (p92)","DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; premeiotic DNA replication [GO:0006279]; regulation of DNA-templated DNA replication initiation [GO:0030174]","GO:0000785; GO:0003688; GO:0004386; GO:0005524; GO:0006268; GO:0006270; GO:0006279; GO:0016887; GO:0030174; GO:0042555; GO:0071162","chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA replication origin binding [GO:0003688]; helicase activity [GO:0004386]"
"596","Pocillopora_acuta_HIv2___RNAseq.g19040.t1",487.652648254541,9.86367082486073,3.95379461964349,1.18901030426537e-07,2.51798609676345e-06,"O35125",1.38e-111,"Leucine-rich repeat-containing protein 23 (Leucine-rich protein B7)","flagellated sperm motility [GO:0030317]; radial spoke assembly [GO:0062177]","GO:0005737; GO:0005829; GO:0005856; GO:0030317; GO:0036126; GO:0062177","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; sperm flagellum [GO:0036126]",""
"597","Pocillopora_acuta_HIv2___RNAseq.g14615.t1",376.115634416498,6.53847966478079,3.66762535414464,1.20023776052155e-07,2.53804663277539e-06,"Q7Z591",1.4e-16,"Microtubule organization protein AKNA (AT-hook-containing transcription factor)","delamination [GO:0060232]; epithelial to mesenchymal transition [GO:0001837]; neuroblast delamination [GO:0060234]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727]","GO:0001650; GO:0001837; GO:0003677; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0016020; GO:0021849; GO:0043231; GO:0045944; GO:0050727; GO:0060232; GO:0060234","centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]","DNA binding [GO:0003677]"
"598","Pocillopora_acuta_HIv2___RNAseq.g20876.t1",5283.94813479518,-3.12415590997643,0.668448922623433,1.20728928912993e-07,2.54923098948545e-06,"Q9R0R1",1.28e-16,"Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228)","iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756]","GO:0005506; GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0009986; GO:0010756; GO:0055037; GO:0090091; GO:0098552; GO:1900025","cell surface [GO:0009986]; early endosome [GO:0005769]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; side of membrane [GO:0098552]","iron ion binding [GO:0005506]"
"599","Pocillopora_acuta_HIv2___RNAseq.g21849.t1a",277.488248781524,7.988947348297,2.71532212717299,1.22080700120671e-07,2.57401639438102e-06,NA,NA,NA,NA,NA,NA,NA
"600","Pocillopora_acuta_HIv2___RNAseq.g5340.t1",196.919419142573,8.62517477176158,2.79718887501914,1.28721944195464e-07,2.71009345100901e-06,NA,NA,NA,NA,NA,NA,NA
"601","Pocillopora_acuta_HIv2___RNAseq.g6079.t1",264.628793326,9.32987659268767,3.19635425314715,1.2896689364734e-07,2.71130399667896e-06,"Q54468",2.71e-141,"Chitobiase (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (N-acetyl-beta-glucosaminidase)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004563; GO:0006032; GO:0030247; GO:0042597; GO:0102148","periplasmic space [GO:0042597]","beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]"
"602","Pocillopora_acuta_HIv2___RNAseq.g2743.t1",91.7251371381789,10.8474890343953,3.49752810196618,1.30031382175405e-07,2.72971540171997e-06,NA,NA,NA,NA,NA,NA,NA
"603","Pocillopora_acuta_HIv2___RNAseq.2533_t",3992.1710047385,-5.96900495807999,3.9905621941869,1.31221030264878e-07,2.74675945962546e-06,"Q96RW7",4.56e-34,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711","adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927]","calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]"
"604","Pocillopora_acuta_HIv2___TS.g4671.t2",270.193672336745,9.61575749518128,3.28827485135329,1.31223090887804e-07,2.74675945962546e-06,"P52485",3.94e-98,"Ubiquitin-conjugating enzyme E2-24 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 2) (Ubiquitin carrier protein) (Ubiquitin-protein ligase)","lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209]","GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0019915; GO:0061631","nucleus [GO:0005634]","ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]"
"605","Pocillopora_acuta_HIv2___RNAseq.g18125.t1",6023.76035719744,-3.13145627145489,0.67093220068438,1.32531595111939e-07,2.76614284516462e-06,"Q9R0R1",1.28e-16,"Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228)","iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756]","GO:0005506; GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0009986; GO:0010756; GO:0055037; GO:0090091; GO:0098552; GO:1900025","cell surface [GO:0009986]; early endosome [GO:0005769]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; side of membrane [GO:0098552]","iron ion binding [GO:0005506]"
"606","Pocillopora_acuta_HIv2___RNAseq.g24441.t1",244.393654049457,-5.41489290756547,1.48765156337868,1.40333276607772e-07,2.92475578221154e-06,NA,NA,NA,NA,NA,NA,NA
"607","Pocillopora_acuta_HIv2___RNAseq.g4969.t1",364.825354305009,9.78247332362473,3.97585162304614,1.40899300520574e-07,2.93232731327998e-06,"F1NPG5",2.04e-30,"Centromere protein T (CENP-T)","cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278]","GO:0000278; GO:0000776; GO:0003677; GO:0005634; GO:0007059; GO:0046982; GO:0051301; GO:0051382","kinetochore [GO:0000776]; nucleus [GO:0005634]","DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]"
"608","Pocillopora_acuta_HIv2___RNAseq.g12987.t1",5067.40203808066,-5.02069401090425,1.40885144221685,1.41296937284067e-07,2.93637773114476e-06,"Q6V0I7",1.97e-109,"Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)","cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008]","GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609","extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]","calcium ion binding [GO:0005509]"
"609","Pocillopora_acuta_HIv2___RNAseq.g10902.t1",169.234427106844,8.93189961623741,3.0883704959205,1.42453770399507e-07,2.95617121242247e-06,NA,NA,NA,NA,NA,NA,NA
"610","Pocillopora_acuta_HIv2___RNAseq.g20846.t1",519.710041943882,8.66683382603524,3.15166545925389,1.43437581263227e-07,2.97232260084715e-06,"Q80ZA4",0,"Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86)","sensory perception of sound [GO:0007605]","GO:0007605; GO:0016020; GO:0032426; GO:0120234","membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium tip [GO:0032426]",""
"611","Pocillopora_acuta_HIv2___RNAseq.g7881.t1",255.101254925566,9.39284736596447,3.30165727174222,1.44537821551565e-07,2.98656435845977e-06,"Q8IY21",1.62e-32,"Probable ATP-dependent RNA helicase DDX60 (EC 3.6.4.13) (DEAD box protein 60)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615]","GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0009615; GO:0016887; GO:0045087; GO:0045111; GO:0051607; GO:1900245; GO:1900246","cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]"
"612","Pocillopora_acuta_HIv2___RNAseq.g17622.t1",186.939159792039,9.20160056385201,3.22552382349469,1.47732205243777e-07,3.04387267328489e-06,"P35521",1.81e-42,"Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln))","cell volume homeostasis [GO:0006884]; chloride transmembrane transport [GO:1902476]; mRNA cis splicing, via spliceosome [GO:0045292]; potassium ion transmembrane transport [GO:0071805]; spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0005229; GO:0005267; GO:0005634; GO:0005681; GO:0005829; GO:0005856; GO:0005886; GO:0006884; GO:0008289; GO:0016020; GO:0032991; GO:0034709; GO:0034715; GO:0036094; GO:0045292; GO:0071805; GO:1902476; GO:1990935","cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]","intracellularly calcium-gated chloride channel activity [GO:0005229]; lipid binding [GO:0008289]; potassium channel activity [GO:0005267]; small molecule binding [GO:0036094]; splicing factor binding [GO:1990935]"
"613","Pocillopora_acuta_HIv2___RNAseq.g10343.t1",180.956691067974,-9.47433000850089,3.33243791721313,1.50016092643061e-07,3.08653309244556e-06,"Q8R508",1.12e-09,"Protocadherin Fat 3 (FAT tumor suppressor homolog 3)","cell morphogenesis involved in neuron differentiation [GO:0048667]; cell-cell adhesion [GO:0098609]; dendrite development [GO:0016358]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; interneuron migration [GO:1904936]; negative regulation of dendrite development [GO:2000171]; retina layer formation [GO:0010842]","GO:0005509; GO:0005886; GO:0007156; GO:0010842; GO:0016358; GO:0030425; GO:0048667; GO:0098609; GO:1904936; GO:2000171","dendrite [GO:0030425]; plasma membrane [GO:0005886]","calcium ion binding [GO:0005509]"
"614","Pocillopora_acuta_HIv2___RNAseq.g16169.t1",850.974397506806,1.17458721521076,2.25318399238969,1.51735983555135e-07,3.11748475304185e-06,"P29674",7.07e-103,"LIM/homeobox protein Lhx1 (LIM homeobox protein 1) (Homeobox protein Lim-1) (Xlim1) (x-Lhx1) (xLIM-1)","anterior/posterior pattern specification [GO:0009952]; axis specification [GO:0009798]; cell migration involved in gastrulation [GO:0042074]; chordate embryonic development [GO:0043009]; muscle organ development [GO:0007517]; nephron tubule development [GO:0072080]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; notochord development [GO:0030903]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric field specification [GO:0039003]; pronephric nephron tubule development [GO:0039020]; pronephros development [GO:0048793]; regionalization [GO:0003002]; regulation of pronephros size [GO:0035565]; response to retinoic acid [GO:0032526]","GO:0000977; GO:0000981; GO:0001221; GO:0003002; GO:0005634; GO:0005667; GO:0007517; GO:0008270; GO:0009798; GO:0009952; GO:0022008; GO:0030182; GO:0030903; GO:0032526; GO:0035565; GO:0039003; GO:0039020; GO:0042074; GO:0043009; GO:0043565; GO:0045893; GO:0045944; GO:0048793; GO:0072080","nucleus [GO:0005634]; transcription regulator complex [GO:0005667]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]"
"615","Pocillopora_acuta_HIv2___TS.g10386.t1",510.331627417504,6.3433772255595,3.26837579775376,1.53800377653671e-07,3.15541654238681e-06,NA,NA,NA,NA,NA,NA,NA
"616","Pocillopora_acuta_HIv2___RNAseq.g15370.t1",233.924568565192,9.54962903152177,3.33361086874506,1.56931833971113e-07,3.20601983977145e-06,"P97259",5.31e-175,"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]","positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0000139; GO:0004864; GO:0005576; GO:0018279; GO:0030144; GO:0030145; GO:0030335; GO:1904894","extracellular region [GO:0005576]; Golgi membrane [GO:0000139]","alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]"
"617","Pocillopora_acuta_HIv2___RNAseq.g28765.t1",262.858077742028,9.49127973040339,3.42308542685639,1.5755880485682e-07,3.21428850980119e-06,NA,NA,NA,NA,NA,NA,NA
"618","Pocillopora_acuta_HIv2___RNAseq.g25935.t1",41416.6959166268,-3.64971027631303,0.838078970862475,1.57871455872316e-07,3.21613061653125e-06,"B3EWZ6",0,"MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2)","","GO:0005576; GO:0016020","extracellular region [GO:0005576]; membrane [GO:0016020]",""
"619","Pocillopora_acuta_HIv2___RNAseq.g3924.t1",149.157933080526,-8.60944511811657,3.25749359386583,1.58462545948924e-07,3.22363187708191e-06,NA,NA,NA,NA,NA,NA,NA
"620","Pocillopora_acuta_HIv2___RNAseq.g6948.t1",113.892902721942,11.1645036501715,3.65811735076823,1.61233382322134e-07,3.27079893675645e-06,NA,NA,NA,NA,NA,NA,NA
"621","Pocillopora_acuta_HIv2___RNAseq.g9093.t1",4489.42847936995,1.00014360688464,1.81870470862125,1.66093240872364e-07,3.36466755739197e-06,"O75897",1.15e-54,"Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1) (Sulfotransferase 1C2) (SULT1C#2)","3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; doxorubicin metabolic process [GO:0044598]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805]","GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006805; GO:0008146; GO:0009812; GO:0044598; GO:0050427; GO:0051923","cytoplasm [GO:0005737]; cytosol [GO:0005829]","aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]"
"622","Pocillopora_acuta_HIv2___RNAseq.g21964.t1",554.628006865098,9.79087353706756,3.89652039806094,1.68456968408215e-07,3.40361981507399e-06,NA,NA,NA,NA,NA,NA,NA
"623","Pocillopora_acuta_HIv2___RNAseq.g6074.t1",332.265630230546,9.37268458204103,3.45837844216817,1.68486710978497e-07,3.40361981507399e-06,NA,NA,NA,NA,NA,NA,NA
"624","Pocillopora_acuta_HIv2___RNAseq.g6157.t1",430.777539107758,1.0847608769677,2.06880348402559,1.69315475393755e-07,3.4108343121104e-06,"Q96DC8",5.6e-121,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial","fatty acid metabolic process [GO:0006631]; positive regulation of cellular response to insulin stimulus [GO:1900078]","GO:0004300; GO:0005739; GO:0006631; GO:0016836; GO:1900078","mitochondrion [GO:0005739]","enoyl-CoA hydratase activity [GO:0004300]; hydro-lyase activity [GO:0016836]"
"625","Pocillopora_acuta_HIv2___RNAseq.g11700.t1",324.376977836821,9.71607724975812,3.94317010069698,1.71040240352893e-07,3.44078725516586e-06,"P43247",0,"DNA mismatch repair protein Msh2 (MutS protein homolog 2)","B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; regulation of cell cycle [GO:0051726]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]","GO:0000287; GO:0000400; GO:0001701; GO:0002204; GO:0003677; GO:0003682; GO:0003684; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0006119; GO:0006281; GO:0006298; GO:0006301; GO:0006302; GO:0006312; GO:0006974; GO:0007281; GO:0008340; GO:0008584; GO:0008630; GO:0010165; GO:0010224; GO:0016446; GO:0016447; GO:0016887; GO:0019237; GO:0019724; GO:0030183; GO:0030983; GO:0031573; GO:0032137; GO:0032142; GO:0032143; GO:0032181; GO:0032301; GO:0032302; GO:0032357; GO:0032405; GO:0042771; GO:0042803; GO:0043524; GO:0043531; GO:0043570; GO:0045190; GO:0045910; GO:0048298; GO:0048304; GO:0051726; GO:0071168; GO:0140664","chromosome [GO:0005694]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide repeat insertion binding [GO:0032181]; DNA binding [GO:0003677]; four-way junction DNA binding [GO:0000400]; guanine/thymine mispair binding [GO:0032137]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; MutLalpha complex binding [GO:0032405]; oxidized purine DNA binding [GO:0032357]; protein homodimerization activity [GO:0042803]; single guanine insertion binding [GO:0032142]; single thymine insertion binding [GO:0032143]; single-stranded DNA binding [GO:0003697]"
"626","Pocillopora_acuta_HIv2___RNAseq.g14867.t1",236.324861356435,9.42560280509872,3.20595798770258,1.74028304797537e-07,3.49118640858748e-06,"Q5PQM2",1.36e-07,"Kinesin light chain 4 (KLC 4) (Kinesin-like protein 8)","microtubule-based movement [GO:0007018]","GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0019894","cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]","kinesin binding [GO:0019894]"
"627","Pocillopora_acuta_HIv2___RNAseq.g4213.t1",315.846919435748,9.79947099030437,3.6028392661711,1.84656713618042e-07,3.68905346101016e-06,"Q8CBH5",2.63e-25,"Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2)","adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]","GO:0002250; GO:0005886; GO:0032393; GO:0042288; GO:0042590","plasma membrane [GO:0005886]","MHC class I protein binding [GO:0042288]; MHC class I receptor activity [GO:0032393]"
"628","Pocillopora_acuta_HIv2___RNAseq.g8316.t1",245.116187540382,9.5705513358587,3.51038349227277,1.8648161431978e-07,3.71680636573115e-06,"Q9Z160",0,"Conserved oligomeric Golgi complex subunit 1 (COG complex subunit 1) (Component of oligomeric Golgi complex 1) (Low density lipoprotein receptor defect B-complementing protein)","glycosylation [GO:0070085]; Golgi organization [GO:0007030]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]","GO:0000139; GO:0000301; GO:0005794; GO:0007030; GO:0015031; GO:0017119; GO:0070085","Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]",""
"629","Pocillopora_acuta_HIv2___RNAseq.g28909.t1",374.167179606024,7.31913176219405,3.04490398556545,1.88203100313932e-07,3.7443874043201e-06,"Q3UHX0",2.26e-46,"Nucleolar protein 8","cellular response to leukemia inhibitory factor [GO:1990830]; protein localization to nucleolus [GO:1902570]; rRNA processing [GO:0006364]","GO:0003723; GO:0005730; GO:0006364; GO:1902570; GO:1990830","nucleolus [GO:0005730]","RNA binding [GO:0003723]"
"630","Pocillopora_acuta_HIv2___RNAseq.g7452.t1",80.6849919977347,10.7059022407379,3.5017337941371,1.97497675010849e-07,3.9235925613923e-06,"P0CI65",3.08e-32,"Nephrocystin-3","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546","ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]",""
"631","Pocillopora_acuta_HIv2___TS.g29166.t1",302.343248489353,5.87317486398814,3.66935186873995,1.97971981139885e-07,3.9235925613923e-06,"Q13163",0,"Dual specificity mitogen-activated protein kinase kinase 5 (MAP kinase kinase 5) (MAPKK 5) (EC 2.7.12.2) (MAPK/ERK kinase 5) (MEK 5)","cellular response to growth factor stimulus [GO:0071363]; cellular response to laminar fluid shear stress [GO:0071499]; ERK5 cascade [GO:0070375]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; MAPK cascade [GO:0000165]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165]","GO:0000122; GO:0000165; GO:0004672; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005819; GO:0007165; GO:0007507; GO:0030307; GO:0032088; GO:0032717; GO:0034115; GO:0034392; GO:0043154; GO:0043406; GO:0045944; GO:0046872; GO:0048009; GO:0050679; GO:0051247; GO:0060761; GO:0070375; GO:0071363; GO:0071499; GO:0090051; GO:0106310; GO:2000342; GO:2001240","spindle [GO:0005819]","ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]"
"632","Pocillopora_acuta_HIv2___RNAseq.g8864.t1",28998.8049452589,4.42868183524595,1.12213227589721,1.9802423740434e-07,3.9235925613923e-06,NA,NA,NA,NA,NA,NA,NA
"633","Pocillopora_acuta_HIv2___RNAseq.g12898.t1",423.478465215243,9.62937710726235,3.93206741538363,2.02231807005812e-07,4.00147859990707e-06,"Q8NFF2",1.74e-134,"Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4)","amelogenesis [GO:0097186]; calcium ion export across plasma membrane [GO:1990034]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; drinking behavior [GO:0042756]; enamel mineralization [GO:0070166]; intracellular calcium ion homeostasis [GO:0006874]; membrane repolarization [GO:0086009]; monoatomic ion transport [GO:0006811]; negative regulation of calcium-mediated signaling [GO:0050849]; olfactory nerve maturation [GO:0021630]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; potassium ion transmembrane transport [GO:0071805]; regulation of eating behavior [GO:1903998]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to high light intensity [GO:0009644]; response to melanocyte-stimulating hormone [GO:1990680]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725]","GO:0005262; GO:0005516; GO:0005737; GO:0005886; GO:0006811; GO:0006874; GO:0007602; GO:0007608; GO:0008273; GO:0008277; GO:0009644; GO:0010628; GO:0015293; GO:0016020; GO:0016324; GO:0021630; GO:0031982; GO:0035725; GO:0036368; GO:0042756; GO:0048306; GO:0050849; GO:0050911; GO:0055074; GO:0070166; GO:0070588; GO:0071486; GO:0071805; GO:0086009; GO:0097186; GO:0098703; GO:0120199; GO:1903998; GO:1990034; GO:1990680; GO:1990834","apical plasma membrane [GO:0016324]; cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]","calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; symporter activity [GO:0015293]"
"634","Pocillopora_acuta_HIv2___RNAseq.g18059.t1",326.768182193263,9.37510635230119,3.42655119382156,2.03392151865408e-07,4.01645905030973e-06,"Q9NHW7",1.68e-63,"Aquaporin AQPAe.a","","GO:0015267; GO:0016020","membrane [GO:0016020]","channel activity [GO:0015267]"
"635","Pocillopora_acuta_HIv2___RNAseq.g4732.t1",8464.82536451138,4.19067395458961,1.0886631620901,2.07477865980796e-07,4.08293857625337e-06,"O97341",2.12e-38,"Calmodulin (CaM)","","GO:0005509; GO:0030234","","calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]"
"636","Pocillopora_acuta_HIv2___RNAseq.g17047.t1",87.493730148627,8.60061594925949,2.70092881929229,2.08780486957427e-07,4.10299043933726e-06,"P32456",2.12e-09,"Guanylate-binding protein 2 (EC 3.6.5.-) (GTP-binding protein 2) (GBP-2) (HuGBP-2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2)","activation of innate immune response [GO:0002218]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to type II interferon [GO:0071346]; cytolysis in another organism [GO:0051715]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; immune response [GO:0006955]; positive regulation of AIM2 inflammasome complex assembly [GO:0140973]; positive regulation of pyroptotic inflammatory response [GO:0140639]; protein localization to nucleus [GO:0034504]","GO:0000139; GO:0002218; GO:0003924; GO:0004866; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006955; GO:0030659; GO:0031410; GO:0034504; GO:0042742; GO:0042802; GO:0042803; GO:0042832; GO:0048471; GO:0050830; GO:0051607; GO:0051715; GO:0071222; GO:0071346; GO:0071347; GO:0071356; GO:0140639; GO:0140678; GO:0140973","cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]","endopeptidase inhibitor activity [GO:0004866]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular function inhibitor activity [GO:0140678]; protein homodimerization activity [GO:0042803]"
"637","Pocillopora_acuta_HIv2___RNAseq.g584.t3a",436.600226122974,9.55035354493668,4.09569083792454,2.09558048199308e-07,4.11268332314083e-06,"Q28295",4.27e-97,"von Willebrand factor (vWF)","blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; hemostasis [GO:0007599]; platelet activation [GO:0030168]","GO:0002020; GO:0005178; GO:0005518; GO:0005576; GO:0005615; GO:0005783; GO:0007155; GO:0007596; GO:0007599; GO:0019865; GO:0030168; GO:0031012; GO:0031589; GO:0033093; GO:0042802; GO:0051087; GO:0062023","collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Weibel-Palade body [GO:0033093]","collagen binding [GO:0005518]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein-folding chaperone binding [GO:0051087]"
"638","Pocillopora_acuta_HIv2___RNAseq.g28502.t1",2555.16546812714,-6.4653648514892,2.44604738439726,2.10668825882396e-07,4.1277605523095e-06,"B3EWY9",4.64e-28,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020","extracellular space [GO:0005615]; membrane [GO:0016020]","calcium ion binding [GO:0005509]"
"639","Pocillopora_acuta_HIv2___TS.g11111.t2",5024.11627672245,-2.92192122800896,0.629980760205004,2.10897058086056e-07,4.1277605523095e-06,"Q13228",0,"Methanethiol oxidase (MTO) (EC 1.8.3.4) (56 kDa selenium-binding protein) (SBP56) (SP56) (Selenium-binding protein 1)","protein transport [GO:0015031]","GO:0001650; GO:0005615; GO:0005730; GO:0005829; GO:0008430; GO:0015031; GO:0016020; GO:0018549; GO:0070062","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]","methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]"
"640","Pocillopora_acuta_HIv2___RNAseq.g9085.t1",7563.81025980618,-3.02297958983161,0.655704329500227,2.14605910507112e-07,4.19467552645252e-06,"Q96PZ7",8.15e-53,"CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)","conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964]","GO:0001964; GO:0007613; GO:0008584; GO:0008585; GO:0016020; GO:0035846; GO:0042593; GO:0060745; GO:1990708","membrane [GO:0016020]",""
"641","Pocillopora_acuta_HIv2___RNAseq.g28742.t1",119.786451567165,11.3640563289962,3.81546646547135,2.19949628176675e-07,4.29332175701407e-06,"Q25060",2.23e-22,"LWamide neuropeptides [Cleaved into: LWamide I; LWamide II; LWS]","neuropeptide signaling pathway [GO:0007218]","GO:0005576; GO:0007218","extracellular region [GO:0005576]",""
"642","Pocillopora_acuta_HIv2___RNAseq.g7998.t1",122.376097363134,10.7444247872558,3.61470558280273,2.2142391835242e-07,4.31627433295067e-06,"Q6H601",1.44e-23,"DEAD-box ATP-dependent RNA helicase 22 (EC 3.6.4.13)","","GO:0003724; GO:0003729; GO:0005524; GO:0009507; GO:0016887","chloroplast [GO:0009507]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]"
"643","Pocillopora_acuta_HIv2___RNAseq.g28991.t1",292.533200340185,9.1318657847744,3.41685134490524,2.22980081645424e-07,4.33873748516387e-06,"Q8C4M7",1.03e-13,"Centromere protein U (CENP-U) (MLF1-interacting protein)","chordate embryonic development [GO:0043009]; chromosome segregation [GO:0007059]","GO:0000939; GO:0005634; GO:0005654; GO:0005737; GO:0007059; GO:0034451; GO:0043009","centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; inner kinetochore [GO:0000939]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",""
"644","Pocillopora_acuta_HIv2___RNAseq.g26058.t1",292.935288567139,7.81972982772652,2.6437686693749,2.25384404509396e-07,4.36991960700254e-06,"O15973",1.7e-18,"Rhodopsin, GQ-coupled (GQ-rhodopsin)","cellular response to light stimulus [GO:0071482]; phototransduction [GO:0007602]; visual perception [GO:0007601]","GO:0005886; GO:0007601; GO:0007602; GO:0008020; GO:0071482","plasma membrane [GO:0005886]","G protein-coupled photoreceptor activity [GO:0008020]"
"645","Pocillopora_acuta_HIv2___RNAseq.g30929.t1",215.760983612499,9.52710995741144,3.40371828552473,2.28450603673959e-07,4.42343980125856e-06,"Q53FA7",2.68e-124,"Quinone oxidoreductase PIG3 (EC 1.6.5.5) (NADPH:quinone reductase PIG3) (Tumor protein p53-inducible protein 3) (Protein PIG3) (p53-induced gene 3 protein)","NADP metabolic process [GO:0006739]","GO:0003960; GO:0005829; GO:0006739; GO:0042803; GO:0048038; GO:0070402","cytosol [GO:0005829]","NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038]"
"646","Pocillopora_acuta_HIv2___RNAseq.g11868.t1",321.45389292764,9.20673079911806,3.74556544711971,2.32756674059196e-07,4.50079215720884e-06,"Q8IYF3",1.8e-155,"Testis-expressed protein 11 (Protein ZIP4 homolog) (ZIP4H)","apoptotic process [GO:0006915]; chiasma assembly [GO:0051026]; ectopic germ cell programmed cell death [GO:0035234]; fertilization [GO:0009566]; male gonad development [GO:0008584]; male meiosis chromosome segregation [GO:0007060]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130]","GO:0000712; GO:0000801; GO:0005694; GO:0006311; GO:0006915; GO:0007060; GO:0007130; GO:0007131; GO:0008584; GO:0009566; GO:0035234; GO:0043066; GO:0051026; GO:0051093; GO:2000242","central element [GO:0000801]; chromosome [GO:0005694]",""
"647","Pocillopora_acuta_HIv2___RNAseq.g13936.t1",415.01767237816,1.10950855366202,2.10195812659886,2.41807640496005e-07,4.6571314409244e-06,NA,NA,NA,NA,NA,NA,NA
"648","Pocillopora_acuta_HIv2___TS.g25579.t1",144.152661188822,8.35492907680672,2.78328050233252,2.46503067700383e-07,4.73495401224214e-06,NA,NA,NA,NA,NA,NA,NA
"649","Pocillopora_acuta_HIv2___RNAseq.g21527.t1",228.335292813313,9.49608082439257,3.57200338565658,2.4887349749039e-07,4.77414624363527e-06,"Q6BZW3",8.15e-41,"Protein BTN1","L-arginine transmembrane transport [GO:1903826]; lysine transport [GO:0015819]; regulation of intracellular pH [GO:0051453]","GO:0000324; GO:0005773; GO:0005774; GO:0015819; GO:0022857; GO:0051453; GO:1903826","fungal-type vacuole [GO:0000324]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]","transmembrane transporter activity [GO:0022857]"
"650","Pocillopora_acuta_HIv2___RNAseq.g29870.t1",86.7106421628634,10.6356466220199,3.48660477413169,2.50238296171122e-07,4.79396916002531e-06,NA,NA,NA,NA,NA,NA,NA
"651","Pocillopora_acuta_HIv2___RNAseq.g12115.t1",238.615884202611,8.66731050286316,3.51766130728686,2.57842829873736e-07,4.93311996202873e-06,"O14495",2.17e-48,"Phospholipid phosphatase 3 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b) (Vascular endothelial growth factor and type I collagen-inducible protein) (VCIP)","Bergmann glial cell differentiation [GO:0060020]; blood vessel development [GO:0001568]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by integrin [GO:0033631]; ceramide metabolic process [GO:0006672]; gastrulation with mouth forming second [GO:0001702]; homotypic cell-cell adhesion [GO:0034109]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of protein phosphorylation [GO:0001933]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein stabilization [GO:0050821]; regulation of sphingolipid mediated signaling pathway [GO:1902068]; regulation of Wnt signaling pathway [GO:0030111]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]; sphingolipid catabolic process [GO:0030149]; sphingosine metabolic process [GO:0006670]; wound healing [GO:0042060]","GO:0000139; GO:0001568; GO:0001702; GO:0001933; GO:0005178; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005912; GO:0006644; GO:0006670; GO:0006672; GO:0006890; GO:0007165; GO:0007229; GO:0008195; GO:0010595; GO:0016020; GO:0016323; GO:0022409; GO:0030111; GO:0030149; GO:0033116; GO:0033631; GO:0034109; GO:0042060; GO:0042392; GO:0045121; GO:0046839; GO:0050731; GO:0050821; GO:0051091; GO:0060020; GO:0070971; GO:0098609; GO:0106235; GO:1902068","adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]","ceramide-1-phosphate phosphatase activity [GO:0106235]; integrin binding [GO:0005178]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392]"
"652","Pocillopora_acuta_HIv2___RNAseq.g15950.t1",144.145123775651,-7.97990801175753,2.81817428226541,2.63863404413635e-07,5.04163841669594e-06,NA,NA,NA,NA,NA,NA,NA
"653","Pocillopora_acuta_HIv2___RNAseq.g3723.t1",703.784720849938,1.04743616570118,1.90660380622904,2.66924822859874e-07,5.08000083927002e-06,"A6QLU6",3.82e-31,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189","plasma membrane [GO:0005886]","G protein-coupled receptor activity [GO:0004930]"
"654","Pocillopora_acuta_HIv2___RNAseq.g24923.t1",212.854913156409,9.11226953374898,3.47264954079743,2.69305525361583e-07,5.11857440056497e-06,"Q96IY1",7.53e-11,"Kinetochore-associated protein NSL1 homolog","attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]","GO:0000070; GO:0000444; GO:0000776; GO:0000922; GO:0000940; GO:0005634; GO:0005829; GO:0008608; GO:0016607; GO:0051301","cytosol [GO:0005829]; kinetochore [GO:0000776]; MIS12/MIND type complex [GO:0000444]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle pole [GO:0000922]",""
"655","Pocillopora_acuta_HIv2___RNAseq.g8821.t1",15967.8005170179,-2.99315589752014,0.654495530605719,2.71287426643319e-07,5.13599651697508e-06,"P01026",2.73e-170,"Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2]","amyloid-beta clearance [GO:0097242]; chemotaxis [GO:0006935]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement receptor mediated signaling pathway [GO:0002430]; complement-dependent cytotoxicity [GO:0097278]; complement-mediated synapse pruning [GO:0150062]; fatty acid metabolic process [GO:0006631]; inflammatory response [GO:0006954]; neuron remodeling [GO:0016322]; oviduct epithelium development [GO:0035846]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of developmental growth [GO:0048639]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of lipid storage [GO:0010884]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of type IIa hypersensitivity [GO:0001798]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of triglyceride biosynthetic process [GO:0010866]; response to bacterium [GO:0009617]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to magnesium ion [GO:0032026]; response to progesterone [GO:0032570]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; tolerance induction [GO:0002507]; vascular associated smooth muscle cell differentiation [GO:0035886]; vertebrate eye-specific patterning [GO:0150064]","GO:0001798; GO:0001934; GO:0001970; GO:0002430; GO:0002507; GO:0004866; GO:0005576; GO:0005615; GO:0006631; GO:0006935; GO:0006954; GO:0006956; GO:0006957; GO:0006958; GO:0008289; GO:0009410; GO:0009617; GO:0009986; GO:0010575; GO:0010828; GO:0010866; GO:0010884; GO:0016322; GO:0031715; GO:0032026; GO:0032355; GO:0032570; GO:0032991; GO:0035846; GO:0035886; GO:0043627; GO:0045745; GO:0045766; GO:0048260; GO:0048639; GO:0050766; GO:0051384; GO:0060041; GO:0060100; GO:0070374; GO:0097242; GO:0097278; GO:0150062; GO:0150064; GO:2000427","cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]","C5L2 anaphylatoxin chemotactic receptor binding [GO:0031715]; endopeptidase inhibitor activity [GO:0004866]; lipid binding [GO:0008289]"
"656","Pocillopora_acuta_HIv2___RNAseq.g3911.t1",242.524364160997,9.34671072321256,3.38242951441361,2.73459824808696e-07,5.1703567399124e-06,"Q6DGQ8",1.38e-96,"Nucleoside diphosphate kinase homolog 5 (3'-5' exonuclease NME5) (EC 3.1.-.-)","cilium movement [GO:0003341]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; UTP biosynthetic process [GO:0006228]","GO:0003341; GO:0004550; GO:0005929; GO:0006183; GO:0006228; GO:0006241; GO:0008408; GO:1902176","cilium [GO:0005929]","3'-5' exonuclease activity [GO:0008408]; nucleoside diphosphate kinase activity [GO:0004550]"
"657","Pocillopora_acuta_HIv2___RNAseq.g7100.t1",313.96233441298,5.26768892054446,4.37245239502045,2.74503080052919e-07,5.1833062008948e-06,"Q9DBN1",1.28e-72,"Stimulated by retinoic acid gene 6 protein-like (STRA6-like protein) (Retinol-binding protein 4 receptor 2) (RBP4 receptor 2)","establishment of localization in cell [GO:0051649]; retinol transport [GO:0034633]; vitamin A import into cell [GO:0071939]","GO:0005886; GO:0034632; GO:0034633; GO:0038023; GO:0051649; GO:0071939","plasma membrane [GO:0005886]","retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023]"
"658","Pocillopora_acuta_HIv2___RNAseq.g7217.t1",250.824848780073,9.13580683815489,3.44913549464891,2.84944937665703e-07,5.37345968500225e-06,"Q3U481",1.02e-29,"Major facilitator superfamily domain-containing protein 12 (Protein grizzled)","carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021]","GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:0048022; GO:1903712","late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886]","cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293]"
"659","Pocillopora_acuta_HIv2___RNAseq.g15551.t1",74.3271776341929,8.23408855217191,2.45614583538954,2.87126860883867e-07,5.40755587997949e-06,NA,NA,NA,NA,NA,NA,NA
"660","Pocillopora_acuta_HIv2___RNAseq.g25869.t1",286.420135232824,9.43799166491134,3.48855310435236,2.92770047390874e-07,5.50666575482653e-06,"Q5RJA1",1.33e-153,"DNA-binding protein RFX6 (Regulatory factor X 6)","endocrine pancreas development [GO:0031018]; glucose homeostasis [GO:0042593]; pancreatic A cell differentiation [GO:0003310]; pancreatic D cell differentiation [GO:0003311]; pancreatic epsilon cell differentiation [GO:0090104]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309]","GO:0000976; GO:0000978; GO:0000981; GO:0003309; GO:0003310; GO:0003311; GO:0005634; GO:0006357; GO:0031018; GO:0035774; GO:0042593; GO:0045893; GO:0045944; GO:0050796; GO:0090104","nucleus [GO:0005634]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]"
"661","Pocillopora_acuta_HIv2___RNAseq.g5360.t1",214.921094055806,9.16714599774516,3.78292272212823,2.96732853741228e-07,5.56543212040518e-06,"E2RYF8",6.49e-74,"Targeting protein for Xklp2 homolog (TPX2 homolog) (Microtubule-associated protein TPX2 homolog)","regulation of mitotic spindle organization [GO:0060236]","GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0060236","cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]",""
"662","Pocillopora_acuta_HIv2___RNAseq.g15816.t1",245.604656988575,8.95572349758541,3.44804606290514,2.97278146699167e-07,5.56543212040518e-06,"Q9XWN7",2.18e-51,"Nucleoside hydrolase (EC 3.2.2.-) (EC 3.2.2.1) (EC 3.2.2.2) (EC 3.2.2.3) (EC 3.2.2.7) (EC 3.2.2.8)","nucleobase-containing compound metabolic process [GO:0006139]","GO:0006139; GO:0016799; GO:0046872","","hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; metal ion binding [GO:0046872]"
"663","Pocillopora_acuta_HIv2___TS.g22016.t1",313.331384951986,6.52488176754969,2.41468853420369,2.9820702823304e-07,5.56550510498411e-06,"A2TLM1",3.3e-97,"Ribose-5-phosphate isomerase (EC 5.3.1.6) (Phosphoriboisomerase)","D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]","GO:0004751; GO:0005737; GO:0006014; GO:0009052","cytoplasm [GO:0005737]","ribose-5-phosphate isomerase activity [GO:0004751]"
"664","Pocillopora_acuta_HIv2___RNAseq.g439.t1",278.048121039085,9.3967089220611,3.66051913988887,2.99328055868519e-07,5.57922809288951e-06,"O08760",5.68e-103,"N-glycosylase/DNA lyase [Includes: 8-oxoguanine DNA glycosylase (EC 3.2.2.-); DNA-(apurinic or apyrimidinic site) lyase (AP lyase) (EC 4.2.99.18)]","base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; nucleotide-excision repair [GO:0006289]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to light stimulus [GO:0009416]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314]; response to xenobiotic stimulus [GO:0009410]","GO:0000702; GO:0000978; GO:0003677; GO:0003684; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0006285; GO:0006289; GO:0006355; GO:0006974; GO:0006979; GO:0008017; GO:0008534; GO:0009314; GO:0009410; GO:0009416; GO:0016363; GO:0016607; GO:0019104; GO:0019899; GO:0032355; GO:0032357; GO:0032991; GO:0034039; GO:0034614; GO:0043066; GO:0044029; GO:0045471; GO:0045944; GO:0051593; GO:0071276; GO:0140078; GO:1901291","mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]","8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; enzyme binding [GO:0019899]; microtubule binding [GO:0008017]; oxidized base lesion DNA N-glycosylase activity [GO:0000702]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"665","Pocillopora_acuta_HIv2___TS.g14315.t1b",424.844763112884,9.3470028706657,4.00723205042546,3.08080685972572e-07,5.73497946191413e-06,"Q6A4L1",0,"Solute carrier family 12 member 8","potassium ion transport [GO:0006813]","GO:0006813; GO:0015377; GO:0016020","membrane [GO:0016020]","chloride:monoatomic cation symporter activity [GO:0015377]"
"666","Pocillopora_acuta_HIv2___TS.g13410.t1",150.95880037018,-9.05868329211443,3.5318114255043,3.11421426961652e-07,5.78228436402226e-06,NA,NA,NA,NA,NA,NA,NA
"667","Pocillopora_acuta_HIv2___RNAseq.g3485.t1",73.3054284006749,10.6678092718121,3.51722548153827,3.16929555310888e-07,5.86948666839524e-06,"V6CLA2",7.35e-23,"E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26)","determination of adult lifespan [GO:0008340]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of cell fate specification [GO:0042659]; regulation of germ cell proliferation [GO:1905936]; regulation of response to oxidative stress [GO:1902882]; regulation of vulval development [GO:0040028]","GO:0008340; GO:0016607; GO:0032436; GO:0040028; GO:0042659; GO:0043161; GO:0045746; GO:0045747; GO:0046872; GO:0061630; GO:0070534; GO:1902882; GO:1905936","nuclear speck [GO:0016607]","metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
"668","Pocillopora_acuta_HIv2___RNAseq.g18062.t1",303.700828246994,-8.87827384858225,3.5608721618965,3.26837778416582e-07,6.02982350384878e-06,NA,NA,NA,NA,NA,NA,NA
"669","Pocillopora_acuta_HIv2___RNAseq.g5488.t1",115.404113864968,11.3021709230597,3.79865125457586,3.27615119613078e-07,6.03646508290899e-06,"Q5KQT7",1.69e-101,"Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)","estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]","GO:0004497; GO:0005506; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0008210; GO:0020037; GO:0030544; GO:0042572; GO:0043231; GO:0051879; GO:0070330; GO:0101020; GO:0101021; GO:0106256","endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]","aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]"
"670","Pocillopora_acuta_HIv2___RNAseq.g25912.t1",515.76815183459,9.78727496737178,4.88027851935309,3.3026179989213e-07,6.07694416661508e-06,NA,NA,NA,NA,NA,NA,NA
"671","Pocillopora_acuta_HIv2___RNAseq.g6743.t1",631.464652238243,5.32878118080544,3.82022449391942,3.30652313269225e-07,6.07694416661508e-06,"B2GUB3",2.27e-180,"Tubulin tyrosine ligase 3 (EC 6.3.2.-) (Tubulin--tyrosine ligase protein 3)","protein polyglycylation [GO:0018094]","GO:0005524; GO:0005737; GO:0005874; GO:0018094; GO:0031514; GO:0046872; GO:0070736","cytoplasm [GO:0005737]; microtubule [GO:0005874]; motile cilium [GO:0031514]","ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity, initiating [GO:0070736]"
"672","Pocillopora_acuta_HIv2___RNAseq.g6350.t1",1498.34017104801,6.06863426356969,2.19258887588539,3.36665654120043e-07,6.17177695968607e-06,"B3EWY8",8.13e-08,"Skeletal aspartic acid-rich protein 2","","GO:0016020","membrane [GO:0016020]",""
"673","Pocillopora_acuta_HIv2___RNAseq.g26790.t1",144.921778528511,8.99135539053247,3.28726640652431,3.4475074518546e-07,6.31199339033227e-06,NA,NA,NA,NA,NA,NA,NA
"674","Pocillopora_acuta_HIv2___RNAseq.g15172.t1",11660.5074946994,-3.63178689964033,0.887130551786844,3.55234278497313e-07,6.49571252109373e-06,"P86982",1.98e-27,"Insoluble matrix shell protein 1 (IMSP1)","","GO:0005576","extracellular region [GO:0005576]",""
"675","Pocillopora_acuta_HIv2___RNAseq.g30609.t1",72.7282646220258,10.5925545696213,3.53706358611183,3.58273415718901e-07,6.54301349110882e-06,NA,NA,NA,NA,NA,NA,NA
"676","Pocillopora_acuta_HIv2___RNAseq.g24800.t1",329.339442485158,5.80216266646893,1.92804299721725,3.65571041919398e-07,6.66786828539997e-06,"E7FAM5",1.82e-11,"E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177","P-body [GO:0000932]","miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
"677","Pocillopora_acuta_HIv2___TS.g28493.t1",653.628186451029,1.39577608361418,2.56707406749482,3.66427340018559e-07,6.67506932749174e-06,NA,NA,NA,NA,NA,NA,NA
"678","Pocillopora_acuta_HIv2___RNAseq.g21637.t1",81.1276123362451,7.98947844092005,2.37464498146464,3.84492415760867e-07,6.97778958791114e-06,"A0A1D5PUP4",1.11e-24,"Reversion-inducing cysteine-rich protein with Kazal motifs","blood vessel maturation [GO:0001955]; canonical Wnt signaling pathway [GO:0060070]; extracellular matrix organization [GO:0030198]; negative regulation of metalloendopeptidase activity [GO:1904684]; regulation of angiogenesis [GO:0045765]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]","GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005615; GO:0005886; GO:0008191; GO:0015026; GO:0030198; GO:0045765; GO:0060070; GO:0090210; GO:0098552; GO:1904684; GO:1990909","extracellular space [GO:0005615]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; Wnt signalosome [GO:1990909]","coreceptor activity [GO:0015026]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867]"
"679","Pocillopora_acuta_HIv2___RNAseq.g20556.t1",154.652189714123,8.68341962326304,3.25329993810268,4.01090746293099e-07,7.25172069297923e-06,"Q9HB75",6.98e-08,"p53-induced death domain-containing protein 1 (EC 3.4.21.-) (Leucine-rich repeat and death domain-containing protein) [Cleaved into: PIDD-N; PIDD-C; PIDD-CC]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoprocessing [GO:0016540]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; signal transduction [GO:0007165]","GO:0004175; GO:0005123; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006915; GO:0006919; GO:0006974; GO:0006977; GO:0007165; GO:0008625; GO:0016540; GO:0043065; GO:0043066; GO:0043122; GO:0051092; GO:1905369","cytoplasm [GO:0005737]; cytosol [GO:0005829]; endopeptidase complex [GO:1905369]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","death receptor binding [GO:0005123]; endopeptidase activity [GO:0004175]"
"680","Pocillopora_acuta_HIv2___RNAseq.g13103.t1",2431.04611628532,-6.15754451551919,2.60297404488863,4.05172691229461e-07,7.3163767864456e-06,NA,NA,NA,NA,NA,NA,NA
"681","Pocillopora_acuta_HIv2___TS.g1897.t1",90.6378895175458,11.0197083110565,3.70615257427539,4.08496317465879e-07,7.36719543120507e-06,NA,NA,NA,NA,NA,NA,NA
"682","Pocillopora_acuta_HIv2___RNAseq.g22559.t1",3596.94262808464,-3.23193503958311,0.748532472761146,4.14061079713343e-07,7.44897942409676e-06,"Q9GLP1",6.04e-27,"Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain]","blood circulation [GO:0008015]; blood coagulation [GO:0007596]","GO:0005507; GO:0005576; GO:0007596; GO:0008015; GO:0031091","extracellular region [GO:0005576]; platelet alpha granule [GO:0031091]","copper ion binding [GO:0005507]"
"683","Pocillopora_acuta_HIv2___TS.g20880.t1",77.2218040403559,10.6618439702988,3.53728346207017,4.14975509463223e-07,7.45615623462864e-06,"Q8R1U2",2.51e-08,"Cell growth regulator with EF hand domain protein 1 (Cell growth regulatory gene 11 protein) (Hydrophobestin)","cell adhesion [GO:0007155]; negative regulation of cell growth [GO:0030308]; regulation of cell cycle [GO:0051726]","GO:0005509; GO:0005576; GO:0007155; GO:0030308; GO:0051726","extracellular region [GO:0005576]","calcium ion binding [GO:0005509]"
"684","Pocillopora_acuta_HIv2___RNAseq.g15875.t1",280.674465994762,1.03918470419404,1.95967057973825,4.1777112720694e-07,7.49707392546052e-06,"Q8R016",0,"Bleomycin hydrolase (BH) (BLM hydrolase) (BMH) (EC 3.4.22.40)","homocysteine catabolic process [GO:0043418]; proteolysis [GO:0006508]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]","GO:0004177; GO:0004197; GO:0005737; GO:0006508; GO:0008233; GO:0008234; GO:0009410; GO:0009636; GO:0042802; GO:0043418; GO:0070005","cytoplasm [GO:0005737]","aminopeptidase activity [GO:0004177]; cysteine-type aminopeptidase activity [GO:0070005]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]"
"685","Pocillopora_acuta_HIv2___RNAseq.g26161.t1",508.625014092727,9.14018768971643,4.11990495300291,4.26325541530296e-07,7.62266679064863e-06,"Q9Y711",2.01e-82,"Alternative oxidase, mitochondrial (EC 1.-.-.-)","alternative respiration [GO:0010230]","GO:0005743; GO:0009916; GO:0010230; GO:0046872; GO:0070469","mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]","alternative oxidase activity [GO:0009916]; metal ion binding [GO:0046872]"
"686","Pocillopora_acuta_HIv2___RNAseq.g19299.t1",266.147435815686,-1.47345291867183,3.12661459636841,4.2635076283426e-07,7.62266679064863e-06,NA,NA,NA,NA,NA,NA,NA
"687","Pocillopora_acuta_HIv2___RNAseq.g11580.t1",148.096171726209,11.1120298273433,3.95536525986574,4.35151554266195e-07,7.74533168377262e-06,"Q96RW7",9.94e-21,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711","adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927]","calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]"
"688","Pocillopora_acuta_HIv2___TS.g19499.t2",256.054527035565,9.14825333207334,3.57611567846127,4.35889103331783e-07,7.74533168377262e-06,"P49013",5.45e-61,"Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III)","","GO:0005509; GO:0005576; GO:0009374","extracellular region [GO:0005576]","biotin binding [GO:0009374]; calcium ion binding [GO:0005509]"
"689","Pocillopora_acuta_HIv2___TS.g14578.t2",278.536602023994,1.00596977070772,1.87344855896561,4.38316053590048e-07,7.77889987622878e-06,NA,NA,NA,NA,NA,NA,NA
"690","Pocillopora_acuta_HIv2___RNAseq.4782_t",303.099993745203,4.91326982741928,4.71192561463624,4.39457468674907e-07,7.7895990525905e-06,NA,NA,NA,NA,NA,NA,NA
"691","Pocillopora_acuta_HIv2___RNAseq.g24760.t1",205.983533024016,8.93189904255252,3.4784742793145,4.52913777541123e-07,7.99558523617177e-06,"Q9TT38",0,"Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)]","arachidonic acid metabolic process [GO:0019369]; glycerol metabolic process [GO:0006071]; leukotriene biosynthetic process [GO:0019370]; monoacylglycerol biosynthetic process [GO:0006640]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylglycerol catabolic process [GO:0034478]; prostaglandin biosynthetic process [GO:0001516]","GO:0000139; GO:0001516; GO:0004622; GO:0005509; GO:0005544; GO:0005635; GO:0005737; GO:0005783; GO:0005829; GO:0006071; GO:0006640; GO:0008374; GO:0010314; GO:0019369; GO:0019370; GO:0032266; GO:0034478; GO:0034638; GO:0047498; GO:0047499; GO:0070273; GO:1902387","cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]","calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; calcium-independent phospholipase A2 activity [GO:0047499]; ceramide 1-phosphate binding [GO:1902387]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]"
"692","Pocillopora_acuta_HIv2___RNAseq.g26341.t1",452.741673719425,7.14417614982046,3.13604920194496,4.53289539108189e-07,7.99558523617177e-06,"Q8LAD0",4.32e-57,"Probable pyridoxal 5'-phosphate synthase subunit PDX2 (AtPDX2) (EC 4.3.3.6) (Protein EMBRYO DEFECTIVE 2407) (Pyridoxal 5'-phosphate synthase glutaminase subunit) (EC 3.5.1.2)","glutamine metabolic process [GO:0006541]; pyridoxal phosphate biosynthetic process [GO:0042823]; vitamin B6 biosynthetic process [GO:0042819]","GO:0004359; GO:0005829; GO:0006541; GO:0036381; GO:0042819; GO:0042823; GO:0046982","cytosol [GO:0005829]","glutaminase activity [GO:0004359]; protein heterodimerization activity [GO:0046982]; pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381]"
"693","Pocillopora_acuta_HIv2___RNAseq.g4498.t1",118.221039505953,10.7242302942505,3.70992045822612,4.55688806105454e-07,8.02811558040109e-06,NA,NA,NA,NA,NA,NA,NA
"694","Pocillopora_acuta_HIv2___TS.g17854.t1",2083.02089718451,1.63759837238799,4.76668519838998,4.73081684829773e-07,8.2941254416701e-06,NA,NA,NA,NA,NA,NA,NA
"695","Pocillopora_acuta_HIv2___TS.g14960.t2",557.925299343715,1.20136430271679,2.29669640714864,4.85494924628573e-07,8.49117120898148e-06,"Q91755",4.95e-80,"Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6)","detection of cold stimulus involved in thermoception [GO:0120169]","GO:0004970; GO:0005234; GO:0005886; GO:0015277; GO:0022849; GO:0045211; GO:0120169","plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]","extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate-gated calcium ion channel activity [GO:0022849]; glutamate-gated receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]"
"696","Pocillopora_acuta_HIv2___RNAseq.g4214.t1",70.4172962348968,10.4499386275274,3.51225094537143,4.9605904002312e-07,8.66545646726378e-06,"A1DWM3",1.17e-29,"Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog)","antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]","GO:0005886; GO:0042590","plasma membrane [GO:0005886]",""
"697","Pocillopora_acuta_HIv2___TS.g6578.t1",358.663427869422,1.69029023457675,4.44730406371519,4.97044969689697e-07,8.67220559902506e-06,"B8V7Q1",0,"Protocadherin-like protein","adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0000902; GO:0005509; GO:0005912; GO:0007043; GO:0007156; GO:0016339; GO:0016342; GO:0034332; GO:0044331; GO:0045296","adherens junction [GO:0005912]; catenin complex [GO:0016342]","cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]"
"698","Pocillopora_acuta_HIv2___RNAseq.g24299.t1",517.007717691082,-4.30609703138317,1.18650579221309,4.98018581366147e-07,8.67872380828909e-06,NA,NA,NA,NA,NA,NA,NA
"699","Pocillopora_acuta_HIv2___RNAseq.g4886.t1",175.210210735635,8.68438657153804,3.26839127870072,5.04271068551238e-07,8.76655857635228e-06,"Q19673",3.3e-10,"Putative tyrosinase-like protein tyr-3","","GO:0004497; GO:0046872","","metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]"
"700","Pocillopora_acuta_HIv2___RNAseq.g15196.t1",310.382272120971,-5.56184544184168,3.56485474742365,5.09678586041011e-07,8.84992925389819e-06,"Q55DA0",1.11e-53,"ABC transporter G family member 22 (ABC transporter ABCG.22)","aggregation involved in sorocarp development [GO:0031152]; cell motility [GO:0048870]; sorocarp morphogenesis [GO:0031288]; transmembrane transport [GO:0055085]","GO:0005524; GO:0016020; GO:0016887; GO:0031152; GO:0031288; GO:0042626; GO:0048870; GO:0055085; GO:0140359","membrane [GO:0016020]","ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]"
"701","Pocillopora_acuta_HIv2___RNAseq.g28226.t2",750.903428387654,-5.44460339482004,4.78923402156256,5.16033601761321e-07,8.93881439027036e-06,"P07207",5.94e-69,"Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]","GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048","adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]","calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699]"
"702","Pocillopora_acuta_HIv2___RNAseq.g1013.t1",224.539873585205,8.95598464974029,3.89917613182314,5.19628160891641e-07,8.9903130611683e-06,NA,NA,NA,NA,NA,NA,NA
"703","Pocillopora_acuta_HIv2___RNAseq.g1000.t1",555.25501334569,5.13984733850513,4.38981036994122,5.22207237133834e-07,9.0241403559185e-06,NA,NA,NA,NA,NA,NA,NA
"704","Pocillopora_acuta_HIv2___TS.g11473.t1",316.836395328846,8.83769276179556,3.47429735730652,5.36376345121201e-07,9.23588982837267e-06,NA,NA,NA,NA,NA,NA,NA
"705","Pocillopora_acuta_HIv2___RNAseq.g219.t1",168.31613187294,5.11025796981686,1.3229849087429,5.48476831912589e-07,9.42181579190462e-06,"A4IF63",8.41e-25,"Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)","negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]","GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017148; GO:0030371; GO:0043161; GO:0043523; GO:0061630","cytoplasm [GO:0005737]","translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
"706","Pocillopora_acuta_HIv2___RNAseq.g17090.t1",5915.60172920038,5.82861838460033,2.88095539456158,5.62485950551738e-07,9.62816188021342e-06,"G5EG78",7e-92,"Peroxidasin homolog pxn-2 (EC 1.11.2.-)","axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; embryonic body morphogenesis [GO:0010172]; muscle attachment [GO:0016203]; negative regulation of axon regeneration [GO:0048681]; regulation of basement membrane organization [GO:0110011]; response to oxidative stress [GO:0006979]","GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0007411; GO:0010172; GO:0016203; GO:0020037; GO:0046872; GO:0048681; GO:0071711; GO:0110011; GO:0140825","basement membrane [GO:0005604]; extracellular space [GO:0005615]","heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
"707","Pocillopora_acuta_HIv2___RNAseq.g11876.t1",195.788641002293,-9.00448118750218,3.73653023752959,5.65534996164087e-07,9.66891038359025e-06,"B3EWY9",4.02e-13,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020","extracellular space [GO:0005615]; membrane [GO:0016020]","calcium ion binding [GO:0005509]"
"708","Pocillopora_acuta_HIv2___RNAseq.g4469.t1",556.814435217407,5.31942825966606,3.58889047268218,5.68075058793082e-07,9.70087089773688e-06,"Q5ZKY0",3.8e-54,"Endosomal/lysosomal proton channel TMEM175 (Potassium channel TMEM175) (Transmembrane protein 175)","lysosomal lumen pH elevation [GO:0035752]; neuron cellular homeostasis [GO:0070050]; phagosome-lysosome fusion [GO:0090385]; potassium ion transmembrane transport [GO:0071805]; proton transmembrane transport [GO:1902600]; regulation of lysosomal lumen pH [GO:0035751]","GO:0005267; GO:0005764; GO:0005765; GO:0005768; GO:0010008; GO:0015252; GO:0022841; GO:0035751; GO:0035752; GO:0050544; GO:0070050; GO:0071805; GO:0090385; GO:1902600","endosome [GO:0005768]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]","arachidonic acid binding [GO:0050544]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; proton channel activity [GO:0015252]"
"709","Pocillopora_acuta_HIv2___RNAseq.g709.t1",15945.586082239,-3.30086799760806,0.790796695783106,5.712354743385e-07,9.73186089615083e-06,NA,NA,NA,NA,NA,NA,NA
"710","Pocillopora_acuta_HIv2___RNAseq.g29560.t1",4031.65016075501,5.14794567569829,1.89387404845921,5.73816281393585e-07,9.76432787538449e-06,"Q8T882",9.23e-164,"Tauropine dehydrogenase (TaDH) (EC 1.5.1.23) (NAD: tauropine oxidoreductase)","","GO:0050325","","tauropine dehydrogenase activity [GO:0050325]"
"711","Pocillopora_acuta_HIv2___RNAseq.g19258.t1",102.97848240713,8.10581444635499,2.80290959141518,5.77811183613626e-07,9.82075318423911e-06,"Q7VWH8",3.5e-21,"Phosphonoacetaldehyde hydrolase (Phosphonatase) (EC 3.11.1.1) (Phosphonoacetaldehyde phosphonohydrolase)","organic phosphonate catabolic process [GO:0019700]","GO:0000287; GO:0019700; GO:0050194","","magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]"
"712","Pocillopora_acuta_HIv2___RNAseq.g22691.t1",536.924145347434,-5.81836780985753,2.01976029157613,5.79877842531068e-07,9.8443111671002e-06,"E9PUQ8",0,"Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107)","diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]","GO:0004143; GO:0005524; GO:0005829; GO:0005886; GO:0005905; GO:0006654; GO:0006897; GO:0007205; GO:0015031; GO:0019900; GO:0031410; GO:0035556; GO:0042802; GO:0042803; GO:0045742; GO:0046339; GO:0046834; GO:0046872; GO:0046982; GO:0090038; GO:2000370","clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]","ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"
"713","Pocillopora_acuta_HIv2___RNAseq.g4785.t1",1227.37861831238,-3.08886585652113,0.714506766036754,6.0042048660502e-07,1.01691825740691e-05,"P12263",1.54e-09,"Coagulation factor VIII (Procoagulant component)","acute-phase response [GO:0006953]; blood coagulation, intrinsic pathway [GO:0007597]","GO:0005507; GO:0005615; GO:0006953; GO:0007597; GO:0016491","extracellular space [GO:0005615]","copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]"
"714","Pocillopora_acuta_HIv2___TS.g28596.t2",335.501844755243,1.89565785381329,5.23601527540727,6.06166376099887e-07,1.0230560634666e-05,NA,NA,NA,NA,NA,NA,NA
"715","Pocillopora_acuta_HIv2___RNAseq.g15552.t1",171.76777785772,8.58400367764128,3.30573010012655,6.29597825629096e-07,1.05889569184875e-05,NA,NA,NA,NA,NA,NA,NA
"716","Pocillopora_acuta_HIv2___RNAseq.g2983.t1",110.937925636901,8.33262036736263,3.02033413695524,6.34060960396981e-07,1.06516349955655e-05,NA,NA,NA,NA,NA,NA,NA
"717","Pocillopora_acuta_HIv2___RNAseq.g25003.t1",714.910070440306,5.9062951392894,2.73105510767847,6.38463738774174e-07,1.07131548928418e-05,"B3EWY9",0,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020","extracellular space [GO:0005615]; membrane [GO:0016020]","calcium ion binding [GO:0005509]"
"718","Pocillopora_acuta_HIv2___RNAseq.g29861.t1",105.932476822471,7.92282495088935,2.7062064368014,6.42125271738839e-07,1.07621088417504e-05,"Q6ZV65",5.43e-38,"Protein FAM47E","protein localization to chromatin [GO:0071168]; transcription initiation-coupled chromatin remodeling [GO:0045815]","GO:0000785; GO:0005634; GO:0005737; GO:0008047; GO:0045815; GO:0071168","chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]","enzyme activator activity [GO:0008047]"
"719","Pocillopora_acuta_HIv2___RNAseq.g11547.t1",85.2066714849237,10.7553204942066,3.74629224344901,6.43265590308234e-07,1.07687424747897e-05,"Q96P65",8.58e-28,"Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155)","cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0016020; GO:0032870; GO:0042277","membrane [GO:0016020]; plasma membrane [GO:0005886]","G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; peptide binding [GO:0042277]"
"720","Pocillopora_acuta_HIv2___RNAseq.g20058.t1",93.9282699414583,10.5211919662014,3.62371214042841,6.47693200277529e-07,1.08303288425597e-05,NA,NA,NA,NA,NA,NA,NA
"721","Pocillopora_acuta_HIv2___RNAseq.g4080.t1",2298.64897734108,-4.26718094453368,1.23346673721073,6.56669089137479e-07,1.09550884720698e-05,NA,NA,NA,NA,NA,NA,NA
"722","Pocillopora_acuta_HIv2___RNAseq.g30772.t1",345.136392942817,1.06438498592956,2.09517060853911,6.60683664901254e-07,1.0996695660681e-05,NA,NA,NA,NA,NA,NA,NA
"723","Pocillopora_acuta_HIv2___RNAseq.g29595.t1",364.638587823375,6.04852966000504,3.58903764447608,6.68097455396494e-07,1.11073121779941e-05,"Q8R197",7.75e-59,"S-acyl fatty acid synthase thioesterase, medium chain (EC 3.1.2.14) (Oleoyl-ACP hydrolase) (Thioesterase II) (Thioesterase domain-containing protein 1)","lipid biosynthetic process [GO:0008610]; medium-chain fatty acid biosynthetic process [GO:0051792]","GO:0005829; GO:0008610; GO:0016297; GO:0051792","cytosol [GO:0005829]","fatty acyl-[ACP] hydrolase activity [GO:0016297]"
"724","Pocillopora_acuta_HIv2___RNAseq.g7498.t1",335.771119262811,1.0585367223635,2.00636188288308,6.73012069820766e-07,1.11633561673023e-05,"A7SLW1",0,"Branched-chain-amino-acid aminotransferase (EC 2.6.1.42)","L-leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099]","GO:0004084; GO:0005739; GO:0009098; GO:0009099; GO:0050048; GO:0052654; GO:0052655; GO:0052656","mitochondrion [GO:0005739]","branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-leucine:2-oxoglutarate aminotransferase activity [GO:0050048]; L-valine transaminase activity [GO:0052655]"
"725","Pocillopora_acuta_HIv2___RNAseq.g20766.t1",128.288280525557,8.55561785604724,3.18122696081195,6.74069707158649e-07,1.11680919179183e-05,"P16157",9.43e-08,"Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)","cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]","GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014","ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]","ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325]"
"726","Pocillopora_acuta_HIv2___RNAseq.g25161.t1",299.217201356151,8.66425442740737,3.69302448929619,6.85644504098758e-07,1.13468673996389e-05,"Q9Y3B7",8.69e-55,"Large ribosomal subunit protein uL11m (39S ribosomal protein L11, mitochondrial) (L11mt) (MRP-L11)","mitochondrial translation [GO:0032543]; translation [GO:0006412]","GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0032543; GO:0070180","mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]","large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]"
"727","Pocillopora_acuta_HIv2___RNAseq.g14060.t1",664.041919546602,1.14779426319994,2.05092321794083,6.96608745387326e-07,1.15019964535186e-05,"A7UKY7",9.87e-67,"Insulinoma-associated protein 1 (Zinc finger protein IA-1)","endocrine pancreas development [GO:0031018]; endodermal cell differentiation [GO:0035987]; gland development [GO:0048732]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; pancreatic A cell differentiation [GO:0003310]; transdifferentiation [GO:0060290]; type B pancreatic cell differentiation [GO:0003309]","GO:0000122; GO:0000978; GO:0003309; GO:0003310; GO:0003700; GO:0005634; GO:0007399; GO:0017053; GO:0031018; GO:0031490; GO:0035987; GO:0046872; GO:0048732; GO:0060290","nucleus [GO:0005634]; transcription repressor complex [GO:0017053]","chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"728","Pocillopora_acuta_HIv2___RNAseq.g23879.t1",310.566223860072,4.57392692763083,4.27095648481782,6.98501616322064e-07,1.15200996333892e-05,"Q60HG9",0,"Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)","carnitine metabolic process [GO:0009437]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid metabolic process [GO:0001676]","GO:0001676; GO:0004095; GO:0005743; GO:0006635; GO:0008458; GO:0009437; GO:0016746","mitochondrial inner membrane [GO:0005743]","acyltransferase activity [GO:0016746]; carnitine O-octanoyltransferase activity [GO:0008458]; carnitine O-palmitoyltransferase activity [GO:0004095]"
"729","Pocillopora_acuta_HIv2___RNAseq.g9824.t1",3467.23763013346,5.61737892002066,2.62491074933329,7.16872965674256e-07,1.17961895057024e-05,"B8NHE3",6.7e-11,"Methyltransferase flvH (EC 2.1.1.-) (Flavunoidine biosynthesis cluster protein H)","methylation [GO:0032259]; terpenoid biosynthetic process [GO:0016114]","GO:0008168; GO:0016114; GO:0032259; GO:0046872","","metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]"
"730","Pocillopora_acuta_HIv2___TS.g805.t1a",1602.31304332393,1.4636927143052,2.99732043698788,7.20315223787463e-07,1.18393629509794e-05,"P19623",1.01e-149,"Spermidine synthase (SPDSY) (EC 2.5.1.16) (Putrescine aminopropyltransferase)","cellular response to leukemia inhibitory factor [GO:1990830]; polyamine metabolic process [GO:0006595]; spermidine biosynthetic process [GO:0008295]","GO:0004766; GO:0005829; GO:0006595; GO:0008295; GO:0042802; GO:0042803; GO:1990830","cytosol [GO:0005829]","identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spermidine synthase activity [GO:0004766]"
"731","Pocillopora_acuta_HIv2___RNAseq.g13784.t1",113.997873020613,-8.55045097599926,3.47028848799645,7.22681595583867e-07,1.18513226740647e-05,"Q04604",7.19e-103,"Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase)","melanin biosynthetic process from tyrosine [GO:0006583]","GO:0004503; GO:0005507; GO:0006583; GO:0033162; GO:0042470","melanosome [GO:0042470]; melanosome membrane [GO:0033162]","copper ion binding [GO:0005507]; tyrosinase activity [GO:0004503]"
"732","Pocillopora_acuta_HIv2___RNAseq.g9723.t1",149.270272404236,8.84707556789959,3.43073937509533,7.38132250759884e-07,1.2050050648974e-05,"P29241",1.2e-48,"ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (EC 3.2.2.-) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase) (ADPRC) (ADRC) (NAD glycohydrolase) (NAD(+) nucleosidase) (NADase)","positive regulation of B cell proliferation [GO:0030890]; single fertilization [GO:0007338]","GO:0003953; GO:0005886; GO:0007338; GO:0016740; GO:0016849; GO:0030890; GO:0031410; GO:0061809","cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]","NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; phosphorus-oxygen lyase activity [GO:0016849]; transferase activity [GO:0016740]"
"733","Pocillopora_acuta_HIv2___TS.g17699.t2",262.889461154415,1.20310427371728,2.43607842500134,7.43397051919969e-07,1.21223167519396e-05,"Q3UVD5",3.11e-27,"Leucine-rich repeat-containing G-protein coupled receptor 6","bone regeneration [GO:1990523]; cell population proliferation [GO:0008283]; positive regulation of cell migration [GO:0030335]; positive regulation of Wnt signaling pathway [GO:0030177]; tissue regeneration [GO:0042246]; Wnt signaling pathway [GO:0016055]","GO:0004930; GO:0005615; GO:0005886; GO:0008283; GO:0016055; GO:0016500; GO:0030177; GO:0030335; GO:0031012; GO:0031982; GO:0042246; GO:1990523","extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle [GO:0031982]","G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]"
"734","Pocillopora_acuta_HIv2___RNAseq.g8913.t1",760.921789243271,3.01346333635206,0.696501630445532,7.74294462827477e-07,1.25977447810311e-05,"P10079",3.51e-11,"Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","","GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579","apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]","biotin binding [GO:0009374]; calcium ion binding [GO:0005509]"
"735","Pocillopora_acuta_HIv2___RNAseq.g6559.t1",684.897710987234,-5.8204092903109,2.30473781103555,8.04510854706329e-07,1.30562630590833e-05,"A7RX26",0,"Probable imidazolonepropionase (EC 3.5.2.7) (Amidohydrolase domain-containing protein 1 homolog)","L-histidine catabolic process [GO:0006548]; L-histidine catabolic process to glutamate and formamide [GO:0019556]; L-histidine catabolic process to glutamate and formate [GO:0019557]","GO:0005737; GO:0006548; GO:0019556; GO:0019557; GO:0046872; GO:0050480","cytoplasm [GO:0005737]","imidazolonepropionase activity [GO:0050480]; metal ion binding [GO:0046872]"
"736","Pocillopora_acuta_HIv2___RNAseq.g23181.t1",528.624851597731,8.94150822834063,4.59473333501332,8.05184364539707e-07,1.30562630590833e-05,"Q17LW0",7.15e-107,"Myosin-VIIa (Protein crinkled)","actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]","GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0032027; GO:0035317; GO:0048800; GO:0071944; GO:0120025","cell periphery [GO:0071944]; cytoplasm [GO:0005737]; myosin complex [GO:0016459]; plasma membrane bounded cell projection [GO:0120025]","actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027]"
"737","Pocillopora_acuta_HIv2___RNAseq.g9090.t1",169.7101423904,7.19398294958749,2.6741778737149,8.20976162064588e-07,1.32381262074718e-05,"Q9WUW9",7.37e-52,"Sulfotransferase 1C2A (ST1C2A) (rSULT1C2A) (EC 2.8.2.1) (Sulfotransferase K2)","sulfation [GO:0051923]","GO:0004062; GO:0005737; GO:0005764; GO:0008146; GO:0051923","cytoplasm [GO:0005737]; lysosome [GO:0005764]","aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]"
"738","Pocillopora_acuta_HIv2___RNAseq.g3509.t1",137.23526639955,-5.49407439892408,3.17157157678876,8.25732872279928e-07,1.3285206078595e-05,"V6CLA2",7.25e-18,"E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26)","determination of adult lifespan [GO:0008340]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of cell fate specification [GO:0042659]; regulation of germ cell proliferation [GO:1905936]; regulation of response to oxidative stress [GO:1902882]; regulation of vulval development [GO:0040028]","GO:0008340; GO:0016607; GO:0032436; GO:0040028; GO:0042659; GO:0043161; GO:0045746; GO:0045747; GO:0046872; GO:0061630; GO:0070534; GO:1902882; GO:1905936","nuclear speck [GO:0016607]","metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
"739","Pocillopora_acuta_HIv2___RNAseq.g30904.t1",207.366849951932,8.80074813044068,3.35384148205304,8.27865609692494e-07,1.33047201984358e-05,"P27163",4.14e-15,"Calmodulin-2 (CaM-2)","","GO:0005509; GO:0030234","","calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]"
"740","Pocillopora_acuta_HIv2___RNAseq.26328_t",293.952567178692,6.60543422117221,2.73758885948565,8.43912733624254e-07,1.3532542992396e-05,NA,NA,NA,NA,NA,NA,NA
"741","Pocillopora_acuta_HIv2___TS.g28908.t1",330.892129866623,5.67504464836199,1.94591162862653,8.52007774979031e-07,1.36472208829421e-05,"Q0IIL7",7.88e-06,"Complexin-1","regulation of neurotransmitter secretion [GO:0046928]; synaptic vesicle exocytosis [GO:0016079]","GO:0000149; GO:0005829; GO:0016079; GO:0019905; GO:0031201; GO:0043195; GO:0043204; GO:0046928","cytosol [GO:0005829]; perikaryon [GO:0043204]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]","SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
"742","Pocillopora_acuta_HIv2___RNAseq.17790_t",8086.66498713056,-3.36208466042872,0.838421156498503,8.61645277706747e-07,1.37863244433079e-05,NA,NA,NA,NA,NA,NA,NA
"743","Pocillopora_acuta_HIv2___RNAseq.26321_t",275.957116094281,8.7131439505026,3.73104372058505,8.6717047780543e-07,1.38593964541191e-05,"Q5U374",3.26e-111,"Kelch-like protein 12","anterior/posterior pattern specification [GO:0009952]; convergent extension involved in axis elongation [GO:0060028]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]","GO:0006513; GO:0006888; GO:0009952; GO:0014029; GO:0014032; GO:0016055; GO:0030127; GO:0030134; GO:0031463; GO:0048208; GO:0060028","COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; Cul3-RING ubiquitin ligase complex [GO:0031463]",""
"744","Pocillopora_acuta_HIv2___TS.g17564.t1",121.614244317315,8.57590505959119,3.36735467262873,8.69479103516669e-07,1.38656513266429e-05,"O15254",0,"Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase)","fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]","GO:0005504; GO:0005777; GO:0005782; GO:0005829; GO:0016020; GO:0016402; GO:0033540; GO:0050660; GO:0055088; GO:0071949","cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]","FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402]"
"745","Pocillopora_acuta_HIv2___TS.g29618.t1",80.5444454545595,8.12313355152708,2.84319100285507,9.03858906926722e-07,1.43678993466957e-05,"O75581",0,"Low-density lipoprotein receptor-related protein 6 (LRP-6)","canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]","GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0051091; GO:0060070; GO:0071397; GO:0071542; GO:0071901; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909","cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]","coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
"746","Pocillopora_acuta_HIv2___RNAseq.g28986.t1",400.526022720074,5.99928178682667,3.68887362255918,9.03953844406324e-07,1.43678993466957e-05,NA,NA,NA,NA,NA,NA,NA
"747","Pocillopora_acuta_HIv2___RNAseq.g15149.t1",1373.29593512977,1.65900529446765,3.82473411906067,9.38204264021056e-07,1.48959236825473e-05,NA,NA,NA,NA,NA,NA,NA
"748","Pocillopora_acuta_HIv2___RNAseq.g17695.t1",183.227814604133,5.64688383902019,1.96762464796141,9.44260674925644e-07,1.49756429847857e-05,"Q7RTR2",4.3e-74,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223","centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]","ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]"
"749","Pocillopora_acuta_HIv2___TS.g23073.t1",71.5722372876972,10.2378073928077,3.53053491186646,9.45934922830467e-07,1.49857642100984e-05,NA,NA,NA,NA,NA,NA,NA
"750","Pocillopora_acuta_HIv2___RNAseq.g17236.t1",86.7427442155141,6.3607917599811,2.04333851044372,9.61296412167958e-07,1.51958374924561e-05,NA,NA,NA,NA,NA,NA,NA
"751","Pocillopora_acuta_HIv2___RNAseq.g13970.t2",372.905921792342,8.58300331336117,3.78726002334848,9.79793473391347e-07,1.54544523436559e-05,"Q8TAM2",0,"Tetratricopeptide repeat protein 8 (TPR repeat protein 8) (Bardet-Biedl syndrome 8 protein)","axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cilium assembly [GO:0060271]; establishment of anatomical structure orientation [GO:0048560]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; fat cell differentiation [GO:0045444]; inner ear receptor cell stereocilium organization [GO:0060122]; multi-ciliated epithelial cell differentiation [GO:1903251]; multicellular organism growth [GO:0035264]; non-motile cilium assembly [GO:1905515]; olfactory bulb development [GO:0021772]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of protein localization [GO:0032880]; regulation of stress fiber assembly [GO:0051492]; renal tubule development [GO:0061326]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]","GO:0001736; GO:0005813; GO:0005829; GO:0005929; GO:0007411; GO:0007608; GO:0015031; GO:0021772; GO:0032391; GO:0032880; GO:0034451; GO:0034464; GO:0035264; GO:0036064; GO:0045198; GO:0045444; GO:0048560; GO:0050893; GO:0051492; GO:0060122; GO:0060170; GO:0060219; GO:0060271; GO:0061326; GO:0061629; GO:0072659; GO:0097730; GO:1903251; GO:1905515","BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]","RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]"
"752","Pocillopora_acuta_HIv2___RNAseq.g2384.t1",386.949675165107,1.55082278232078,3.24297517517677,9.89530693402403e-07,1.55910369818871e-05,"P02597",2.19e-39,"Calmodulin, striated muscle","","GO:0005509; GO:0005737","cytoplasm [GO:0005737]","calcium ion binding [GO:0005509]"
"753","Pocillopora_acuta_HIv2___RNAseq.g17162.t1",189.760137595328,8.55615070018896,3.46057326372782,1.00557966490401e-06,1.57977850930235e-05,"Q76KP1",1.37e-82,"N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (NGalNAc-T1) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase IV) (Beta4GalNAc-T4) (Beta4GalNAcT4)","","GO:0008376; GO:0032580; GO:0033842","Golgi cisterna membrane [GO:0032580]","acetylgalactosaminyltransferase activity [GO:0008376]; N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity [GO:0033842]"
"754","Pocillopora_acuta_HIv2___TS.g29536.t1",347.746780710837,1.05050509673839,1.93229972749888,1.00592920842607e-06,1.57977850930235e-05,"Q3USF0",2.96e-17,"Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase (EC 2.4.1.147) (Core 3 synthase) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6) (BGnT-6) (Beta-1,3-Gn-T6) (Beta-1,3-N-acetylglucosaminyltransferase 6) (Beta3Gn-T6)","poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein O-linked glycosylation [GO:0006493]","GO:0000139; GO:0006493; GO:0008194; GO:0008378; GO:0030311; GO:0047224","Golgi membrane [GO:0000139]","acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047224]; galactosyltransferase activity [GO:0008378]; UDP-glycosyltransferase activity [GO:0008194]"
"755","Pocillopora_acuta_HIv2___RNAseq.g12801.t1b",184.466244039598,8.49263788953389,3.33985459592594,1.044674272948e-06,1.6370713633716e-05,"Q56A36",1.5e-22,"Hematopoietic SH2 domain-containing protein homolog","signal transduction [GO:0007165]","GO:0005737; GO:0007165","cytoplasm [GO:0005737]",""
"756","Pocillopora_acuta_HIv2___TS.g21317.t2",279.534150315599,7.91803423636794,3.14991562048514,1.05370402668768e-06,1.64765135589303e-05,"Q9D3U0",2.3e-125,"tRNA pseudouridine synthase Pus10 (EC 5.4.99.25) (Coiled-coil domain-containing protein 139) (tRNA pseudouridine 55 synthase) (Psi55 synthase) (tRNA pseudouridylate synthase) (tRNA-uridine isomerase)","primary miRNA processing [GO:0031053]; tRNA pseudouridine synthesis [GO:0031119]","GO:0005634; GO:0005737; GO:0005739; GO:0009982; GO:0031053; GO:0031119; GO:0046872; GO:0070878; GO:0106029; GO:0160148","cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]","metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; pseudouridine synthase activity [GO:0009982]; tRNA pseudouridine synthase activity [GO:0106029]; tRNA pseudouridine(55) synthase activity [GO:0160148]"
"757","Pocillopora_acuta_HIv2___RNAseq.g5341.t1",2339.32055669593,-4.70278246387325,3.04736295287787,1.07668097713482e-06,1.67994753541295e-05,NA,NA,NA,NA,NA,NA,NA
"758","Pocillopora_acuta_HIv2___RNAseq.18718_t",265.132738380105,8.61509445031412,3.42552198073605,1.10506812676459e-06,1.71867799844334e-05,NA,NA,NA,NA,NA,NA,NA
"759","Pocillopora_acuta_HIv2___TS.g28111.t1",363.677410884631,4.38628525292604,4.84165282052527,1.11362801832177e-06,1.72642182818929e-05,"Q7TPD1",0,"F-box only protein 11","negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004842; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0042981; GO:0043161; GO:0045732; GO:1904878; GO:1990756","chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]","protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
"760","Pocillopora_acuta_HIv2___RNAseq.g26862.t1",335.489418510941,1.52027003325649,3.22101295102816,1.1255866831775e-06,1.74309269651814e-05,NA,NA,NA,NA,NA,NA,NA
"761","Pocillopora_acuta_HIv2___TS.g21601.t1",154.91928275956,6.15064199411909,1.93796651006941,1.16256285709117e-06,1.78886267712411e-05,NA,NA,NA,NA,NA,NA,NA
"762","Pocillopora_acuta_HIv2___RNAseq.g5807.t1",9139.3164167662,-4.41668787432377,1.41247186887488,1.18488608340547e-06,1.82127442193164e-05,"Q8I335",2.76e-08,"Translation factor GUF1 homolog, mitochondrial (EC 3.6.5.-) (Elongation factor 4 homolog) (EF-4) (GTPase GUF1 homolog) (Ribosomal back-translocase)","positive regulation of translation [GO:0045727]; translation [GO:0006412]","GO:0003924; GO:0005525; GO:0005743; GO:0006412; GO:0043022; GO:0045727","mitochondrial inner membrane [GO:0005743]","GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]"
"763","Pocillopora_acuta_HIv2___RNAseq.g25207.t1",281.735649112322,1.65669882793117,3.77906158563516,1.18921045261286e-06,1.82380052807616e-05,NA,NA,NA,NA,NA,NA,NA
"764","Pocillopora_acuta_HIv2___RNAseq.g7215.t1",116.668353188051,8.01642149662986,3.00405261216952,1.19007274130287e-06,1.82380052807616e-05,"Q3U481",4.13e-30,"Major facilitator superfamily domain-containing protein 12 (Protein grizzled)","carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021]","GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:0048022; GO:1903712","late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886]","cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293]"
"765","Pocillopora_acuta_HIv2___RNAseq.g4097.t1",64440.9190646108,4.76846044613663,1.41934288281677,1.19031229155413e-06,1.82380052807616e-05,NA,NA,NA,NA,NA,NA,NA
"766","Pocillopora_acuta_HIv2___RNAseq.g31067.t1",208.117822889682,7.80572611001782,3.28040035842394,1.19644662201779e-06,1.83125967628204e-05,NA,NA,NA,NA,NA,NA,NA
"767","Pocillopora_acuta_HIv2___RNAseq.g9293.t1",214.074366971945,1.32850855284868,3.16336744738829,1.25187128890346e-06,1.90801541861956e-05,"Q9CR50",1.88e-50,"RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0051865; GO:0061630; GO:0072344","cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]","p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
"768","Pocillopora_acuta_HIv2___RNAseq.g2436.t1",3002.38733152766,3.04145799678235,0.733699389363674,1.28957277089889e-06,1.95722776057519e-05,NA,NA,NA,NA,NA,NA,NA
"769","Pocillopora_acuta_HIv2___RNAseq.g24329.t1",231.600608073125,8.83906438759826,4.01638879812142,1.37015484778309e-06,2.07300415463751e-05,"G7H7V7",2.12e-09,"Protein TOPAZ1 (Testis- and ovary-specific PAZ domain-containing protein 1)","cell differentiation [GO:0030154]; spermatocyte division [GO:0048137]","GO:0005829; GO:0030154; GO:0048137","cytosol [GO:0005829]",""
"770","Pocillopora_acuta_HIv2___RNAseq.g1508.t1",634.708891492389,4.9416075291609,4.5206195873545,1.38415327625072e-06,2.09199508753295e-05,"Q27084",1.79e-76,"Tachylectin-2 (Lectin L10c)","innate immune response [GO:0045087]","GO:0005576; GO:0030246; GO:0045087","extracellular region [GO:0005576]","carbohydrate binding [GO:0030246]"
"771","Pocillopora_acuta_HIv2___RNAseq.g31.t1",1891.4383734855,1.11920611625868,1.9277326162048,1.39786296401059e-06,2.11051042917007e-05,"G8HTB6",3.14e-49,"ZP domain-containing protein","","GO:0016020","membrane [GO:0016020]",""
"772","Pocillopora_acuta_HIv2___RNAseq.g832.t1",245.177669393564,6.53671919364962,2.44279401253325,1.43207507812547e-06,2.1599096903031e-05,"A0A2B4RNI3",6.97e-23,"Cyclic GMP-AMP synthase-like receptor 2 (Sp-cGLR2) (EC 2.7.7.86)","innate immune response [GO:0045087]","GO:0005524; GO:0005525; GO:0045087; GO:0046872; GO:0061501","","2',3'-cyclic GMP-AMP synthase activity [GO:0061501]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"
"773","Pocillopora_acuta_HIv2___RNAseq.g15454.t1",1988.13473761149,5.71227667086016,2.63204140868405,1.4606193487641e-06,2.19153508926598e-05,NA,NA,NA,NA,NA,NA,NA
"774","Pocillopora_acuta_HIv2___RNAseq.2466_t",596.648890404588,-5.59795308931619,2.54593175229441,1.48992377459054e-06,2.2308755150805e-05,NA,NA,NA,NA,NA,NA,NA
"775","Pocillopora_acuta_HIv2___RNAseq.g19327.t1",462.840455730804,1.20301013748238,2.15012884439063,1.50877616495691e-06,2.25676716131714e-05,NA,NA,NA,NA,NA,NA,NA
"776","Pocillopora_acuta_HIv2___TS.g21980.t1",267.082552881012,7.7536586854834,3.30271438982904,1.53829290514624e-06,2.29380088453971e-05,"Q9GSB0",3.83e-10,"Crt homolog 1 (Chloroquine resistance transporter paralog 1) (DdCRTp1)","amino acid transport [GO:0006865]","GO:0005774; GO:0006865; GO:0012506; GO:0042910","vacuolar membrane [GO:0005774]; vesicle membrane [GO:0012506]","xenobiotic transmembrane transporter activity [GO:0042910]"
"777","Pocillopora_acuta_HIv2___RNAseq.g28425.t1",213.883144529234,1.61558894818794,6.12192859321505,1.5497425978313e-06,2.30611902623785e-05,"O60678",2.98e-171,"Protein arginine N-methyltransferase 3 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3)","chromatin remodeling [GO:0006338]; methylation [GO:0032259]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of retinoic acid biosynthetic process [GO:1900053]","GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0008168; GO:0016274; GO:0031397; GO:0032259; GO:0035241; GO:0035242; GO:0042054; GO:0043022; GO:0046872; GO:1900053","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]","histone methyltransferase activity [GO:0042054]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; ribosome binding [GO:0043022]"
"778","Pocillopora_acuta_HIv2___RNAseq.g3025.t1",345.304050505396,1.06466401384755,2.0023172837657,1.570611578395e-06,2.33237431929212e-05,"Q9QXV3",1.25e-69,"Inhibitor of growth protein 1","negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell population maintenance [GO:1902459]; protein import into nucleus [GO:0006606]; regulation of programmed cell death [GO:0043067]","GO:0000122; GO:0005634; GO:0006606; GO:0030336; GO:0030512; GO:0035064; GO:0043067; GO:0045893; GO:0046872; GO:0070822; GO:1902455; GO:1902459","nucleus [GO:0005634]; Sin3-type complex [GO:0070822]","metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]"
"779","Pocillopora_acuta_HIv2___RNAseq.g898.t1b",482.16296318021,1.04630242193876,1.93519713748194,1.57912585950442e-06,2.34261296737147e-05,"Q9WUA6",0,"RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma)","brain morphogenesis [GO:0048854]; cellular response to insulin stimulus [GO:0032869]; homeostasis of number of cells within a tissue [GO:0048873]; intracellular signal transduction [GO:0035556]; mitochondrial genome maintenance [GO:0000002]; negative regulation of cellular senescence [GO:2000773]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell size [GO:0045793]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vascular endothelial cell proliferation [GO:1905564]","GO:0000002; GO:0004672; GO:0004674; GO:0005080; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0010765; GO:0032008; GO:0032869; GO:0035556; GO:0045766; GO:0045793; GO:0048854; GO:0048873; GO:0090050; GO:0106310; GO:1905564; GO:1905653; GO:2000773","cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]","ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]"
"780","Pocillopora_acuta_HIv2___RNAseq.g17476.t1",168.463613696132,8.1855024624608,3.54146904545845,1.59622965786998e-06,2.35831111046286e-05,"A5PJF4",7.28e-10,"Transmembrane protein 218","","GO:0005929; GO:0016020","cilium [GO:0005929]; membrane [GO:0016020]",""
"781","Pocillopora_acuta_HIv2___RNAseq.g14133.t1",310.444710132695,8.80537614089958,4.39075083246891,1.65185595542022e-06,2.43551932101917e-05,"Q941Q2",1.28e-14,"Anaerobic nitrite reductase HB2 (EC 1.7.2.-) (BRAna GLB2) (Hb2) (Non-symbiotic hemoglobin 2)","","GO:0005634; GO:0005737; GO:0016491; GO:0019825; GO:0020037; GO:0046872","cytoplasm [GO:0005737]; nucleus [GO:0005634]","heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]"
"782","Pocillopora_acuta_HIv2___RNAseq.g15279.t1",1874.32537199299,-5.57613339848818,2.58505936481126,1.66900500493131e-06,2.45829820685606e-05,"O95236",1.64e-12,"Apolipoprotein L3 (Apolipoprotein L-III) (ApoL-III) (TNF-inducible protein CG12-1) (CG12_1)","inflammatory response [GO:0006954]; lipoprotein metabolic process [GO:0042157]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]","GO:0005319; GO:0005576; GO:0005737; GO:0006954; GO:0008289; GO:0016020; GO:0042157; GO:0043123","cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]","lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]"
"783","Pocillopora_acuta_HIv2___RNAseq.g29984.t1",336.568885572805,8.17441836740654,3.69590848779681,1.67602828101104e-06,2.46613154186609e-05,"P87387",1.57e-100,"Protein Wnt-2b-A (Wnt-2b) (XWnt-2b) (XWnt-2)","system development [GO:0048731]; Wnt signaling pathway [GO:0016055]","GO:0005102; GO:0005576; GO:0016055; GO:0048731","extracellular region [GO:0005576]","signaling receptor binding [GO:0005102]"
"784","Pocillopora_acuta_HIv2___RNAseq.g7625.t1",56.7660190644875,10.0732984344096,3.51014635003108,1.67802646877466e-06,2.46656248418259e-05,"Q15399",3.37e-10,"Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein) (TIL) (CD antigen CD281)","cellular response to triacyl bacterial lipopeptide [GO:0071727]; detection of triacyl bacterial lipopeptide [GO:0042495]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor production [GO:0032760]; signal transduction [GO:0007165]; toll-like receptor signaling pathway [GO:0002224]","GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0006955; GO:0007165; GO:0016020; GO:0030670; GO:0032755; GO:0032757; GO:0032760; GO:0034137; GO:0035354; GO:0035663; GO:0038023; GO:0042116; GO:0042495; GO:0042802; GO:0043235; GO:0045087; GO:0045121; GO:0061809; GO:0071723; GO:0071727","Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 1-Toll-like receptor 2 protein complex [GO:0035354]","identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]"
"785","Pocillopora_acuta_HIv2___RNAseq.g29124.t1",396.744424828575,4.04320468502007,3.99488116258912,1.72582845040847e-06,2.53425205144246e-05,"Q6NX31",0,"DNA replication licensing factor mcm7 (EC 3.6.4.12) (CDC47 homolog) (Minichromosome maintenance protein 7)","DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-templated DNA replication initiation [GO:0030174]","GO:0000785; GO:0003677; GO:0003678; GO:0005524; GO:0006268; GO:0006270; GO:0016887; GO:0030174; GO:0042555; GO:0046872; GO:0071162","chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]"
"786","Pocillopora_acuta_HIv2___RNAseq.g10069.t1",218.452432099583,-3.08400793098847,0.75566583762732,1.73269265800242e-06,2.54175117701288e-05,NA,NA,NA,NA,NA,NA,NA
"787","Pocillopora_acuta_HIv2___RNAseq.g12287.t1",160.939659886312,6.41008078937229,3.09057448517191,1.73722405756232e-06,2.54581649124431e-05,"P16621",3.33e-16,"Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124]","GO:0004725; GO:0005001; GO:0005158; GO:0005925; GO:0007155; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0009986; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0045467; GO:0046627; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0061484; GO:0120034; GO:1903386","axon [GO:0030424]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; focal adhesion [GO:0005925]","heparin binding [GO:0008201]; insulin receptor binding [GO:0005158]; protein tyrosine phosphatase activity [GO:0004725]; SAM domain binding [GO:0032093]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
"788","Pocillopora_acuta_HIv2___TS.g19040.t1",79.63900163295,10.6417037309249,3.81465897753288,1.7641766004196e-06,2.5826974036912e-05,"Q9UIJ7",1.38e-58,"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (Adenylate kinase 3 alpha-like 1) (Adenylate kinase isozyme 3)","ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; blood coagulation [GO:0007596]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; UTP metabolic process [GO:0046051]","GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0006172; GO:0007596; GO:0009142; GO:0046033; GO:0046039; GO:0046041; GO:0046051; GO:0046899","cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]","ATP binding [GO:0005524]; GTP binding [GO:0005525]; nucleoside triphosphate adenylate kinase activity [GO:0046899]"
"789","Pocillopora_acuta_HIv2___RNAseq.g26393.t1",555.40944293767,3.62771536447218,0.98143732431271,1.76640136082399e-06,2.5833396646065e-05,"Q2HJ86",0,"Tubulin alpha-1D chain (EC 3.6.5.-) [Cleaved into: Detyrosinated tubulin alpha-1D chain]","microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]","GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0016787; GO:0046872","cytoplasm [GO:0005737]; microtubule [GO:0005874]","GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200]"
"790","Pocillopora_acuta_HIv2___RNAseq.g22509.t1",1219.75158996978,-5.63855940838963,2.58684999878523,1.7818945782579e-06,2.60336597776993e-05,"Q95JR6",1.75e-25,"Cyclic nucleotide-binding domain-containing protein 2","spermatogenesis [GO:0007283]","GO:0005829; GO:0007283; GO:0030552","cytosol [GO:0005829]","cAMP binding [GO:0030552]"
"791","Pocillopora_acuta_HIv2___RNAseq.g11548.t1",128.492710830693,8.04046514105038,3.25721040859099,1.81465580964184e-06,2.64588524502617e-05,"Q96P65",1.17e-28,"Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155)","cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0016020; GO:0032870; GO:0042277","membrane [GO:0016020]; plasma membrane [GO:0005886]","G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; peptide binding [GO:0042277]"
"792","Pocillopora_acuta_HIv2___TS.g23115.t1",82.0184673278625,10.4262542798607,3.83010615003506,1.87556410937e-06,2.71825243265808e-05,"P10079",8.89e-84,"Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","","GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579","apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]","biotin binding [GO:0009374]; calcium ion binding [GO:0005509]"
"793","Pocillopora_acuta_HIv2___TS.g9513.t1",11530.1786131575,3.95621916468695,3.66008972704708,1.89347780880532e-06,2.73872630265602e-05,"Q9VIK2",1.18e-56,"Carcinine transporter","carcinine import across plasma membrane [GO:1905130]; detection of light stimulus involved in visual perception [GO:0050908]; neurotransmitter uptake [GO:0001504]; positive phototaxis [GO:0046956]; visual perception [GO:0007601]","GO:0001504; GO:0005326; GO:0005886; GO:0007601; GO:0043679; GO:0046956; GO:0050908; GO:1905130; GO:1905131","axon terminus [GO:0043679]; plasma membrane [GO:0005886]","carcinine transmembrane transporter activity [GO:1905131]; neurotransmitter transmembrane transporter activity [GO:0005326]"
"794","Pocillopora_acuta_HIv2___RNAseq.g936.t1",2339.96311251566,3.09062167955526,0.766537884775669,1.90094682547612e-06,2.746782705663e-05,"Q86TI4",2.51e-93,"WD repeat-containing protein 86","","","",""
"795","Pocillopora_acuta_HIv2___RNAseq.g11877.t2b",2944.03655162024,-3.64205438608712,1.0163247582245,1.92082994367791e-06,2.77274294464643e-05,"Q8IUL8",7.39e-55,"Cartilage intermediate layer protein 2 (CILP-2) [Cleaved into: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2]","","GO:0005615; GO:0070062","extracellular exosome [GO:0070062]; extracellular space [GO:0005615]",""
"796","Pocillopora_acuta_HIv2___RNAseq.g701.t1",129.222877659363,8.27288591673433,3.49396875374417,2.05059705089939e-06,2.93661740041672e-05,"H2LRU7",3.96e-27,"Polycystin-2 (Polycystic kidney disease 2 protein homolog)","calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]","GO:0003127; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005789; GO:0005886; GO:0005929; GO:0007166; GO:0015271; GO:0016020; GO:0016055; GO:0016323; GO:0030659; GO:0034703; GO:0050982; GO:0051209; GO:0051262; GO:0051290; GO:0051371; GO:0060170; GO:0070588; GO:0071277; GO:0071805; GO:0098662","basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]","calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; monoatomic cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]"
"797","Pocillopora_acuta_HIv2___RNAseq.g4030.t1",142.268472866387,7.93929923968639,3.36941517947621,2.05357052412154e-06,2.93796677160177e-05,"Q6DCV0",5.29e-164,"WD repeat domain phosphoinositide-interacting protein 4 (WIPI-4) (WD repeat-containing protein 45)","autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]; positive regulation of autophagosome assembly [GO:2000786]","GO:0000045; GO:0000407; GO:0009267; GO:0032266; GO:1901981; GO:2000786","phagophore assembly site [GO:0000407]","phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]"
"798","Pocillopora_acuta_HIv2___RNAseq.g702.t1",58.2086220298453,10.0085558825208,3.54371691721307,2.06744989550378e-06,2.94992050734015e-05,"Q26627",2.92e-39,"Sperm receptor for egg jelly (suREJ)","detection of mechanical stimulus [GO:0050982]","GO:0005262; GO:0005509; GO:0005886; GO:0016020; GO:0030246; GO:0050982","membrane [GO:0016020]; plasma membrane [GO:0005886]","calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]"
"799","Pocillopora_acuta_HIv2___TS.g25599.t1",10009.4862760367,-6.14733949060061,2.5581949449294,2.06804438221993e-06,2.94992050734015e-05,NA,NA,NA,NA,NA,NA,NA
"800","Pocillopora_acuta_HIv2___RNAseq.g29841.t1",816.002237387024,5.19577208103447,2.0141475546546,2.07846698456404e-06,2.96186664677184e-05,"O00339",8.25e-51,"Matrilin-2","axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; response to axon injury [GO:0048678]","GO:0001764; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0048678; GO:0062023; GO:0120216","basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; matrilin complex [GO:0120216]","calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]"
"801","Pocillopora_acuta_HIv2___RNAseq.g18958.t1",1870.13484021893,-3.74129295868939,1.09114245902179,2.12334988983771e-06,3.01987539888029e-05,NA,NA,NA,NA,NA,NA,NA
"802","Pocillopora_acuta_HIv2___RNAseq.g4383.t1",634.590364681193,5.0089696681515,3.99937235296087,2.15438609603003e-06,3.05500396989984e-05,"D2GXS7",1.41e-15,"Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]","GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0030371; GO:0043161; GO:0043523; GO:0061630","cytoplasm [GO:0005737]","translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
"803","Pocillopora_acuta_HIv2___RNAseq.g9603.t1",749.297124870208,5.09293093677302,1.9428843503392,2.25394979316062e-06,3.18370408283937e-05,"P36514",2.08e-91,"UDP-glucuronosyltransferase 2C1 (UDPGT 2C1) (EC 2.4.1.17)","lipid metabolic process [GO:0006629]","GO:0005789; GO:0006629; GO:0015020","endoplasmic reticulum membrane [GO:0005789]","glucuronosyltransferase activity [GO:0015020]"
"804","Pocillopora_acuta_HIv2___RNAseq.g26782.t1",73.0933474465787,10.3429402194222,3.73985532950332,2.27877001520241e-06,3.21562239023294e-05,"Q9DER7",2.57e-97,"Tolloid-like protein 1 (EC 3.4.24.-) (Chicken tolloid-like protein 1) (Metalloprotease colloid)","cell differentiation [GO:0030154]; dorsal/ventral pattern formation [GO:0009953]; protein processing [GO:0016485]","GO:0004222; GO:0005509; GO:0005615; GO:0008270; GO:0009953; GO:0016485; GO:0030154","extracellular space [GO:0005615]","calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
"805","Pocillopora_acuta_HIv2___RNAseq.g9150.t1",479.913053914647,-4.891172091004,1.84084846741842,2.32019289974871e-06,3.27088402553269e-05,NA,NA,NA,NA,NA,NA,NA
"806","Pocillopora_acuta_HIv2___RNAseq.g25708.t1",635.875602112745,1.2683909237108,2.32981897605402,2.39821189450621e-06,3.36774144098425e-05,"Q8IVV2",0,"Lipoxygenase homology domain-containing protein 1","sensory perception of sound [GO:0007605]","GO:0007605; GO:0032420","stereocilium [GO:0032420]",""
"807","Pocillopora_acuta_HIv2___RNAseq.g28169.t1",119.66311298677,5.40576536529265,1.51391528963853,2.43625742461974e-06,3.41430577127643e-05,"F6QEU4",1.29e-49,"E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177","P-body [GO:0000932]","miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
"808","Pocillopora_acuta_HIv2___RNAseq.g9863.t1",107.331067328028,7.78876539160786,3.07043142045292,2.43845261458003e-06,3.41430577127643e-05,NA,NA,NA,NA,NA,NA,NA
"809","Pocillopora_acuta_HIv2___RNAseq.g28450.t1",209.330492281868,-3.28796294938676,0.850669591239701,2.45515729976622e-06,3.43105267476509e-05,"P35033",1.19e-62,"Trypsin-3 (EC 3.4.21.4) (Trypsin III)","digestion [GO:0007586]; proteolysis [GO:0006508]","GO:0004252; GO:0005615; GO:0006508; GO:0007586; GO:0046872","extracellular space [GO:0005615]","metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
"810","Pocillopora_acuta_HIv2___RNAseq.5685_t",266.65376562013,5.25855082824764,3.45663874100725,2.45917260969379e-06,3.4333467786304e-05,NA,NA,NA,NA,NA,NA,NA
"811","Pocillopora_acuta_HIv2___TS.g24185.t1",681.196054409371,1.60341658136252,3.06582572919971,2.51332214426511e-06,3.50218607848272e-05,NA,NA,NA,NA,NA,NA,NA
"812","Pocillopora_acuta_HIv2___RNAseq.g18951.t1",944.681077776357,5.36655178434403,3.2807076324475,2.52742735878974e-06,3.51506820360912e-05,"Q3SYV5",2.73e-65,"Tetraspanin-33 (Tspan-33)","protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]","GO:0005737; GO:0005886; GO:0005912; GO:0051604; GO:0072659","adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]",""
"813","Pocillopora_acuta_HIv2___RNAseq.g19787.t1",104.271855347264,6.76127338978921,2.13144731655674,2.54759846587113e-06,3.53971798370413e-05,NA,NA,NA,NA,NA,NA,NA
"814","Pocillopora_acuta_HIv2___RNAseq.7292_t",196.49604090737,1.12764332785691,2.08778275005687,2.65011953367808e-06,3.6715832313333e-05,"Q99PW8",0,"Kinesin-like protein KIF17 (MmKIF17)","anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based process [GO:0007017]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192]","GO:0001750; GO:0001917; GO:0003777; GO:0005524; GO:0005815; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007017; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016192; GO:0016887; GO:0030030; GO:0031503; GO:0032391; GO:0032839; GO:0036064; GO:0042073; GO:0043005; GO:0098794; GO:0098971; GO:1990075","axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]"
"815","Pocillopora_acuta_HIv2___RNAseq.g17311.t1",2064.858451302,-3.50933795058301,0.987183046751565,2.68160737509176e-06,3.71165254290213e-05,"A6QLN9",1.27e-13,"von Willebrand factor A domain-containing protein 1","translation [GO:0006412]","GO:0003735; GO:0005576; GO:0005604; GO:0005840; GO:0006412; GO:0062023","basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; ribosome [GO:0005840]","structural constituent of ribosome [GO:0003735]"
"816","Pocillopora_acuta_HIv2___RNAseq.g26093.t1",292.704893782478,1.36547306786299,2.52379163513026,2.7118670909592e-06,3.74279061103377e-05,NA,NA,NA,NA,NA,NA,NA
"817","Pocillopora_acuta_HIv2___RNAseq.g11768.t1",182.547353640695,8.08378834681578,3.86089086834948,2.73352059616311e-06,3.75833097936342e-05,NA,NA,NA,NA,NA,NA,NA
"818","Pocillopora_acuta_HIv2___TS.g10198.t2",278.968072165855,1.37882947575715,2.59159071247331,2.75532577251754e-06,3.78422508508572e-05,"Q9UMZ3",1.08e-40,"Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48)","regulation of fat cell differentiation [GO:0045598]","GO:0004725; GO:0009925; GO:0016324; GO:0043235; GO:0045598; GO:0120044","apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; receptor complex [GO:0043235]; stereocilium base [GO:0120044]","protein tyrosine phosphatase activity [GO:0004725]"
"819","Pocillopora_acuta_HIv2___RNAseq.g25885.t1",338.278471721624,-6.11710844884214,2.91982626659707,2.77491396904002e-06,3.8007912545639e-05,"Q8IZD6",8.86e-61,"Solute carrier family 22 member 15 (Fly-like putative transporter 1) (Flipt 1)","amino acid transport [GO:0006865]; monoatomic ion transport [GO:0006811]","GO:0005886; GO:0006811; GO:0006865; GO:0015199","plasma membrane [GO:0005886]","amino-acid betaine transmembrane transporter activity [GO:0015199]"
"820","Pocillopora_acuta_HIv2___RNAseq.g12339.t1",344.816169567317,1.0164811416724,1.72971805686262,2.78530912859087e-06,3.81142017369332e-05,"Q08DP0",0,"Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1)","carbohydrate metabolic process [GO:0005975]; glucose metabolic process [GO:0006006]","GO:0000287; GO:0004614; GO:0005829; GO:0005975; GO:0006006","cytosol [GO:0005829]","magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]"
"821","Pocillopora_acuta_HIv2___RNAseq.g13940.t1",129.696031600665,7.69712857499943,3.27656998183657,2.79121020014747e-06,3.81588509781976e-05,NA,NA,NA,NA,NA,NA,NA
"822","Pocillopora_acuta_HIv2___RNAseq.g1217.t1",278.804556139816,4.86849399812631,5.32983452403084,2.81555241110513e-06,3.84552880776436e-05,"P29274",2.79e-14,"Adenosine receptor A2a","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; astrocyte activation [GO:0048143]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; central nervous system development [GO:0007417]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; inflammatory response [GO:0006954]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vascular permeability [GO:0043116]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of urine volume [GO:0035810]; prepulse inhibition [GO:0060134]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of calcium ion transport [GO:0051924]; regulation of DNA-templated transcription [GO:0006355]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of norepinephrine secretion [GO:0014061]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to purine-containing compound [GO:0014074]; response to xenobiotic stimulus [GO:0009410]; sensory perception [GO:0007600]; synaptic transmission, cholinergic [GO:0007271]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; vasodilation [GO:0042311]","GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0005516; GO:0005882; GO:0005886; GO:0006355; GO:0006909; GO:0006915; GO:0006954; GO:0006968; GO:0007188; GO:0007189; GO:0007205; GO:0007267; GO:0007271; GO:0007417; GO:0007596; GO:0007600; GO:0007626; GO:0008015; GO:0008285; GO:0008289; GO:0009410; GO:0014049; GO:0014057; GO:0014061; GO:0014074; GO:0016020; GO:0019899; GO:0030425; GO:0030673; GO:0031000; GO:0031802; GO:0032230; GO:0032279; GO:0035249; GO:0035810; GO:0042311; GO:0042734; GO:0042755; GO:0042802; GO:0043025; GO:0043116; GO:0043524; GO:0044877; GO:0045211; GO:0045938; GO:0046636; GO:0048143; GO:0048786; GO:0048812; GO:0050714; GO:0050728; GO:0051393; GO:0051881; GO:0051899; GO:0051924; GO:0051968; GO:0060079; GO:0060080; GO:0060134; GO:0097190; GO:0098978; GO:0099171; GO:1900273; GO:2001235","asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intermediate filament [GO:0005882]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]","alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; type 5 metabotropic glutamate receptor binding [GO:0031802]"
"823","Pocillopora_acuta_HIv2___RNAseq.g1030.t1",175.971739544299,7.78722942295839,3.42562779310785,2.82818022445871e-06,3.85913195911045e-05,"Q90X67",3.13e-30,"Suppressor of cytokine signaling 3 (SOCS-3)","intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein ubiquitination [GO:0016567]","GO:0005942; GO:0009968; GO:0016567; GO:0035556; GO:0046854; GO:0046935","phosphatidylinositol 3-kinase complex [GO:0005942]","1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]"
"824","Pocillopora_acuta_HIv2___RNAseq.g25805.t1",213.115870933737,1.18378664039865,2.51938540795984,2.84509079559804e-06,3.87489578790302e-05,"O74549",2.16e-27,"NEDD8-conjugating enzyme ubc12 (EC 2.3.2.34) (RUB1-conjugating enzyme) (Ubiquitin carrier protein 12)","protein neddylation [GO:0045116]","GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0045116; GO:0061654","cytosol [GO:0005829]; nucleus [GO:0005634]","ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788]"
"825","Pocillopora_acuta_HIv2___RNAseq.g30774.t1",358.183784846663,7.91991302102203,3.7425029040264,2.85131530950611e-06,3.87972009752554e-05,NA,NA,NA,NA,NA,NA,NA
"826","Pocillopora_acuta_HIv2___RNAseq.g10498.t1",139.481185162316,8.30181381597817,4.11216744406737,2.93819318628496e-06,3.9866816366253e-05,NA,NA,NA,NA,NA,NA,NA
"827","Pocillopora_acuta_HIv2___TS.g11855.t2",102.794813779928,8.02605928292349,3.44737259730106,2.9613101858848e-06,4.01227699517211e-05,NA,NA,NA,NA,NA,NA,NA
"828","Pocillopora_acuta_HIv2___RNAseq.g7683.t1",792.420962683035,4.73547323202542,3.8564509281997,2.96260497154578e-06,4.01227699517211e-05,"Q9ULH7",2.01e-40,"Myocardin-related transcription factor B (MRTF-B) (MKL/myocardin-like protein 2) (Megakaryoblastic leukemia 2)","muscle organ development [GO:0007517]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; smooth muscle cell differentiation [GO:0051145]","GO:0003713; GO:0005634; GO:0007517; GO:0045296; GO:0045844; GO:0045944; GO:0051145; GO:1902895","nucleus [GO:0005634]","cadherin binding [GO:0045296]; transcription coactivator activity [GO:0003713]"
"829","Pocillopora_acuta_HIv2___TS.g4466.t2",150.34533257272,7.92105250261797,3.77023702039992,2.96855267718055e-06,4.01657118079882e-05,"Q1RLY6",9.2e-175,"Kynurenine 3-monooxygenase (EC 1.14.13.9) (Kynurenine 3-hydroxylase)","'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; kynurenine metabolic process [GO:0070189]; NAD metabolic process [GO:0019674]; podocyte development [GO:0072015]; quinolinate biosynthetic process [GO:0019805]; response to yeast [GO:0001878]; tryptophan catabolic process [GO:0006569]","GO:0001878; GO:0004502; GO:0005741; GO:0006569; GO:0019674; GO:0019805; GO:0034354; GO:0043420; GO:0070189; GO:0071949; GO:0072015","mitochondrial outer membrane [GO:0005741]","FAD binding [GO:0071949]; kynurenine 3-monooxygenase activity [GO:0004502]"
"830","Pocillopora_acuta_HIv2___RNAseq.g13196.t1",183.167377393119,-3.60393990731319,1.02001818441589,3.22766729435098e-06,4.33472421035214e-05,NA,NA,NA,NA,NA,NA,NA
"831","Pocillopora_acuta_HIv2___TS.g15668.t1",900.817267723889,4.8450064308352,1.73212294343223,3.29979206412996e-06,4.42044384704626e-05,"A2TF48",3.83e-07,"Myeloid differentiation primary response protein MyD88","defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 8 signaling pathway [GO:0034158]","GO:0002755; GO:0005634; GO:0005737; GO:0005886; GO:0006954; GO:0008063; GO:0032731; GO:0034142; GO:0034158; GO:0035325; GO:0043123; GO:0045087; GO:0050830; GO:0051607; GO:0070976; GO:1900227","cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]","TIR domain binding [GO:0070976]; Toll-like receptor binding [GO:0035325]"
"832","Pocillopora_acuta_HIv2___RNAseq.g2214.t1c",148.01235283777,7.58178320494013,3.24778134916526,3.30066327074804e-06,4.42044384704626e-05,NA,NA,NA,NA,NA,NA,NA
"833","Pocillopora_acuta_HIv2___RNAseq.g5063.t1",132.008536846297,7.69293207510118,3.63924273199487,3.39300853390833e-06,4.5357186168623e-05,"Q8GYB1",4.56e-37,"Nudix hydrolase 15, mitochondrial (AtNUDT15) (EC 3.6.1.-) (Coenzyme A diphosphatase NUDT15)","coenzyme A biosynthetic process [GO:0015937]; nucleoside phosphate metabolic process [GO:0006753]; succinyl-CoA metabolic process [GO:0006104]","GO:0005739; GO:0006104; GO:0006753; GO:0008893; GO:0010945; GO:0015937; GO:0046872","mitochondrion [GO:0005739]","coenzyme A diphosphatase activity [GO:0010945]; guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872]"
"834","Pocillopora_acuta_HIv2___RNAseq.g30215.t1",4238.85293381068,-2.91925095502876,0.749227837114174,3.46017110733497e-06,4.61696631886466e-05,"Q9GLP1",1.48e-30,"Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain]","blood circulation [GO:0008015]; blood coagulation [GO:0007596]","GO:0005507; GO:0005576; GO:0007596; GO:0008015; GO:0031091","extracellular region [GO:0005576]; platelet alpha granule [GO:0031091]","copper ion binding [GO:0005507]"
"835","Pocillopora_acuta_HIv2___RNAseq.g26553.t1",96.4502692492265,10.4530027518348,4.01333252545126,3.50959337713473e-06,4.66569472489676e-05,NA,NA,NA,NA,NA,NA,NA
"836","Pocillopora_acuta_HIv2___RNAseq.g28911.t1",5629.05905301619,-2.93135046166797,0.756307448068212,3.53949812254354e-06,4.69350843710888e-05,"Q75N90",7.52e-85,"Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide]","anatomical structure morphogenesis [GO:0009653]","GO:0001527; GO:0005201; GO:0005509; GO:0005576; GO:0009653; GO:0031012","extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]","calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]"
"837","Pocillopora_acuta_HIv2___RNAseq.g7741.t1",144.532540952573,7.74572615648736,3.59420020936079,3.58072398671483e-06,4.7428197567622e-05,"Q8BH95",1.32e-42,"Enoyl-CoA hydratase, mitochondrial (mECH) (mECH1) (EC 4.2.1.17) (EC 5.3.3.8) (Enoyl-CoA hydratase 1) (ECHS1) (Short-chain enoyl-CoA hydratase) (SCEH)","fatty acid beta-oxidation [GO:0006635]","GO:0004165; GO:0004300; GO:0005739; GO:0005759; GO:0006635; GO:0043956; GO:0120092","mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]","3-hydroxypropionyl-CoA dehydratase activity [GO:0043956]; crotonyl-CoA hydratase activity [GO:0120092]; delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]"
"838","Pocillopora_acuta_HIv2___RNAseq.g703.t1",1021.55520835017,-3.8233556404586,1.27923491641169,3.88978050045017e-06,5.09617619189413e-05,NA,NA,NA,NA,NA,NA,NA
"839","Pocillopora_acuta_HIv2___TS.g5618.t1",10064.3811847063,-5.31090157766001,1.86645822467183,3.92443323721396e-06,5.13227869286281e-05,"Q9UGM3",3.42e-55,"Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)","defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031]","GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062","cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]","calcium-dependent protein binding [GO:0048306]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]"
"840","Pocillopora_acuta_HIv2___RNAseq.g27846.t1",186.338223706541,5.8058508896359,3.01531784373619,3.97997904640197e-06,5.19686179345562e-05,"Q17RP2",6.86e-62,"Tigger transposable element-derived protein 6","","GO:0003677; GO:0005634","nucleus [GO:0005634]","DNA binding [GO:0003677]"
"841","Pocillopora_acuta_HIv2___TS.g26020.t2",54.2941816349516,9.804505589587,3.54101668841107,3.98100308846019e-06,5.19686179345562e-05,NA,NA,NA,NA,NA,NA,NA
"842","Pocillopora_acuta_HIv2___RNAseq.g28639.t1",192.271680732401,5.4696731257201,3.86364286650246,3.99843582834529e-06,5.21491215700507e-05,"A0A1L8H0H2",2.61e-37,"DNA-binding protein RFX7 (Regulatory factor X 7)","positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000979; GO:0003700; GO:0005634; GO:0045944","nucleus [GO:0005634]","DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]"
"843","Pocillopora_acuta_HIv2___RNAseq.g14608.t1",320.741677579826,4.59376709128107,1.65378331024268,4.00673180504967e-06,5.21770459675293e-05,NA,NA,NA,NA,NA,NA,NA
"844","Pocillopora_acuta_HIv2___RNAseq.g20831.t1",377.10084804157,7.96676951342695,5.09113211177839,4.07866932312898e-06,5.30520441454475e-05,"Q9UBH6",2.13e-104,"Solute carrier family 53 member 1 (Phosphate exporter SLC53A1) (Protein SYG1 homolog) (Xenotropic and polytropic murine leukemia virus receptor X3) (X-receptor) (Xenotropic and polytropic retrovirus receptor 1)","cellular response to phosphate starvation [GO:0016036]; intracellular phosphate ion homeostasis [GO:0030643]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; response to virus [GO:0009615]","GO:0000822; GO:0001618; GO:0005315; GO:0005737; GO:0005794; GO:0005886; GO:0006817; GO:0009615; GO:0015562; GO:0016036; GO:0030643; GO:0035435","cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]","efflux transmembrane transporter activity [GO:0015562]; inositol hexakisphosphate binding [GO:0000822]; phosphate transmembrane transporter activity [GO:0005315]; virus receptor activity [GO:0001618]"
"845","Pocillopora_acuta_HIv2___RNAseq.10171_t",13842.4547164277,-3.92331136967056,1.37570947944912,4.08569497580916e-06,5.30956802606502e-05,"Q95218",1.53e-53,"Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin)","cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031]","GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830","extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589]","zymogen binding [GO:0035375]"
"846","Pocillopora_acuta_HIv2___TS.g27662.t3a",628.387289769325,1.02563230275945,1.76014271714862,4.12458900793137e-06,5.34186645392058e-05,"Q5NVD0",0,"U4/U6 small nuclear ribonucleoprotein Prp4 (U4/U6 snRNP 60 kDa protein) (WD splicing factor Prp4)","mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0005681; GO:0016607; GO:0017070; GO:0030621; GO:0046540; GO:0071001; GO:0097525","nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; spliceosomal snRNP complex [GO:0097525]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]","U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]"
"847","Pocillopora_acuta_HIv2___TS.g8082.t1",184.930661949782,5.85171608631678,2.43803678170893,4.23166179078158e-06,5.46977266683331e-05,"Q60855",5.97e-07,"Receptor-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (Cell death protein RIP) (Receptor-interacting protein 1) (RIP-1)","amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to tumor necrosis factor [GO:0071356]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response [GO:0006954]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of necroptotic process [GO:0060546]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA processing [GO:1903800]; positive regulation of necroptotic process [GO:0060545]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; regulation of reactive oxygen species metabolic process [GO:2000377]; ripoptosome assembly [GO:0097343]; ripoptosome assembly involved in necroptotic process [GO:1901026]; T cell apoptotic process [GO:0070231]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0001934; GO:0004672; GO:0004674; GO:0004706; GO:0005123; GO:0005524; GO:0005739; GO:0006915; GO:0006954; GO:0008625; GO:0030163; GO:0031264; GO:0031625; GO:0032757; GO:0032760; GO:0032991; GO:0033209; GO:0035591; GO:0036289; GO:0042327; GO:0042803; GO:0043065; GO:0043066; GO:0043123; GO:0043124; GO:0043235; GO:0043410; GO:0043525; GO:0044877; GO:0045651; GO:0045944; GO:0046330; GO:0046777; GO:0050729; GO:0051092; GO:0060545; GO:0060546; GO:0070105; GO:0070231; GO:0070266; GO:0070301; GO:0070513; GO:0071356; GO:0071363; GO:0097300; GO:0097342; GO:0097343; GO:0097527; GO:0106310; GO:1900119; GO:1901026; GO:1901224; GO:1903265; GO:1903800; GO:1990000; GO:2000377; GO:2001237; GO:2001238; GO:2001240","death-inducing signaling complex [GO:0031264]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ripoptosome [GO:0097342]","ATP binding [GO:0005524]; death domain binding [GO:0070513]; death receptor binding [GO:0005123]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling adaptor activity [GO:0035591]; ubiquitin protein ligase binding [GO:0031625]"
"848","Pocillopora_acuta_HIv2___TS.g16611.t1",68.5021010470253,10.0812761722982,3.79678939355429,4.25115267855609e-06,5.49006003059244e-05,"Q8N972",1.61e-170,"Zinc finger protein 709","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872","nucleus [GO:0005634]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"
"849","Pocillopora_acuta_HIv2___RNAseq.g6071.t1",129.661178378612,7.6502391970853,3.60345327672106,4.32012223082118e-06,5.57415235919693e-05,NA,NA,NA,NA,NA,NA,NA
"850","Pocillopora_acuta_HIv2___TS.g21616.t3a",735.605053854112,3.73143822862611,1.14608729158175,4.38597259637226e-06,5.64401313469114e-05,"Q6R520",2.51e-51,"Calmodulin (CaM)","","GO:0005509; GO:0030234","","calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]"
"851","Pocillopora_acuta_HIv2___RNAseq.g334.t1",1218.88336377857,3.35717891124054,0.948892550627809,4.3979281868977e-06,5.65436740402564e-05,"F8WLE0",0,"Kinesin-like protein KIF28P (Kinesin-like protein 6)","cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]","GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007005; GO:0007018; GO:0008017; GO:0016887; GO:0030705; GO:0031966; GO:0072384","kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
"852","Pocillopora_acuta_HIv2___RNAseq.665_t",411.692398983122,1.07231774377674,1.89895644622266,4.45137056961776e-06,5.70785673040348e-05,"Q15319",1.61e-90,"POU domain, class 4, transcription factor 3 (Brain-specific homeobox/POU domain protein 3C) (Brain-3C) (Brn-3C)","axon extension [GO:0048675]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve development [GO:0021562]; visual perception [GO:0007601]","GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007601; GO:0007605; GO:0021562; GO:0031290; GO:0042472; GO:0042491; GO:0045944; GO:0048675; GO:0050885; GO:0051402; GO:1990837","chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"
"853","Pocillopora_acuta_HIv2___RNAseq.g29941.t1",26708.5341789636,-3.09583147186888,0.832716427356957,4.53047115771584e-06,5.80413948850327e-05,NA,NA,NA,NA,NA,NA,NA
"854","Pocillopora_acuta_HIv2___RNAseq.g9374.t1",382.09094034297,-8.18274982666744,3.98520269240693,4.62669681373376e-06,5.901282426265e-05,"Q6NXR0",6.95e-58,"Interferon-inducible GTPase 5 (EC 3.6.5.-) (Immunity-related GTPase cinema 1)","positive regulation of flagellated sperm motility [GO:1902093]","GO:0003924; GO:0005525; GO:0005811; GO:0016020; GO:0036126; GO:0097226; GO:1902093","lipid droplet [GO:0005811]; membrane [GO:0016020]; sperm flagellum [GO:0036126]; sperm mitochondrial sheath [GO:0097226]","GTP binding [GO:0005525]; GTPase activity [GO:0003924]"
"855","Pocillopora_acuta_HIv2___RNAseq.g2158.t1",348.127562731297,1.03471992539096,1.84131854669351,4.78232185135357e-06,6.06767572438404e-05,"Q6P255",4.3e-24,"Mediator of RNA polymerase II transcription subunit 11 (Mediator complex subunit 11)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003712; GO:0006357; GO:0016592","mediator complex [GO:0016592]","transcription coregulator activity [GO:0003712]"
"856","Pocillopora_acuta_HIv2___RNAseq.g26722.t1",873.917258774888,2.64333535512805,0.66007597472826,4.79155480829454e-06,6.07406211631658e-05,NA,NA,NA,NA,NA,NA,NA
"857","Pocillopora_acuta_HIv2___TS.g19253.t1",100.145407212621,7.28555433663218,3.49800656585518,4.88308129246636e-06,6.17385382991551e-05,"P54886",0,"Delta-1-pyrroline-5-carboxylate synthase (P5CS) (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase (GK) (EC 2.7.2.11) (Gamma-glutamyl kinase); Gamma-glutamyl phosphate reductase (GPR) (EC 1.2.1.41) (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase)]","citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; proline biosynthetic process [GO:0006561]; response to temperature stimulus [GO:0009266]","GO:0003723; GO:0004349; GO:0004350; GO:0005524; GO:0005739; GO:0005743; GO:0006536; GO:0006561; GO:0006592; GO:0009266; GO:0019240; GO:0042802; GO:0055129","mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]","ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]"
"858","Pocillopora_acuta_HIv2___TS.g19435.t1",970.051656199186,-5.0040283368748,2.34222548138183,4.98641780738023e-06,6.29899975248451e-05,"Q70AG8",2.82e-26,"Alpha-(1,3)-fucosyltransferase 11 (EC 2.4.1.-) (Fucosyltransferase XI) (Fuc-TXI) (FucT-XI) (Galactoside 3-L-fucosyltransferase 11) (Fucosyltransferase 11)","protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0032580; GO:0046920","Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]","alpha-(1->3)-fucosyltransferase activity [GO:0046920]"
"859","Pocillopora_acuta_HIv2___RNAseq.g20518.t1",3244.62904135567,-4.56011828937761,1.42858013804302,5.02239549733722e-06,6.33891173416104e-05,NA,NA,NA,NA,NA,NA,NA
"860","Pocillopora_acuta_HIv2___RNAseq.g8736.t1",714.256779080191,1.19155963341775,1.94720149196464,5.06464267252398e-06,6.38666012339902e-05,NA,NA,NA,NA,NA,NA,NA
"861","Pocillopora_acuta_HIv2___RNAseq.g26711.t1",1640.37593047741,2.51629982555209,0.624892831724044,5.11989434110018e-06,6.44449289311726e-05,NA,NA,NA,NA,NA,NA,NA
"862","Pocillopora_acuta_HIv2___RNAseq.g10278.t1",303.544186117648,5.89050587695898,3.7264997431758,5.12387087049561e-06,6.44449289311726e-05,"Q3KR73",3.51e-165,"KAT8 regulatory NSL complex subunit 3 (NSL complex protein NSL3) (Non-specific lethal 3 homolog)","chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitochondrial transcription [GO:1903108]","GO:0000123; GO:0005634; GO:0005739; GO:0006325; GO:0044545; GO:0045944; GO:1903108","histone acetyltransferase complex [GO:0000123]; mitochondrion [GO:0005739]; NSL complex [GO:0044545]; nucleus [GO:0005634]",""
"863","Pocillopora_acuta_HIv2___RNAseq.g13060.t1",7815.93678153804,5.22854954787622,2.06372314466052,5.43357381977268e-06,6.7868058488076e-05,"O88572",1.08e-113,"Low-density lipoprotein receptor-related protein 6 (LRP-6)","anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesenchymal cell proliferation [GO:0010463]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of developmental process [GO:0051093]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of morphogenesis of an epithelium [GO:1905331]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell proliferation [GO:2000648]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of anatomical structure morphogenesis [GO:0022603]; regulation of cell development [GO:0060284]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation [GO:0050678]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244]","GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003151; GO:0003344; GO:0003401; GO:0005041; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0010463; GO:0010976; GO:0016020; GO:0017147; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0022603; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0034185; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042475; GO:0042733; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045444; GO:0045599; GO:0045778; GO:0045780; GO:0045893; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050678; GO:0050680; GO:0051091; GO:0051093; GO:0051593; GO:0055008; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060412; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071542; GO:0072089; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:0110135; GO:1905331; GO:1990963; GO:2000051; GO:2000149; GO:2000151; GO:2000164; GO:2000166; GO:2000168; GO:2000648","early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]","apolipoprotein binding [GO:0034185]; low-density lipoprotein particle receptor activity [GO:0005041]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
"864","Pocillopora_acuta_HIv2___RNAseq.g15935.t1",237.673397775777,-5.99134585301367,2.68247683356944,5.59308556557452e-06,6.96799221537209e-05,NA,NA,NA,NA,NA,NA,NA
"865","Pocillopora_acuta_HIv2___RNAseq.g4682.t1",270.940324536305,1.05613324496311,1.96404894587786,5.60349718815873e-06,6.97203255328785e-05,NA,NA,NA,NA,NA,NA,NA
"866","Pocillopora_acuta_HIv2___RNAseq.g17443.t1",120.960900507032,7.3691488911895,3.30045382012212,5.60596920594149e-06,6.97203255328785e-05,"Q5REY7",7.09e-132,"UBX domain-containing protein 7","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]","GO:0005654; GO:0031625; GO:0034098; GO:0043130; GO:0043161; GO:0061629","nucleoplasm [GO:0005654]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]","RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]"
"867","Pocillopora_acuta_HIv2___RNAseq.g26035.t1",2844.02785962697,-3.4527908470303,1.04496790429293,5.70731687587949e-06,7.07981400452152e-05,"B3EWZ7",2.34e-11,"Threonine-rich protein","","GO:0005576","extracellular region [GO:0005576]",""
"868","Pocillopora_acuta_HIv2___RNAseq.g23499.t1",45.6032550073575,9.69907733766114,3.51231459076349,6.02473959572139e-06,7.4278332175255e-05,NA,NA,NA,NA,NA,NA,NA
"869","Pocillopora_acuta_HIv2___RNAseq.g26270.t1a",2780.75438924398,-4.73715241462736,1.58195945659586,6.029435892488e-06,7.4278332175255e-05,"P55012",0,"Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (mNKCC1)","ammonium transmembrane transport [GO:0072488]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell volume homeostasis [GO:0006884]; cellular response to chemokine [GO:1990869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to potassium ion [GO:0035865]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; inorganic anion import across plasma membrane [GO:0098658]; intracellular chloride ion homeostasis [GO:0030644]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; maintenance of blood-brain barrier [GO:0035633]; mammary duct terminal end bud growth [GO:0060763]; multicellular organism growth [GO:0035264]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; T cell chemotaxis [GO:0010818]","GO:0006813; GO:0006814; GO:0006821; GO:0006883; GO:0006884; GO:0006972; GO:0007214; GO:0008511; GO:0008519; GO:0010818; GO:0015079; GO:0016323; GO:0016324; GO:0030007; GO:0030644; GO:0035264; GO:0035633; GO:0035725; GO:0035865; GO:0042995; GO:0043025; GO:0044297; GO:0045795; GO:0050910; GO:0055064; GO:0055075; GO:0055078; GO:0060444; GO:0060763; GO:0061044; GO:0071222; GO:0071944; GO:0072488; GO:0098658; GO:0098719; GO:0150003; GO:1902476; GO:1904450; GO:1904464; GO:1990573; GO:1990869","apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; neuronal cell body [GO:0043025]","ammonium channel activity [GO:0008519]; potassium ion transmembrane transporter activity [GO:0015079]; sodium:potassium:chloride symporter activity [GO:0008511]"
"870","Pocillopora_acuta_HIv2___RNAseq.g25184.t1",1197.80217612348,-4.18638412801837,4.58692131333072,6.05137040339578e-06,7.44277393832624e-05,"P70191",5.24e-44,"TNF receptor-associated factor 5","apoptotic process [GO:0006915]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0005164; GO:0005737; GO:0005813; GO:0005829; GO:0006915; GO:0007165; GO:0008270; GO:0008284; GO:0009898; GO:0023019; GO:0031625; GO:0031996; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0043123; GO:0048255; GO:0051092; GO:0070534; GO:0097400","CD40 receptor complex [GO:0035631]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]","identical protein binding [GO:0042802]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"
"871","Pocillopora_acuta_HIv2___RNAseq.g30624.t2a",46.9199198828432,9.78939393060089,3.5922308367003,6.14214188861598e-06,7.54159085542797e-05,NA,NA,NA,NA,NA,NA,NA
"872","Pocillopora_acuta_HIv2___TS.g4055.t1",42.8677633033214,6.14806686640372,2.15367989488623,6.1931451591058e-06,7.59132640519545e-05,NA,NA,NA,NA,NA,NA,NA
"873","Pocillopora_acuta_HIv2___RNAseq.g11916.t1",585.852403749978,1.28986259757121,2.38297056110255,6.26417935821179e-06,7.66418441676741e-05,"Q9I8C7",6.31e-78,"Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10)","","GO:0004888; GO:0005262; GO:0005886; GO:0022848; GO:0043005; GO:0045202; GO:0045211; GO:1902495","neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495]","acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; transmembrane signaling receptor activity [GO:0004888]"
"874","Pocillopora_acuta_HIv2___TS.g8258.t1",75.7322744331064,-6.90268382355009,3.37541542624349,6.26848047914536e-06,7.66418441676741e-05,"Q8NDA2",9.73e-30,"Hemicentin-2","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808]","GO:0005509; GO:0005576; GO:0005886; GO:0007156; GO:0008046; GO:0030424; GO:0032154; GO:0043025; GO:0050808; GO:0062023","axon [GO:0030424]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]","axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509]"
"875","Pocillopora_acuta_HIv2___RNAseq.g17573.t1",2170.58915866496,-2.44941999756288,0.614476107567169,6.50995875263467e-06,7.94599522346902e-05,"Q28IU6",4.07e-11,"Homeobox protein Hox-D1","","GO:0000981; GO:0005634; GO:0043565","nucleus [GO:0005634]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"
"876","Pocillopora_acuta_HIv2___RNAseq.g24040.t1",1807.45892921878,-4.4275180954927,2.08823306055128,6.55785702931463e-06,7.98424613400731e-05,"Q9BQG1",1.04e-25,"Synaptotagmin-3 (Synaptotagmin III) (SytIII)","calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; positive regulation of dendrite extension [GO:1903861]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005768; GO:0005886; GO:0017156; GO:0030154; GO:0030276; GO:0030658; GO:0070382; GO:1903861","endosome [GO:0005768]; exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]","calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]"
"877","Pocillopora_acuta_HIv2___RNAseq.g26958.t1",765.317738878119,1.32256876947462,2.28417255200424,6.74439174495611e-06,8.18241938081475e-05,"A7RZS0",1.42e-48,"Biogenesis of lysosome-related organelles complex 1 subunit 2 (BLOC-1 subunit 2)","endosomal transport [GO:0016197]; lysosome localization [GO:0032418]","GO:0000930; GO:0005765; GO:0005813; GO:0016197; GO:0031083; GO:0032418; GO:0043015; GO:0099078","BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; centrosome [GO:0005813]; gamma-tubulin complex [GO:0000930]; lysosomal membrane [GO:0005765]","gamma-tubulin binding [GO:0043015]"
"878","Pocillopora_acuta_HIv2___TS.g27239.t2",5362.68132109276,-2.76691338617429,0.731741462732349,6.88372826282318e-06,8.32917163862609e-05,"Q08D11",1.95e-166,"Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II)","phosphatidylserine biosynthetic process [GO:0006659]","GO:0005789; GO:0006659; GO:0106245","endoplasmic reticulum membrane [GO:0005789]","L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]"
"879","Pocillopora_acuta_HIv2___RNAseq.g2263.t1b",1355.99328185568,5.06986328649794,2.46834426352827,6.88722986711615e-06,8.32917163862609e-05,"P42893",6.72e-148,"Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)","axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; blood vessel diameter maintenance [GO:0097746]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; gene expression [GO:0010467]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; neuron projection development [GO:0031175]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of blood pressure [GO:0008217]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to cadmium ion [GO:0046686]; response to hypoxia [GO:0001666]; response to muscle stretch [GO:0035994]; response to xenobiotic stimulus [GO:0009410]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492]","GO:0001666; GO:0001921; GO:0004175; GO:0004222; GO:0005768; GO:0005769; GO:0005886; GO:0007411; GO:0007507; GO:0008217; GO:0008270; GO:0009410; GO:0009897; GO:0010467; GO:0010613; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016485; GO:0016486; GO:0030141; GO:0031175; GO:0031982; GO:0033093; GO:0034959; GO:0035050; GO:0035994; GO:0042447; GO:0042733; GO:0042802; GO:0042803; GO:0043583; GO:0043950; GO:0045745; GO:0046686; GO:0048471; GO:0060037; GO:0060385; GO:0070372; GO:0097492; GO:0097746; GO:1902287","early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093]","endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]"
"880","Pocillopora_acuta_HIv2___RNAseq.g6094.t2",191.372272897173,7.8379528524086,4.23737474688736,6.96882497573801e-06,8.4067626729837e-05,"Q12791",0,"Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (hSlo)","intracellular potassium ion homeostasis [GO:0030007]; micturition [GO:0060073]; negative regulation of cell volume [GO:0045794]; positive regulation of apoptotic process [GO:0043065]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of membrane potential [GO:0042391]; response to calcium ion [GO:0051592]; response to carbon monoxide [GO:0034465]; response to hypoxia [GO:0001666]; response to osmotic stress [GO:0006970]; smooth muscle contraction involved in micturition [GO:0060083]; vasodilation [GO:0042311]","GO:0001666; GO:0003779; GO:0005249; GO:0005886; GO:0005901; GO:0006813; GO:0006970; GO:0008076; GO:0015269; GO:0016020; GO:0016324; GO:0030007; GO:0034465; GO:0042311; GO:0042391; GO:0042802; GO:0043065; GO:0045211; GO:0045794; GO:0046872; GO:0051592; GO:0060072; GO:0060073; GO:0060083; GO:0071805","apical plasma membrane [GO:0016324]; caveola [GO:0005901]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076]","actin binding [GO:0003779]; calcium-activated potassium channel activity [GO:0015269]; identical protein binding [GO:0042802]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249]"
"881","Pocillopora_acuta_HIv2___RNAseq.g16001.t1",226.580039841484,5.14487488539189,3.40858072881538,7.14610322054686e-06,8.5991045742088e-05,"Q9VX98",2.13e-61,"Density-regulated protein homolog","formation of translation preinitiation complex [GO:0001731]; positive regulation of ecdysone receptor signaling pathway [GO:0120142]; positive regulation of insulin receptor signaling pathway [GO:0046628]; translation reinitiation [GO:0002188]","GO:0001731; GO:0002188; GO:0003729; GO:0003743; GO:0032991; GO:0046628; GO:0048027; GO:0120142","protein-containing complex [GO:0032991]","mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]"
"882","Pocillopora_acuta_HIv2___TS.g11286.t1",2158.52113630256,-4.85576994191524,1.82328448869049,7.17812537455308e-06,8.61613322967101e-05,"B3EWZ3",3.6e-28,"Coadhesin","","GO:0016020","membrane [GO:0016020]",""
"883","Pocillopora_acuta_HIv2___RNAseq.g5445.t1",128.865940556453,7.47508226857984,3.90856107300883,7.25816877256294e-06,8.70498782142208e-05,"Q96DM1",1.11e-69,"PiggyBac transposable element-derived protein 4","","","",""
"884","Pocillopora_acuta_HIv2___RNAseq.g16905.t1",276.179521322004,6.04912462184335,2.6964937346331,7.37255041764093e-06,8.82753056628795e-05,"E7FAM5",1.96e-63,"E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177","P-body [GO:0000932]","miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
"885","Pocillopora_acuta_HIv2___TS.g568.t1",575.612194494433,-4.89335423193416,2.30186579188165,7.65417981386282e-06,9.11193883355652e-05,"P28741",7.63e-61,"Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)","anterior/posterior pattern specification [GO:0009952]; anterograde axonal transport [GO:0008089]; anterograde dendritic transport [GO:0098937]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dentate gyrus development [GO:0021542]; determination of left/right symmetry [GO:0007368]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; forebrain development [GO:0030900]; heart development [GO:0007507]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; inner ear receptor cell stereocilium organization [GO:0060122]; keratinocyte proliferation [GO:0043616]; kidney development [GO:0001822]; microtubule anchoring at centrosome [GO:0034454]; motile cilium assembly [GO:0044458]; neural precursor cell proliferation [GO:0061351]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of axo-dendritic protein transport [GO:1905128]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of establishment or maintenance of cell polarity regulating cell shape [GO:2000771]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of receptor-mediated endocytosis [GO:0048260]; smoothened signaling pathway [GO:0007224]","GO:0001701; GO:0001822; GO:0001947; GO:0003341; GO:0003777; GO:0005524; GO:0005814; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007224; GO:0007368; GO:0007507; GO:0008017; GO:0008089; GO:0008544; GO:0009952; GO:0009953; GO:0010457; GO:0010838; GO:0016887; GO:0016939; GO:0019894; GO:0021542; GO:0021904; GO:0021915; GO:0030507; GO:0030900; GO:0031514; GO:0032391; GO:0032839; GO:0034454; GO:0036334; GO:0043005; GO:0043025; GO:0043616; GO:0044458; GO:0044877; GO:0048260; GO:0050679; GO:0060122; GO:0060271; GO:0061351; GO:0090316; GO:0098794; GO:0098937; GO:0098971; GO:0098978; GO:0120170; GO:1904115; GO:1905128; GO:1905515; GO:2000771","axon cytoplasm [GO:1904115]; axoneme [GO:0005930]; centriole [GO:0005814]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor connecting cilium [GO:0032391]; postsynapse [GO:0098794]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein-containing complex binding [GO:0044877]; spectrin binding [GO:0030507]"
"886","Pocillopora_acuta_HIv2___RNAseq.g30723.t1",262.89087602265,1.04003492718513,1.77619265939858,7.72716301861651e-06,9.1686370714741e-05,"Q63ZW7",4.72e-10,"InaD-like protein (Inadl protein) (Channel-interacting PDZ domain-containing protein) (Pals1-associated tight junction protein) (Protein associated to tight junctions)","establishment of apical/basal cell polarity [GO:0035089]; tight junction assembly [GO:0120192]","GO:0005737; GO:0005886; GO:0005923; GO:0016324; GO:0032991; GO:0035003; GO:0035089; GO:0045177; GO:0048471; GO:0070160; GO:0120192","apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; tight junction [GO:0070160]",""
"887","Pocillopora_acuta_HIv2___RNAseq.g20579.t1",130.793328055589,3.09164712962612,4.99035306109927,7.89215236934855e-06,9.34141504666591e-05,"Q3ZAV0",1.8e-19,"Coiled-coil domain-containing protein 60","","","",""
"888","Pocillopora_acuta_HIv2___RNAseq.g25336.t1",3879.28098932196,4.71891998591708,1.99118673566981,8.19779970854812e-06,9.65577972185994e-05,NA,NA,NA,NA,NA,NA,NA
"889","Pocillopora_acuta_HIv2___RNAseq.g29210.t1",51.1667733145563,7.20064786167337,2.66849991669563,8.520925312391e-06,9.99567426751204e-05,NA,NA,NA,NA,NA,NA,NA
"890","Pocillopora_acuta_HIv2___RNAseq.g26716.t1",935.049124170182,2.47651592803599,0.634178453276321,8.53762785932938e-06,0.000100071514876289,NA,NA,NA,NA,NA,NA,NA
"891","Pocillopora_acuta_HIv2___RNAseq.13026_t",123.729474042855,1.03561458918279,1.94192476931546,8.60404153217354e-06,0.000100768305037537,NA,NA,NA,NA,NA,NA,NA
"892","Pocillopora_acuta_HIv2___TS.g18901.t1",82.7258345383486,7.36234881250515,3.72393047942386,8.66183131964184e-06,0.000101363048711407,NA,NA,NA,NA,NA,NA,NA
"893","Pocillopora_acuta_HIv2___RNAseq.g30806.t1",802.009611151024,-3.75897611350452,0.995475108100289,8.74586208437238e-06,0.000102181057502716,"Q9NXG6",1.54e-55,"Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4)","regulation of erythrocyte differentiation [GO:0045646]","GO:0004656; GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0016706; GO:0031418; GO:0045646; GO:0160082","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]","2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; calcium ion binding [GO:0005509]; hypoxia-inducible factor-proline dioxygenase activity [GO:0160082]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]"
"894","Pocillopora_acuta_HIv2___RNAseq.g20718.t1",515.313742037359,-5.11811234878905,2.27070516067628,8.75664099301315e-06,0.000102220931822954,"Q9SCN0",9.13e-15,"Probable glycosyltransferase STELLO2 (EC 2.4.-.-)","plant-type cell wall cellulose biosynthetic process [GO:0052324]; regulation of plant-type cell wall cellulose biosynthetic process [GO:2001009]","GO:0000139; GO:0005794; GO:0016757; GO:0042802; GO:0052324; GO:2001009","Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]","glycosyltransferase activity [GO:0016757]; identical protein binding [GO:0042802]"
"895","Pocillopora_acuta_HIv2___RNAseq.g4879.t1",8387.62210612352,5.18719843962607,2.27479718998899,8.85253337915494e-06,0.000103177310875179,"O93429",8.28e-60,"Serotransferrin","antibacterial humoral response [GO:0019731]; iron ion transport [GO:0006826]","GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0019731; GO:0046872; GO:0055037","early endosome [GO:0005769]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]","metal ion binding [GO:0046872]"
"896","Pocillopora_acuta_HIv2___RNAseq.g26133.t1",48.1650983738402,9.75134031389711,3.61343424111311,8.98749895248153e-06,0.000104581805992512,NA,NA,NA,NA,NA,NA,NA
"897","Pocillopora_acuta_HIv2___RNAseq.g16665.t1",2103.55166903586,-4.69895923268563,1.7527270968321,9.04595903676944e-06,0.000105014475572562,"Q09YM8",9.73e-09,"Cortactin-binding protein 2 (CortBP2)","","GO:0005938; GO:0043197; GO:0090443","cell cortex [GO:0005938]; dendritic spine [GO:0043197]; FAR/SIN/STRIPAK complex [GO:0090443]",""
"898","Pocillopora_acuta_HIv2___RNAseq.g4354.t1",70.7119686645363,7.44559030110441,3.45473978337977,9.22938821885213e-06,0.000106880601439133,NA,NA,NA,NA,NA,NA,NA
"899","Pocillopora_acuta_HIv2___RNAseq.g11192.t1",127.800366897645,7.27962911214462,3.68805361995744,9.4104205897242e-06,0.000108802816474637,NA,NA,NA,NA,NA,NA,NA
"900","Pocillopora_acuta_HIv2___RNAseq.g4202.t1",32661.3244858288,-2.81045917855037,0.767637067820147,9.48324556924791e-06,0.000109557239547605,"Q9U943",1.28e-76,"Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)]","Wnt signaling pathway [GO:0016055]","GO:0005319; GO:0005576; GO:0008289; GO:0016055","extracellular region [GO:0005576]","lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]"
"901","Pocillopora_acuta_HIv2___RNAseq.g8581.t1",44.9465383223538,9.58842424007195,3.60699646767491,9.53211689782604e-06,0.000110009740291857,NA,NA,NA,NA,NA,NA,NA
"902","Pocillopora_acuta_HIv2___TS.g14552.t1",1206.9654152097,4.26982626393134,1.36810433560989,9.53762543736097e-06,0.000110009740291857,"P58365",0,"Cadherin-23 (Otocadherin)","adult locomotory behavior [GO:0008344]; auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; cell-cell adhesion [GO:0098609]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; righting reflex [GO:0060013]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]","GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0005911; GO:0006816; GO:0007156; GO:0007605; GO:0007626; GO:0008344; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060013; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098609; GO:0098683; GO:0098684","apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]","calcium ion binding [GO:0005509]"
"903","Pocillopora_acuta_HIv2___RNAseq.g7219.t1",2365.96211385938,-5.11475644401654,1.7325366012201,9.57598891083459e-06,0.000110364225981125,"Q09YI1",3.67e-17,"Cortactin-binding protein 2 (CortBP2)","regulation of synapse organization [GO:0050807]","GO:0005938; GO:0043197; GO:0050807; GO:0090443; GO:0098978","cell cortex [GO:0005938]; dendritic spine [GO:0043197]; FAR/SIN/STRIPAK complex [GO:0090443]; glutamatergic synapse [GO:0098978]",""
"904","Pocillopora_acuta_HIv2___RNAseq.g24413.t1",2120.4187580133,-2.92916957266444,0.824929084643326,9.60177072582428e-06,0.000110573257785289,"B2LT62",2.13e-19,"Toll-like receptor 2 (CD antigen CD282)","cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; toll-like receptor signaling pathway [GO:0002224]","GO:0002224; GO:0004888; GO:0005794; GO:0006954; GO:0030670; GO:0042497; GO:0045087; GO:0045121; GO:0061809; GO:0071726; GO:0071727","Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]","NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; transmembrane signaling receptor activity [GO:0004888]; triacyl lipopeptide binding [GO:0042497]"
"905","Pocillopora_acuta_HIv2___TS.g10825.t1",23047.6843347451,-2.31772571779582,0.591179149696726,9.91963096684794e-06,0.000113690604044761,"Q9NS62",1.96e-10,"Thrombospondin type-1 domain-containing protein 1 (Transmembrane molecule with thrombospondin module)","focal adhesion assembly [GO:0048041]","GO:0005576; GO:0005768; GO:0005829; GO:0005925; GO:0010008; GO:0048041; GO:0050840; GO:0071944","cell periphery [GO:0071944]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]","extracellular matrix binding [GO:0050840]"
"906","Pocillopora_acuta_HIv2___RNAseq.g14729.t1",1792.45168228751,-4.74444765940532,2.86812086634915,9.92933283962762e-06,0.000113711694530779,NA,NA,NA,NA,NA,NA,NA
"907","Pocillopora_acuta_HIv2___RNAseq.g20413.t2",268.659268004744,4.49019038114715,3.61081300867839,1.00383736000626e-05,0.000114869490309577,"P49961",3.37e-43,"Ectonucleoside triphosphate diphosphohydrolase 1 (EC 3.6.1.5) (ATP diphosphohydrolase) (ATP-DPH) (ATPDase) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoid cell activation antigen) (Nucleoside triphosphate diphosphohydrolase 1) (NTPDase1) (CD antigen CD39)","blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; nucleoside diphosphate catabolic process [GO:0009134]; platelet aggregation [GO:0070527]","GO:0003924; GO:0004050; GO:0004382; GO:0005524; GO:0005886; GO:0005901; GO:0007155; GO:0007596; GO:0009134; GO:0016020; GO:0016887; GO:0017110; GO:0017111; GO:0036384; GO:0043262; GO:0043273; GO:0045134; GO:0070062; GO:0070527; GO:0103023; GO:1990003","caveola [GO:0005901]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]","ADP phosphatase activity [GO:0043262]; apyrase activity [GO:0004050]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; CDP phosphatase activity [GO:0036384]; CTPase activity [GO:0043273]; GDP phosphatase activity [GO:0004382]; GTPase activity [GO:0003924]; IDP phosphatase activity [GO:1990003]; ITPase activity [GO:0103023]; nucleoside diphosphate phosphatase activity [GO:0017110]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; UDP phosphatase activity [GO:0045134]"
"908","Pocillopora_acuta_HIv2___RNAseq.g25351.t1",48599.9596373917,-2.4917606246365,0.655618883276136,1.00556276176909e-05,0.000114975966689551,"A6QLI0",1.15e-31,"Mammalian ependymin-related protein 1 (MERP-1)","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005576; GO:0005764; GO:0007160; GO:0008289; GO:0043202","extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]","calcium ion binding [GO:0005509]; lipid binding [GO:0008289]"
"909","Pocillopora_acuta_HIv2___RNAseq.g22682.t1b",1326.13611977452,-4.03150416744439,1.39494185283864,1.00830272648449e-05,0.000115107266265759,NA,NA,NA,NA,NA,NA,NA
"910","Pocillopora_acuta_HIv2___RNAseq.g26613.t1",376.897202416782,1.22220805579289,2.21992298411375,1.00993830460986e-05,0.000115203057081049,"Q8BUG5",1.67e-101,"Calcyphosin-2 (Calcyphosine-2)","","GO:0005509","","calcium ion binding [GO:0005509]"
"911","Pocillopora_acuta_HIv2___RNAseq.g9864.t1",245.22951242933,1.62901626741957,3.59060103671724,1.01179819772299e-05,0.000115324264238497,NA,NA,NA,NA,NA,NA,NA
"912","Pocillopora_acuta_HIv2___RNAseq.2618_t",181.750869429989,3.36683696322445,5.05260387657118,1.01465157998473e-05,0.000115558428762986,"Q9UHJ3",2.82e-10,"Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1)","cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283]","GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635","nucleoplasm [GO:0005654]; nucleus [GO:0005634]","chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]"
"913","Pocillopora_acuta_HIv2___TS.g23133.t3",4216.88558149283,-2.84431984899874,0.7877001132657,1.01767934304595e-05,0.000115721022152646,"Q61838",0,"Pregnancy zone protein (Alpha-2-macroglobulin) (Alpha-2-M) [Cleaved into: Alpha-2-macroglobulin 165 kDa subunit; Alpha-2-macroglobulin 35 kDa subunit]","embryo implantation [GO:0007566]","GO:0002020; GO:0004866; GO:0004867; GO:0005576; GO:0005615; GO:0007566; GO:0044877; GO:0048403; GO:0048406; GO:0062023","collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]","brain-derived neurotrophic factor binding [GO:0048403]; endopeptidase inhibitor activity [GO:0004866]; nerve growth factor binding [GO:0048406]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase inhibitor activity [GO:0004867]"
"914","Pocillopora_acuta_HIv2___RNAseq.g14883.t1",216.59486890865,-3.29179357893534,0.990476341756862,1.02644797168297e-05,0.00011647292060549,NA,NA,NA,NA,NA,NA,NA
"915","Pocillopora_acuta_HIv2___RNAseq.g21588.t1a",368.385709673478,-4.58999087083528,2.48331619233789,1.02670750672013e-05,0.00011647292060549,"Q8BYW1",3.48e-08,"Rho GTPase-activating protein 25 (Rho-type GTPase-activating protein 25)","actin filament organization [GO:0007015]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; signal transduction [GO:0007165]","GO:0001891; GO:0005096; GO:0006911; GO:0007015; GO:0007165; GO:0051058","phagocytic cup [GO:0001891]","GTPase activator activity [GO:0005096]"
"916","Pocillopora_acuta_HIv2___RNAseq.g12617.t1",93.7118160412986,7.15496742704726,3.37786081691187,1.03018570288419e-05,0.000116775909141982,"Q54RB9",1.02e-13,"Calcium-binding mitochondrial carrier protein (Mitochondrial substrate carrier family protein O)","aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]","GO:0005313; GO:0005509; GO:0005739; GO:0005743; GO:0015183; GO:0015810; GO:0015813; GO:0042802; GO:0043490","mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]","calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]"
"917","Pocillopora_acuta_HIv2___RNAseq.g8914.t1",4734.09510362457,-4.57508180281111,2.68044008197403,1.03959185567997e-05,0.000117749855916641,"O75096",0,"Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)","amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395","cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]","apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]"
"918","Pocillopora_acuta_HIv2___RNAseq.g21460.t2a",320.658590728494,8.11569994985172,4.03531991930969,1.04751400588865e-05,0.000118554323796349,NA,NA,NA,NA,NA,NA,NA
"919","Pocillopora_acuta_HIv2___TS.g8967.t1",101.952342767167,-6.38726714731755,4.56730841731375,1.05213990362099e-05,0.000118891809109172,"O05485",3.77e-29,"Extracellular protease (EC 3.4.24.-)","proteolysis [GO:0006508]","GO:0004222; GO:0006508; GO:0046872","","metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
"920","Pocillopora_acuta_HIv2___RNAseq.g16328.t1",40.5521430511232,9.46445460209905,3.48649021109004,1.0729811059452e-05,0.000121057712296345,NA,NA,NA,NA,NA,NA,NA
"921","Pocillopora_acuta_HIv2___RNAseq.g5707.t1",57.1293290731454,9.87648403549083,3.82733990699519,1.09632924456583e-05,0.000123595527618083,"Q559T8",2.38e-06,"Probable serine/threonine-protein kinase DDB_G0272282 (EC 2.7.11.1)","intracellular signal transduction [GO:0035556]","GO:0004674; GO:0005524; GO:0035091; GO:0035556; GO:0106310","","ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]"
"922","Pocillopora_acuta_HIv2___RNAseq.g20516.t1",130.085698469165,3.66622292309024,3.93846953772748,1.15452441090546e-05,0.000129550357481277,NA,NA,NA,NA,NA,NA,NA
"923","Pocillopora_acuta_HIv2___RNAseq.18788_t",50.2841889209094,9.51960780704635,3.6831016901183,1.15806073979641e-05,0.000129846438297793,"P31422",1.26e-121,"Metabotropic glutamate receptor 3 (mGluR3)","G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]","GO:0001641; GO:0005246; GO:0005886; GO:0007216; GO:0010467; GO:0014069; GO:0019233; GO:0030424; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0050804; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170","astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]","calcium channel regulator activity [GO:0005246]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110]"
"924","Pocillopora_acuta_HIv2___RNAseq.g25911.t1",427.104293769442,4.12271027556125,2.62259809729768,1.17966722035727e-05,0.000131880058807113,NA,NA,NA,NA,NA,NA,NA
"925","Pocillopora_acuta_HIv2___TS.g5338.t1",2352.95724361698,-5.24946424827796,2.57903191290669,1.179845105755e-05,0.000131880058807113,"P45452",4.05e-45,"Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)","bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; collagen catabolic process [GO:0030574]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]","GO:0001958; GO:0003417; GO:0004175; GO:0004222; GO:0004252; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030198; GO:0030282; GO:0030574; GO:0031012; GO:0060349; GO:1904645","extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]","calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]"
"926","Pocillopora_acuta_HIv2___RNAseq.g183.t1",340.729076017681,-4.57268561961012,2.18962470150978,1.18225440609888e-05,0.000132047318376944,"B7WFQ1",7.31e-42,"Uncharacterized skeletal organic matrix protein 2 (Uncharacterized SOMP-2)","","GO:0016020","membrane [GO:0016020]",""
"927","Pocillopora_acuta_HIv2___RNAseq.g14489.t1",220.230371049627,1.0180778266902,1.87215216630774,1.24089907505526e-05,0.000138064340166148,"Q7TSH8",0,"Transmembrane protein 94 (Endoplasmic reticulum magnesium ATPase)","embryonic brain development [GO:1990403]; embryonic heart tube development [GO:0035050]; intracellular magnesium ion homeostasis [GO:0010961]; magnesium ion transport from cytosol to endoplasmic reticulum [GO:0160176]","GO:0005789; GO:0010961; GO:0015444; GO:0035050; GO:0160176; GO:1990403","endoplasmic reticulum membrane [GO:0005789]","P-type magnesium transporter activity [GO:0015444]"
"928","Pocillopora_acuta_HIv2___RNAseq.g6274.t1",113.9945549342,3.91622564105044,1.27408207338262,1.24298172289916e-05,0.000138189758954753,"Q5F4A1",2.41e-54,"G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase)","apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]","GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006915; GO:0016567; GO:0046872","cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]","metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
"929","Pocillopora_acuta_HIv2___RNAseq.g30214.t1",394.110628099166,4.27348520317336,1.46766928799206,1.25163476083568e-05,0.000139044893861193,"B2RQL2",6.59e-30,"Storkhead-box protein 1","cell division [GO:0051301]; cellular response to nitrosative stress [GO:0071500]; inner ear development [GO:0048839]; negative regulation of gene expression [GO:0010629]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of otic vesicle morphogenesis [GO:1904120]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of mitochondrial DNA metabolic process [GO:1901858]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of mitotic cell cycle [GO:0007346]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0006357; GO:0007346; GO:0010628; GO:0010629; GO:0010800; GO:0010821; GO:0010971; GO:0033138; GO:0045787; GO:0048839; GO:0051301; GO:0051881; GO:0051897; GO:0071500; GO:1900087; GO:1901858; GO:1902882; GO:1904120","cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"
"930","Pocillopora_acuta_HIv2___RNAseq.g24683.t1",108.883660724108,6.21244480041238,2.92982759433727,1.25961870640008e-05,0.000139717216022782,"H3ZPL1",1.23e-48,"Aromatic-amino-acid aminotransferase 1 (ARAT-I) (AROAT) (EC 2.6.1.57)","biosynthetic process [GO:0009058]","GO:0009058; GO:0030170; GO:0080130","","L-phenylalanine:2-oxoglutarate aminotransferase activity [GO:0080130]; pyridoxal phosphate binding [GO:0030170]"
"931","Pocillopora_acuta_HIv2___TS.g26640.t2",321.217153466364,1.07331249716749,2.00533790373869,1.29187843710233e-05,0.000142966562465556,"P34568",1.94e-12,"Speckle-type POZ protein homolog (BTB and MATH domain-containing protein 43) (HIB homolog)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]","GO:0005634; GO:0005737; GO:0016567; GO:0016607; GO:0030162; GO:0031625; GO:0043161","cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]","ubiquitin protein ligase binding [GO:0031625]"
"932","Pocillopora_acuta_HIv2___RNAseq.g5755.t1",258.536958638658,4.80359982935976,4.21195248029669,1.29507691122556e-05,0.000143210951406471,"Q9QX29",2e-47,"Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5)","calcium ion transmembrane transport [GO:0070588]; negative regulation of dendrite morphogenesis [GO:0050774]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane hyperpolarization [GO:1902630]","GO:0003779; GO:0005886; GO:0007204; GO:0008284; GO:0010800; GO:0015279; GO:0030182; GO:0030276; GO:0030425; GO:0030426; GO:0034703; GO:0034704; GO:0042805; GO:0043025; GO:0045666; GO:0045773; GO:0050774; GO:0051117; GO:0051402; GO:0051480; GO:0070588; GO:0070679; GO:0070782; GO:0098793; GO:1902630","calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynapse [GO:0098793]","actin binding [GO:0003779]; actinin binding [GO:0042805]; ATPase binding [GO:0051117]; clathrin binding [GO:0030276]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]"
"933","Pocillopora_acuta_HIv2___RNAseq.g16526.t1",568.210053125228,-4.92013596743863,2.33017436036088,1.33992358127573e-05,0.000147831080698491,"P47179",6.41e-12,"Cell wall protein DAN4 (Delayed anaerobic protein 4)","fungal-type cell wall organization [GO:0031505]","GO:0005199; GO:0005576; GO:0005886; GO:0009277; GO:0031505; GO:0071944; GO:0098552","cell periphery [GO:0071944]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]","structural constituent of cell wall [GO:0005199]"
"934","Pocillopora_acuta_HIv2___RNAseq.g3423.t2",188.524505033016,1.18531169942126,2.03127944531487,1.36045792722152e-05,0.00014952631808003,"Q80UG8",0,"Tubulin monoglutamylase TTLL4 (EC 6.3.2.-) (Protein monoglutamylase TTLL4) (Tubulin--tyrosine ligase-like protein 4)","microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222]","GO:0000226; GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0036064; GO:0046872; GO:0070739; GO:0070740; GO:0097731; GO:0120222","9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]","ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]"
"935","Pocillopora_acuta_HIv2___RNAseq.g5181.t1",400.629188017808,-4.67058853867627,2.09681215470081,1.38140930546202e-05,0.000151209667184229,"Q9HCK4",3.69e-30,"Roundabout homolog 2","aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]","GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609","axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]","axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]"
"936","Pocillopora_acuta_HIv2___RNAseq.g30322.t1",2426.55028242543,-2.99075902929448,0.897206335470742,1.42690632947973e-05,0.000155529564051204,"P98064",1.04e-155,"Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain]","complement activation, lectin pathway [GO:0001867]; zymogen activation [GO:0031638]","GO:0001867; GO:0004252; GO:0005509; GO:0005615; GO:0005654; GO:0005829; GO:0031638; GO:0042803; GO:0048306","cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]","calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]"
"937","Pocillopora_acuta_HIv2___RNAseq.g12292.t1",44.2167118929873,9.32653717955935,3.53802685659221,1.43030697819717e-05,0.000155782832324126,"Q7SIC1",4.31e-15,"Fucolectin","regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]","GO:0001868; GO:0005509; GO:0005576; GO:0010185; GO:0030246; GO:0042806; GO:0045088","extracellular region [GO:0005576]","calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]"
"938","Pocillopora_acuta_HIv2___TS.g17409.t1",258.305641564203,1.19331253858379,2.08787268558111,1.43251898432578e-05,0.00015590635507365,"Q969V4",2.94e-141,"Tektin-1","cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]","GO:0005634; GO:0005879; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0160111","axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]",""
"939","Pocillopora_acuta_HIv2___RNAseq.g15036.t2",215.571648799652,5.82932736182203,3.30095520437546,1.44764725773701e-05,0.000157434360420361,"Q17RW2",3.49e-11,"Collagen alpha-1(XXIV) chain","extracellular matrix organization [GO:0030198]","GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0062023","collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]","extracellular matrix structural constituent conferring tensile strength [GO:0030020]"
"940","Pocillopora_acuta_HIv2___RNAseq.g22119.t1",47.6485687071175,9.29891183985144,3.57085995952417,1.47071196421982e-05,0.000159704009938303,NA,NA,NA,NA,NA,NA,NA
"941","Pocillopora_acuta_HIv2___RNAseq.g30418.t1",88.4299537526726,1.00302899357144,1.86022825761658,1.47072553400041e-05,0.000159704009938303,NA,NA,NA,NA,NA,NA,NA
"942","Pocillopora_acuta_HIv2___RNAseq.g11254.t1",2215.16772567462,4.89927185030408,2.86696118107963,1.50387204807108e-05,0.000162692635028422,NA,NA,NA,NA,NA,NA,NA
"943","Pocillopora_acuta_HIv2___RNAseq.g13234.t1",7877.73619950051,5.00341736526101,3.22193358986029,1.51636095004503e-05,0.000163767451928833,NA,NA,NA,NA,NA,NA,NA
"944","Pocillopora_acuta_HIv2___RNAseq.g25079.t1",726.610847277969,4.6311222604214,2.43137883994786,1.53958888688249e-05,0.000165689089731163,NA,NA,NA,NA,NA,NA,NA
"945","Pocillopora_acuta_HIv2___RNAseq.g4878.t1",2068.41975489463,-3.81049519983549,3.53957915735356,1.59659325629931e-05,0.000171186989318853,"O97490",3.41e-67,"Melanotransferrin (Membrane-bound transferrin-like protein p97) (CD antigen CD228)","iron ion transport [GO:0006826]","GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0046872; GO:0055037; GO:0098552","early endosome [GO:0005769]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; side of membrane [GO:0098552]","metal ion binding [GO:0046872]"
"946","Pocillopora_acuta_HIv2___RNAseq.g28814.t1",142.643508793693,1.56527315123291,4.87648580300884,1.59875531574953e-05,0.000171291828792602,NA,NA,NA,NA,NA,NA,NA
"947","Pocillopora_acuta_HIv2___TS.g9370.t1",3756.79217575597,-3.25932566966772,1.07745090931174,1.69161776541793e-05,0.000180572393793394,"Q5R9H4",0,"APOBEC1 complementation factor (APOBEC1-stimulating protein)","mRNA processing [GO:0006397]; protein stabilization [GO:0050821]","GO:0003727; GO:0005737; GO:0005783; GO:0006397; GO:0030895; GO:0050821","apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]","single-stranded RNA binding [GO:0003727]"
"948","Pocillopora_acuta_HIv2___TS.g23724.t1a",3514.2101435833,-4.46389527422006,1.4865619158934,1.72009704390117e-05,0.000183334234754885,"B8RJM0",1.96e-36,"Uncharacterized skeletal organic matrix protein 3 (Uncharacterized SOMP-3)","","GO:0016020","membrane [GO:0016020]",""
"949","Pocillopora_acuta_HIv2___RNAseq.g15293.t1",1839.70464286307,-4.44946386234817,1.99519998852593,1.72075483636483e-05,0.000183334234754885,NA,NA,NA,NA,NA,NA,NA
"950","Pocillopora_acuta_HIv2___RNAseq.g19870.t1",593.27662889163,2.95244535279519,4.07787465999136,1.72810860743918e-05,0.000183924671802798,"Q9Z0U4",7.43e-73,"Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932]","GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430","axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]","extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982]"
"951","Pocillopora_acuta_HIv2___TS.g16484.t1",154.454617079156,3.7817090720359,4.10728204846136,1.77804449737429e-05,0.000188131935698769,"P31649",0,"Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13)","amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; taurine transmembrane transport [GO:0015734]","GO:0005283; GO:0005308; GO:0005332; GO:0005368; GO:0005369; GO:0005886; GO:0006836; GO:0006865; GO:0015185; GO:0015734; GO:0015881; GO:0016323; GO:0016597; GO:0035725; GO:0042995; GO:0051939; GO:0089718","basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; plasma membrane [GO:0005886]","amino acid binding [GO:0016597]; amino acid:sodium symporter activity [GO:0005283]; creatine transmembrane transporter activity [GO:0005308]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; taurine transmembrane transporter activity [GO:0005368]; taurine:sodium symporter activity [GO:0005369]"
"952","Pocillopora_acuta_HIv2___RNAseq.30019_t",2423.82724239577,-4.55358377956769,1.66795039100231,1.82574786317171e-05,0.000192475343242826,NA,NA,NA,NA,NA,NA,NA
"953","Pocillopora_acuta_HIv2___TS.g20447.t1",224.601958130723,-3.4826971302582,1.23644017929513,1.86184119920509e-05,0.000195567691396531,NA,NA,NA,NA,NA,NA,NA
"954","Pocillopora_acuta_HIv2___RNAseq.g28398.t1",252.971186387421,6.65638516768666,4.07256206313704,1.87330315411976e-05,0.000196628859370016,"Q9Y6H5",2.51e-30,"Synphilin-1 (Sph1) (Alpha-synuclein-interacting protein)","cell death [GO:0008219]; dopamine metabolic process [GO:0042417]; regulation of inclusion body assembly [GO:0090083]; regulation of neurotransmitter secretion [GO:0046928]","GO:0005654; GO:0005737; GO:0005829; GO:0008021; GO:0008219; GO:0031625; GO:0036464; GO:0042417; GO:0042734; GO:0042802; GO:0043025; GO:0046928; GO:0090083","cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]","identical protein binding [GO:0042802]; ubiquitin protein ligase binding [GO:0031625]"
"955","Pocillopora_acuta_HIv2___TS.g16066.t1",41.2613579680828,9.27091610592138,3.56949272219741,1.89404681328934e-05,0.000198205237208173,NA,NA,NA,NA,NA,NA,NA
"956","Pocillopora_acuta_HIv2___RNAseq.g28816.t1",119.345492272193,4.44615883128824,1.85683447389365,1.89517314061742e-05,0.000198205237208173,"Q5I020",3.91e-74,"Proton-coupled zinc antiporter SLC30A8 (Solute carrier family 30 member 8) (Zinc transporter 8) (ZnT-8)","zinc ion import into organelle [GO:0062111]","GO:0005886; GO:0030658; GO:0030667; GO:0046872; GO:0062111; GO:0140826","plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]","metal ion binding [GO:0046872]; zinc:proton antiporter activity [GO:0140826]"
"957","Pocillopora_acuta_HIv2___RNAseq.g26331.t1",1081.697046677,-3.99394775360288,2.06348698324379,1.90492027572009e-05,0.000198936944895418,"Q5ZMH1",0,"Septin-2","cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224]","GO:0003924; GO:0005525; GO:0005737; GO:0005819; GO:0005940; GO:0007224; GO:0008021; GO:0008104; GO:0015630; GO:0017157; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0060090; GO:0060170; GO:0060271; GO:0061640","cell division site [GO:0032153]; ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]","GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]"
"958","Pocillopora_acuta_HIv2___RNAseq.g9789.t1",220.438535080701,6.64252319791494,4.23471521566487,1.92831847739572e-05,0.000201235198102826,"Q8C0S1",0,"DIS3-like exonuclease 1 (EC 3.1.13.1)","mRNA catabolic process [GO:0006402]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]","GO:0000175; GO:0000177; GO:0003723; GO:0005813; GO:0005829; GO:0005886; GO:0006396; GO:0006401; GO:0006402; GO:0008859; GO:0016075; GO:0019899","centrosome [GO:0005813]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; plasma membrane [GO:0005886]","3'-5'-RNA exonuclease activity [GO:0000175]; enzyme binding [GO:0019899]; exoribonuclease II activity [GO:0008859]; RNA binding [GO:0003723]"
"959","Pocillopora_acuta_HIv2___RNAseq.g5859.t1",52.25457011884,9.65910418252717,3.90836340880331,1.94760085497568e-05,0.000203100928380449,"P16157",8.66e-29,"Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)","cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]","GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014","ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]","ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325]"
"960","Pocillopora_acuta_HIv2___RNAseq.g623.t1",259.234238914522,2.95272742803225,5.48389046037997,1.95051804878572e-05,0.000203258595516114,"F1MKX4",0,"Proteasome activator complex subunit 4 (Proteasome activator PA200)","DNA damage response [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; sperm DNA condensation [GO:0035092]","GO:0005634; GO:0005829; GO:0006281; GO:0006974; GO:0010499; GO:0016504; GO:0016607; GO:0035092; GO:0070577; GO:0070628; GO:1990111","cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111]","lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628]"
"961","Pocillopora_acuta_HIv2___RNAseq.g3826.t1",12381.153714469,-2.77053079007252,0.80374140986085,1.98143080849923e-05,0.000206034616924032,"Q9ER58",5.79e-23,"Testican-2 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2)","cellular response to leukemia inhibitory factor [GO:1990830]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005539; GO:0005576; GO:0010811; GO:0030198; GO:0050840; GO:0062023; GO:1990830","collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]","calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]"
"962","Pocillopora_acuta_HIv2___RNAseq.g23210.t1",91.1601050956309,-6.90997608068636,4.41799424191815,1.99020883604528e-05,0.00020665025559626,"A2AJ76",1.35e-106,"Hemicentin-2","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808]","GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0032154; GO:0043025; GO:0050808; GO:0062023","axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]","axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509]"
"963","Pocillopora_acuta_HIv2___RNAseq.g20060.t1",4926.13035022732,2.49811327926244,0.686881189569327,2.03748021505864e-05,0.000211103967267967,NA,NA,NA,NA,NA,NA,NA
"964","Pocillopora_acuta_HIv2___RNAseq.g22964.t1",1389.15835526996,4.73969270440528,2.59510082217795,2.04583799727174e-05,0.000211818187491327,"Q6QNK2",6.08e-29,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0016607","cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]","G protein-coupled receptor activity [GO:0004930]"
"965","Pocillopora_acuta_HIv2___RNAseq.g28800.t1",5118.41942028873,-2.50552050801572,0.693696594191477,2.07691553252298e-05,0.000214343052164237,"O42401",5.96e-15,"Matrilin-3","","GO:0005509; GO:0005576; GO:0062023","collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]","calcium ion binding [GO:0005509]"
"966","Pocillopora_acuta_HIv2___RNAseq.g3486.t1",1322.77803553658,-3.06302344935344,0.987142806142501,2.15462123363445e-05,0.000221495675360972,"Q9VL06",2.54e-27,"E3 ubiquitin-protein ligase Ufd4 (EC 2.3.2.26) (Ubiquitin fusion-degradation 4-like)","negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005634; GO:0006511; GO:0016607; GO:0032436; GO:0043161; GO:0046872; GO:0061630; GO:0070373; GO:0070534","nuclear speck [GO:0016607]; nucleus [GO:0005634]","metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
"967","Pocillopora_acuta_HIv2___RNAseq.g24766.t1",946.345253742189,-2.86739951195643,0.862286738139533,2.17649188487739e-05,0.000223109699665957,"Q868Z9",1.25e-120,"Papilin","extracellular matrix organization [GO:0030198]","GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198","basement membrane [GO:0005604]; extracellular region [GO:0005576]","extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867]"
"968","Pocillopora_acuta_HIv2___RNAseq.g8794.t1",3354.94669077861,-3.13219876138933,0.985387639312398,2.18591732494535e-05,0.000223917196798934,NA,NA,NA,NA,NA,NA,NA
"969","Pocillopora_acuta_HIv2___RNAseq.g15874.t1",70.7956442298273,6.54869467595029,4.40185937169034,2.22184415045216e-05,0.000226634370889563,NA,NA,NA,NA,NA,NA,NA
"970","Pocillopora_acuta_HIv2___RNAseq.g4612.t1",81.1077759665498,6.84787735922559,3.50112401114544,2.24261218755035e-05,0.00022837318961144,"Q7Z4Q2",9.58e-43,"HEAT repeat-containing protein 3","erythrocyte maturation [GO:0043249]; protein import into nucleus [GO:0006606]; ribosomal large subunit biogenesis [GO:0042273]","GO:0006606; GO:0042273; GO:0043249; GO:0051082","","unfolded protein binding [GO:0051082]"
"971","Pocillopora_acuta_HIv2___RNAseq.g26589.t1",6569.48131392173,-2.32827210100554,0.634292978646578,2.31023123712714e-05,0.00023372135671469,"Q5VXJ0",5.57e-109,"Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2)","cornification [GO:0070268]; lipid catabolic process [GO:0016042]","GO:0004465; GO:0005576; GO:0016042; GO:0043231; GO:0070268","extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]","lipoprotein lipase activity [GO:0004465]"
"972","Pocillopora_acuta_HIv2___RNAseq.g18425.t1",1910.41124896392,-2.1463305815397,0.568641898434963,2.35155938849528e-05,0.000237354884823417,"Q0EEE2",1.85e-99,"Patched domain-containing protein 3 (RND-type protein RNDEu-3)","","GO:0005783; GO:0005789; GO:0005886; GO:0016020; GO:0097225","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]",""
"973","Pocillopora_acuta_HIv2___TS.g23740.t1",77.6023914050985,6.95110054082561,4.22739889151935,2.4591584975292e-05,0.000247126631755588,NA,NA,NA,NA,NA,NA,NA
"974","Pocillopora_acuta_HIv2___TS.g26333.t1",364.815535134934,7.55020393876916,5.92178766526822,2.46033151084103e-05,0.000247126631755588,"Q9C0D5",1.07e-15,"Protein TANC1 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1)","dendritic spine maintenance [GO:0097062]; myoblast fusion [GO:0007520]; regulation of postsynapse organization [GO:0099175]; visual learning [GO:0008542]","GO:0007520; GO:0008542; GO:0014069; GO:0030425; GO:0043025; GO:0043679; GO:0097062; GO:0098978; GO:0099175","axon terminus [GO:0043679]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]",""
"975","Pocillopora_acuta_HIv2___RNAseq.g8520.t1",75.4558839837935,9.70205982217643,4.05507932622583,2.46288152352086e-05,0.000247205794336689,"Q96RW7",2.26e-24,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711","adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927]","calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]"
"976","Pocillopora_acuta_HIv2___RNAseq.g565.t1",2194.070175455,-4.48779685652995,2.39676264576722,2.48852463381487e-05,0.000249438810142053,"Q13467",4.39e-52,"Frizzled-5 (Fz-5) (hFz5) (FzE5)","angiogenesis [GO:0001525]; anterior/posterior axis specification, embryo [GO:0008595]; apoptotic process involved in morphogenesis [GO:0060561]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; canonical Wnt signaling pathway [GO:0060070]; cellular response to molecule of bacterial origin [GO:0071219]; chorionic trophoblast cell differentiation [GO:0060718]; embryonic axis specification [GO:0000578]; embryonic camera-type eye morphogenesis [GO:0048596]; eye development [GO:0001654]; glandular epithelial cell maturation [GO:0002071]; intestinal epithelial cell maturation [GO:0060574]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type II interferon production [GO:0032729]; post-embryonic camera-type eye development [GO:0031077]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of chorionic trophoblast cell proliferation [GO:1901382]; regulation of mitophagy [GO:1901524]; Spemann organizer formation [GO:0060061]; synapse assembly [GO:0007416]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell differentiation in thymus [GO:0033077]","GO:0000139; GO:0000578; GO:0001525; GO:0001540; GO:0001654; GO:0002071; GO:0002726; GO:0004930; GO:0005886; GO:0005923; GO:0007416; GO:0008285; GO:0008289; GO:0008595; GO:0009986; GO:0017147; GO:0019901; GO:0030182; GO:0030424; GO:0030425; GO:0030669; GO:0031077; GO:0031625; GO:0031901; GO:0032729; GO:0032731; GO:0032760; GO:0033077; GO:0035567; GO:0042813; GO:0043204; GO:0044877; GO:0045202; GO:0045944; GO:0048471; GO:0048596; GO:0060061; GO:0060070; GO:0060561; GO:0060574; GO:0060670; GO:0060715; GO:0060716; GO:0060718; GO:0071219; GO:1901382; GO:1901524; GO:1903955; GO:2000810","axon [GO:0030424]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]","amyloid-beta binding [GO:0001540]; G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
"977","Pocillopora_acuta_HIv2___RNAseq.g30961.t2",101.185827490747,2.68751326808216,0.737772654018487,2.49336015143026e-05,0.000249750424032461,NA,NA,NA,NA,NA,NA,NA
"978","Pocillopora_acuta_HIv2___RNAseq.g2420.t1",514.853497632878,3.12418112526827,0.985016598821246,2.52154793185077e-05,0.000252224545548337,NA,NA,NA,NA,NA,NA,NA
"979","Pocillopora_acuta_HIv2___RNAseq.g29828.t1",957.537009005633,4.37613079779188,3.12145570488064,2.54822382562152e-05,0.000254540810868713,"J7GQ11",1.39e-80,"L-tyrosine decarboxylase (TDC) (EC 4.1.1.25)","carboxylic acid metabolic process [GO:0019752]","GO:0004837; GO:0019752; GO:0030170; GO:0036468","","L-dopa decarboxylase activity [GO:0036468]; pyridoxal phosphate binding [GO:0030170]; tyrosine decarboxylase activity [GO:0004837]"
"980","Pocillopora_acuta_HIv2___RNAseq.g25494.t1",218.95501064894,1.00134038020033,1.64935886933372,2.56778403355926e-05,0.000256317655358186,"Q60803",7.2e-131,"TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3)","apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0001817; GO:0002224; GO:0005164; GO:0005737; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0045087; GO:0050688; GO:0061630; GO:0070534","CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739]","identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"
"981","Pocillopora_acuta_HIv2___TS.g26046.t2",86.2823929881733,6.55587773056082,3.17099666541097,2.61902031082839e-05,0.000260712386619559,"Q922Q5",2.24e-152,"Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (Solute carrier family 35 member B3)","3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; transmembrane transport [GO:0055085]","GO:0000139; GO:0005739; GO:0005789; GO:0015297; GO:0046963; GO:0046964; GO:0055085","endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]","3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; antiporter activity [GO:0015297]"
"982","Pocillopora_acuta_HIv2___RNAseq.g5401.t1",227.927050314172,6.23747744432596,3.6186770275193,2.64430777403824e-05,0.000263048608278467,"O00750",0,"Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.137) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta)","autophagosome organization [GO:1905037]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]","GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005942; GO:0009267; GO:0016303; GO:0030139; GO:0035005; GO:0035091; GO:0036092; GO:0043231; GO:0043491; GO:0048015; GO:1905037","cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]","1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]"
"983","Pocillopora_acuta_HIv2___RNAseq.g2419.t1",485.949602170474,3.06961574078968,0.974541128734456,2.70494458179857e-05,0.000268710978235814,NA,NA,NA,NA,NA,NA,NA
"984","Pocillopora_acuta_HIv2___RNAseq.g13082.t1",57.2334389873204,6.74846816270805,3.36657142428278,2.77155061785108e-05,0.000274573343401356,"Q5T280",8e-133,"Putative methyltransferase C9orf114 (EC 2.1.1.-) (Centromere protein 32) (CENP-32) (Kinetochore-associated protein) (SPOUT domain-containing methyltransferase 1)","cell division [GO:0051301]; maintenance of centrosome location [GO:0051661]; methylation [GO:0032259]; miRNA processing [GO:0035196]; post-transcriptional regulation of gene expression [GO:0010608]","GO:0000776; GO:0003723; GO:0005737; GO:0008168; GO:0010608; GO:0031616; GO:0032259; GO:0035196; GO:0035198; GO:0051301; GO:0051661; GO:0072686","cytoplasm [GO:0005737]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; spindle pole centrosome [GO:0031616]","methyltransferase activity [GO:0008168]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]"
"985","Pocillopora_acuta_HIv2___TS.g26127.t2b",3433.77439236694,-4.23708983761587,2.21713490204318,2.81919755213663e-05,0.000278720939125798,"Q27409",2.4e-33,"Adhesive plaque matrix protein (Foot protein 1) (MGFP-1) (MGFP1)","","GO:0005576","extracellular region [GO:0005576]",""
"986","Pocillopora_acuta_HIv2___RNAseq.g17226.t1",291.104969011209,7.16283015189745,7.19730290303964,2.8383091795133e-05,0.000280418742981423,"Q8WV93",9.39e-77,"AFG1-like ATPase (Lactation elevated protein 1) (EC 3.6.-.-) (Protein AFG1 homolog)","mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]","GO:0005524; GO:0005737; GO:0005739; GO:0006123; GO:0007005; GO:0016887; GO:0031966; GO:0035694","cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]"
"987","Pocillopora_acuta_HIv2___RNAseq.g29507.t1",985.759468535731,-1.50962187105428,3.15992378146789,2.87163015105326e-05,0.000283130596488305,NA,NA,NA,NA,NA,NA,NA
"988","Pocillopora_acuta_HIv2___RNAseq.g16162.t1",1084.49910428811,1.28024022843053,2.58408407049543,2.97436812472845e-05,0.000292263998342882,"P12256",5.72e-42,"Penicillin V acylase (PVA) (EC 3.5.1.11) (BspPVA) (Penicillin V amidase) (Penicillin amidohydrolase)","response to antibiotic [GO:0046677]","GO:0008953; GO:0046677","","penicillin amidase activity [GO:0008953]"
"989","Pocillopora_acuta_HIv2___RNAseq.g2001.t1",150.310448532961,1.04006738028948,1.93391417086309,3.16631739854407e-05,0.000308817362458135,NA,NA,NA,NA,NA,NA,NA
"990","Pocillopora_acuta_HIv2___TS.g17632.t1",37.6214674462873,9.06635570725076,3.59750546173784,3.16847669497775e-05,0.000308819723154705,"Q3T1H5",2.54e-07,"Tyrosyl-DNA phosphodiesterase 2 (Tyr-DNA phosphodiesterase 2) (EC 3.1.4.-) (5'-tyrosyl-DNA phosphodiesterase) (5'-Tyr-DNA phosphodiesterase) (TRAF and TNF receptor-associated protein)","double-strand break repair [GO:0006302]; neuron development [GO:0048666]","GO:0000287; GO:0003697; GO:0004518; GO:0005634; GO:0005730; GO:0005737; GO:0006302; GO:0016605; GO:0030145; GO:0036317; GO:0048666; GO:0070260","cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PML body [GO:0016605]","5'-tyrosyl-DNA phosphodiesterase activity [GO:0070260]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA binding [GO:0003697]; tyrosyl-RNA phosphodiesterase activity [GO:0036317]"
"991","Pocillopora_acuta_HIv2___RNAseq.g13323.t1",686.059182187685,4.31528252228083,2.66953699101502,3.28612077589396e-05,0.000318996314782082,"Q5RDU7",1.11e-66,"Protein yippee-like 5","cell population proliferation [GO:0008283]","GO:0000151; GO:0005634; GO:0005737; GO:0005813; GO:0008283; GO:0030496; GO:0046872; GO:0097431","centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]","metal ion binding [GO:0046872]"
"992","Pocillopora_acuta_HIv2___RNAseq.g12272.t1",69.0793080890973,-4.51190063646875,2.72567306681491,3.30629223825591e-05,0.000320524201971404,"P18052",2.13e-67,"Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28)","insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of focal adhesion assembly [GO:0051893]","GO:0004725; GO:0005925; GO:0007229; GO:0008286; GO:0016020; GO:0043235; GO:0044877; GO:0048714; GO:0050804; GO:0051893; GO:0097060; GO:0098685","focal adhesion [GO:0005925]; membrane [GO:0016020]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]","protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]"
"993","Pocillopora_acuta_HIv2___RNAseq.g25338.t1",89.5428391617885,4.29820419772207,3.11458394800823,3.41351296878221e-05,0.000329580082949923,NA,NA,NA,NA,NA,NA,NA
"994","Pocillopora_acuta_HIv2___TS.g29372.t2",2289.76798425546,-4.2890046669705,2.31361061607861,3.4140372217295e-05,0.000329580082949923,"A0A0B5RUB0",2.18e-105,"Trimethylamine transporter (TMA transporter) (TMA-specific transporter)","","GO:0005886; GO:0022857","plasma membrane [GO:0005886]","transmembrane transporter activity [GO:0022857]"
"995","Pocillopora_acuta_HIv2___RNAseq.g14126.t1",93.2131367121753,6.51545619976401,4.75126093011897,3.44996224704485e-05,0.000332668359608378,"Q8K2X3",7.77e-21,"CST complex subunit STN1 (Alpha-accessory factor of 44 kDa) (AAF-44) (AAF44) (Oligonucleotide/oligosaccharide-binding fold-containing protein 1) (Suppressor of cdc thirteen homolog)","negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA replication [GO:0045740]; telomere capping [GO:0016233]; telomere maintenance via telomere lengthening [GO:0010833]","GO:0000781; GO:0001650; GO:0003697; GO:0005634; GO:0005654; GO:0010833; GO:0016233; GO:0032211; GO:0042162; GO:0043047; GO:0045111; GO:0045740; GO:1990879","chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]; fibrillar center [GO:0001650]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; telomeric DNA binding [GO:0042162]"
"996","Pocillopora_acuta_HIv2___RNAseq.g14257.t1",609.690712100481,-4.13351511110842,1.71635785105963,3.45945325320484e-05,0.000333361304825815,"P61917",3.99e-30,"NPC intracellular cholesterol transporter 2 (EPI-1) (Epididymal secretory protein E1) (Niemann Pick type C2 protein homolog)","cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]","GO:0005615; GO:0005764; GO:0005783; GO:0008203; GO:0015485; GO:0030301; GO:0032367; GO:0033344","endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]","cholesterol binding [GO:0015485]"
"997","Pocillopora_acuta_HIv2___RNAseq.g8459.t1",49.7993375944743,-1.2569222039259,2.52679373568229,3.46981942727551e-05,0.000334137604501418,NA,NA,NA,NA,NA,NA,NA
"998","Pocillopora_acuta_HIv2___RNAseq.g2094.t1b",284.077097040679,4.19942648014092,1.47427503380171,3.51472201897966e-05,0.000337562677838791,"A7SDW5",0,"Eukaryotic translation initiation factor 3 subunit L (eIF3l)","formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]","GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290","eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]","translation initiation factor activity [GO:0003743]"
"999","Pocillopora_acuta_HIv2___RNAseq.g12481.t1",34.1116058001867,9.08364633683556,3.60389489914197,3.53786945829673e-05,0.000338885720826516,"A0A2K5X3B6",1.03e-51,"Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1)","3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; flavonoid metabolic process [GO:0009812]","GO:0004062; GO:0005829; GO:0008146; GO:0009812; GO:0050427","cytosol [GO:0005829]","aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]"
"1000","Pocillopora_acuta_HIv2___RNAseq.g12955.t1",549.14848724659,-2.52146810275107,0.733957157196211,3.60515565460653e-05,0.00034396419121523,NA,NA,NA,NA,NA,NA,NA
"1001","Pocillopora_acuta_HIv2___RNAseq.g7833.t1",316.008295885859,1.38258874422103,2.69599490069489,3.63598632039691e-05,0.000346677034530132,"Q86U44",0,"N6-adenosine-methyltransferase catalytic subunit (EC 2.1.1.348) (Methyltransferase-like protein 3) (hMETTL3) (N6-adenosine-methyltransferase 70 kDa subunit) (MT-A70)","cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA destabilization [GO:0061157]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oogenesis [GO:0048477]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]","GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006397; GO:0006974; GO:0007283; GO:0007623; GO:0008173; GO:0009048; GO:0016556; GO:0016604; GO:0016607; GO:0019827; GO:0021861; GO:0031053; GO:0034644; GO:0036396; GO:0042063; GO:0045087; GO:0045580; GO:0045727; GO:0045746; GO:0046982; GO:0048477; GO:0051445; GO:0060339; GO:0061157; GO:0098508; GO:1902036; GO:1903679; GO:1904047; GO:1990204","cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxidoreductase complex [GO:1990204]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]","mRNA binding [GO:0003729]; mRNA m(6)A methyltransferase activity [GO:0001734]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047]"
"1002","Pocillopora_acuta_HIv2___TS.g186.t2",1622.80559521189,-2.27375217533016,0.638031868772373,3.64555750024163e-05,0.000347360630326054,"Q6P2X9",7.06e-28,"Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)","creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449]","GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0046449","basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]","creatine transmembrane transporter activity [GO:0005308]; uniporter activity [GO:0015292]"
"1003","Pocillopora_acuta_HIv2___RNAseq.g25458.t1",285.361323981426,7.34067173291136,5.66690626318727,3.69900379971181e-05,0.000351757994470951,"A7MCS3",1.35e-17,"UPF0764 protein C16orf89 homolog","","GO:0005576; GO:0005829; GO:0016020","cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]",""
"1004","Pocillopora_acuta_HIv2___RNAseq.g27673.t1",3815.81336061895,4.30894896510604,2.26971174477633,3.78142623312132e-05,0.000358652780563061,"P63016",2.54e-98,"Paired box protein Pax-6 (Oculorhombin)","anterior/posterior pattern specification [GO:0009952]; astrocyte differentiation [GO:0048708]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; blood vessel development [GO:0001568]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cell population proliferation [GO:0008283]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; cerebral cortex regionalization [GO:0021796]; chromatin remodeling [GO:0006338]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; cornea development in camera-type eye [GO:0061303]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; embryonic camera-type eye morphogenesis [GO:0048596]; epithelial cell development [GO:0002064]; establishment of mitotic spindle orientation [GO:0000132]; eye photoreceptor cell development [GO:0042462]; forebrain development [GO:0030900]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain-midbrain boundary formation [GO:0021905]; gene expression [GO:0010467]; glandular epithelial cell differentiation [GO:0002067]; glucose homeostasis [GO:0042593]; habenula development [GO:0021986]; hindbrain development [GO:0030902]; insulin metabolic process [GO:1901142]; interkinetic nuclear migration [GO:0022027]; iris morphogenesis [GO:0061072]; keratinocyte differentiation [GO:0030216]; lacrimal gland development [GO:0032808]; learned vocalization behavior or vocal learning [GO:0098598]; lens development in camera-type eye [GO:0002088]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neural precursor cell proliferation [GO:0061351]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; olfactory bulb mitral cell layer development [GO:0061034]; oligodendrocyte cell fate specification [GO:0021778]; pallium development [GO:0021543]; pancreatic A cell development [GO:0003322]; pancreatic A cell differentiation [GO:0003310]; pituitary gland development [GO:0021983]; positive regulation of cell fate specification [GO:0042660]; positive regulation of core promoter binding [GO:1904798]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamatergic neuron differentiation [GO:0120008]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron migration [GO:2001224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to organelle [GO:0033365]; regionalization [GO:0003002]; regulation of asymmetric cell division [GO:0009786]; regulation of cell migration [GO:0030334]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of neuron projection development [GO:0010975]; regulation of timing of cell differentiation [GO:0048505]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ethanol [GO:0045471]; response to wounding [GO:0009611]; retina development in camera-type eye [GO:0060041]; rhombomere morphogenesis [GO:0021593]; salivary gland morphogenesis [GO:0007435]; sensory neuron migration [GO:1904937]; signal transduction involved in regulation of gene expression [GO:0023019]; smoothened signaling pathway [GO:0007224]; spinal cord development [GO:0021510]; telencephalon regionalization [GO:0021978]; transcription by RNA polymerase II [GO:0006366]; type B pancreatic cell differentiation [GO:0003309]; ventral spinal cord development [GO:0021517]","GO:0000122; GO:0000132; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0000981; GO:0001221; GO:0001227; GO:0001228; GO:0001568; GO:0001709; GO:0001755; GO:0001764; GO:0001933; GO:0002052; GO:0002064; GO:0002067; GO:0002088; GO:0003002; GO:0003309; GO:0003310; GO:0003322; GO:0003677; GO:0003680; GO:0003682; GO:0003690; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006357; GO:0006366; GO:0007224; GO:0007399; GO:0007405; GO:0007406; GO:0007409; GO:0007411; GO:0007420; GO:0007435; GO:0008283; GO:0009611; GO:0009786; GO:0009950; GO:0009952; GO:0009953; GO:0010467; GO:0010468; GO:0010628; GO:0010975; GO:0019901; GO:0021510; GO:0021517; GO:0021543; GO:0021549; GO:0021593; GO:0021772; GO:0021778; GO:0021796; GO:0021798; GO:0021902; GO:0021905; GO:0021978; GO:0021983; GO:0021986; GO:0021987; GO:0022027; GO:0023019; GO:0030154; GO:0030182; GO:0030216; GO:0030334; GO:0030858; GO:0030900; GO:0030902; GO:0031490; GO:0031625; GO:0032808; GO:0032869; GO:0033365; GO:0035035; GO:0042462; GO:0042593; GO:0042660; GO:0043010; GO:0043565; GO:0044344; GO:0045165; GO:0045471; GO:0045664; GO:0045665; GO:0045893; GO:0045944; GO:0048505; GO:0048596; GO:0048708; GO:0050680; GO:0050767; GO:0060041; GO:0061034; GO:0061072; GO:0061303; GO:0061351; GO:0070410; GO:0070412; GO:0071333; GO:0071380; GO:0071466; GO:0071837; GO:0098598; GO:0120008; GO:1901142; GO:1902895; GO:1904798; GO:1904937; GO:1990830; GO:1990837; GO:2000178; GO:2001224","chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; histone acetyltransferase binding [GO:0035035]; HMG box domain binding [GO:0071837]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein kinase binding [GO:0019901]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; ubiquitin protein ligase binding [GO:0031625]"
"1005","Pocillopora_acuta_HIv2___RNAseq.g10529.t1",2425.59091314201,-4.20083117196157,2.06017022732792,3.7909468013298e-05,0.000359320147669949,NA,NA,NA,NA,NA,NA,NA
"1006","Pocillopora_acuta_HIv2___RNAseq.g17519.t1",1719.95496711286,-1.00665814169458,1.78491532119967,3.79878465002876e-05,0.00035980862417931,"Q9VBW3",4.3e-76,"Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303","apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]","ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
"1007","Pocillopora_acuta_HIv2___RNAseq.g6279.t1",62.0898809323004,5.05322839493865,2.42115067668454,3.83597571626234e-05,0.000362874772792796,"Q5F4A1",3.47e-68,"G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase)","apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]","GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006915; GO:0016567; GO:0046872","cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]","metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
"1008","Pocillopora_acuta_HIv2___RNAseq.g31061.t1",140.156502876075,1.06936578613373,1.98739057670518,3.86400169252071e-05,0.000365287061964834,NA,NA,NA,NA,NA,NA,NA
"1009","Pocillopora_acuta_HIv2___RNAseq.g20555.t1",53.4795269263418,6.57711553412499,3.71495193169518,3.94283009925399e-05,0.000372252575428261,NA,NA,NA,NA,NA,NA,NA
"1010","Pocillopora_acuta_HIv2___RNAseq.g7618.t1",326.496348298609,3.65119245755926,3.84861720992188,4.0410888345534e-05,0.000381280553835489,NA,NA,NA,NA,NA,NA,NA
"1011","Pocillopora_acuta_HIv2___TS.g19790.t1",184.727420450665,2.51765500279562,5.55271503621671,4.09767335314618e-05,0.000385613190500367,"O95833",4.17e-29,"Chloride intracellular channel protein 3 (Glutaredoxin-like oxidoreductase CLIC3) (EC 1.8.-.-)","chloride transport [GO:0006821]; positive regulation of sprouting angiogenesis [GO:1903672]; signal transduction [GO:0007165]","GO:0005254; GO:0005634; GO:0005737; GO:0005886; GO:0006821; GO:0007165; GO:0016020; GO:0016604; GO:0019153; GO:0031012; GO:0034707; GO:0070062; GO:1903672","chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]","chloride channel activity [GO:0005254]; protein-disulfide reductase (glutathione) activity [GO:0019153]"
"1012","Pocillopora_acuta_HIv2___RNAseq.g434.t1",4373.17759770191,-2.97383673782484,1.04073474803859,4.13409817569587e-05,0.000388536464919218,"P58421",0,"Frizzled-5 (Fz-5) (Xfz5)","camera-type eye development [GO:0043010]; neuron development [GO:0048666]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; Wnt signaling pathway [GO:0016055]","GO:0000139; GO:0004930; GO:0005886; GO:0016055; GO:0042127; GO:0043010; GO:0045595; GO:0048666","Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]","G protein-coupled receptor activity [GO:0004930]"
"1013","Pocillopora_acuta_HIv2___RNAseq.g22527.t1",411.940995574875,-3.99198397752604,2.20497969954465,4.13410964816563e-05,0.000388536464919218,"Q9DER7",0,"Tolloid-like protein 1 (EC 3.4.24.-) (Chicken tolloid-like protein 1) (Metalloprotease colloid)","cell differentiation [GO:0030154]; dorsal/ventral pattern formation [GO:0009953]; protein processing [GO:0016485]","GO:0004222; GO:0005509; GO:0005615; GO:0008270; GO:0009953; GO:0016485; GO:0030154","extracellular space [GO:0005615]","calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
"1014","Pocillopora_acuta_HIv2___RNAseq.g887.t1",291.753066340651,3.93352312899596,1.85175924173788,4.21393809462064e-05,0.000394756480573788,NA,NA,NA,NA,NA,NA,NA
"1015","Pocillopora_acuta_HIv2___RNAseq.g1273.t1",2144.39075430026,-4.17608378366951,2.72866473172044,4.31056836664965e-05,0.000402245553904649,"Q8N2E2",1.77e-45,"von Willebrand factor D and EGF domain-containing protein","","GO:0005102; GO:0005576; GO:0009986","cell surface [GO:0009986]; extracellular region [GO:0005576]","signaling receptor binding [GO:0005102]"
"1016","Pocillopora_acuta_HIv2___RNAseq.g12378.t1",643.772313607207,-4.03802309969944,1.47966282259734,4.5071400870674e-05,0.000418967057964928,"P81546",8.83e-17,"Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1) (TIMP-1)","cellular response to UV-A [GO:0071492]; negative regulation of catalytic activity [GO:0043086]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; positive regulation of cell population proliferation [GO:0008284]; regulation of integrin-mediated signaling pathway [GO:2001044]; response to cytokine [GO:0034097]; response to hormone [GO:0009725]","GO:0002020; GO:0005125; GO:0005615; GO:0008083; GO:0008191; GO:0008284; GO:0009725; GO:0010951; GO:0031012; GO:0034097; GO:0043086; GO:0046872; GO:0051045; GO:0071492; GO:2001044","extracellular matrix [GO:0031012]; extracellular space [GO:0005615]","cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; metal ion binding [GO:0046872]; metalloendopeptidase inhibitor activity [GO:0008191]; protease binding [GO:0002020]"
"1017","Pocillopora_acuta_HIv2___RNAseq.g7079.t1",72.9557720249617,-6.53333970269857,3.16557369549295,4.52535467969248e-05,0.000420051888342774,NA,NA,NA,NA,NA,NA,NA
"1018","Pocillopora_acuta_HIv2___RNAseq.g25648.t1",191.567774494503,3.92689615105542,2.05409515282208,4.52752277327423e-05,0.000420051888342774,NA,NA,NA,NA,NA,NA,NA
"1019","Pocillopora_acuta_HIv2___RNAseq.g7895.t1",734.801675679575,-1.05034082197959,1.88517096879624,4.57500079296937e-05,0.000423641558703643,"Q63722",8.99e-22,"Protein jagged-1 (Jagged1) (CD antigen CD339)","animal organ morphogenesis [GO:0009887]; animal organ regeneration [GO:0031100]; aorta morphogenesis [GO:0035909]; blood vessel remodeling [GO:0001974]; camera-type eye development [GO:0043010]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; podocyte development [GO:0072015]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of gene expression [GO:0010628]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456]; wound healing [GO:0042060]","GO:0001709; GO:0001953; GO:0001974; GO:0002011; GO:0002085; GO:0002456; GO:0003184; GO:0003215; GO:0005112; GO:0005509; GO:0005543; GO:0005886; GO:0005912; GO:0007219; GO:0009887; GO:0010628; GO:0016020; GO:0016324; GO:0022408; GO:0030182; GO:0030336; GO:0031100; GO:0032495; GO:0035909; GO:0042060; GO:0042127; GO:0042491; GO:0043010; GO:0045177; GO:0045596; GO:0045599; GO:0045602; GO:0045639; GO:0045665; GO:0045669; GO:0045747; GO:0045944; GO:0048018; GO:0048839; GO:0050678; GO:0060090; GO:0060411; GO:0061073; GO:0061101; GO:0061156; GO:0061309; GO:0061444; GO:0062043; GO:0072006; GO:0072015; GO:0072017; GO:0072070; GO:0097150; GO:2000737","adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; membrane [GO:0016020]; plasma membrane [GO:0005886]","calcium ion binding [GO:0005509]; molecular adaptor activity [GO:0060090]; Notch binding [GO:0005112]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018]"
"1020","Pocillopora_acuta_HIv2___RNAseq.g17907.t1b",417.116643396374,1.0169461351291,1.72469471719495,4.62190380146867e-05,0.00042743744619209,"P35668",2.12e-138,"Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase)","","GO:0000287; GO:0004363; GO:0005524; GO:0042803; GO:0043295","","ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]"
"1021","Pocillopora_acuta_HIv2___TS.g9644.t2",110.413699532373,5.12471622736499,2.69686087266319,4.64873256973753e-05,0.00042936952674766,"Q68EL3",2.24e-29,"BET1-like protein","protein transport [GO:0015031]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0000139; GO:0005484; GO:0005829; GO:0015031; GO:0031201; GO:0042147; GO:2000156","cytosol [GO:0005829]; Golgi membrane [GO:0000139]; SNARE complex [GO:0031201]","SNAP receptor activity [GO:0005484]"
"1022","Pocillopora_acuta_HIv2___TS.g30914.t1",1235.88291131494,-3.88313598397961,3.60643489101404,4.7133339726817e-05,0.000434781011357577,"Q64487",0,"Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling [GO:0099537]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]","GO:0004725; GO:0005102; GO:0007157; GO:0030182; GO:0042734; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099151; GO:0099537; GO:0099545; GO:0099560","glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]","cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]"
"1023","Pocillopora_acuta_HIv2___RNAseq.g8058.t1",175.466270740882,4.03564321397722,3.57714221043838,4.94889881238903e-05,0.000455059583104862,"Q8K3X3",0,"GDP-mannose 4,6 dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase) (GMD)","'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219]","GO:0005737; GO:0007219; GO:0008446; GO:0019673; GO:0042351; GO:0042802; GO:0070401","cytoplasm [GO:0005737]","GDP-mannose 4,6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]"
"1024","Pocillopora_acuta_HIv2___RNAseq.g3776.t1",304.38140369965,4.17402371602374,2.6375142414047,4.95809212195425e-05,0.00045561527606065,"Q95YM9",4.55e-06,"Fibroblast growth factor receptor (HrFGFR) (EC 2.7.10.1)","positive regulation of cell population proliferation [GO:0008284]","GO:0005007; GO:0005524; GO:0008284; GO:0016020; GO:0017134; GO:0043235","membrane [GO:0016020]; receptor complex [GO:0043235]","ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]"
"1025","Pocillopora_acuta_HIv2___RNAseq.g17469.t1",2827.33405261627,-2.87431857400892,0.943643491083372,4.99848425061449e-05,0.000458453241603602,NA,NA,NA,NA,NA,NA,NA
"1026","Pocillopora_acuta_HIv2___RNAseq.g775.t1",686.76072988379,-4.03907497184427,3.21951309524296,5.08390962131694e-05,0.000465103931636383,"Q924H0",2.76e-32,"Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor)","cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of MAPK cascade [GO:0043408]","GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0042277; GO:0043408","actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]","neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628]; peptide binding [GO:0042277]"
"1027","Pocillopora_acuta_HIv2___RNAseq.g17719.t1",60.6723974892898,1.05923068698949,1.98481497808011,5.08703249449765e-05,0.000465103931636383,"Q09575",9.25e-24,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0005737; GO:0008270; GO:0015074; GO:0019899; GO:0042575","cytoplasm [GO:0005737]; DNA polymerase complex [GO:0042575]","enzyme binding [GO:0019899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
"1028","Pocillopora_acuta_HIv2___RNAseq.g11497.t1",636.622673074196,-3.44857552069335,1.1611458678851,5.09055261684547e-05,0.000465127940935268,"B0S6T2",9.93e-176,"Solute carrier family 15 member 2 (Peptide transporter 2) (PEPT2)","dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; peptide transport [GO:0015833]; peptidoglycan transport [GO:0015835]; protein transport [GO:0015031]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; response to yeast [GO:0001878]; tripeptide import across plasma membrane [GO:0140207]","GO:0001878; GO:0005886; GO:0015031; GO:0015333; GO:0015833; GO:0015835; GO:0016324; GO:0030670; GO:0042937; GO:0045087; GO:0070424; GO:0071916; GO:0140206; GO:0140207","apical plasma membrane [GO:0016324]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]","dipeptide transmembrane transporter activity [GO:0071916]; peptide:proton symporter activity [GO:0015333]; tripeptide transmembrane transporter activity [GO:0042937]"
"1029","Pocillopora_acuta_HIv2___RNAseq.g9056.t1",1100.93738901822,-3.9402021661159,2.48655848113069,5.14931871945189e-05,0.000470154314887518,"Q80T79",4.49e-83,"CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)","regulation of dendrite development [GO:0050773]","GO:0005886; GO:0050773","plasma membrane [GO:0005886]",""
"1030","Pocillopora_acuta_HIv2___RNAseq.g14094.t1",86.2705700482992,6.30011005288685,4.17464790077014,5.1777666821832e-05,0.00047190433075676,"F1QMV3",2.74e-70,"Trafficking protein particle complex subunit 6b (TRAPP complex subunit 6B)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nervous system development [GO:0007399]","GO:0005783; GO:0005801; GO:0005802; GO:0006888; GO:0007399; GO:0030008","cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]",""
"1031","Pocillopora_acuta_HIv2___RNAseq.g727.t1",31.1027796244483,8.8933989840646,3.55245232952572,5.22878498403488e-05,0.000476254068067258,NA,NA,NA,NA,NA,NA,NA
"1032","Pocillopora_acuta_HIv2___TS.g19792.t3c",397.742553976533,1.29952694933096,2.20006393459545,5.26087698625929e-05,0.000478875548956919,"Q55E58",5.83e-18,"Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)","cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856]","GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310","actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]","ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]"
"1033","Pocillopora_acuta_HIv2___RNAseq.g23053.t1",1003.7088565745,1.19848801240083,2.18577368634164,5.29405402251285e-05,0.000481289738413739,"Q924A2",2.47e-40,"Protein capicua homolog","brain development [GO:0007420]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; social behavior [GO:0035176]; transcription by RNA polymerase II [GO:0006366]","GO:0000122; GO:0000977; GO:0000981; GO:0003682; GO:0005634; GO:0006357; GO:0006366; GO:0007420; GO:0007612; GO:0007613; GO:0032991; GO:0035176; GO:0045892; GO:0048286","nucleus [GO:0005634]; protein-containing complex [GO:0032991]","chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"
"1034","Pocillopora_acuta_HIv2___TS.g12436.t1a",71.7747898860387,6.18162913515703,4.43238244801897,5.33964993083146e-05,0.000484825465157227,NA,NA,NA,NA,NA,NA,NA
"1035","Pocillopora_acuta_HIv2___RNAseq.g14097.t1",194.514542690077,1.01888872374894,1.70565136560977,5.42234343012475e-05,0.000491716460020843,"F1QMV3",2.74e-70,"Trafficking protein particle complex subunit 6b (TRAPP complex subunit 6B)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nervous system development [GO:0007399]","GO:0005783; GO:0005801; GO:0005802; GO:0006888; GO:0007399; GO:0030008","cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]",""
"1036","Pocillopora_acuta_HIv2___TS.g21741.t1",6778.30722367671,3.88620420374524,2.59030506332221,5.46380052873015e-05,0.000494477010400719,NA,NA,NA,NA,NA,NA,NA
"1037","Pocillopora_acuta_HIv2___RNAseq.22092_t",343.233674107457,-1.91783781550378,3.76492077950457,5.4818492301927e-05,0.000495249639384804,"Q9JME2",2.7e-41,"Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)","apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0006915; GO:0007179; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216","Golgi membrane [GO:0000139]","chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]"
"1038","Pocillopora_acuta_HIv2___RNAseq.g30304.t2",2520.38767280819,-4.21101604684746,2.41415970886484,5.56782055715237e-05,0.000501450538845902,"D9IQ16",4.06e-39,"Galaxin","","GO:0005576","extracellular region [GO:0005576]",""
"1039","Pocillopora_acuta_HIv2___RNAseq.g8859.t1b",69.873321900024,6.3629116621553,4.09997848021729,5.60373363163942e-05,0.000504370897623103,NA,NA,NA,NA,NA,NA,NA
"1040","Pocillopora_acuta_HIv2___RNAseq.g1838.t1",74.0163059089429,6.18195799146719,4.48389417617659,5.64704691905931e-05,0.000507637580094928,"Q8WWC4",3.3e-13,"m-AAA protease-interacting protein 1, mitochondrial (Matrix AAA peptidase-interacting protein 1)","calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein insertion into mitochondrial membrane [GO:0051204]","GO:0005743; GO:0005759; GO:0032979; GO:0036444; GO:0043022; GO:0051204; GO:0051560","mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]","ribosome binding [GO:0043022]"
"1041","Pocillopora_acuta_HIv2___RNAseq.g12372.t1",1892.12047322306,-3.93355145359104,2.0026265155837,5.68693361328361e-05,0.000510271760437556,"H9JW44",1.09e-95,"Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004099; GO:0005615; GO:0006032; GO:0046872","extracellular space [GO:0005615]","chitin deacetylase activity [GO:0004099]; metal ion binding [GO:0046872]"
"1042","Pocillopora_acuta_HIv2___RNAseq.g1942.t1",243.380270176727,1.47109011549676,3.15699593776489,5.71974644373652e-05,0.000512580003483303,NA,NA,NA,NA,NA,NA,NA
"1043","Pocillopora_acuta_HIv2___RNAseq.g19452.t1",173.485215914209,3.93740067429315,3.55432465365133,5.78379536898252e-05,0.000517678318174277,"Q8BX94",3.58e-45,"Oxysterol-binding protein-related protein 2 (ORP-2) (OSBP-related protein 2)","intracellular cholesterol transport [GO:0032367]; plasma membrane organization [GO:0007009]; protein homotetramerization [GO:0051289]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]","GO:0005546; GO:0005811; GO:0005829; GO:0005886; GO:0007009; GO:0008526; GO:0009898; GO:0015485; GO:0032367; GO:0051289; GO:0097038; GO:0098831; GO:0098978; GO:0099509; GO:0120020","cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; presynaptic active zone cytoplasmic component [GO:0098831]","cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidylinositol transfer activity [GO:0008526]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"
"1044","Pocillopora_acuta_HIv2___TS.g5112.t1",7861.55930595759,2.95855919452301,1.03114627042791,5.79976477586865e-05,0.00051878662781796,NA,NA,NA,NA,NA,NA,NA
"1045","Pocillopora_acuta_HIv2___RNAseq.g1239.t1",1155.76204457354,2.39469587496285,3.20374053880329,5.86094366340741e-05,0.00052328820461435,"Q552Z6",1.81e-12,"GTP-binding protein A","","GO:0005525","","GTP binding [GO:0005525]"
"1046","Pocillopora_acuta_HIv2___RNAseq.g27066.t1",7657.02166339574,-2.35431591208334,0.708396801999648,6.11040889706776e-05,0.000544888744064045,NA,NA,NA,NA,NA,NA,NA
"1047","Pocillopora_acuta_HIv2___RNAseq.g15163.t1",1240.28670083128,-3.22847070176645,3.69043377530092,6.17091894814447e-05,0.000549945604842647,"Q9W740",2.52e-25,"Noggin-2","cartilage development [GO:0051216]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell differentiation [GO:0045596]; osteoblast differentiation [GO:0001649]","GO:0001649; GO:0005615; GO:0009953; GO:0030514; GO:0045596; GO:0051216","extracellular space [GO:0005615]",""
"1048","Pocillopora_acuta_HIv2___RNAseq.g24675.t1",35.5676223044538,8.7269337391477,3.61394042782908,6.28384744203496e-05,0.000558976441584217,"Q9GYF0",1.77e-06,"Cholesterol uptake protein 1","cholesterol import [GO:0070508]; RNA transport [GO:0050658]","GO:0003725; GO:0005764; GO:0005768; GO:0005794; GO:0005886; GO:0015485; GO:0031410; GO:0050658; GO:0051033; GO:0070508","cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; plasma membrane [GO:0005886]","cholesterol binding [GO:0015485]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]"
"1049","Pocillopora_acuta_HIv2___RNAseq.g28652.t1",962.258919711437,-4.02847721343123,2.5289222931142,6.30013859700622e-05,0.000559737129404778,NA,NA,NA,NA,NA,NA,NA
"1050","Pocillopora_acuta_HIv2___TS.g15585.t1",3589.91101719033,-3.714840526302,2.50487233417397,6.34668419747273e-05,0.00056283531718115,"Q5VST9",4.7e-15,"Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)","protein localization to M-band [GO:0036309]; regulation of small GTPase mediated signal transduction [GO:0051056]; sarcomere organization [GO:0045214]","GO:0004674; GO:0005085; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005829; GO:0005886; GO:0008307; GO:0010314; GO:0016604; GO:0030016; GO:0030018; GO:0030506; GO:0031430; GO:0031432; GO:0032266; GO:0036309; GO:0042383; GO:0043325; GO:0045214; GO:0046872; GO:0051056; GO:0070273; GO:0106310","cytosol [GO:0005829]; M band [GO:0031430]; myofibril [GO:0030016]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]","ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]"
"1051","Pocillopora_acuta_HIv2___RNAseq.g28109.t1",2232.43567180149,-3.74921726470494,2.57122583869988,6.42004949507498e-05,0.00056899262191645,"P37889",1.21e-71,"Fibulin-2 (FIBL-2)","positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005576; GO:0010811; GO:0050840; GO:0062023","collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]","calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]"
"1052","Pocillopora_acuta_HIv2___RNAseq.g26727.t1",2428.7531099245,2.53209167576414,0.787103741872117,6.44762183242405e-05,0.000570580180262004,NA,NA,NA,NA,NA,NA,NA
"1053","Pocillopora_acuta_HIv2___TS.g305.t1",340.354574462484,1.16676219955825,1.8750224783613,6.59724578270288e-05,0.000582911197318353,"O75899",4.3e-126,"Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]","GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712","cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]","G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888]"
"1054","Pocillopora_acuta_HIv2___RNAseq.g17949.t2",747.49311440671,3.2494733252384,1.40416451852679,6.94510665300046e-05,0.000610291753517611,NA,NA,NA,NA,NA,NA,NA
"1055","Pocillopora_acuta_HIv2___RNAseq.g8690.t1",1186.97644649534,3.83082763779198,3.15722023099213,6.99239941249187e-05,0.00061379736845498,"Q6VFT5",3.36e-59,"Forkhead box protein L2","anatomical structure morphogenesis [GO:0009653]; apoptotic DNA fragmentation [GO:0006309]; cell differentiation [GO:0030154]; extraocular skeletal muscle development [GO:0002074]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA-templated transcription [GO:0045893]","GO:0000978; GO:0000981; GO:0001541; GO:0002074; GO:0003677; GO:0003700; GO:0005634; GO:0006309; GO:0009653; GO:0030154; GO:0043028; GO:0043065; GO:0043280; GO:0045893","nucleus [GO:0005634]","cysteine-type endopeptidase regulator activity involved in apoptotic process [GO:0043028]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"1056","Pocillopora_acuta_HIv2___TS.g4835.t2",2307.74808167478,-2.53455485052296,0.804721763268065,7.00909556914682e-05,0.000614794168054213,"O94854",9.82e-08,"Microtubule-actin cross-linking factor 1, isoforms 6/7 (Uncharacterized protein KIAA0754)","intermediate filament cytoskeleton organization [GO:0045104]","GO:0005509; GO:0005737; GO:0005856; GO:0008017; GO:0045104","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]","calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]"
"1057","Pocillopora_acuta_HIv2___RNAseq.g11142.t1",147.738604790583,6.17690296611388,8.50840756716879,7.03642358533668e-05,0.000616817155989756,"Q8N945",1.73e-44,"PRELI domain-containing protein 2","phospholipid transport [GO:0015914]","GO:0005758; GO:0015914; GO:1990050","mitochondrial intermembrane space [GO:0005758]","phosphatidic acid transfer activity [GO:1990050]"
"1058","Pocillopora_acuta_HIv2___RNAseq.g24012.t1",616.503792806688,1.47451589950948,2.6440475436213,7.20847234188617e-05,0.000629447411031324,NA,NA,NA,NA,NA,NA,NA
"1059","Pocillopora_acuta_HIv2___TS.g3218.t1",667.006638835375,-3.95661182846982,2.50041882878787,7.25324158706219e-05,0.000632755647257343,NA,NA,NA,NA,NA,NA,NA
"1060","Pocillopora_acuta_HIv2___RNAseq.g26675.t1",11803.2317031444,-2.44097002963044,0.760514904614641,7.45292045711982e-05,0.0006478307781958,NA,NA,NA,NA,NA,NA,NA
"1061","Pocillopora_acuta_HIv2___RNAseq.g24500.t1",60.1286021470813,6.39657961875126,2.73382710357703,7.58297985051641e-05,0.000657161297530674,NA,NA,NA,NA,NA,NA,NA
"1062","Pocillopora_acuta_HIv2___RNAseq.g20345.t1",226.895174944419,1.41312872739947,2.76859410810112,7.59449886633639e-05,0.00065776545869874,NA,NA,NA,NA,NA,NA,NA
"1063","Pocillopora_acuta_HIv2___RNAseq.g4959.t1",1090.4585784368,2.87687976107993,1.01908847153795,7.81765197087522e-05,0.000674668962450711,"Q9QXE4",6.14e-15,"Tumor protein p53-inducible nuclear protein 1 (Stress-induced protein) (Thymus-expressed acidic protein) (TEAP) (p53-dependent damage-inducible nuclear protein 1) (p53DINP1)","apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; autophagosome assembly [GO:0000045]; cellular response to ethanol [GO:0071361]; cellular response to hydroperoxide [GO:0071447]; cellular response to methyl methanesulfonate [GO:0072703]; cellular response to UV [GO:0034644]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of myofibroblast differentiation [GO:1904761]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; response to heat [GO:0009408]","GO:0000045; GO:0005634; GO:0005776; GO:0005829; GO:0006915; GO:0008285; GO:0009408; GO:0010508; GO:0010628; GO:0010629; GO:0016209; GO:0016605; GO:0030336; GO:0031410; GO:0034644; GO:0043065; GO:0045893; GO:0048102; GO:0048147; GO:0071361; GO:0071447; GO:0072703; GO:1904761","autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]","antioxidant activity [GO:0016209]"
"1064","Pocillopora_acuta_HIv2___RNAseq.g758.t1",3358.4593161405,-2.50895969367646,0.807772484639116,8.04863295648123e-05,0.000691303011179006,NA,NA,NA,NA,NA,NA,NA
"1065","Pocillopora_acuta_HIv2___TS.g800.t1",356.420590991389,3.26186959376207,1.57172145938175,8.05584117022927e-05,0.000691511493686624,"O95185",5.64e-06,"Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C)","anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]; ectopic germ cell programmed cell death [GO:0035234]; positive regulation of apoptotic process [GO:0043065]; positive regulation of developmental process [GO:0051094]; positive regulation of reproductive process [GO:2000243]; regulation of neuron migration [GO:2001222]","GO:0005042; GO:0005043; GO:0005886; GO:0006915; GO:0007411; GO:0007420; GO:0009986; GO:0015631; GO:0019901; GO:0030027; GO:0030175; GO:0030425; GO:0030426; GO:0033564; GO:0035234; GO:0043025; GO:0043065; GO:0045202; GO:0051094; GO:0061643; GO:1990791; GO:2000243; GO:2001222","cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]","netrin receptor activity [GO:0005042]; netrin receptor activity involved in chemorepulsion [GO:0005043]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]"
"1066","Pocillopora_acuta_HIv2___TS.g24030.t1",4457.23889416617,-4.10632296679163,1.98112646614747,8.06205281457375e-05,0.000691634234341606,"O35136",1.02e-41,"Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2) (Neural cell adhesion molecule RB-8) (R4B12)","axonal fasciculation [GO:0007413]; cell adhesion [GO:0007155]","GO:0007155; GO:0007413; GO:0016604; GO:0030424; GO:0042802; GO:0097060; GO:0098552","axon [GO:0030424]; nuclear body [GO:0016604]; side of membrane [GO:0098552]; synaptic membrane [GO:0097060]","identical protein binding [GO:0042802]"
"1067","Pocillopora_acuta_HIv2___RNAseq.g20665.t1",3005.83945632987,3.71878137649453,3.13655718391166,8.09656109561079e-05,0.000694073089587842,"Q09596",7.51e-40,"Probable glutathione S-transferase 5 (EC 2.5.1.18) (GST class-sigma)","innate immune response [GO:0045087]","GO:0004364; GO:0045087","","glutathione transferase activity [GO:0004364]"
"1068","Pocillopora_acuta_HIv2___RNAseq.g26200.t1",29175.7743379683,-2.4979525230606,0.792795162634748,8.13132084518247e-05,0.000696337624065833,"P02466",3.84e-151,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096","collagen trimer [GO:0005581]; collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]","extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]"
"1069","Pocillopora_acuta_HIv2___TS.g28196.t1",42.2064226824668,8.82194252421879,3.92587814786271,8.15140226095001e-05,0.000697644273978586,"Q1ZXD6",1.41e-17,"Probable serine/threonine-protein kinase roco5 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 5)","signal transduction [GO:0007165]; sorocarp development [GO:0030587]","GO:0004672; GO:0004674; GO:0005085; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0007165; GO:0030587; GO:0106310","cytoplasm [GO:0005737]; cytosol [GO:0005829]","ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]"
"1070","Pocillopora_acuta_HIv2___RNAseq.g30377.t2",463.558343261751,-2.01856021636181,3.5463172433074,8.35373015534024e-05,0.000712851639922367,"O15973",9.93e-16,"Rhodopsin, GQ-coupled (GQ-rhodopsin)","cellular response to light stimulus [GO:0071482]; phototransduction [GO:0007602]; visual perception [GO:0007601]","GO:0005886; GO:0007601; GO:0007602; GO:0008020; GO:0071482","plasma membrane [GO:0005886]","G protein-coupled photoreceptor activity [GO:0008020]"
"1071","Pocillopora_acuta_HIv2___TS.g10300.t1",391.287719790513,4.32278004186967,3.04492393554844,8.51871643035255e-05,0.000723869254013147,"Q0P5L5",2.74e-154,"Formylglycine-generating enzyme (FGE) (EC 1.8.3.7) (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1)","post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158]","GO:0005783; GO:0005788; GO:0018158; GO:0043687; GO:0120147; GO:1903135","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]","cupric ion binding [GO:1903135]; formylglycine-generating oxidase activity [GO:0120147]"
"1072","Pocillopora_acuta_HIv2___RNAseq.g14375.t1",4079.04011946024,-3.57257223492773,2.94727176410692,8.60690334230426e-05,0.000729720105176371,"A6H584",7.12e-09,"Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain)","cell adhesion [GO:0007155]","GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023","collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]",""
"1073","Pocillopora_acuta_HIv2___RNAseq.g31038.t1",1101.92807608059,4.02596070884383,1.76012637223733,8.69656905302099e-05,0.000735597513350266,"P50549",1.41e-68,"ETS translocation variant 1 (Ets-related protein 81)","axon guidance [GO:0007411]; mechanosensory behavior [GO:0007638]; muscle organ development [GO:0007517]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]","GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0007411; GO:0007517; GO:0007638; GO:0045944; GO:0048935; GO:1990837","chromatin [GO:0000785]; nucleus [GO:0005634]","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"
"1074","Pocillopora_acuta_HIv2___RNAseq.g22295.t2",213.56297169106,4.52218578047559,3.10597476727942,8.8804373568392e-05,0.000749397000754505,"P79942",5.16e-78,"Nocturnin (EC 3.1.3.-) (Carbon catabolite repression 4-like protein) (Rhythmic message 1) (RM1)","circadian rhythm [GO:0007623]; NADP metabolic process [GO:0006739]","GO:0004535; GO:0005634; GO:0005739; GO:0006739; GO:0007623; GO:0019178; GO:0046872; GO:0048471; GO:0102757","mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]","metal ion binding [GO:0046872]; NADP phosphatase activity [GO:0019178]; NADPH phosphatase activity [GO:0102757]; poly(A)-specific ribonuclease activity [GO:0004535]"
"1075","Pocillopora_acuta_HIv2___RNAseq.g28208.t1",170.155080228177,4.12462496287329,3.69141322572762,9.14111531356378e-05,0.00076915120357991,NA,NA,NA,NA,NA,NA,NA
"1076","Pocillopora_acuta_HIv2___RNAseq.g10158.t1",1479.44456660291,3.31806983977447,3.69914029949296,9.61170596008396e-05,0.000804070069442767,"Q812E0",2.04e-137,"Cytoplasmic polyadenylation element-binding protein 2 (CPE-BP2) (CPE-binding protein 2) (mCPEB-2)","cellular response to arsenic-containing substance [GO:0071243]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of cytoplasmic translational elongation [GO:1900248]; negative regulation of translational elongation [GO:0045900]; regulation of translation at synapse, modulating synaptic transmission [GO:0099547]","GO:0000900; GO:0003730; GO:0005095; GO:0005634; GO:0005737; GO:0005840; GO:0008135; GO:0008187; GO:0032869; GO:0034599; GO:0035925; GO:0043005; GO:0043022; GO:0043023; GO:0043024; GO:0045202; GO:0045900; GO:0071243; GO:0071456; GO:0098978; GO:0099547; GO:1900248; GO:1990124; GO:2000766","cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; messenger ribonucleoprotein complex [GO:1990124]; neuron projection [GO:0043005]; nucleus [GO:0005634]; ribosome [GO:0005840]; synapse [GO:0045202]","GTPase inhibitor activity [GO:0005095]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA regulatory element binding translation repressor activity [GO:0000900]; poly-pyrimidine tract binding [GO:0008187]; ribosomal large subunit binding [GO:0043023]; ribosomal small subunit binding [GO:0043024]; ribosome binding [GO:0043022]; translation factor activity, RNA binding [GO:0008135]"
"1077","Pocillopora_acuta_HIv2___RNAseq.g16095.t1",188.282424293033,3.73741918802199,2.72085191445244,9.76579906959058e-05,0.00081554571444895,"P86733",5.24e-23,"BPTI/Kunitz domain-containing protein","","GO:0004867; GO:0005576; GO:0005615","extracellular region [GO:0005576]; extracellular space [GO:0005615]","serine-type endopeptidase inhibitor activity [GO:0004867]"
"1078","Pocillopora_acuta_HIv2___RNAseq.g26340.t1",1514.87206485343,3.23327052137344,2.89870202378103,9.84694566705489e-05,0.000820900415724968,"Q8WPW2",3.9e-154,"Pyridoxal 5'-phosphate synthase subunit SNZERR (PLP synthase subunit SNZERR) (EC 4.3.3.6) (Ethylene response protein) (PDX1)","amino acid metabolic process [GO:0006520]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]","GO:0006520; GO:0008615; GO:0036381; GO:0042823","","pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381]"
"1079","Pocillopora_acuta_HIv2___RNAseq.g24353.t1",120.74700534995,-3.60060547100771,1.75284892525948,0.000100070553172745,0.000832329201317185,NA,NA,NA,NA,NA,NA,NA
"1080","Pocillopora_acuta_HIv2___RNAseq.g4031.t1c",874.900395188356,1.49373263377686,2.32550865767227,0.000101567550750051,0.000842358402550881,"Q5R4J5",3.68e-42,"Synaptotagmin-1 (Synaptotagmin I) (SytI)","calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903235]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]","GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0019905; GO:0030154; GO:0030276; GO:0030424; GO:0030672; GO:0031045; GO:0042584; GO:0048488; GO:0048791; GO:0071277; GO:1903235","axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; dense core granule [GO:0031045]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]","calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; syntaxin binding [GO:0019905]"
"1081","Pocillopora_acuta_HIv2___RNAseq.g19325.t1",242.890544148897,1.13750147933663,1.99589576118934,0.000102706293168805,0.000848948792889129,"Q567I9",3.97e-109,"Cytochrome b5 domain-containing protein 1","cilium movement [GO:0003341]; regulation of cilium beat frequency [GO:0003356]","GO:0003341; GO:0003356; GO:0005737; GO:0005856; GO:0042995; GO:0046872","cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]","metal ion binding [GO:0046872]"
"1082","Pocillopora_acuta_HIv2___RNAseq.g17517.t1",1733.32182958728,-3.93054735370484,1.95353655151499,0.000102714352015762,0.000848948792889129,"Q9VBW3",2.87e-73,"Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303","apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]","ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
"1083","Pocillopora_acuta_HIv2___TS.g16941.t1",108.856139701982,1.47160015004224,2.51948604842171,0.000102775688364523,0.000848970620505116,NA,NA,NA,NA,NA,NA,NA
"1084","Pocillopora_acuta_HIv2___TS.g7278.t1",68.8518742448097,-1.45655134206703,2.6180059737985,0.000103785127589191,0.000855842694099232,"Q9Y4B6",1.28e-18,"DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein)","B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]","GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756","Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","ATP binding [GO:0005524]; histone H2AT120 kinase activity [GO:1990244]; nuclear estrogen receptor binding [GO:0030331]; protein serine kinase activity [GO:0106310]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]"
"1085","Pocillopora_acuta_HIv2___RNAseq.g6896.t1",870.17172066181,3.6344728377671,2.7127457868748,0.000104302588420381,0.000858731716884702,"Q5BK26",0,"Patatin-like phospholipase domain-containing protein 7 (EC 3.1.1.-) (EC 3.1.1.5) (Liver NTE-related protein 1) (NTE-related esterase)","phosphatidylcholine catabolic process [GO:0034638]","GO:0004622; GO:0005783; GO:0005789; GO:0005811; GO:0034638","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]","lysophospholipase activity [GO:0004622]"
"1086","Pocillopora_acuta_HIv2___RNAseq.g1970.t1",1578.77647794326,-2.10507565054168,3.2397936152313,0.000105626006341872,0.000868547217583194,"B3EWY6",3.2e-87,"Skeletal aspartic acid-rich protein 1","","GO:0005576","extracellular region [GO:0005576]",""
"1087","Pocillopora_acuta_HIv2___RNAseq.g7754.t1",235.063684751222,1.05262673447877,1.77361165419664,0.000109690243027471,0.000898391662032466,NA,NA,NA,NA,NA,NA,NA
"1088","Pocillopora_acuta_HIv2___RNAseq.g14354.t1",755.049483355471,-2.48606295847245,7.29764605366022,0.000110090180588633,0.000901156973420483,NA,NA,NA,NA,NA,NA,NA
"1089","Pocillopora_acuta_HIv2___TS.g24066.t1",6081.75958151818,-2.26620261619242,0.71244009680436,0.00011070224575694,0.000905654571622387,"P27393",8.24e-154,"Collagen alpha-2(IV) chain","extracellular matrix organization [GO:0030198]","GO:0005581; GO:0005604; GO:0005615; GO:0030020; GO:0030198","basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]","extracellular matrix structural constituent conferring tensile strength [GO:0030020]"
"1090","Pocillopora_acuta_HIv2___RNAseq.g30565.t1",41.697831037724,5.92283785622456,3.47827613052575,0.000111386531669786,0.000910737588508642,"Q96DX5",7.26e-34,"Ankyrin repeat and SOCS box protein 9 (ASB-9)","intracellular signal transduction [GO:0035556]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]","GO:0005739; GO:0005829; GO:0016567; GO:0031466; GO:0035556; GO:0043161; GO:0045732; GO:1990756","Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; mitochondrion [GO:0005739]","ubiquitin-like ligase-substrate adaptor activity [GO:1990756]"
"1091","Pocillopora_acuta_HIv2___TS.g25584.t1",120.839747336801,-1.03246201545418,1.7450467792442,0.000112465207926093,0.000917482666352513,"Q7Z407",1.85e-20,"CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)","regulation of dendrite development [GO:0050773]","GO:0005886; GO:0050773","plasma membrane [GO:0005886]",""
"1092","Pocillopora_acuta_HIv2___RNAseq.g12049.t1",62.8991078524264,1.08149898491101,2.0205303061442,0.000114344808407567,0.000931240601805767,"P00389",0,"NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4)","response to hormone [GO:0009725]","GO:0003958; GO:0005789; GO:0005829; GO:0009725; GO:0010181; GO:0050660; GO:0050661","cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]","flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]"
"1093","Pocillopora_acuta_HIv2___RNAseq.g12376.t1",1045.73785985076,-3.68355794167747,1.7682903272306,0.000114452789724877,0.000931595470219817,"H9JW44",5.86e-96,"Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004099; GO:0005615; GO:0006032; GO:0046872","extracellular space [GO:0005615]","chitin deacetylase activity [GO:0004099]; metal ion binding [GO:0046872]"
"1094","Pocillopora_acuta_HIv2___RNAseq.g13877.t1",169.236130838179,1.15303044924437,2.06060547921162,0.000115376570030955,0.0009370054513912,"A0JPQ7",4.86e-29,"Uncharacterized protein C19orf47 homolog","","GO:0005634","nucleus [GO:0005634]",""
"1095","Pocillopora_acuta_HIv2___RNAseq.g610.t1",104.253915296151,1.02975102117575,1.79460473681387,0.000119311544731553,0.000965709111917844,"Q05609",7.44e-21,"Serine/threonine-protein kinase CTR1 (EC 2.7.11.1) (Protein CONSTITUTIVE TRIPLE RESPONSE1)","ethylene-activated signaling pathway [GO:0009873]; gibberellin biosynthetic process [GO:0009686]; negative regulation of ethylene-activated signaling pathway [GO:0010105]; protein autophosphorylation [GO:0046777]; regulation of post-embryonic root development [GO:2000069]; regulation of stem cell division [GO:2000035]; regulation of timing of transition from vegetative to reproductive phase [GO:0048510]; response to ethylene [GO:0009723]; response to fructose [GO:0009750]; response to hypoxia [GO:0001666]; response to sucrose [GO:0009744]; sugar mediated signaling pathway [GO:0010182]","GO:0001666; GO:0004674; GO:0004712; GO:0005524; GO:0005789; GO:0009686; GO:0009723; GO:0009744; GO:0009750; GO:0009873; GO:0010105; GO:0010182; GO:0046777; GO:0048510; GO:0106310; GO:2000035; GO:2000069","endoplasmic reticulum membrane [GO:0005789]","ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]"
"1096","Pocillopora_acuta_HIv2___TS.g15832.t1",7865.30278436561,-2.46737478175176,0.829912819476366,0.000122143195431161,0.000986420535296654,"P02466",7.07e-153,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096","collagen trimer [GO:0005581]; collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]","extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]"
"1097","Pocillopora_acuta_HIv2___RNAseq.g8876.t1",28.7330248390001,8.48032881341657,3.61103005475825,0.000123180248012872,0.000992578889837426,"Q91770",1.98e-20,"Homeobox protein not2 (Xnot-2) (Xnot2)","negative regulation of DNA-templated transcription [GO:0045892]; notochord formation [GO:0014028]","GO:0000981; GO:0003677; GO:0005634; GO:0014028; GO:0045892","nucleus [GO:0005634]","DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"
"1098","Pocillopora_acuta_HIv2___RNAseq.g8587.t1",456.761246394455,-2.52342896060041,4.00086127564404,0.000123896724096412,0.000997241078091542,"Q19269",2.14e-45,"Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14)","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270","extracellular region [GO:0005576]","metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
"1099","Pocillopora_acuta_HIv2___RNAseq.g2626.t1",237.041366217848,-5.61214086134079,2.26827024131772,0.000124718185465635,0.00100156004766942,NA,NA,NA,NA,NA,NA,NA
"1100","Pocillopora_acuta_HIv2___RNAseq.g6972.t1",41.9246463005393,5.77972356973932,3.63379592481293,0.000124718639934123,0.00100156004766942,NA,NA,NA,NA,NA,NA,NA
"1101","Pocillopora_acuta_HIv2___RNAseq.g8670.t1",5976.07967302424,-3.1466818314578,1.32807427345221,0.000124785614190631,0.00100156004766942,"P02752",1.2e-55,"Riboflavin-binding protein (RBP) [Cleaved into: Riboflavin-binding protein, plasma form; Riboflavin-binding protein, yolk major form; Riboflavin-binding protein, yolk minor form]","negative regulation of sensory perception of bitter taste [GO:1904661]; negative regulation of sensory perception of sweet taste [GO:1904657]; riboflavin transport [GO:0032218]","GO:0009897; GO:0032217; GO:0032218; GO:0038023; GO:1902444; GO:1904657; GO:1904661","external side of plasma membrane [GO:0009897]","riboflavin binding [GO:1902444]; riboflavin transmembrane transporter activity [GO:0032217]; signaling receptor activity [GO:0038023]"
"1102","Pocillopora_acuta_HIv2___RNAseq.g15885.t1",54.5100177919839,5.7715986493096,2.88122235594762,0.000125185436627254,0.00100370407725976,"Q15649",3.56e-26,"Zinc finger HIT domain-containing protein 3 (HNF-4a coactivator) (Thyroid hormone receptor interactor 3) (Thyroid receptor-interacting protein 3) (TR-interacting protein 3) (TRIP-3)","box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of DNA-templated transcription [GO:0006355]; snoRNA localization [GO:0048254]","GO:0000463; GO:0000492; GO:0005634; GO:0005737; GO:0006355; GO:0046872; GO:0046966; GO:0048254; GO:0070761","cytoplasm [GO:0005737]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]","metal ion binding [GO:0046872]; nuclear thyroid hormone receptor binding [GO:0046966]"
"1103","Pocillopora_acuta_HIv2___RNAseq.g15236.t1",339.408054364753,-3.70525604743476,2.33881513574274,0.000125284616183672,0.00100394276370118,"Q2TBT8",6.44e-19,"RING finger protein 151","protein ubiquitination [GO:0016567]","GO:0008270; GO:0016567; GO:0061630","","ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"
"1104","Pocillopora_acuta_HIv2___RNAseq.g26979.t1",16227.093016946,-2.30063243637912,0.724637116179174,0.000128397394352567,0.00102717915482054,"P83205",3.33e-135,"Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]","cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in protein catabolic process [GO:0051603]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590]","GO:0004175; GO:0004197; GO:0005518; GO:0005615; GO:0005764; GO:0006590; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0042470; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0051603; GO:0097067; GO:1904090","apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471]","collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; proteoglycan binding [GO:0043394]"
"1105","Pocillopora_acuta_HIv2___RNAseq.g7248.t1",34.8871881954713,8.5820618645294,3.86931178605805,0.000131051645493846,0.0010460987861054,"Q8WU66",9.09e-34,"Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170","cell surface [GO:0009986]; ciliary membrane [GO:0060170]; extracellular region [GO:0005576]; stereocilium [GO:0032420]",""
"1106","Pocillopora_acuta_HIv2___RNAseq.g26700.t1",3564.82512470245,2.87636109057197,1.08238395987855,0.000131314031040493,0.00104761508271908,"E9PUL5",2.16e-08,"Proline-rich transmembrane protein 2 (Dispanin subfamily B member 3) (DSPB3)","negative regulation of short-term synaptic potentiation [GO:1905513]; negative regulation of SNARE complex assembly [GO:0035544]; neuromuscular process controlling posture [GO:0050884]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]","GO:0005886; GO:0008021; GO:0016020; GO:0017075; GO:0017124; GO:0030672; GO:0031629; GO:0031982; GO:0035544; GO:0042734; GO:0043005; GO:0043197; GO:0043679; GO:0050884; GO:0098793; GO:0098839; GO:0098978; GO:0150037; GO:1905513","axon terminus [GO:0043679]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]","SH3 domain binding [GO:0017124]; syntaxin-1 binding [GO:0017075]"
"1107","Pocillopora_acuta_HIv2___TS.g7149.t2",312.848616037606,2.41938563282737,3.53284666012094,0.000132087760315857,0.00105320692679634,"Q8CDT7",1.55e-28,"Ciliary-associated calcium-binding coiled-coil protein 1","","GO:0005509; GO:0005737; GO:0005813; GO:0036126","centrosome [GO:0005813]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]","calcium ion binding [GO:0005509]"
"1108","Pocillopora_acuta_HIv2___RNAseq.g28803.t1b",11712.5269697605,-2.22306463068853,0.704586879139023,0.000132273067730096,0.0010541033893378,"P02466",4.64e-152,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096","collagen trimer [GO:0005581]; collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]","extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]"
"1109","Pocillopora_acuta_HIv2___RNAseq.g7645.t1",1667.13017235351,3.79958585011146,1.72652645052698,0.00013415336590799,0.00106498039763621,"Q9BYK8",0,"3'-5' exoribonuclease HELZ2 (EC 3.1.13.1) (ATP-dependent RNA helicase PRIC285) (EC 3.6.4.13) (Helicase with zinc finger 2, transcriptional coactivator) (Helicase with zinc finger domain 2) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein)","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]","GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0008859; GO:0016020; GO:0016887; GO:0030374; GO:0035194; GO:0043186; GO:0045944; GO:0046872","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; P granule [GO:0043186]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; exoribonuclease II activity [GO:0008859]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
"1110","Pocillopora_acuta_HIv2___RNAseq.g10777.t1",187.45508411074,1.19066330685188,2.03706729067592,0.00013542248385147,0.00107328811311105,"Q8CAQ8",1.39e-70,"MICOS complex subunit Mic60 (Mitochondrial inner membrane protein) (Mitofilin)","cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]; neuron cellular homeostasis [GO:0070050]","GO:0005739; GO:0005743; GO:0005758; GO:0042407; GO:0043209; GO:0051560; GO:0061617; GO:0070050","MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]",""
"1111","Pocillopora_acuta_HIv2___TS.g15232.t1a",167.812907590762,1.54594405157565,2.89181643827526,0.000136996660334012,0.00108296167227227,NA,NA,NA,NA,NA,NA,NA
"1112","Pocillopora_acuta_HIv2___RNAseq.g26031.t1a",11043.6237038499,3.42763953805029,4.0441959279412,0.000137215314188321,0.00108393353600212,"Q505H7",1.53e-11,"Protein IWS1 homolog (IWS1-like protein)","mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]","GO:0005634; GO:0006397; GO:0008380; GO:0051028","nucleus [GO:0005634]",""
"1113","Pocillopora_acuta_HIv2___RNAseq.g5711.t2",347.776168613039,1.46132246558275,2.90861134293837,0.000137735407927005,0.00108744811149356,"Q8CGF6",1.7e-111,"WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin)","adult locomotory behavior [GO:0008344]; anterior commissure morphogenesis [GO:0021960]; autophagy [GO:0006914]; brain development [GO:0007420]; cerebral cortex development [GO:0021987]; cerebral cortex radial glia-guided migration [GO:0021801]; corpus callosum development [GO:0022038]; detection of hot stimulus involved in thermoception [GO:0120168]; locomotory behavior [GO:0007626]; microtubule cytoskeleton organization [GO:0000226]; motor behavior [GO:0061744]; negative regulation of microtubule depolymerization [GO:0007026]; neural precursor cell proliferation [GO:0061351]; neuron projection development [GO:0031175]; neuronal stem cell population maintenance [GO:0097150]","GO:0000226; GO:0005737; GO:0005874; GO:0006914; GO:0007026; GO:0007420; GO:0007626; GO:0008344; GO:0021801; GO:0021960; GO:0021987; GO:0022038; GO:0030424; GO:0030425; GO:0030426; GO:0031175; GO:0043005; GO:0043025; GO:0044877; GO:0061351; GO:0061744; GO:0097150; GO:0120168","axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; microtubule [GO:0005874]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]","protein-containing complex binding [GO:0044877]"
"1114","Pocillopora_acuta_HIv2___RNAseq.12371_t",4891.91865740084,2.55976481039278,0.876998487391465,0.000141800931243628,0.00111649900354264,NA,NA,NA,NA,NA,NA,NA
"1115","Pocillopora_acuta_HIv2___RNAseq.g26015.t1",107.96012525571,1.08337828623157,1.79541996577376,0.000141946170770171,0.00111703450164296,NA,NA,NA,NA,NA,NA,NA
"1116","Pocillopora_acuta_HIv2___RNAseq.g3515.t1",95.7288092904257,-3.35099704305307,3.11856671472974,0.000142885158300008,0.0011235463664544,"Q9UBC2",2.99e-08,"Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein) (Eps15R)","endocytosis [GO:0006897]; endosomal transport [GO:0016197]","GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006897; GO:0016020; GO:0016197; GO:0030132; GO:0045296","clathrin coat of coated pit [GO:0030132]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]","cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]"
"1117","Pocillopora_acuta_HIv2___RNAseq.g14741.t1",196.94047861251,3.28002129721449,3.48803100278194,0.000144182306656515,0.00113216768918558,"Q92733",8.99e-40,"Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein)","regulation of cell cycle [GO:0051726]","GO:0005634; GO:0005654; GO:0016607; GO:0051726","nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",""
"1118","Pocillopora_acuta_HIv2___RNAseq.g4399.t2",947.117373759097,2.30123739842898,3.94169325052654,0.000144930796244169,0.00113562148787171,"Q14114",1.03e-27,"Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2)","ammon gyrus development [GO:0021541]; cellular response to cholesterol [GO:0071397]; cellular response to growth factor stimulus [GO:0071363]; chemical synaptic transmission [GO:0007268]; cytokine-mediated signaling pathway [GO:0019221]; dendrite morphogenesis [GO:0048813]; endocytosis [GO:0006897]; layer formation in cerebral cortex [GO:0021819]; lipid metabolic process [GO:0006629]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of dendrite development [GO:1900006]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; proteolysis [GO:0006508]; reelin-mediated signaling pathway [GO:0038026]; regulation of apoptotic process [GO:0042981]; regulation of innate immune response [GO:0045088]; response to xenobiotic stimulus [GO:0009410]; retinoid metabolic process [GO:0001523]; signal transduction [GO:0007165]; ventral spinal cord development [GO:0021517]","GO:0001523; GO:0001540; GO:0004888; GO:0005041; GO:0005509; GO:0005615; GO:0005875; GO:0005886; GO:0005901; GO:0006508; GO:0006629; GO:0006897; GO:0007165; GO:0007268; GO:0008035; GO:0009410; GO:0009986; GO:0016020; GO:0019221; GO:0019894; GO:0021517; GO:0021541; GO:0021819; GO:0030229; GO:0030424; GO:0030425; GO:0034185; GO:0038024; GO:0038025; GO:0038026; GO:0042981; GO:0043025; GO:0043235; GO:0045088; GO:0045202; GO:0048306; GO:0048813; GO:0050731; GO:0050804; GO:0061003; GO:0071363; GO:0071397; GO:1900006","axon [GO:0030424]; caveola [GO:0005901]; cell surface [GO:0009986]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]","amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; high-density lipoprotein particle binding [GO:0008035]; kinesin binding [GO:0019894]; low-density lipoprotein particle receptor activity [GO:0005041]; reelin receptor activity [GO:0038025]; transmembrane signaling receptor activity [GO:0004888]; very-low-density lipoprotein particle receptor activity [GO:0030229]"
"1119","Pocillopora_acuta_HIv2___RNAseq.g23414.t1",258.40787731036,3.28515136783107,1.75534962907109,0.000146388499586757,0.00114637967407843,"P35404",3.73e-12,"5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (Serotonin receptor 1B)","adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; bone remodeling [GO:0046849]; cellular response to alkaloid [GO:0071312]; cellular response to xenobiotic stimulus [GO:0071466]; chemical synaptic transmission [GO:0007268]; negative regulation of serotonin secretion [GO:0014063]; regulation of behavior [GO:0050795]; vasoconstriction [GO:0042310]","GO:0004993; GO:0005886; GO:0007198; GO:0007268; GO:0014063; GO:0042310; GO:0045202; GO:0046849; GO:0050795; GO:0071312; GO:0071466","plasma membrane [GO:0005886]; synapse [GO:0045202]","G protein-coupled serotonin receptor activity [GO:0004993]"
"1120","Pocillopora_acuta_HIv2___RNAseq.g25250.t1",302.114740379049,1.23267069010477,2.148487105612,0.000146684824777504,0.00114807862856159,"Q66J85",3.32e-39,"AN1-type zinc finger protein 3 homolog","","GO:0003677; GO:0008270","","DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
"1121","Pocillopora_acuta_HIv2___RNAseq.g21418.t1",788.438671528168,-3.2900314695181,1.61885141439791,0.000152076128792286,0.00118060163854997,"P16241",2.72e-76,"POU domain protein CF1A (Chorion factor 1A) (CF1-A) (Protein drifter) (Ventral veins lacking protein)","brain development [GO:0007420]; brain segmentation [GO:0035284]; dendrite morphogenesis [GO:0048813]; motor neuron axon guidance [GO:0008045]; peripheral nervous system development [GO:0007422]; positive regulation of antimicrobial peptide biosynthetic process [GO:0002807]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of dendrite morphogenesis [GO:0048814]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0002807; GO:0005634; GO:0006357; GO:0007420; GO:0007422; GO:0008045; GO:0035284; GO:0045944; GO:0048813; GO:0048814","nucleus [GO:0005634]","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"
"1122","Pocillopora_acuta_HIv2___TS.g15792.t1",1425.84151006973,-1.57403552925705,3.14980592150623,0.000152146118242336,0.00118060163854997,"B3EWY7",1.02e-70,"Acidic skeletal organic matrix protein (Acidic SOMP)","","GO:0005576","extracellular region [GO:0005576]",""
"1123","Pocillopora_acuta_HIv2___RNAseq.g13857.t1",2577.46422040318,-2.27275839982516,3.43120873691051,0.000152849021191459,0.00118541996917601,"O19006",6.6e-91,"Bone morphogenetic protein 2 (BMP-2)","cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of odontoblast differentiation [GO:1901331]","GO:0001503; GO:0005125; GO:0005615; GO:0008083; GO:0030154; GO:0051216; GO:1901331","extracellular space [GO:0005615]","cytokine activity [GO:0005125]; growth factor activity [GO:0008083]"
"1124","Pocillopora_acuta_HIv2___RNAseq.g14731.t1",2676.28324034623,-2.86617205166106,1.18247476820024,0.000154687787366934,0.00119775383108958,NA,NA,NA,NA,NA,NA,NA
"1125","Pocillopora_acuta_HIv2___RNAseq.g17678.t1",25.3077056700698,8.44935098271614,3.61527824804632,0.000155130657058371,0.00120054030160101,"Q7RTR2",2.35e-22,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223","centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]","ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]"
"1126","Pocillopora_acuta_HIv2___RNAseq.g26886.t1",80.7576063521977,-3.27857075862302,1.33269261810012,0.000156232288882376,0.00120777329043008,NA,NA,NA,NA,NA,NA,NA
"1127","Pocillopora_acuta_HIv2___RNAseq.g9662.t1",1449.54985538158,3.83224707052229,1.37660417033035,0.00015641573344235,0.00120854549599901,NA,NA,NA,NA,NA,NA,NA
"1128","Pocillopora_acuta_HIv2___TS.g5415.t1",30.9487271906282,5.85822088406573,2.3111427577589,0.000157527577573901,0.00121648632249274,"Q9P126",5.14e-19,"C-type lectin domain family 1 member B (C-type lectin-like receptor 2) (CLEC-2)","cell surface receptor signaling pathway [GO:0007166]; defense response [GO:0006952]; platelet formation [GO:0030220]; signal transduction [GO:0007165]","GO:0004888; GO:0005886; GO:0006952; GO:0007165; GO:0007166; GO:0009986; GO:0030220; GO:0030246","cell surface [GO:0009986]; plasma membrane [GO:0005886]","carbohydrate binding [GO:0030246]; transmembrane signaling receptor activity [GO:0004888]"
"1129","Pocillopora_acuta_HIv2___RNAseq.g5342.t1",1956.29110885674,-3.2298045624218,3.5392106046692,0.000159652991190255,0.00122961707378905,"P78504",9.12e-17,"Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339)","angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; aortic valve morphogenesis [GO:0003180]; blood vessel remodeling [GO:0001974]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; endothelial cell differentiation [GO:0045446]; hemopoiesis [GO:0030097]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; keratinocyte differentiation [GO:0030216]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; myoblast differentiation [GO:0045445]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; nervous system development [GO:0007399]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; podocyte development [GO:0072015]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of reproductive process [GO:2000241]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456]","GO:0001525; GO:0001709; GO:0001953; GO:0001974; GO:0002011; GO:0002085; GO:0002456; GO:0003180; GO:0003184; GO:0003215; GO:0005112; GO:0005198; GO:0005509; GO:0005543; GO:0005576; GO:0005886; GO:0005912; GO:0007219; GO:0007399; GO:0008083; GO:0016020; GO:0016324; GO:0022408; GO:0030097; GO:0030216; GO:0030336; GO:0032495; GO:0035909; GO:0042127; GO:0042491; GO:0045445; GO:0045446; GO:0045599; GO:0045602; GO:0045639; GO:0045665; GO:0045669; GO:0045747; GO:0045944; GO:0050678; GO:0060090; GO:0060411; GO:0061073; GO:0061101; GO:0061156; GO:0061309; GO:0061444; GO:0062043; GO:0072006; GO:0072015; GO:0072017; GO:0072070; GO:0097150; GO:2000241; GO:2000737","adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]","calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; molecular adaptor activity [GO:0060090]; Notch binding [GO:0005112]; phospholipid binding [GO:0005543]; structural molecule activity [GO:0005198]"
"1130","Pocillopora_acuta_HIv2___RNAseq.g3666.t1a",167.700938232003,1.05854981317584,1.83587771977463,0.000159837675247666,0.0012303843186707,"Q6GPQ3",2.23e-17,"Major facilitator superfamily domain-containing protein 8","","GO:0005765; GO:0022857","lysosomal membrane [GO:0005765]","transmembrane transporter activity [GO:0022857]"
"1131","Pocillopora_acuta_HIv2___RNAseq.g8980.t1",106.101495155826,-3.39559265345025,2.36723331376022,0.00016276870532767,0.0012509492847287,"B8EIZ7",8.19e-180,"Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148)","","GO:0004499; GO:0034899; GO:0047822; GO:0050660; GO:0050661","","flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; trimethylamine monooxygenase activity [GO:0034899]"
"1132","Pocillopora_acuta_HIv2___RNAseq.g30759.t1",401.229753927853,3.75595629191431,1.84992623966983,0.000163607017731194,0.00125605727413163,NA,NA,NA,NA,NA,NA,NA
"1133","Pocillopora_acuta_HIv2___RNAseq.g1033.t1",2322.63113884992,2.10747607664017,0.661074836978102,0.000164115641352878,0.00125929370638092,NA,NA,NA,NA,NA,NA,NA
"1134","Pocillopora_acuta_HIv2___RNAseq.g27609.t1",647.195843838856,3.46208634953058,1.98743185270644,0.000164383957579222,0.00126001566636241,"Q01062",0,"cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; cAMP-mediated signaling [GO:0019933]; cardiac septum development [GO:0003279]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; coronary vasculature development [GO:0060976]; establishment of endothelial barrier [GO:0061028]; heart development [GO:0007507]; heart valve development [GO:0003170]; intracellular signal transduction [GO:0035556]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of mitochondrion organization [GO:0010821]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to hydrogen sulfide [GO:1904880]; ventricular septum development [GO:0003281]","GO:0000122; GO:0000287; GO:0003170; GO:0003279; GO:0003281; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007193; GO:0007507; GO:0008270; GO:0010628; GO:0010749; GO:0010752; GO:0010754; GO:0010821; GO:0019933; GO:0019934; GO:0030424; GO:0030425; GO:0030552; GO:0030553; GO:0030911; GO:0035556; GO:0035904; GO:0036004; GO:0036006; GO:0042301; GO:0042734; GO:0042802; GO:0042803; GO:0043116; GO:0043117; GO:0043949; GO:0043951; GO:0046069; GO:0047555; GO:0048471; GO:0050729; GO:0060976; GO:0061028; GO:0071222; GO:0071260; GO:0071320; GO:0071321; GO:0071560; GO:0090324; GO:0097011; GO:0097060; GO:0097457; GO:0106072; GO:1904613; GO:1904880","axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber [GO:0097457]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060]","3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; GAF domain binding [GO:0036004]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; zinc ion binding [GO:0008270]"
"1135","Pocillopora_acuta_HIv2___RNAseq.g2255.t1",2924.51760305112,3.72592044473134,1.9459198771765,0.000165448434508438,0.0012675032609799,NA,NA,NA,NA,NA,NA,NA
"1136","Pocillopora_acuta_HIv2___RNAseq.g614.t1",2049.65500897357,-3.36555886055331,1.87396037674365,0.000168570952964929,0.00128733382454315,"Q61321",2.37e-90,"Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3)","embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic skeletal system morphogenesis [GO:0048704]; fungiform papilla morphogenesis [GO:0061197]; generation of neurons [GO:0048699]; inner ear morphogenesis [GO:0042472]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; male sex differentiation [GO:0046661]; metanephric mesenchyme development [GO:0072075]; myoblast migration [GO:0051451]; myotome development [GO:0061055]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of satellite cell differentiation [GO:1902725]; olfactory placode formation [GO:0030910]; pharyngeal system development [GO:0060037]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ureteric bud formation [GO:0072107]; protein localization to nucleus [GO:0034504]; regulation of branch elongation involved in ureteric bud branching [GO:0072095]; regulation of epithelial cell proliferation [GO:0050678]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue development [GO:0007519]; thymus development [GO:0048538]; tongue development [GO:0043586]; trigeminal ganglion development [GO:0061551]","GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0007519; GO:0008582; GO:0008584; GO:0010468; GO:0030238; GO:0030910; GO:0032880; GO:0034504; GO:0042472; GO:0043066; GO:0043524; GO:0043565; GO:0043586; GO:0045214; GO:0045892; GO:0045893; GO:0045944; GO:0046661; GO:0048538; GO:0048699; GO:0048701; GO:0048704; GO:0050678; GO:0051451; GO:0060037; GO:0061055; GO:0061197; GO:0061551; GO:0072075; GO:0072095; GO:0072107; GO:0090190; GO:0098528; GO:1902725","cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]","DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"
"1137","Pocillopora_acuta_HIv2___RNAseq.g26608.t1",1585.09370711908,2.46502433902762,0.859675253954441,0.000170298928427706,0.00129847322128537,"P22735",5.1e-173,"Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1)","cell envelope organization [GO:0043163]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]; protein modification process [GO:0036211]","GO:0001533; GO:0003810; GO:0005829; GO:0005886; GO:0010838; GO:0016020; GO:0018149; GO:0030216; GO:0031424; GO:0036211; GO:0042802; GO:0043163; GO:0045787; GO:0046872; GO:0070062","cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]","identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]"
"1138","Pocillopora_acuta_HIv2___RNAseq.g20764.t1",109.580587839618,2.99586295668689,1.24835604882247,0.000170896375574025,0.00130234203177171,"A1R8N8",1.83e-10,"D-inositol 3-phosphate glycosyltransferase (EC 2.4.1.250) (N-acetylglucosamine-inositol-phosphate N-acetylglucosaminyltransferase) (GlcNAc-Ins-P N-acetylglucosaminyltransferase)","mycothiol biosynthetic process [GO:0010125]","GO:0000287; GO:0008375; GO:0010125; GO:0102710","","acetylglucosaminyltransferase activity [GO:0008375]; D-inositol-3-phosphate glycosyltransferase activity [GO:0102710]; magnesium ion binding [GO:0000287]"
"1139","Pocillopora_acuta_HIv2___RNAseq.g25208.t1",3909.7379627209,-1.90224052676594,0.578774969623004,0.000171959636338054,0.00130975470247163,"A7ISW1",2.32e-79,"Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (QC) (Glutaminyl-tRNA cyclotransferase)","peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186]","GO:0005576; GO:0008270; GO:0016603; GO:0017186","extracellular region [GO:0005576]","glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]"
"1140","Pocillopora_acuta_HIv2___RNAseq.g715.t1",367.339410568285,-3.18907596888038,1.7190909286327,0.00017728403811105,0.0013473563084737,"Q9JHA8",9.6e-26,"von Willebrand factor A domain-containing protein 7 (Protein G7c)","","GO:0005576","extracellular region [GO:0005576]",""
"1141","Pocillopora_acuta_HIv2___TS.g17638.t1",2636.16298133553,3.0039305052994,3.99861157189349,0.000177455321324834,0.0013473563084737,NA,NA,NA,NA,NA,NA,NA
"1142","Pocillopora_acuta_HIv2___RNAseq.g16215.t1",550.147465141243,-2.5714210982176,0.947769939734155,0.000178387329592691,0.00135301223661703,NA,NA,NA,NA,NA,NA,NA
"1143","Pocillopora_acuta_HIv2___TS.g958.t1",61.2580426743589,3.20645310791449,3.96361702160242,0.000181432707397966,0.00137251186182227,NA,NA,NA,NA,NA,NA,NA
"1144","Pocillopora_acuta_HIv2___RNAseq.g26735.t1",923.096739732059,-2.93372111948301,1.4119566741566,0.000182063794694386,0.0013765659835126,NA,NA,NA,NA,NA,NA,NA
"1145","Pocillopora_acuta_HIv2___RNAseq.g9118.t1",3898.31463056834,-3.46881326818627,2.45447128557454,0.00018730906103768,0.00141032704781312,"Q13219",0,"Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A)","cell surface receptor signaling pathway [GO:0007166]; female pregnancy [GO:0007565]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to dexamethasone [GO:0071548]; response to follicle-stimulating hormone [GO:0032354]","GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0007166; GO:0007565; GO:0008237; GO:0008270; GO:0030163; GO:0032354; GO:0071548","extracellular region [GO:0005576]; extracellular space [GO:0005615]","metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]"
"1146","Pocillopora_acuta_HIv2___TS.g370.t2",1450.61376741721,-2.13519511915917,0.687155859978168,0.000187797357729552,0.00141253301206461,NA,NA,NA,NA,NA,NA,NA
"1147","Pocillopora_acuta_HIv2___RNAseq.g4516.t1",3380.31050688834,3.74187297676126,3.01849634964879,0.000189236832413564,0.00142262034512983,"G8HTB6",3.67e-25,"ZP domain-containing protein","","GO:0016020","membrane [GO:0016020]",""
"1148","Pocillopora_acuta_HIv2___RNAseq.g9423.t1",299.739005122343,2.38822073745329,0.800132652151856,0.000189972369743089,0.00142666685148704,NA,NA,NA,NA,NA,NA,NA
"1149","Pocillopora_acuta_HIv2___RNAseq.g15474.t1",42.8208233604579,4.59195975295122,2.19000965528506,0.000190514737928631,0.00142925579325712,NA,NA,NA,NA,NA,NA,NA
"1150","Pocillopora_acuta_HIv2___RNAseq.g19855.t1",2206.24934791836,3.38588627229488,2.05372541685816,0.000194114657045399,0.00145324761879123,"Q87NG3",7.74e-106,"Glycine betaine transporter 1","amino acid transport [GO:0006865]","GO:0005886; GO:0006865; GO:0022857","plasma membrane [GO:0005886]","transmembrane transporter activity [GO:0022857]"
"1151","Pocillopora_acuta_HIv2___TS.g4252.t1",88.8407182957697,1.64410362720822,2.6963982453689,0.000194231135209371,0.00145336737696241,NA,NA,NA,NA,NA,NA,NA
"1152","Pocillopora_acuta_HIv2___RNAseq.g11214.t1",286.003491976719,2.69641746775179,4.22387437275522,0.000195173844019473,0.0014589118759161,"P61752",1.54e-17,"Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I)","chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; positive regulation of vasoconstriction [GO:0045907]","GO:0001696; GO:0004969; GO:0004993; GO:0005886; GO:0007187; GO:0007268; GO:0030425; GO:0030594; GO:0045202; GO:0045907","dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202]","G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]"
"1153","Pocillopora_acuta_HIv2___RNAseq.g7909.t1",68.1348379078686,1.41631105271939,3.15494222304783,0.00020140259847945,0.00150159133216843,"C0HK24",3.03e-08,"L-rhamnose-binding lectin ELEL-1","","GO:0030246","","carbohydrate binding [GO:0030246]"
"1154","Pocillopora_acuta_HIv2___RNAseq.g1510.t1",67.9421519896673,3.82473605129953,2.71637749271356,0.00020369186829668,0.00151631455637837,"Q27084",7.16e-78,"Tachylectin-2 (Lectin L10c)","innate immune response [GO:0045087]","GO:0005576; GO:0030246; GO:0045087","extracellular region [GO:0005576]","carbohydrate binding [GO:0030246]"
"1155","Pocillopora_acuta_HIv2___RNAseq.g2094.t1a",59.9956099768579,1.33035142861961,2.862704685126,0.00020395296668456,0.00151747721714273,"Q5RCY5",1.26e-63,"Single-strand DNA endonuclease ASTE1 (EC 3.1.-.-) (Protein asteroid homolog 1)","double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]","GO:0000014; GO:0000724; GO:0006303; GO:1990599","","3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]"
"1156","Pocillopora_acuta_HIv2___RNAseq.g15904.t1",2168.24234252399,1.73418957087847,3.90750064940693,0.000205120868298564,0.00152459827290361,NA,NA,NA,NA,NA,NA,NA
"1157","Pocillopora_acuta_HIv2___RNAseq.g21477.t1",251.626015782724,-3.3082544155459,2.68277124907325,0.000205927960451184,0.00152981100152333,"P24821",6.13e-40,"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)","bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611]","GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0062023; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098966","basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; interstitial matrix [GO:0005614]; membrane [GO:0016020]; perisynaptic extracellular matrix [GO:0098966]; tenascin complex [GO:0090733]","extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; syndecan binding [GO:0045545]"
"1158","Pocillopora_acuta_HIv2___RNAseq.g82.t1",64.9391617500023,5.30441956279399,3.79761682551377,0.000211793920142842,0.00156935822794368,"Q9NRG9",6.33e-136,"Aladin (Adracalin)","fertilization [GO:0009566]; learning [GO:0007612]; microtubule bundle formation [GO:0001578]; mitotic spindle assembly [GO:0090307]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of nucleocytoplasmic transport [GO:0046822]","GO:0000922; GO:0001578; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005813; GO:0005829; GO:0006913; GO:0007612; GO:0009566; GO:0015031; GO:0016020; GO:0031965; GO:0046822; GO:0051028; GO:0072686; GO:0090307","centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]",""
"1159","Pocillopora_acuta_HIv2___RNAseq.g8820.t1",1129.70986215374,-3.19666582303082,2.64585481480929,0.000212355974936216,0.00157191239584311,"Q3SYW2",2.58e-53,"Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment]","complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]","GO:0004252; GO:0005576; GO:0006508; GO:0006956; GO:0006958; GO:0009617; GO:0045087; GO:0046872","extracellular region [GO:0005576]","metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
"1160","Pocillopora_acuta_HIv2___RNAseq.11267_t",1417.79626460539,2.09477992798306,3.94692856605033,0.000212717026504885,0.00157308066248256,"Q05A36",4.03e-116,"RNA-binding E3 ubiquitin-protein ligase MEX3C (EC 2.3.2.27) (RING finger and KH domain-containing protein 2) (RING-type E3 ubiquitin transferase MEX3C)","chondrocyte hypertrophy [GO:0003415]; energy homeostasis [GO:0097009]; regulation of fat cell differentiation [GO:0045598]","GO:0003415; GO:0003723; GO:0005634; GO:0005737; GO:0045598; GO:0046872; GO:0061630; GO:0097009","cytoplasm [GO:0005737]; nucleus [GO:0005634]","metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]"
"1161","Pocillopora_acuta_HIv2___TS.g15614.t1",252.814842680518,3.28449322694849,2.91195856507352,0.000212731317465147,0.00157308066248256,"Q54HT5",2.43e-07,"Putative uncharacterized protein DDB_G0289245","","","",""
"1162","Pocillopora_acuta_HIv2___RNAseq.g19051.t1",23.5398908061935,8.30680100677598,3.6443815834409,0.00021708498220761,0.0016026994023287,NA,NA,NA,NA,NA,NA,NA
"1163","Pocillopora_acuta_HIv2___RNAseq.g9335.t1",5254.4169357378,2.8260922320918,5.18783584427186,0.000217507050810752,0.00160429473887135,NA,NA,NA,NA,NA,NA,NA
"1164","Pocillopora_acuta_HIv2___RNAseq.g1763.t1",844.616833144935,-3.10216196934266,1.79257152161673,0.000217789574298929,0.00160555983825674,"Q4LAL6",3.91e-36,"Homeobox protein aristaless-like 4","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0001228; GO:0005634; GO:0006357","nucleus [GO:0005634]","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"
"1165","Pocillopora_acuta_HIv2___RNAseq.g15290.t1",2980.34601632217,-3.79669527475026,1.79303750971875,0.000224584434240414,0.00165312430374216,"P00734",3.01e-53,"Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain]","acute-phase response [GO:0006953]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blood coagulation [GO:0007596]; cell surface receptor signaling pathway [GO:0007166]; cytolysis by host of symbiont cells [GO:0051838]; fibrinolysis [GO:0042730]; G protein-coupled receptor signaling pathway [GO:0007186]; ligand-gated ion channel signaling pathway [GO:1990806]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of platelet activation [GO:0010544]; negative regulation of proteolysis [GO:0045861]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; platelet activation [GO:0030168]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid kinase activity [GO:0090218]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; proteolysis [GO:0006508]; regulation of blood coagulation [GO:0030193]; regulation of cell shape [GO:0008360]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to wounding [GO:0009611]","GO:0001530; GO:0001934; GO:0004252; GO:0005102; GO:0005509; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006508; GO:0006953; GO:0007166; GO:0007186; GO:0007596; GO:0008083; GO:0008201; GO:0008284; GO:0008360; GO:0009611; GO:0010544; GO:0030168; GO:0030193; GO:0030194; GO:0030307; GO:0032024; GO:0032967; GO:0042730; GO:0045861; GO:0046427; GO:0048712; GO:0051281; GO:0051480; GO:0051838; GO:0051897; GO:0051918; GO:0061844; GO:0062023; GO:0070053; GO:0070062; GO:0070945; GO:0072562; GO:0090218; GO:1900016; GO:1900182; GO:1900738; GO:1990806; GO:2000379","blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]","calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; thrombospondin receptor activity [GO:0070053]"
"1166","Pocillopora_acuta_HIv2___RNAseq.g24097.t1",153.212837031582,1.03658189413677,1.95815040084291,0.000227061700988919,0.00167050887238236,"Q5F364",0,"Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)","cyclic nucleotide transport [GO:0070729]; glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; xenobiotic transport [GO:0042908]","GO:0005524; GO:0006869; GO:0008559; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042908; GO:0070729","basolateral plasma membrane [GO:0016323]","ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; glutathione transmembrane transporter activity [GO:0034634]"
"1167","Pocillopora_acuta_HIv2___RNAseq.g11343.t1",2459.01675963391,2.51522140728209,0.945122335114679,0.000228820841720387,0.00168259514725149,NA,NA,NA,NA,NA,NA,NA
"1168","Pocillopora_acuta_HIv2___RNAseq.g8748.t1",27.7479687232215,8.14059859640245,3.71808784320975,0.000231701156840434,0.00170118047337058,NA,NA,NA,NA,NA,NA,NA
"1169","Pocillopora_acuta_HIv2___RNAseq.g2185.t1b",2655.89435504385,3.52239516886981,3.13313016119285,0.0002328278202649,0.00170771886019853,"Q00223",2.33e-33,"Putative gastrointestinal growth factor xP4 (TFF p4.1)","","GO:0005576; GO:0008083","extracellular region [GO:0005576]","growth factor activity [GO:0008083]"
"1170","Pocillopora_acuta_HIv2___RNAseq.g6924.t1",223.007489333949,-3.21777610455031,2.10469961363973,0.000233154945217577,0.00170838557630549,NA,NA,NA,NA,NA,NA,NA
"1171","Pocillopora_acuta_HIv2___RNAseq.g627.t1",1143.28191094706,2.31483692793763,0.800695868179614,0.000233519313282026,0.00171018903661328,"Q5F3Z9",5.19e-57,"Zinc finger CCCH domain-containing protein 14","regulation of mRNA stability [GO:0043488]","GO:0005634; GO:0005737; GO:0008143; GO:0016607; GO:0043488; GO:0046872","cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]","metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]"
"1172","Pocillopora_acuta_HIv2___RNAseq.g11537.t1",24.1249821700645,8.26092708793476,3.76146369845385,0.000234560834831637,0.00171694732540729,NA,NA,NA,NA,NA,NA,NA
"1173","Pocillopora_acuta_HIv2___TS.g19260.t1",36.0768785823353,8.06832142552379,3.84616119815401,0.00023641076796898,0.00172873880076002,"A7SLX5",0,"2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 (EC 2.5.1.108) (Diphthamide biosynthesis protein 1) (Diphtheria toxin resistance protein 1) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1)","protein histidyl modification to diphthamide [GO:0017183]","GO:0017183; GO:0032991; GO:0046872; GO:0051539; GO:0090560","protein-containing complex [GO:0032991]","2-(3-amino-3-carboxypropyl)histidine synthase activity [GO:0090560]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]"
"1174","Pocillopora_acuta_HIv2___TS.g14217.t2",79.3250448038697,-3.29119143126012,2.64895829781056,0.000238350651442365,0.00174085072584774,"Q28DL4",2.16e-19,"TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6)","intracellular signaling cassette [GO:0141124]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]","GO:0004842; GO:0005164; GO:0005634; GO:0005811; GO:0005938; GO:0008270; GO:0042981; GO:0043122; GO:0070534; GO:0141124","cell cortex [GO:0005938]; lipid droplet [GO:0005811]; nucleus [GO:0005634]","tumor necrosis factor receptor binding [GO:0005164]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
"1175","Pocillopora_acuta_HIv2___RNAseq.g20561.t1b",138.612186869492,3.74161311027737,3.05759785134115,0.000243023014019409,0.00177171616672214,"Q9ULJ7",2.78e-80,"Ankyrin repeat domain-containing protein 50","endocytic recycling [GO:0032456]; protein transport [GO:0015031]","GO:0005768; GO:0015031; GO:0032456","endosome [GO:0005768]",""
"1176","Pocillopora_acuta_HIv2___TS.g1359.t1",25529.286334581,-2.45146050446534,0.915055186474845,0.000246125392532423,0.00178979698965789,"B8V7R6",0,"Collagen alpha chain","","GO:0005201; GO:0005576; GO:0005581","collagen trimer [GO:0005581]; extracellular region [GO:0005576]","extracellular matrix structural constituent [GO:0005201]"
"1177","Pocillopora_acuta_HIv2___TS.g1376.t2",280.402569190165,1.10538842301493,1.72279563091818,0.000246245575872456,0.00178979698965789,"A8XI14",1.34e-28,"Sugar transporter SWEET1","carbohydrate transport [GO:0008643]","GO:0000139; GO:0005794; GO:0005886; GO:0008643; GO:0016020; GO:0051119","Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]","sugar transmembrane transporter activity [GO:0051119]"
"1178","Pocillopora_acuta_HIv2___RNAseq.g20216.t1",23.4456244826826,-1.12310305103243,2.14528646768692,0.000248322902042281,0.00180308356181704,"Q80TR8",3.48e-35,"DDB1- and CUL4-associated factor 1 (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1)","B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]","GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0008180; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756","COP9 signalosome [GO:0008180]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","ATP binding [GO:0005524]; histone H2AT120 kinase activity [GO:1990244]; nuclear estrogen receptor binding [GO:0030331]; protein serine kinase activity [GO:0106310]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]"
"1179","Pocillopora_acuta_HIv2___RNAseq.g6231.t1",198.906719907403,-1.38957618265429,2.39976431542146,0.000249935865414648,0.0018129751039907,NA,NA,NA,NA,NA,NA,NA
"1180","Pocillopora_acuta_HIv2___RNAseq.g13581.t1",1030.77615703046,3.01013768094468,3.18443893294346,0.000250415984540109,0.00181554726836498,"Q5EAU9",3.56e-54,"Regulator of microtubule dynamics protein 3 (RMD-3) (Protein FAM82A2) (Protein FAM82C)","","GO:0000922; GO:0005634; GO:0005741","mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; spindle pole [GO:0000922]",""
"1181","Pocillopora_acuta_HIv2___RNAseq.g19647.t1",77.8397591748566,3.2639551691192,3.44853208222269,0.000251119000071835,0.00181791051903855,"Q7T105",2.63e-65,"Mesoderm induction early response protein 1 (Early response 1) (Er1) (Mi-er1) (Xmi-er1)","chromatin remodeling [GO:0006338]; regulation of DNA-templated transcription [GO:0006355]","GO:0003677; GO:0005634; GO:0006338; GO:0006355; GO:0017053","nucleus [GO:0005634]; transcription repressor complex [GO:0017053]","DNA binding [GO:0003677]"
"1182","Pocillopora_acuta_HIv2___RNAseq.g18027.t1",1566.63734852305,-2.40245143460641,0.893039178160187,0.000251657906334642,0.00182090042882654,NA,NA,NA,NA,NA,NA,NA
"1183","Pocillopora_acuta_HIv2___RNAseq.g25186.t1",446.619209424149,-2.01768328256854,3.311302494093,0.000252179415431176,0.00182200577029876,"P70191",7.73e-42,"TNF receptor-associated factor 5","apoptotic process [GO:0006915]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0005164; GO:0005737; GO:0005813; GO:0005829; GO:0006915; GO:0007165; GO:0008270; GO:0008284; GO:0009898; GO:0023019; GO:0031625; GO:0031996; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0043123; GO:0048255; GO:0051092; GO:0070534; GO:0097400","CD40 receptor complex [GO:0035631]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]","identical protein binding [GO:0042802]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"
"1184","Pocillopora_acuta_HIv2___RNAseq.g243.t1",69.7075816177688,3.2389320120134,1.37381924839138,0.000252188575230788,0.00182200577029876,"P0CI65",5.9e-38,"Nephrocystin-3","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546","ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]",""
"1185","Pocillopora_acuta_HIv2___RNAseq.g12374.t1",3131.42127049564,-3.72837365479276,1.76955853787313,0.000254122636017076,0.00183506231021018,"Q9VH14",3.51e-17,"Tissue inhibitor of metalloproteinase","basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; delamination [GO:0060232]; imaginal disc-derived wing expansion [GO:0048526]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; oogenesis [GO:0048477]; phototaxis [GO:0042331]; tracheal outgrowth, open tracheal system [GO:0007426]; tracheal pit formation in open tracheal system [GO:0035202]; ventral cord development [GO:0007419]; wing disc morphogenesis [GO:0007472]","GO:0002020; GO:0005615; GO:0007155; GO:0007419; GO:0007426; GO:0007472; GO:0008191; GO:0008270; GO:0030425; GO:0031012; GO:0035202; GO:0042331; GO:0048477; GO:0048526; GO:0051045; GO:0060232; GO:0071711","dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]","metalloendopeptidase inhibitor activity [GO:0008191]; protease binding [GO:0002020]; zinc ion binding [GO:0008270]"
"1186","Pocillopora_acuta_HIv2___RNAseq.g23004.t1",645.619041811558,2.71258041718639,1.14576984455785,0.000256298309067808,0.00184708457516531,"Q6GPD0",6.04e-171,"Rho GTPase-activating protein 32 (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS)","signal transduction [GO:0007165]","GO:0005096; GO:0005737; GO:0005886; GO:0007165; GO:0014069; GO:1901981","cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]","GTPase activator activity [GO:0005096]; phosphatidylinositol phosphate binding [GO:1901981]"
"1187","Pocillopora_acuta_HIv2___RNAseq.g25761.t1",1143.87904687794,-2.55110584776823,1.009589453948,0.000257007255508836,0.00185127138629473,"A6NMZ7",1.41e-45,"Collagen alpha-6(VI) chain","cell adhesion [GO:0007155]","GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023","collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]",""
"1188","Pocillopora_acuta_HIv2___RNAseq.15128_t",61.342460158374,1.22312111382271,2.42977997422016,0.000257416917523397,0.00185329930067616,NA,NA,NA,NA,NA,NA,NA
"1189","Pocillopora_acuta_HIv2___TS.g2757.t1",150.917679634835,3.09693774558139,3.36394381406164,0.000262431435475351,0.00188749937161027,"Q9BSF4",1.86e-33,"Mitochondrial import inner membrane translocase subunit Tim29 (TIM29)","protein insertion into mitochondrial inner membrane [GO:0045039]","GO:0005743; GO:0005758; GO:0042721; GO:0045039; GO:0140318","mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]","protein transporter activity [GO:0140318]"
"1190","Pocillopora_acuta_HIv2___RNAseq.g22638.t1",17813.0516537474,-2.4199425057082,0.909511274523521,0.000266867078930036,0.00191371612773626,"P08120",0,"Collagen alpha-1(IV) chain (Collagen type IV alpha 1)","basement membrane organization [GO:0071711]; cardiac muscle cell development [GO:0055013]; dorsal closure [GO:0007391]; extracellular matrix organization [GO:0030198]; intestinal epithelial structure maintenance [GO:0060729]; post-embryonic digestive tract morphogenesis [GO:0048621]","GO:0005201; GO:0005587; GO:0005604; GO:0005615; GO:0007391; GO:0030020; GO:0030198; GO:0048621; GO:0055013; GO:0060729; GO:0062023; GO:0071711","basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]","extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]"
"1191","Pocillopora_acuta_HIv2___RNAseq.g687.t1",352.086281235166,1.14602460604941,2.19696881845443,0.000268304889961203,0.00192219787089881,"Q9H9S5",1.16e-146,"Ribitol 5-phosphate transferase FKRP (EC 2.7.8.-) (Fukutin-related protein) (Ribitol-5-phosphate transferase)","adult walking behavior [GO:0007628]; basement membrane organization [GO:0071711]; bone mineralization [GO:0030282]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; connective tissue development [GO:0061448]; connective tissue replacement [GO:0097709]; creatine metabolic process [GO:0006600]; diaphragm development [GO:0060539]; filtration diaphragm assembly [GO:0036058]; glial cell differentiation [GO:0010001]; glycolytic process [GO:0006096]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; localization of cell [GO:0051674]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; muscle contraction [GO:0006936]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; oxygen metabolic process [GO:0072592]; pentitol metabolic process [GO:0019519]; pentose metabolic process [GO:0019321]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; protein import [GO:0017038]; protein O-linked mannosylation [GO:0035269]; protein processing [GO:0016485]; protein tetramerization [GO:0051262]; reelin-mediated signaling pathway [GO:0038026]; reproductive process [GO:0022414]; respiratory system process [GO:0003016]; response to activity [GO:0014823]; response to alcohol [GO:0097305]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue regeneration [GO:0043403]","GO:0000139; GO:0001701; GO:0001764; GO:0002162; GO:0003007; GO:0003016; GO:0005615; GO:0005654; GO:0005791; GO:0005794; GO:0005829; GO:0006096; GO:0006600; GO:0006629; GO:0006936; GO:0006954; GO:0007420; GO:0007628; GO:0009410; GO:0010001; GO:0014823; GO:0016485; GO:0016780; GO:0017038; GO:0019321; GO:0019519; GO:0022414; GO:0030282; GO:0035269; GO:0035437; GO:0036058; GO:0038026; GO:0042383; GO:0042802; GO:0043010; GO:0043236; GO:0043403; GO:0043491; GO:0046872; GO:0050905; GO:0051262; GO:0051384; GO:0051674; GO:0060539; GO:0061448; GO:0071711; GO:0072592; GO:0097305; GO:0097709; GO:0098528; GO:0098723","cytosol [GO:0005829]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; rough endoplasmic reticulum [GO:0005791]; sarcolemma [GO:0042383]; skeletal muscle myofibril [GO:0098723]","dystroglycan binding [GO:0002162]; identical protein binding [GO:0042802]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]"
"1192","Pocillopora_acuta_HIv2___RNAseq.g23455.t1",86.4851502214077,-3.28454805113132,1.82783558961652,0.000270807143278777,0.00193716840770733,"P27401",5.78e-07,"Pro-Pol polyprotein (Pr125Pol) [Cleaved into: Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (EC 3.4.23.-) (p87Pro-RT-RNaseH); Protease/Reverse transcriptase (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.4.23.-) (p65Pro-RT); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42In)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; proteolysis [GO:0006508]; symbiont entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]","GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0006508; GO:0015074; GO:0030430; GO:0042025; GO:0043657; GO:0044423; GO:0044826; GO:0046718; GO:0046872; GO:0075713; GO:0075732","host cell [GO:0043657]; host cell cytoplasm [GO:0030430]; host cell nucleus [GO:0042025]; virion component [GO:0044423]","aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]"
"1193","Pocillopora_acuta_HIv2___RNAseq.g28025.t1",909.958746722603,2.38543066918045,0.853053431726213,0.000272272998053659,0.00194669137115577,"Q9JLB4",4.52e-24,"Cubilin (Intrinsic factor-cobalamin receptor)","cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584]","GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062","apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]","calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]"
"1194","Pocillopora_acuta_HIv2___RNAseq.g5494.t1",338.00767677427,2.7883121394277,1.38762519453013,0.000274350215994545,0.00196057387556576,"Q3SZV6",2.06e-26,"Mitochondrial import inner membrane translocase subunit Tim21 (TIM21-like protein, mitochondrial)","mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; protein import into mitochondrial matrix [GO:0030150]","GO:0005744; GO:0030150; GO:0032981; GO:0033617","TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]",""
"1195","Pocillopora_acuta_HIv2___RNAseq.g29951.t1",553.480578933693,-2.31162861207442,0.798980915607724,0.000274518237760729,0.00196080582270182,NA,NA,NA,NA,NA,NA,NA
"1196","Pocillopora_acuta_HIv2___RNAseq.g23588.t1",1186.7343084127,-2.43476065262272,0.896619998443951,0.000274758997356514,0.00196097486763484,"Q01484",3.68e-69,"Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)","atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]","GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259","A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]","ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325]"
"1197","Pocillopora_acuta_HIv2___RNAseq.g28270.t1",299.79990274016,6.44812689685943,5.22698049487644,0.000279392113718815,0.00198678836422268,"O08734",1.42e-26,"Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK)","animal organ regeneration [GO:0031100]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell negative selection [GO:0002352]; blood vessel remodeling [GO:0001974]; calcium ion transport into cytosol [GO:0060402]; cellular response to mechanical stimulus [GO:0071260]; cellular response to UV [GO:0034644]; endocrine pancreas development [GO:0031018]; epithelial cell proliferation [GO:0050673]; establishment of localization in cell [GO:0051649]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fibroblast apoptotic process [GO:0044346]; homeostasis of number of cells [GO:0048872]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; leukocyte homeostasis [GO:0001776]; limb morphogenesis [GO:0035108]; mitochondrial fusion [GO:0008053]; myeloid cell homeostasis [GO:0002262]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; post-embryonic camera-type eye morphogenesis [GO:0048597]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to ethanol [GO:0045471]; response to fungus [GO:0009620]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to mycotoxin [GO:0010046]; response to organic cyclic compound [GO:0014070]; response to UV-C [GO:0010225]; response to xenobiotic stimulus [GO:0009410]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068]","GO:0001776; GO:0001782; GO:0001783; GO:0001836; GO:0001974; GO:0002262; GO:0002352; GO:0005739; GO:0005741; GO:0005783; GO:0005829; GO:0008053; GO:0008285; GO:0008630; GO:0009410; GO:0009620; GO:0010046; GO:0010225; GO:0010248; GO:0010332; GO:0010524; GO:0010629; GO:0014070; GO:0015288; GO:0031018; GO:0031072; GO:0031100; GO:0031334; GO:0031966; GO:0032471; GO:0033137; GO:0034644; GO:0035108; GO:0042542; GO:0042802; GO:0042803; GO:0043065; GO:0044325; GO:0044346; GO:0044877; GO:0045471; GO:0045862; GO:0046872; GO:0046902; GO:0046930; GO:0046982; GO:0048597; GO:0048872; GO:0050673; GO:0051087; GO:0051400; GO:0051649; GO:0051726; GO:0051881; GO:0060068; GO:0060402; GO:0070059; GO:0070242; GO:0071260; GO:0090200; GO:0090201; GO:0097145; GO:0097192; GO:1900103; GO:1901029; GO:1901030; GO:1902262","BAK complex [GO:0097145]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; pore complex [GO:0046930]","BH domain binding [GO:0051400]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; porin activity [GO:0015288]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; transmembrane transporter binding [GO:0044325]"
"1198","Pocillopora_acuta_HIv2___RNAseq.g6299.t1",72.0797018030765,2.82859367806625,1.10045011049509,0.000279890484864632,0.0019893542865268,NA,NA,NA,NA,NA,NA,NA
"1199","Pocillopora_acuta_HIv2___RNAseq.g802.t1",510.719432962993,-3.27714562662575,1.49532816359234,0.000283213755750515,0.00200902587698649,"Q90Z00",1.16e-08,"Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)","anatomical structure homeostasis [GO:0060249]; cardiac muscle tissue development [GO:0048738]; cartilage development [GO:0051216]; cell migration in hindbrain [GO:0021535]; dorsal/ventral pattern formation [GO:0009953]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; liver development [GO:0001889]; mesoderm development [GO:0007498]; negative regulation of endodermal cell fate specification [GO:0042664]; olfactory nerve formation [GO:0021628]; olfactory placode morphogenesis [GO:0071699]; pectoral fin development [GO:0033339]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line development [GO:0048916]; response to ethanol [GO:0045471]; skin morphogenesis [GO:0043589]","GO:0001889; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007498; GO:0008201; GO:0008284; GO:0008543; GO:0009953; GO:0017134; GO:0018108; GO:0021535; GO:0021628; GO:0031101; GO:0031410; GO:0033339; GO:0036342; GO:0042664; GO:0043235; GO:0043406; GO:0043589; GO:0045471; GO:0045597; GO:0048738; GO:0048916; GO:0051216; GO:0060249; GO:0071699","cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]","ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]"
"1200","Pocillopora_acuta_HIv2___RNAseq.g27067.t1",1363.7001598054,-1.0627743795261,1.7751784760158,0.000285358726613713,0.00202324932438272,NA,NA,NA,NA,NA,NA,NA
"1201","Pocillopora_acuta_HIv2___RNAseq.g14426.t1",202.977365817956,3.24152807191741,2.17076881596211,0.000290013499905627,0.00205323311925354,"Q9H0C5",2.86e-16,"BTB/POZ domain-containing protein 1 (Hepatitis C virus NS5A-transactivated protein 8) (HCV NS5A-transactivated protein 8)","muscle organ development [GO:0007517]; neurogenesis [GO:0022008]; protein ubiquitination [GO:0016567]; regulation of protein binding [GO:0043393]","GO:0000932; GO:0005654; GO:0005829; GO:0007517; GO:0016567; GO:0022008; GO:0032991; GO:0036464; GO:0042802; GO:0043393; GO:0097602","cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; protein-containing complex [GO:0032991]","cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]"
"1202","Pocillopora_acuta_HIv2___RNAseq.g7076.t1",1274.53713067447,-3.49004384500056,1.51960532376361,0.000296737077611694,0.00209366101979295,NA,NA,NA,NA,NA,NA,NA
"1203","Pocillopora_acuta_HIv2___RNAseq.g15832.t1",1352.41797806265,-3.32397106606691,2.20886573263959,0.000297081209244766,0.00209506709435217,"B3EWZ5",2.52e-152,"MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1)","","GO:0005576; GO:0016020","extracellular region [GO:0005576]; membrane [GO:0016020]",""
"1204","Pocillopora_acuta_HIv2___RNAseq.g2577.t1",2312.20319626339,-2.74883926101326,1.2376810000735,0.000300887026587783,0.00211777613263537,"B2RVL6",9.01e-80,"Zinc finger CCHC domain-containing protein 24","","GO:0003676; GO:0008270","","nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
"1205","Pocillopora_acuta_HIv2___RNAseq.g11589.t1",43.6256406216019,4.41979847973461,1.7720118124152,0.00030323480897649,0.00213222570589983,"Q86YH6",1.29e-83,"All trans-polyprenyl-diphosphate synthase PDSS2 (All-trans-decaprenyl-diphosphate synthase subunit 2) (EC 2.5.1.91) (Candidate tumor suppressor protein) (Decaprenyl pyrophosphate synthase subunit 2) (Decaprenyl-diphosphate synthase subunit 2) (Solanesyl-diphosphate synthase subunit 2)","cerebellum development [GO:0021549]; isoprenoid biosynthetic process [GO:0008299]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744]","GO:0004659; GO:0005759; GO:0005829; GO:0006744; GO:0008299; GO:0021549; GO:0032478; GO:0046982; GO:0050878; GO:0052923; GO:0097269; GO:1990234","cytosol [GO:0005829]; heterotetrameric polyprenyl diphosphate synthase complex [GO:0032478]; mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]","all-trans-decaprenyl-diphosphate synthase activity [GO:0097269]; all-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific) activity [GO:0052923]; prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982]"
"1206","Pocillopora_acuta_HIv2___RNAseq.g3788.t1",210.873224673444,2.60436046253459,2.7165054148739,0.000309380910466078,0.002171526267657,"Q6DG32",1.12e-98,"Solute carrier family 25 member 36-A","mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleotide import into mitochondrion [GO:1990519]","GO:0000002; GO:0005739; GO:0005743; GO:0015218; GO:1990519","mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]","pyrimidine nucleotide transmembrane transporter activity [GO:0015218]"
"1207","Pocillopora_acuta_HIv2___TS.g23178.t1",7125.51468368757,-2.58878553527511,1.07033674005084,0.000310848778396089,0.00217992861262038,"A0MSJ1",4.25e-146,"Collagen alpha-1(XXVII) chain B","bone mineralization [GO:0030282]; extracellular matrix organization [GO:0030198]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501]","GO:0001501; GO:0005581; GO:0005615; GO:0030020; GO:0030198; GO:0030282; GO:0046872; GO:0048570; GO:0062023","collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]","extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]"
"1208","Pocillopora_acuta_HIv2___RNAseq.g15155.t1",1418.71685129792,-1.87034251816184,0.60203770201095,0.000310923169789535,0.00217992861262038,NA,NA,NA,NA,NA,NA,NA
"1209","Pocillopora_acuta_HIv2___RNAseq.g9066.t1",473.905013300093,-1.98252246151783,0.650901909750448,0.000311464880517698,0.00218266862006201,NA,NA,NA,NA,NA,NA,NA
"1210","Pocillopora_acuta_HIv2___TS.g435.t1",746.467681055603,2.50656085181737,0.973609057427663,0.000312881757100441,0.00219047518620561,NA,NA,NA,NA,NA,NA,NA
"1211","Pocillopora_acuta_HIv2___RNAseq.g25867.t1",750.997782165744,2.92479315683628,2.97908823041713,0.000314761112706343,0.00220256639292914,"Q0VCA2",7.31e-30,"Arrestin domain-containing protein 3","protein transport [GO:0015031]","GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005886; GO:0015031","cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; plasma membrane [GO:0005886]",""
"1212","Pocillopora_acuta_HIv2___RNAseq.g20669.t1",343.77235351548,1.10916381199164,1.74006873838228,0.000316518134981142,0.00221272030177247,"P46428",2.23e-31,"Glutathione S-transferase (EC 2.5.1.18) (GST class-sigma)","","GO:0004364","","glutathione transferase activity [GO:0004364]"
"1213","Pocillopora_acuta_HIv2___RNAseq.g19687.t1",82.4098037014261,1.44573942061932,2.32470941151579,0.000319470329803488,0.00222797437332577,NA,NA,NA,NA,NA,NA,NA
"1214","Pocillopora_acuta_HIv2___TS.g8275.t1",401.495413003185,2.13542110585039,5.38764278768964,0.00032123211912776,0.00223918138364526,"P08059",0,"Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI)","gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]","GO:0004347; GO:0005125; GO:0005615; GO:0005829; GO:0006094; GO:0006096; GO:0048029; GO:0051156; GO:0097367","cytosol [GO:0005829]; extracellular space [GO:0005615]","carbohydrate derivative binding [GO:0097367]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; monosaccharide binding [GO:0048029]"
"1215","Pocillopora_acuta_HIv2___RNAseq.g7585.t1",4729.51343393641,2.19797268324685,0.771442592602056,0.000321759327639367,0.00224177597060491,"Q5T089",9.66e-06,"MORN repeat-containing protein 1","","","",""
"1216","Pocillopora_acuta_HIv2___RNAseq.g2037.t1",67.5959589518068,-2.68330291724781,1.00300934030982,0.000323767011550614,0.00225467792733177,"Q6JEL3",3.36e-34,"Kelch-like protein 10","cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]","GO:0000902; GO:0005737; GO:0007286; GO:0008584; GO:0009566; GO:0016567; GO:0048808; GO:0048873","cytoplasm [GO:0005737]",""
"1217","Pocillopora_acuta_HIv2___RNAseq.g28255.t1",1346.05577356654,2.51213042897125,1.01487868394401,0.000330420640693732,0.00229769430143949,"Q6DIR8",0,"Paladin","","GO:0005829","cytosol [GO:0005829]",""
"1218","Pocillopora_acuta_HIv2___RNAseq.g12286.t1",225.884972465831,2.88836136775645,1.16155334306348,0.000333831618984662,0.00231807034901304,"Q9I928",1.2e-13,"Fucolectin-4","regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]","GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088","extracellular space [GO:0005615]","calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]"
"1219","Pocillopora_acuta_HIv2___RNAseq.g12892.t1",323.703214811455,-2.53403917331591,3.04111318518992,0.000341150935662335,0.00236322180719349,"Q2KHZ8",1.26e-164,"Lysosomal acid glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase)","autophagy [GO:0006914]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; regulation of TOR signaling [GO:0032006]","GO:0004336; GO:0004348; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006680; GO:0006914; GO:0007040; GO:0008203; GO:0030259; GO:0032006; GO:0046527; GO:0050295","endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]","galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295]"
"1220","Pocillopora_acuta_HIv2___RNAseq.g28910.t1",2807.76704565131,-3.22172993197825,1.98561511760122,0.000345904992563137,0.00238860489396348,"O00339",4.12e-72,"Matrilin-2","axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; response to axon injury [GO:0048678]","GO:0001764; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0048678; GO:0062023; GO:0120216","basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; matrilin complex [GO:0120216]","calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]"
"1221","Pocillopora_acuta_HIv2___RNAseq.g20688.t1",4154.69321679724,1.94452871335674,0.645234786097317,0.000353256111671869,0.00243425269138729,"Q8WU66",2.96e-18,"Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170","cell surface [GO:0009986]; ciliary membrane [GO:0060170]; extracellular region [GO:0005576]; stereocilium [GO:0032420]",""
"1222","Pocillopora_acuta_HIv2___RNAseq.5656_t",23.6643379102425,5.65188912786975,2.76711998544485,0.00035599082341179,0.00244843141694157,NA,NA,NA,NA,NA,NA,NA
"1223","Pocillopora_acuta_HIv2___RNAseq.g1863.t1",1426.30050883794,2.69747865614568,1.19827649629484,0.000357396924627848,0.00245693399135798,"Q8TD57",0,"Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b)","cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]","GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729","9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]"
"1224","Pocillopora_acuta_HIv2___RNAseq.g23886.t1",1411.88130779252,-3.17380457474412,1.74426358496937,0.000368162491211696,0.00252254963187398,"P07942",0,"Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta)","cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]","GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005788; GO:0007155; GO:0021812; GO:0030335; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043257; GO:0043259; GO:0045785; GO:0048471; GO:0050679; GO:0051149; GO:0062023; GO:0070062; GO:0098637; GO:0110011; GO:2001046","basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637]","extracellular matrix structural constituent [GO:0005201]; structural molecule activity [GO:0005198]"
"1225","Pocillopora_acuta_HIv2___RNAseq.g16037.t1",1991.33855410664,-2.43072300491515,0.986489136364551,0.000372142520492595,0.00254740625480592,"Q96AY4",4.01e-24,"Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301","centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922]","kinase binding [GO:0019900]"
"1226","Pocillopora_acuta_HIv2___RNAseq.g16772.t1",257.697434426489,-3.06553001395368,2.50086891577774,0.000372411116769096,0.00254803897490455,NA,NA,NA,NA,NA,NA,NA
"1227","Pocillopora_acuta_HIv2___TS.g26218.t1",5184.38010298222,1.77594109772744,0.56776984087269,0.000374070669895918,0.00255818353161918,NA,NA,NA,NA,NA,NA,NA
"1228","Pocillopora_acuta_HIv2___TS.g30706.t1",241.33656049606,-1.05041846501629,2.04193995568725,0.000375378101730545,0.00256591156116758,"P33450",4.31e-16,"Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]","GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008285; GO:0009888; GO:0010629; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0090175; GO:0090176; GO:0090251; GO:0098609","apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]","cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]"
"1229","Pocillopora_acuta_HIv2___RNAseq.g4073.t1",505.37798999216,-2.61589934072828,3.33384167847799,0.000382219895153945,0.00260529150023877,"P17124",1.31e-44,"Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I)","chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; positive regulation of vasoconstriction [GO:0045907]","GO:0001696; GO:0004969; GO:0004993; GO:0005886; GO:0007187; GO:0007268; GO:0030425; GO:0030594; GO:0045202; GO:0045907","dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202]","G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]"
"1230","Pocillopora_acuta_HIv2___RNAseq.g20678.t1b",6419.05717657914,1.87951082914751,0.619006971403062,0.000389641165191795,0.00265212697098077,"Q6DK93",4.71e-19,"Cornifelin homolog","","","",""
"1231","Pocillopora_acuta_HIv2___RNAseq.g19367.t1",1104.62737374208,2.69373406221319,1.24400015385251,0.000392460632249018,0.00266755196656476,"Q9WU20",0,"Methylenetetrahydrofolate reductase (NADPH) (EC 1.5.1.53)","methionine biosynthetic process [GO:0009086]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]","GO:0004489; GO:0009086; GO:0035999; GO:0046653; GO:0050660; GO:0050661; GO:0071949; GO:0106313","","FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methylenetetrahydrofolate reductase (NADPH) activity [GO:0106313]; NADP binding [GO:0050661]"
"1232","Pocillopora_acuta_HIv2___RNAseq.g27039.t1",5675.97667964296,-3.27738985231532,1.51829336754077,0.000392789032393909,0.00266853009137881,"P51029",9.02e-25,"Protein Wnt-8b","canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]; Wnt signaling pathway [GO:0016055]","GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0016055; GO:0021854; GO:0021879; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679","extracellular space [GO:0005615]","cytokine activity [GO:0005125]; frizzled binding [GO:0005109]"
"1233","Pocillopora_acuta_HIv2___TS.g4251.t1b",497.781081653622,1.15536928654613,1.87798622254513,0.000394267745502888,0.00267606225760383,NA,NA,NA,NA,NA,NA,NA
"1234","Pocillopora_acuta_HIv2___RNAseq.g7809.t1",1634.90870211496,2.56901234349717,1.10769171032958,0.000398717677793977,0.00270246133627558,NA,NA,NA,NA,NA,NA,NA
"1235","Pocillopora_acuta_HIv2___RNAseq.g29617.t1",448.989736755592,3.13030491393471,2.11407774526527,0.000404428565095657,0.00273604058257417,"Q5ZMH1",8.79e-168,"Septin-2","cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224]","GO:0003924; GO:0005525; GO:0005737; GO:0005819; GO:0005940; GO:0007224; GO:0008021; GO:0008104; GO:0015630; GO:0017157; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0060090; GO:0060170; GO:0060271; GO:0061640","cell division site [GO:0032153]; ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]","GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]"
"1236","Pocillopora_acuta_HIv2___TS.g23932.t1",273.508241549708,1.7495609694542,3.2935017529565,0.00041110919791863,0.00277604268846641,"P52784",0,"ATP-dependent 6-phosphofructokinase, muscle type (ATP-PFK) (PFK-M) (EC 2.7.1.11) (6-phosphofructokinase type A) (Phosphofructo-1-kinase isozyme A) (PFK-A) (Phosphohexokinase)","canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]","GO:0003872; GO:0005524; GO:0005945; GO:0006002; GO:0016020; GO:0016208; GO:0030388; GO:0042802; GO:0046872; GO:0048029; GO:0061621; GO:0070095","6-phosphofructokinase complex [GO:0005945]; membrane [GO:0016020]","6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]"
"1237","Pocillopora_acuta_HIv2___TS.g15692.t1",21.425933578978,7.97702112609064,3.78526244456207,0.00041637660528179,0.0028076788898815,NA,NA,NA,NA,NA,NA,NA
"1238","Pocillopora_acuta_HIv2___RNAseq.g29895.t1",397.987178506803,-3.09598703098146,1.20187114337745,0.000417920676875267,0.00281546561263338,"P57102",3.63e-27,"Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND)","cardiac muscle cell differentiation [GO:0055007]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cardiogenic plate morphogenesis [GO:0003142]; determination of intestine left/right asymmetry [GO:0071908]; embryonic heart tube formation [GO:0003144]; embryonic pectoral fin morphogenesis [GO:0035118]; embryonic viscerocranium morphogenesis [GO:0048703]; heart contraction [GO:0060047]; heart development [GO:0007507]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; noradrenergic neuron differentiation [GO:0003357]; polarized epithelial cell differentiation [GO:0030859]; proepicardium development [GO:0003342]; regulation of transcription by RNA polymerase II [GO:0006357]; sympathetic nervous system development [GO:0048485]; thyroid gland development [GO:0030878]","GO:0000977; GO:0000981; GO:0001947; GO:0003007; GO:0003142; GO:0003144; GO:0003342; GO:0003357; GO:0005634; GO:0006357; GO:0007507; GO:0010002; GO:0030859; GO:0030878; GO:0035051; GO:0035118; GO:0046983; GO:0048485; GO:0048703; GO:0055007; GO:0060047; GO:0071908","nucleus [GO:0005634]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"
"1239","Pocillopora_acuta_HIv2___RNAseq.g15784.t1",122.293115182267,1.94825808616593,3.30978449585221,0.000419609485472578,0.00282421200459533,"Q8K301",0,"Probable ATP-dependent RNA helicase DDX52 (EC 3.6.4.13) (ATP-dependent RNA helicase ROK1-like) (DEAD box protein 52)","maturation of SSU-rRNA [GO:0030490]","GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016887; GO:0030490","nucleolus [GO:0005730]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
"1240","Pocillopora_acuta_HIv2___RNAseq.g12745.t1",1468.13090961765,-2.40836176958319,1.00479507503044,0.000421129202536233,0.00283180510715206,"Q9Y5Z4",1.25e-35,"Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL)","","GO:0005576; GO:0005737; GO:0005739; GO:0020037; GO:0035578; GO:0070062","azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]","heme binding [GO:0020037]"
"1241","Pocillopora_acuta_HIv2___RNAseq.g24688.t1",1510.13690624933,-2.91589115021917,1.91052461234196,0.000426694882216907,0.00286124931682214,"Q9ULB1",6.92e-34,"Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha)","adult behavior [GO:0030534]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; learning [GO:0007612]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]","GO:0005246; GO:0005509; GO:0005730; GO:0005783; GO:0005886; GO:0007158; GO:0007268; GO:0007269; GO:0007411; GO:0007416; GO:0007612; GO:0009986; GO:0030534; GO:0031965; GO:0031982; GO:0033130; GO:0035176; GO:0038023; GO:0042297; GO:0042734; GO:0042995; GO:0043025; GO:0050839; GO:0050885; GO:0051965; GO:0051968; GO:0071625; GO:0090129; GO:0097104; GO:0097109; GO:0097116; GO:0097118; GO:0097119; GO:2000463","cell projection [GO:0042995]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; vesicle [GO:0031982]","acetylcholine receptor binding [GO:0033130]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]"
"1242","Pocillopora_acuta_HIv2___TS.g24743.t1",131.030297610325,-2.62631395126161,1.13758197241892,0.000429861827363579,0.00287848216249389,"Q8NDA2",7.89e-19,"Hemicentin-2","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808]","GO:0005509; GO:0005576; GO:0005886; GO:0007156; GO:0008046; GO:0030424; GO:0032154; GO:0043025; GO:0050808; GO:0062023","axon [GO:0030424]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]","axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509]"
"1243","Pocillopora_acuta_HIv2___RNAseq.g16781.t1",2783.43402669958,-2.73310463575204,3.75146099568392,0.00043144440413424,0.00288640696641889,NA,NA,NA,NA,NA,NA,NA
"1244","Pocillopora_acuta_HIv2___RNAseq.g10855.t1",430.375091833424,-2.84689066869956,1.51851945152019,0.000435700000097994,0.00290815173115708,"Q8HYN8",5.31e-09,"Adrenocorticotropic hormone receptor (ACTH receptor) (ACTH-R) (Adrenocorticotropin receptor) (Melanocortin receptor 2) (MC2-R)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; regulation of metabolic process [GO:0019222]","GO:0004930; GO:0004978; GO:0005737; GO:0005886; GO:0007189; GO:0019222","cytoplasm [GO:0005737]; plasma membrane [GO:0005886]","corticotropin receptor activity [GO:0004978]; G protein-coupled receptor activity [GO:0004930]"
"1245","Pocillopora_acuta_HIv2___RNAseq.g11391.t1",1682.58469282923,-2.71667403544795,2.69147322253698,0.000440661773456743,0.0029372036365338,NA,NA,NA,NA,NA,NA,NA
"1246","Pocillopora_acuta_HIv2___RNAseq.g29952.t1",1303.87918489441,-2.81145324612558,1.4747277990208,0.000441361979953549,0.00294051574299776,NA,NA,NA,NA,NA,NA,NA
"1247","Pocillopora_acuta_HIv2___RNAseq.g20712.t1",452.795435298219,1.0552311973753,1.79254618089567,0.000441808075062158,0.00294213259562571,"Q08CS6",7.06e-17,"DBH-like monooxygenase protein 2 homolog (EC 1.14.17.-)","dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]","GO:0004500; GO:0005507; GO:0005615; GO:0006589; GO:0030667; GO:0042420; GO:0042421","extracellular space [GO:0005615]; secretory granule membrane [GO:0030667]","copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]"
"1248","Pocillopora_acuta_HIv2___TS.g22351.t2",823.990219553825,-1.38894508918156,2.61824697086935,0.000445369195380025,0.00296427136470877,"P04927",6.84e-11,"S-antigen protein","","GO:0020003","symbiont-containing vacuole [GO:0020003]",""
"1249","Pocillopora_acuta_HIv2___RNAseq.g2519.t1",2787.3644931296,2.19968857902123,4.62773664034904,0.000445542446548455,0.00296427136470877,"O75899",1.2e-86,"Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]","GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712","cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]","G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888]"
"1250","Pocillopora_acuta_HIv2___TS.g28207.t1",188.339515035872,2.35027392027756,3.17803341327143,0.000450502774874668,0.0029931429195164,"A0A8V1ABE9",2.07e-122,"D-serine dehydratase (EC 4.3.1.18) (D-serine deaminase)","D-serine catabolic process [GO:0036088]","GO:0005737; GO:0008270; GO:0008721; GO:0030170; GO:0030425; GO:0036088","cytoplasm [GO:0005737]; dendrite [GO:0030425]","D-serine ammonia-lyase activity [GO:0008721]; pyridoxal phosphate binding [GO:0030170]; zinc ion binding [GO:0008270]"
"1251","Pocillopora_acuta_HIv2___TS.g23176.t1",24.8894874951279,7.80838514596373,3.8346582944725,0.000453224910784715,0.00300984623948123,NA,NA,NA,NA,NA,NA,NA
"1252","Pocillopora_acuta_HIv2___TS.g3265.t1",667.550514401953,-3.11329958785023,1.67089519312368,0.000456345295461261,0.00302609217541602,"Q64487",3.22e-154,"Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling [GO:0099537]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]","GO:0004725; GO:0005102; GO:0007157; GO:0030182; GO:0042734; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099151; GO:0099537; GO:0099545; GO:0099560","glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]","cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]"
"1253","Pocillopora_acuta_HIv2___TS.g12121.t1",3563.48809330222,-2.16268989749835,6.32524914259267,0.000456594778971777,0.00302609217541602,"F4JKH6",2.72e-13,"Protein REDUCED CHLOROPLAST COVERAGE 2 (Protein TPR-domain suppressor of STIMPY)","chloroplast localization [GO:0019750]","GO:0003729; GO:0005634; GO:0005829; GO:0005886; GO:0019750","cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]","mRNA binding [GO:0003729]"
"1254","Pocillopora_acuta_HIv2___RNAseq.11667_t",93.157064543126,2.74559090862384,5.03320578396106,0.000460089940509274,0.00304564800893645,NA,NA,NA,NA,NA,NA,NA
"1255","Pocillopora_acuta_HIv2___RNAseq.g5347.t1",2005.24813127323,-1.33225180237018,2.27398839985035,0.000461703063629067,0.00305492823070944,"Q5XJN2",6.82e-53,"Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30)","cell redox homeostasis [GO:0045454]; hematopoietic stem cell proliferation [GO:0071425]; immune system process [GO:0002376]","GO:0002376; GO:0005576; GO:0005764; GO:0016667; GO:0016671; GO:0045454; GO:0047134; GO:0071425","extracellular region [GO:0005576]; lysosome [GO:0005764]","oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein-disulfide reductase (NAD(P)H) activity [GO:0047134]"
"1256","Pocillopora_acuta_HIv2___TS.g3883.t1",1043.08603250223,-2.15612148013356,0.790337676457486,0.000462801128308347,0.00305939466172392,"P50238",1.41e-43,"Cysteine-rich protein 1 (CRP-1) (Cysteine-rich heart protein) (CRHP) (hCRHP) (Cysteine-rich intestinal protein) (CRIP)","cellular response to antibiotic [GO:0071236]; cellular response to UV-B [GO:0071493]; heart development [GO:0007507]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; prostate gland stromal morphogenesis [GO:0060741]; regulation of gene expression [GO:0010468]; response to zinc ion [GO:0010043]","GO:0005737; GO:0006955; GO:0007507; GO:0008270; GO:0008630; GO:0010043; GO:0010468; GO:0042277; GO:0060741; GO:0071236; GO:0071493","cytoplasm [GO:0005737]","peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"
"1257","Pocillopora_acuta_HIv2___RNAseq.g27887.t1",63.4878315257775,-3.65350179174976,1.47355324601946,0.00046458149430505,0.00306976095643136,"Q9P215",3.62e-21,"Pogo transposable element with KRAB domain","regulation of DNA-templated transcription [GO:0006355]","GO:0003677; GO:0005634; GO:0005654; GO:0006355","nucleoplasm [GO:0005654]; nucleus [GO:0005634]","DNA binding [GO:0003677]"
"1258","Pocillopora_acuta_HIv2___RNAseq.g22361.t1",523.476698097692,-2.85385104686522,2.27041723669913,0.000466383165410353,0.00308025849520335,"A0A1U8QWA2",0,"Glycine betaine reductase ATRR (Nonribosomal peptide synthetase-like protein ATRR) [Includes: Carboxylic acid reductase (EC 1.2.1.-); Aldehyde reductase (EC 1.1.1.-)]","secondary metabolite biosynthetic process [GO:0044550]; small molecule metabolic process [GO:0044281]","GO:0016491; GO:0031177; GO:0044281; GO:0044550","","oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]"
"1259","Pocillopora_acuta_HIv2___RNAseq.g22120.t1",26.0358264448358,5.29026640154882,3.60450528216579,0.000482460783412284,0.00317340280640076,"Q9CXI3",3.56e-117,"DBH-like monooxygenase protein 1 (EC 1.14.17.-) (DBH-related protein) (Monooxygenase X)","dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]","GO:0004500; GO:0005507; GO:0005615; GO:0005789; GO:0006589; GO:0030667; GO:0042420; GO:0042421","endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; secretory granule membrane [GO:0030667]","copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]"
"1260","Pocillopora_acuta_HIv2___TS.g25624.t1",436.653625393772,-4.10992893144637,3.82962217844859,0.000492004627698971,0.00322883617742192,NA,NA,NA,NA,NA,NA,NA
"1261","Pocillopora_acuta_HIv2___RNAseq.g11345.t1",1518.01744178848,1.16572216333899,1.7806682738351,0.000492302936437248,0.00322932864971808,"P28289",4.12e-83,"Tropomodulin-1 (Erythrocyte tropomodulin) (E-Tmod)","actin filament organization [GO:0007015]; adult locomotory behavior [GO:0008344]; lens fiber cell development [GO:0070307]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]","GO:0003779; GO:0005523; GO:0005829; GO:0005856; GO:0005865; GO:0005884; GO:0006936; GO:0007015; GO:0008344; GO:0016020; GO:0030016; GO:0030017; GO:0030239; GO:0030863; GO:0051694; GO:0070307","actin filament [GO:0005884]; cortical cytoskeleton [GO:0030863]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]","actin binding [GO:0003779]; tropomyosin binding [GO:0005523]"
"1262","Pocillopora_acuta_HIv2___RNAseq.g14748.t1",2261.5533321687,-2.02466402616664,0.723262373170678,0.000493274719568728,0.00323277097591395,"P13234",5.81e-135,"Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) (Calspermin)","adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; neuron-neuron synaptic transmission [GO:0007270]; nucleocytoplasmic transport [GO:0006913]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein export from nucleus [GO:0046827]; postsynapse to nucleus signaling pathway [GO:0099527]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; signal transduction [GO:0007165]","GO:0002250; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006913; GO:0006954; GO:0007165; GO:0007270; GO:0007616; GO:0009931; GO:0035556; GO:0043011; GO:0045893; GO:0046827; GO:0098794; GO:0098978; GO:0098982; GO:0099170; GO:0099527; GO:0106310","cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]","ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]"
"1263","Pocillopora_acuta_HIv2___RNAseq.g12619.t1",190.023160077095,2.00718078846424,4.43203221973905,0.000496914037316672,0.00325367344307304,"Q8LGG8",2.57e-09,"Universal stress protein A-like protein","","GO:0005829; GO:0005886; GO:0016208","cytosol [GO:0005829]; plasma membrane [GO:0005886]","AMP binding [GO:0016208]"
"1264","Pocillopora_acuta_HIv2___RNAseq.g805.t1",877.333875088288,-3.11260559900895,1.69398971096792,0.000498199167347819,0.00326061210702211,"D3ZB51",2.71e-09,"Protein turtle homolog B (Immunoglobulin superfamily member 9B)","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; synaptic membrane adhesion [GO:0099560]","GO:0007156; GO:0007399; GO:0014069; GO:0019900; GO:0030425; GO:0043005; GO:0043025; GO:0045211; GO:0060077; GO:0097151; GO:0098982; GO:0099560; GO:0099629","dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization of symmetric synapse [GO:0099629]","kinase binding [GO:0019900]"
"1265","Pocillopora_acuta_HIv2___RNAseq.g3016.t1",1002.55051305483,3.10711481610169,1.60502370044263,0.000500792798920196,0.00327610449732325,"P07756",0,"Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I)","'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; carbamoyl phosphate biosynthetic process [GO:0070409]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucagon stimulus [GO:0071377]; cellular response to oleic acid [GO:0071400]; glutamine metabolic process [GO:0006541]; hepatocyte differentiation [GO:0070365]; homocysteine metabolic process [GO:0050667]; liver development [GO:0001889]; midgut development [GO:0007494]; monoatomic anion homeostasis [GO:0055081]; nitric oxide metabolic process [GO:0046209]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to cAMP [GO:0051591]; response to dexamethasone [GO:0071548]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to growth hormone [GO:0060416]; response to lipopolysaccharide [GO:0032496]; response to oleic acid [GO:0034201]; response to starvation [GO:0042594]; response to steroid hormone [GO:0048545]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; triglyceride catabolic process [GO:0019433]; urea cycle [GO:0000050]; vasodilation [GO:0042311]","GO:0000050; GO:0001889; GO:0004087; GO:0004088; GO:0004175; GO:0005509; GO:0005524; GO:0005543; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005886; GO:0006207; GO:0006541; GO:0007494; GO:0009410; GO:0009636; GO:0010043; GO:0014075; GO:0016595; GO:0019433; GO:0030955; GO:0032094; GO:0032496; GO:0032991; GO:0033762; GO:0034201; GO:0036094; GO:0042311; GO:0042594; GO:0042645; GO:0043200; GO:0044344; GO:0044877; GO:0046209; GO:0046872; GO:0048545; GO:0050667; GO:0051384; GO:0051591; GO:0055081; GO:0060416; GO:0070365; GO:0070409; GO:0071242; GO:0071320; GO:0071377; GO:0071400; GO:0071548; GO:0072341","cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]","ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; endopeptidase activity [GO:0004175]; glutamate binding [GO:0016595]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; phospholipid binding [GO:0005543]; potassium ion binding [GO:0030955]; protein-containing complex binding [GO:0044877]; small molecule binding [GO:0036094]"
"1266","Pocillopora_acuta_HIv2___RNAseq.g16302.t1a",98.93323474434,-2.99105799064372,1.70151032384012,0.000505143556939152,0.00330008871163861,NA,NA,NA,NA,NA,NA,NA
"1267","Pocillopora_acuta_HIv2___RNAseq.g26455.t1",2244.83015482519,-2.23219080955315,2.48801818010018,0.000506822383467393,0.00330657598307279,NA,NA,NA,NA,NA,NA,NA
"1268","Pocillopora_acuta_HIv2___RNAseq.g28585.t1",244.392613219257,-2.72614012925315,2.57083399570361,0.000521957792815101,0.00339155324136461,NA,NA,NA,NA,NA,NA,NA
"1269","Pocillopora_acuta_HIv2___TS.g28685.t1",239.649795067491,-3.25158649459068,1.54756361212163,0.000530672420668931,0.00343911220921949,NA,NA,NA,NA,NA,NA,NA
"1270","Pocillopora_acuta_HIv2___RNAseq.g764.t1",3728.93005945397,-2.28505435492169,0.948685376090802,0.000532530544684149,0.00344786114517078,NA,NA,NA,NA,NA,NA,NA
"1271","Pocillopora_acuta_HIv2___RNAseq.g18763.t1",1126.26146301497,-2.11093076346615,0.776245857486524,0.000535611876808802,0.00346316056600917,"P50430",3.56e-139,"Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)","anterior head development [GO:0097065]; autophagy [GO:0006914]; colon epithelial cell migration [GO:0061580]; dermatan sulfate catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]","GO:0003943; GO:0004065; GO:0005764; GO:0006914; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065","cell surface [GO:0009986]; lysosome [GO:0005764]","arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484]"
"1272","Pocillopora_acuta_HIv2___RNAseq.g6037.t1",834.39555573937,-2.50577889426858,1.19928151747015,0.000538921969674717,0.00348300597380478,NA,NA,NA,NA,NA,NA,NA
"1273","Pocillopora_acuta_HIv2___RNAseq.g22262.t1",54.6132730203529,-2.49918334177138,4.70955403855789,0.000541084731223115,0.00349230234378007,"P54422",4.68e-26,"Glutathione hydrolase proenzyme (EC 3.4.19.13) (Gamma-glutamyltranspeptidase proenzyme) (EC 2.3.2.2) [Cleaved into: Glutathione hydrolase large chain; Glutathione hydrolase small chain]","glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; proteolysis [GO:0006508]","GO:0005576; GO:0006508; GO:0006750; GO:0006751; GO:0036374; GO:0103068","extracellular region [GO:0005576]","glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]"
"1274","Pocillopora_acuta_HIv2___TS.g1462.t1",972.093848949411,-1.04321056377645,1.71539219151262,0.000543163108447633,0.0035041530778709,"P98133",0,"Fibrillin-1 (MP340) [Cleaved into: Asprosin]","anatomical structure morphogenesis [GO:0009653]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0008201; GO:0009653; GO:0031012","extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]","calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]"
"1275","Pocillopora_acuta_HIv2___RNAseq.g706.t1",4411.72644151322,-2.62315210684408,2.92328967278499,0.000549235982792259,0.0035401734648428,NA,NA,NA,NA,NA,NA,NA
"1276","Pocillopora_acuta_HIv2___RNAseq.g618.t1",549.372576804797,2.40013306302721,2.79044057448913,0.000550546189129318,0.003547037897357,"Q9Y3B3",9.19e-42,"Transmembrane emp24 domain-containing protein 7 (p24 family protein gamma-3) (p24gamma3) (p27)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]","GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0030126; GO:0030127; GO:0030133; GO:0030134; GO:0033116; GO:0038024","COPI vesicle coat [GO:0030126]; COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]","cargo receptor activity [GO:0038024]"
"1277","Pocillopora_acuta_HIv2___RNAseq.g28746.t1",1193.65422691206,3.23433870984538,1.70486807119073,0.000553401168702624,0.00356384439185875,"A8MY62",2.07e-49,"Putative beta-lactamase-like 1","","","",""
"1278","Pocillopora_acuta_HIv2___RNAseq.g19308.t1",60.1177448583493,-2.30573384420692,0.861837620662782,0.000556323534203276,0.00358106969235255,NA,NA,NA,NA,NA,NA,NA
"1279","Pocillopora_acuta_HIv2___RNAseq.g28504.t1",1178.74503629064,-3.09470967593362,2.16593926556827,0.000567846265400822,0.0036471262800877,"O89029",2.03e-13,"Matrilin-4 (MAT-4)","extracellular matrix organization [GO:0030198]; response to axon injury [GO:0048678]","GO:0005509; GO:0005576; GO:0030198; GO:0048678; GO:0062023; GO:0120216","collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; matrilin complex [GO:0120216]","calcium ion binding [GO:0005509]"
"1280","Pocillopora_acuta_HIv2___RNAseq.g26117.t1b",157.327138404517,3.44131333340469,4.14236341364822,0.000569977717535436,0.00365919117018755,NA,NA,NA,NA,NA,NA,NA
"1281","Pocillopora_acuta_HIv2___RNAseq.g29506.t1",560.385379456574,2.12466696915528,3.14803020954112,0.000571189986032221,0.00366534692012868,"Q9BSR8",2e-87,"Protein YIPF4 (YIP1 family member 4)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle fusion with Golgi apparatus [GO:0048280]","GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006888; GO:0043231; GO:0048280","endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]",""
"1282","Pocillopora_acuta_HIv2___RNAseq.g9553.t1b",710.800425580721,-2.00731947464287,0.720658157503855,0.000574190928047468,0.00368191071240655,"A0A411L030",9.6e-39,"Proline hydroxylase buaE (EC 1.14.11.-) (2-oxoglutarate-dependent dioxygenase buaE) (Burnettramic acids biosynthesis cluster protein E)","antibiotic biosynthetic process [GO:0017000]; small molecule biosynthetic process [GO:0044283]","GO:0017000; GO:0044283; GO:0046872; GO:0051213","","dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]"
"1283","Pocillopora_acuta_HIv2___TS.g27153.t2",357.955992596386,2.86087678043189,1.363010833555,0.000574280321293499,0.00368191071240655,"A6H8I2",0,"Small G protein signaling modulator 3 homolog (RUN and TBC1 domain-containing protein 3)","","","",""
"1284","Pocillopora_acuta_HIv2___RNAseq.g8148.t1",2320.13158146332,-3.33323167465776,1.76680486834926,0.000578803444117736,0.00370762312476481,"Q96RW7",0,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711","adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927]","calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]"
"1285","Pocillopora_acuta_HIv2___RNAseq.g13823.t1",2705.40623241689,-2.57017377686336,2.60353337622522,0.000582722255003843,0.00372777297495603,"B3EWY9",0,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020","extracellular space [GO:0005615]; membrane [GO:0016020]","calcium ion binding [GO:0005509]"
"1286","Pocillopora_acuta_HIv2___RNAseq.g11960.t1",114.827699348794,2.87678527542598,1.27020716614588,0.000588571016710822,0.00376186088630373,"Q1RLX4",9.93e-70,"Trafficking protein particle complex subunit 11 (Protein foie gras)","Golgi organization [GO:0007030]; lipid homeostasis [GO:0055088]; liver development [GO:0001889]; protein N-linked glycosylation [GO:0006487]; protein secretion [GO:0009306]; regulation of response to endoplasmic reticulum stress [GO:1905897]; retina development in camera-type eye [GO:0060041]; vesicle-mediated transport [GO:0016192]","GO:0001889; GO:0005794; GO:0006487; GO:0007030; GO:0009306; GO:0016192; GO:0055088; GO:0060041; GO:1905897","Golgi apparatus [GO:0005794]",""
"1287","Pocillopora_acuta_HIv2___RNAseq.g2586.t1c",338.049591336376,2.25408427588802,0.875222173479209,0.00059354926151921,0.00378865689259217,NA,NA,NA,NA,NA,NA,NA
"1288","Pocillopora_acuta_HIv2___TS.g1350.t1",11229.3611067898,-2.41694175668363,1.0804637274133,0.000598762754821782,0.0038187173165815,"P02466",8.4e-152,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096","collagen trimer [GO:0005581]; collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]","extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]"
"1289","Pocillopora_acuta_HIv2___RNAseq.g18025.t1",231.886845394456,-2.01740992590972,0.729893040259044,0.000598786703125473,0.0038187173165815,NA,NA,NA,NA,NA,NA,NA
"1290","Pocillopora_acuta_HIv2___TS.g16387.t1",1616.47444472284,2.28144250020066,0.912383416506777,0.000603899247180232,0.00384368704953021,"Q24UI6",7.04e-55,"Translation initiation factor IF-2","","GO:0003743; GO:0003924; GO:0005525; GO:0005737","cytoplasm [GO:0005737]","GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]"
"1291","Pocillopora_acuta_HIv2___RNAseq.g3724.t1",2912.48215599092,2.10033414743953,0.79282977203552,0.000604098911932932,0.00384368704953021,"P14207",2.02e-53,"Folate receptor beta (FR-beta) (Folate receptor 2) (Folate receptor, fetal/placental) (Placental folate-binding protein) (FBP)","cell adhesion [GO:0007155]; folic acid transport [GO:0015884]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; inflammatory response [GO:0006954]; positive regulation of cell population proliferation [GO:0008284]; sperm-egg recognition [GO:0035036]","GO:0005542; GO:0005576; GO:0005886; GO:0006954; GO:0007155; GO:0007342; GO:0008284; GO:0009897; GO:0009986; GO:0015884; GO:0035036; GO:0038023; GO:0061714","cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]","folic acid binding [GO:0005542]; folic acid receptor activity [GO:0061714]; signaling receptor activity [GO:0038023]"
"1292","Pocillopora_acuta_HIv2___RNAseq.g7450.t1",126.099581119041,2.83396734205692,1.95893985408571,0.000605257580461906,0.00384810797529715,NA,NA,NA,NA,NA,NA,NA
"1293","Pocillopora_acuta_HIv2___RNAseq.g6836.t1",25.2147696725998,7.6968848131443,4.03166030058821,0.000606578531192421,0.00385311896142608,"Q8WU66",5.46e-17,"Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170","cell surface [GO:0009986]; ciliary membrane [GO:0060170]; extracellular region [GO:0005576]; stereocilium [GO:0032420]",""
"1294","Pocillopora_acuta_HIv2___TS.g30131.t1",1929.24112474161,-2.32620035857413,1.02406307515968,0.000609359014805178,0.00386908199742849,"P24369",3.4e-74,"Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP)","bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; neutrophil chemotaxis [GO:0030593]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]","GO:0000413; GO:0003755; GO:0005654; GO:0005737; GO:0005788; GO:0005790; GO:0006457; GO:0016018; GO:0030593; GO:0032991; GO:0034663; GO:0040018; GO:0042470; GO:0043231; GO:0044829; GO:0048471; GO:0050821; GO:0060348; GO:0061077; GO:0070063","cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790]","cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]"
"1295","Pocillopora_acuta_HIv2___RNAseq.g23492.t1",61.1243654153646,-2.86549648386861,2.0705653965359,0.000610061191929717,0.0038702866474637,NA,NA,NA,NA,NA,NA,NA
"1296","Pocillopora_acuta_HIv2___TS.g13806.t1a",492.285474633909,2.5461715888749,1.46205769034871,0.000623384894637282,0.00394701254446192,"Q9P2G9",0,"Kelch-like protein 8","protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005654; GO:0006511; GO:0016567; GO:0031463","Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleoplasm [GO:0005654]",""
"1297","Pocillopora_acuta_HIv2___RNAseq.g1930.t1",1599.4340437655,2.42592650787363,1.06520667657699,0.000623542841820761,0.00394701254446192,"P52160",2.39e-29,"Transcriptional regulator Myc-A (c-Myc-A) (zc-Myc)","hematopoietic stem cell differentiation [GO:0060218]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vasculature development [GO:1901342]; vasculature development [GO:0001944]","GO:0000978; GO:0000981; GO:0001944; GO:0003677; GO:0005634; GO:0006357; GO:0008284; GO:0046983; GO:0060218; GO:1901342","nucleus [GO:0005634]","DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"1298","Pocillopora_acuta_HIv2___RNAseq.g18501.t1",113.7136644653,4.92920521979049,2.50897877763547,0.000631436588977928,0.00399173899605627,"Q13490",1.05e-31,"Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2) (hIAP-2) (hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2)","apoptotic process [GO:0006915]; canonical NF-kappaB signal transduction [GO:0007249]; cell surface receptor signaling pathway [GO:0007166]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; non-canonical NF-kappaB signal transduction [GO:0038061]; placenta development [GO:0001890]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000209; GO:0001666; GO:0001741; GO:0001890; GO:0003713; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007166; GO:0007249; GO:0008270; GO:0009898; GO:0016740; GO:0031398; GO:0033209; GO:0034121; GO:0035631; GO:0038061; GO:0039535; GO:0042127; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043130; GO:0043161; GO:0044877; GO:0045088; GO:0045471; GO:0045595; GO:0050727; GO:0051087; GO:0051591; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0070424; GO:0098770; GO:1901222; GO:1902443; GO:1902523; GO:1902524; GO:1902527; GO:2000116; GO:2000377","CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleus [GO:0005634]; XY body [GO:0001741]","cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
"1299","Pocillopora_acuta_HIv2___RNAseq.g21280.t1",1104.52950906445,-3.04763142545396,1.92229037199298,0.000642247782806753,0.00404946466020788,NA,NA,NA,NA,NA,NA,NA
"1300","Pocillopora_acuta_HIv2___RNAseq.g2851.t1",58.5546497026431,2.19234630650135,3.35266007279299,0.000645520072795752,0.00406462829434718,NA,NA,NA,NA,NA,NA,NA
"1301","Pocillopora_acuta_HIv2___RNAseq.g25436.t1",482.642446992219,-2.6487429096314,2.4262799670122,0.000645776812804883,0.00406462829434718,NA,NA,NA,NA,NA,NA,NA
"1302","Pocillopora_acuta_HIv2___RNAseq.g28678.t1",1207.91590211953,2.78968110342288,2.19414309549494,0.00065583287200196,0.0041225409216151,"D3UW23",0,"Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Rhiminopeptidase A)","proteolysis [GO:0006508]","GO:0004177; GO:0005886; GO:0006508; GO:0008237; GO:0008270","plasma membrane [GO:0005886]","aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]"
"1303","Pocillopora_acuta_HIv2___RNAseq.g2221.t1",740.328647264728,2.94146180200192,1.96676092223388,0.000657350376656704,0.0041284914667662,"Q76KP1",5.51e-61,"N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (NGalNAc-T1) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase IV) (Beta4GalNAc-T4) (Beta4GalNAcT4)","","GO:0008376; GO:0032580; GO:0033842","Golgi cisterna membrane [GO:0032580]","acetylgalactosaminyltransferase activity [GO:0008376]; N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity [GO:0033842]"
"1304","Pocillopora_acuta_HIv2___RNAseq.g22142.t1",72.1082421324344,-2.86473478546796,1.90419069314477,0.000668622852439783,0.00418475159571139,NA,NA,NA,NA,NA,NA,NA
"1305","Pocillopora_acuta_HIv2___RNAseq.g12528.t1",624.351712648832,2.3743951844227,2.98596497603731,0.000672688148708188,0.00420837430056887,"Q91ZM9",1.15e-07,"Docking protein 5 (Downstream of tyrosine kinase 5)","cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; neuron differentiation [GO:0030182]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]","GO:0005737; GO:0007169; GO:0007265; GO:0030182; GO:0043410; GO:0051386","cytoplasm [GO:0005737]",""
"1306","Pocillopora_acuta_HIv2___RNAseq.10263_t",3036.53535946797,-2.4977545224205,1.43707798737607,0.000674850295764853,0.00421825180550684,"Q8IWU5",1.83e-153,"Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form]","bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; liver regeneration [GO:0097421]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelin production [GO:1904472]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of hepatocyte proliferation [GO:2000345]; response to wounding [GO:0009611]","GO:0001822; GO:0002063; GO:0003094; GO:0004065; GO:0005509; GO:0005539; GO:0005576; GO:0005615; GO:0005783; GO:0005795; GO:0005886; GO:0008449; GO:0009611; GO:0009986; GO:0010575; GO:0014846; GO:0030177; GO:0030201; GO:0032836; GO:0035860; GO:0040037; GO:0048706; GO:0051216; GO:0060348; GO:0060384; GO:0090263; GO:0097421; GO:1904472; GO:2000345","cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]","arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]"
"1307","Pocillopora_acuta_HIv2___RNAseq.g10557.t1",571.935275930207,-2.62014359291319,1.00390880841015,0.000684094064992909,0.00426865252634056,"Q7T2H2",5.67e-28,"Fibroblast growth factor receptor-like 1","negative regulation of cell population proliferation [GO:0008285]","GO:0005007; GO:0005886; GO:0008201; GO:0008285; GO:0017134","plasma membrane [GO:0005886]","fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]"
"1308","Pocillopora_acuta_HIv2___RNAseq.g9084.t1",3736.00912665436,-2.85608922111555,1.40374054763601,0.000693589981738202,0.00431590351521831,"Q8SQ75",1.5e-56,"Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment]","complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]","GO:0004252; GO:0005601; GO:0006508; GO:0006958; GO:0009617; GO:0045087; GO:0046872; GO:0070062","classical-complement-pathway C3/C5 convertase complex [GO:0005601]; extracellular exosome [GO:0070062]","metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]"
"1309","Pocillopora_acuta_HIv2___TS.g8131.t1",198.189302709465,-1.04133600285606,2.00291266597384,0.000693755231808806,0.00431590351521831,"Q8C419",2.94e-67,"Metabotropic glycine receptor (mGlyR) (G-protein coupled receptor 158)","brain development [GO:0007420]; cognition [GO:0050890]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of neurotransmitter secretion [GO:0001956]; protein localization to plasma membrane [GO:0072659]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synapse organization [GO:0050807]","GO:0001956; GO:0004888; GO:0005634; GO:0005886; GO:0007186; GO:0007420; GO:0008047; GO:0008277; GO:0016020; GO:0042734; GO:0042995; GO:0045211; GO:0050807; GO:0050890; GO:0072659; GO:0098839; GO:0160079","cell projection [GO:0042995]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]","enzyme activator activity [GO:0008047]; G protein-coupled glycine receptor activity [GO:0160079]; transmembrane signaling receptor activity [GO:0004888]"
"1310","Pocillopora_acuta_HIv2___RNAseq.g2273.t1",3039.3243582818,1.87609958112053,0.669404651474272,0.000709185066392491,0.00439629658258478,"P54145",6.92e-138,"Putative ammonium transporter 1","ammonium homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488]","GO:0005886; GO:0008519; GO:0072488; GO:0097272","plasma membrane [GO:0005886]","ammonium channel activity [GO:0008519]"
"1311","Pocillopora_acuta_HIv2___TS.g19616.t2b",636.782212174969,1.67919934374557,2.45155775117494,0.000709461435731463,0.00439629658258478,NA,NA,NA,NA,NA,NA,NA
"1312","Pocillopora_acuta_HIv2___RNAseq.g4013.t1",171.118611476062,1.12636822901378,1.87228766878797,0.000719396162862272,0.00444863022643861,NA,NA,NA,NA,NA,NA,NA
"1313","Pocillopora_acuta_HIv2___RNAseq.g5896.t1",3440.59614231845,-2.11182155217158,2.33715348527004,0.000724290098019591,0.00447506705585449,"Q9I8W5",8.72e-24,"Probable N-acetyltransferase camello (EC 2.3.1.-) (Xcml)","gastrulation with mouth forming second [GO:0001702]; negative regulation of cell adhesion [GO:0007162]","GO:0000139; GO:0001702; GO:0005794; GO:0007162; GO:0008080","Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]","N-acetyltransferase activity [GO:0008080]"
"1314","Pocillopora_acuta_HIv2___RNAseq.820_t",2229.99269376669,-1.87849094454679,0.670794332769713,0.000725930630167479,0.004483288059241,"Q91821",0,"Maternal embryonic leucine zipper kinase (MELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase)","apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; hemopoiesis [GO:0030097]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]","GO:0004674; GO:0004715; GO:0005509; GO:0005524; GO:0005886; GO:0005938; GO:0006915; GO:0008283; GO:0008289; GO:0030097; GO:0043065; GO:0046777; GO:0061351; GO:0106310","cell cortex [GO:0005938]; plasma membrane [GO:0005886]","ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]"
"1315","Pocillopora_acuta_HIv2___RNAseq.g28577.t1",46.9812007729321,-2.93275851140774,2.38928037112029,0.000730187157483089,0.00450563385978248,"G5EBQ8",3.6e-107,"Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)","cell wall chitin biosynthetic process [GO:0006038]; chitin biosynthetic process [GO:0006031]; positive regulation of nematode larval development [GO:0061063]","GO:0004100; GO:0005886; GO:0006031; GO:0006038; GO:0030428; GO:0061063; GO:0071944","cell periphery [GO:0071944]; cell septum [GO:0030428]; plasma membrane [GO:0005886]","chitin synthase activity [GO:0004100]"
"1316","Pocillopora_acuta_HIv2___RNAseq.g23361.t1",51.9369832263055,1.321665616857,2.54497200838,0.000734693103221075,0.00452580964437378,"Q26614",5.37e-07,"Fibroblast growth factor receptor (SpFGFR) (EC 2.7.10.1)","","GO:0005007; GO:0005524; GO:0005886; GO:0017134; GO:0043235","plasma membrane [GO:0005886]; receptor complex [GO:0043235]","ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]"
"1317","Pocillopora_acuta_HIv2___RNAseq.g237.t1",386.013334923639,2.36040088520024,1.04940880892094,0.000736534740332077,0.00453522285404987,"A0JM23",2.01e-36,"Nephrocystin-3","cilium assembly [GO:0060271]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]","GO:0005929; GO:0016055; GO:0060271; GO:0090090; GO:2000095","cilium [GO:0005929]",""
"1318","Pocillopora_acuta_HIv2___TS.g1340.t1b",4631.38078039568,-1.96204052057738,0.728982997154802,0.000740202454064637,0.00455392951747806,"Q28668",6.52e-72,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","extracellular matrix organization [GO:0030198]","GO:0005581; GO:0005615; GO:0030020; GO:0030198; GO:0046872; GO:0062023","collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]","extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]"
"1319","Pocillopora_acuta_HIv2___RNAseq.g1315.t1",470.976544572365,-1.82452492100678,2.85847542758467,0.000744827385509606,0.00457459437825126,"Q0V9P1",3.74e-22,"Histamine N-methyltransferase (HMT) (EC 2.1.1.8)","histamine catabolic process [GO:0001695]; methylation [GO:0032259]","GO:0001695; GO:0005737; GO:0032259; GO:0046539","cytoplasm [GO:0005737]","histamine N-methyltransferase activity [GO:0046539]"
"1320","Pocillopora_acuta_HIv2___TS.g14240.t1",40.6435769702235,-2.86473915665728,1.27666989198273,0.000748930408235497,0.00459394801726812,NA,NA,NA,NA,NA,NA,NA
"1321","Pocillopora_acuta_HIv2___RNAseq.g8922.t1",605.533010139431,-2.04441394090161,2.71523713333916,0.000758805883591175,0.00464684610839121,"Q00685",0,"Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3 gamma chain]","complement activation, classical pathway [GO:0006958]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]","GO:0004866; GO:0005615; GO:0006954; GO:0006958; GO:0045087","extracellular space [GO:0005615]","endopeptidase inhibitor activity [GO:0004866]"
"1322","Pocillopora_acuta_HIv2___RNAseq.g26271.t1",456.897978789053,2.56420787962786,1.64340622202664,0.000759378778561754,0.00464818224846264,"P68373",0,"Tubulin alpha-1C chain (EC 3.6.5.-) (Alpha-tubulin 6) (Alpha-tubulin isotype M-alpha-6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain]","microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]","GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0005881; GO:0016787; GO:0045121; GO:0046872","cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; membrane raft [GO:0045121]; microtubule [GO:0005874]; nucleus [GO:0005634]","GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200]"
"1323","Pocillopora_acuta_HIv2___RNAseq.g7074.t1",133.808489773768,-2.78549760534281,1.42114990121545,0.000761971529249016,0.00466207961043053,NA,NA,NA,NA,NA,NA,NA
"1324","Pocillopora_acuta_HIv2___TS.g29599.t2",283.253432583366,1.66796743020261,2.3774624535097,0.000770038439215036,0.00470347803412427,"Q8IYQ7",0,"Threonine synthase-like 1 (TSH1)","","GO:0005737","cytoplasm [GO:0005737]",""
"1325","Pocillopora_acuta_HIv2___TS.g2746.t1",2190.07588565629,2.15264566059886,0.886613977267893,0.000774274311138066,0.0047233672021514,NA,NA,NA,NA,NA,NA,NA
"1326","Pocillopora_acuta_HIv2___RNAseq.g9734.t1",321.144709954626,-2.56489726758801,2.11714031738687,0.000775055905620686,0.00472614191353188,NA,NA,NA,NA,NA,NA,NA
"1327","Pocillopora_acuta_HIv2___RNAseq.g30593.t1",319.597733468068,-1.60479647859015,2.32131444352541,0.000790054730961791,0.00480342649375004,"Q2HJI8",3.45e-51,"Ras-related protein Rab-8B","endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; protein secretion [GO:0009306]","GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006887; GO:0008021; GO:0009306; GO:0010008; GO:0019003; GO:0030140; GO:0030670; GO:0032456; GO:0045335","endosome [GO:0005768]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]","GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]"
"1328","Pocillopora_acuta_HIv2___RNAseq.g15577.t1",225.946430385387,2.03570796410387,0.769256216838137,0.000799851093913064,0.0048548242645231,"P05123",1.79e-103,"Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK)","phosphocreatine biosynthetic process [GO:0046314]; response to heat [GO:0009408]","GO:0004111; GO:0005524; GO:0005615; GO:0005737; GO:0009408; GO:0046314","cytoplasm [GO:0005737]; extracellular space [GO:0005615]","ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]"
"1329","Pocillopora_acuta_HIv2___RNAseq.g763.t1",97.7345988190866,2.98093056345441,1.64721781517526,0.000806102008872414,0.00488270423700841,"O70277",2.65e-20,"Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22)","negative regulation of translation [GO:0017148]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252]","GO:0000209; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0017148; GO:0030371; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061630; GO:0070534; GO:0098794; GO:0098978; GO:0140252","cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]","identical protein binding [GO:0042802]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
"1330","Pocillopora_acuta_HIv2___TS.g22883.t1",2589.67808780979,-2.49714631279899,1.97090353841024,0.000806132309041488,0.00488270423700841,NA,NA,NA,NA,NA,NA,NA
"1331","Pocillopora_acuta_HIv2___TS.g18665.t1",106.168312872365,4.58658786380807,3.23941848247601,0.000809986652954191,0.00490194432984494,NA,NA,NA,NA,NA,NA,NA
"1332","Pocillopora_acuta_HIv2___RNAseq.g11124.t1",8118.19874141245,-2.01239326182047,0.787926428417862,0.000810591409850231,0.0049035525521011,NA,NA,NA,NA,NA,NA,NA
"1333","Pocillopora_acuta_HIv2___TS.g18622.t1b",4572.98017033914,-3.30231153008581,1.7669143201301,0.00082277432732492,0.00497101414804831,"A2ASQ1",1.54e-86,"Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]","cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; enzyme-linked receptor protein signaling pathway [GO:0007167]; motor neuron apoptotic process [GO:0097049]; negative regulation of P-type sodium:potassium-exchanging transporter activity [GO:1903407]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; neuromuscular junction development [GO:0007528]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of motor neuron apoptotic process [GO:2000673]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; regulation of synaptic activity [GO:0060025]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]","GO:0001932; GO:0001934; GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0007009; GO:0007167; GO:0007268; GO:0007416; GO:0007528; GO:0007623; GO:0009986; GO:0015031; GO:0030154; GO:0030548; GO:0032092; GO:0033691; GO:0035022; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043083; GO:0043087; GO:0043113; GO:0043395; GO:0043547; GO:0044295; GO:0044325; GO:0045202; GO:0045887; GO:0045944; GO:0048018; GO:0050431; GO:0050731; GO:0050807; GO:0051491; GO:0055117; GO:0060025; GO:0061098; GO:0062023; GO:0070507; GO:0071340; GO:0086036; GO:0097049; GO:0098978; GO:1902667; GO:1903277; GO:1903407; GO:1904395; GO:2000541; GO:2000673","axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; sarcolemma [GO:0042383]; synapse [GO:0045202]; synaptic cleft [GO:0043083]","acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; receptor ligand activity [GO:0048018]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; transmembrane transporter binding [GO:0044325]"
"1334","Pocillopora_acuta_HIv2___RNAseq.g14769.t1",2602.28641466178,-2.71027844576902,2.10440006158233,0.000826573320375408,0.0049897982078088,"Q61555",0,"Fibrillin-2 [Cleaved into: Placensin]","anatomical structure morphogenesis [GO:0009653]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0009653; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023","collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]","calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179]"
"1335","Pocillopora_acuta_HIv2___RNAseq.g21967.t1",1724.85187375922,-1.92006543112762,0.715342010841847,0.000835287564864221,0.00503819822276735,"P53634",5.21e-171,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; T cell mediated cytotoxicity [GO:0001913]","GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005813; GO:0006508; GO:0006955; GO:0008234; GO:0008239; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0043231; GO:0051087; GO:0051603; GO:0062023; GO:0070062; GO:1903052; GO:1903980; GO:2001235","azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]","chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein-folding chaperone binding [GO:0051087]; serine-type endopeptidase activity [GO:0004252]"
"1336","Pocillopora_acuta_HIv2___RNAseq.g15938.t1",191.513469864645,-2.31322014708477,1.00652415116927,0.000835642264611232,0.0050382366466598,NA,NA,NA,NA,NA,NA,NA
"1337","Pocillopora_acuta_HIv2___RNAseq.g20666.t1",917.510474861776,3.06621316991966,1.63002747427711,0.000838749215954335,0.00505486194148479,"P46434",7.02e-34,"Glutathione S-transferase 1 (EC 2.5.1.18)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749","","glutathione transferase activity [GO:0004364]"
"1338","Pocillopora_acuta_HIv2___RNAseq.g24449.t1",114.361387954748,1.35038258684644,2.23147111565362,0.000845246006815842,0.0050876563639552,NA,NA,NA,NA,NA,NA,NA
"1339","Pocillopora_acuta_HIv2___TS.g28827.t1",585.91619590565,-2.12538028863238,0.871406659561645,0.00084858656422169,0.00510269434155013,NA,NA,NA,NA,NA,NA,NA
"1340","Pocillopora_acuta_HIv2___RNAseq.g11156.t1",598.963172983968,-1.8391291388484,2.38886907522852,0.000854099630897592,0.00513027286598952,NA,NA,NA,NA,NA,NA,NA
"1341","Pocillopora_acuta_HIv2___RNAseq.g8915.t1",1709.59092303431,2.55095397276058,1.29781489498944,0.000879036688948608,0.0052665560364166,"P10079",9.58e-16,"Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","","GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579","apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]","biotin binding [GO:0009374]; calcium ion binding [GO:0005509]"
"1342","Pocillopora_acuta_HIv2___RNAseq.g16844.t1",101.446831546233,2.8838437662375,2.30696051661347,0.000879337170073705,0.0052665560364166,"Q96PQ7",3.95e-24,"Kelch-like protein 5","","GO:0003779; GO:0005737; GO:0005829; GO:0005856","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]","actin binding [GO:0003779]"
"1343","Pocillopora_acuta_HIv2___TS.g4253.t1",277.454642673524,1.09992959282433,1.71043295601688,0.000890352884338258,0.00532151409878866,NA,NA,NA,NA,NA,NA,NA
"1344","Pocillopora_acuta_HIv2___RNAseq.g20160.t1",1122.97064399026,2.0257410517818,3.20532953723468,0.00090011515617921,0.00537098416624426,NA,NA,NA,NA,NA,NA,NA
"1345","Pocillopora_acuta_HIv2___RNAseq.g9715.t1",184.285875622447,2.56697173838766,1.42220887853617,0.000915121625010775,0.00544704493175138,NA,NA,NA,NA,NA,NA,NA
"1346","Pocillopora_acuta_HIv2___RNAseq.g26701.t1",1070.5255059844,2.41021691367875,1.46059433345236,0.000917078695667709,0.00545644847969467,"Q8CQD9",2.31e-10,"Accumulation-associated protein","","GO:0005576","extracellular region [GO:0005576]",""
"1347","Pocillopora_acuta_HIv2___RNAseq.g9589.t2",2396.75766737527,-2.89542954337278,1.91889589915309,0.000930811973768748,0.00552679162093233,"Q91994",3.89e-37,"Homeobox protein OTX1 B (zOtx1) (Orthodenticle homolog 1 B)","inner ear morphogenesis [GO:0042472]; lateral semicircular canal development [GO:0060875]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal pigment epithelium development [GO:0003406]","GO:0000978; GO:0000981; GO:0003406; GO:0005634; GO:0006357; GO:0042472; GO:0060875","nucleus [GO:0005634]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"1348","Pocillopora_acuta_HIv2___RNAseq.g9334.t1",6238.79877234631,1.86673359780412,0.69264126692591,0.000935131048732374,0.00554560700650474,"P16621",0,"Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124]","GO:0004725; GO:0005001; GO:0005158; GO:0005925; GO:0007155; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0009986; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0045467; GO:0046627; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0061484; GO:0120034; GO:1903386","axon [GO:0030424]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; focal adhesion [GO:0005925]","heparin binding [GO:0008201]; insulin receptor binding [GO:0005158]; protein tyrosine phosphatase activity [GO:0004725]; SAM domain binding [GO:0032093]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
"1349","Pocillopora_acuta_HIv2___RNAseq.g11563.t1",510.933175310693,1.35796309184259,2.12356511043581,0.000939158907931335,0.00556493012876642,"Q28BR5",0,"Presequence protease, mitochondrial (EC 3.4.24.-) (Pitrilysin metalloproteinase 1)","proteolysis [GO:0006508]","GO:0004222; GO:0005759; GO:0006508; GO:0046872","mitochondrial matrix [GO:0005759]","metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]"
"1350","Pocillopora_acuta_HIv2___RNAseq.g14505.t1",13007.13582953,1.66401459102249,0.584667319796444,0.000942167997525467,0.00558047416716149,"P12716",0,"Actin, cytoplasmic (EC 3.6.4.-) [Cleaved into: Actin, cytoplasmic, intermediate form]","","GO:0005524; GO:0005737; GO:0005856; GO:0016787","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]","ATP binding [GO:0005524]; hydrolase activity [GO:0016787]"
"1351","Pocillopora_acuta_HIv2___RNAseq.g9068.t1",271.676330149337,-2.84500343342309,1.48895429923782,0.000943885037703865,0.00558783876554601,"P04186",2.84e-55,"Complement factor B (EC 3.4.21.47) (C3/C5 convertase) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]","B cell proliferation [GO:0042100]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]","GO:0004252; GO:0005576; GO:0006508; GO:0006956; GO:0006957; GO:0009617; GO:0042100","extracellular region [GO:0005576]","serine-type endopeptidase activity [GO:0004252]"
"1352","Pocillopora_acuta_HIv2___RNAseq.g21911.t1",606.500147466504,-2.17280403500516,0.929939750078929,0.000944944934102669,0.00559005461221309,NA,NA,NA,NA,NA,NA,NA
"1353","Pocillopora_acuta_HIv2___RNAseq.g8488.t1",2529.15127212934,2.20551990459577,0.92858593354531,0.000947884496325144,0.00560328380327074,"P23098",0,"Dynein beta chain, ciliary","cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]","GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008569; GO:0030030; GO:0030286; GO:0031514; GO:0045505; GO:0051959","cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]","ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]"
"1354","Pocillopora_acuta_HIv2___RNAseq.g15699.t1",865.146250204035,-1.71104124052422,0.609267289686012,0.000955184966418356,0.00563220356880355,"P54357",2.63e-35,"Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain)","actin filament-based movement [GO:0030048]","GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036","cytosol [GO:0005829]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]","calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]"
"1355","Pocillopora_acuta_HIv2___TS.g10811.t1",491.89720636027,1.33367409512364,2.14476632039937,0.000969191387064642,0.0057054880840468,"Q9JLG8",0,"Calpain-15 (EC 3.4.22.-) (Small optic lobes homolog)","proteolysis [GO:0006508]","GO:0004198; GO:0005737; GO:0006508; GO:0046872","cytoplasm [GO:0005737]","calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]"
"1356","Pocillopora_acuta_HIv2___RNAseq.g3099.t1",443.207179018389,2.71581381187237,1.68531679576417,0.000971777023453436,0.00571838196388547,NA,NA,NA,NA,NA,NA,NA
"1357","Pocillopora_acuta_HIv2___RNAseq.g23898.t1",814.369081255654,-2.26894501147456,2.03658486864422,0.000976260637351831,0.00574009506449467,"Q9JHA8",2.31e-27,"von Willebrand factor A domain-containing protein 7 (Protein G7c)","","GO:0005576","extracellular region [GO:0005576]",""
"1358","Pocillopora_acuta_HIv2___TS.g12320.t1",73.6609249231075,-1.51869636251797,3.94148164853167,0.000981424333520902,0.00576151252755698,"Q60HG8",4.27e-14,"Alpha-crystallin B chain (Alpha(B)-crystallin)","negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; protein refolding [GO:0042026]; response to heat [GO:0009408]","GO:0005212; GO:0005576; GO:0005634; GO:0005737; GO:0005764; GO:0009408; GO:0032991; GO:0042026; GO:0042803; GO:0043066; GO:0045892; GO:0046872; GO:0051082","cytoplasm [GO:0005737]; extracellular region [GO:0005576]; lysosome [GO:0005764]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]","metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212]; unfolded protein binding [GO:0051082]"
"1359","Pocillopora_acuta_HIv2___RNAseq.g30994.t1a",1228.79079190103,2.53550740281905,2.91693831691985,0.000981474109900909,0.00576151252755698,"B0JZG0",0,"Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2)","sodium ion transport [GO:0006814]","GO:0005886; GO:0006814; GO:0015293","plasma membrane [GO:0005886]","symporter activity [GO:0015293]"
"1360","Pocillopora_acuta_HIv2___TS.g24890.t1",159.555559772517,-3.06448193371416,1.3241501909673,0.00098149660314577,0.00576151252755698,"Q5ZJP7",1.09e-37,"BTB/POZ domain-containing protein KCTD7","membrane hyperpolarization [GO:0060081]; protein homooligomerization [GO:0051260]","GO:0005829; GO:0005886; GO:0051260; GO:0060081","cytosol [GO:0005829]; plasma membrane [GO:0005886]",""
"1361","Pocillopora_acuta_HIv2___RNAseq.g14607.t1",1821.93583211297,2.82596485602679,2.21258956255348,0.000991025161477214,0.00581067168545891,NA,NA,NA,NA,NA,NA,NA
"1362","Pocillopora_acuta_HIv2___RNAseq.g25248.t1a",397.797339458725,1.39129356047264,2.21068623398649,0.0010037916482006,0.0058756950220856,"Q7SXM7",0,"U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31)","mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; retina development in camera-type eye [GO:0060041]; spliceosomal tri-snRNP complex assembly [GO:0000244]","GO:0000244; GO:0000381; GO:0000398; GO:0005634; GO:0005687; GO:0005690; GO:0015030; GO:0016607; GO:0030622; GO:0046540; GO:0060041; GO:0071005; GO:0071011; GO:0071339; GO:0097526","Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]","U4atac snRNA binding [GO:0030622]"
"1363","Pocillopora_acuta_HIv2___RNAseq.g15972.t1",1348.21796755039,-2.81355058620631,1.78557682065981,0.00100485162394075,0.00587939252956916,NA,NA,NA,NA,NA,NA,NA
"1364","Pocillopora_acuta_HIv2___TS.g6576.t2",502.264756076173,-2.01294151292619,0.802134377951057,0.00100636589892796,0.00588362019486417,"Q9VY77",1.21e-67,"LIM domain-containing protein jub","cytoskeleton organization [GO:0007010]; follicle cell of egg chamber development [GO:0030707]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; regulation of DNA-templated transcription [GO:0006355]; response to hypoxia [GO:0001666]","GO:0000278; GO:0000932; GO:0001666; GO:0003714; GO:0005634; GO:0005667; GO:0005912; GO:0006355; GO:0007010; GO:0030707; GO:0035331; GO:0045179; GO:0045572; GO:0046872; GO:0071539; GO:0140311","adherens junction [GO:0005912]; apical cortex [GO:0045179]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription regulator complex [GO:0005667]","metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; transcription corepressor activity [GO:0003714]"
"1365","Pocillopora_acuta_HIv2___TS.g15602.t1",134.775287682405,-1.37469540315396,2.2080846946783,0.00100745098254976,0.00588758424711101,NA,NA,NA,NA,NA,NA,NA
"1366","Pocillopora_acuta_HIv2___RNAseq.g4068.t1",231.0319046947,2.97590505147414,2.79832332614319,0.00100818159016953,0.00588947436195963,"Q9BQA1",1.73e-59,"Methylosome protein WDR77 (Androgen receptor cofactor p44) (Methylosome protein 50) (MEP-50) (WD repeat-containing protein 77) (p44/Mep50)","epithelial cell proliferation involved in prostate gland development [GO:0060767]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; oocyte axis specification [GO:0007309]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein polyubiquitination [GO:0000209]; regulation of transcription by RNA polymerase II [GO:0006357]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; spliceosomal snRNP assembly [GO:0000387]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000209; GO:0000387; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006357; GO:0006511; GO:0007309; GO:0008284; GO:0008327; GO:0030374; GO:0031465; GO:0034709; GO:0048026; GO:0060528; GO:0060767; GO:0060770; GO:1990756","Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","methyl-CpG binding [GO:0008327]; nuclear receptor coactivator activity [GO:0030374]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]"
"1367","Pocillopora_acuta_HIv2___RNAseq.g21032.t1",1708.35825151064,-1.99084841769176,0.789307818608043,0.00101745844437621,0.00594126723433893,"A4ZNR5",8.21e-14,"Protein naked cuticle homolog 2-like (Naked-2-like) (Protein naked cuticle homolog 2-B) (Naked-2B)","negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]","GO:0005509; GO:0005737; GO:0005886; GO:0016055; GO:0030178; GO:0090090","cytoplasm [GO:0005737]; plasma membrane [GO:0005886]","calcium ion binding [GO:0005509]"
"1368","Pocillopora_acuta_HIv2___RNAseq.g8890.t1",29.9877935858864,1.5045068685396,2.817302963603,0.00102044892245112,0.00595392223248608,"Q7ZTV5",4.87e-16,"Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of protein kinase A signaling [GO:0010738]","GO:0004963; GO:0005886; GO:0007186; GO:0007189; GO:0008528; GO:0008584; GO:0009755; GO:0010738; GO:0016020; GO:0042699; GO:0043235; GO:0051897; GO:0070374; GO:0071372","membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]","follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled peptide receptor activity [GO:0008528]"
"1369","Pocillopora_acuta_HIv2___RNAseq.g8916.t1",2710.00133414159,-2.91554312859348,2.05749417065229,0.0010235700897886,0.00596956095604608,"Q9QYP1",0,"Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)","amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001932; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395","cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060]","apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]"
"1370","Pocillopora_acuta_HIv2___RNAseq.g16957.t1",448.045848089533,1.01648639427977,1.66361871555901,0.00102395469662267,0.00596956095604608,"Q06831",1.86e-37,"Transcription factor SOX-4","ascending aorta morphogenesis [GO:0035910]; atrial septum primum morphogenesis [GO:0003289]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to glucose stimulus [GO:0071333]; endocrine pancreas development [GO:0031018]; gene expression [GO:0010467]; glial cell development [GO:0021782]; glial cell proliferation [GO:0014009]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; hematopoietic stem cell homeostasis [GO:0061484]; kidney morphogenesis [GO:0060993]; mesenchyme development [GO:0060485]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; noradrenergic neuron differentiation [GO:0003357]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of insulin secretion [GO:0032024]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of N-terminal peptidyl-lysine acetylation [GO:2000761]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; pro-B cell differentiation [GO:0002328]; protein stabilization [GO:0050821]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein stability [GO:0031647]; response to hypoxia [GO:0001666]; somatic stem cell population maintenance [GO:0035019]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; T cell differentiation [GO:0030217]; ventricular septum morphogenesis [GO:0060412]","GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001666; GO:0002328; GO:0003183; GO:0003215; GO:0003289; GO:0003357; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005739; GO:0006355; GO:0007399; GO:0007420; GO:0007507; GO:0008284; GO:0008285; GO:0010467; GO:0014009; GO:0021510; GO:0021782; GO:0030182; GO:0030217; GO:0031018; GO:0031397; GO:0031647; GO:0032024; GO:0035019; GO:0035198; GO:0035910; GO:0042593; GO:0043065; GO:0043516; GO:0045588; GO:0045662; GO:0045663; GO:0045727; GO:0045893; GO:0045944; GO:0048485; GO:0048593; GO:0050821; GO:0060412; GO:0060485; GO:0060563; GO:0060993; GO:0061484; GO:0071333; GO:0090263; GO:2000761","cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]","DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; miRNA binding [GO:0035198]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]"
"1371","Pocillopora_acuta_HIv2___TS.g4588.t1",1270.79567156701,1.91406268779596,3.44853809080682,0.00103487187891115,0.00603077633222034,"Q6BEB4",3.66e-59,"Transcription factor Sp5","bone morphogenesis [GO:0060349]; cellular response to organic cyclic compound [GO:0071407]; post-anal tail morphogenesis [GO:0036342]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0036342; GO:0046872; GO:0060349; GO:0071407","chromatin [GO:0000785]; nucleus [GO:0005634]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"1372","Pocillopora_acuta_HIv2___TS.g12990.t1",319.323234430846,1.50088078101305,2.76723823385177,0.00104142136599184,0.00606405742258694,"P57769",1.16e-43,"Sorting nexin-16","early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]","GO:0005764; GO:0005769; GO:0005770; GO:0006622; GO:0008333; GO:0010008; GO:0031901; GO:0031902; GO:0035091; GO:0042802; GO:0045022","early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]","identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]"
"1373","Pocillopora_acuta_HIv2___RNAseq.g13718.t1",929.284439213473,2.42935157891328,2.60591435486059,0.00104988493292264,0.00610105892719691,"Q7TN83",7.64e-08,"Synaptotagmin-16 (Synaptotagmin 14-like protein) (Synaptotagmin XIV-related protein)","","GO:0005543; GO:0016020; GO:0042802","membrane [GO:0016020]","identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]"
"1374","Pocillopora_acuta_HIv2___TS.g23144.t1",1933.98573877367,-2.79838246714104,2.12289714441154,0.00105254739425054,0.00611162003630661,"Q00685",6.8e-149,"Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3 gamma chain]","complement activation, classical pathway [GO:0006958]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]","GO:0004866; GO:0005615; GO:0006954; GO:0006958; GO:0045087","extracellular space [GO:0005615]","endopeptidase inhibitor activity [GO:0004866]"
"1375","Pocillopora_acuta_HIv2___RNAseq.g3746.t1",1372.87908430224,1.00866648980961,1.59047255252836,0.00105755075554268,0.00613382173528022,"P37235",1.27e-68,"Hippocalcin-like protein 1 (Calcium-binding protein BDR-1) (HLP2) (Visinin-like protein 3) (VILIP-3)","","GO:0005509; GO:0016020","membrane [GO:0016020]","calcium ion binding [GO:0005509]"
"1376","Pocillopora_acuta_HIv2___RNAseq.g9955.t1",485.428905626887,2.07429850609435,2.71952846184736,0.00105764321126859,0.00613382173528022,"Q9VNJ5",4.89e-33,"Protein dispatched","germ cell migration [GO:0008354]; patched ligand maturation [GO:0007225]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc pattern formation [GO:0035222]","GO:0005886; GO:0007224; GO:0007225; GO:0007367; GO:0008354; GO:0016020; GO:0022857; GO:0035222; GO:0035230","cytoneme [GO:0035230]; membrane [GO:0016020]; plasma membrane [GO:0005886]","transmembrane transporter activity [GO:0022857]"
"1377","Pocillopora_acuta_HIv2___RNAseq.g24174.t1",754.986216723705,2.1814308723281,2.30088466915668,0.00106884054594715,0.00619627641546276,"Q4G5Y1",2.7e-97,"Kelch domain-containing protein 2 (Endothelial differentiation inhibitory protein TNG)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0016567; GO:0016604; GO:0031462; GO:0031965; GO:0043161; GO:0140627; GO:1990756","Cul2-RING ubiquitin ligase complex [GO:0031462]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]","ubiquitin-like ligase-substrate adaptor activity [GO:1990756]"
"1378","Pocillopora_acuta_HIv2___RNAseq.g25727.t1",445.280596568869,2.44778427483,1.35818664476796,0.00107368264936083,0.00622185330142431,"Q54271",1.52e-53,"Phosphonopyruvate decarboxylase (PnPy decarboxylase) (EC 4.1.1.82)","antibiotic biosynthetic process [GO:0017000]; organic phosphonate biosynthetic process [GO:0032923]","GO:0000287; GO:0017000; GO:0030976; GO:0032923; GO:0033980","","magnesium ion binding [GO:0000287]; phosphonopyruvate decarboxylase activity [GO:0033980]; thiamine pyrophosphate binding [GO:0030976]"
"1379","Pocillopora_acuta_HIv2___RNAseq.g2884.t1",1112.13170716239,-1.83446501205545,3.31362141793151,0.00109028484196884,0.00631047617216379,"A9Y006",1.15e-87,"Aquaporin-3 (Aquaglyceroporin-3)","glycerol transmembrane transport [GO:0015793]; polyol transmembrane transport [GO:0015791]; water transport [GO:0006833]","GO:0005886; GO:0006833; GO:0015166; GO:0015204; GO:0015250; GO:0015254; GO:0015791; GO:0015793; GO:0016323","basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]","glycerol channel activity [GO:0015254]; polyol transmembrane transporter activity [GO:0015166]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]"
"1380","Pocillopora_acuta_HIv2___RNAseq.g13818.t1",1420.88291894327,-2.35301322162957,1.64192059598728,0.00109333158018916,0.0063205227721247,"O95084",4.31e-42,"Serine protease 23 (EC 3.4.21.-) (Putative secreted protein Zsig13)","proteolysis [GO:0006508]","GO:0004252; GO:0005634; GO:0005788; GO:0006508; GO:0070062","endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]","serine-type endopeptidase activity [GO:0004252]"
"1381","Pocillopora_acuta_HIv2___RNAseq.g6284.t1",124.919317252501,1.89383711086373,0.706667610014407,0.00111546415464608,0.00643560970594374,"A4YI89",5.39e-12,"3-hydroxypropionyl-coenzyme A dehydratase (3-hydroxypropionyl-CoA dehydratase) (EC 4.2.1.116)","fatty acid metabolic process [GO:0006631]","GO:0006631; GO:0043956","","3-hydroxypropionyl-CoA dehydratase activity [GO:0043956]"
"1382","Pocillopora_acuta_HIv2___RNAseq.g26743.t1",533.321382848229,2.47074298559174,1.74590496900225,0.00112003515059494,0.00645940527041677,"P27545",1.95e-75,"Ceramide synthase 1 (CerS1) (Longevity assurance gene 1 protein homolog 1) (Protein UOG-1) (Sphingoid base N-stearoyltransferase CERS1) (EC 2.3.1.299)","brain development [GO:0007420]; ceramide biosynthetic process [GO:0046513]; negative regulation of glucose import [GO:0046325]","GO:0005783; GO:0005789; GO:0007420; GO:0016410; GO:0043231; GO:0046325; GO:0046513; GO:0050291","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]","N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]"
"1383","Pocillopora_acuta_HIv2___RNAseq.26508_t",840.771081085752,-2.2369460697683,2.80023054929489,0.00112191068824095,0.00646488566480676,"Q9JJS0",3.3e-27,"Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You)","chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of smoothened signaling pathway [GO:0045880]; signal transduction [GO:0007165]","GO:0003413; GO:0005509; GO:0005615; GO:0007165; GO:0008289; GO:0009986; GO:0019897; GO:0042802; GO:0045669; GO:0045778; GO:0045880; GO:0097108; GO:1902732","cell surface [GO:0009986]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]","calcium ion binding [GO:0005509]; hedgehog family protein binding [GO:0097108]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]"
"1384","Pocillopora_acuta_HIv2___RNAseq.g27047.t1",2115.7622800643,-2.4429863423795,2.43959709464271,0.00112856143605547,0.006498213619071,"P51028",5.66e-55,"Protein Wnt-8a","anterior/posterior pattern specification [GO:0009952]; brain segmentation [GO:0035284]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell migration involved in gastrulation [GO:0042074]; cell proliferation involved in pronephros development [GO:0039015]; central nervous system development [GO:0007417]; determination of dorsal identity [GO:0048263]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; endoderm development [GO:0007492]; eye development [GO:0001654]; hindbrain development [GO:0030902]; mesoderm development [GO:0007498]; mesoderm formation [GO:0001707]; mesodermal cell fate commitment [GO:0001710]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neural crest cell fate specification [GO:0014036]; neural plate anterior/posterior regionalization [GO:0021999]; neural plate pattern specification [GO:0060896]; neuron differentiation [GO:0030182]; notochord development [GO:0030903]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; post-anal tail morphogenesis [GO:0036342]; regulation of anterior head development [GO:2000742]; regulation of cell population proliferation [GO:0042127]; somitogenesis [GO:0001756]; Spemann organizer formation [GO:0060061]; spinal cord anterior/posterior patterning [GO:0021512]; Wnt signaling pathway [GO:0016055]","GO:0000578; GO:0001654; GO:0001707; GO:0001710; GO:0001756; GO:0005109; GO:0005125; GO:0005615; GO:0007398; GO:0007417; GO:0007492; GO:0007498; GO:0009950; GO:0009952; GO:0009953; GO:0009986; GO:0010628; GO:0014036; GO:0016055; GO:0021512; GO:0021999; GO:0030182; GO:0030902; GO:0030903; GO:0035284; GO:0036342; GO:0039015; GO:0042074; GO:0042127; GO:0045165; GO:0045743; GO:0048263; GO:0060061; GO:0060070; GO:0060896; GO:0090090; GO:0090263; GO:0097189; GO:2000742","apoptotic body [GO:0097189]; cell surface [GO:0009986]; extracellular space [GO:0005615]","cytokine activity [GO:0005125]; frizzled binding [GO:0005109]"
"1385","Pocillopora_acuta_HIv2___TS.g27519.t1",742.015542841422,1.65624026243471,2.8349844010457,0.00113344513355879,0.00652130723765068,"Q9VVU5",8.47e-19,"COP9 signalosome complex subunit 1b (Dch1-2) (Signalosome subunit 1b)","female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; germarium-derived cystoblast division [GO:0048142]; male germ-line cyst encapsulation [GO:0048140]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]","GO:0000338; GO:0005737; GO:0007281; GO:0008180; GO:0036099; GO:0048140; GO:0048142; GO:0050821","COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]",""
"1386","Pocillopora_acuta_HIv2___RNAseq.g13205.t1",1874.07141110417,-2.46260122954006,1.27635862381882,0.00113392475820599,0.00652130723765068,NA,NA,NA,NA,NA,NA,NA
"1387","Pocillopora_acuta_HIv2___RNAseq.953_t",1081.97867628544,2.33733308950913,2.39234700562067,0.00113828760236652,0.00653859884059944,"Q87PP5",5.95e-102,"Glycine betaine/proline/choline/ectoine transporter VP1456","amino acid transport [GO:0006865]","GO:0005886; GO:0006865; GO:0022857","plasma membrane [GO:0005886]","transmembrane transporter activity [GO:0022857]"
"1388","Pocillopora_acuta_HIv2___RNAseq.g17611.t1",44238.8316123337,-1.84017551968765,0.709144021918908,0.00113966482641874,0.00654391109540319,NA,NA,NA,NA,NA,NA,NA
"1389","Pocillopora_acuta_HIv2___TS.g14962.t1",1936.99986158019,2.17213944438746,0.980443458431898,0.00114206682606823,0.0065551010207345,"Q6NS52",0,"Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta)","diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of postsynapse organization [GO:0099175]; response to bacterium [GO:0009617]","GO:0004143; GO:0005509; GO:0005524; GO:0005737; GO:0005886; GO:0006654; GO:0007205; GO:0009617; GO:0035556; GO:0046339; GO:0046473; GO:0046834; GO:0050804; GO:0098685; GO:0098978; GO:0099147; GO:0099175","cytoplasm [GO:0005737]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]","ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; calcium ion binding [GO:0005509]"
"1390","Pocillopora_acuta_HIv2___RNAseq.g682.t1",2333.47091477811,-2.7285554152214,1.74356524066012,0.00116432869679157,0.00667228616101159,"O55005",1.77e-28,"Roundabout homolog 1","aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hypoxia [GO:0071456]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; coronary vasculature development [GO:0060976]; endocardial cushion formation [GO:0003272]; heart development [GO:0007507]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; kidney development [GO:0001822]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; neuron projection extension [GO:1990138]; olfactory bulb interneuron development [GO:0021891]; oligodendrocyte development [GO:0014003]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; regulation of dendrite morphogenesis [GO:0048814]; Roundabout signaling pathway [GO:0035385]; spinal cord development [GO:0021510]; synapse organization [GO:0050808]; ventricular septum development [GO:0003281]; ventricular septum morphogenesis [GO:0060412]","GO:0001822; GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0003281; GO:0005737; GO:0005886; GO:0007156; GO:0007411; GO:0007507; GO:0008046; GO:0008285; GO:0009986; GO:0010628; GO:0010629; GO:0014003; GO:0016199; GO:0021510; GO:0021836; GO:0021891; GO:0030275; GO:0030336; GO:0030424; GO:0030425; GO:0030673; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043025; GO:0045747; GO:0048814; GO:0050772; GO:0050808; GO:0050925; GO:0051964; GO:0060412; GO:0060763; GO:0060976; GO:0070100; GO:0071456; GO:1900748; GO:1990138","axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]","axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275]"
"1391","Pocillopora_acuta_HIv2___RNAseq.g27433.t1",732.86833028706,-2.34550103700099,1.41412796063541,0.00116682240968743,0.00668227838924803,NA,NA,NA,NA,NA,NA,NA
"1392","Pocillopora_acuta_HIv2___RNAseq.10616_t",908.191368335668,-2.19863882636497,1.03902625311529,0.00117222364207999,0.00670424782880385,"J9VG42",9.96e-06,"Transcription factor MBS1 (Mbp1/Swi4-like protein 1)","","GO:0001228; GO:0003677; GO:0090575","RNA polymerase II transcription regulator complex [GO:0090575]","DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]"
"1393","Pocillopora_acuta_HIv2___RNAseq.g9223.t1",116.611128183097,1.98822408206823,3.587673985132,0.00117773708226798,0.00673045798416598,"Q684M4",3.34e-167,"Kelch-like ECH-associated protein 1","cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; in utero embryonic development [GO:0001701]; negative regulation of response to oxidative stress [GO:1902883]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of DNA-templated transcription [GO:0006355]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0001701; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005884; GO:0006355; GO:0006511; GO:0010506; GO:0016234; GO:0016567; GO:0030496; GO:0031463; GO:0034451; GO:0034599; GO:0042802; GO:0045604; GO:0061629; GO:0071353; GO:0097718; GO:1902883; GO:1990756","actin filament [GO:0005884]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]","disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]"
"1394","Pocillopora_acuta_HIv2___RNAseq.g2827.t1",2015.11450619594,1.32854596685323,2.29548031791152,0.00117934683215884,0.00673699548986787,"O43581",9.75e-12,"Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII)","calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; regulation of synaptic vesicle endocytosis [GO:1900242]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle fusion [GO:0006906]; vesicle-mediated cholesterol transport [GO:0090119]","GO:0000149; GO:0001778; GO:0001786; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006906; GO:0006909; GO:0008021; GO:0019905; GO:0030276; GO:0030424; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042734; GO:0045202; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0070062; GO:0070092; GO:0090119; GO:0090385; GO:0098686; GO:1900242; GO:1990926; GO:1990927","axon [GO:0030424]; cytosol [GO:0005829]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; extracellular exosome [GO:0070062]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]","calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
"1395","Pocillopora_acuta_HIv2___RNAseq.g4028.t1",1336.23793996349,1.89947200424434,2.95883051433836,0.00120452665416904,0.00686396467578725,"O43581",5.45e-110,"Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII)","calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; regulation of synaptic vesicle endocytosis [GO:1900242]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle fusion [GO:0006906]; vesicle-mediated cholesterol transport [GO:0090119]","GO:0000149; GO:0001778; GO:0001786; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006906; GO:0006909; GO:0008021; GO:0019905; GO:0030276; GO:0030424; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042734; GO:0045202; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0070062; GO:0070092; GO:0090119; GO:0090385; GO:0098686; GO:1900242; GO:1990926; GO:1990927","axon [GO:0030424]; cytosol [GO:0005829]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; extracellular exosome [GO:0070062]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]","calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"
"1396","Pocillopora_acuta_HIv2___RNAseq.g8087.t1",1383.60419693104,-2.88102955461786,1.84151203714464,0.00120865747887847,0.0068826857379914,"Q8R151",5.27e-143,"NFX1-type zinc finger-containing protein 1","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607","cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380]","helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]"
"1397","Pocillopora_acuta_HIv2___RNAseq.g16484.t1",2367.06412104972,-2.74150322920188,2.15048548607454,0.00121410381642076,0.00690376447775206,"Q9VBW3",7.07e-96,"Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303","apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]","ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]"
"1398","Pocillopora_acuta_HIv2___RNAseq.g27337.t1",784.209680573377,-2.89108834176517,2.03368342590186,0.00121443190877818,0.00690376447775206,"Q6PBD4",1.72e-41,"Transcription factor HES-4 (Hairy and enhancer of split 4) (Protein hairy-2)","eye photoreceptor cell development [GO:0042462]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neurogenesis [GO:0050768]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest formation [GO:0014029]; Notch signaling pathway [GO:0007219]; photoreceptor cell maintenance [GO:0045494]; prechordal plate formation [GO:0021501]","GO:0000122; GO:0002088; GO:0005634; GO:0007219; GO:0007517; GO:0014029; GO:0021501; GO:0033504; GO:0042462; GO:0043066; GO:0043565; GO:0045494; GO:0045892; GO:0046982; GO:0048642; GO:0050768","nucleus [GO:0005634]","protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]"
"1399","Pocillopora_acuta_HIv2___RNAseq.g16050.t1",1242.56235257443,2.29965586352936,1.12737956313786,0.00122795066515904,0.00697022816784122,"Q04859",0,"Serine/threonine-protein kinase MAK (EC 2.7.11.1) (Male germ cell-associated kinase) (Protein kinase RCK)","cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary transport [GO:0042073]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]","GO:0001750; GO:0001917; GO:0003713; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005929; GO:0005930; GO:0006468; GO:0030496; GO:0031514; GO:0032391; GO:0035556; GO:0042073; GO:0045494; GO:0046777; GO:0046872; GO:0060271; GO:0072686; GO:0106310; GO:1902856; GO:1905515","axoneme [GO:0005930]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; motile cilium [GO:0031514]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]","ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]"
"1400","Pocillopora_acuta_HIv2___RNAseq.g23638.t1",1021.22070160144,-2.45171383955761,1.38227584614998,0.00123579933427721,0.00700492438053552,"Q4R8M9",7.1e-20,"Gametocyte-specific factor 1 (Protein FAM112B)","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","GO:0005737; GO:0007283; GO:0030154; GO:0046872","cytoplasm [GO:0005737]","metal ion binding [GO:0046872]"
"1401","Pocillopora_acuta_HIv2___RNAseq.g27596.t1",285.237795323668,1.06407733933922,1.72207847717798,0.00124579772695781,0.00705253163315763,NA,NA,NA,NA,NA,NA,NA
"1402","Pocillopora_acuta_HIv2___RNAseq.g16553.t1",159.761145956839,1.3583494830955,2.17871673616365,0.00125064580125927,0.0070772069129163,"Q5U584",4.28e-62,"SH3 domain-binding protein 5-like (SH3BP-5-like)","intracellular signal transduction [GO:0035556]","GO:0005085; GO:0035556","","guanyl-nucleotide exchange factor activity [GO:0005085]"
"1403","Pocillopora_acuta_HIv2___RNAseq.g31347.t1",3829.18725638947,-1.72155448635999,0.643366022952328,0.00125148184526622,0.00707916832613634,"P81439",1.3e-28,"Equistatin (EI) (Cysteine proteinase inhibitor)","","GO:0004869; GO:0005615","extracellular space [GO:0005615]","cysteine-type endopeptidase inhibitor activity [GO:0004869]"
"1404","Pocillopora_acuta_HIv2___RNAseq.g13070.t1",903.146272180001,1.97052264298801,0.794698147136954,0.00126873930773323,0.00716557803477291,"A7SKE9",6.57e-147,"Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4)","formation of cytoplasmic translation initiation complex [GO:0001732]","GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0016282; GO:0033290","eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]","RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]"
"1405","Pocillopora_acuta_HIv2___TS.g13222.t1b",83516.7658841999,-2.01182411125871,0.857397533119286,0.00126965440577878,0.00716622147726561,"P18709",1.42e-50,"Vitellogenin-A2 (VTG A2) [Cleaved into: Lipovitellin I; Lipovitellin II; Phosvitin]","","GO:0005319; GO:0045735","","lipid transporter activity [GO:0005319]; nutrient reservoir activity [GO:0045735]"
"1406","Pocillopora_acuta_HIv2___RNAseq.g12278.t1",173.362676067824,-3.36294857472283,3.13486928550118,0.00129081446015332,0.00727321400532045,"P18052",5.24e-63,"Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28)","insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of focal adhesion assembly [GO:0051893]","GO:0004725; GO:0005925; GO:0007229; GO:0008286; GO:0016020; GO:0043235; GO:0044877; GO:0048714; GO:0050804; GO:0051893; GO:0097060; GO:0098685","focal adhesion [GO:0005925]; membrane [GO:0016020]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]","protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]"
"1407","Pocillopora_acuta_HIv2___RNAseq.g22283.t1",4427.24165739326,1.87446145876588,0.737875673698462,0.00130018621731436,0.00732031663963988,"Q76B49",4.79e-46,"CD63 antigen (CD antigen CD63)","cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]","GO:0002092; GO:0005576; GO:0005765; GO:0005886; GO:0007160; GO:0009986; GO:0015031; GO:0016477; GO:0031902; GO:0032585; GO:0035646; GO:0042470; GO:0048757; GO:0097487; GO:1900746; GO:2001046","cell surface [GO:0009986]; extracellular region [GO:0005576]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; plasma membrane [GO:0005886]",""
"1408","Pocillopora_acuta_HIv2___RNAseq.g6413.t1",17.443379719631,7.26624146258683,4.06146665663447,0.00130294629180576,0.00733300200960254,NA,NA,NA,NA,NA,NA,NA
"1409","Pocillopora_acuta_HIv2___RNAseq.g15584.t1",1587.90694979045,2.26101818768863,1.43739085547972,0.00133984357300117,0.00751434565331093,"P05123",0,"Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK)","phosphocreatine biosynthetic process [GO:0046314]; response to heat [GO:0009408]","GO:0004111; GO:0005524; GO:0005615; GO:0005737; GO:0009408; GO:0046314","cytoplasm [GO:0005737]; extracellular space [GO:0005615]","ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]"
"1410","Pocillopora_acuta_HIv2___RNAseq.g1800.t1",103.53093248477,1.68797909041464,2.76935769222567,0.00134268739469316,0.00752737615381467,"E7FAM5",2.92e-50,"E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177","P-body [GO:0000932]","miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
"1411","Pocillopora_acuta_HIv2___RNAseq.g9373.t1",462.526492373285,-1.61258495333939,3.6141200152584,0.00134596681005433,0.00754283763681742,"Q32KW9",1.23e-49,"Interferon-inducible GTPase 5 (EC 3.6.5.-) (Immunity-related GTPase cinema 1)","positive regulation of flagellated sperm motility [GO:1902093]","GO:0003924; GO:0005525; GO:0005811; GO:0016020; GO:0036126; GO:0097226; GO:1902093","lipid droplet [GO:0005811]; membrane [GO:0016020]; sperm flagellum [GO:0036126]; sperm mitochondrial sheath [GO:0097226]","GTP binding [GO:0005525]; GTPase activity [GO:0003924]"
"1412","Pocillopora_acuta_HIv2___RNAseq.g22369.t1",1789.89550639446,-1.96821288405634,0.829543346467213,0.00134875855438699,0.0075554931939595,"Q58D55",0,"Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)","carbohydrate metabolic process [GO:0005975]","GO:0004565; GO:0005764; GO:0005773; GO:0005975","lysosome [GO:0005764]; vacuole [GO:0005773]","beta-galactosidase activity [GO:0004565]"
"1413","Pocillopora_acuta_HIv2___RNAseq.g10514.t1",251.700966660513,1.58057605522245,2.5268497649608,0.00135143405873734,0.00756401331169004,"Q92547",0,"DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1)","broken chromosome clustering [GO:0141112]; chromosome organization [GO:0051276]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein localization to site of double-strand break [GO:1990166]; response to ionizing radiation [GO:0010212]","GO:0000076; GO:0000077; GO:0000724; GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005886; GO:0006259; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0035825; GO:0035861; GO:0042802; GO:0043539; GO:0051276; GO:0070532; GO:0090734; GO:0097680; GO:0097681; GO:0140031; GO:0140463; GO:0141112; GO:1990166","actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; centrosome [GO:0005813]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; spindle pole [GO:0000922]","chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539]"
"1414","Pocillopora_acuta_HIv2___RNAseq.g25936.t1",4149.59914181813,-2.81953373746601,2.09607193050867,0.0013584069742976,0.00759196231693989,NA,NA,NA,NA,NA,NA,NA
"1415","Pocillopora_acuta_HIv2___RNAseq.g12306.t1",727.113927494196,-1.1000911414274,1.84954428338228,0.00136268418005442,0.0076129254462368,"B7ZCC9",1.01e-57,"Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; neurogenesis [GO:0022008]","GO:0004930; GO:0005886; GO:0007166; GO:0007189; GO:0022008","plasma membrane [GO:0005886]","G protein-coupled receptor activity [GO:0004930]"
"1416","Pocillopora_acuta_HIv2___RNAseq.g28794.t1",4693.2014611543,-2.4049899159267,1.51956660694847,0.0013950634155824,0.00778479831905241,"P02466",2e-164,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096","collagen trimer [GO:0005581]; collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]","extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]"
"1417","Pocillopora_acuta_HIv2___RNAseq.g3088.t1",1522.71637747625,-1.97526494579686,1.68315856822134,0.00143859374554212,0.00799993077105776,"Q6AZT7",0,"Nephrocystin-3","cilium assembly [GO:0060271]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]","GO:0005929; GO:0016055; GO:0060027; GO:0060271; GO:0090090; GO:2000095","cilium [GO:0005929]",""
"1418","Pocillopora_acuta_HIv2___TS.g7609.t1b",211.460256392235,2.3564628625151,2.64561676026758,0.0014547159088062,0.00808026532449037,"Q5RB83",2.6e-75,"Phosphoserine phosphatase (PSP) (PSPase) (EC 3.1.3.3) (O-phosphoserine phosphohydrolase)","L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]","GO:0000287; GO:0005829; GO:0006563; GO:0006564; GO:0036424","cytosol [GO:0005829]","L-phosphoserine phosphatase activity [GO:0036424]; magnesium ion binding [GO:0000287]"
"1419","Pocillopora_acuta_HIv2___RNAseq.g17948.t1",6554.25297373893,-1.72762418407531,0.66388305517374,0.00146051709968983,0.0081093740229995,NA,NA,NA,NA,NA,NA,NA
"1420","Pocillopora_acuta_HIv2___RNAseq.g28858.t1",1376.33822861957,2.48059133992085,1.31670093494715,0.00146405897077794,0.00811825699241875,"Q3SXB8",1.44e-06,"Collectin-11 (Collectin kidney protein 1) (CL-K1)","antimicrobial humoral response [GO:0019730]; complement activation, lectin pathway [GO:0001867]; developmental process [GO:0032502]","GO:0001867; GO:0003677; GO:0005509; GO:0005537; GO:0005581; GO:0005615; GO:0019730; GO:0032502; GO:0042806; GO:0070492; GO:0120153","collagen trimer [GO:0005581]; extracellular space [GO:0005615]","calcium ion binding [GO:0005509]; calcium-dependent carbohydrate binding [GO:0120153]; D-mannose binding [GO:0005537]; DNA binding [GO:0003677]; fucose binding [GO:0042806]; oligosaccharide binding [GO:0070492]"
"1421","Pocillopora_acuta_HIv2___RNAseq.g3142.t1a",165.535663324294,1.04776257450853,1.62654499737683,0.00147036377995293,0.00814216757780979,"Q7T2B9",6.59e-14,"Myotrophin","regulation of barbed-end actin filament capping [GO:2000812]","GO:0005634; GO:0005737; GO:0048471; GO:2000812","cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]",""
"1422","Pocillopora_acuta_HIv2___RNAseq.g13856.t1",416.501011933529,2.15446583896307,2.59088656961607,0.00149503224327115,0.00826927203314488,"D3Z902",4.81e-56,"F-box/WD repeat-containing protein 7","DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; Notch signaling pathway [GO:0007219]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculogenesis [GO:0001570]","GO:0001570; GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0006281; GO:0006974; GO:0007062; GO:0007219; GO:0010629; GO:0010992; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0070374; GO:0070534; GO:0090049; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2001205","chromosome [GO:0005694]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]","cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027]"
"1423","Pocillopora_acuta_HIv2___TS.g22239.t1",25.6625567158209,1.08795506636857,1.98984661315894,0.00150987106213202,0.00833541032163266,NA,NA,NA,NA,NA,NA,NA
"1424","Pocillopora_acuta_HIv2___RNAseq.g20910.t1",16.2540859568451,1.01837394489575,2.08268601896479,0.00151097045963369,0.00833829711108037,NA,NA,NA,NA,NA,NA,NA
"1425","Pocillopora_acuta_HIv2___RNAseq.g21518.t1",1281.13793582765,-1.5149140969879,2.62706312443716,0.00152313557468467,0.00840222461946567,"Q8JZQ5",0,"Diamine oxidase [copper-containing] (Diamine oxidase) (EC 1.4.3.22) (Amine oxidase copper domain-containing protein 1) (Histaminase)","amine metabolic process [GO:0009308]; cellular response to copper ion starvation [GO:0035874]; putrescine metabolic process [GO:0009445]; response to antibiotic [GO:0046677]","GO:0005507; GO:0005615; GO:0005886; GO:0005923; GO:0008131; GO:0008201; GO:0009308; GO:0009445; GO:0035874; GO:0046677; GO:0048038; GO:0050232; GO:0052597; GO:0052598; GO:0052599; GO:0052600; GO:0097159","bicellular tight junction [GO:0005923]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]","copper ion binding [GO:0005507]; diamine oxidase activity [GO:0052597]; heparin binding [GO:0008201]; histamine oxidase activity [GO:0052598]; methylputrescine oxidase activity [GO:0052599]; organic cyclic compound binding [GO:0097159]; primary amine oxidase activity [GO:0008131]; propane-1,3-diamine oxidase activity [GO:0052600]; putrescine oxidase activity [GO:0050232]; quinone binding [GO:0048038]"
"1426","Pocillopora_acuta_HIv2___RNAseq.g12927.t1",81.9520341217083,2.66361566398709,1.56155720356994,0.00152681740178905,0.00841932401810018,NA,NA,NA,NA,NA,NA,NA
"1427","Pocillopora_acuta_HIv2___TS.g24662.t1",21.0156364379834,3.22721305162851,2.98793153902892,0.00152739976382187,0.00841932552740838,"P97686",4.39e-08,"Neuronal cell adhesion molecule (Nr-CAM) (Ankyrin-binding cell adhesion molecule NrCAM) (Neuronal surface protein Bravo) (rBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related)","angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; clustering of voltage-gated sodium channels [GO:0045162]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuronal action potential propagation [GO:0019227]; protein localization [GO:0008104]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; retinal ganglion cell axon guidance [GO:0031290]","GO:0001525; GO:0005576; GO:0005886; GO:0007155; GO:0007156; GO:0007411; GO:0007417; GO:0008104; GO:0010975; GO:0019227; GO:0030424; GO:0030506; GO:0031290; GO:0033268; GO:0043194; GO:0045162; GO:0045202; GO:0045211; GO:0070593; GO:0086080; GO:0098609; GO:0098632; GO:0098839; GO:0098978; GO:0099175","axon [GO:0030424]; axon initial segment [GO:0043194]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]","ankyrin binding [GO:0030506]; cell-cell adhesion mediator activity [GO:0098632]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]"
"1428","Pocillopora_acuta_HIv2___RNAseq.19150_t",1429.28441585307,-2.30343294722581,2.14338400756345,0.00152837043069548,0.00842146663222073,NA,NA,NA,NA,NA,NA,NA
"1429","Pocillopora_acuta_HIv2___RNAseq.g28818.t1",1048.18105913842,-1.83057816098375,0.73695353436354,0.00153343816761546,0.0084452782568338,"Q6XYQ8",5.38e-20,"Synaptotagmin-10 (Synaptotagmin X) (SytX)","calcium-ion regulated exocytosis [GO:0017156]; chemical synaptic transmission [GO:0007268]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; sensory perception of smell [GO:0007608]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0007608; GO:0017156; GO:0030276; GO:0030658; GO:0042803; GO:0045956; GO:0046982; GO:0070382; GO:0098793; GO:0098978","exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; transport vesicle membrane [GO:0030658]","calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]"
"1430","Pocillopora_acuta_HIv2___RNAseq.g19600.t1",907.261226942243,2.21662321546163,1.46032332442974,0.0015343355122548,0.0084452782568338,"Q6P8Y1",2.6e-98,"Calcyphosin-like protein","","GO:0005509; GO:0005737","cytoplasm [GO:0005737]","calcium ion binding [GO:0005509]"
"1431","Pocillopora_acuta_HIv2___TS.g4840.t1",26.7177972799547,-2.91898475076686,1.93383795652613,0.0015416733156147,0.00847861704830834,"Q7ZWG6",8.43e-25,"Proton-coupled folate transporter (Solute carrier family 46 member 1)","transmembrane transport [GO:0055085]","GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085","apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886]","folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]"
"1432","Pocillopora_acuta_HIv2___RNAseq.g9309.t1",27.5165488014735,3.11596433130725,2.76454300929487,0.00157666291723936,0.00866116689515765,"Q0R4F1",0,"ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1)","DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]","GO:0000002; GO:0000723; GO:0003677; GO:0005524; GO:0005634; GO:0005739; GO:0006281; GO:0006310; GO:0016887; GO:0043139","mitochondrion [GO:0005739]; nucleus [GO:0005634]","5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]"
"1433","Pocillopora_acuta_HIv2___RNAseq.g30102.t1",193.291378289905,4.14190668182301,4.70960202404066,0.00157840496567177,0.00866744473176785,"O16616",6.42e-13,"E3 ubiquitin-protein ligase trim-21 (EC 2.3.2.27)","protein ubiquitination [GO:0016567]","GO:0005737; GO:0008270; GO:0016567; GO:0016740","cytoplasm [GO:0005737]","transferase activity [GO:0016740]; zinc ion binding [GO:0008270]"
"1434","Pocillopora_acuta_HIv2___RNAseq.g15220.t1",887.67403368448,1.81396178506954,2.91400279698618,0.00159706981809261,0.00876661018933264,NA,NA,NA,NA,NA,NA,NA
"1435","Pocillopora_acuta_HIv2___RNAseq.21012_t",36.489976006713,-2.64401406670216,1.38541694102022,0.00160508314379315,0.00880391452097997,"Q8CHN8",1.18e-40,"Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain]","complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; zymogen activation [GO:0031638]","GO:0001867; GO:0004252; GO:0005509; GO:0005615; GO:0006956; GO:0008233; GO:0031638; GO:0042803; GO:0048306","extracellular space [GO:0005615]","calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]"
"1436","Pocillopora_acuta_HIv2___TS.g29156.t1",96.8200384455112,2.52060622642058,2.38035936348725,0.00160620251362758,0.00880671461603839,NA,NA,NA,NA,NA,NA,NA
"1437","Pocillopora_acuta_HIv2___RNAseq.g29611.t1",28007.0215218009,-1.52034815959385,0.553938934994398,0.00161405938630724,0.00884643992555813,NA,NA,NA,NA,NA,NA,NA
"1438","Pocillopora_acuta_HIv2___RNAseq.g842.t1",667.519968577847,-2.27234144522765,1.52845966194149,0.00162764067324711,0.00891412143046049,NA,NA,NA,NA,NA,NA,NA
"1439","Pocillopora_acuta_HIv2___RNAseq.g9756.t1",1987.64126929979,-1.71849405480157,0.669732988079968,0.00163181336301101,0.00893021130631526,"Q5ZJF4",2.94e-91,"Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Glutathione-dependent peroxiredoxin) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx)","cell redox homeostasis [GO:0045454]; lipid catabolic process [GO:0016042]","GO:0004623; GO:0005615; GO:0005739; GO:0005764; GO:0005829; GO:0016042; GO:0045454; GO:0047184; GO:0051920","cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]; mitochondrion [GO:0005739]","1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity [GO:0004623]"
"1440","Pocillopora_acuta_HIv2___RNAseq.g17833.t1",16.0860774492867,1.00406806781594,2.0393023006688,0.00164614426435872,0.00899842427803648,NA,NA,NA,NA,NA,NA,NA
"1441","Pocillopora_acuta_HIv2___RNAseq.g21055.t1",1810.23198076969,-2.22991548521741,1.23422398393281,0.00165417936995061,0.00903551752528912,"Q6P1B1",0,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)","bradykinin catabolic process [GO:0010815]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508]","GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0043069; GO:0070006","cytoplasm [GO:0005737]; cytosol [GO:0005829]","aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]"
"1442","Pocillopora_acuta_HIv2___RNAseq.g28809.t1",745.50663997748,-2.07325526098651,1.02405174022466,0.00168393687657053,0.00917602248876718,NA,NA,NA,NA,NA,NA,NA
"1443","Pocillopora_acuta_HIv2___RNAseq.g27793.t1",505.80329188519,1.78480428093412,2.45309128281311,0.00168434317669226,0.00917602248876718,"Q9N293",8.75e-35,"Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5)","lipid metabolic process [GO:0006629]; protein O-linked glycosylation [GO:0006493]","GO:0000139; GO:0006493; GO:0006629; GO:0008499","Golgi membrane [GO:0000139]","UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"
"1444","Pocillopora_acuta_HIv2___RNAseq.g27206.t1",1311.00459748368,1.81071385858594,1.87640304316282,0.0016979836305704,0.00924685061467257,"Q86U86",0,"Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D)","chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368]","GO:0000228; GO:0000278; GO:0000776; GO:0000785; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0006368; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0045582; GO:0045597; GO:0045663; GO:0070316; GO:2000045; GO:2000781; GO:2000819","chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]","chromatin binding [GO:0003682]; DNA binding [GO:0003677]"
"1445","Pocillopora_acuta_HIv2___TS.g7609.t1a",37.417393894475,2.3332746578545,2.34755406561557,0.00170619421041765,0.00928457225714104,NA,NA,NA,NA,NA,NA,NA
"1446","Pocillopora_acuta_HIv2___RNAseq.g14360.t1",1548.37344868615,-2.69114537041644,1.9696170732541,0.0017163368336547,0.00932923561141737,NA,NA,NA,NA,NA,NA,NA
"1447","Pocillopora_acuta_HIv2___TS.g18770.t2",1578.70198555442,1.3856019841439,2.33730563632959,0.0017469893067417,0.00947093453250074,NA,NA,NA,NA,NA,NA,NA
"1448","Pocillopora_acuta_HIv2___RNAseq.g6073.t1",17.8806840183318,1.10590332368689,2.36150885024319,0.00177601186443276,0.00962106202515186,NA,NA,NA,NA,NA,NA,NA
"1449","Pocillopora_acuta_HIv2___RNAseq.g9098.t1",2116.3987309538,-1.89980500439209,2.43225979674441,0.00180386746313294,0.00975369681747843,"O60235",1.87e-36,"Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain]","proteolysis [GO:0006508]; respiratory gaseous exchange by respiratory system [GO:0007585]","GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0007585; GO:0008233; GO:0070062","extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]","peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]"
"1450","Pocillopora_acuta_HIv2___RNAseq.g12088.t1",135.026335841181,-2.41864148278006,2.84878605380488,0.0018098556886416,0.00978241878942902,"Q9EQD2",2.18e-33,"Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor)","cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of MAPK cascade [GO:0043408]","GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0042277; GO:0043408","actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]","neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628]; peptide binding [GO:0042277]"
"1451","Pocillopora_acuta_HIv2___TS.g1420.t1b",141.813401693939,2.41641047777079,1.27174364234131,0.00182937514480098,0.00985111023618817,NA,NA,NA,NA,NA,NA,NA
"1452","Pocillopora_acuta_HIv2___TS.g24259.t1",62.744234372737,2.66737387527675,1.89972173766965,0.00183645928613792,0.0098855776385184,"Q8R3W5",4.44e-13,"tRNA-splicing endonuclease subunit Sen15 (tRNA-intron endonuclease Sen15)","mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]","GO:0003676; GO:0005730; GO:0006388; GO:0006397","nucleolus [GO:0005730]","nucleic acid binding [GO:0003676]"
"1453","Pocillopora_acuta_HIv2___RNAseq.g5388.t1",1054.28576452956,-2.0338601857415,2.02746578692931,0.00183801214381343,0.00989025582147227,"D3YXG0",8.08e-06,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]","GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711","adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]","calcium ion binding [GO:0005509]"
"1454","Pocillopora_acuta_HIv2___RNAseq.g30952.t1",104.092184356208,1.9950812940257,2.56809303160794,0.00184367208082352,0.00991702230458587,"Q9Z1K5",4.83e-30,"E3 ubiquitin-protein ligase ARIH1 (EC 2.3.2.31) (Protein ariadne-1 homolog) (ARI-1) (UbcH7-binding protein) (UbcM4-interacting protein 77) (Ubiquitin-conjugating enzyme E2-binding protein 1)","protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0006511; GO:0008270; GO:0015030; GO:0016567; GO:0016604; GO:0019005; GO:0031462; GO:0031463; GO:0031464; GO:0031624; GO:0031625; GO:0061630; GO:0097413","Cajal body [GO:0015030]; Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]","ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
"1455","Pocillopora_acuta_HIv2___TS.g19590.t1",522.382671885679,2.08454336108583,0.966178560185035,0.00185047967873275,0.00994993980416001,"Q8VEE0",5.75e-98,"Ribulose-phosphate 3-epimerase (EC 5.1.3.1) (Ribulose-5-phosphate-epimerase)","carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]","GO:0004750; GO:0005829; GO:0005975; GO:0006098; GO:0009052; GO:0030246; GO:0046872; GO:0048029","cytosol [GO:0005829]","carbohydrate binding [GO:0030246]; D-ribulose-phosphate 3-epimerase activity [GO:0004750]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]"
"1456","Pocillopora_acuta_HIv2___RNAseq.g21912.t1",1446.16922174492,2.38516629899951,2.51225604225446,0.0018646696575336,0.0100150694120186,"Q504H8",1e-48,"Homeobox protein HMX3 (Homeobox protein H6 family member 3) (Homeobox protein Nkx-5.1)","cell differentiation [GO:0030154]; inner ear morphogenesis [GO:0042472]; otolith development [GO:0048840]; posterior lateral line development [GO:0048916]; posterior lateral line neuromast primordium migration [GO:0048920]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0021510; GO:0030154; GO:0042472; GO:0048840; GO:0048916; GO:0048920","nucleus [GO:0005634]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"
"1457","Pocillopora_acuta_HIv2___TS.g28689.t1",160.346030570493,-1.02667002504198,1.94731330539736,0.00188227120734027,0.0101058540248588,NA,NA,NA,NA,NA,NA,NA
"1458","Pocillopora_acuta_HIv2___RNAseq.g949.t1",537.975017112117,1.95111810074269,0.867914862866274,0.0018873394688399,0.0101293054090168,"Q5RBX7",1.35e-34,"Signal recognition particle 14 kDa protein (SRP14)","SRP-dependent cotranslational protein targeting to membrane [GO:0006614]","GO:0005786; GO:0006614; GO:0008312; GO:0030942","signal recognition particle, endoplasmic reticulum targeting [GO:0005786]","7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]"
"1459","Pocillopora_acuta_HIv2___RNAseq.g28339.t1",1279.96101528552,1.24302226775148,2.06170096667767,0.00190343888160627,0.0102081349586774,NA,NA,NA,NA,NA,NA,NA
"1460","Pocillopora_acuta_HIv2___RNAseq.g26011.t1",154.81058003676,2.30880574934645,2.17058044957565,0.00191295990084441,0.0102523913968721,NA,NA,NA,NA,NA,NA,NA
"1461","Pocillopora_acuta_HIv2___RNAseq.g13672.t1",133.713372981856,2.59218520407798,2.95276273810041,0.00191411647229133,0.0102539928352673,"P43166",2.26e-47,"Carbonic anhydrase 7 (EC 4.2.1.1) (Carbonate dehydratase VII) (Carbonic anhydrase VII) (CA-VII)","neuron cellular homeostasis [GO:0070050]; one-carbon metabolic process [GO:0006730]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]","GO:0004089; GO:0005737; GO:0005829; GO:0006730; GO:0008270; GO:0032230; GO:0032849; GO:0051453; GO:0070050; GO:2001225","cytoplasm [GO:0005737]; cytosol [GO:0005829]","carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]"
"1462","Pocillopora_acuta_HIv2___TS.g4401.t1",256.948979317925,-1.94984714459318,1.7426142862586,0.00192816840137865,0.0103254453008296,NA,NA,NA,NA,NA,NA,NA
"1463","Pocillopora_acuta_HIv2___RNAseq.g2410.t1",569.26919791403,2.12229139237117,1.2960368896572,0.00194162004432343,0.0103897862823137,"P70187",0,"Hippocampus abundant transcript 1 protein (Major facilitator superfamily domain-containing 14A)","acrosome assembly [GO:0001675]; sperm mitochondrion organization [GO:0030382]; spermatid development [GO:0007286]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]","GO:0001675; GO:0007283; GO:0007286; GO:0007289; GO:0016020; GO:0022857; GO:0030382","membrane [GO:0016020]","transmembrane transporter activity [GO:0022857]"
"1464","Pocillopora_acuta_HIv2___RNAseq.g17508.t1b",2272.76926165412,-2.66162778679673,1.97943759871145,0.00195091337830283,0.0104356549939986,"Q8CG08",2.54e-19,"Collagen triple helix repeat-containing protein 1","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0031012; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177","collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; sarcoplasm [GO:0016528]","frizzled binding [GO:0005109]; Wnt-protein binding [GO:0017147]"
"1465","Pocillopora_acuta_HIv2___RNAseq.g4746.t1",3648.60232233247,-2.0415896652756,0.984209280979835,0.00197335847496968,0.0105479146274802,NA,NA,NA,NA,NA,NA,NA
"1466","Pocillopora_acuta_HIv2___RNAseq.g8098.t1",11539.4189961409,-1.89720015704723,0.851820632558823,0.00198033965716933,0.0105806378926274,"Q95029",1.75e-127,"Cathepsin L1 (EC 3.4.22.15) (Cysteine proteinase 1) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]","digestion [GO:0007586]; immune response [GO:0006955]; positive regulation of apoptotic signaling pathway [GO:2001235]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]","GO:0004197; GO:0005615; GO:0005764; GO:0005770; GO:0006508; GO:0006955; GO:0007586; GO:0008233; GO:0008234; GO:0008656; GO:0044754; GO:0045169; GO:0051603; GO:2001235","autolysosome [GO:0044754]; extracellular space [GO:0005615]; fusome [GO:0045169]; late endosome [GO:0005770]; lysosome [GO:0005764]","cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]"
"1467","Pocillopora_acuta_HIv2___RNAseq.g3840.t1",611.166561274037,2.32368426124872,1.4346134510961,0.0019910812164577,0.0106230168627238,"O75366",0,"Advillin (p92)","actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480]","GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480","actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]","actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"
"1468","Pocillopora_acuta_HIv2___RNAseq.g10739.t1",289.757265145104,1.48943564881288,2.36777190801232,0.00200781505870154,0.0107004557881574,"A0A0C2SRU0",1.49e-78,"Decarboxylase iboD (EC 4.1.1.-) (Ibotenic acid biosynthesis cluster protein D)","phospholipid biosynthetic process [GO:0008654]","GO:0004609; GO:0008654","","phosphatidylserine decarboxylase activity [GO:0004609]"
"1469","Pocillopora_acuta_HIv2___RNAseq.g242.t1",25.2777026865998,1.54543637239189,3.7405169595766,0.0020112898389209,0.0107150262357834,NA,NA,NA,NA,NA,NA,NA
"1470","Pocillopora_acuta_HIv2___RNAseq.g24307.t1",336.818402277547,-2.0857235063452,1.04968592836351,0.00201269205716538,0.0107185485695287,NA,NA,NA,NA,NA,NA,NA
"1471","Pocillopora_acuta_HIv2___RNAseq.g18294.t1b",206.959235047174,2.11173977521894,2.06821084046737,0.00201743758238151,0.0107359150815181,NA,NA,NA,NA,NA,NA,NA
"1472","Pocillopora_acuta_HIv2___RNAseq.g18290.t1",953.967303461302,-2.48923758780691,1.93297155969445,0.00202993296097697,0.0107984370531706,NA,NA,NA,NA,NA,NA,NA
"1473","Pocillopora_acuta_HIv2___RNAseq.g22722.t1",716.088092866138,1.19851764116787,1.89170582319365,0.00203274434311506,0.0108034729422977,"G5EDU6",2.38e-50,"Transcription factor ovo-like homolog lin-48 (Abnormal cell lineage protein 48)","animal organ morphogenesis [GO:0009887]; epidermal cell differentiation [GO:0009913]; hindgut morphogenesis [GO:0007442]; nematode male tail tip morphogenesis [GO:0045138]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to salt stress [GO:0009651]","GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007442; GO:0009651; GO:0009887; GO:0009913; GO:0045138; GO:0046872","nucleus [GO:0005634]","DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"1474","Pocillopora_acuta_HIv2___RNAseq.g9554.t1",665.832549353688,-2.00718859078762,2.523373100513,0.00204300441427608,0.010848023439093,"Q9UDT6",4.44e-10,"CAP-Gly domain-containing linker protein 2 (Cytoplasmic linker protein 115) (CLIP-115) (Cytoplasmic linker protein 2) (Williams-Beuren syndrome chromosomal region 3 protein) (Williams-Beuren syndrome chromosomal region 4 protein)","cytoplasmic microtubule organization [GO:0031122]","GO:0005634; GO:0005875; GO:0005938; GO:0008017; GO:0031122; GO:0035371; GO:0051010","cell cortex [GO:0005938]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]","microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]"
"1475","Pocillopora_acuta_HIv2___RNAseq.g13027.t1",552.978205740474,-1.86225903793446,1.7610747938774,0.00204902760461252,0.0108760129442626,NA,NA,NA,NA,NA,NA,NA
"1476","Pocillopora_acuta_HIv2___RNAseq.g31256.t1",180.948442550252,1.20449463032485,1.93345860876482,0.0020683043788596,0.0109502029779741,"Q5BJN5",1.38e-47,"Mitochondrial intermembrane space import and assembly protein 40 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 4)","'de novo' post-translational protein folding [GO:0051084]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to oxidative stress [GO:0034599]; establishment of protein localization to mitochondrion [GO:0072655]; mitochondrial DNA repair [GO:0043504]; mitochondrial respiratory chain complex assembly [GO:0033108]; peptidyl-cysteine oxidation [GO:0018171]; positive regulation of cellular respiration [GO:1901857]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417]; regulation of protein export from nucleus [GO:0046825]","GO:0005739; GO:0005758; GO:0015035; GO:0018171; GO:0022417; GO:0033108; GO:0034599; GO:0043504; GO:0045041; GO:0046825; GO:0051084; GO:0072655; GO:1901857; GO:1990830","mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]","protein-disulfide reductase activity [GO:0015035]"
"1477","Pocillopora_acuta_HIv2___TS.g5006.t1b",819.971019769495,-2.00421922501266,1.00859723761081,0.00207474846217552,0.0109722712091067,"Q90Z00",2.94e-45,"Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)","anatomical structure homeostasis [GO:0060249]; cardiac muscle tissue development [GO:0048738]; cartilage development [GO:0051216]; cell migration in hindbrain [GO:0021535]; dorsal/ventral pattern formation [GO:0009953]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; liver development [GO:0001889]; mesoderm development [GO:0007498]; negative regulation of endodermal cell fate specification [GO:0042664]; olfactory nerve formation [GO:0021628]; olfactory placode morphogenesis [GO:0071699]; pectoral fin development [GO:0033339]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line development [GO:0048916]; response to ethanol [GO:0045471]; skin morphogenesis [GO:0043589]","GO:0001889; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007498; GO:0008201; GO:0008284; GO:0008543; GO:0009953; GO:0017134; GO:0018108; GO:0021535; GO:0021628; GO:0031101; GO:0031410; GO:0033339; GO:0036342; GO:0042664; GO:0043235; GO:0043406; GO:0043589; GO:0045471; GO:0045597; GO:0048738; GO:0048916; GO:0051216; GO:0060249; GO:0071699","cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]","ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]"
"1478","Pocillopora_acuta_HIv2___RNAseq.g10479.t1",249.833793516816,1.59641679528723,2.40051651511431,0.00210195204291044,0.0110999030115577,"Q5ZJJ8",3.48e-152,"Ubiquitin-like domain-containing CTD phosphatase 1 (EC 3.1.3.16) (Nuclear proteasome inhibitor UBLCP1)","regulation of proteasome assembly [GO:0090364]","GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0017018; GO:0046872; GO:0090364; GO:1904855","nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; proteasome regulatory particle binding [GO:1904855]; protein serine/threonine phosphatase activity [GO:0004722]"
"1479","Pocillopora_acuta_HIv2___RNAseq.g8978.t1",118.626825157533,-1.23190802152045,1.84016657669009,0.00215107496550834,0.0113510209051852,"B8EIZ7",6.75e-177,"Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148)","","GO:0004499; GO:0034899; GO:0047822; GO:0050660; GO:0050661","","flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; trimethylamine monooxygenase activity [GO:0034899]"
"1480","Pocillopora_acuta_HIv2___RNAseq.g16773.t1",517.173950836484,-1.55066860738939,2.25231531188791,0.00215367990915014,0.0113606222487045,NA,NA,NA,NA,NA,NA,NA
"1481","Pocillopora_acuta_HIv2___RNAseq.g26860.t1",579.249932008465,2.46720626253159,1.71493481911232,0.00215675756823574,0.0113697286964461,NA,NA,NA,NA,NA,NA,NA
"1482","Pocillopora_acuta_HIv2___TS.g26912.t1",3498.5357432004,-1.63885355239108,0.653401352894726,0.00216564766288765,0.0114029587899552,"P50460",1.34e-21,"Cysteine and glycine-rich protein 2 (Beta-cysteine-rich protein) (Beta-CRP) (Cysteine-rich protein 2) (CRP2)","muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214]","GO:0005634; GO:0005737; GO:0008307; GO:0030018; GO:0042805; GO:0045214; GO:0046872; GO:0060537","cytoplasm [GO:0005737]; nucleus [GO:0005634]; Z disc [GO:0030018]","actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]"
"1483","Pocillopora_acuta_HIv2___RNAseq.g14837.t1",1136.33667680131,-2.34350372703089,2.21693209023663,0.00216727016863994,0.0114073492427977,"Q9CR40",1.04e-41,"Kelch-like protein 28 (BTB/POZ domain-containing protein 5)","","","",""
"1484","Pocillopora_acuta_HIv2___TS.g23673.t1",128.018589930355,-2.37512467776718,1.37236509114783,0.00217328275043339,0.0114306769826431,"Q8IX30",1.31e-09,"Signal peptide, CUB and EGF-like domain-containing protein 3","positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of osteoblast differentiation [GO:0045669]; signal transduction [GO:0007165]","GO:0005509; GO:0005615; GO:0005886; GO:0007165; GO:0009986; GO:0030513; GO:0036122; GO:0042802; GO:0045669; GO:0070700","cell surface [GO:0009986]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]","BMP binding [GO:0036122]; BMP receptor binding [GO:0070700]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]"
"1485","Pocillopora_acuta_HIv2___RNAseq.g12419.t1",232.644070027198,2.23814932263107,1.53717972588007,0.00221482547421172,0.0116407106319034,"Q66KE8",7.41e-90,"Coiled-coil domain-containing protein 78 (xCCDC78)","cell projection organization [GO:0030030]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]","GO:0005737; GO:0005814; GO:0030030; GO:0098535; GO:0098536","centriole [GO:0005814]; cytoplasm [GO:0005737]; deuterosome [GO:0098536]",""
"1486","Pocillopora_acuta_HIv2___RNAseq.g12293.t1",2187.86841419271,2.05012904988729,0.996931761485776,0.00221565412817844,0.0116408359280686,"O14522",2.01e-135,"Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho)","cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; signal transduction [GO:0007165]","GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0050807; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:0098839; GO:0098978; GO:1904893; GO:1990264","cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]","alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
"1487","Pocillopora_acuta_HIv2___TS.g29999.t1a",389.426937178768,1.86515090210804,0.81711588167039,0.00224058719640502,0.0117547527054052,"Q9DBN9",5.38e-165,"Probable ATP-dependent RNA helicase DDX59 (EC 3.6.4.13) (DEAD box protein 59) (Zinc finger HIT domain-containing protein 5)","","GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0016887; GO:0046872","cytoplasm [GO:0005737]; nucleus [GO:0005634]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]"
"1488","Pocillopora_acuta_HIv2___RNAseq.g24896.t1",966.600333200339,-2.39310704684399,2.05910561226988,0.00226855366784832,0.0118928453250301,"P51512",1.58e-53,"Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP)","chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]","GO:0001501; GO:0001958; GO:0004222; GO:0005615; GO:0005796; GO:0005886; GO:0006508; GO:0008047; GO:0008270; GO:0009986; GO:0016485; GO:0030198; GO:0030574; GO:0031012; GO:0035988; GO:0048701; GO:0070006; GO:0097094","cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]","enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
"1489","Pocillopora_acuta_HIv2___RNAseq.g4954.t1",467.379911644555,2.15485405320134,2.11748566743405,0.00229726162803393,0.0120215601258621,"Q9NXC2",1.49e-115,"Glucose-fructose oxidoreductase domain-containing protein 1 (EC 1.-.-.-)","","GO:0000166; GO:0005576; GO:0016491","extracellular region [GO:0005576]","nucleotide binding [GO:0000166]; oxidoreductase activity [GO:0016491]"
"1490","Pocillopora_acuta_HIv2___RNAseq.g28195.t1",4609.47300551703,-1.99570853497302,1.04002165354495,0.00236281735373728,0.0123289286451862,"O96790",9.75e-24,"Serine protease inhibitor dipetalogastin (Dipetalin)","negative regulation of coagulation [GO:0050819]","GO:0004867; GO:0005576; GO:0050819","extracellular region [GO:0005576]","serine-type endopeptidase inhibitor activity [GO:0004867]"
"1491","Pocillopora_acuta_HIv2___RNAseq.g24761.t1",3524.0390642244,2.71432047664675,1.86979964530287,0.00237767672483679,0.0123975184383703,"P79134",7.56e-108,"Annexin A6 (Annexin VI) (Annexin-6)","apoptotic signaling pathway [GO:0097190]; biomineral tissue development [GO:0031214]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; growth plate cartilage chondrocyte differentiation [GO:0003418]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; regulation of muscle contraction [GO:0006937]","GO:0001725; GO:0001786; GO:0003418; GO:0005262; GO:0005509; GO:0005544; GO:0005737; GO:0005886; GO:0005925; GO:0006816; GO:0006937; GO:0008201; GO:0012506; GO:0016020; GO:0019899; GO:0030061; GO:0031214; GO:0031982; GO:0035374; GO:0038024; GO:0042383; GO:0042470; GO:0042584; GO:0048306; GO:0048471; GO:0051015; GO:0051283; GO:0051560; GO:0070509; GO:0070588; GO:0097190","chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrial crista [GO:0030061]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]","actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; chondroitin sulfate binding [GO:0035374]; enzyme binding [GO:0019899]; heparin binding [GO:0008201]; phosphatidylserine binding [GO:0001786]"
"1492","Pocillopora_acuta_HIv2___TS.g14528.t1a",288.453628603143,-1.53922976806349,2.27732926975714,0.00239811547667162,0.0124815913114712,"Q92626",1.01e-22,"Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment]","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825","basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]","extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; interleukin-1 receptor antagonist activity [GO:0005152]; lactoperoxidase activity [GO:0140825]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601]"
"1493","Pocillopora_acuta_HIv2___TS.g2835.t1",79.4348268517831,1.47358749405105,2.09741626029376,0.00242341215602385,0.0126011797410972,"Q5F4A1",3.58e-61,"G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase)","apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]","GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006915; GO:0016567; GO:0046872","cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]","metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
"1494","Pocillopora_acuta_HIv2___RNAseq.g18716.t1",619.555710014511,-1.42309202795241,2.25837670419818,0.0024237058932337,0.0126011797410972,"Q96PM5",8.02e-24,"RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2)","error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630; GO:0070987; GO:0072344","cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]","p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
"1495","Pocillopora_acuta_HIv2___RNAseq.g16948.t1",2941.74848879862,2.11751544225698,1.10478986015562,0.00243294103307658,0.0126355687979963,"P42325",2.16e-121,"Neurocalcin homolog (DrosNCa)","negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]","GO:0005509; GO:0045938; GO:1902848","","calcium ion binding [GO:0005509]"
"1496","Pocillopora_acuta_HIv2___RNAseq.g28209.t1",2192.24727625233,2.31376764162574,2.04772795545434,0.00246404828550329,0.0127879420170505,NA,NA,NA,NA,NA,NA,NA
"1497","Pocillopora_acuta_HIv2___TS.g15590.t1",303.51019977438,-3.15925445807972,2.17083758522674,0.00247395392543099,0.0128329916490152,"Q96RW7",2.07e-06,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711","adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927]","calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]"
"1498","Pocillopora_acuta_HIv2___RNAseq.g3780.t1",5713.7004064335,-1.56946611705561,0.624510317010331,0.00247450316019796,0.0128329916490152,"Q2VWQ2",5.25e-13,"Protein kinase C-binding protein NELL1 (NEL-like protein 1)","generation of neurons [GO:0048699]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]","GO:0005080; GO:0005509; GO:0005615; GO:0005635; GO:0005737; GO:0008201; GO:0010468; GO:0030501; GO:0033689; GO:0042177; GO:0042802; GO:0043065; GO:0045667; GO:0045669; GO:0045778; GO:0048471; GO:0048699","cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]","calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein kinase C binding [GO:0005080]"
"1499","Pocillopora_acuta_HIv2___RNAseq.g8004.t1",599.105525428108,2.04680778731006,1.0618789112787,0.00254635053234384,0.0131819663922052,"Q96EV8",1.8e-25,"Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein)","actin cytoskeleton organization [GO:0030036]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; blood coagulation [GO:0007596]; cilium assembly [GO:0060271]; dendrite morphogenesis [GO:0048813]; kidney development [GO:0001822]; melanosome organization [GO:0032438]; memory [GO:0007613]; negative regulation of dendritic spine morphogenesis [GO:0061002]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; platelet dense granule organization [GO:0060155]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transmembrane transport [GO:0071806]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of dopamine secretion [GO:0014059]; regulation of synaptic vesicle exocytosis [GO:2000300]; retina development in camera-type eye [GO:0060041]","GO:0001822; GO:0001934; GO:0001956; GO:0002092; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0007596; GO:0007613; GO:0008089; GO:0010008; GO:0010628; GO:0014059; GO:0014069; GO:0015630; GO:0016528; GO:0030036; GO:0030424; GO:0030426; GO:0030496; GO:0030672; GO:0031083; GO:0031175; GO:0032438; GO:0033162; GO:0042383; GO:0043005; GO:0043025; GO:0043197; GO:0045211; GO:0048490; GO:0048812; GO:0048813; GO:0060041; GO:0060155; GO:0060159; GO:0060271; GO:0061002; GO:0061646; GO:0071806; GO:0098685; GO:0098686; GO:0098978; GO:1904115; GO:2000300","axon [GO:0030424]; axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; melanosome membrane [GO:0033162]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle membrane [GO:0030672]",""
"1500","Pocillopora_acuta_HIv2___RNAseq.g25237.t1",576.469052137045,1.99204916086717,1.79417099154829,0.00255310399868977,0.0132121990114665,"Q43469",2.49e-124,"Delta(8)-fatty-acid desaturase (EC 1.14.19.29) (Delta(8)-sphingolipid desaturase) (Sphingolipid 8-(E/Z)-desaturase)","sphingolipid metabolic process [GO:0006665]","GO:0006665; GO:0016020; GO:0046872; GO:0052631","membrane [GO:0016020]","metal ion binding [GO:0046872]; sphingolipid 8-(E/Z)-desaturase activity [GO:0052631]"
"1501","Pocillopora_acuta_HIv2___RNAseq.g17731.t1",199.78662059948,2.10071255314528,1.23380350114605,0.00255582241987985,0.0132168092531792,"Q7RTR2",1.44e-83,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223","centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]","ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]"
"1502","Pocillopora_acuta_HIv2___RNAseq.g21957.t1",266.022006239229,2.54754385029293,2.22843700669007,0.00256075891477659,0.0132328749350942,"Q6UVY6",1.84e-14,"DBH-like monooxygenase protein 1 (EC 1.14.17.-) (Monooxygenase X)","dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]","GO:0004500; GO:0005507; GO:0005615; GO:0005789; GO:0006589; GO:0030667; GO:0042420; GO:0042421","endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; secretory granule membrane [GO:0030667]","copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]"
"1503","Pocillopora_acuta_HIv2___RNAseq.g10385.t1",500.556338227262,-1.88837426388697,0.894408006493966,0.00256791538456408,0.013260381336071,"Q8N441",3.27e-39,"Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5)","cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; diaphragm development [GO:0060539]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412]","GO:0001501; GO:0003179; GO:0005007; GO:0005794; GO:0005886; GO:0008201; GO:0008285; GO:0017134; GO:0030133; GO:0042802; GO:0044291; GO:0060412; GO:0060539; GO:0098742","cell-cell contact zone [GO:0044291]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]","fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]"
"1504","Pocillopora_acuta_HIv2___TS.g9744.t1",42.2436684971209,2.37896141062703,2.05701956814019,0.00259680839005179,0.0134000130409237,NA,NA,NA,NA,NA,NA,NA
"1505","Pocillopora_acuta_HIv2___RNAseq.g9839.t1",3421.84144561209,-1.41684453085049,0.539586973228128,0.00260576152940466,0.0134318370496468,"O42412",1.77e-54,"Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase)","hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]","GO:0004800; GO:0005886; GO:0010008; GO:0033798; GO:0042403; GO:0042446","endosome membrane [GO:0010008]; plasma membrane [GO:0005886]","thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798]"
"1506","Pocillopora_acuta_HIv2___RNAseq.g24672.t1",86.6084520670653,2.43365672860534,1.55294726618527,0.00260936417228546,0.0134443421204299,"Q8U3Y2",4.89e-77,"Glyoxylate reductase (EC 1.1.1.26)","","GO:0005737; GO:0047964; GO:0051287","cytoplasm [GO:0005737]","glyoxylate reductase (NADH) activity [GO:0047964]; NAD binding [GO:0051287]"
"1507","Pocillopora_acuta_HIv2___RNAseq.26564_t",6653.23248307922,2.29886817331042,2.37695505417471,0.0026530928852636,0.0136272498197631,"P58197",8.9e-87,"Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2)","anterior neuropore closure [GO:0021506]; basement membrane organization [GO:0071711]; bone morphogenesis [GO:0060349]; cell population proliferation [GO:0008283]; cellular response to iron ion [GO:0071281]; cornea development in camera-type eye [GO:0061303]; embryonic body morphogenesis [GO:0010172]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermis morphogenesis [GO:0048730]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; fibroblast migration [GO:0010761]; forebrain neuron development [GO:0021884]; forelimb morphogenesis [GO:0035136]; inner ear morphogenesis [GO:0042472]; keratinocyte development [GO:0003334]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lens morphogenesis in camera-type eye [GO:0002089]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; outflow tract morphogenesis [GO:0003151]; positive regulation of bone mineralization [GO:0030501]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; retina layer formation [GO:0010842]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]; trigeminal nerve development [GO:0021559]","GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001822; GO:0001843; GO:0002089; GO:0003151; GO:0003334; GO:0003404; GO:0003409; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0003714; GO:0005634; GO:0005905; GO:0006355; GO:0006357; GO:0006366; GO:0007173; GO:0007399; GO:0007423; GO:0007605; GO:0008283; GO:0008285; GO:0009880; GO:0010172; GO:0010628; GO:0010761; GO:0010763; GO:0010842; GO:0010944; GO:0014032; GO:0014044; GO:0021506; GO:0021559; GO:0021623; GO:0021884; GO:0030501; GO:0032496; GO:0035115; GO:0035136; GO:0042059; GO:0042127; GO:0042472; GO:0042802; GO:0043066; GO:0043524; GO:0043525; GO:0043565; GO:0043588; GO:0045595; GO:0045664; GO:0045892; GO:0045893; GO:0045944; GO:0048485; GO:0048596; GO:0048701; GO:0048705; GO:0048730; GO:0051402; GO:0060021; GO:0060235; GO:0060325; GO:0060349; GO:0061029; GO:0061303; GO:0070172; GO:0071281; GO:0071711; GO:0072210; GO:0140536; GO:1990837; GO:2000378","clathrin-coated pit [GO:0005905]; nucleus [GO:0005634]","chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; nuclear receptor corepressor activity [GO:0140536]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]"
"1508","Pocillopora_acuta_HIv2___RNAseq.g3523.t1",2327.91634013368,-1.83820005120132,1.56769668715968,0.00265941505536876,0.0136475902411475,"Q6DIV6",1.08e-72,"Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter)","beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836]","GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800","cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]","gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton antiporter activity [GO:0140800]; glycine transmembrane transporter activity [GO:0015187]; glycine:proton antiporter activity [GO:0140799]"
"1509","Pocillopora_acuta_HIv2___RNAseq.g30027.t1",1878.08236006063,-2.08123949703632,2.17617590140385,0.00268374140178666,0.0137504908379179,"O97563",8.09e-19,"Metalloproteinase inhibitor 4 (Tissue inhibitor of metalloproteinases 4) (TIMP-4)","negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; response to cytokine [GO:0034097]; response to hormone [GO:0009725]","GO:0002020; GO:0005615; GO:0008191; GO:0009725; GO:0031012; GO:0034097; GO:0046872; GO:0051045","extracellular matrix [GO:0031012]; extracellular space [GO:0005615]","metal ion binding [GO:0046872]; metalloendopeptidase inhibitor activity [GO:0008191]; protease binding [GO:0002020]"
"1510","Pocillopora_acuta_HIv2___RNAseq.g28606.t1",1750.27220872435,1.21058439331054,2.00858247587016,0.00272693979949676,0.013947120671825,NA,NA,NA,NA,NA,NA,NA
"1511","Pocillopora_acuta_HIv2___RNAseq.g3097.t1",290.125582934751,2.13634930284264,1.72347062163954,0.0027569021504104,0.0140854230673034,NA,NA,NA,NA,NA,NA,NA
"1512","Pocillopora_acuta_HIv2___RNAseq.g11722.t1",37.352150895933,-2.25960239400898,1.75843767186019,0.00278148932485882,0.014201010093455,NA,NA,NA,NA,NA,NA,NA
"1513","Pocillopora_acuta_HIv2___TS.g21212.t1",71.0531706971678,2.37879535076265,1.39749511985014,0.00284433852067177,0.0145010829103297,NA,NA,NA,NA,NA,NA,NA
"1514","Pocillopora_acuta_HIv2___RNAseq.g26959.t1",415.376553593932,2.04956723188926,1.4010495167832,0.00284527608542007,0.0145010829103297,"Q6GPV5",6.93e-50,"E3 ubiquitin-protein ligase RNF181 (EC 2.3.2.27) (RING finger protein 181)","protein ubiquitination [GO:0016567]","GO:0016567; GO:0046872; GO:0061630","","metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
"1515","Pocillopora_acuta_HIv2___RNAseq.g13617.t2",2007.47700811452,1.96281003749455,1.39363481579394,0.00285652036242492,0.0145430167272489,"Q17RD7",2.94e-77,"Synaptotagmin-16 (Chr14Syt) (Synaptotagmin 14-like protein) (Synaptotagmin XIV-related protein)","","GO:0005543; GO:0042802","","identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]"
"1516","Pocillopora_acuta_HIv2___RNAseq.g1638.t1",309.477082151102,-1.85715394943083,2.01375975062896,0.00290480828242941,0.014768065728316,"P10079",2.53e-115,"Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","","GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579","apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]","biotin binding [GO:0009374]; calcium ion binding [GO:0005509]"
"1517","Pocillopora_acuta_HIv2___RNAseq.g12682.t1",2977.74264656386,1.91845134049846,0.980272603750745,0.00291273092799059,0.0148031413009332,"O35598",5.45e-143,"Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c)","adherens junction organization [GO:0034332]; amyloid-beta formation [GO:0034205]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; nucleocytoplasmic transport [GO:0006913]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein catabolic process at postsynapse [GO:0140249]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of postsynapse organization [GO:0099175]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; signaling receptor ligand precursor processing [GO:0140448]","GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005802; GO:0005886; GO:0005912; GO:0006468; GO:0006509; GO:0006913; GO:0007162; GO:0007219; GO:0007220; GO:0008021; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0014069; GO:0016485; GO:0017124; GO:0019901; GO:0030136; GO:0030307; GO:0030424; GO:0030425; GO:0034205; GO:0034332; GO:0034612; GO:0038004; GO:0042117; GO:0042169; GO:0042803; GO:0043025; GO:0043065; GO:0043197; GO:0045211; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0061001; GO:0062023; GO:0070573; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098794; GO:0098978; GO:0099173; GO:0099175; GO:0140249; GO:0140448; GO:1901342; GO:1902945","adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; tetraspanin-enriched microdomain [GO:0097197]; trans-Golgi network [GO:0005802]","endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]"
"1518","Pocillopora_acuta_HIv2___RNAseq.g24836.t1",441.333049861554,1.66151985116794,0.692624778679108,0.00291581969074626,0.0148084325867113,NA,NA,NA,NA,NA,NA,NA
"1519","Pocillopora_acuta_HIv2___TS.g24829.t1a",2915.50267882844,1.47380045797354,0.577526595901876,0.00295176109568604,0.0149646941773582,NA,NA,NA,NA,NA,NA,NA
"1520","Pocillopora_acuta_HIv2___RNAseq.g10180.t1",3100.04406047856,2.00519386552453,1.22646418574231,0.00301296971899429,0.0152232087762959,"P42583",1.46e-41,"Homeobox protein Nkx-2.5 (xNKx-2.5) (Homeobox protein NK-2 homolog E)","","GO:0000978; GO:0000981; GO:0005634; GO:0032991; GO:0032993","nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"1521","Pocillopora_acuta_HIv2___RNAseq.g31081.t1",2788.55766565212,-2.49287642630735,2.08489534921504,0.0030132775668235,0.0152232087762959,"Q29121",9.66e-164,"Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form]","protein O-linked glycosylation [GO:0006493]","GO:0004653; GO:0005576; GO:0005794; GO:0006493; GO:0030145; GO:0030246; GO:0032580","extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]","carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]"
"1522","Pocillopora_acuta_HIv2___RNAseq.g29143.t2",4185.18788079436,-1.48499237266937,0.588094545937693,0.00302072386657314,0.0152554993038107,"Q9HCK4",1.34e-91,"Roundabout homolog 2","aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]","GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609","axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]","axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]"
"1523","Pocillopora_acuta_HIv2___RNAseq.g12410.t1",6201.14923901467,1.90448582951323,0.936120122518919,0.00304136277296031,0.0153478812796507,"P43006",6.62e-159,"Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2)","adult behavior [GO:0030534]; cellular response to cocaine [GO:0071314]; D-aspartate import across plasma membrane [GO:0070779]; glutathione biosynthetic process [GO:0006750]; L-aspartate import across plasma membrane [GO:0140009]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; monoatomic anion transmembrane transport [GO:0098656]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neurotransmitter reuptake [GO:0098810]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; telencephalon development [GO:0021537]; visual behavior [GO:0007632]","GO:0005313; GO:0005314; GO:0005886; GO:0006750; GO:0007399; GO:0007632; GO:0008509; GO:0009410; GO:0009416; GO:0009611; GO:0009986; GO:0015175; GO:0015501; GO:0015813; GO:0016020; GO:0021537; GO:0030424; GO:0030534; GO:0030673; GO:0031982; GO:0033229; GO:0035264; GO:0042734; GO:0043197; GO:0043198; GO:0043200; GO:0044297; GO:0044306; GO:0045121; GO:0045202; GO:0046326; GO:0046872; GO:0070207; GO:0070778; GO:0070779; GO:0071314; GO:0097449; GO:0098656; GO:0098712; GO:0098796; GO:0098810; GO:0098978; GO:0140009","astrocyte projection [GO:0097449]; axolemma [GO:0030673]; axon [GO:0030424]; cell body [GO:0044297]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; vesicle [GO:0031982]","cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity L-glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; monoatomic anion transmembrane transporter activity [GO:0008509]; neutral L-amino acid transmembrane transporter activity [GO:0015175]"
"1524","Pocillopora_acuta_HIv2___RNAseq.g28041.t1",212.401682139925,1.58260824411688,2.20437354558177,0.00305376245088252,0.0154008438248134,NA,NA,NA,NA,NA,NA,NA
"1525","Pocillopora_acuta_HIv2___RNAseq.g13338.t1",132.811231156371,1.58270309877713,2.13595147178902,0.00305787617992024,0.0154108435771312,"P86854",4.98e-19,"Perlucin-like protein","","GO:0005576; GO:0030246; GO:0038023","extracellular region [GO:0005576]","carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]"
"1526","Pocillopora_acuta_HIv2___RNAseq.g20762.t1",86.4979593293527,1.79537659376352,2.01174183886969,0.00312044312679337,0.0156933551411472,"A1R8N8",2.28e-12,"D-inositol 3-phosphate glycosyltransferase (EC 2.4.1.250) (N-acetylglucosamine-inositol-phosphate N-acetylglucosaminyltransferase) (GlcNAc-Ins-P N-acetylglucosaminyltransferase)","mycothiol biosynthetic process [GO:0010125]","GO:0000287; GO:0008375; GO:0010125; GO:0102710","","acetylglucosaminyltransferase activity [GO:0008375]; D-inositol-3-phosphate glycosyltransferase activity [GO:0102710]; magnesium ion binding [GO:0000287]"
"1527","Pocillopora_acuta_HIv2___TS.g29496.t1",1258.16864349179,-1.96158804578607,1.38697305930003,0.00313387594961,0.0157444882720247,NA,NA,NA,NA,NA,NA,NA
"1528","Pocillopora_acuta_HIv2___RNAseq.g25873.t1",50.5071965629293,-2.28327382954248,1.40546871748598,0.0031637112035816,0.015877834437406,"Q9VLR9",1.91e-13,"Metallophosphoesterase 1 homolog (EC 3.1.-.-) (Post-GPI attachment to proteins 5 ortholog)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]","GO:0005793; GO:0006506; GO:0006888; GO:0008081; GO:0016020; GO:0046872","endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; membrane [GO:0016020]","metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]"
"1529","Pocillopora_acuta_HIv2___RNAseq.g26575.t1",441.940946214695,2.10184544546149,1.7988676013585,0.00320128043486196,0.0160274559397174,"P97603",7.05e-08,"Neogenin","axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; intracellular iron ion homeostasis [GO:0006879]; multicellular organismal-level iron ion homeostasis [GO:0060586]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; protein secretion [GO:0009306]; regulation of axon regeneration [GO:0048679]; regulation of DNA-templated transcription [GO:0006355]; trans-synaptic signaling, modulating synaptic transmission [GO:0099550]","GO:0001764; GO:0005886; GO:0006355; GO:0006879; GO:0007411; GO:0007520; GO:0009306; GO:0009986; GO:0016020; GO:0030426; GO:0030513; GO:0038023; GO:0039706; GO:0043025; GO:0044295; GO:0045296; GO:0048679; GO:0048681; GO:0050709; GO:0060586; GO:0070700; GO:0097708; GO:0098609; GO:0098797; GO:0098839; GO:0098978; GO:0099550","axonal growth cone [GO:0044295]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; postsynaptic density membrane [GO:0098839]","BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023]"
"1530","Pocillopora_acuta_HIv2___RNAseq.g19159.t1",4254.38174929535,-2.52804183512192,1.85892522597056,0.00320354448665753,0.0160288072272004,"Q8BLQ7",4.17e-90,"Cationic amino acid transporter 4 (CAT-4) (CAT4) (Solute carrier family 7 member 4)","amino acid transport [GO:0006865]; carboxylic acid transmembrane transport [GO:1905039]","GO:0005886; GO:0006865; GO:0015171; GO:1905039","plasma membrane [GO:0005886]","amino acid transmembrane transporter activity [GO:0015171]"
"1531","Pocillopora_acuta_HIv2___TS.g6518.t1",277.043664034136,-1.31881420804683,1.95790010656736,0.00323361065888677,0.0161501880421748,NA,NA,NA,NA,NA,NA,NA
"1532","Pocillopora_acuta_HIv2___RNAseq.g21479.t1",86.7028971796023,-1.44667832547897,2.07385968570243,0.00323720682568512,0.0161625680106005,"P24821",8.17e-40,"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)","bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611]","GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0062023; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098966","basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; interstitial matrix [GO:0005614]; membrane [GO:0016020]; perisynaptic extracellular matrix [GO:0098966]; tenascin complex [GO:0090733]","extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; syndecan binding [GO:0045545]"
"1533","Pocillopora_acuta_HIv2___RNAseq.g9253.t1",161.304064460142,-2.22408466170136,1.76645332397649,0.00324036017572667,0.0161727293242618,"Q64487",8.98e-10,"Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling [GO:0099537]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]","GO:0004725; GO:0005102; GO:0007157; GO:0030182; GO:0042734; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099151; GO:0099537; GO:0099545; GO:0099560","glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]","cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]"
"1534","Pocillopora_acuta_HIv2___RNAseq.g8443.t1",118.552428314398,1.37623624489917,1.91957210850164,0.00325415840991604,0.0162303956003536,"Q24133",1.59e-86,"DnaJ protein homolog 1 (DROJ1)","chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]","GO:0005829; GO:0006457; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087; GO:0140297","cytosol [GO:0005829]","DNA-binding transcription factor binding [GO:0140297]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]"
"1535","Pocillopora_acuta_HIv2___RNAseq.g25798.t1",502.490244617237,1.78516070031343,1.59856556193471,0.00325671947262078,0.0162375699593199,"P76482",1.58e-10,"Uncharacterized protein YfbL","proteolysis [GO:0006508]","GO:0006508; GO:0008235; GO:0016020","membrane [GO:0016020]","metalloexopeptidase activity [GO:0008235]"
"1536","Pocillopora_acuta_HIv2___RNAseq.g2445.t1",2116.81954437018,-1.90849196449002,1.02887701118483,0.00327354327468897,0.0163034080046596,"Q9HCI5",9.11e-15,"Melanoma-associated antigen E1 (Alpha-dystrobrevin-associated MAGE Protein) (DAMAGE) (Hepatocellular carcinoma-associated protein 1) (MAGE-E1 antigen)","negative regulation of transcription by RNA polymerase II [GO:0000122]","GO:0000122; GO:0005634; GO:0005886; GO:0030425; GO:0045211; GO:0048471","dendrite [GO:0030425]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]",""
"1537","Pocillopora_acuta_HIv2___RNAseq.g15527.t1",321.710751027024,1.03309926017277,1.59883193207747,0.00327443309275001,0.0163034080046596,"Q5R5U3",2.04e-169,"Zinc finger protein 271","","GO:0003677; GO:0005634; GO:0046872","nucleus [GO:0005634]","DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
"1538","Pocillopora_acuta_HIv2___RNAseq.g29942.t1",7120.04692307367,-2.16825760755706,2.28175824846619,0.00330289044188682,0.0164224844797013,NA,NA,NA,NA,NA,NA,NA
"1539","Pocillopora_acuta_HIv2___RNAseq.g17193.t1",432.085193715848,1.29852311540633,1.94877865383693,0.00333607022644535,0.0165646823739463,NA,NA,NA,NA,NA,NA,NA
"1540","Pocillopora_acuta_HIv2___RNAseq.1286_t",1420.6844537146,1.52651006980928,0.625015140526465,0.00333887018766187,0.0165672104268752,"Q95108",1.33e-38,"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)","cell redox homeostasis [GO:0045454]","GO:0005739; GO:0015035; GO:0045454","mitochondrion [GO:0005739]","protein-disulfide reductase activity [GO:0015035]"
"1541","Pocillopora_acuta_HIv2___RNAseq.g16108.t1",274.876509956482,1.20091772277352,1.83067550996142,0.00334321844306786,0.0165830972429813,"Q9DG67",0,"DNA repair and recombination protein RAD54B (EC 3.6.4.-) (RAD54 homolog B)","double-strand break repair via homologous recombination [GO:0000724]; reciprocal meiotic recombination [GO:0007131]","GO:0000724; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0007131; GO:0015616; GO:0016787; GO:0140658","nucleus [GO:0005634]","ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]"
"1542","Pocillopora_acuta_HIv2___RNAseq.g30425.t2",973.470836468521,1.64575800890028,2.35394060152762,0.00334621334010832,0.0165921581234848,"Q5TZA2",0,"Rootletin (Ciliary rootlet coiled-coil protein)","cellular homeostasis [GO:0019725]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of localization in cell [GO:0051649]; establishment of organelle localization [GO:0051656]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]","GO:0001917; GO:0003779; GO:0005198; GO:0005200; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007098; GO:0008104; GO:0010457; GO:0010669; GO:0015629; GO:0019725; GO:0019894; GO:0032053; GO:0033365; GO:0035253; GO:0045494; GO:0045724; GO:0051649; GO:0051656; GO:0070062; GO:0097729; GO:0120219; GO:1903566","9+2 motile cilium [GO:0097729]; actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; subapical part of cell [GO:0120219]","actin binding [GO:0003779]; kinesin binding [GO:0019894]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]"
"1543","Pocillopora_acuta_HIv2___RNAseq.g17217.t1",833.157247816079,1.06014169386208,1.57227446628309,0.00337787192688011,0.0167091448530759,NA,NA,NA,NA,NA,NA,NA
"1544","Pocillopora_acuta_HIv2___RNAseq.g25038.t1",453.448692552547,-1.37879764790759,2.01613698870182,0.00338550394024816,0.0167411723048716,NA,NA,NA,NA,NA,NA,NA
"1545","Pocillopora_acuta_HIv2___RNAseq.g11932.t1",608.698896528797,1.51579306065066,2.05285265227319,0.00339353885482169,0.016775169513377,"Q5I0D1",1.73e-148,"Glyoxalase domain-containing protein 4","","GO:0005739","mitochondrion [GO:0005739]",""
"1546","Pocillopora_acuta_HIv2___RNAseq.g23618.t1",134.379815296173,2.3518583848719,1.87528922547059,0.00339974763484061,0.0167943817589941,NA,NA,NA,NA,NA,NA,NA
"1547","Pocillopora_acuta_HIv2___TS.g5148.t1",1566.5342192108,1.49740450131313,2.02907495682914,0.00342047282187196,0.0168852282919987,"P52209",0,"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)","D-gluconate catabolic process [GO:0046177]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]","GO:0004616; GO:0005634; GO:0005829; GO:0006098; GO:0009051; GO:0019322; GO:0046177; GO:0050661; GO:0070062","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]","NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]"
"1548","Pocillopora_acuta_HIv2___TS.g23962.t1",316.365215382108,1.79590037580123,0.845492027603803,0.0034368473502485,0.0169464347721626,NA,NA,NA,NA,NA,NA,NA
"1549","Pocillopora_acuta_HIv2___RNAseq.g20774.t1",197.140174013224,2.0074740802141,1.24848557579884,0.00345475506396041,0.0170196107783118,"A1R8N8",8.97e-12,"D-inositol 3-phosphate glycosyltransferase (EC 2.4.1.250) (N-acetylglucosamine-inositol-phosphate N-acetylglucosaminyltransferase) (GlcNAc-Ins-P N-acetylglucosaminyltransferase)","mycothiol biosynthetic process [GO:0010125]","GO:0000287; GO:0008375; GO:0010125; GO:0102710","","acetylglucosaminyltransferase activity [GO:0008375]; D-inositol-3-phosphate glycosyltransferase activity [GO:0102710]; magnesium ion binding [GO:0000287]"
"1550","Pocillopora_acuta_HIv2___RNAseq.g17242.t1",281.121555175781,1.04649519655604,1.58841864136051,0.00347874402154488,0.0171144739889882,NA,NA,NA,NA,NA,NA,NA
"1551","Pocillopora_acuta_HIv2___RNAseq.g11673.t1",4278.69044370854,1.65549675653149,0.723222086608869,0.00348195678117095,0.0171244552474861,"P70030",1.8e-91,"POU domain, class 3, transcription factor 2-B (Transcription factor POU3-B) (XlPOU3B)","brain development [GO:0007420]","GO:0000981; GO:0003677; GO:0005634; GO:0007420","nucleus [GO:0005634]","DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"
"1552","Pocillopora_acuta_HIv2___RNAseq.g24660.t1",1374.35171462858,1.21041139897532,1.79740854701099,0.00350200051684224,0.017205480800138,"Q5XIL0",1.81e-09,"E3 ubiquitin-protein ligase RNF167 (EC 2.3.2.27) (RING finger protein 167)","cellular response to leucine starvation [GO:1990253]; lysosome localization [GO:0032418]; negative regulation of cell cycle [GO:0045786]; negative regulation of TORC1 signaling [GO:1904262]; organelle localization [GO:0051640]; positive regulation of TORC1 signaling [GO:1904263]; protein K29-linked ubiquitination [GO:0035519]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of synaptic transmission, glutamatergic [GO:0051966]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000209; GO:0004842; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005886; GO:0006511; GO:0008270; GO:0032418; GO:0035519; GO:0036020; GO:0045786; GO:0051640; GO:0051966; GO:0061630; GO:0070534; GO:1904262; GO:1904263; GO:1990253","cytoplasm [GO:0005737]; endolysosome membrane [GO:0036020]; endosome [GO:0005768]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]","ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
"1553","Pocillopora_acuta_HIv2___RNAseq.g2258.t1",1914.01503713316,1.73983358999743,1.60637688065592,0.00354597121028289,0.0173905008312289,"O15992",0,"Arginine kinase (AK) (EC 2.7.3.3)","phosphocreatine biosynthetic process [GO:0046314]","GO:0004054; GO:0004111; GO:0005524; GO:0046314","","arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]"
"1554","Pocillopora_acuta_HIv2___RNAseq.g6737.t1",2988.27370964141,-1.60236514505565,0.69584485199666,0.00354687344110379,0.0173905008312289,"P41969",3.1e-30,"ETS domain-containing protein Elk-1","cellular response to gamma radiation [GO:0071480]; cellular response to lipid [GO:0071396]; cellular response to testosterone stimulus [GO:0071394]; gene expression [GO:0010467]; hippocampal neuron apoptotic process [GO:0110088]; liver development [GO:0001889]; lung development [GO:0030324]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to light stimulus [GO:0009416]","GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0003682; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0009416; GO:0010467; GO:0030324; GO:0030374; GO:0030425; GO:0031966; GO:0043025; GO:0043679; GO:0045471; GO:0045893; GO:0045944; GO:0061629; GO:0071394; GO:0071396; GO:0071480; GO:0071774; GO:0110088","axon terminus [GO:0043679]; dendrite [GO:0030425]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; nuclear receptor coactivator activity [GO:0030374]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]"
"1555","Pocillopora_acuta_HIv2___RNAseq.g14417.t1",293.973079284975,-1.78820415165218,1.71321130374887,0.00356357722173855,0.0174652892855631,NA,NA,NA,NA,NA,NA,NA
"1556","Pocillopora_acuta_HIv2___TS.g21857.t1",165.622742328238,1.97709402490533,1.15071256284235,0.00358258206586547,0.0175417965472844,"Q7Z443",2.58e-49,"Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3)","cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of mechanical stimulus [GO:0050982]; monoatomic cation transport [GO:0006812]; sensory perception of sour taste [GO:0050915]","GO:0001581; GO:0005262; GO:0005886; GO:0006812; GO:0016020; GO:0030246; GO:0034703; GO:0043235; GO:0050915; GO:0050982; GO:0070062; GO:0071468","cation channel complex [GO:0034703]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]","calcium channel activity [GO:0005262]; carbohydrate binding [GO:0030246]"
"1557","Pocillopora_acuta_HIv2___RNAseq.g25971.t1",356.616030347835,1.03474308683514,1.64354548383535,0.00360382445351127,0.017639836512889,NA,NA,NA,NA,NA,NA,NA
"1558","Pocillopora_acuta_HIv2___TS.g26429.t1",534.234509372186,2.06127428287967,1.75926641756919,0.00362038058397061,0.0177029022199293,NA,NA,NA,NA,NA,NA,NA
"1559","Pocillopora_acuta_HIv2___RNAseq.g25874.t1",16.8711622162434,-1.48758093486146,3.40063957892495,0.00363962456966883,0.0177849762755709,"Q9UR07",5.1e-30,"Transposon Tf2-11 polyprotein (Retrotransposable element Tf2 155 kDa protein)","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; proteolysis [GO:0006508]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0005634; GO:0006310; GO:0006508; GO:0015074; GO:0046872","nucleus [GO:0005634]","aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]"
"1560","Pocillopora_acuta_HIv2___RNAseq.g12614.t2",522.335970739427,1.54100842927051,2.01327527405352,0.00364849585888061,0.0178049364199424,"A2AL36",3.89e-109,"Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110)","aorta development [GO:0035904]; axoneme assembly [GO:0035082]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; female germ-line stem cell asymmetric division [GO:0048132]; kidney development [GO:0001822]; ventricular septum development [GO:0003281]","GO:0001822; GO:0003279; GO:0003281; GO:0005813; GO:0005829; GO:0005930; GO:0034451; GO:0035082; GO:0035904; GO:0048132; GO:0048471; GO:0060976; GO:0070840; GO:0072687; GO:0090543; GO:0090619; GO:0097431; GO:0120103","axoneme [GO:0005930]; centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; meiotic spindle [GO:0072687]; meiotic spindle pole [GO:0090619]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]","dynein complex binding [GO:0070840]"
"1561","Pocillopora_acuta_HIv2___RNAseq.g17416.t1",5807.49046974574,-1.72634699693919,0.806083704119366,0.00364863326525921,0.0178049364199424,"Q8CAL5",1.62e-40,"Glypican-5 [Cleaved into: Secreted glypican-5]","cell migration [GO:0016477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of protein localization to membrane [GO:1905475]","GO:0005576; GO:0005796; GO:0005886; GO:0009986; GO:0016477; GO:0062023; GO:0090263; GO:0098552; GO:1905475","cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]",""
"1562","Pocillopora_acuta_HIv2___RNAseq.g28252.t1",5381.46974038774,-2.18490854015431,1.9569657466087,0.00367266129415035,0.0179161460231334,"P30531",0,"Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1)","amino acid transport [GO:0006865]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid reuptake [GO:0051936]; inorganic anion import across plasma membrane [GO:0098658]; memory [GO:0007613]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104]","GO:0005332; GO:0005886; GO:0006865; GO:0007268; GO:0007613; GO:0008306; GO:0009636; GO:0009744; GO:0009986; GO:0010288; GO:0014054; GO:0014074; GO:0015185; GO:0015378; GO:0016020; GO:0030424; GO:0032229; GO:0032355; GO:0035725; GO:0042220; GO:0042734; GO:0042802; GO:0043025; GO:0045211; GO:0046872; GO:0050808; GO:0051592; GO:0051936; GO:0051939; GO:0098658; GO:0098719; GO:0098982; GO:0150104; GO:1902476","axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]","gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; sodium:chloride symporter activity [GO:0015378]"
"1563","Pocillopora_acuta_HIv2___RNAseq.g25739.t1",677.434318998229,-1.9350468548149,1.90887823381912,0.00369524635166282,0.018002035443062,"P52800",2.26e-12,"Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L)","adherens junction organization [GO:0034332]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; keratinocyte proliferation [GO:0043616]; lymph vessel development [GO:0001945]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of neuron projection development [GO:0010977]; nephric duct morphogenesis [GO:0072178]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell population proliferation [GO:0008284]; presynapse assembly [GO:0099054]; regulation of chemotaxis [GO:0050920]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; T cell costimulation [GO:0031295]; venous blood vessel morphogenesis [GO:0048845]","GO:0001945; GO:0002042; GO:0005102; GO:0005886; GO:0005912; GO:0007155; GO:0007411; GO:0008284; GO:0009887; GO:0010839; GO:0010977; GO:0030425; GO:0031295; GO:0034332; GO:0042734; GO:0043616; GO:0046875; GO:0048013; GO:0048514; GO:0048845; GO:0050920; GO:0072178; GO:0098685; GO:0098839; GO:0098978; GO:0099054; GO:0099072; GO:0099149; GO:1903849; GO:2000727","adherens junction [GO:0005912]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]","ephrin receptor binding [GO:0046875]; signaling receptor binding [GO:0005102]"
"1564","Pocillopora_acuta_HIv2___RNAseq.g5279.t1",280.941136210132,-2.1612869426871,1.0744004773951,0.00373313753141572,0.0181743861509246,NA,NA,NA,NA,NA,NA,NA
"1565","Pocillopora_acuta_HIv2___RNAseq.g30836.t1",893.512611702344,1.15732373991777,1.83761732820798,0.00374476388560354,0.0182187234582474,"Q9QWN8",9.69e-61,"Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41)","actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; adult behavior [GO:0030534]; cellular response to ethanol [GO:0071361]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; multicellular organism growth [GO:0035264]; postsynapse organization [GO:0099173]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of postsynaptic specialization assembly [GO:0099150]; synapse assembly [GO:0007416]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005200; GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0007416; GO:0008021; GO:0008091; GO:0016079; GO:0016081; GO:0016192; GO:0016324; GO:0016363; GO:0017158; GO:0021692; GO:0030036; GO:0030054; GO:0030534; GO:0030864; GO:0033010; GO:0035264; GO:0042995; GO:0043025; GO:0048471; GO:0051015; GO:0051693; GO:0071361; GO:0098688; GO:0098793; GO:0098918; GO:0098978; GO:0099150; GO:0099173; GO:0099186; GO:0099189","apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; parallel fiber to Purkinje cell synapse [GO:0098688]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic spectrin-associated cytoskeleton [GO:0099189]; presynapse [GO:0098793]; spectrin [GO:0008091]; synaptic vesicle [GO:0008021]","actin filament binding [GO:0051015]; phospholipid binding [GO:0005543]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of postsynapse [GO:0099186]; structural constituent of synapse [GO:0098918]"
"1566","Pocillopora_acuta_HIv2___RNAseq.g942.t1",2094.46903772343,-1.09488476431266,1.77506527147034,0.00375280569770091,0.0182517086790672,"Q90481",1.26e-37,"Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A)","cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0045893","nucleus [GO:0005634]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"1567","Pocillopora_acuta_HIv2___RNAseq.g17071.t1",6072.9740389316,-1.49153252656476,0.621352316970768,0.00378217110005129,0.0183883437953418,NA,NA,NA,NA,NA,NA,NA
"1568","Pocillopora_acuta_HIv2___TS.g9271.t1",348.035711989756,-1.34041361105714,1.92014529783009,0.00381653002572867,0.0185491566841867,NA,NA,NA,NA,NA,NA,NA
"1569","Pocillopora_acuta_HIv2___RNAseq.g27566.t1",2397.19026154867,-1.86014655511415,1.01780498337748,0.00382088663733052,0.018554823080635,"B3EWZ9",0,"Hephaestin-like protein (EC 1.-.-.-)","copper ion transport [GO:0006825]","GO:0005507; GO:0005576; GO:0006825; GO:0016020; GO:0016491","extracellular region [GO:0005576]; membrane [GO:0016020]","copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]"
"1570","Pocillopora_acuta_HIv2___TS.g23869.t1",114.476451354839,1.09917233559943,1.70643362631107,0.00382154438310368,0.018554823080635,"Q4UMH6",9.68e-57,"Putative ankyrin repeat protein RF_0381","guanosine tetraphosphate metabolic process [GO:0015969]","GO:0015969","",""
"1571","Pocillopora_acuta_HIv2___TS.g1918.t1",1647.6018770717,-1.6090160563411,0.709186156035439,0.00384115459417525,0.018641098120168,"P53199",5.91e-08,"Sterol-4-alpha-carboxylate 3-dehydrogenase ERG26, decarboxylating (EC 1.1.1.170) (C-3 sterol dehydrogenase ERG26) (C-4 decarboxylase ERG26) (Ergosterol biosynthetic protein 26)","ergosterol biosynthetic process [GO:0006696]","GO:0000252; GO:0005783; GO:0005789; GO:0006696; GO:0047012; GO:0103066; GO:0103067","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]","4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity [GO:0103066]; 4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity [GO:0103067]; C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity [GO:0000252]; sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity [GO:0047012]"
"1572","Pocillopora_acuta_HIv2___RNAseq.g17093.t1",549.0524577421,1.92978348407356,1.1176673827616,0.00384189114326748,0.018641098120168,"Q9H706",2.63e-09,"GRB2-associated and regulator of MAPK protein 1 (GRB2-associated and regulator of MAPK1)","cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]","GO:0005886; GO:0007173; GO:0008284; GO:0051781; GO:0070064; GO:0070374; GO:0071364","plasma membrane [GO:0005886]","proline-rich region binding [GO:0070064]"
"1573","Pocillopora_acuta_HIv2___RNAseq.g31383.t1",305.369015172424,1.95707746714744,1.23693026574553,0.00384611552884652,0.018649083140877,"Q9SY73",4.23e-66,"NADPH-dependent pterin aldehyde reductase (EC 1.1.1.-)","folic acid-containing compound metabolic process [GO:0006760]","GO:0005829; GO:0006760; GO:0016616","cytosol [GO:0005829]","oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"
"1574","Pocillopora_acuta_HIv2___RNAseq.g18380.t1",396.631973087688,-2.50127840730329,1.77704432281271,0.00388575762327234,0.0188223704832589,NA,NA,NA,NA,NA,NA,NA
"1575","Pocillopora_acuta_HIv2___RNAseq.g19800.t1",83.1305005530481,1.12902035201781,1.90201802609854,0.00389762761369233,0.0188546106369384,"Q96AY4",1.89e-49,"Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301","centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922]","kinase binding [GO:0019900]"
"1576","Pocillopora_acuta_HIv2___RNAseq.g11533.t2c",63.9602247010522,3.60405142348401,5.76131437288444,0.0039058030713567,0.0188844279594907,"Q505D9",8.52e-16,"Tripartite motif-containing protein 67","negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]","GO:0005737; GO:0005856; GO:0008270; GO:0010976; GO:0046580; GO:2000060","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]","zinc ion binding [GO:0008270]"
"1577","Pocillopora_acuta_HIv2___RNAseq.g12347.t1",220.765062937396,2.01958499077134,1.60083689335494,0.00391366623437083,0.0189103484639984,"P53349",1.16e-128,"Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1)","apoptotic mitochondrial changes [GO:0008637]; camera-type eye development [GO:0043010]; epithelial cell morphogenesis [GO:0003382]; eyelid development in camera-type eye [GO:0061029]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of actin filament bundle assembly [GO:0032232]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein polyubiquitination [GO:0000209]; regulation of cell migration [GO:0030334]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]; wound healing [GO:0042060]","GO:0000165; GO:0000209; GO:0002011; GO:0003382; GO:0004672; GO:0004674; GO:0004706; GO:0004708; GO:0004709; GO:0004842; GO:0005524; GO:0005737; GO:0005829; GO:0006511; GO:0007179; GO:0007254; GO:0008092; GO:0008270; GO:0008432; GO:0008637; GO:0030054; GO:0030334; GO:0030838; GO:0031434; GO:0031941; GO:0032232; GO:0042060; GO:0043010; GO:0043065; GO:0043410; GO:0043507; GO:0044877; GO:0045893; GO:0045944; GO:0046330; GO:0046625; GO:0050434; GO:0051019; GO:0061029; GO:0090263; GO:0106310","cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]","ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; JUN kinase binding [GO:0008432]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; sphingolipid binding [GO:0046625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
"1578","Pocillopora_acuta_HIv2___RNAseq.g28795.t1",11904.6298542831,-1.87265735724239,1.13182467508645,0.00392912823683163,0.0189752623764717,NA,NA,NA,NA,NA,NA,NA
"1579","Pocillopora_acuta_HIv2___TS.g24153.t1",229.374719532268,1.09686314649745,1.6882504901912,0.00394620658107164,0.0190196374503899,NA,NA,NA,NA,NA,NA,NA
"1580","Pocillopora_acuta_HIv2___TS.g7845.t1",624.395249472847,-1.78246898552448,0.945998371750374,0.0039943393612369,0.0192323983092312,NA,NA,NA,NA,NA,NA,NA
"1581","Pocillopora_acuta_HIv2___TS.g12846.t1",763.407221878272,-1.45850012304068,1.98973528529582,0.00405211064953879,0.0194846171658674,"Q9JMH4",7.32e-06,"Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog]","extracellular matrix organization [GO:0030198]; hemidesmosome assembly [GO:0031581]","GO:0005581; GO:0005604; GO:0005615; GO:0016020; GO:0030020; GO:0030056; GO:0030198; GO:0031581","basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; hemidesmosome [GO:0030056]; membrane [GO:0016020]","extracellular matrix structural constituent conferring tensile strength [GO:0030020]"
"1582","Pocillopora_acuta_HIv2___RNAseq.g11410.t1",981.941658430094,1.24740472351025,1.76719413167149,0.0040611668464751,0.0195100137397218,"Q6Q759",2.1e-100,"Sperm-associated antigen 17 (Projection protein PF6 homolog)","axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283]","GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0031514; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953","acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874]; motile cilium [GO:0031514]",""
"1583","Pocillopora_acuta_HIv2___RNAseq.g23634.t1",3369.65392602801,2.13400249127121,1.87708413206011,0.00406143883920786,0.0195100137397218,"C3ZAH2",1.28e-88,"Acireductone dioxygenase (Acireductone dioxygenase (Fe(2+)-requiring)) (ARD') (Fe-ARD) (EC 1.13.11.54) (Acireductone dioxygenase (Ni(2+)-requiring)) (ARD) (Ni-ARD) (EC 1.13.11.53)","L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555]","GO:0005506; GO:0005634; GO:0005737; GO:0006555; GO:0010308; GO:0010309; GO:0016151; GO:0019509","cytoplasm [GO:0005737]; nucleus [GO:0005634]","acireductone dioxygenase (Ni2+-requiring) activity [GO:0010308]; acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; iron ion binding [GO:0005506]; nickel cation binding [GO:0016151]"
"1584","Pocillopora_acuta_HIv2___TS.g11680.t1",5027.48802736602,-2.15888357846821,2.15287716734301,0.00407144159654787,0.0195383965308694,NA,NA,NA,NA,NA,NA,NA
"1585","Pocillopora_acuta_HIv2___RNAseq.g25270.t1",1919.36235294777,-1.34908802736941,1.82242268470254,0.00407390241798122,0.0195383965308694,"H9JW44",4.16e-64,"Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004099; GO:0005615; GO:0006032; GO:0046872","extracellular space [GO:0005615]","chitin deacetylase activity [GO:0004099]; metal ion binding [GO:0046872]"
"1586","Pocillopora_acuta_HIv2___RNAseq.g30230.t1",669.039346157881,1.02404728012694,1.61849118612673,0.00407410148901426,0.0195383965308694,"Q19269",6.5e-55,"Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14)","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270","extracellular region [GO:0005576]","metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
"1587","Pocillopora_acuta_HIv2___RNAseq.g15128.t1",520.563712725987,1.15653286590018,1.7276106788726,0.00410168716763238,0.0196488914415382,"P51892",0,"DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1)","cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]","GO:0003677; GO:0003910; GO:0005524; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0046872; GO:0051301; GO:0071897","nucleus [GO:0005634]","ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]"
"1588","Pocillopora_acuta_HIv2___RNAseq.g23870.t1",356.272724314354,1.09588496670721,1.61154707300166,0.00412268404103233,0.0197349836432416,"Q9VY28",3.89e-33,"Small ribosomal subunit protein mS25 (28S ribosomal protein S25, mitochondrial) (MRP-S25) (S25mt)","mitochondrial translation [GO:0032543]","GO:0003735; GO:0005739; GO:0005763; GO:0032543","mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]","structural constituent of ribosome [GO:0003735]"
"1589","Pocillopora_acuta_HIv2___RNAseq.g4502.t1",264.524049981882,1.19995413353735,1.60519504445628,0.00412327990665625,0.0197349836432416,"Q66H61",0,"Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS)","brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stress-activated MAPK cascade [GO:0032873]","GO:0004819; GO:0004860; GO:0005524; GO:0005737; GO:0005829; GO:0006425; GO:0007420; GO:0017101; GO:0019901; GO:0032873; GO:0032991; GO:0045892; GO:2001234","aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]","ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]"
"1590","Pocillopora_acuta_HIv2___RNAseq.g10854.t2",1353.64991330021,1.10359832915786,1.75098262560432,0.00414434243492867,0.0198292322126392,"Q2KIH7",0,"Phenylalanine-4-hydroxylase (PAH) (EC 1.14.16.1) (Phe-4-monooxygenase)","L-phenylalanine catabolic process [GO:0006559]; tyrosine biosynthetic process [GO:0006571]","GO:0004505; GO:0005506; GO:0006559; GO:0006571","","iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]"
"1591","Pocillopora_acuta_HIv2___RNAseq.g12289.t1",169.185864836578,1.82611434775478,2.02475740856411,0.00417629387754971,0.0199622982963909,"P16621",3.7e-13,"Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124]","GO:0004725; GO:0005001; GO:0005158; GO:0005925; GO:0007155; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0009986; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0045467; GO:0046627; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0061484; GO:0120034; GO:1903386","axon [GO:0030424]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; focal adhesion [GO:0005925]","heparin binding [GO:0008201]; insulin receptor binding [GO:0005158]; protein tyrosine phosphatase activity [GO:0004725]; SAM domain binding [GO:0032093]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]"
"1592","Pocillopora_acuta_HIv2___RNAseq.g8441.t1",394.780397911369,-2.47398627716208,1.75413634032866,0.00418043669001444,0.0199689023396198,NA,NA,NA,NA,NA,NA,NA
"1593","Pocillopora_acuta_HIv2___RNAseq.g15574.t1",34.1673831055947,1.84389201339402,2.49872471862576,0.00418494401818874,0.0199838330403044,"P24722",4.44e-50,"Creatine kinase, testis isozyme (EC 2.7.3.2)","phosphocreatine biosynthetic process [GO:0046314]","GO:0004111; GO:0005524; GO:0046314","","ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]"
"1594","Pocillopora_acuta_HIv2___RNAseq.g25709.t3",975.148066046963,-2.00764485581002,1.98498246738767,0.0042608068075216,0.0203125608648624,NA,NA,NA,NA,NA,NA,NA
"1595","Pocillopora_acuta_HIv2___RNAseq.g25665.t1",117.634957674554,1.22118251441267,1.77540827847519,0.00428046829974213,0.0203928502923156,NA,NA,NA,NA,NA,NA,NA
"1596","Pocillopora_acuta_HIv2___RNAseq.g4955.t2",727.131161895092,-1.84164664077715,1.11848516295505,0.00431499363819741,0.0205335294961248,"O14841",0,"5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase)","glutathione metabolic process [GO:0006749]","GO:0005524; GO:0005829; GO:0006749; GO:0017168; GO:0042802","cytosol [GO:0005829]","5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]"
"1597","Pocillopora_acuta_HIv2___TS.g9126.t1",399.880056416913,1.19986563207226,1.82390322120391,0.00431567544719436,0.0205335294961248,"Q6DFR2",0,"E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B)","cell surface receptor signaling pathway [GO:0007166]; protein ubiquitination [GO:0016567]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]","GO:0001784; GO:0004842; GO:0005509; GO:0005737; GO:0007166; GO:0016567; GO:2000583","cytoplasm [GO:0005737]","calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; ubiquitin-protein transferase activity [GO:0004842]"
"1598","Pocillopora_acuta_HIv2___RNAseq.g12045.t1",2823.08197055924,-1.76587744041968,1.03872155946633,0.004347285669713,0.0206465254320054,"Q8IVN8",6.21e-24,"Somatomedin-B and thrombospondin type-1 domain-containing protein (RPE-spondin)","","GO:0005576; GO:0062023","collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]",""
"1599","Pocillopora_acuta_HIv2___RNAseq.g848.t1",611.913336827958,1.30735402040515,1.69966831086998,0.00434798924681197,0.0206465254320054,"Q5NVP8",2.01e-51,"Protein lin-52 homolog","regulation of DNA-templated transcription [GO:0006355]","GO:0006355; GO:0070176","DRM complex [GO:0070176]",""
"1600","Pocillopora_acuta_HIv2___TS.g13017.t1",482.057190142572,-1.68203031642639,2.01210141229268,0.00435798581726024,0.0206872027767811,"Q95LD9",2.8e-43,"Aryl hydrocarbon receptor (Ah receptor) (AhR)","cAMP-mediated signaling [GO:0019933]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cellular response to molecule of bacterial origin [GO:0071219]; circadian regulation of gene expression [GO:0032922]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell proliferation [GO:0030888]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; xenobiotic metabolic process [GO:0006805]","GO:0001094; GO:0001223; GO:0002819; GO:0002841; GO:0004879; GO:0005634; GO:0005737; GO:0005829; GO:0006805; GO:0009410; GO:0009636; GO:0017025; GO:0019933; GO:0030888; GO:0032922; GO:0034753; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0050728; GO:0051879; GO:0061629; GO:0070888; GO:0071219; GO:0071320; GO:1904322; GO:1904613; GO:1990837","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear aryl hydrocarbon receptor complex [GO:0034753]; nucleus [GO:0005634]","E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator binding [GO:0001223]"
"1601","Pocillopora_acuta_HIv2___RNAseq.g24029.t1",216.491270403315,1.35265958323321,3.06153908585297,0.00436129026178883,0.0206960965703785,"H1AFJ5",6.19e-57,"Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha) (Alpha-ENaC) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA)","sodium ion transmembrane transport [GO:0035725]","GO:0001669; GO:0005737; GO:0015280; GO:0016324; GO:0031514; GO:0034706; GO:0035725","acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; sodium channel complex [GO:0034706]","ligand-gated sodium channel activity [GO:0015280]"
"1602","Pocillopora_acuta_HIv2___RNAseq.g7172.t1",427.374765933611,-1.80376300067254,1.6521383334117,0.00445403921675282,0.0210671102783233,"O50224",3.48e-08,"ATP-dependent DNA helicase RecG (EC 3.6.4.12)","DNA recombination [GO:0006310]; DNA repair [GO:0006281]","GO:0003677; GO:0003678; GO:0005524; GO:0006281; GO:0006310; GO:0016887","","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]"
"1603","Pocillopora_acuta_HIv2___RNAseq.g3778.t1",847.937059955879,1.94558052532861,1.50038191950652,0.00446509481340861,0.0211124979997195,"Q9UDY8",6.11e-11,"Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase)","B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]","GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0036094; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0043280; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051092; GO:0051168; GO:0051603; GO:2000321","CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096]; protein-containing complex [GO:0032991]","cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; small molecule binding [GO:0036094]; ubiquitin-protein transferase activity [GO:0004842]"
"1604","Pocillopora_acuta_HIv2___RNAseq.g2110.t1",395.297756840887,-1.22034673146927,2.16593286447398,0.00450890071751641,0.0212987393788887,"Q67XX3",2.98e-08,"Arginine-specific demethylase JMJ22 (EC 1.14.11.-) (Arginine-specific histone demethylase JMJ22) (F-box protein JMJ22) (Jumonji domain-containing protein 22) (AtJMJ22) (Protein JUMONJI 22) ([histone H4]-dimethyl-L-arginine(3) monodemethylase JMJ22)","epigenetic regulation of gene expression [GO:0040029]; gibberellic acid mediated signaling pathway [GO:0009740]; gibberellin mediated signaling pathway [GO:0010476]; positive regulation of seed germination [GO:0010030]; regulation of photomorphogenesis [GO:0010099]; response to red light [GO:0010114]","GO:0000976; GO:0000987; GO:0005634; GO:0009740; GO:0010030; GO:0010099; GO:0010114; GO:0010476; GO:0016491; GO:0040029; GO:0046872","nucleus [GO:0005634]","cis-regulatory region sequence-specific DNA binding [GO:0000987]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; transcription cis-regulatory region binding [GO:0000976]"
"1605","Pocillopora_acuta_HIv2___RNAseq.g7667.t1",654.3126396625,1.96736504988956,1.79352004365066,0.00455797335969942,0.021495443976098,"Q8IV36",0,"Protein HID1 (Down-regulated in multiple cancers 1) (HID1 domain-containing protein) (Protein hid-1 homolog)","","GO:0000138; GO:0005737; GO:0005794; GO:0005797; GO:0005829; GO:0005881; GO:0016020; GO:0070062; GO:0098548","cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic side of Golgi membrane [GO:0098548]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020]",""
"1606","Pocillopora_acuta_HIv2___RNAseq.g15948.t1",179.21690453972,-2.05234748445291,1.67294022985784,0.00457123796397713,0.021536933521487,"Q923Y9",9.89e-08,"Trace amine-associated receptor 1 (TaR-1) (Trace amine receptor 1)","G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cAMP-mediated signaling [GO:0043950]","GO:0001594; GO:0004930; GO:0005886; GO:0007186; GO:0008227; GO:0043950","plasma membrane [GO:0005886]","G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594]"
"1607","Pocillopora_acuta_HIv2___RNAseq.g21181.t1",523.598782675193,1.98377741464815,1.55544936516942,0.00459832442223042,0.0216472392193879,"Q6DJG6",3.73e-22,"BRISC and BRCA1-A complex member 1 (Mediator of RAP80 interactions and targeting subunit of 40 kDa) (New component of the BRCA1-A complex)","cell division [GO:0051301]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212]","GO:0005634; GO:0005737; GO:0006302; GO:0007095; GO:0010212; GO:0045739; GO:0051301; GO:0070531; GO:0070552; GO:0140861","BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]",""
"1608","Pocillopora_acuta_HIv2___RNAseq.g24762.t1",15.282830436932,2.38250942925457,2.75303410757272,0.0045991403568293,0.0216472392193879,NA,NA,NA,NA,NA,NA,NA
"1609","Pocillopora_acuta_HIv2___RNAseq.g4791.t1",744.783624613668,-1.80962914746932,1.93115403110627,0.0046288103333163,0.0217656413072454,"O18806",1.36e-09,"Coagulation factor VIII (Procoagulant component)","acute-phase response [GO:0006953]; blood coagulation, intrinsic pathway [GO:0007597]","GO:0005507; GO:0005615; GO:0006953; GO:0007597; GO:0016491","extracellular space [GO:0005615]","copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]"
"1610","Pocillopora_acuta_HIv2___RNAseq.g14359.t1",471.491197269295,-1.81122183693477,1.89800226121745,0.00466164566232579,0.0218822603459833,NA,NA,NA,NA,NA,NA,NA
"1611","Pocillopora_acuta_HIv2___TS.g5226.t1",327.575763277583,-2.15389959890714,1.76208151770053,0.00471846047358738,0.0221224675170074,NA,NA,NA,NA,NA,NA,NA
"1612","Pocillopora_acuta_HIv2___RNAseq.g12223.t1",1942.75963931324,1.95652508795841,2.09650581428984,0.00474572943589264,0.0222287016064609,"P25228",3.56e-96,"Ras-related protein Rab-3","cytoskeletal matrix organization at active zone [GO:0048789]; exocytosis [GO:0006887]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; symbiont entry into host cell [GO:0046718]; vesicle-mediated transport [GO:0016192]","GO:0000287; GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006887; GO:0007269; GO:0008021; GO:0009306; GO:0016192; GO:0031489; GO:0031630; GO:0031982; GO:0032482; GO:0045202; GO:0046718; GO:0046928; GO:0048172; GO:0048786; GO:0048789; GO:0048790","endosome [GO:0005768]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]","GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; myosin V binding [GO:0031489]"
"1613","Pocillopora_acuta_HIv2___RNAseq.g24899.t1",1384.37364325167,-1.3374662265202,1.85000038211198,0.00475214760336412,0.0222515580883971,"Q9R0S3",1.48e-79,"Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP)","collagen catabolic process [GO:0030574]; drinking behavior [GO:0042756]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508]","GO:0001822; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0042756; GO:0098552","extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]","metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]"
"1614","Pocillopora_acuta_HIv2___TS.g9052.t1",367.026110219639,-1.84732680595806,1.19611538477794,0.00476053145360542,0.0222763917647845,NA,NA,NA,NA,NA,NA,NA
"1615","Pocillopora_acuta_HIv2___RNAseq.g1994.t1",344.815468679523,2.40708101888261,1.33473089837105,0.00479445839760683,0.0224278933580159,NA,NA,NA,NA,NA,NA,NA
"1616","Pocillopora_acuta_HIv2___TS.g13467.t1",1087.05815970966,1.87891353351366,1.21688717187242,0.00483978081101819,0.0226252713802738,NA,NA,NA,NA,NA,NA,NA
"1617","Pocillopora_acuta_HIv2___TS.g23602.t1",770.124420251313,-1.75190561405034,0.965050372152901,0.00484592807006768,0.0226466893717153,"Q2PZL6",0,"Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)","branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]","GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307; GO:0098609","apical part of cell [GO:0045177]; plasma membrane [GO:0005886]","calcium ion binding [GO:0005509]"
"1618","Pocillopora_acuta_HIv2___RNAseq.g4919.t1",187.632811836304,3.46330550487124,2.59685708607642,0.00485080594223454,0.0226621631616539,"Q01484",1.12e-24,"Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)","atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]","GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259","A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]","ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325]"
"1619","Pocillopora_acuta_HIv2___RNAseq.g26474.t1a",14692.8901996415,1.78443456033794,1.01578042273574,0.00487889292592135,0.0227713156761944,"P09057",9.03e-160,"Ornithine decarboxylase (ODC) (EC 4.1.1.17)","cell population proliferation [GO:0008283]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process [GO:0009446]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]","GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006595; GO:0008283; GO:0008284; GO:0009446; GO:0009615; GO:0033387; GO:0042176; GO:0042803; GO:0048471","cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]","ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]"
"1620","Pocillopora_acuta_HIv2___TS.g13071.t1",26.3321986328994,1.00822489793499,1.62890189722815,0.00492078273871681,0.0229520159731699,"Q09575",8.42e-105,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0005737; GO:0008270; GO:0015074; GO:0019899; GO:0042575","cytoplasm [GO:0005737]; DNA polymerase complex [GO:0042575]","enzyme binding [GO:0019899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
"1621","Pocillopora_acuta_HIv2___RNAseq.g4128.t2",1313.59585907275,1.64900700382074,0.795752380871611,0.00495871986888036,0.0231066121725147,"B2RX14",0,"Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11)","interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; retrotransposon silencing by mRNA destabilization [GO:0141008]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]","GO:0001556; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0010586; GO:0010587; GO:0019827; GO:0031054; GO:0031123; GO:0031664; GO:0032755; GO:0035198; GO:0036464; GO:0050265; GO:0070102; GO:0070569; GO:0071076; GO:0141008; GO:1990074","cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleus [GO:0005634]","miRNA binding [GO:0035198]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270]"
"1622","Pocillopora_acuta_HIv2___RNAseq.g562.t1",543.010904142639,-1.90084254147383,1.54338366616688,0.00497585359466268,0.0231715216977466,"Q8CHL0",1.31e-52,"Frizzled-5 (Fz-5)","angiogenesis [GO:0001525]; anterior/posterior axis specification, embryo [GO:0008595]; apoptotic process involved in morphogenesis [GO:0060561]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; canonical Wnt signaling pathway [GO:0060070]; cellular response to molecule of bacterial origin [GO:0071219]; chorionic trophoblast cell differentiation [GO:0060718]; embryonic axis specification [GO:0000578]; embryonic camera-type eye development [GO:0031076]; embryonic camera-type eye morphogenesis [GO:0048596]; eye development [GO:0001654]; glandular epithelial cell maturation [GO:0002071]; intestinal epithelial cell maturation [GO:0060574]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type II interferon production [GO:0032729]; post-embryonic camera-type eye development [GO:0031077]; presynapse assembly [GO:0099054]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of chorionic trophoblast cell proliferation [GO:1901382]; Spemann organizer formation [GO:0060061]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell differentiation in thymus [GO:0033077]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055]","GO:0000139; GO:0000578; GO:0001525; GO:0001540; GO:0001654; GO:0001944; GO:0002071; GO:0002726; GO:0004930; GO:0005769; GO:0005794; GO:0005886; GO:0005923; GO:0008285; GO:0008289; GO:0008595; GO:0009986; GO:0016055; GO:0017147; GO:0019901; GO:0030424; GO:0030425; GO:0031076; GO:0031077; GO:0031625; GO:0032729; GO:0032731; GO:0032760; GO:0033077; GO:0035567; GO:0042813; GO:0043204; GO:0044877; GO:0045202; GO:0045944; GO:0048471; GO:0048596; GO:0060061; GO:0060070; GO:0060561; GO:0060574; GO:0060670; GO:0060715; GO:0060716; GO:0060718; GO:0071219; GO:0098978; GO:0099054; GO:1901382; GO:2000810","axon [GO:0030424]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]","amyloid-beta binding [GO:0001540]; G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"
"1623","Pocillopora_acuta_HIv2___RNAseq.g24815.t1",21.0544099274968,1.16365254717255,2.10307002168804,0.00497925618508501,0.0231799039140874,"Q9NUC0",1.31e-06,"SERTA domain-containing protein 4","","GO:0005634","nucleus [GO:0005634]",""
"1624","Pocillopora_acuta_HIv2___TS.g14050.t1",158.666925752811,1.74041611354126,0.886743410965748,0.0049931071138465,0.0232369051784671,NA,NA,NA,NA,NA,NA,NA
"1625","Pocillopora_acuta_HIv2___TS.g23568.t2d",533.682088671004,2.39614484108697,2.35115314015061,0.00501279963732388,0.0233210466240761,"Q04073",1.56e-152,"DNA-binding protein P3A2","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357","nucleus [GO:0005634]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"1626","Pocillopora_acuta_HIv2___TS.g23391.t1",270.085511781274,-1.99517872662369,1.8412079090003,0.0050361113564138,0.0234069134508898,"Q923L3",1.44e-86,"CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)","conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964]","GO:0001964; GO:0007613; GO:0008584; GO:0008585; GO:0016020; GO:0035846; GO:0042593; GO:0060745; GO:1990708","membrane [GO:0016020]",""
"1627","Pocillopora_acuta_HIv2___RNAseq.g5089.t1",120.491178273966,1.81626848541155,1.79520352225936,0.00505401242836128,0.0234750275413672,"Q1RMU2",3.22e-20,"Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD)","innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-18-mediated signaling pathway [GO:2000493]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of mitotic cell cycle [GO:0007346]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; Wnt signaling pathway [GO:0016055]","GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006508; GO:0007346; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0032088; GO:0036064; GO:0045087; GO:0046329; GO:0048471; GO:0050727; GO:0050728; GO:0061578; GO:0070266; GO:0070536; GO:0090090; GO:0097542; GO:1901223; GO:1902017; GO:1903753; GO:1990108; GO:2000493; GO:2001238; GO:2001242","centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytosol [GO:0005829]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]","cysteine-type deubiquitinase activity [GO:0004843]; K63-linked deubiquitinase activity [GO:0061578]; zinc ion binding [GO:0008270]"
"1628","Pocillopora_acuta_HIv2___RNAseq.g1336.t1",15.7247237686746,1.61475488915566,2.6394985237046,0.00506990388585204,0.0235261757475021,"Q55E58",6.49e-20,"Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)","cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856]","GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310","actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]","ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]"
"1629","Pocillopora_acuta_HIv2___RNAseq.g6698.t1",263.576088505531,-1.17664881371256,1.75212409978917,0.00509177998743287,0.0236201108846148,NA,NA,NA,NA,NA,NA,NA
"1630","Pocillopora_acuta_HIv2___TS.g26909.t1",252.60490560428,1.09979751554669,1.6525549924447,0.00511292592549729,0.0237030001879464,NA,NA,NA,NA,NA,NA,NA
"1631","Pocillopora_acuta_HIv2___RNAseq.6617_t",379.729722087825,-1.51105975931812,2.78728900004742,0.00514550055926997,0.0238310983315021,NA,NA,NA,NA,NA,NA,NA
"1632","Pocillopora_acuta_HIv2___RNAseq.g25282.t1",3864.94043646493,1.33220223079029,0.550897324278668,0.00517272649674508,0.0239418611356547,NA,NA,NA,NA,NA,NA,NA
"1633","Pocillopora_acuta_HIv2___RNAseq.g4762.t1",147.479458524692,1.63578119390507,1.98729577197125,0.00518565439568589,0.0239940195710815,NA,NA,NA,NA,NA,NA,NA
"1634","Pocillopora_acuta_HIv2___TS.g20588.t1",2606.30839091533,-1.13966319880684,1.73493687248348,0.00518829348312645,0.0239985535465114,NA,NA,NA,NA,NA,NA,NA
"1635","Pocillopora_acuta_HIv2___TS.g28604.t1",2013.84859828296,-2.13943624548101,1.75354632637237,0.00519315732447753,0.0240133719761007,"O54962",1.64e-17,"Barrier-to-autointegration factor (LAP2-binding protein 1) [Cleaved into: Barrier-to-autointegration factor, N-terminally processed]","chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; DNA integration [GO:0015074]; establishment of integrated proviral latency [GO:0075713]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of innate immune response [GO:0045824]; negative regulation of protein ADP-ribosylation [GO:0010836]; negative regulation of type I interferon production [GO:0032480]; negative regulation of viral genome replication [GO:0045071]; response to oxidative stress [GO:0006979]","GO:0000785; GO:0000793; GO:0003677; GO:0003690; GO:0005634; GO:0005635; GO:0005654; GO:0005829; GO:0006325; GO:0006979; GO:0007084; GO:0010836; GO:0015074; GO:0032480; GO:0042802; GO:0042803; GO:0045071; GO:0045824; GO:0051276; GO:0075713; GO:0160049","chromatin [GO:0000785]; condensed chromosome [GO:0000793]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]"
"1636","Pocillopora_acuta_HIv2___TS.g3024.t4",5769.89334618293,1.34557464092865,0.560958017635933,0.00527447558978528,0.0243349329922342,"Q62770",1.1e-08,"Protein unc-13 homolog C (Munc13-3)","chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; negative regulation of synaptic plasticity [GO:0031914]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of neurotransmitter secretion [GO:0046928]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]","GO:0005509; GO:0005516; GO:0005543; GO:0005886; GO:0007268; GO:0016079; GO:0016081; GO:0016082; GO:0017075; GO:0019905; GO:0019992; GO:0030672; GO:0031594; GO:0031914; GO:0035249; GO:0042734; GO:0043195; GO:0044305; GO:0046928; GO:0061789; GO:0098688; GO:0098793; GO:0098831; GO:0099525","calyx of Held [GO:0044305]; neuromuscular junction [GO:0031594]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]","calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; phospholipid binding [GO:0005543]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]"
"1637","Pocillopora_acuta_HIv2___RNAseq.g25228.t1",276.991026192191,1.07478602515542,1.70785928151617,0.0052860027613294,0.0243803392665397,"Q8BUV3",3.5e-161,"Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)]","establishment of protein localization [GO:0045184]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; maintenance of postsynaptic specialization structure [GO:0098880]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]","GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0006777; GO:0007529; GO:0008092; GO:0009898; GO:0014069; GO:0019897; GO:0030425; GO:0032324; GO:0042802; GO:0043025; GO:0045184; GO:0045211; GO:0046872; GO:0060077; GO:0060090; GO:0061598; GO:0061599; GO:0072579; GO:0097060; GO:0097112; GO:0098690; GO:0098794; GO:0098879; GO:0098880; GO:0098970; GO:0098982; GO:0099091; GO:0099572; GO:0099634; GO:0099645","cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of plasma membrane [GO:0019897]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization membrane [GO:0099634]; postsynaptic specialization, intracellular component [GO:0099091]; synaptic membrane [GO:0097060]","ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin molybdotransferase activity [GO:0061599]; signaling receptor binding [GO:0005102]; structural constituent of postsynaptic specialization [GO:0098879]"
"1638","Pocillopora_acuta_HIv2___RNAseq.g9049.t1",14251.4373068824,-1.35412175627516,0.572848103481188,0.00530493737561642,0.0244520759085137,"P55008",8.21e-51,"Allograft inflammatory factor 1 (AIF-1) (Ionized calcium-binding adapter molecule 1) (Protein G1)","actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to oxidative stress [GO:0034599]; cellular response to type II interferon [GO:0071346]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parallel actin filament bundle assembly [GO:0030046]; phagocytosis, engulfment [GO:0006911]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemotaxis [GO:0050921]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; regulation of gene expression [GO:0010468]; ruffle assembly [GO:0097178]","GO:0001726; GO:0001774; GO:0001891; GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005884; GO:0006911; GO:0006954; GO:0008284; GO:0010468; GO:0016601; GO:0030027; GO:0030041; GO:0030046; GO:0030335; GO:0032587; GO:0032722; GO:0032755; GO:0034599; GO:0042102; GO:0048471; GO:0048661; GO:0048662; GO:0050921; GO:0051015; GO:0051017; GO:0051764; GO:0071346; GO:0071672; GO:0071673; GO:0071677; GO:0090026; GO:0090271; GO:0097178; GO:0097386; GO:1900087; GO:2000406","actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]","actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]"
"1639","Pocillopora_acuta_HIv2___RNAseq.g6852.t1",194.644238443925,1.06964033056513,1.61063184617851,0.00531100191202029,0.0244722305369422,"Q54TD7",1.82e-43,"ATP-dependent RNA helicase ddx24 (EC 3.6.4.13) (DEAD box protein 24)","","GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016887","nucleolus [GO:0005730]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]"
"1640","Pocillopora_acuta_HIv2___RNAseq.g20170.t1",65.8639879659293,1.20762519278103,1.71949371658389,0.00532822357604875,0.0245359521820978,"P42688",5.12e-24,"Tyrosine-protein kinase SRK2 (EC 2.7.10.2)","cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; innate immune response [GO:0045087]","GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0007169; GO:0030154; GO:0031234; GO:0045087","cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]","ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; signaling receptor binding [GO:0005102]"
"1641","Pocillopora_acuta_HIv2___RNAseq.g17386.t1",205.307743912488,-1.14428323317426,1.75864220016675,0.00539301291145468,0.0247869522565238,NA,NA,NA,NA,NA,NA,NA
"1642","Pocillopora_acuta_HIv2___RNAseq.g10504.t1",1931.38047756694,-1.81504465045789,1.01995862172089,0.0054440953267361,0.0249741182384748,NA,NA,NA,NA,NA,NA,NA
"1643","Pocillopora_acuta_HIv2___TS.g29319.t1",869.443334045035,2.15629841497028,1.79212889667447,0.00548890721842314,0.0251637255173605,"Q8CFV2",9.75e-39,"Protein FAM149A","","","",""
"1644","Pocillopora_acuta_HIv2___RNAseq.g25274.t1",793.466349354076,-1.57889758470479,2.11744892643438,0.00551796542021728,0.0252489249724843,"Q8BX37",1.74e-164,"Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form)","","GO:0003993; GO:0005576; GO:0046872","extracellular region [GO:0005576]","acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]"
"1645","Pocillopora_acuta_HIv2___RNAseq.g14663.t1b",1001.55205396497,2.0579564823249,1.67310429607497,0.00564246912910162,0.0257615762257973,NA,NA,NA,NA,NA,NA,NA
"1646","Pocillopora_acuta_HIv2___RNAseq.g29813.t1",87.0149157465166,-2.57208644717577,1.9182445013465,0.00565695345248815,0.0258195565594158,"Q01456",9.87e-13,"Ovarian abundant message protein (Protein OAM)","","","",""
"1647","Pocillopora_acuta_HIv2___RNAseq.g27978.t1",1346.56742915342,1.00178769725918,1.59044005787738,0.00566368575558299,0.0258411883334636,"P23634",1.01e-131,"Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4)","calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; nitric oxide-cGMP-mediated signaling [GO:0038060]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832]","GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005886; GO:0005901; GO:0006357; GO:0006874; GO:0007283; GO:0010629; GO:0014832; GO:0015085; GO:0016020; GO:0016323; GO:0016525; GO:0016887; GO:0017080; GO:0019901; GO:0021766; GO:0030018; GO:0030165; GO:0030315; GO:0030317; GO:0030346; GO:0032991; GO:0034220; GO:0036126; GO:0036487; GO:0038060; GO:0043231; GO:0043537; GO:0045019; GO:0045121; GO:0046872; GO:0048787; GO:0050998; GO:0051001; GO:0051480; GO:0051599; GO:0070588; GO:0070885; GO:0071872; GO:0071878; GO:0097110; GO:0097228; GO:0097553; GO:0098703; GO:0098736; GO:0098978; GO:0150104; GO:1900082; GO:1901660; GO:1902083; GO:1902305; GO:1902548; GO:1902806; GO:1903078; GO:1903243; GO:1903249; GO:1903779; GO:1905145","basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; P-type calcium transporter activity [GO:0005388]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]"
"1648","Pocillopora_acuta_HIv2___TS.g5347.t1",849.577819501918,1.12564509926289,1.65710106541748,0.00567280813609787,0.0258674328122697,"O09012",0,"Peroxisomal targeting signal 1 receptor (PTS1 receptor) (PTS1R) (PTS1-BP) (PXR1P) (Peroxin-5) (Peroxisomal C-terminal targeting signal import receptor) (Peroxisome receptor 1)","cell development [GO:0048468]; cellular lipid metabolic process [GO:0044255]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; cerebral cortex neuron differentiation [GO:0021895]; endoplasmic reticulum organization [GO:0007029]; fatty acid beta-oxidation [GO:0006635]; mitochondrial membrane organization [GO:0007006]; mitochondrion organization [GO:0007005]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; pexophagy [GO:0000425]; positive regulation of multicellular organism growth [GO:0040018]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0000268; GO:0000425; GO:0001764; GO:0005052; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005794; GO:0005829; GO:0006625; GO:0006635; GO:0007005; GO:0007006; GO:0007029; GO:0007031; GO:0016558; GO:0016560; GO:0016562; GO:0021795; GO:0021895; GO:0031267; GO:0031333; GO:0032991; GO:0033328; GO:0034614; GO:0040018; GO:0044255; GO:0044721; GO:0045046; GO:0048468; GO:0050905; GO:0140597","cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]","peroxisome matrix targeting signal-1 binding [GO:0005052]; peroxisome membrane targeting sequence binding [GO:0033328]; peroxisome targeting sequence binding [GO:0000268]; protein carrier chaperone [GO:0140597]; small GTPase binding [GO:0031267]"
"1649","Pocillopora_acuta_HIv2___RNAseq.g13643.t1",516.181601699315,1.84764569542824,1.10738135190049,0.00571398950625306,0.0260142097004861,"Q9JJ93",6.18e-21,"Uncharacterized protein C14orf119 homolog","","GO:0005739; GO:0005829","cytosol [GO:0005829]; mitochondrion [GO:0005739]",""
"1650","Pocillopora_acuta_HIv2___TS.g25022.t1b",326.131313736852,2.18175935436894,4.28547180804322,0.00574898490708569,0.0261570675357306,NA,NA,NA,NA,NA,NA,NA
"1651","Pocillopora_acuta_HIv2___RNAseq.g12231.t1",629.626738790545,1.54505391834322,0.72612309692464,0.00576601120533988,0.026218040262193,NA,NA,NA,NA,NA,NA,NA
"1652","Pocillopora_acuta_HIv2___RNAseq.g14750.t1",399.540143125754,-1.74149070381679,1.927109297895,0.00584545327635942,0.0265375505929889,"Q9Y2Y9",6.76e-44,"Krueppel-like factor 13 (Basic transcription element-binding protein 3) (BTE-binding protein 3) (Novel Sp1-like zinc finger transcription factor 1) (RANTES factor of late activated T-lymphocytes 1) (RFLAT-1) (Transcription factor BTEB3) (Transcription factor NSLP1)","negative regulation of cell population proliferation [GO:0008285]; negative regulation of erythrocyte differentiation [GO:0045647]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]","GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006366; GO:0008285; GO:0045647; GO:0046872; GO:1990837","chromatin [GO:0000785]; nucleus [GO:0005634]","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"
"1653","Pocillopora_acuta_HIv2___RNAseq.g29819.t1",656.270291485275,-1.8690750534003,1.82757458207637,0.00586968903519055,0.0266392162550976,NA,NA,NA,NA,NA,NA,NA
"1654","Pocillopora_acuta_HIv2___RNAseq.g27031.t1",1984.42921036949,-1.71593315074811,1.00604103431867,0.00590244743405267,0.026772968808641,"Q91ZU6",3.4e-10,"Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060]","GO:0001725; GO:0003779; GO:0005198; GO:0005509; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007409; GO:0008017; GO:0008090; GO:0009898; GO:0014069; GO:0014704; GO:0015629; GO:0015630; GO:0016020; GO:0030018; GO:0030056; GO:0030424; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042383; GO:0042803; GO:0045098; GO:0045104; GO:0046907; GO:0048471; GO:0051010; GO:0097038; GO:1904115","actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; type III intermediate filament [GO:0045098]; Z disc [GO:0030018]","actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]"
"1655","Pocillopora_acuta_HIv2___RNAseq.g19230.t1",924.708573679374,1.06064848953321,1.48313709980073,0.00595486464291581,0.026974995989707,"Q7SYJ9",4.88e-77,"Sperm-associated antigen 7 homolog","","GO:0003676","","nucleic acid binding [GO:0003676]"
"1656","Pocillopora_acuta_HIv2___RNAseq.g15698.t1",842.378649324237,-1.69928485300566,0.89306035865538,0.0060056663094518,0.027179586201474,"P54357",8.01e-10,"Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain)","actin filament-based movement [GO:0030048]","GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036","cytosol [GO:0005829]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]","calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]"
"1657","Pocillopora_acuta_HIv2___TS.g3644.t2",2525.75513754071,-1.35437515790503,0.577427527210725,0.00605344523465696,0.0273786841382359,"P97379",4.85e-46,"Ras GTPase-activating protein-binding protein 2 (G3BP-2) (GAP SH3 domain-binding protein 2)","innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of stress granule assembly [GO:0062029]; protein homooligomerization [GO:0051260]; small GTPase-mediated signal transduction [GO:0007264]; stress granule assembly [GO:0034063]","GO:0003729; GO:0005829; GO:0007264; GO:0010494; GO:0034063; GO:0045087; GO:0051028; GO:0051260; GO:0062029; GO:0140693; GO:1990904","cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]","molecular condensate scaffold activity [GO:0140693]; mRNA binding [GO:0003729]"
"1658","Pocillopora_acuta_HIv2___RNAseq.g626.t1",825.478450901913,1.78231658887188,1.97991884433578,0.00611859858753915,0.027656065615677,"Q9VXE5",2.68e-145,"Serine/threonine-protein kinase PAK mbt (EC 2.7.11.1) (Protein mushroom bodies tiny) (p21-activated kinase-related protein)","compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; positive regulation of compound eye photoreceptor development [GO:0045315]; positive regulation of developmental growth [GO:0048639]; protein phosphorylation [GO:0006468]; regulation of cell-cell adhesion mediated by cadherin [GO:2000047]; regulation of MAPK cascade [GO:0043408]","GO:0001751; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0005912; GO:0006468; GO:0007010; GO:0007030; GO:0016319; GO:0031267; GO:0035556; GO:0043408; GO:0045315; GO:0045792; GO:0048639; GO:0048749; GO:0106310; GO:2000047","adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]","ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]"
"1659","Pocillopora_acuta_HIv2___RNAseq.g12290.t1",272.61928918956,1.39672119270878,1.86385157709398,0.00612564954091194,0.0276706417738133,"Q7SIC1",1.31e-14,"Fucolectin","regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]","GO:0001868; GO:0005509; GO:0005576; GO:0010185; GO:0030246; GO:0042806; GO:0045088","extracellular region [GO:0005576]","calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]"
"1660","Pocillopora_acuta_HIv2___RNAseq.g29674.t1",113.266429183346,-1.70035420961218,0.893441498207862,0.00618836330696393,0.0279170767578981,"E2JA28",5.73e-07,"Dapdiamide synthesis protein DdaC (EC 1.-.-.-)","antibiotic biosynthetic process [GO:0017000]","GO:0016491; GO:0017000","","oxidoreductase activity [GO:0016491]"
"1661","Pocillopora_acuta_HIv2___RNAseq.g2565.t1",1916.73678394501,-1.68975604321916,2.13213812421955,0.00619178527650284,0.0279170767578981,"Q9XSC1",1.1e-27,"Secreted frizzled-related protein 5 (sFRP-5)","canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; negative regulation of Wnt signaling pathway [GO:0030178]; non-canonical Wnt signaling pathway [GO:0035567]","GO:0005615; GO:0017147; GO:0030154; GO:0030178; GO:0035567; GO:0060070","extracellular space [GO:0005615]","Wnt-protein binding [GO:0017147]"
"1662","Pocillopora_acuta_HIv2___RNAseq.6832_t",2401.02573552091,-1.26508143006364,1.79560596915078,0.00622622087022489,0.0280373781652966,"Q9UPX0",2.77e-78,"Protein turtle homolog B (Immunoglobulin superfamily member 9B) (IgSF9B)","cell adhesion [GO:0007155]; nervous system development [GO:0007399]","GO:0007155; GO:0007399; GO:0014069; GO:0043005; GO:0045211","neuron projection [GO:0043005]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]",""
"1663","Pocillopora_acuta_HIv2___RNAseq.g28871.t1",1051.68497089319,1.54162920828658,0.739769198392478,0.00632226170890035,0.0283991283719052,NA,NA,NA,NA,NA,NA,NA
"1664","Pocillopora_acuta_HIv2___RNAseq.g26299.t1",441.621586848928,1.68531757197736,0.901979305484748,0.00634995554161023,0.0285074494341485,"Q6P4K6",1.03e-40,"Serine/threonine-protein kinase 11-interacting protein","","GO:0005737","cytoplasm [GO:0005737]",""
"1665","Pocillopora_acuta_HIv2___RNAseq.g29898.t1",1879.11610484277,2.09700215300412,1.85318812463951,0.00635031817455935,0.0285074494341485,"P16068",5.26e-167,"Guanylate cyclase soluble subunit beta-1 (GCS-beta-1) (EC 4.6.1.2) (Guanylate cyclase soluble subunit beta-3) (GCS-beta-3) (Soluble guanylate cyclase small subunit)","cellular response to nitric oxide [GO:0071732]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling [GO:0038060]; response to oxygen levels [GO:0070482]","GO:0004383; GO:0005525; GO:0005737; GO:0006182; GO:0008074; GO:0019934; GO:0020037; GO:0038060; GO:0046872; GO:0070482; GO:0071732","cytoplasm [GO:0005737]; guanylate cyclase complex, soluble [GO:0008074]","GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"
"1666","Pocillopora_acuta_HIv2___RNAseq.g5096.t1",550.227807764451,-1.64280640560527,1.74515244114758,0.00645250135574063,0.0288883649458271,NA,NA,NA,NA,NA,NA,NA
"1667","Pocillopora_acuta_HIv2___TS.g24807.t1",6598.60729910285,1.32139408624439,0.567954868225985,0.00647988524772032,0.0289721979051087,"Q96RW7",1.03e-15,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711","adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927]","calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]"
"1668","Pocillopora_acuta_HIv2___RNAseq.g3532.t1",2305.54393704525,1.83398742518124,1.15673363580761,0.00650272978223224,0.0290563742879849,"Q5E9E2",1.04e-88,"Myosin regulatory light polypeptide 9 (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9)","actomyosin structure organization [GO:0031032]","GO:0005509; GO:0005737; GO:0005938; GO:0016460; GO:0031032; GO:0042641; GO:0097513","actomyosin [GO:0042641]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]","calcium ion binding [GO:0005509]"
"1669","Pocillopora_acuta_HIv2___TS.g2830.t1",177.100315907635,1.51026839198765,0.70084049832507,0.00650975879420195,0.0290699795984316,"Q5F4A1",2.4e-18,"G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase)","apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]","GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006915; GO:0016567; GO:0046872","cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]","metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
"1670","Pocillopora_acuta_HIv2___RNAseq.g21831.t1",1714.44668418446,1.72397689441115,1.08474049926131,0.00653950131676658,0.0291846180332341,"O35066",1.36e-32,"Kinesin-like protein KIF3C","microtubule-based movement [GO:0007018]; positive regulation of neuron projection development [GO:0010976]","GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008021; GO:0010976; GO:0015630; GO:0016887; GO:0019894; GO:0030424; GO:0030425; GO:0030426; GO:0035371; GO:0043025; GO:0071598","axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; synaptic vesicle [GO:0008021]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]"
"1671","Pocillopora_acuta_HIv2___RNAseq.g24929.t1",669.400544451373,1.11012853395923,1.644332995879,0.00665376080245764,0.0296579341284275,NA,NA,NA,NA,NA,NA,NA
"1672","Pocillopora_acuta_HIv2___TS.g29912.t2",1245.44592349205,-1.33662122974854,1.49415065914105,0.00673139181683794,0.0299762473025689,"E7FDW2",1.57e-61,"E3 ubiquitin-protein ligase PDZRN3-B (EC 2.3.2.27) (PDZ domain-containing RING finger protein 3-B)","neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567]","GO:0005737; GO:0007528; GO:0016567; GO:0045202; GO:0046872; GO:0061630","cytoplasm [GO:0005737]; synapse [GO:0045202]","metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]"
"1673","Pocillopora_acuta_HIv2___TS.g3256.t1",295.295562269589,1.10916399345617,1.64234440872523,0.00675410575386166,0.0300681396195306,"Q9I929",3.19e-13,"Fucolectin-3","regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]","GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088","extracellular space [GO:0005615]","calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]"
"1674","Pocillopora_acuta_HIv2___RNAseq.g14772.t1",631.815407480776,-1.68056698304114,1.09314187477381,0.00678009878761181,0.0301662538252822,NA,NA,NA,NA,NA,NA,NA
"1675","Pocillopora_acuta_HIv2___RNAseq.g12054.t1",845.453698293954,1.67134923245118,1.61121326828143,0.0068075867199958,0.0302689622865107,"Q5EAJ7",0,"Major vault protein (MVP)","","GO:0005634; GO:0005737; GO:1990904","cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]",""
"1676","Pocillopora_acuta_HIv2___RNAseq.g16254.t1",374.33469469375,1.47827562128149,1.69948384075698,0.00682401210082503,0.0303326708747183,"Q3KP44",3.99e-26,"Ankyrin repeat domain-containing protein 55","","","",""
"1677","Pocillopora_acuta_HIv2___RNAseq.g22674.t1",265.737790158686,-2.16983400245399,1.85591909310887,0.00684323872821015,0.0303994486992726,NA,NA,NA,NA,NA,NA,NA
"1678","Pocillopora_acuta_HIv2___RNAseq.g12336.t1",233.822229841872,1.07194020285671,1.58263717969713,0.0068772055804346,0.0305315842588723,NA,NA,NA,NA,NA,NA,NA
"1679","Pocillopora_acuta_HIv2___RNAseq.g6273.t1",715.748271921282,1.63161599910914,0.892214637709131,0.00697813208279393,0.0309321797258754,"Q5F4A1",1.91e-75,"G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase)","apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]","GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006915; GO:0016567; GO:0046872","cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]","metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]"
"1680","Pocillopora_acuta_HIv2___RNAseq.g18209.t1",614.583780373003,1.24713244211318,1.77963668638096,0.00701861918091882,0.0310925904541531,"P49695",2.93e-30,"Probable serine/threonine-protein kinase PkwA (EC 2.7.11.1)","","GO:0004674; GO:0005524; GO:0106310","","ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]"
"1681","Pocillopora_acuta_HIv2___RNAseq.g23661.t1",164.099075007577,1.3079790854369,1.62491137602348,0.00703634293839805,0.0311615628478228,NA,NA,NA,NA,NA,NA,NA
"1682","Pocillopora_acuta_HIv2___RNAseq.g11318.t1",3151.41830680575,-1.64502376208382,0.970261011677304,0.00705625030581063,0.0312210475445839,NA,NA,NA,NA,NA,NA,NA
"1683","Pocillopora_acuta_HIv2___TS.g11857.t2",566.943042861022,1.96988228022411,1.68567559938802,0.00707192229566258,0.0312729650801993,"Q6NTV6",1.9e-82,"Inverted formin-2","actin cytoskeleton organization [GO:0030036]","GO:0003779; GO:0030036; GO:0031267","","actin binding [GO:0003779]; small GTPase binding [GO:0031267]"
"1684","Pocillopora_acuta_HIv2___TS.g5728.t1",48.5930896482267,1.92894993049424,1.77724043648867,0.00710803699677068,0.0314021524499973,NA,NA,NA,NA,NA,NA,NA
"1685","Pocillopora_acuta_HIv2___TS.g31609.t2",1410.38041752249,-1.45909761043167,0.688040293908579,0.00715148734483989,0.0315555561182929,"Q9DAN9",4.14e-25,"Sperm axonemal maintenance protein CFAP97D1 (CFAP97 domain-containing protein 1)","sperm axoneme assembly [GO:0007288]","GO:0007288","",""
"1686","Pocillopora_acuta_HIv2___RNAseq.g25999.t1",2200.92623455925,1.57351301446877,0.808826563117124,0.00717660404038601,0.0316567248673813,"Q2HJ23",1.37e-50,"Microtubule-associated proteins 1A/1B light chain 3A (Autophagy-related protein LC3 A) (Autophagy-related ubiquitin-like modifier LC3 A) (MAP1 light chain 3-like protein 1) (MAP1A/MAP1B light chain 3 A) (MAP1A/MAP1B LC3 A) (Microtubule-associated protein 1 light chain 3 alpha)","autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]","GO:0000045; GO:0000421; GO:0000422; GO:0005543; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008017; GO:0008429; GO:0012505; GO:0031090; GO:0031410; GO:0031625; GO:0097352","autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]","microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; phospholipid binding [GO:0005543]; ubiquitin protein ligase binding [GO:0031625]"
"1687","Pocillopora_acuta_HIv2___RNAseq.g1720.t1",926.303232608277,1.64248837534448,0.921190216774891,0.00720009597898855,0.031750667146369,"Q8BH18",1.07e-163,"Transmembrane protein 117","intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]","GO:0005783; GO:0005886; GO:0070059","endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]",""
"1688","Pocillopora_acuta_HIv2___RNAseq.g30726.t1",3698.97198668318,-1.99175068418298,1.95750259461063,0.00721104434776865,0.0317698889570898,"O76082",1.84e-83,"Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5)","(R)-carnitine transmembrane transport [GO:1902270]; (R)-carnitine transport [GO:1900749]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; response to symbiotic bacterium [GO:0009609]; response to tumor necrosis factor [GO:0034612]; response to type II interferon [GO:0034341]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]","GO:0005524; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006814; GO:0009609; GO:0009925; GO:0015199; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0016324; GO:0030165; GO:0031526; GO:0034341; GO:0034612; GO:0042910; GO:0060731; GO:0070062; GO:0070715; GO:0150104; GO:1900749; GO:1901235; GO:1902270; GO:1902603; GO:1990961","apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]","(R)-carnitine transmembrane transporter activity [GO:1901235]; amino-acid betaine transmembrane transporter activity [GO:0015199]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; xenobiotic transmembrane transporter activity [GO:0042910]"
"1689","Pocillopora_acuta_HIv2___RNAseq.g3051.t1",4957.84105687557,1.43243692903633,0.669844926744163,0.0072287044702248,0.0318283048576352,"P02640",0,"Villin-1","actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]","GO:0001726; GO:0005509; GO:0005546; GO:0005737; GO:0005902; GO:0007173; GO:0008154; GO:0008360; GO:0009617; GO:0010634; GO:0015629; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0032233; GO:0032432; GO:0032433; GO:0035727; GO:0035729; GO:0042803; GO:0043027; GO:0051014; GO:0051015; GO:0051016; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0071364; GO:2000392","actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]","actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]"
"1690","Pocillopora_acuta_HIv2___RNAseq.g3839.t1",1229.59562668963,-1.59769523319475,0.875235049099428,0.00728770793252131,0.0320685754596861,NA,NA,NA,NA,NA,NA,NA
"1691","Pocillopora_acuta_HIv2___RNAseq.g8406.t1",1412.21776731526,1.31919407132252,1.62398317745466,0.0073415500140915,0.0322858557019822,"Q9JHS4",0,"ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial","ATP metabolic process [GO:0046034]; proteolysis involved in protein catabolic process [GO:0051603]","GO:0004176; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0008270; GO:0009368; GO:0009841; GO:0016504; GO:0016887; GO:0042645; GO:0046034; GO:0046983; GO:0051082; GO:0051603; GO:0140662","cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; ATP-dependent protein folding chaperone [GO:0140662]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]"
"1692","Pocillopora_acuta_HIv2___RNAseq.g18779.t1",1389.65760866196,1.37647209664312,0.622788010210458,0.00737254931408335,0.0324024774472506,"Q32P51",2.27e-39,"Heterogeneous nuclear ribonucleoprotein A1-like 2 (hnRNP A1-like 2) (hnRNP core protein A1-like 2)","mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]","GO:0000398; GO:0003730; GO:0005737; GO:0051028; GO:0071013","catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]","mRNA 3'-UTR binding [GO:0003730]"
"1693","Pocillopora_acuta_HIv2___TS.g13497.t1c",2223.1297318709,1.75957542770706,1.18193249149013,0.00741967227422763,0.0325663699800902,"Q94738",0,"97 kDa heat shock protein (Heat shock protein 110)","","GO:0005524; GO:0005634; GO:0005829; GO:0140662","cytosol [GO:0005829]; nucleus [GO:0005634]","ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662]"
"1694","Pocillopora_acuta_HIv2___RNAseq.g14084.t2",1622.62014090379,-1.60433342136464,0.852042834202139,0.00742414992062391,0.0325698830609354,NA,NA,NA,NA,NA,NA,NA
"1695","Pocillopora_acuta_HIv2___RNAseq.g24196.t1",123.563319715981,-1.71848357662357,1.19367634027196,0.00744260333113958,0.0326310441290097,"P70115",2.37e-13,"Adrenocorticotropic hormone receptor (ACTH receptor) (ACTH-R) (Adrenocorticotropin receptor) (Melanocortin receptor 2) (MC2-R)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; regulation of metabolic process [GO:0019222]","GO:0004978; GO:0005737; GO:0005886; GO:0007189; GO:0019222","cytoplasm [GO:0005737]; plasma membrane [GO:0005886]","corticotropin receptor activity [GO:0004978]"
"1696","Pocillopora_acuta_HIv2___RNAseq.g3266.t1",498.749949263909,1.45029891867153,1.84368286371836,0.00752814904754473,0.0329071482893095,"Q4R6V2",0,"T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)","","GO:0005524; GO:0005813; GO:0005832; GO:0016887; GO:0031681; GO:0051082; GO:0140662","centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; G-protein beta-subunit binding [GO:0031681]; unfolded protein binding [GO:0051082]"
"1697","Pocillopora_acuta_HIv2___RNAseq.g10899.t1",537.611459652144,1.46553345212834,1.70928361777925,0.00756790360935747,0.0330601503490627,"O35972",2.96e-31,"Large ribosomal subunit protein uL23m (39S ribosomal protein L23, mitochondrial) (L23mt) (MRP-L23) (L23 mitochondrial-related protein)","mitochondrial translation [GO:0032543]; translation [GO:0006412]","GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0032543","mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]","structural constituent of ribosome [GO:0003735]"
"1698","Pocillopora_acuta_HIv2___RNAseq.g22366.t1",2478.84737977224,1.73780668286029,1.49347484355051,0.00764126352333357,0.0333504030179531,"O43602",8.56e-46,"Neuronal migration protein doublecortin (Doublin) (Lissencephalin-X) (Lis-X)","axoneme assembly [GO:0035082]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; retina development in camera-type eye [GO:0060041]","GO:0001764; GO:0005829; GO:0005856; GO:0005874; GO:0005875; GO:0007399; GO:0007417; GO:0008017; GO:0019901; GO:0035082; GO:0035556; GO:0043005; GO:0060041","cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]","microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]"
"1699","Pocillopora_acuta_HIv2___TS.g26021.t1",2935.17911250005,1.98299434235072,1.91413859364864,0.00769036192893737,0.0335444496200694,"Q795M8",9.5e-11,"Putative potassium channel protein YugO","","GO:0005267; GO:0005886","plasma membrane [GO:0005886]","potassium channel activity [GO:0005267]"
"1700","Pocillopora_acuta_HIv2___TS.g6579.t1",663.596942693354,1.39881207147757,0.645650363628191,0.00772168522414843,0.0336607760946603,"Q969N2",0,"GPI transamidase component PIG-T (Phosphatidylinositol-glycan biosynthesis class T protein)","attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]","GO:0005789; GO:0016020; GO:0016255; GO:0030182; GO:0031410; GO:0042765; GO:0051402","cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]",""
"1701","Pocillopora_acuta_HIv2___RNAseq.g26319.t1",4443.85252487756,-1.37097165653352,0.627113902915667,0.00773786769648445,0.0337211564814556,"Q9UJA9",4.2e-89,"Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-)","cell communication [GO:0007154]","GO:0000210; GO:0005576; GO:0005886; GO:0007154; GO:0008270","extracellular region [GO:0005576]; plasma membrane [GO:0005886]","NAD+ diphosphatase activity [GO:0000210]; zinc ion binding [GO:0008270]"
"1702","Pocillopora_acuta_HIv2___RNAseq.g13683.t1",3735.23922183156,-1.38710745299288,0.650997725136639,0.0077584738458816,0.0338007728032625,"Q9BXW4",4.18e-61,"Microtubule-associated proteins 1A/1B light chain 3C (Autophagy-related protein LC3 C) (Autophagy-related ubiquitin-like modifier LC3 C) (MAP1 light chain 3-like protein 3) (MAP1A/MAP1B light chain 3 C) (MAP1A/MAP1B LC3 C) (Microtubule-associated protein 1 light chain 3 gamma)","aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; protein exit from endoplasmic reticulum [GO:0032527]","GO:0000045; GO:0000421; GO:0000422; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008429; GO:0009267; GO:0012505; GO:0016236; GO:0031090; GO:0031410; GO:0031625; GO:0032527; GO:0035973; GO:0036464; GO:0097352","autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]","phosphatidylethanolamine binding [GO:0008429]; ubiquitin protein ligase binding [GO:0031625]"
"1703","Pocillopora_acuta_HIv2___RNAseq.g10408.t1",1143.39865747466,1.62498684646105,1.01581543572702,0.00786362566282248,0.0342073628833276,"P23511",7.2e-32,"Nuclear transcription factor Y subunit alpha (CAAT box DNA-binding protein subunit A) (Nuclear transcription factor Y subunit A) (NF-YA)","positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; transcription by RNA polymerase II [GO:0006366]","GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0006366; GO:0016602; GO:0032993; GO:0045893; GO:0045944; GO:0048511; GO:0090575","CCAAT-binding factor complex [GO:0016602]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]","DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"1704","Pocillopora_acuta_HIv2___RNAseq.g16055.t1",521.287148657092,1.05704636131779,1.52312093137646,0.00789909269352746,0.0343409908984614,NA,NA,NA,NA,NA,NA,NA
"1705","Pocillopora_acuta_HIv2___RNAseq.g8093.t1",2555.99530538479,1.43819463664563,0.688131772968896,0.00790519233836239,0.0343571820859596,"Q06A37",0,"Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7)","adult heart development [GO:0007512]; adult walking behavior [GO:0007628]; aorta morphogenesis [GO:0035909]; atrioventricular canal development [GO:0036302]; blood circulation [GO:0008015]; blood vessel remodeling [GO:0001974]; cardiac septum morphogenesis [GO:0060411]; central nervous system development [GO:0007417]; chordate embryonic development [GO:0043009]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; cranial nerve development [GO:0021545]; embryonic hindlimb morphogenesis [GO:0035116]; epithelium development [GO:0060429]; face development [GO:0060324]; female genitalia development [GO:0030540]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; innervation [GO:0060384]; nose development [GO:0043584]; olfactory behavior [GO:0042048]; olfactory bulb development [GO:0021772]; olfactory nerve development [GO:0021553]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of growth hormone secretion [GO:0060123]; regulation of neurogenesis [GO:0050767]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to bacterium [GO:0009617]; retina development in camera-type eye [GO:0060041]; right ventricular compact myocardium morphogenesis [GO:0003226]; rRNA processing [GO:0006364]; secondary palate development [GO:0062009]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366]; ventricular trabecula myocardium morphogenesis [GO:0003222]","GO:0000785; GO:0000978; GO:0001501; GO:0001974; GO:0003007; GO:0003222; GO:0003226; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0006364; GO:0006366; GO:0007417; GO:0007512; GO:0007605; GO:0007628; GO:0008015; GO:0009617; GO:0010468; GO:0010880; GO:0016887; GO:0021545; GO:0021553; GO:0021772; GO:0030217; GO:0030540; GO:0035116; GO:0035909; GO:0036302; GO:0040018; GO:0042048; GO:0042393; GO:0042472; GO:0043009; GO:0043584; GO:0045944; GO:0048752; GO:0050767; GO:0050890; GO:0060041; GO:0060123; GO:0060324; GO:0060384; GO:0060411; GO:0060429; GO:0062009; GO:0140658; GO:1990841","chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"1706","Pocillopora_acuta_HIv2___RNAseq.g17534.t1",547.211464427983,1.65580508946291,1.64489198240478,0.00791116223431284,0.0343727998068792,"Q8JFV8",7.59e-39,"Synaptic vesicle membrane protein VAT-1 homolog (EC 1.-.-.-)","negative regulation of mitochondrial fusion [GO:0010637]","GO:0005741; GO:0008270; GO:0010637; GO:0016491","mitochondrial outer membrane [GO:0005741]","oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]"
"1707","Pocillopora_acuta_HIv2___RNAseq.g2716.t1",3466.38289277091,-1.71030162244079,1.06578693915606,0.00808699260159469,0.0350105540225877,"O88818",0,"Plastin-3 (T-plastin)","actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]","GO:0005509; GO:0005737; GO:0005884; GO:0032432; GO:0051015; GO:0051017; GO:0051639","actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]","actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]"
"1708","Pocillopora_acuta_HIv2___RNAseq.g16101.t1",346.323567582662,1.15751122505103,1.56046614234843,0.0080926272749849,0.0350244646634894,"Q8CG45",1.38e-112,"Aflatoxin B1 aldehyde reductase member 2 (rAFAR2) (EC 1.1.1.n11) (Succinic semialdehyde reductase) (SSA reductase)","daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; lipid metabolic process [GO:0006629]","GO:0004032; GO:0004033; GO:0005635; GO:0005737; GO:0005739; GO:0005795; GO:0006629; GO:0019119; GO:0044597; GO:0044598","cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]","aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; phenanthrene-9,10-epoxide hydrolase activity [GO:0019119]"
"1709","Pocillopora_acuta_HIv2___RNAseq.g7454.t2",22.4460646048048,1.22876468590202,1.78230996254888,0.00811449185835152,0.035098853387684,"P0CI65",3.24e-37,"Nephrocystin-3","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546","ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]",""
"1710","Pocillopora_acuta_HIv2___RNAseq.g4679.t1",670.394943168705,-1.45461137394069,0.710473349141266,0.00811466853763933,0.035098853387684,"P57729",1.11e-23,"Ras-related protein Rab-38 (Melanoma antigen NY-MEL-1)","endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome acidification [GO:0090383]; platelet dense granule organization [GO:0060155]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of protein localization to cell periphery [GO:1904377]; protein localization to membrane [GO:0072657]; protein transport [GO:0015031]; small GTPase-mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]","GO:0003924; GO:0005525; GO:0005739; GO:0005764; GO:0005769; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0007005; GO:0007264; GO:0012505; GO:0015031; GO:0016020; GO:0016192; GO:0030670; GO:0030742; GO:0032438; GO:0033162; GO:0035646; GO:0035650; GO:0035651; GO:0036461; GO:0042470; GO:0044233; GO:0044297; GO:0045335; GO:0048023; GO:0048471; GO:0060155; GO:0072657; GO:0090383; GO:1903232; GO:1904377; GO:2001247","cell body [GO:0044297]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]","AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]"
"1711","Pocillopora_acuta_HIv2___RNAseq.g26590.t1",238.771899532041,-1.66723356690883,1.11918467633043,0.00825718879348167,0.0355892540743288,"Q3YBN2",8.89e-07,"Tear acid lipase-like protein (TALLP)","sterol metabolic process [GO:0016125]","GO:0004771; GO:0005615; GO:0008289; GO:0016125; GO:0043231","extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]","lipid binding [GO:0008289]; sterol esterase activity [GO:0004771]"
"1712","Pocillopora_acuta_HIv2___TS.g22622.t1",5425.1406131193,1.34076133567341,0.612989377230244,0.00827706316237933,0.0356520076178245,"P14105",6.83e-36,"Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA)","actin cytoskeleton organization [GO:0030036]; actin filament-based movement [GO:0030048]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myosin filament assembly [GO:0031034]; platelet formation [GO:0030220]; protein transport [GO:0015031]; regulation of cell shape [GO:0008360]","GO:0000146; GO:0001525; GO:0001725; GO:0001726; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005826; GO:0005829; GO:0005886; GO:0005938; GO:0006509; GO:0008360; GO:0015031; GO:0015629; GO:0016460; GO:0030036; GO:0030048; GO:0030220; GO:0030224; GO:0031034; GO:0031252; GO:0032154; GO:0032506; GO:0032982; GO:0032991; GO:0042803; GO:0043495; GO:0043534; GO:0051015; GO:0060471; GO:0060473","actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cleavage furrow [GO:0032154]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; stress fiber [GO:0001725]","actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]"
"1713","Pocillopora_acuta_HIv2___RNAseq.g21021.t1",4513.05543217475,1.59562884766664,0.920640201151512,0.00831767540917072,0.0358130915330624,"Q66KI8",2.81e-79,"Protein APCDD1 (Adenomatosis polyposis coli down-regulated 1 protein homolog) (Protein primglo) (xPgo)","negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]","GO:0005886; GO:0016055; GO:0017147; GO:0030178","plasma membrane [GO:0005886]","Wnt-protein binding [GO:0017147]"
"1714","Pocillopora_acuta_HIv2___RNAseq.g26052.t1",970.461569766474,-1.74754909157154,1.12760346239079,0.00831941285613175,0.0358130915330624,NA,NA,NA,NA,NA,NA,NA
"1715","Pocillopora_acuta_HIv2___RNAseq.g7660.t2",598.410608282049,1.76127827318927,1.19980562996364,0.00832286431536393,0.0358172893357405,"Q91WC9",6.84e-117,"Diacylglycerol lipase-beta (DAGL-beta) (DAGLbeta) (DGL-beta) (EC 3.1.1.116) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta)","arachidonic acid metabolic process [GO:0019369]; cannabinoid biosynthetic process [GO:1901696]; diacylglycerol catabolic process [GO:0046340]; icosanoid metabolic process [GO:0006690]; monoacylglycerol biosynthetic process [GO:0006640]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]","GO:0001516; GO:0004806; GO:0005654; GO:0005886; GO:0006640; GO:0006690; GO:0007405; GO:0010898; GO:0016298; GO:0019369; GO:0022008; GO:0046340; GO:0046872; GO:0047372; GO:0050727; GO:1901696","nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]","acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]"
"1716","Pocillopora_acuta_HIv2___RNAseq.g14581.t1",79.5838713103448,1.16738242727851,1.61375555284691,0.00835122605332057,0.0359286536690151,NA,NA,NA,NA,NA,NA,NA
"1717","Pocillopora_acuta_HIv2___RNAseq.g15837.t1",4778.99036055545,-1.65545865547543,1.01771942404118,0.00838594595907246,0.0360137536674656,"Q9U5M4",4.16e-14,"Tropomyosin-2","actin filament organization [GO:0007015]; muscle contraction [GO:0006936]","GO:0005884; GO:0006936; GO:0007015; GO:0051015","actin filament [GO:0005884]","actin filament binding [GO:0051015]"
"1718","Pocillopora_acuta_HIv2___TS.g17199.t1",3983.64133206497,-1.57293614655294,0.885206819558638,0.00845333423593415,0.0362251801190869,"P19137",9.77e-10,"Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha)","animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; morphogenesis of an epithelial sheet [GO:0002011]; neuron projection development [GO:0031175]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retina development in camera-type eye [GO:0060041]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888]","GO:0002011; GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005608; GO:0005615; GO:0005911; GO:0006468; GO:0007155; GO:0007166; GO:0007411; GO:0009887; GO:0009888; GO:0016020; GO:0030334; GO:0031012; GO:0031175; GO:0043010; GO:0043208; GO:0043256; GO:0045198; GO:0045785; GO:0045995; GO:0048514; GO:0051149; GO:0060041; GO:0060441; GO:0060445; GO:0061304; GO:0062023; GO:0098637; GO:0110011; GO:2001046","basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]; protein complex involved in cell-matrix adhesion [GO:0098637]","extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; signaling receptor binding [GO:0005102]"
"1719","Pocillopora_acuta_HIv2___RNAseq.g19470.t1",4616.90231220607,-1.40657845709389,0.680700435801571,0.00845521350124705,0.0362251801190869,"A0A481NSZ4",3.75e-90,"Bactericidal permeability-increasing protein (BPI) (Lipopolysaccharide-binding protein) (LBP)","defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]","GO:0005615; GO:0008289; GO:0042742; GO:0045087","extracellular space [GO:0005615]","lipid binding [GO:0008289]"
"1720","Pocillopora_acuta_HIv2___RNAseq.g16928.t3",5447.65606021035,-1.78313395240513,1.26437003390366,0.00852516085568643,0.0364724109632569,"O70521",4.34e-40,"Regulator of G-protein signaling 19 (RGS19) (G-alpha-interacting protein) (GAIP)","negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to ethanol [GO:0045471]","GO:0000139; GO:0001965; GO:0005096; GO:0005903; GO:0008277; GO:0009968; GO:0030136; GO:0045471","brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; Golgi membrane [GO:0000139]","G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]"
"1721","Pocillopora_acuta_HIv2___RNAseq.g22909.t1",33.6916398391469,-2.20619907590568,1.30186672332512,0.00852552692662968,0.0364724109632569,NA,NA,NA,NA,NA,NA,NA
"1722","Pocillopora_acuta_HIv2___RNAseq.g3094.t1",661.57875312293,-1.69076168803013,1.2958602215622,0.00865867666545615,0.0369654956579568,"P49288",2.49e-29,"Melatonin receptor type 1C (Mel-1C-R) (Mel1c receptor) (CKB)","G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of glucose import [GO:0046325]; negative regulation of glycolytic process [GO:0045820]","GO:0004930; GO:0005654; GO:0005886; GO:0007186; GO:0008502; GO:0045820; GO:0046325; GO:1904408","nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]","G protein-coupled receptor activity [GO:0004930]; melatonin binding [GO:1904408]; melatonin receptor activity [GO:0008502]"
"1723","Pocillopora_acuta_HIv2___RNAseq.g3482.t1",140.225661148268,1.61614833906458,0.927210829743082,0.00867626911219697,0.0370078314476016,"Q8JIR0",1.62e-57,"Polycomb complex protein BMI-1-A (Polycomb group RING finger protein 4-A)","cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; hematopoietic stem cell migration [GO:0035701]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; primitive hemopoiesis [GO:0060215]","GO:0000122; GO:0006338; GO:0021549; GO:0031519; GO:0035102; GO:0035701; GO:0045814; GO:0046872; GO:0060215; GO:1990841","PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]","metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]"
"1724","Pocillopora_acuta_HIv2___RNAseq.g8644.t1",1640.57207405207,1.62230692191332,0.95749157996573,0.00869501636594392,0.0370768622396854,"Q95NR9",4.08e-102,"Calmodulin (CaM)","","GO:0005509; GO:0030234","","calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]"
"1725","Pocillopora_acuta_HIv2___TS.g11523.t1b",1097.73965747704,1.32562536244507,1.80650376410755,0.00870762782784427,0.037108759252192,"A0A1B0GVH7",1.51e-21,"IQ domain-containing protein M","","","",""
"1726","Pocillopora_acuta_HIv2___RNAseq.g15953.t1",211.507091715162,-1.63238534752233,0.999227037420963,0.0087463738831826,0.037252834829523,"Q923Y9",2.14e-06,"Trace amine-associated receptor 1 (TaR-1) (Trace amine receptor 1)","G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cAMP-mediated signaling [GO:0043950]","GO:0001594; GO:0004930; GO:0005886; GO:0007186; GO:0008227; GO:0043950","plasma membrane [GO:0005886]","G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594]"
"1727","Pocillopora_acuta_HIv2___RNAseq.g29446.t1",1041.78086355631,-1.63266581419835,1.25145905174865,0.00874658649620161,0.037252834829523,"Q13613",1.47e-67,"Phosphatidylinositol-3-phosphate phosphatase MTMR1 (EC 3.1.3.-) (Myotubularin-related protein 1) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95)","phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]","GO:0004438; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0016020; GO:0042803; GO:0046856; GO:0052629; GO:0060304","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]","phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein homodimerization activity [GO:0042803]"
"1728","Pocillopora_acuta_HIv2___RNAseq.g22356.t1",667.680950335881,1.02050372734195,1.49799935557832,0.00879508356066577,0.037426327926293,"Q8BXX9",2.11e-32,"Coiled-coil domain-containing protein 169","","","",""
"1729","Pocillopora_acuta_HIv2___TS.g10282.t1",19189.455270053,-1.37380290297195,0.643684356025922,0.00889478391324838,0.0377838926640894,"Q9I954",3.83e-08,"Thymosin beta-b","actin filament organization [GO:0007015]; regulation of cell migration [GO:0030334]; sequestering of actin monomers [GO:0042989]","GO:0003785; GO:0005737; GO:0005856; GO:0007015; GO:0030334; GO:0042989","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]","actin monomer binding [GO:0003785]"
"1730","Pocillopora_acuta_HIv2___RNAseq.g5348.t1a",913.41216561374,-1.59719240034108,1.49531020402607,0.00890413932348889,0.0378125282369182,"Q5XJN2",3.63e-60,"Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30)","cell redox homeostasis [GO:0045454]; hematopoietic stem cell proliferation [GO:0071425]; immune system process [GO:0002376]","GO:0002376; GO:0005576; GO:0005764; GO:0016667; GO:0016671; GO:0045454; GO:0047134; GO:0071425","extracellular region [GO:0005576]; lysosome [GO:0005764]","oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein-disulfide reductase (NAD(P)H) activity [GO:0047134]"
"1731","Pocillopora_acuta_HIv2___TS.g7298.t1",19.503064510069,-1.82060156537194,1.53191484258546,0.00896637717153016,0.0380210141920294,NA,NA,NA,NA,NA,NA,NA
"1732","Pocillopora_acuta_HIv2___RNAseq.g20144.t1",1237.88897709302,-1.64939648362578,1.80806403978808,0.00898125011525126,0.0380617643325503,"Q6HA10",1.11e-57,"Growth/differentiation factor 6 (GDF-6) (Bone morphogenetic protein 13) (BMP-13) (Growth/differentiation factor 16)","activin receptor signaling pathway [GO:0032924]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell migration involved in metanephros development [GO:0035788]; epithelial cell migration [GO:0010631]; fat cell differentiation [GO:0045444]; metanephros development [GO:0001656]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of SMAD protein signal transduction [GO:0060391]; retinal cell apoptotic process [GO:1990009]; SMAD protein signal transduction [GO:0060395]","GO:0001656; GO:0005125; GO:0005615; GO:0006915; GO:0008083; GO:0010631; GO:0030509; GO:0032332; GO:0032924; GO:0035788; GO:0042802; GO:0045444; GO:0045666; GO:0045893; GO:0060391; GO:0060395; GO:1900745; GO:1990009","extracellular space [GO:0005615]","cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]"
"1733","Pocillopora_acuta_HIv2___RNAseq.g9027.t1",2280.97939329074,1.63156415884842,1.92968220007958,0.0089939953474286,0.0381046129775065,"P22004",2.5e-42,"Bone morphogenetic protein 6 (BMP-6) (VG-1-related protein) (VG-1-R) (VGR-1)","BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; cartilage development [GO:0051216]; cellular response to BMP stimulus [GO:0071773]; cellular response to iron ion [GO:0071281]; cellular response to mechanical stimulus [GO:0071260]; endochondral ossification [GO:0001958]; eye development [GO:0001654]; immune response [GO:0006955]; inflammatory response [GO:0006954]; intracellular iron ion homeostasis [GO:0006879]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of aldosterone secretion [GO:2000860]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein secretion [GO:0050714]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular permeability [GO:0043117]; response to activity [GO:0014823]; response to glucocorticoid [GO:0051384]; response to magnesium ion [GO:0032026]; response to retinoic acid [GO:0032526]; skeletal system development [GO:0001501]; type B pancreatic cell development [GO:0003323]","GO:0000122; GO:0001501; GO:0001649; GO:0001654; GO:0001822; GO:0001938; GO:0001958; GO:0003323; GO:0005125; GO:0005615; GO:0006879; GO:0006954; GO:0006955; GO:0008083; GO:0008284; GO:0010628; GO:0014823; GO:0030182; GO:0030501; GO:0030509; GO:0030539; GO:0031666; GO:0031982; GO:0032026; GO:0032332; GO:0032349; GO:0032526; GO:0043117; GO:0045603; GO:0045666; GO:0045669; GO:0045944; GO:0046982; GO:0050679; GO:0050714; GO:0050731; GO:0051216; GO:0051384; GO:0060348; GO:0060391; GO:0060586; GO:0070700; GO:0071260; GO:0071281; GO:0071773; GO:1903392; GO:2000048; GO:2000860","extracellular space [GO:0005615]; vesicle [GO:0031982]","BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein heterodimerization activity [GO:0046982]"
"1734","Pocillopora_acuta_HIv2___RNAseq.g26540.t1",3285.50603487383,1.66491659690637,0.996812129068077,0.00900418559231964,0.0381366150533855,"Q9U6Y6",5.86e-13,"GFP-like fluorescent chromoprotein amFP486","bioluminescence [GO:0008218]; generation of precursor metabolites and energy [GO:0006091]","GO:0006091; GO:0008218","",""
"1735","Pocillopora_acuta_HIv2___RNAseq.g23178.t1",407.628301957371,-1.63465067577388,1.18087220665161,0.00901016427658972,0.0381507658362394,"A2AJ76",1.99e-12,"Hemicentin-2","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808]","GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0032154; GO:0043025; GO:0050808; GO:0062023","axon [GO:0030424]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]","axon guidance receptor activity [GO:0008046]; calcium ion binding [GO:0005509]"
"1736","Pocillopora_acuta_HIv2___TS.g201.t2",806.722490334943,1.4753938205015,0.732450756955622,0.00901627238956604,0.0381654562021315,"Q8TE73",0,"Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)","cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158]","GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097728; GO:0097729","9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]"
"1737","Pocillopora_acuta_HIv2___TS.g7543.t1",290.825295473673,-1.60823693157577,0.998658091389621,0.00906115897011792,0.0383106119099052,"A1ZAY1",1.88e-42,"SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains)","establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251]","GO:0001736; GO:0005737; GO:0005929; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219","apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cilium [GO:0005929]; cytoplasm [GO:0005737]; subapical part of cell [GO:0120219]","cadherin binding [GO:0045296]"
"1738","Pocillopora_acuta_HIv2___TS.g1110.t1",348.885701825709,1.27286193034445,1.75584639143038,0.00912680050051309,0.0385513803224862,"Q5U5A6",5.57e-24,"Notch-regulated ankyrin repeat-containing protein","Notch signaling pathway [GO:0007219]","GO:0004857; GO:0005737; GO:0007219; GO:0019208","cytoplasm [GO:0005737]","enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]"
"1739","Pocillopora_acuta_HIv2___RNAseq.g11922.t1",219.469499058424,1.06213066921731,1.63458260383923,0.00912876642730331,0.0385513803224862,"Q5EBP3",8.97e-37,"Armadillo repeat-containing protein 5","adrenal cortex development [GO:0035801]; anatomical structure morphogenesis [GO:0009653]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; gastrulation [GO:0007369]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; regulation of steroid biosynthetic process [GO:0050810]; T cell proliferation [GO:0042098]","GO:0001701; GO:0001707; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0007369; GO:0009653; GO:0016020; GO:0030097; GO:0035801; GO:0042098; GO:0043367; GO:0050810; GO:0051607","cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]",""
"1740","Pocillopora_acuta_HIv2___RNAseq.g19906.t1",359.704646920077,1.7143456380698,1.494429194441,0.00914084006183053,0.0385911005996254,NA,NA,NA,NA,NA,NA,NA
"1741","Pocillopora_acuta_HIv2___RNAseq.g3743.t1",1180.333072061,1.72904481384888,1.72098816202705,0.00917454080924693,0.0386882094066903,"Q08E39",9.08e-18,"Protein sprouty homolog 2 (Spry-2)","animal organ development [GO:0048513]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of lens fiber cell differentiation [GO:1902747]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]","GO:0005829; GO:0005874; GO:0010719; GO:0030512; GO:0031397; GO:0032587; GO:0040037; GO:0046580; GO:0048513; GO:0070373; GO:1902747","cytosol [GO:0005829]; microtubule [GO:0005874]; ruffle membrane [GO:0032587]",""
"1742","Pocillopora_acuta_HIv2___RNAseq.g16303.t1",204.667465233608,1.81829265160971,1.47299202211182,0.00919281242858896,0.0387426686967106,"P54797",1.6e-64,"Transport and Golgi organization 2 homolog (Ser/Thr-rich protein T10 in DGCR region)","Golgi organization [GO:0007030]; protein secretion [GO:0009306]","GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0007030; GO:0009306","cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]",""
"1743","Pocillopora_acuta_HIv2___RNAseq.g25724.t1",651.359024047346,-1.57976639549053,0.966639867231085,0.00925950630166375,0.0390010189712477,NA,NA,NA,NA,NA,NA,NA
"1744","Pocillopora_acuta_HIv2___TS.g6241.t1e",2993.3977054003,1.4371858524714,0.720207519083721,0.0093598702969994,0.0394008044167053,"P94598",0,"Glutamate dehydrogenase (GDH) (EC 1.4.1.3) (NAD(P)H-utilizing glutamate dehydrogenase)","glutamate biosynthetic process [GO:0006537]","GO:0004352; GO:0004354; GO:0005829; GO:0006537","cytosol [GO:0005829]","glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase (NADP+) activity [GO:0004354]"
"1745","Pocillopora_acuta_HIv2___RNAseq.g5138.t1",10953.8344849687,-1.40747972084403,0.703975266046288,0.00941271970341211,0.0396002262333196,"Q90XW6",8.82e-46,"Iroquois-class homeodomain protein irx-4-A (Iroquois homeobox protein 4-A)","brain development [GO:0007420]; cell differentiation [GO:0030154]; dorsal/ventral pattern formation [GO:0009953]; heart development [GO:0007507]; proximal/distal pattern formation [GO:0009954]","GO:0000981; GO:0003677; GO:0005634; GO:0007420; GO:0007507; GO:0009953; GO:0009954; GO:0030154","nucleus [GO:0005634]","DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"
"1746","Pocillopora_acuta_HIv2___RNAseq.g1221.t1",1344.58561338708,-1.91315228164871,1.68423617504782,0.00944308337365029,0.0396933327278343,NA,NA,NA,NA,NA,NA,NA
"1747","Pocillopora_acuta_HIv2___RNAseq.g18123.t1",2002.50661812281,1.61001448099342,0.949878747783031,0.00946355826408844,0.0397678404217825,"Q9R0R1",1.38e-24,"Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228)","iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756]","GO:0005506; GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0009986; GO:0010756; GO:0055037; GO:0090091; GO:0098552; GO:1900025","cell surface [GO:0009986]; early endosome [GO:0005769]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; side of membrane [GO:0098552]","iron ion binding [GO:0005506]"
"1748","Pocillopora_acuta_HIv2___RNAseq.g25968.t1",976.044804729979,-1.58729379223079,1.0485314329059,0.00960190153198269,0.0403023516420771,NA,NA,NA,NA,NA,NA,NA
"1749","Pocillopora_acuta_HIv2___RNAseq.g26887.t1",51.7649026085977,-1.64075457158581,0.95615789135347,0.00965962366587394,0.0405093640774719,NA,NA,NA,NA,NA,NA,NA
"1750","Pocillopora_acuta_HIv2___TS.g2574.t2",153.207809911563,1.50334009315542,1.55222866210823,0.00968863671467522,0.0406074881023073,"Q0VAA2",2.05e-22,"Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)","","","",""
"1751","Pocillopora_acuta_HIv2___RNAseq.g18121.t1",6819.87418322837,1.88052518404405,1.97809912450881,0.00975796596695164,0.0408270812108732,"Q6K3R5",3.79e-66,"Sodium/calcium exchanger NCL2 (Na(+)/Ca(2+)-exchange protein NCL2) (OsEFCAX2) (Protein NCX-like 2) (OsNCL2)","calcium ion transmembrane transport [GO:0070588]; intracellular calcium ion homeostasis [GO:0006874]; sodium ion transport [GO:0006814]","GO:0005509; GO:0005774; GO:0005886; GO:0006814; GO:0006874; GO:0015369; GO:0070588","plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]","calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]"
"1752","Pocillopora_acuta_HIv2___RNAseq.g20930.t1",68.1766318227456,-1.6650572149087,1.17358730031662,0.00980538482579669,0.0410017595028399,NA,NA,NA,NA,NA,NA,NA
"1753","Pocillopora_acuta_HIv2___TS.g20846.t1",2193.74330397519,-1.57867697982245,1.13026682681297,0.00988905506968295,0.0412919435704082,NA,NA,NA,NA,NA,NA,NA
"1754","Pocillopora_acuta_HIv2___TS.g7062.t1",144.731161654044,-1.83374473336051,1.43215683226242,0.0100581543921266,0.041937487785448,"P97821",9.42e-34,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; T cell mediated cytotoxicity [GO:0001913]","GO:0001913; GO:0004197; GO:0004252; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0005813; GO:0006508; GO:0008234; GO:0008239; GO:0016505; GO:0019902; GO:0031404; GO:0031642; GO:0042802; GO:0051087; GO:0051603; GO:0062023; GO:1903052; GO:1903980; GO:2001235","centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]","chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein-folding chaperone binding [GO:0051087]; serine-type endopeptidase activity [GO:0004252]"
"1755","Pocillopora_acuta_HIv2___RNAseq.g28251.t1",2338.02487402005,1.50784101226045,0.861498077549412,0.0100750254230118,0.041966518455694,"P23978",1.73e-167,"Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1)","amino acid transport [GO:0006865]; associative learning [GO:0008306]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid import [GO:0051939]; inorganic anion import across plasma membrane [GO:0098658]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to organic cyclic compound [GO:0014070]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]","GO:0005283; GO:0005332; GO:0005886; GO:0006865; GO:0007612; GO:0007613; GO:0008306; GO:0009636; GO:0009744; GO:0009986; GO:0010288; GO:0014054; GO:0014070; GO:0014074; GO:0015185; GO:0015378; GO:0030424; GO:0032229; GO:0032355; GO:0035725; GO:0042220; GO:0042734; GO:0042802; GO:0043025; GO:0045211; GO:0046872; GO:0050808; GO:0051592; GO:0051939; GO:0098658; GO:0098719; GO:0098793; GO:0098810; GO:0098982; GO:1902476","axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]","amino acid:sodium symporter activity [GO:0005283]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; sodium:chloride symporter activity [GO:0015378]"
"1756","Pocillopora_acuta_HIv2___RNAseq.g18045.t1",1760.60580652435,-1.35146986923703,1.76240836509227,0.0100767228012047,0.041966518455694,"Q6GL62",5.25e-12,"DNA-binding protein inhibitor ID-4 (Inhibitor of DNA binding 4) (Inhibitor of differentiation 4)","negative regulation of transcription by RNA polymerase II [GO:0000122]","GO:0000122; GO:0005634; GO:0005737; GO:0043425; GO:0046983","cytoplasm [GO:0005737]; nucleus [GO:0005634]","bHLH transcription factor binding [GO:0043425]; protein dimerization activity [GO:0046983]"
"1757","Pocillopora_acuta_HIv2___RNAseq.g16474.t1",150.768359591201,1.60872491097103,1.86424247087498,0.0101321407158499,0.0421487728829603,"P55013",0,"Solute carrier family 12 member 2 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (NKCC1) (Na-K-CL symporter)","cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; inorganic cation import across plasma membrane [GO:0098659]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; sodium ion homeostasis [GO:0055078]","GO:0006884; GO:0008511; GO:0008519; GO:0016323; GO:0016324; GO:0046873; GO:0055064; GO:0055075; GO:0055078; GO:0071944; GO:0098659; GO:1990573","apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell periphery [GO:0071944]","ammonium channel activity [GO:0008519]; metal ion transmembrane transporter activity [GO:0046873]; sodium:potassium:chloride symporter activity [GO:0008511]"
"1758","Pocillopora_acuta_HIv2___RNAseq.g8902.t1",4224.05660317593,1.5420813047763,0.87808634900862,0.0101436188746526,0.042184388557497,NA,NA,NA,NA,NA,NA,NA
"1759","Pocillopora_acuta_HIv2___RNAseq.g30657.t1",881.370342871197,-1.34096450766588,0.651504923361476,0.0101475887538436,0.0421887679607914,"Q5ZK62",0,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)","cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]","GO:0005096; GO:0010008; GO:0032456; GO:0046872; GO:1990090","endosome membrane [GO:0010008]","GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]"
"1760","Pocillopora_acuta_HIv2___RNAseq.g2501.t1",11.9190115551043,1.40961219374808,2.06360387657554,0.0101651086893322,0.0422373260794314,"Q8N8K9",8.71e-07,"Uncharacterized protein KIAA1958","","","",""
"1761","Pocillopora_acuta_HIv2___RNAseq.g30525.t1",23.2499278764302,1.7256138354612,2.00542351233506,0.0101872674225073,0.042305092161684,"Q09575",1.09e-26,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0005737; GO:0008270; GO:0015074; GO:0019899; GO:0042575","cytoplasm [GO:0005737]; DNA polymerase complex [GO:0042575]","enzyme binding [GO:0019899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]"
"1762","Pocillopora_acuta_HIv2___RNAseq.g12417.t1",170.56934460637,1.05324756211448,1.51071425913205,0.0101999752710955,0.0423335559027619,"Q60HG7",0,"Cystathionine gamma-lyase (CGL) (CSE) (EC 4.4.1.1) (Cysteine desulfhydrase) (Cysteine-protein sulfhydrase) (Gamma-cystathionase) (Homocysteine desulfhydrase) (EC 4.4.1.2)","cysteine biosynthetic process [GO:0019344]; hydrogen sulfide biosynthetic process [GO:0070814]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein sulfhydration [GO:0044524]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272]; transsulfuration [GO:0019346]","GO:0004123; GO:0005516; GO:0005737; GO:0006629; GO:0018272; GO:0019344; GO:0019346; GO:0030170; GO:0043066; GO:0043123; GO:0044524; GO:0044540; GO:0047982; GO:0051092; GO:0070814; GO:0080146; GO:0098606","cytoplasm [GO:0005737]","calmodulin binding [GO:0005516]; cystathionine gamma-lyase activity [GO:0004123]; homocysteine desulfhydrase activity [GO:0047982]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]; selenocystathionine gamma-lyase activity [GO:0098606]"
"1763","Pocillopora_acuta_HIv2___RNAseq.g26013.t1",218.412116806322,1.10416583645005,1.53628447561577,0.010233864521148,0.0424498469841942,NA,NA,NA,NA,NA,NA,NA
"1764","Pocillopora_acuta_HIv2___TS.g11002.t4",167.397861014845,-1.65986593399304,1.37081808119142,0.010261368288108,0.0425395330808811,"P07207",6.79e-80,"Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]","GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048","adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]","calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699]"
"1765","Pocillopora_acuta_HIv2___RNAseq.g30139.t1",821.795906152358,1.51243681175821,1.34124650695864,0.0102828382888538,0.0426041171612667,"Q921G7",0,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)","electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]","GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031966; GO:0033539; GO:0046872; GO:0048039; GO:0051536; GO:0051539","membrane [GO:0016020]; mitochondrial electron transfer flavoprotein complex [GO:0017133]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]","4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinone binding [GO:0048039]"
"1766","Pocillopora_acuta_HIv2___TS.g2709.t1",2877.74011371784,1.60333986102227,0.941096710665306,0.0103745384307628,0.0429594399835537,"G8HTB6",1.65e-39,"ZP domain-containing protein","","GO:0016020","membrane [GO:0016020]",""
"1767","Pocillopora_acuta_HIv2___RNAseq.g19685.t1",27.801113165429,-1.63525644436588,1.64173859279299,0.010425170606515,0.0431320559647119,NA,NA,NA,NA,NA,NA,NA
"1768","Pocillopora_acuta_HIv2___RNAseq.g29836.t1",906.661444393449,1.56517733508678,1.11390303828769,0.0104482985764632,0.0432153819302156,"Q8QGQ6",3.28e-60,"Circadian locomoter output cycles protein kaput","circadian regulation of gene expression [GO:0032922]; DNA damage response [GO:0006974]; protein acetylation [GO:0006473]; regulation of transcription by RNA polymerase II [GO:0006357]; response to redox state [GO:0051775]","GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005829; GO:0006357; GO:0006473; GO:0006974; GO:0032922; GO:0046983; GO:0051775; GO:0070888; GO:1990513","CLOCK-BMAL transcription complex [GO:1990513]; cytosol [GO:0005829]; nucleus [GO:0005634]","DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"1769","Pocillopora_acuta_HIv2___RNAseq.g866.t1",88.6705691286377,1.71920647765279,1.60330588392084,0.0104592331538976,0.0432358812054803,NA,NA,NA,NA,NA,NA,NA
"1770","Pocillopora_acuta_HIv2___RNAseq.g20576.t1",429.999734686616,-1.26864004608561,1.58091290772314,0.0105547062660492,0.0435807226469126,"A1KZ92",9.84e-23,"Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2)","hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]","GO:0004519; GO:0004601; GO:0005615; GO:0005783; GO:0005886; GO:0006979; GO:0020037; GO:0042744; GO:0046872; GO:0140825","endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]","endonuclease activity [GO:0004519]; heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]"
"1771","Pocillopora_acuta_HIv2___TS.g8264.t1",1804.33726633526,-1.54888466032326,1.2193581021491,0.0107338655506672,0.0442194905510824,NA,NA,NA,NA,NA,NA,NA
"1772","Pocillopora_acuta_HIv2___RNAseq.g28196.t1",129.232933922407,-1.57445013810566,1.44732435057185,0.0107677018268855,0.0443336291557276,"P16112",8.16e-20,"Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2]","cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; glial cell differentiation [GO:0010001]; positive regulation of neuroblast proliferation [GO:0002052]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]","GO:0001501; GO:0002052; GO:0005201; GO:0005540; GO:0005576; GO:0005615; GO:0005796; GO:0006508; GO:0007155; GO:0007417; GO:0010001; GO:0030246; GO:0043202; GO:0045202; GO:0046872; GO:0062023; GO:0072534","collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; perineuronal net [GO:0072534]; synapse [GO:0045202]","carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; metal ion binding [GO:0046872]"
"1773","Pocillopora_acuta_HIv2___RNAseq.g14240.t1",913.107922433722,-1.03110885556966,1.44537109517707,0.0108154720794011,0.0445119125861476,"Q58CQ9",5.33e-148,"Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Vascular non-inflammatory molecule 1) (Vanin-1)","pantothenate metabolic process [GO:0015939]","GO:0005886; GO:0015939; GO:0017159; GO:0098552","plasma membrane [GO:0005886]; side of membrane [GO:0098552]","pantetheine hydrolase activity [GO:0017159]"
"1774","Pocillopora_acuta_HIv2___RNAseq.g30596.t1",3380.50433137246,-1.42071968240528,0.761120099218047,0.0108171579604749,0.0445119125861476,"Q6AZG8",1.31e-48,"Prostamide/prostaglandin F synthase (Prostamide/PG F synthase) (Prostamide/PGF synthase) (EC 1.11.1.20) (Peroxiredoxin-like 2B)","prostaglandin biosynthetic process [GO:0001516]","GO:0001516; GO:0005829; GO:0016616","cytosol [GO:0005829]","oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"
"1775","Pocillopora_acuta_HIv2___TS.g28867.t2",1865.24976729371,1.45242451565281,0.792313752272931,0.0108391960772182,0.0445645628370904,"Q8VHT6",2.29e-104,"Arsenite methyltransferase (EC 2.1.1.137) (Methylarsonite methyltransferase) (S-adenosyl-L-methionine:arsenic(III) methyltransferase)","arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; response to arsenic-containing substance [GO:0046685]; toxin metabolic process [GO:0009404]","GO:0005829; GO:0008276; GO:0008757; GO:0009404; GO:0018872; GO:0030791; GO:0032259; GO:0046685","cytosol [GO:0005829]","arsenite methyltransferase activity [GO:0030791]; protein methyltransferase activity [GO:0008276]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]"
"1776","Pocillopora_acuta_HIv2___RNAseq.g26272.t1",715.231439450758,1.18355930195895,1.55456584195049,0.0108519535204968,0.0446043352430992,"Q5TJF5",7.19e-91,"(3R)-3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12) (17-beta-hydroxysteroid dehydrogenase 8) (17-beta-HSD 8) (3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit) (KAR alpha subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (Estradiol 17-beta-dehydrogenase 8) (EC 1.1.1.62) (Testosterone 17-beta-dehydrogenase 8) (EC 1.1.1.239)","estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; protein heterotetramerization [GO:0051290]","GO:0004303; GO:0005759; GO:0006633; GO:0006703; GO:0047035; GO:0051290; GO:0070404; GO:0106386","mitochondrial matrix [GO:0005759]","(3R)-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0106386]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; NADH binding [GO:0070404]; testosterone dehydrogenase (NAD+) activity [GO:0047035]"
"1777","Pocillopora_acuta_HIv2___RNAseq.g14613.t1",5362.45358858501,1.26782527439191,0.598748107892635,0.0109059985770473,0.0447882917144838,NA,NA,NA,NA,NA,NA,NA
"1778","Pocillopora_acuta_HIv2___TS.g25068.t1",467.082718224001,-1.71108079662983,1.60040913008006,0.010917903641228,0.0448244559371905,"Q9H3S4",1.68e-78,"Thiamine pyrophosphokinase 1 (hTPK1) (Placental protein 20) (PP20) (Thiamin pyrophosphokinase 1)","regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772]","GO:0004788; GO:0005524; GO:0005829; GO:0006772; GO:0009229; GO:0010510; GO:0016301; GO:0030975; GO:0042802; GO:0141200","cytosol [GO:0005829]","ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; thiamine binding [GO:0030975]; thiamine diphosphokinase activity [GO:0004788]; UTP thiamine diphosphokinase activity [GO:0141200]"
"1779","Pocillopora_acuta_HIv2___RNAseq.g16934.t1",360.232186009988,1.21999275176835,1.51076820330191,0.0109301853912278,0.0448594879507256,"Q8IV20",1.43e-77,"Purine nucleoside phosphorylase LACC1 (EC 2.4.2.1) (Adenosine deaminase LACC1) (EC 3.5.4.4) (Fatty acid metabolism-immunity nexus) (Guanosine phosphorylase LACC1) (Laccase domain-containing protein 1) (S-methyl-5'-thioadenosine phosphorylase LACC1) (EC 2.4.2.28)","inflammatory response [GO:0006954]; innate immune response [GO:0045087]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine production involved in immune response [GO:0002720]; regulation of cellular pH [GO:0030641]; regulation of inflammatory response [GO:0050727]; regulation of purine nucleotide metabolic process [GO:1900542]","GO:0002221; GO:0002720; GO:0004000; GO:0004731; GO:0005507; GO:0005634; GO:0005777; GO:0005783; GO:0006954; GO:0017061; GO:0030641; GO:0045087; GO:0046936; GO:0047975; GO:0050727; GO:0070431; GO:1900542","endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; peroxisome [GO:0005777]","2'-deoxyadenosine deaminase activity [GO:0046936]; adenosine deaminase activity [GO:0004000]; copper ion binding [GO:0005507]; guanosine phosphorylase activity [GO:0047975]; purine-nucleoside phosphorylase activity [GO:0004731]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]"
"1780","Pocillopora_acuta_HIv2___RNAseq.g5400.t1",480.60962427782,1.28166120341368,1.65623293587183,0.0109657309475051,0.0449442710186212,NA,NA,NA,NA,NA,NA,NA
"1781","Pocillopora_acuta_HIv2___RNAseq.g3624.t1",4031.25327898199,1.52407399129133,0.876738319908281,0.0112601812161211,0.0459947080231502,"Q1LW01",3.56e-39,"Hatching enzyme 1.2 (EC 3.4.24.67) (Choriolysin H homolog 1) (High choriolytic enzyme 1 homolog) (zHCE-1)","hatching [GO:0035188]; proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0008270; GO:0035188","extracellular region [GO:0005576]","metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]"
"1782","Pocillopora_acuta_HIv2___RNAseq.g3166.t1",575.39470804944,1.59322886334444,1.67021059700292,0.0112782863386861,0.0460426569581587,"P09241",1.16e-26,"Rhodopsin","cellular response to light stimulus [GO:0071482]; phototransduction [GO:0007602]; visual perception [GO:0007601]","GO:0005886; GO:0007601; GO:0007602; GO:0008020; GO:0016020; GO:0016918; GO:0033583; GO:0071482","membrane [GO:0016020]; plasma membrane [GO:0005886]; rhabdomere membrane [GO:0033583]","G protein-coupled photoreceptor activity [GO:0008020]; retinal binding [GO:0016918]"
"1783","Pocillopora_acuta_HIv2___RNAseq.g17728.t1",107.924740577755,1.11944899359531,1.44969093992559,0.0113002624961471,0.0460803486733217,"Q7RTR2",3.38e-73,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223","centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]","ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]"
"1784","Pocillopora_acuta_HIv2___TS.g20153.t1a",2002.14050558377,1.60130252988337,0.98164154104915,0.0113897222610229,0.0464058993756154,"P14733",3.96e-89,"Lamin-B1","cellular response to L-glutamate [GO:1905232]; heterochromatin formation [GO:0031507]; nuclear envelope organization [GO:0006998]; nuclear migration [GO:0007097]; nuclear pore localization [GO:0051664]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of JNK cascade [GO:0046330]; protein localization to nuclear envelope [GO:0090435]","GO:0003690; GO:0005200; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005652; GO:0005654; GO:0006998; GO:0007097; GO:0008432; GO:0010971; GO:0016363; GO:0031507; GO:0031965; GO:0034399; GO:0043274; GO:0046330; GO:0051664; GO:0090435; GO:0160123; GO:1905232; GO:1990837","lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","double-stranded DNA binding [GO:0003690]; JUN kinase binding [GO:0008432]; phospholipase binding [GO:0043274]; sequence-specific double-stranded DNA binding [GO:1990837]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of nuclear lamina [GO:0160123]"
"1785","Pocillopora_acuta_HIv2___RNAseq.g5145.t1",726.791347380608,-1.02576974296746,1.55977800560639,0.0114417819908944,0.0465917608998584,"Q0V7M1",8.77e-150,"Serine/threonine-protein kinase H1 (EC 2.7.11.1) (Protein serine kinase H1) (PSK-H1)","determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]","GO:0004674; GO:0005524; GO:0005789; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0007368; GO:0007507; GO:0016607; GO:0106310","centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]","ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]"
"1786","Pocillopora_acuta_HIv2___RNAseq.g26503.t1",559.871419353052,1.10188895635419,1.59754813677632,0.0114767103769646,0.0467208384161035,"Q99L13",1.87e-139,"3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31)","valine catabolic process [GO:0006574]","GO:0005739; GO:0006574; GO:0008442; GO:0050661; GO:0051287","mitochondrion [GO:0005739]","3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]"
"1787","Pocillopora_acuta_HIv2___RNAseq.g2915.t1",1410.82770154705,1.48315391960433,0.846120266294162,0.0115478247631768,0.0469717338685435,"Q9NYQ6",5.7e-42,"Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2)","apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lateral sprouting involved in lung morphogenesis [GO:0060490]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001736; GO:0001764; GO:0001843; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007266; GO:0007417; GO:0016020; GO:0032956; GO:0042249; GO:0045176; GO:0048105; GO:0060071; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0098609","membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]","calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]"
"1788","Pocillopora_acuta_HIv2___RNAseq.17885_t",1565.4831661472,1.53675195070989,0.92414828525022,0.0115789958856391,0.0470764679695523,NA,NA,NA,NA,NA,NA,NA
"1789","Pocillopora_acuta_HIv2___RNAseq.g15510.t1",230.215674423879,-1.62043079950008,1.91354366315888,0.0115803424388597,0.0470764679695523,"O42097",9.12e-81,"Hepatocyte nuclear factor 3-beta (HNF-3-beta) (HNF-3B) (Forkhead box protein A2) (Me-HNF3B)","anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0019904; GO:0030154","nucleus [GO:0005634]","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"
"1790","Pocillopora_acuta_HIv2___RNAseq.g24790.t1",397.68046846859,1.31813166893863,1.60849050080919,0.0115884916395869,0.0470963593916788,"A0A1X7TVA9",6.63e-12,"Death domain-containing ATP nucleosidase (DDAN) (EC 3.5.99.-)","nucleoside metabolic process [GO:0009116]","GO:0009116; GO:0016787","","hydrolase activity [GO:0016787]"
"1791","Pocillopora_acuta_HIv2___RNAseq.g24051.t1",302.817257977235,1.45052129844426,1.59144171453271,0.0116529838255899,0.0473318612898995,"A4IF63",1.6e-06,"Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)","negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]","GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017148; GO:0030371; GO:0043161; GO:0043523; GO:0061630","cytoplasm [GO:0005737]","translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]"
"1792","Pocillopora_acuta_HIv2___RNAseq.g30473.t1",13.3243030004102,1.35727267449014,1.91249084372988,0.0116973122402887,0.0474319944613221,"Q8N8K9",7.8e-06,"Uncharacterized protein KIAA1958","","","",""
"1793","Pocillopora_acuta_HIv2___RNAseq.g26135.t1",108.182951888324,1.16651075742789,1.57818424017164,0.0117268690035719,0.0475153937564091,NA,NA,NA,NA,NA,NA,NA
"1794","Pocillopora_acuta_HIv2___RNAseq.g17945.t2",1248.0805225734,1.06436264566936,1.41099019361688,0.0117277347697995,0.0475153937564091,NA,NA,NA,NA,NA,NA,NA
"1795","Pocillopora_acuta_HIv2___RNAseq.g1075.t1",2897.25249885627,-1.45802794755075,0.841070930498697,0.0117368692111273,0.0475390860458541,"Q9H3U7",4.25e-21,"SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2)","extracellular matrix organization [GO:0030198]; positive regulation of angiogenesis [GO:0045766]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; positive regulation of vascular wound healing [GO:0035470]","GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0010595; GO:0030198; GO:0035470; GO:0045743; GO:0045766; GO:0045931; GO:0050840; GO:0071944; GO:1900748; GO:2000573; GO:2001028","basement membrane [GO:0005604]; cell periphery [GO:0071944]; extracellular space [GO:0005615]","calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]"
"1796","Pocillopora_acuta_HIv2___TS.g18294.t2",481.562996550435,1.51403737317859,0.907913902404448,0.0117435905549112,0.0475405328157954,"A8JF70",3.39e-82,"Outer dynein arm protein 1 (Docking complex component 2)","cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158]","GO:0036157; GO:0036158; GO:0060294","outer dynein arm [GO:0036157]",""
"1797","Pocillopora_acuta_HIv2___RNAseq.g25890.t1",3245.87267948305,-1.46886258013648,0.831160220151293,0.0117438000380833,0.0475405328157954,"B3EWZ5",2.83e-80,"MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1)","","GO:0005576; GO:0016020","extracellular region [GO:0005576]; membrane [GO:0016020]",""
"1798","Pocillopora_acuta_HIv2___RNAseq.g21706.t1",18.4887026819451,1.94673805949828,4.25680059445462,0.01181937397173,0.0477929620148457,NA,NA,NA,NA,NA,NA,NA
"1799","Pocillopora_acuta_HIv2___TS.g11671.t1",525.269075381019,1.35724892085553,0.686509368402903,0.011884880315152,0.0480444127664499,NA,NA,NA,NA,NA,NA,NA
"1800","Pocillopora_acuta_HIv2___RNAseq.g28353.t1",47.0974867061529,-1.6239239688304,1.23327288405668,0.0118992775994402,0.0480891732881538,NA,NA,NA,NA,NA,NA,NA
"1801","Pocillopora_acuta_HIv2___RNAseq.g9149.t1",7807.41741925036,-1.63226404525069,1.34893277891603,0.011912784956303,0.0481303132983148,NA,NA,NA,NA,NA,NA,NA
"1802","Pocillopora_acuta_HIv2___RNAseq.g9330.t1",101.073997493127,1.48210770504925,1.60978850100845,0.0119946074119534,0.0484203186174975,NA,NA,NA,NA,NA,NA,NA
"1803","Pocillopora_acuta_HIv2___TS.g30330.t1",702.806760936339,1.59130844629688,1.21850999385143,0.0120520597666621,0.0486353551140596,"P42638",1.54e-13,"Tropomyosin-2 (Tropomyosin II) (SmTMII) (TMII)","actin filament organization [GO:0007015]; muscle contraction [GO:0006936]","GO:0005884; GO:0006936; GO:0007015; GO:0051015","actin filament [GO:0005884]","actin filament binding [GO:0051015]"
"1804","Pocillopora_acuta_HIv2___TS.g15134.t1",4469.94208328515,1.40826963549137,0.76167217591459,0.0121647399647995,0.0490386841836287,"Q27433",1.32e-128,"Mechanosensory protein 2","detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612]","GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792","neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]","cholesterol binding [GO:0015485]; sodium channel activity [GO:0005272]"
"1805","Pocillopora_acuta_HIv2___RNAseq.g12166.t1",309.814925036758,1.41767029156696,1.53244748726444,0.0123271736485973,0.0495691519747877,"Q9D119",1.81e-12,"Protein phosphatase 1 regulatory subunit 27 (Dysferlin-interacting protein 1)","","GO:0004864; GO:0019902","","phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864]"
